#Chr	Start	End	Ref	Alt	Ref.Gene	Func.refGene	ExonicFunc.refGene	Gene.ensGene	avsnp150	AAChange.ensGene	AAChange.refGene	clinvar: Clinvar 	 CancerVar: CancerVar and Evidence 	Freq_ExAC_ALL	Freq_esp6500siv2_all	Freq_1000g2015aug_all	Freq_gnomAD_genome_ALL	CADD_raw	CADD_phred	SIFT_score	GERP++_RS	phastCons20way_mammalian	dbscSNV_ADA_SCORE	dbscSNV_RF_SCORE	Interpro_domain	AAChange.knownGene	MetaSVM_score	Freq_gnomAD_genome_POPs	OMIM	Phenotype_MIM	OrphaNumber	Orpha	Pathway	Therap_list	Diag_list	Prog_list	Polyphen2_HDIV_score	FATHMM_score	MetaLR_score	MutationAssessor_score	cosmic91	icgc28	Otherinfo
1	2179270	2179270	G	A	SKI	intronic	.	ENSG00000157933	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	164780	182212;	2462;	2462|Marfanoid craniosynostosis syndrome<br>SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182212 ~	.	.	.	.	.	.	.	.	1	.	hom
1	2235270	2235270	C	T	SKI	intronic	.	ENSG00000157933	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.0001	0	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	164780	182212;	2462;	2462|Marfanoid craniosynostosis syndrome<br>SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182212 ~	.	.	.	.	.	.	.	.	1	.	hom
1	2488153	2488153	A	G	TNFRSF14	exonic	nonsynonymous SNV	ENSG00000157873	rs4870	ENSG00000157873:ENST00000355716:exon1:c.A50G:p.K17R,ENSG00000157873:ENST00000409119:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000426449:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000434817:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000435221:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000451778:exon2:c.A50G:p.K17R	TNFRSF14:NM_001297605:exon1:c.A50G:p.K17R,TNFRSF14:NM_003820:exon1:c.A50G:p.K17R	clinvar: not_provided 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5443	0.5580	0.614816	MU4560918	-0.182	1.198	0.471	-1.09	0.000	.	.	.	TNFRSF14:uc001ajr.3:exon1:c.A50G:p.K17R,TNFRSF14:uc009vlf.1:exon1:c.A50G:p.K17R,TNFRSF14:uc010nzc.1:exon1:c.A50G:p.K17R	-0.931	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.5446,EAS:0.5143,FIN:0.4467,NFE:0.4609,OTH:0.4842,ASJ:0.7156	602746	.	.	.	.	.	.	.	0.61	-2.37	0.000	1.175	1	1(pancreas)	0.4735
1	3328358	3328358	T	C	PRDM16	exonic	nonsynonymous SNV	ENSG00000142611	rs870124	ENSG00000142611:ENST00000509860:exon5:c.T1024C:p.S342P,ENSG00000142611:ENST00000270722:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000378391:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000441472:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000442529:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000511072:exon9:c.T1600C:p.S534P,ENSG00000142611:ENST00000514189:exon9:c.T1600C:p.S534P,ENSG00000142611:ENST00000378398:exon10:c.T1600C:p.S534P	PRDM16:NM_022114:exon9:c.T1597C:p.S533P,PRDM16:NM_199454:exon9:c.T1597C:p.S533P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8897	0.8777	0.945088	0.9008	-0.543	0.172	0.651	5.33	0.826	.	.	.	PRDM16:uc001akc.3:exon9:c.T1597C:p.S533P,PRDM16:uc001ake.3:exon9:c.T1597C:p.S533P,PRDM16:uc001akf.3:exon9:c.T1597C:p.S533P,PRDM16:uc009vlh.3:exon9:c.T700C:p.S234P	-0.955	AFR:0.9696,AMR:0.9332,EAS:0.9994,FIN:0.9196,NFE:0.8459,OTH:0.8794,ASJ:0.86	605557	615373;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	0.0	3.38	0.000	-1.7	1	MU113190	hom
1	3329263	3329263	C	T	PRDM16	exonic	synonymous SNV	ENSG00000142611	rs115226069	ENSG00000142611:ENST00000509860:exon5:c.C1929T:p.G643G,ENSG00000142611:ENST00000270722:exon9:c.C2502T:p.G834G,ENSG00000142611:ENST00000378391:exon9:c.C2502T:p.G834G,ENSG00000142611:ENST00000441472:exon9:c.C2502T:p.G834G,ENSG00000142611:ENST00000442529:exon9:c.C2502T:p.G834G,ENSG00000142611:ENST00000511072:exon9:c.C2505T:p.G835G,ENSG00000142611:ENST00000514189:exon9:c.C2505T:p.G835G,ENSG00000142611:ENST00000378398:exon10:c.C2505T:p.G835G	PRDM16:NM_022114:exon9:c.C2502T:p.G834G,PRDM16:NM_199454:exon9:c.C2502T:p.G834G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0841	0.0392	0.0537141	0.0424	.	.	.	.	.	.	.	.	PRDM16:uc001akc.3:exon9:c.C2502T:p.G834G,PRDM16:uc001ake.3:exon9:c.C2502T:p.G834G,PRDM16:uc001akf.3:exon9:c.C2502T:p.G834G,PRDM16:uc009vlh.3:exon9:c.C1605T:p.G535G	.	AFR:0.1025,AMR:0.0084,EAS:0.0148,FIN:0.0155,NFE:0.0207,OTH:0.0214,ASJ:0.0066	605557	615373;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	1	.	hom
1	6704635	6704635	A	G	DNAJC11	exonic	synonymous SNV	ENSG00000007923	rs200458	ENSG00000007923:ENST00000377573:exon9:c.T810C:p.G270G,ENSG00000007923:ENST00000294401:exon10:c.T1080C:p.G360G,ENSG00000007923:ENST00000377577:exon10:c.T1080C:p.G360G,ENSG00000007923:ENST00000542246:exon10:c.T966C:p.G322G	DNAJC11:NM_018198:exon10:c.T1080C:p.G360G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8836	0.9000	0.833067	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	DNAJC11:uc010nzu.1:exon9:c.T810C:p.G270G,DNAJC11:uc001aof.2:exon10:c.T1080C:p.G360G,DNAJC11:uc001aog.2:exon10:c.T1080C:p.G360G	.	AFR:0.8748,AMR:0.8724,EAS:0.8841,FIN:0.5730,NFE:0.8712,OTH:0.9033,ASJ:0.9499	614827	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.9041
1	10318652	10318652	C	G	KIF1B	exonic	synonymous SNV	ENSG00000054523	rs12402052	ENSG00000054523:ENST00000377081:exon3:c.C285G:p.A95A,ENSG00000054523:ENST00000263934:exon4:c.C285G:p.A95A,ENSG00000054523:ENST00000377083:exon4:c.C285G:p.A95A,ENSG00000054523:ENST00000377086:exon4:c.C285G:p.A95A,ENSG00000054523:ENST00000377093:exon4:c.C285G:p.A95A	KIF1B:NM_001365951:exon4:c.C285G:p.A95A,KIF1B:NM_001365952:exon4:c.C285G:p.A95A,KIF1B:NM_001365953:exon4:c.C285G:p.A95A,KIF1B:NM_015074:exon4:c.C285G:p.A95A,KIF1B:NM_183416:exon4:c.C285G:p.A95A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2689	0.2273	0.230032	MU102638	.	.	.	.	.	.	.	.	KIF1B:uc001aqy.3:exon3:c.C285G:p.A95A,KIF1B:uc001aqz.3:exon3:c.C285G:p.A95A,KIF1B:uc001ara.3:exon3:c.C285G:p.A95A,KIF1B:uc001arb.3:exon3:c.C285G:p.A95A,KIF1B:uc001aqv.4:exon4:c.C285G:p.A95A,KIF1B:uc001aqw.4:exon4:c.C285G:p.A95A,KIF1B:uc001aqx.4:exon4:c.C285G:p.A95A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,AMR:0.2391,EAS:0.3198,FIN:0.2947,NFE:0.2910,OTH:0.3039,ASJ:0.0905	605995	118210;171300;256700;	635;29072;99946;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~99946|CMT2A1|<1 / 1 000 000|Autosomal dominant|Childhood|118210 ~	.	.	.	.	.	.	.	.	1	2(stomach)	0.2973
1	10328338	10328338	C	T	KIF1B	intronic	.	ENSG00000054523	rs1339458	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2847	0.2482	0.253994	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:MU579964,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,EAS:0.1529,FIN:0.3242,NFE:0.2947,OTH:0.2944,ASJ:0.2570	605995	118210;171300;256700;	635;29072;99946;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~99946|CMT2A1|<1 / 1 000 000|Autosomal dominant|Childhood|118210 ~	.	.	.	.	.	.	.	.	1	1(stomach)	0.3036
1	10339210	10339211	AT	-	KIF1B	intronic	.	ENSG00000054523	rs35347635	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2526	.	0.234625	0.2407	.	.	.	.	.	.	.	.	.	.	AFR:0.0998,AMR:0.3213,EAS:0.2922,FIN:0.3034,NFE:0.2953,OTH:0.2729,ASJ:0.29	605995	118210;171300;256700;	635;29072;99946;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~99946|CMT2A1|<1 / 1 000 000|Autosomal dominant|Childhood|118210 ~	.	.	.	.	.	.	.	.	1	.	het
1	10435324	10435324	C	A	KIF1B	exonic	synonymous SNV	ENSG00000054523	rs11121552	ENSG00000054523:ENST00000263934:exon46:c.C5163A:p.T1721T,ENSG00000054523:ENST00000377081:exon47:c.C5301A:p.T1767T,ENSG00000054523:ENST00000377086:exon48:c.C5301A:p.T1767T	KIF1B:NM_015074:exon46:c.C5163A:p.T1721T,KIF1B:NM_001365951:exon48:c.C5301A:p.T1767T,KIF1B:NM_001365952:exon48:c.C5301A:p.T1767T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2717	0.2305	0.231629	MU102673	.	.	.	.	.	.	.	.	KIF1B:uc001aqw.4:exon46:c.C5163A:p.T1721T,KIF1B:uc001ara.3:exon46:c.C5181A:p.T1727T,KIF1B:uc001arb.3:exon46:c.C5259A:p.T1753T,KIF1B:uc001aqy.3:exon47:c.C5223A:p.T1741T,KIF1B:uc001aqz.3:exon47:c.C5301A:p.T1767T,KIF1B:uc001aqx.4:exon48:c.C5301A:p.T1767T	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,AMR:0.2409,EAS:0.3206,FIN:0.2947,NFE:0.2836,OTH:0.3075,ASJ:0.0914	605995	118210;171300;256700;	635;29072;99946;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~99946|CMT2A1|<1 / 1 000 000|Autosomal dominant|Childhood|118210 ~	.	.	.	.	.	.	.	.	1	2(stomach)	0.3002
1	11181327	11181327	C	T	MTOR	exonic	synonymous SNV	ENSG00000198793	rs11121691	ENSG00000198793:ENST00000376838:exon11:c.G1524A:p.L508L,ENSG00000198793:ENST00000361445:exon49:c.G6909A:p.L2303L	MTOR:NM_004958:exon49:c.G6909A:p.L2303L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2184	0.3021	0.220647	23(meninges)	.	.	.	.	.	.	.	.	MTOR:uc001asc.3:exon11:c.G1524A:p.L508L,MTOR:uc001asd.3:exon49:c.G6909A:p.L2303L	.	AFR:.,AMR:.,EAS:0.4310,FIN:0.1337,NFE:0.3633,OTH:0.0593,ASJ:0.2797	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	7629,,7625	.	,7626	.	.	.	.	1	1(stomach)	0.2270
1	11205058	11205058	C	T	MTOR	exonic	synonymous SNV	ENSG00000198793	rs1057079	ENSG00000198793:ENST00000361445:exon33:c.G4731A:p.A1577A	MTOR:NM_004958:exon33:c.G4731A:p.A1577A	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6779	0.5459	0.547524	COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	MTOR:uc001asd.3:exon33:c.G4731A:p.A1577A	.	AFR:0.5689,AMR:0.1535,EAS:0.5530,FIN:0.8004,NFE:0.7093,OTH:0.7379,ASJ:0.7124	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	7629,,7625	.	,7626	.	.	.	.	1	2(breast)	0.6735
1	11288758	11288758	G	A	MTOR	exonic	synonymous SNV	ENSG00000198793	rs1064261	ENSG00000198793:ENST00000361445:exon19:c.C2997T:p.N999N	MTOR:NM_004958:exon19:c.C2997T:p.N999N	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.7429	0.6176	0.700479	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MTOR:uc001asd.3:exon19:c.C2997T:p.N999N	.	AFR:0.6449,AMR:0.3858,EAS:0.6126,FIN:0.9283,NFE:0.7467,OTH:0.7263,ASJ:0.8365	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	7629,,7625	.	,7626	.	.	.	.	1	1(breast)	0.7157
1	11301714	11301714	A	G	MTOR	exonic	synonymous SNV	ENSG00000198793	rs1135172	ENSG00000198793:ENST00000361445:exon10:c.T1437C:p.D479D	MTOR:NM_004958:exon10:c.T1437C:p.D479D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7170	0.5853	0.639577	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MTOR:uc001asd.3:exon10:c.T1437C:p.D479D	.	AFR:0.6129,AMR:0.2871,EAS:0.6126,FIN:0.8837,NFE:0.7487,OTH:0.7263,ASJ:0.7751	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	7629,,7625	.	,7626	.	.	.	.	1	1(breast)	0.7070
1	11854457	11854457	G	A	MTHFR	exonic	synonymous SNV	ENSG00000177000	rs4846051	ENSG00000177000:ENST00000376592:exon7:c.C1305T:p.F435F,ENSG00000177000:ENST00000376583:exon8:c.C1428T:p.F476F,ENSG00000177000:ENST00000376590:exon8:c.C1305T:p.F435F,ENSG00000177000:ENST00000376585:exon9:c.C1428T:p.F476F	MTHFR:NM_001330358:exon8:c.C1428T:p.F476F,MTHFR:NM_005957:exon8:c.C1305T:p.F435F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9697	0.8905	0.902955	0.9091	.	.	.	.	.	.	.	.	MTHFR:uc031plg.1:exon4:c.C570T:p.F190F,MTHFR:uc001atb.1:exon7:c.C1374T:p.F458F,MTHFR:uc001atc.2:exon8:c.C1305T:p.F435F	.	AFR:0.6825,AMR:0.9809,EAS:0.9988,FIN:1,NFE:0.9992,OTH:0.9867,ASJ:0.9768	607093	181500;188050;236250;601634;	268357;823;395;	268357|-|Unknown|-|-|182940 301410 601634 ~823|-|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182940 301410 601634 ~395|MTHFR deficiency<br>Methylene tetrahydrofolate reductase deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|236250 ~	.	.	.	.	.	.	.	.	1	MU81691184	hom
1	12057443	12057443	C	T	MFN2	exonic	synonymous SNV	ENSG00000116688	rs536007087	ENSG00000116688:ENST00000444836:exon5:c.C564T:p.C188C,ENSG00000116688:ENST00000235329:exon6:c.C564T:p.C188C	MFN2:NM_001127660:exon5:c.C564T:p.C188C,MFN2:NM_014874:exon6:c.C564T:p.C188C	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0003	.	0.000998403	.	.	.	.	.	.	.	.	.	MFN2:uc009vni.3:exon5:c.C564T:p.C188C,MFN2:uc001atn.4:exon6:c.C564T:p.C188C	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608507	601152;609260;617087;	99947;90120;	99947|CMT2A2|Unknown|Autosomal dominant|Childhood|609260 ~90120|CMT6<br>Charcot-Marie-Tooth disease type 6<br>Peripheral neuropathy and optic atrophy|-|Autosomal dominant|-|601152 616505 ~	.	.	.	.	.	.	.	.	1	.	hom
1	14105298	14105298	G	A	PRDM2	exonic	synonymous SNV	ENSG00000116731	rs1203678	ENSG00000116731:ENST00000413440:exon3:c.G405A:p.E135E,ENSG00000116731:ENST00000343137:exon4:c.G405A:p.E135E,ENSG00000116731:ENST00000235372:exon8:c.G1008A:p.E336E,ENSG00000116731:ENST00000311066:exon8:c.G1008A:p.E336E	PRDM2:NM_001007257:exon3:c.G405A:p.E135E,PRDM2:NM_012231:exon8:c.G1008A:p.E336E,PRDM2:NM_015866:exon8:c.G1008A:p.E336E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3560	0.3104	0.316294	0.3200	.	.	.	.	.	.	.	.	PRDM2:uc001avk.3:exon4:c.G405A:p.E135E,PRDM2:uc021ogk.1:exon4:c.G297A:p.E99E,PRDM2:uc001avh.3:exon8:c.G1008A:p.E336E,PRDM2:uc001avi.3:exon8:c.G1008A:p.E336E	.	AFR:0.2357,AMR:0.5490,EAS:0.3284,FIN:0.3496,NFE:0.3463,OTH:0.3620,ASJ:0.2881	601196	.	.	.	.	.	.	.	.	.	.	.	1	MU147772	hom
1	19027239	19027239	A	G	PAX7	exonic	synonymous SNV	ENSG00000009709	rs2743201	ENSG00000009709:ENST00000375375:exon6:c.A879G:p.P293P,ENSG00000009709:ENST00000400661:exon6:c.A873G:p.P291P,ENSG00000009709:ENST00000420770:exon6:c.A879G:p.P293P	PAX7:NM_001135254:exon6:c.A879G:p.P293P,PAX7:NM_002584:exon6:c.A879G:p.P293P,PAX7:NM_013945:exon6:c.A873G:p.P291P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3747	0.3721	0.488618	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	PAX7:uc001bay.3:exon6:c.A879G:p.P293P,PAX7:uc001baz.3:exon6:c.A873G:p.P291P,PAX7:uc010oct.2:exon6:c.A879G:p.P293P	.	AFR:MU760649,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.5991,FIN:0.4414,NFE:0.3767,OTH:0.5857,ASJ:0.3923	167410	268220;	780;99756;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~	 ~	.	.	.	.	.	.	.	1	2(liver)	0.3289
1	20982631	20982631	G	A	DDOST	exonic	synonymous SNV	ENSG00000244038	rs4704	ENSG00000244038:ENST00000415136:exon2:c.C255T:p.G85G,ENSG00000244038:ENST00000375048:exon3:c.C366T:p.G122G,ENSG00000244038:ENST00000602624:exon3:c.C315T:p.G105G	DDOST:NM_005216:exon3:c.C366T:p.G122G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5844	0.6502	0.58726	1(oesophagus)	.	.	.	.	.	.	.	.	DDOST:uc010ode.1:exon2:c.C255T:p.G85G,DDOST:uc001bdo.1:exon3:c.C366T:p.G122G	.	AFR:MU4553462,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205,EAS:0.7344,FIN:0.5573,NFE:0.59,OTH:0.3861,ASJ:0.6286	602202	614507;	300536;	300536|CDG syndrome type Ir<br>CDG-Ir<br>CDG1R<br>Carbohydrate deficient glycoprotein syndrome type Ir<br>Congenital disorder of glycosylation type 1r<br>Congenital disorder of glycosylation type Ir|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614507 ~	.	.	.	.	.	.	.	.	1	1(lung)	0.6179
1	23885832	23885832	C	T	ID3	exonic	nonsynonymous SNV	ENSG00000117318	.	ENSG00000117318:ENST00000374561:exon1:c.G86A:p.G29E	ID3:NM_002167:exon1:c.G86A:p.G29E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	2.862	21.7	0.012	4.67	0.315	.	.	Myc-type, basic helix-loop-helix (bHLH) domain	ID3:uc001bhh.4:exon1:c.G86A:p.G29E	-0.972	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600277	.	.	.	.	.	.	.	0.146	-0.66	0.150	0.895	1	.	hom
1	40363054	40363054	G	C	MYCL	exonic	nonsynonymous SNV	ENSG00000116990	rs3134614	ENSG00000116990:ENST00000372816:exon2:c.C1085G:p.T362S,ENSG00000116990:ENST00000397332:exon3:c.C1175G:p.T392S	MYCL:NM_001033081:exon2:c.C1085G:p.T362S,MYCL:NM_001033082:exon3:c.C1175G:p.T392S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8865	0.9037	0.935703	0.9116	0.145	4.091	1.0	4.53	0.999	.	.	.	MYCL1:uc001ces.2:exon2:c.C1085G:p.T362S,MYCL1:uc001cer.2:exon3:c.C1175G:p.T392S	-0.955	AFR:0.9750,AMR:0.8568,EAS:0.9975,FIN:0.8808,NFE:0.8796,OTH:0.8707,ASJ:0.8477	164850	.	.	.	.	.	.	.	0.0	-0.9	0.000	-0.77	1	MU3888723	hom
1	40980559	40980559	G	A	EXO5	exonic	nonsynonymous SNV	ENSG00000164002	rs1134586	ENSG00000164002:ENST00000372703:exon2:c.G343A:p.D115N,ENSG00000164002:ENST00000418186:exon2:c.G343A:p.D115N,ENSG00000164002:ENST00000419161:exon2:c.G343A:p.D115N,ENSG00000164002:ENST00000420209:exon2:c.G343A:p.D115N,ENSG00000164002:ENST00000296380:exon3:c.G343A:p.D115N,ENSG00000164002:ENST00000443729:exon3:c.G343A:p.D115N,ENSG00000164002:ENST00000358527:exon4:c.G343A:p.D115N,ENSG00000164002:ENST00000415550:exon4:c.G343A:p.D115N	EXO5:NM_001346948:exon2:c.G343A:p.D115N,EXO5:NM_001346954:exon2:c.G343A:p.D115N,EXO5:NM_001346956:exon2:c.G343A:p.D115N,EXO5:NM_001346946:exon3:c.G343A:p.D115N,EXO5:NM_001346951:exon3:c.G343A:p.D115N,EXO5:NM_001346952:exon3:c.G343A:p.D115N,EXO5:NM_001346955:exon3:c.G343A:p.D115N,EXO5:NM_022774:exon3:c.G343A:p.D115N,EXO5:NM_001346947:exon4:c.G343A:p.D115N,EXO5:NM_001346949:exon4:c.G343A:p.D115N,EXO5:NM_001346950:exon4:c.G343A:p.D115N,EXO5:NM_001346953:exon4:c.G343A:p.D115N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1535	0.1562	0.106629	0.1412	1.649	14.12	0.182	3.65	0.987	.	.	.	EXO5:uc021omb.1:exon1:c.G343A:p.D115N,EXO5:uc001cfr.3:exon2:c.G343A:p.D115N,EXO5:uc001cfp.3:exon3:c.G343A:p.D115N,EXO5:uc001cfq.3:exon4:c.G343A:p.D115N	-1.056	AFR:0.1011,AMR:0.1122,EAS:0.0272,FIN:0.1532,NFE:0.1740,OTH:0.1469,ASJ:0.2119	.	.	.	.	.	.	.	.	0.446	1.56	0.000	2.48	1	MU67330825	het
1	40980731	40980731	G	T	EXO5	exonic	nonsynonymous SNV	ENSG00000164002	rs11208299	ENSG00000164002:ENST00000372703:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000418186:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000419161:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000420209:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000296380:exon3:c.G515T:p.G172V,ENSG00000164002:ENST00000443729:exon3:c.G515T:p.G172V,ENSG00000164002:ENST00000358527:exon4:c.G515T:p.G172V	EXO5:NM_001346948:exon2:c.G515T:p.G172V,EXO5:NM_001346954:exon2:c.G515T:p.G172V,EXO5:NM_001346956:exon2:c.G515T:p.G172V,EXO5:NM_001346946:exon3:c.G515T:p.G172V,EXO5:NM_001346951:exon3:c.G515T:p.G172V,EXO5:NM_001346952:exon3:c.G515T:p.G172V,EXO5:NM_001346955:exon3:c.G515T:p.G172V,EXO5:NM_022774:exon3:c.G515T:p.G172V,EXO5:NM_001346947:exon4:c.G515T:p.G172V,EXO5:NM_001346949:exon4:c.G515T:p.G172V,EXO5:NM_001346950:exon4:c.G515T:p.G172V,EXO5:NM_001346953:exon4:c.G515T:p.G172V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4444	0.4619	0.542133	LAML-KR|2|205|0.0097561,COCA-CN|6|321|0.0186916	1.360	12.58	1.0	3.96	0.998	.	.	.	EXO5:uc021omb.1:exon1:c.G515T:p.G172V,EXO5:uc001cfr.3:exon2:c.G515T:p.G172V,EXO5:uc001cfp.3:exon3:c.G515T:p.G172V,EXO5:uc001cfq.3:exon4:c.G515T:p.G172V	-0.951	AFR:0.4570,AMR:0.6495,EAS:0.4967,FIN:0.4858,NFE:0.3426,OTH:0.3644,ASJ:0.5550	.	.	.	.	.	.	.	.	0.0	1.83	0.000	-3.005	1	1(large_intestine)	0.4286
1	40981230	40981230	G	A	EXO5	exonic	synonymous SNV	ENSG00000164002	rs3795344	ENSG00000164002:ENST00000372703:exon2:c.G1014A:p.E338E,ENSG00000164002:ENST00000296380:exon3:c.G1014A:p.E338E,ENSG00000164002:ENST00000358527:exon4:c.G1014A:p.E338E	EXO5:NM_001346948:exon2:c.G1014A:p.E338E,EXO5:NM_001346954:exon2:c.G1014A:p.E338E,EXO5:NM_001346956:exon2:c.G1014A:p.E338E,EXO5:NM_001346946:exon3:c.G1014A:p.E338E,EXO5:NM_001346951:exon3:c.G1014A:p.E338E,EXO5:NM_001346952:exon3:c.G1014A:p.E338E,EXO5:NM_001346955:exon3:c.G1014A:p.E338E,EXO5:NM_022774:exon3:c.G1014A:p.E338E,EXO5:NM_001346947:exon4:c.G1014A:p.E338E,EXO5:NM_001346949:exon4:c.G1014A:p.E338E,EXO5:NM_001346950:exon4:c.G1014A:p.E338E,EXO5:NM_001346953:exon4:c.G1014A:p.E338E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0379	0.0419	0.043131	LAML-KR|2|205|0.0097561	.	.	.	.	.	.	.	.	EXO5:uc021omb.1:exon1:c.G1014A:p.E338E,EXO5:uc001cfr.3:exon2:c.G1014A:p.E338E,EXO5:uc001cfp.3:exon3:c.G1014A:p.E338E,EXO5:uc001cfq.3:exon4:c.G1014A:p.E338E	.	AFR:0.0336,AMR:0.0531,EAS:0.0430,FIN:0.0292,NFE:0.0106,OTH:0.0273,ASJ:0.0538	.	.	.	.	.	.	.	.	.	.	.	.	1	2(haematopoietic_and_lymphoid_tissue)	0.0256
1	41466682	41466683	CT	-	CTPS1	intronic	.	ENSG00000171793	rs140062309	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1019	0.0670	0.0908546	0.0720	.	.	.	.	.	.	.	.	.	.	AFR:0.0152,AMR:0.1492,EAS:0.0932,FIN:0.0943,NFE:0.0916,OTH:0.0982,ASJ:0.0695	123860	615897;	420573;	420573|SCID due to CTPS1 deficiency|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|615897 ~	.	.	.	.	.	.	.	.	1	.	hom
1	41466803	41466803	G	A	CTPS1	intronic	.	ENSG00000171793	rs12718433	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4048	0.3332	0.333067	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.3440,AMR:0.1552,EAS:0.4106,FIN:0.4190,NFE:0.4217,OTH:0.4105,ASJ:0.5395	123860	615897;	420573;	420573|SCID due to CTPS1 deficiency|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|615897 ~	.	.	.	.	.	.	.	.	1	1(lung)	0.4192
1	43396506	43396506	C	A	SLC2A1	exonic	nonsynonymous SNV	ENSG00000117394	rs755330447	ENSG00000117394:ENST00000439722:exon2:c.G22T:p.A8S,ENSG00000117394:ENST00000372500:exon4:c.G307T:p.A103S,ENSG00000117394:ENST00000415851:exon4:c.G307T:p.A103S,ENSG00000117394:ENST00000426263:exon4:c.G307T:p.A103S	SLC2A1:NM_006516:exon4:c.G307T:p.A103S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	1.671e-05	.	.	.	2.723	20.9	0.249	2.54	1.000	.	.	Major facilitator superfamily domain	SLC2A1:uc001cik.2:exon4:c.G307T:p.A103S	-0.681	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	143090	.	.	.	~ko04066 HIF-1 signaling pathway~ko04911 Insulin secretion~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04922 Glucagon signaling pathway~ko04931 Insulin resistance~ko04976 Bile secretion~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma~ko05230 Central carbon metabolism in cancer ~	.	.	.	0.684	-0.74	0.327	1.62	1	.	het
1	43804340	43804340	G	A	MPL	exonic	nonsynonymous SNV	ENSG00000117400	rs12731981	ENSG00000117400:ENST00000372470:exon3:c.G340A:p.V114M,ENSG00000117400:ENST00000413998:exon3:c.G340A:p.V114M	MPL:NM_005373:exon3:c.G340A:p.V114M	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0250	0.0238	0.0189696	MU67770799	0.245	5.142	0.104	0.012	0.667	.	.	Fibronectin type III|Growth hormone/erythropoietin receptor, ligand binding|Immunoglobulin-like fold	MPL:uc001civ.3:exon3:c.G340A:p.V114M,MPL:uc001ciw.3:exon3:c.G340A:p.V114M,MPL:uc009vwr.3:exon3:c.G319A:p.V107M	-0.957	AFR:BRCA-FR|1|72|0.0138889,AMR:0.0211,EAS:0.0119,FIN:0.0265,NFE:0,OTH:0.0212,ASJ:0.0070	159530	254450;601977;604498;	3319;3318;71493;824;	3319|CAMT<br>Congenital amegakaryocytic thrombocytopenic purpura|Unknown|Autosomal recessive|Neonatal|604498 ~3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~	.	.	.	.	0.992	-0.35	0.073	1.6	1	1(soft_tissue)	0.0316
1	45291908	45291908	G	A	PTCH2	intronic	.	ENSG00000117425	rs11211040	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1965	0.1618	0.195687	6(meninges)	.	.	.	.	.	.	.	.	.	.	AFR:MU687302,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.1611,FIN:0.2184,NFE:0.1623,OTH:0.2736,ASJ:0.1836	603673	109400;155255;605462;	251858;251863;251867;616;377;	251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	1	10(soft_tissue)	0.1800
1	45292173	45292173	G	A	PTCH2	exonic	nonsynonymous SNV	ENSG00000117425	rs11573590	ENSG00000117425:ENST00000372192:exon18:c.C2963T:p.T988M,ENSG00000117425:ENST00000447098:exon18:c.C2963T:p.T988M	PTCH2:NM_001166292:exon18:c.C2963T:p.T988M,PTCH2:NM_003738:exon18:c.C2963T:p.T988M	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.0440	0.0161	0.0628994	2(soft_tissue)	1.756	14.73	0.031	0.354	0.963	.	.	.	PTCH2:uc010olg.2:exon17:c.C2057T:p.T686M,PTCH2:uc010olf.2:exon18:c.C2963T:p.T988M,PTCH2:uc021omv.1:exon18:c.C2963T:p.T988M	-0.760	AFR:1(lung),AMR:1(stomach),EAS:MU790861,FIN:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,NFE:0.0333,OTH:0.0048,ASJ:1(meninges)	603673	109400;155255;605462;	251858;251863;251867;616;377;	251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.843	-2.11	0.010	2.265	1	1(thyroid)	0.0883
1	45293752	45293752	T	C	PTCH2	exonic	synonymous SNV	ENSG00000117425	rs2295997	ENSG00000117425:ENST00000372192:exon14:c.A1821G:p.E607E,ENSG00000117425:ENST00000447098:exon14:c.A1821G:p.E607E	PTCH2:NM_001166292:exon14:c.A1821G:p.E607E,PTCH2:NM_003738:exon14:c.A1821G:p.E607E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1897	0.1795	0.21266	6(meninges)	.	.	.	.	.	.	.	.	PTCH2:uc010olg.2:exon13:c.A915G:p.E305E,PTCH2:uc010olf.2:exon14:c.A1821G:p.E607E,PTCH2:uc021omv.1:exon14:c.A1821G:p.E607E	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:1(breast),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,FIN:0.1997,NFE:0.2179,OTH:0.2225,ASJ:MU30714952	603673	109400;155255;605462;	251858;251863;251867;616;377;	251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	1	10(soft_tissue)	0.1623
1	46521517	46521517	G	A	LOC110117498-PIK3R3;PIK3R3	exonic	synonymous SNV	ENSG00000117461	rs785468	ENSG00000117461:ENST00000262741:exon7:c.C891T:p.S297S,ENSG00000117461:ENST00000540385:exon7:c.C1029T:p.S343S,ENSG00000117461:ENST00000372006:exon8:c.C891T:p.S297S,ENSG00000117461:ENST00000420542:exon8:c.C891T:p.S297S	PIK3R3:NM_001328654:exon5:c.C423T:p.S141S,PIK3R3:NM_001328653:exon6:c.C648T:p.S216S,LOC110117498-PIK3R3:NM_001303427:exon7:c.C1029T:p.S343S,PIK3R3:NM_001328648:exon7:c.C759T:p.S253S,PIK3R3:NM_001328649:exon7:c.C759T:p.S253S,PIK3R3:NM_001328650:exon7:c.C759T:p.S253S,PIK3R3:NM_001328651:exon7:c.C759T:p.S253S,PIK3R3:NM_001328652:exon7:c.C891T:p.S297S,PIK3R3:NM_003629:exon7:c.C891T:p.S297S,PIK3R3:NM_001114172:exon8:c.C891T:p.S297S,PIK3R3:NM_001303428:exon8:c.C942T:p.S314S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6810	0.6715	0.637979	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PIK3R3:uc010olv.2:exon2:c.C261T:p.S87S,PIK3R3:uc001cpb.4:exon7:c.C891T:p.S297S,PIK3R3:uc010olw.2:exon7:c.C1029T:p.S343S,PIK3R3:uc001cpc.4:exon8:c.C891T:p.S297S,PIK3R3:uc009vyc.3:exon8:c.C942T:p.S314S	.	AFR:0.6766,AMR:0.5981,EAS:0.7086,FIN:0.645,NFE:0.7415,OTH:0.7094,ASJ:0.6487	.	.	.	.	.	.	.	.	.	.	.	.	1	1(large_intestine)	0.7047
1	46521559	46521559	A	T	LOC110117498-PIK3R3;PIK3R3	exonic	nonsynonymous SNV	ENSG00000117461	rs785467	ENSG00000117461:ENST00000262741:exon7:c.T849A:p.N283K,ENSG00000117461:ENST00000540385:exon7:c.T987A:p.N329K,ENSG00000117461:ENST00000372006:exon8:c.T849A:p.N283K,ENSG00000117461:ENST00000420542:exon8:c.T849A:p.N283K	PIK3R3:NM_001328654:exon5:c.T381A:p.N127K,PIK3R3:NM_001328653:exon6:c.T606A:p.N202K,LOC110117498-PIK3R3:NM_001303427:exon7:c.T987A:p.N329K,PIK3R3:NM_001328648:exon7:c.T717A:p.N239K,PIK3R3:NM_001328649:exon7:c.T717A:p.N239K,PIK3R3:NM_001328650:exon7:c.T717A:p.N239K,PIK3R3:NM_001328651:exon7:c.T717A:p.N239K,PIK3R3:NM_001328652:exon7:c.T849A:p.N283K,PIK3R3:NM_003629:exon7:c.T849A:p.N283K,PIK3R3:NM_001114172:exon8:c.T849A:p.N283K,PIK3R3:NM_001303428:exon8:c.T900A:p.N300K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6940	0.7183	0.682109	MU81700272	0.729	9.016	1.0	3.95	0.999	.	.	PI3K p85 subunit, inter-SH2 domain	PIK3R3:uc010olv.2:exon2:c.T219A:p.N73K,PIK3R3:uc001cpb.4:exon7:c.T849A:p.N283K,PIK3R3:uc010olw.2:exon7:c.T987A:p.N329K,PIK3R3:uc001cpc.4:exon8:c.T849A:p.N283K,PIK3R3:uc009vyc.3:exon8:c.T900A:p.N300K	-0.960	AFR:COCA-CN|5|321|0.0155763,AMR:0.7188,EAS:0.6599,FIN:0.7086,NFE:0.6461,OTH:0.7414,ASJ:0.7464	.	.	.	.	.	.	.	.	0.0	1.75	0.000	-1.725	1	1(skin)	0.7095
1	47050161	47050161	-	T	MKNK1	intronic	.	ENSG00000079277	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	0.0210	.	.	.	.	.	.	.	.	.	.	AFR:0.0068,AMR:0.0527,EAS:0.0735,FIN:0.0701,NFE:0.0168,OTH:0.0314,ASJ:0.0126	606724	.	.	.	.	.	.	.	.	.	.	.	1	MU9797924	het
1	47685455	47685455	T	C	TAL1	exonic	synonymous SNV	ENSG00000162367	rs927462	ENSG00000162367:ENST00000294339:exon4:c.A933G:p.K311K,ENSG00000162367:ENST00000371883:exon4:c.A939G:p.K313K,ENSG00000162367:ENST00000371884:exon5:c.A933G:p.K311K	TAL1:NM_001290406:exon3:c.A456G:p.K152K,TAL1:NM_001287347:exon5:c.A933G:p.K311K,TAL1:NM_001290403:exon5:c.A933G:p.K311K,TAL1:NM_001290405:exon5:c.A933G:p.K311K,TAL1:NM_001290404:exon6:c.A933G:p.K311K,TAL1:NM_003189:exon6:c.A933G:p.K311K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	1.0000	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TAL1:uc009vyq.2:exon3:c.A203G:p.N68S	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	187040	613065;	513;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~	.	.	.	.	.	.	.	.	1	2(large_intestine)	1
1	47694167	47694167	A	G	TAL1	intronic	.	ENSG00000226252	rs11211481	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.310104	0.4617	.	.	.	.	.	.	.	.	.	.	AFR:0.2014,AMR:0.4019,EAS:0.0148,FIN:0.6240,NFE:0.6177,OTH:0.5614,ASJ:0.6133	187040	613065;	513;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~	.	.	.	.	.	.	.	.	1	MU32809863	hom
1	47717189	47717189	A	G	STIL	exonic	synonymous SNV	ENSG00000123473	rs2758735	ENSG00000123473:ENST00000243182:exon17:c.T3483C:p.P1161P,ENSG00000123473:ENST00000337817:exon17:c.T3483C:p.P1161P,ENSG00000123473:ENST00000371877:exon17:c.T3486C:p.P1162P,ENSG00000123473:ENST00000396221:exon17:c.T3432C:p.P1144P,ENSG00000123473:ENST00000360380:exon18:c.T3483C:p.P1161P	STIL:NM_001048166:exon17:c.T3486C:p.P1162P,STIL:NM_003035:exon17:c.T3483C:p.P1161P,STIL:NM_001282936:exon18:c.T3483C:p.P1161P,STIL:NM_001282937:exon18:c.T3432C:p.P1144P,STIL:NM_001282938:exon19:c.T3345C:p.P1115P,STIL:NM_001282939:exon19:c.T3291C:p.P1097P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4979	0.4085	0.393371	0.4384	.	.	.	.	.	.	.	.	STIL:uc001crc.1:exon17:c.T3483C:p.P1161P,STIL:uc001crd.1:exon17:c.T3486C:p.P1162P,STIL:uc010omo.1:exon17:c.T3432C:p.P1144P,STIL:uc001cre.1:exon18:c.T3483C:p.P1161P,STIL:uc010omn.1:exon18:c.T3345C:p.P1115P	.	AFR:0.1619,AMR:0.4426,EAS:0.4621,FIN:0.6309,NFE:0.5404,OTH:0.5510,ASJ:0.6358	181590	612703;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU15861869	hom
1	51826921	51826921	T	C	EPS15	exonic	nonsynonymous SNV	ENSG00000085832	rs17567	ENSG00000085832:ENST00000396122:exon13:c.A1497G:p.I499M,ENSG00000085832:ENST00000371730:exon22:c.A2064G:p.I688M,ENSG00000085832:ENST00000371733:exon24:c.A2466G:p.I822M	EPS15:NM_001159969:exon12:c.A1524G:p.I508M,EPS15:NM_001981:exon24:c.A2466G:p.I822M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.2065	0.3266	0.233427	1(pancreas)	1.996	16.19	0.223	5.85	0.992	.	.	.	EPS15:uc001csp.3:exon12:c.A1524G:p.I508M,EPS15:uc009vyz.1:exon22:c.A2064G:p.I688M,EPS15:uc001csq.1:exon24:c.A2466G:p.I822M	-0.947	AFR:1(thyroid),AMR:MU4549205,EAS:0.2837,FIN:0.5167,NFE:0.1307,OTH:0.2483,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235	600051	.	.	.	.	.	.	.	0.001	0.98	0.000	-1.1	1	10(soft_tissue)	0.0155
1	51873951	51873951	G	A	EPS15	exonic	synonymous SNV	ENSG00000085832	rs1065754	ENSG00000085832:ENST00000396122:exon4:c.C360T:p.Y120Y,ENSG00000085832:ENST00000371733:exon15:c.C1329T:p.Y443Y	EPS15:NM_001159969:exon3:c.C387T:p.Y129Y,EPS15:NM_001981:exon15:c.C1329T:p.Y443Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7347	0.7293	0.822684	0.7522	.	.	.	.	.	.	.	.	EPS15:uc001csp.3:exon3:c.C387T:p.Y129Y,EPS15:uc001csq.1:exon15:c.C1329T:p.Y443Y	.	AFR:0.8763,AMR:0.7840,EAS:0.9975,FIN:0.7030,NFE:0.6682,OTH:0.7290,ASJ:0.5728	600051	.	.	.	.	.	.	.	.	.	.	.	1	MU81700903	hom
1	55505732	55505732	A	G	PCSK9	intronic	.	ENSG00000169174	rs2495482	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9370	0.9116	0.908546	0.9128	.	.	.	.	.	.	.	.	.	.	AFR:0.8318,AMR:0.8389,EAS:0.9353,FIN:0.9691,NFE:0.9459,OTH:0.9440,ASJ:0.9437	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU81701675	hom
1	55523033	55523033	A	G	PCSK9	exonic	synonymous SNV	ENSG00000169174	rs509504	ENSG00000169174:ENST00000543384:exon5:c.A426G:p.Q142Q,ENSG00000169174:ENST00000302118:exon7:c.A1026G:p.Q342Q	PCSK9:NM_174936:exon7:c.A1026G:p.Q342Q	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0] 	0.9945	0.9797	0.981829	0.9829	.	.	.	.	.	.	.	.	PCSK9:uc001cyf.2:exon7:c.A1026G:p.Q342Q	.	AFR:0.9397,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU81701677	hom
1	55524237	55524237	G	A	PCSK9	exonic	nonsynonymous SNV	ENSG00000169174	rs562556	ENSG00000169174:ENST00000302118:exon9:c.G1420A:p.V474I	PCSK9:NM_174936:exon9:c.G1420A:p.V474I	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8544	0.8178	0.86901	COCA-CN|5|321|0.0155763	-1.303	0.004	0.412	-8.95	0.000	.	.	.	PCSK9:uc001cyf.2:exon9:c.G1420A:p.V474I	-0.970	AFR:0.8315,AMR:0.7928,EAS:0.8245,FIN:0.9988,NFE:0.8170,OTH:0.8334,ASJ:0.9069	607786	603776;	.	.	.	.	.	.	0.013	-0.52	0.000	1.555	1	1(thyroid)	0.8571
1	55529187	55529187	G	A	PCSK9	exonic	nonsynonymous SNV	ENSG00000169174	rs505151	ENSG00000169174:ENST00000302118:exon12:c.G2009A:p.G670E	PCSK9:NM_174936:exon12:c.G2009A:p.G670E	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9433	0.8894	0.898962	0.8930	-1.402	0.003	1.0	0.348	0.001	.	.	.	PCSK9:uc001cyf.2:exon12:c.G2009A:p.G670E	-0.976	AFR:0.7349,AMR:0.9761,EAS:0.9427,FIN:0.9485,NFE:0.9569,OTH:0.9532,ASJ:0.9437	607786	603776;	.	.	.	.	.	.	0.0	-0.35	0.000	-2.34	1	MU26731505	hom
1	65325833	65325833	G	-	JAK1	exonic	frameshift deletion	ENSG00000162434	rs777215086	ENSG00000162434:ENST00000342505:exon9:c.1289delC:p.P430fs	JAK1:NM_001321852:exon9:c.1289delC:p.P430fs,JAK1:NM_001321856:exon9:c.1289delC:p.P430fs,JAK1:NM_001321857:exon9:c.1289delC:p.P430fs,JAK1:NM_002227:exon9:c.1289delC:p.P430fs,JAK1:NM_001320923:exon10:c.1289delC:p.P430fs,JAK1:NM_001321854:exon10:c.1289delC:p.P430fs,JAK1:NM_001321855:exon10:c.1289delC:p.P430fs,JAK1:NM_001321853:exon11:c.1289delC:p.P430fs	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, 0, 2, 0, 1, 1] 	8.392e-06	.	.	.	.	.	.	.	.	.	.	.	JAK1:uc001dbu.1:exon9:c.1289delC:p.P430fs,JAK1:uc009wam.1:exon10:c.1289delC:p.P430fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	147795	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05212 Pancreatic cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	6192,,6191,6193	.	.	.	.	.	.	1	MU1819050	het
1	66102577	66102577	A	T	LEPR	exonic	nonsynonymous SNV	ENSG00000116678	.	ENSG00000116678:ENST00000406510:exon6:c.A578T:p.N193I,ENSG00000116678:ENST00000349533:exon20:c.A3377T:p.N1126I	LEPR:NM_002303:exon20:c.A3377T:p.N1126I	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	1.079	11.10	0.003	2.89	1.000	.	.	.	LEPR:uc001dci.3:exon20:c.A3377T:p.N1126I	-0.995	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601007	614963;	179494;	179494|-|-|Autosomal recessive|-|614963 ~	.	.	.	.	0.96	0.44	0.122	2.045	1	.	hom
1	76346920	76346920	-	AT	MSH4	intronic	.	ENSG00000057468	rs5745466	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9880	0.9555	0.956669	0.9644	.	.	.	.	.	.	.	.	.	.	AFR:0.8755,AMR:0.9952,EAS:1,FIN:1,NFE:0.9995,OTH:0.9959,ASJ:1	602105	.	.	.	.	.	.	.	.	.	.	.	1	.	hom
1	91728053	91728053	G	A	HFM1	exonic	synonymous SNV	ENSG00000162669	rs585898	ENSG00000162669:ENST00000370424:exon33:c.C3108T:p.A1036A,ENSG00000162669:ENST00000370425:exon37:c.C4071T:p.A1357A	HFM1:NM_001017975:exon37:c.C4071T:p.A1357A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9997	0.9990	0.999201	0.9987	.	.	.	.	.	.	.	.	HFM1:uc001dob.4:exon18:c.C1635T:p.A545A,HFM1:uc010osu.2:exon33:c.C3108T:p.A1036A,HFM1:uc001doa.4:exon37:c.C4071T:p.A1357A	.	AFR:0.9954,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU81704389	hom
1	91841301	91841301	T	C	HFM1	intronic	.	ENSG00000162669	rs282036	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9997	0.9991	0.999201	0.9987	.	.	.	.	.	.	.	.	.	.	AFR:0.9953,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU81704472	hom
1	91859795	91859795	T	C	HFM1	exonic	nonsynonymous SNV	ENSG00000162669	rs282009	ENSG00000162669:ENST00000427444:exon3:c.A223G:p.I75V,ENSG00000162669:ENST00000370425:exon4:c.A349G:p.I117V,ENSG00000162669:ENST00000455133:exon4:c.A349G:p.I117V	HFM1:NM_001017975:exon4:c.A349G:p.I117V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9997	0.9991	0.999201	0.9987	-2.189	0.001	1.0	1.52	0.304	.	.	.	HFM1:uc001doc.1:exon3:c.A349G:p.I117V,HFM1:uc001doa.4:exon4:c.A349G:p.I117V	-0.972	AFR:0.9954,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	0.0	0.49	0.015	-2.24	1	MU81704512	hom
1	92174260	92174260	A	G	TGFBR3	exonic	synonymous SNV	ENSG00000069702	rs284878	ENSG00000069702:ENST00000525962:exon13:c.T2247C:p.T749T,ENSG00000069702:ENST00000212355:exon14:c.T2247C:p.T749T,ENSG00000069702:ENST00000465892:exon14:c.T2244C:p.T748T,ENSG00000069702:ENST00000370399:exon15:c.T2244C:p.T748T	TGFBR3:NM_001195683:exon14:c.T2244C:p.T748T,TGFBR3:NM_003243:exon14:c.T2247C:p.T749T,TGFBR3:NM_001195684:exon15:c.T2244C:p.T748T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9337	0.9394	0.906749	0.9356	.	.	.	.	.	.	.	.	TGFBR3:uc001doh.3:exon14:c.T2247C:p.T749T,TGFBR3:uc001doi.3:exon14:c.T2244C:p.T748T,TGFBR3:uc001doj.3:exon15:c.T2244C:p.T748T,TGFBR3:uc010osy.2:exon15:c.T2121C:p.T707T,TGFBR3:uc009wde.3:exon17:c.T1332C:p.T444T	.	AFR:0.9334,AMR:0.9582,EAS:0.7531,FIN:0.9699,NFE:0.9472,OTH:0.9491,ASJ:0.9007	600742	.	.	.	.	.	.	.	.	.	.	.	1	MU81704562	hom
1	92177938	92177938	A	G	TGFBR3	exonic	synonymous SNV	ENSG00000069702	rs1805113	ENSG00000069702:ENST00000525962:exon12:c.T2028C:p.F676F,ENSG00000069702:ENST00000212355:exon13:c.T2028C:p.F676F,ENSG00000069702:ENST00000465892:exon13:c.T2025C:p.F675F,ENSG00000069702:ENST00000370399:exon14:c.T2025C:p.F675F	TGFBR3:NM_001195683:exon13:c.T2025C:p.F675F,TGFBR3:NM_003243:exon13:c.T2028C:p.F676F,TGFBR3:NM_001195684:exon14:c.T2025C:p.F675F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3660	0.4048	0.279752	1(liver)	.	.	.	.	.	.	.	.	TGFBR3:uc001doh.3:exon13:c.T2028C:p.F676F,TGFBR3:uc001doi.3:exon13:c.T2025C:p.F675F,TGFBR3:uc001doj.3:exon14:c.T2025C:p.F675F,TGFBR3:uc010osy.2:exon14:c.T1902C:p.F634F	.	AFR:MU749628,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.3425,FIN:0.2876,NFE:0.4040,OTH:0.0912,ASJ:0.3765	600742	.	.	.	.	.	.	.	.	.	.	.	1	2(lung)	0.3693
1	92262874	92262874	T	C	TGFBR3	exonic	synonymous SNV	ENSG00000069702	rs2810904	ENSG00000069702:ENST00000525962:exon2:c.A216G:p.A72A,ENSG00000069702:ENST00000533089:exon2:c.A216G:p.A72A,ENSG00000069702:ENST00000212355:exon3:c.A216G:p.A72A,ENSG00000069702:ENST00000465892:exon3:c.A216G:p.A72A,ENSG00000069702:ENST00000370399:exon4:c.A216G:p.A72A	TGFBR3:NM_001195683:exon3:c.A216G:p.A72A,TGFBR3:NM_003243:exon3:c.A216G:p.A72A,TGFBR3:NM_001195684:exon4:c.A216G:p.A72A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6631	0.6786	0.715256	0.6616	.	.	.	.	.	.	.	.	TGFBR3:uc001doh.3:exon3:c.A216G:p.A72A,TGFBR3:uc001doi.3:exon3:c.A216G:p.A72A,TGFBR3:uc001doj.3:exon4:c.A216G:p.A72A,TGFBR3:uc010osy.2:exon4:c.A90G:p.A30A	.	AFR:0.7388,AMR:0.6730,EAS:0.7667,FIN:0.5975,NFE:0.6226,OTH:0.6375,ASJ:0.5867	600742	.	.	.	.	.	.	.	.	.	.	.	1	MU143026	hom
1	98348885	98348885	G	A	DPYD	exonic	nonsynonymous SNV	ENSG00000188641	rs1801265	ENSG00000188641:ENST00000306031:exon2:c.C85T:p.R29C,ENSG00000188641:ENST00000370192:exon2:c.C85T:p.R29C	DPYD:NM_000110:exon2:c.C85T:p.R29C,DPYD:NM_001160301:exon2:c.C85T:p.R29C	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7652	0.7159	0.739816	0.7199	.	.	.	.	.	.	.	.	DPYD:uc001drv.3:exon2:c.C85T:p.R29C,DPYD:uc001drw.3:exon2:c.C85T:p.R29C	.	AFR:0.5991,AMR:0.7769,EAS:0.9284,FIN:0.7140,NFE:0.7626,OTH:0.7352,ASJ:0.8642	612779	274270;	1675;	1675|Familial pyrimidinemia|Unknown|-|All ages|274270 ~	.	.	.	.	.	.	.	.	1	MU4134499	het
1	98386424	98386424	G	T	DPYD	intronic	.	ENSG00000188641	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	612779	274270;	1675;	1675|Familial pyrimidinemia|Unknown|-|All ages|274270 ~	.	.	.	.	.	.	.	.	1	.	hom
1	104076462	104076462	C	T	RNPC3	exonic	synonymous SNV	ENSG00000185946	rs6697444	ENSG00000185946:ENST00000423855:exon3:c.C342T:p.G114G,ENSG00000185946:ENST00000524631:exon3:c.C342T:p.G114G,ENSG00000185946:ENST00000531883:exon4:c.C342T:p.G114G,ENSG00000185946:ENST00000533099:exon4:c.C342T:p.G114G	RNPC3:NM_017619:exon3:c.C342T:p.G114G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6387	0.6468	0.602037	0.6343	.	.	.	.	.	.	.	.	RNPC3:uc010oul.1:exon3:c.C342T:p.G114G,RNPC3:uc010oum.1:exon3:c.C342T:p.G114G,RNPC3:uc010oun.2:exon3:c.C342T:p.G114G	.	AFR:0.7232,AMR:0.5846,EAS:0.3890,FIN:0.5876,NFE:0.6228,OTH:0.6074,ASJ:0.6443	.	.	.	.	.	.	.	.	.	.	.	.	1	MU26035144	hom
1	109440215	109440215	G	A	GPSM2	exonic	nonsynonymous SNV	ENSG00000121957	rs41279678	ENSG00000121957:ENST00000264126:exon4:c.G380A:p.R127Q,ENSG00000121957:ENST00000435987:exon4:c.G380A:p.R127Q,ENSG00000121957:ENST00000406462:exon5:c.G380A:p.R127Q	GPSM2:NM_001321038:exon4:c.G380A:p.R127Q,GPSM2:NM_001321039:exon4:c.G380A:p.R127Q,GPSM2:NM_013296:exon4:c.G380A:p.R127Q	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0865	0.0980	0.0688898	MU85964	5.361	25.9	0.055	5.01	0.998	.	.	Tetratricopeptide repeat-containing domain|Tetratricopeptide-like helical domain	GPSM2:uc010ovc.2:exon4:c.G380A:p.R127Q,GPSM2:uc010ovd.2:exon4:c.G380A:p.R127Q,GPSM2:uc010ove.1:exon4:c.G380A:p.R127Q	0.103	AFR:LICA-CN|1|402|0.00248756,AMR:0.0971,EAS:0.0576,FIN:0.1093,NFE:0,OTH:0.1206,ASJ:0.0920	609245	604213;	314597;	314597|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|604213 ~	.	.	.	.	0.933	-3.35	0.586	1.06	1	1(large_intestine)	0.1068
1	109465166	109465168	CTT	-	GPSM2	exonic	nonframeshift deletion	ENSG00000121957	rs35029887	ENSG00000121957:ENST00000264126:exon13:c.1568_1570del:p.523_524del,ENSG00000121957:ENST00000406462:exon14:c.1568_1570del:p.523_524del	GPSM2:NM_001321038:exon13:c.1568_1570del:p.523_524del,GPSM2:NM_001321039:exon13:c.1568_1570del:p.523_524del,GPSM2:NM_013296:exon13:c.1568_1570del:p.523_524del	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2907	0.3786	.	0.3574	.	.	.	.	.	.	.	.	GPSM2:uc010ovc.2:exon13:c.1568_1570del:p.523_524del,GPSM2:uc010ovd.2:exon13:c.1568_1570del:p.523_524del,GPSM2:uc010ove.1:exon13:c.1568_1570del:p.523_524del	.	AFR:0.5663,AMR:0.2584,EAS:0.0448,FIN:0.3131,NFE:0.2903,OTH:0.2982,ASJ:0.3267	609245	604213;	314597;	314597|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|604213 ~	.	.	.	.	.	.	.	.	1	MU85980	hom
1	110883395	110883395	C	A	RBM15	exonic	synonymous SNV	ENSG00000162775	.	ENSG00000162775:ENST00000369784:exon1:c.C1368A:p.R456R,ENSG00000162775:ENST00000487146:exon1:c.C1368A:p.R456R,ENSG00000162775:ENST00000602849:exon1:c.C1368A:p.R456R	RBM15:NM_001201545:exon1:c.C1368A:p.R456R,RBM15:NM_022768:exon1:c.C1368A:p.R456R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	RBM15:uc001dzl.1:exon1:c.C1368A:p.R456R,RBM15:uc001dzm.1:exon1:c.C1368A:p.R456R,RBM15:uc021orn.1:exon1:c.C1368A:p.R456R	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606077	.	.	.	.	.	.	.	.	.	.	.	1	.	hom
1	113456546	113456546	A	T	SLC16A1	exonic	nonsynonymous SNV	ENSG00000155380	rs1049434	ENSG00000155380:ENST00000369626:exon5:c.T1470A:p.D490E,ENSG00000155380:ENST00000538576:exon5:c.T1470A:p.D490E	SLC16A1:NM_001166496:exon5:c.T1470A:p.D490E,SLC16A1:NM_003051:exon5:c.T1470A:p.D490E	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5972	0.6662	0.676717	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	-0.947	0.020	1.0	2.74	0.095	.	.	.	SLC16A1:uc001ecx.3:exon5:c.T1470A:p.D490E,SLC16A1:uc001ecy.3:exon5:c.T1470A:p.D490E	-0.939	AFR:0.6639,AMR:0.8573,EAS:0.6358,FIN:0.6710,NFE:0.5837,OTH:0.5817,ASJ:0.5431	600682	245340;610021;616095;	438075;165991;171690;	438075|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Childhood|616095 ~165991|EIHI<br>Exercise-induced hyperinsulinemic hypoglycemia<br>Hyperinsulinism due to SLC16A1 deficiency<br>Hyperinsulinism due to monocarboxylate transporter 1 deficiency|-|Autosomal dominant|-|610021 ~171690|Erythrocyte lactate transporter defect|-|-|-|245340 ~	.	.	.	.	0.0	2.08	0.005	-0.345	1	1(pancreas)	0.5825
1	113456755	113456755	A	G	SLC16A1	exonic	nonsynonymous SNV	ENSG00000155380	.	ENSG00000155380:ENST00000369626:exon5:c.T1261C:p.Y421H,ENSG00000155380:ENST00000458229:exon5:c.T1261C:p.Y421H,ENSG00000155380:ENST00000538576:exon5:c.T1261C:p.Y421H	SLC16A1:NM_001166496:exon5:c.T1261C:p.Y421H,SLC16A1:NM_003051:exon5:c.T1261C:p.Y421H	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	6.292	29.1	0.012	5.91	1.000	.	.	Major facilitator superfamily domain	SLC16A1:uc001ecx.3:exon5:c.T1261C:p.Y421H,SLC16A1:uc001ecy.3:exon5:c.T1261C:p.Y421H	0.436	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600682	245340;610021;616095;	438075;165991;171690;	438075|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Childhood|616095 ~165991|EIHI<br>Exercise-induced hyperinsulinemic hypoglycemia<br>Hyperinsulinism due to SLC16A1 deficiency<br>Hyperinsulinism due to monocarboxylate transporter 1 deficiency|-|Autosomal dominant|-|610021 ~171690|Erythrocyte lactate transporter defect|-|-|-|245340 ~	.	.	.	.	0.993	-1.47	0.647	2.73	1	.	hom
1	114948281	114948281	A	G	TRIM33	exonic	nonsynonymous SNV	ENSG00000197323	rs6537825	ENSG00000197323:ENST00000450349:exon14:c.T1415C:p.I472T,ENSG00000197323:ENST00000358465:exon15:c.T2519C:p.I840T,ENSG00000197323:ENST00000369543:exon15:c.T2519C:p.I840T	TRIM33:NM_015906:exon15:c.T2519C:p.I840T,TRIM33:NM_033020:exon15:c.T2519C:p.I840T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8921	0.9423	0.85643	MU807108	0.726	8.995	1.0	4.35	0.993	.	.	.	TRIM33:uc001eey.1:exon2:c.T104C:p.I35T,TRIM33:uc010owr.2:exon10:c.T1361C:p.I454T,TRIM33:uc010ows.2:exon14:c.T1415C:p.I472T,TRIM33:uc001eew.3:exon15:c.T2519C:p.I840T,TRIM33:uc001eex.3:exon15:c.T2519C:p.I840T	-1.066	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,AMR:0.9250,EAS:0.8266,FIN:0.87,NFE:0.5813,OTH:0.9674,ASJ:0.9707	605769	.	.	.	.	.	.	.	0.0	-0.55	0.039	-1.955	1	86(lung)	0.9320
1	114969926	114969926	A	-	TRIM33	intronic	.	ENSG00000197323	rs36115645	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1512	0.1518	0.104233	0.1480	.	.	.	.	.	.	.	.	.	.	AFR:0.0735,AMR:0.1259,EAS:0.0241,FIN:0.1649,NFE:0.1972,OTH:0.1901,ASJ:0.2649	605769	.	.	.	.	.	.	.	.	.	.	.	1	MU30870579	hom
1	120057246	120057246	C	A	HSD3B1	exonic	nonsynonymous SNV	ENSG00000203857	rs1047303	ENSG00000203857:ENST00000528909:exon3:c.C1100A:p.T367N,ENSG00000203857:ENST00000235547:exon4:c.C1106A:p.T369N,ENSG00000203857:ENST00000369413:exon4:c.C1100A:p.T367N	HSD3B1:NM_000862:exon4:c.C1100A:p.T367N,HSD3B1:NM_001328615:exon4:c.C1100A:p.T367N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7554	0.7492	0.833466	COCA-CN|5|321|0.0155763	-1.422	0.003	0.303	-0.043	0.000	.	.	.	HSD3B1:uc031pnt.1:exon3:c.C1100A:p.T367N,HSD3B1:uc001ehv.1:exon4:c.C1100A:p.T367N	-1.061	AFR:0.7697,AMR:0.8843,EAS:0.6887,FIN:0.9312,NFE:0.7460,OTH:0.6915,ASJ:0.8141	109715	.	.	.	.	.	.	.	0.01	-0.58	0.151	2.52	1	1(large_intestine)	0.7485
1	154561925	154561925	C	T	ADAR	exonic	synonymous SNV	ENSG00000160710	rs1127309	ENSG00000160710:ENST00000529168:exon8:c.G2589A:p.V863V,ENSG00000160710:ENST00000292205:exon9:c.G2811A:p.V937V,ENSG00000160710:ENST00000368471:exon9:c.G1797A:p.V599V,ENSG00000160710:ENST00000368474:exon9:c.G2682A:p.V894V	ADAR:NM_001025107:exon9:c.G1797A:p.V599V,ADAR:NM_001111:exon9:c.G2682A:p.V894V,ADAR:NM_001193495:exon9:c.G1797A:p.V599V,ADAR:NM_001365045:exon9:c.G2709A:p.V903V,ADAR:NM_001365048:exon9:c.G1797A:p.V599V,ADAR:NM_015840:exon9:c.G2604A:p.V868V,ADAR:NM_015841:exon9:c.G2547A:p.V849V,ADAR:NM_001365046:exon10:c.G1797A:p.V599V,ADAR:NM_001365047:exon10:c.G1797A:p.V599V,ADAR:NM_001365049:exon10:c.G1719A:p.V573V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2745	0.2980	0.28095	1(stomach)	.	.	.	.	.	.	.	.	ADAR:uc001ffh.3:exon9:c.G2682A:p.V894V,ADAR:uc001ffi.3:exon9:c.G2604A:p.V868V,ADAR:uc001ffj.3:exon9:c.G2547A:p.V849V,ADAR:uc001ffk.3:exon9:c.G1797A:p.V599V,ADAR:uc021pag.1:exon9:c.G1797A:p.V599V	.	AFR:MU11284454,AMR:COCA-CN|3|321|0.00934579,EAS:0.2978,FIN:0.2124,NFE:0.3113,OTH:0.2776,ASJ:0.2894	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	.	.	.	.	1	1(large_intestine)	0.3124
1	154573967	154573967	T	C	ADAR	exonic	nonsynonymous SNV	ENSG00000160710	rs2229857	ENSG00000160710:ENST00000529168:exon1:c.A1136G:p.K379R,ENSG00000160710:ENST00000292205:exon2:c.A1280G:p.K427R,ENSG00000160710:ENST00000368471:exon2:c.A266G:p.K89R,ENSG00000160710:ENST00000368474:exon2:c.A1151G:p.K384R	ADAR:NM_001025107:exon2:c.A266G:p.K89R,ADAR:NM_001111:exon2:c.A1151G:p.K384R,ADAR:NM_001193495:exon2:c.A266G:p.K89R,ADAR:NM_001365045:exon2:c.A1178G:p.K393R,ADAR:NM_001365048:exon2:c.A266G:p.K89R,ADAR:NM_015840:exon2:c.A1151G:p.K384R,ADAR:NM_015841:exon2:c.A1151G:p.K384R,ADAR:NM_001365046:exon3:c.A266G:p.K89R,ADAR:NM_001365047:exon3:c.A266G:p.K89R,ADAR:NM_001365049:exon3:c.A266G:p.K89R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6956	0.6079	0.622604	0.6279	-1.245	0.005	0.381	-0.812	0.003	.	.	.	ADAR:uc001ffh.3:exon2:c.A1151G:p.K384R,ADAR:uc001ffi.3:exon2:c.A1151G:p.K384R,ADAR:uc001ffj.3:exon2:c.A1151G:p.K384R,ADAR:uc001ffk.3:exon2:c.A266G:p.K89R,ADAR:uc001ffl.1:exon2:c.A266G:p.K89R,ADAR:uc021pag.1:exon2:c.A266G:p.K89R	-0.976	AFR:0.4283,AMR:0.7673,EAS:0.7093,FIN:0.6791,NFE:0.7098,OTH:0.6994,ASJ:0.6689	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	0.0	2.73	0.009	2.015	1	MU20489500	het
1	154574820	154574820	T	C	ADAR	exonic	nonsynonymous SNV	ENSG00000160710	rs1466731	ENSG00000160710:ENST00000529168:exon1:c.A283G:p.R95G,ENSG00000160710:ENST00000292205:exon2:c.A427G:p.R143G,ENSG00000160710:ENST00000368474:exon2:c.A298G:p.R100G	ADAR:NM_001111:exon2:c.A298G:p.R100G,ADAR:NM_001365045:exon2:c.A325G:p.R109G,ADAR:NM_015840:exon2:c.A298G:p.R100G,ADAR:NM_015841:exon2:c.A298G:p.R100G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9988	0.9957	0.996206	0.9969	-1.562	0.002	0.807	-2.82	0.000	.	.	.	ADAR:uc001ffh.3:exon2:c.A298G:p.R100G,ADAR:uc001ffi.3:exon2:c.A298G:p.R100G,ADAR:uc001ffj.3:exon2:c.A298G:p.R100G	-1.015	AFR:0.9892,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	0.0	2.45	0.009	-0.205	1	MU81711582	hom
1	154575040	154575040	C	T	ADAR	exonic	synonymous SNV	ENSG00000160710	rs1802645	ENSG00000160710:ENST00000529168:exon1:c.G63A:p.R21R,ENSG00000160710:ENST00000292205:exon2:c.G207A:p.R69R,ENSG00000160710:ENST00000368474:exon2:c.G78A:p.R26R	ADAR:NM_001111:exon2:c.G78A:p.R26R,ADAR:NM_001365045:exon2:c.G105A:p.R35R,ADAR:NM_015840:exon2:c.G78A:p.R26R,ADAR:NM_015841:exon2:c.G78A:p.R26R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9992	0.9972	0.997005	0.9978	.	.	.	.	.	.	.	.	ADAR:uc001ffh.3:exon2:c.G78A:p.R26R,ADAR:uc001ffi.3:exon2:c.G78A:p.R26R,ADAR:uc001ffj.3:exon2:c.G78A:p.R26R,ADAR:uc001ffn.2:exon2:c.G78A:p.R26R	.	AFR:0.9924,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	.	.	.	.	1	MU81711590	hom
1	155880573	155880573	C	G	RIT1	exonic	nonsynonymous SNV	ENSG00000143622	rs493446	ENSG00000143622:ENST00000368322:exon2:c.G31C:p.E11Q	RIT1:NM_001256821:exon2:c.G31C:p.E11Q	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 1] 	0.8775	0.7952	0.779952	0.8174	-0.532	0.183	0.43	-0.379	0.012	.	.	.	RIT1:uc031pqc.1:exon2:c.G31C:p.E11Q	-1.065	AFR:0.5470,AMR:0.9356,EAS:0.9382,FIN:0.9038,NFE:0.9286,OTH:0.8918,ASJ:0.8676	609591	615355;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	.	,9551,9550	.	.	.	-0.21	0.078	.	1	MU26075246	hom
1	156785617	156785617	G	A	NTRK1	UTR5	.	ENSG00000198400	rs1800601	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6674	0.6177	0.636981	0.6243	.	.	.	.	.	.	.	.	.	.	AFR:0.5074,AMR:0.6926,EAS:0.8288,FIN:0.6437,NFE:0.6591,OTH:0.6449,ASJ:0.6887	191315	155240;256800;	642;653;99361;	642|HSAN4<br>Insensitivity to pain-anhidrosis syndrome|-|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|256800 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	1	MU718802	hom
1	161645259	161645259	T	G	FCGR2B	intronic	.	ENSG00000072694	rs1674759	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.792532	0.8326	.	.	.	.	.	.	.	.	.	.	AFR:0.7640,AMR:0.8604,EAS:0.8306,FIN:0.8873,NFE:0.8578,OTH:0.8535,ASJ:0.7919	604590	152700;611162;	673;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~	.	.	.	.	.	.	.	.	1	MU113392205	hom
1	162737116	162737116	C	G	DDR2	exonic	synonymous SNV	ENSG00000162733	rs2298258	ENSG00000162733:ENST00000458105:exon1:c.C90G:p.L30L,ENSG00000162733:ENST00000367921:exon11:c.C1260G:p.L420L,ENSG00000162733:ENST00000367922:exon12:c.C1260G:p.L420L	DDR2:NM_001354982:exon11:c.C1260G:p.L420L,DDR2:NM_001354983:exon11:c.C1260G:p.L420L,DDR2:NM_006182:exon11:c.C1260G:p.L420L,DDR2:NM_001014796:exon12:c.C1260G:p.L420L	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2242	0.2573	0.348442	0.2473	.	.	.	.	.	.	.	.	DDR2:uc001gcg.3:exon11:c.C1260G:p.L420L,DDR2:uc001gcf.3:exon12:c.C1260G:p.L420L	.	AFR:0.4814,AMR:0.3890,EAS:0.3938,FIN:0.0808,NFE:0.1358,OTH:0.1386,ASJ:0.1391	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	.	,2212	.	.	.	.	.	.	1	MU647178	hom
1	162740327	162740327	T	C	DDR2	intronic	.	ENSG00000162733	rs1780003	ENSG00000162733:ENST00000458105:exon2:c.T359C:p.V120A	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9855	0.9476	0.945487	0.9541	-0.266	0.793	0.0	-10.1	0.000	.	.	.	.	-1.062	AFR:0.8402,AMR:0.9928,EAS:1,FIN:1,NFE:0.9993,OTH:0.9867,ASJ:1	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	.	.	.	.	.	1.39	0.010	.	1	MU81714571	hom
1	170501385	170501385	A	C	GORAB	exonic	synonymous SNV	ENSG00000120370	rs7531125	ENSG00000120370:ENST00000367762:exon1:c.A96C:p.G32G,ENSG00000120370:ENST00000367763:exon1:c.A96C:p.G32G	GORAB:NM_001146039:exon1:c.A96C:p.G32G,GORAB:NM_152281:exon1:c.A96C:p.G32G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9797	0.9355	0.927516	0.9418	.	.	.	.	.	.	.	.	GORAB:uc001ggz.4:exon1:c.A96C:p.G32G,GORAB:uc001gha.2:exon1:c.A96C:p.G32G,GORAB:uc009wvw.2:exon1:c.A96C:p.G32G	.	AFR:0.7985,AMR:0.9821,EAS:0.9994,FIN:1,NFE:0.9987,OTH:0.9919,ASJ:0.9834	607983	231070;	2078;	2078|-|<1 / 1 000 000|Autosomal recessive|Neonatal|231070 ~	.	.	.	.	.	.	.	.	1	MU4568428	hom
1	170521376	170521376	G	A	GORAB	exonic	nonsynonymous SNV	ENSG00000120370	rs913257	ENSG00000120370:ENST00000367763:exon5:c.G958A:p.E320K	GORAB:NM_152281:exon5:c.G958A:p.E320K,GORAB:NM_001320252:exon7:c.G418A:p.E140K	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.5394	0.4859	0.592652	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	5.381	25.9	0.059	2.65	0.171	.	.	.	GORAB:uc001ghd.2:exon2:c.G337A:p.E113K,GORAB:uc001ghc.2:exon4:c.G418A:p.E140K,GORAB:uc001gha.2:exon5:c.G958A:p.E320K,GORAB:uc009wvx.2:exon5:c.G418A:p.E140K,GORAB:uc001ghb.2:exon7:c.G418A:p.E140K	-1.034	AFR:0.5294,AMR:0.5227,EAS:0.4139,FIN:0.9022,NFE:0.5713,OTH:0.4809,ASJ:0.6193	607983	231070;	2078;	2078|-|<1 / 1 000 000|Autosomal recessive|Neonatal|231070 ~	.	.	.	.	0.777	-0.01	0.085	2.16	1	1(large_intestine)	0.5245
1	173878832	173878832	T	C	SERPINC1	exonic	synonymous SNV	ENSG00000117601	rs5878	ENSG00000117601:ENST00000367698:exon5:c.A1011G:p.Q337Q	SERPINC1:NM_000488:exon5:c.A1011G:p.Q337Q,SERPINC1:NM_001365052:exon6:c.A867G:p.Q289Q	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4029	0.4882	0.535743	0.4717	.	.	.	.	.	.	.	.	SERPINC1:uc001gjt.3:exon5:c.A1011G:p.Q337Q	.	AFR:0.7680,AMR:0.2632,EAS:0.6539,FIN:0.2885,NFE:0.3395,OTH:0.3706,ASJ:0.53	107300	613118;	82;	82|Hereditary thrombophilia due to congenital antithrombin 3 deficiency|-|-|-|613118 ~	.	.	.	.	.	.	.	.	1	MU158486	hom
1	173878862	173878862	T	C	SERPINC1	exonic	synonymous SNV	ENSG00000117601	rs5877	ENSG00000117601:ENST00000367698:exon5:c.A981G:p.V327V	SERPINC1:NM_000488:exon5:c.A981G:p.V327V,SERPINC1:NM_001365052:exon6:c.A837G:p.V279V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4079	0.4836	0.545327	0.4688	.	.	.	.	.	.	.	.	SERPINC1:uc001gjt.3:exon5:c.A981G:p.V327V	.	AFR:0.7612,AMR:0.3353,EAS:0.6751,FIN:0.2736,NFE:0.3346,OTH:0.3673,ASJ:0.5265	107300	613118;	82;	82|Hereditary thrombophilia due to congenital antithrombin 3 deficiency|-|-|-|613118 ~	.	.	.	.	.	.	.	.	1	MU158492	hom
1	183177218	183177218	A	G	LAMC2	intronic	.	ENSG00000058085	rs647347	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4739	0.4475	0.496206	0.4515	.	.	.	.	.	.	.	.	.	.	AFR:0.4648,AMR:0.5120,EAS:0.5694,FIN:0.4966,NFE:0.4171,OTH:0.4662,ASJ:0.4073	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU11323905	het
1	183184616	183184616	C	T	LAMC2	exonic	synonymous SNV	ENSG00000058085	rs2274980	ENSG00000058085:ENST00000264144:exon3:c.C297T:p.S99S,ENSG00000058085:ENST00000493293:exon3:c.C297T:p.S99S	LAMC2:NM_005562:exon3:c.C297T:p.S99S,LAMC2:NM_018891:exon3:c.C297T:p.S99S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2460	0.2461	0.313698	0.2528	.	.	.	.	.	.	.	.	LAMC2:uc001gpz.4:exon3:c.C297T:p.S99S,LAMC2:uc001gqa.2:exon3:c.C297T:p.S99S	.	AFR:0.3893,AMR:0.3556,EAS:0.3401,FIN:0.1934,NFE:0.1766,OTH:0.2189,ASJ:0.1490	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU59731	het
1	183206573	183206573	G	A	LAMC2	exonic	synonymous SNV	ENSG00000058085	rs1047981	ENSG00000058085:ENST00000264144:exon18:c.G2688A:p.Q896Q,ENSG00000058085:ENST00000493293:exon18:c.G2688A:p.Q896Q	LAMC2:NM_005562:exon18:c.G2688A:p.Q896Q,LAMC2:NM_018891:exon18:c.G2688A:p.Q896Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2579	0.2864	0.352436	0.2871	.	.	.	.	.	.	.	.	LAMC2:uc001gpz.4:exon18:c.G2688A:p.Q896Q,LAMC2:uc001gqa.2:exon18:c.G2688A:p.Q896Q,LAMC2:uc010poa.2:exon18:c.G1788A:p.Q596Q	.	AFR:0.5071,AMR:0.3648,EAS:0.3428,FIN:0.1929,NFE:0.1780,OTH:0.2254,ASJ:0.1433	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU21003025	hom
1	183212548	183212548	T	G	LAMC2	UTR3	.	ENSG00000058085	rs3768593	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2372	0.2296	0.310903	0.2352	.	.	.	.	.	.	.	.	.	.	AFR:0.3540,AMR:0.3484,EAS:0.3623,FIN:0.1626,NFE:0.1668,OTH:0.2067,ASJ:0.1490	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU21936644	hom
1	196642233	196642233	G	A	CFH	exonic	nonsynonymous SNV	ENSG00000000971	rs800292	ENSG00000000971:ENST00000359637:exon2:c.G184A:p.V62I,ENSG00000000971:ENST00000367429:exon2:c.G184A:p.V62I,ENSG00000000971:ENST00000439155:exon2:c.G184A:p.V62I	CFH:NM_000186:exon2:c.G184A:p.V62I,CFH:NM_001014975:exon2:c.G184A:p.V62I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3210	0.3866	0.468051	MU581298	-0.812	0.040	1.0	5.12	0.028	.	.	Sushi/SCR/CCP domain	CFH:uc001gti.4:exon2:c.G184A:p.V62I,CFH:uc001gtj.4:exon2:c.G184A:p.V62I,CFH:uc009wyw.3:exon2:c.G184A:p.V62I,CFH:uc009wyx.3:exon2:c.G184A:p.V62I	-0.942	AFR:LAML-KR|4|205|0.0195122,COCA-CN|1|321|0.00311526,AMR:0.3934,EAS:0.3640,FIN:0.2318,NFE:0.4191,OTH:0.2930,ASJ:0.7150	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	0.0	-0.09	0.000	-2.885	1	2(stomach)	0.2372
1	196642969	196642969	-	TT	CFH	intronic	.	ENSG00000000971	rs35507625	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2568	.	0.305711	0.2361	.	.	.	.	.	.	.	.	.	.	AFR:0.1806,AMR:0.2958,EAS:0.5019,FIN:0.2693,NFE:0.2270,OTH:0.2716,ASJ:0.2252	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	.	het
1	196659237	196659237	C	T	CFH	exonic	nonsynonymous SNV	ENSG00000000971	rs1061170	ENSG00000000971:ENST00000359637:exon8:c.C1012T:p.H338Y,ENSG00000000971:ENST00000367429:exon9:c.C1204T:p.H402Y,ENSG00000000971:ENST00000439155:exon9:c.C1204T:p.H402Y	CFH:NM_000186:exon9:c.C1204T:p.H402Y,CFH:NM_001014975:exon9:c.C1204T:p.H402Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6721	0.6243	0.733427	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	-3.918	0.001	1.0	-9.09	0.000	.	.	Sushi/SCR/CCP domain	CFH:uc009wyx.3:exon8:c.C1012T:p.H338Y,CFH:uc001gti.4:exon9:c.C1204T:p.H402Y,CFH:uc001gtj.4:exon9:c.C1204T:p.H402Y,CFH:uc009wyw.3:exon9:c.C1129T:p.H377Y	-1.007	AFR:0.6336,AMR:0.6282,EAS:0.6689,FIN:0.9557,NFE:0.55,OTH:0.6144,ASJ:0.7885	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	0.0	-0.03	0.000	.	1	1(large_intestine)	0.6104
1	197053561	197053561	-	A	ASPM	intronic	.	ENSG00000066279	rs200839523	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2816	.	.	0.3436	.	.	.	.	.	.	.	.	.	.	AFR:0.1751,AMR:0.2805,EAS:0.1960,FIN:0.4242,NFE:0.4495,OTH:0.4074,ASJ:0.4405	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU9408466	het
1	197070901	197070901	A	G	ASPM	exonic	nonsynonymous SNV	ENSG00000066279	rs964201	ENSG00000066279:ENST00000367409:exon18:c.T7480C:p.Y2494H	ASPM:NM_018136:exon18:c.T7480C:p.Y2494H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9956	0.9957	0.997404	0.9962	0.626	8.336	1.0	4.83	0.900	.	.	IQ motif, EF-hand binding site|P-loop containing nucleoside triphosphate hydrolase	ASPM:uc001gtw.4:exon4:c.T1024C:p.Y342H,ASPM:uc001gtu.3:exon18:c.T7480C:p.Y2494H	-0.934	AFR:0.9994,AMR:0.9988,EAS:1,FIN:1,NFE:0.9927,OTH:0.9980,ASJ:1	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.001	-0.74	0.000	-2.065	1	MU81717489	hom
1	200522566	200522566	G	C	KIF14	exonic	nonsynonymous SNV	ENSG00000118193	rs12120084	ENSG00000118193:ENST00000367350:exon30:c.C4897G:p.P1633A	KIF14:NM_001305792:exon28:c.C3424G:p.P1142A,KIF14:NM_014875:exon30:c.C4897G:p.P1633A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3203	0.3058	0.219649	0.2696	-0.976	0.018	0.091	0.605	0.017	.	.	.	KIF14:uc010ppj.1:exon28:c.C3424G:p.P1142A,KIF14:uc010ppk.1:exon30:c.C4897G:p.P1633A	-1.020	AFR:0.0894,AMR:0.2093,EAS:0.2261,FIN:0.2695,NFE:0.3773,OTH:0.3020,ASJ:0.4272	611279	616258;	439897;	439897|-|<1 / 1 000 000|Autosomal recessive|Antenatal|616258 ~	.	.	.	.	0.307	-0.77	0.000	1.195	1	MU102596	hom
1	200558363	200558363	T	C	KIF14	exonic	synonymous SNV	ENSG00000118193	rs6665951	ENSG00000118193:ENST00000367350:exon18:c.A3096G:p.E1032E	KIF14:NM_001305792:exon16:c.A1623G:p.E541E,KIF14:NM_014875:exon18:c.A3096G:p.E1032E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7515	0.8067	0.766573	0.7926	.	.	.	.	.	.	.	.	KIF14:uc010ppj.1:exon16:c.A1623G:p.E541E,KIF14:uc010ppk.1:exon18:c.A3096G:p.E1032E	.	AFR:0.8873,AMR:0.6100,EAS:0.6856,FIN:0.7478,NFE:0.7711,OTH:0.7556,ASJ:0.8411	611279	616258;	439897;	439897|-|<1 / 1 000 000|Autosomal recessive|Antenatal|616258 ~	.	.	.	.	.	.	.	.	1	MU9422538	hom
1	201044748	201044748	A	G	CACNA1S	intronic	.	ENSG00000081248	rs1998721	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7814	0.7033	0.759585	0.7224	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.5560,AMR:0.7148,EAS:0.9470,FIN:0.7916,NFE:0.7745,OTH:0.7827,ASJ:0.7583	114208	170400;188580;601887;	423;79102;681;	423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~79102|Thyrotoxic hypokalemic periodic paralysis|<1 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|188580 613239 614834 ~681|Westphall disease|1-9 / 100 000|Autosomal dominant|Childhood|170400 613345 ~	.	.	.	.	.	.	.	.	1	MU81717919	hom
1	202304868	202304868	T	C	UBE2T	exonic	synonymous SNV	ENSG00000077152	rs14451	ENSG00000077152:ENST00000367274:exon2:c.A15G:p.S5S	UBE2T:NM_014176:exon2:c.A15G:p.S5S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4584	0.4882	0.390575	0.4724	.	.	.	.	.	.	.	.	UBE2T:uc001gxx.4:exon2:c.A15G:p.S5S	.	AFR:0.4281,AMR:0.3254,EAS:0.3290,FIN:0.5312,NFE:0.5025,OTH:0.4990,ASJ:0.6656	610538	616435;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	1	MU145935	hom
1	204413297	204413297	C	T	PIK3C2B	intronic	.	ENSG00000133056	rs2292459	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7286	0.7105	0.610823	MU813473	.	.	.	.	.	0.0004	0.054	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.6782,EAS:0.7578,FIN:0.8433,NFE:0.4751,OTH:0.7230,ASJ:0.4977	602838	.	.	.	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.7839
1	204413299	204413299	G	A	PIK3C2B	intronic	.	ENSG00000133056	rs2292460	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7081	0.6927	0.561502	MU731753	.	.	.	.	.	0	0.006	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.6541,EAS:0.7458,FIN:0.8267,NFE:0.3269,OTH:0.7226,ASJ:0.4457	602838	.	.	.	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.7821
1	204416111	204416111	A	G	PIK3C2B	intronic	.	ENSG00000133056	rs3106365	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.865815	0.9020	.	.	.	.	.	.	.	.	.	.	AFR:0.6910,AMR:0.9618,EAS:0.8517,FIN:0.9997,NFE:0.9969,OTH:0.9816,ASJ:0.9801	602838	.	.	.	.	.	.	.	.	.	.	.	1	.	hom
1	204516025	204516025	A	G	MDM4	intronic	.	ENSG00000198625	rs2290854	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6451	0.5536	0.539337	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.6003,AMR:0.2930,EAS:0.6324,FIN:0.6473,NFE:0.7944,OTH:0.7221,ASJ:0.5993	602704	.	.	.	.	.	.	.	.	.	.	.	1	4(soft_tissue)	0.6908
1	206647742	206647742	A	G	IKBKE	exonic	synonymous SNV	ENSG00000143466	rs1539242	ENSG00000143466:ENST00000367120:exon4:c.A156G:p.Q52Q	IKBKE:NM_001193322:exon4:c.A156G:p.Q52Q,IKBKE:NM_014002:exon4:c.A156G:p.Q52Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9986	0.9984	0.999401	0.9985	.	.	.	.	.	.	.	.	IKBKE:uc001hdz.2:exon4:c.A156G:p.Q52Q,IKBKE:uc009xbu.2:exon4:c.A156G:p.Q52Q,IKBKE:uc009xbv.2:exon4:c.A156G:p.Q52Q	.	AFR:0.9998,AMR:0.9988,EAS:1,FIN:0.9991,NFE:0.9974,OTH:0.9980,ASJ:1	605048	.	.	.	.	.	.	.	.	.	.	.	1	MU4564045	hom
1	206647787	206647787	T	C	IKBKE	exonic	synonymous SNV	ENSG00000143466	rs1539243	ENSG00000143466:ENST00000367120:exon4:c.T201C:p.I67I	IKBKE:NM_001193322:exon4:c.T201C:p.I67I,IKBKE:NM_014002:exon4:c.T201C:p.I67I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8591	0.8459	0.899161	0.8525	.	.	.	.	.	.	.	.	IKBKE:uc001hdz.2:exon4:c.T201C:p.I67I,IKBKE:uc009xbu.2:exon4:c.T201C:p.I67I,IKBKE:uc009xbv.2:exon4:c.T201C:p.I67I	.	AFR:0.8711,AMR:0.9129,EAS:0.9846,FIN:0.8333,NFE:0.8311,OTH:0.8299,ASJ:0.7947	605048	.	.	.	.	.	.	.	.	.	.	.	1	MU81719582	hom
1	226026406	226026406	A	G	EPHX1	exonic	nonsynonymous SNV	ENSG00000143819	rs2234922	ENSG00000143819:ENST00000272167:exon4:c.A416G:p.H139R,ENSG00000143819:ENST00000366837:exon4:c.A416G:p.H139R,ENSG00000143819:ENST00000445856:exon4:c.A416G:p.H139R	EPHX1:NM_000120:exon4:c.A416G:p.H139R,EPHX1:NM_001136018:exon4:c.A416G:p.H139R,EPHX1:NM_001291163:exon4:c.A416G:p.H139R	clinvar: drug_response 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1963	0.2497	0.215455	1(haematopoietic_and_lymphoid_tissue)	-1.689	0.002	1.0	2.55	0.001	.	.	Alpha/Beta hydrolase fold|Epoxide hydrolase, N-terminal	EPHX1:uc001hpk.3:exon4:c.A416G:p.H139R,EPHX1:uc001hpl.3:exon4:c.A416G:p.H139R,EPHX1:uc031psj.1:exon4:c.A416G:p.H139R	-0.956	AFR:MU150997,AMR:SKCA-BR|1|100|0.01,EAS:0.3376,FIN:0.1103,NFE:0.1490,OTH:0.1242,ASJ:0.2276	132810	189800;607748;	238475;275555;	238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~275555|-|1-5 / 10 000|-|Adult|189800 609402 609403 609404 614595 ~	~ko00980 Metabolism of xenobiotics by cytochrome P450~ko04976 Bile secretion~ko05204 Chemical carcinogenesis ~	.	.	.	0.0	3.9	0.000	0	1	1(urinary_tract)	0.1645
1	226027068	226027069	GT	-	EPHX1	intronic	.	ENSG00000143819	rs878921666	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	132810	189800;607748;	238475;275555;	238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~275555|-|1-5 / 10 000|-|Adult|189800 609402 609403 609404 614595 ~	~ko00980 Metabolism of xenobiotics by cytochrome P450~ko04976 Bile secretion~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	1	.	het
1	226555302	226555302	A	G	PARP1	exonic	nonsynonymous SNV	ENSG00000143799	rs1136410	ENSG00000143799:ENST00000366794:exon17:c.T2285C:p.V762A	PARP1:NM_001618:exon17:c.T2285C:p.V762A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.2018	0.1233	0.196885	1(liver)	6.781	32	0.176	5.56	0.998	.	.	Poly(ADP-ribose) polymerase, regulatory domain	PARP1:uc001hqd.4:exon17:c.T2285C:p.V762A	-0.836	AFR:1(breast),AMR:1(thyroid),EAS:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,FIN:0.1620,NFE:0.0490,OTH:0.3600,ASJ:MU4559871	173870	.	.	.	.	.	.	.	0.728	2.69	0.000	2.22	1	5(haematopoietic_and_lymphoid_tissue)	0.1589
1	226573364	226573364	A	G	PARP1	exonic	synonymous SNV	ENSG00000143799	rs1805414	ENSG00000143799:ENST00000366794:exon7:c.T852C:p.A284A	PARP1:NM_001618:exon7:c.T852C:p.A284A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4228	0.4077	0.516573	MU4559841	.	.	.	.	.	.	.	.	PARP1:uc001hqd.4:exon7:c.T852C:p.A284A	.	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763,AMR:0.4306,EAS:0.5060,FIN:0.33,NFE:0.8154,OTH:0.3971,ASJ:0.5477	173870	.	.	.	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.3312
1	226580021	226580021	G	T	PARP1	intronic	.	ENSG00000143799	rs1805405	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1944	0.2417	0.255791	0.2283	.	.	.	.	.	0.0304	0.08	.	.	.	AFR:0.3709,AMR:0.1352,EAS:0.3451,FIN:0.1585,NFE:0.1620,OTH:0.1342,ASJ:0.1457	173870	.	.	.	.	.	.	.	.	.	.	.	1	MU737447	het
1	231502231	231502232	AA	-	EGLN1	intronic	.	ENSG00000135766	rs796943191	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0013	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606425	609070;609820;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko04066 HIF-1 signaling pathway~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	1	.	het
1	237617757	237617757	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs3765097	ENSG00000198626:ENST00000542537:exon14:c.C1311T:p.S437S,ENSG00000198626:ENST00000366574:exon15:c.C1359T:p.S453S,ENSG00000198626:ENST00000360064:exon16:c.C1353T:p.S451S	RYR2:NM_001035:exon15:c.C1359T:p.S453S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5755	0.5119	0.535743	0.5238	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon15:c.C1359T:p.S453S	.	AFR:0.3184,AMR:0.5897,EAS:0.7073,FIN:0.5894,NFE:0.5988,OTH:0.5867,ASJ:0.6033	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU18032197	hom
1	237620049	237620049	T	C	RYR2	intronic	.	ENSG00000198626	rs2045955	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5514	0.4634	0.53115	0.4984	.	.	.	.	.	.	.	.	.	.	AFR:0.3107,AMR:0.5624,EAS:0.7823,FIN:0.5657,NFE:0.5521,OTH:0.5643,ASJ:0.57	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU786721	hom
1	237711797	237711797	A	G	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2253273	ENSG00000198626:ENST00000542537:exon25:c.A2925G:p.S975S,ENSG00000198626:ENST00000366574:exon26:c.A2973G:p.S991S,ENSG00000198626:ENST00000360064:exon27:c.A2967G:p.S989S	RYR2:NM_001035:exon26:c.A2973G:p.S991S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9262	0.8511	0.830272	0.8540	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon26:c.A2973G:p.S991S	.	AFR:0.6002,AMR:0.9414,EAS:0.8838,FIN:0.9762,NFE:0.9567,OTH:0.9450,ASJ:0.9603	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU4558519	hom
1	237801770	237801770	T	C	RYR2	exonic	synonymous SNV	ENSG00000198626	rs707189	ENSG00000198626:ENST00000542537:exon44:c.T6858C:p.L2286L,ENSG00000198626:ENST00000366574:exon45:c.T6906C:p.L2302L,ENSG00000198626:ENST00000360064:exon46:c.T6900C:p.L2300L	RYR2:NM_001035:exon45:c.T6906C:p.L2302L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9884	0.9592	0.954872	0.9641	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon45:c.T6906C:p.L2302L	.	AFR:0.8753,AMR:0.9881,EAS:1,FIN:0.9994,NFE:0.9999,OTH:0.9898,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724737	hom
1	237863718	237863718	T	G	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2797436	ENSG00000198626:ENST00000542537:exon64:c.T9270G:p.S3090S,ENSG00000198626:ENST00000366574:exon65:c.T9318G:p.S3106S,ENSG00000198626:ENST00000360064:exon66:c.T9312G:p.S3104S	RYR2:NM_001035:exon65:c.T9318G:p.S3106S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9917	0.9718	0.969249	0.9715	.	.	.	.	.	.	.	.	RYR2:uc010pxz.1:exon4:c.T183G:p.S61S,RYR2:uc001hyl.1:exon65:c.T9318G:p.S3106S	.	AFR:0.9005,AMR:0.9964,EAS:1,FIN:1,NFE:0.9993,OTH:0.9969,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724751	hom
1	237881770	237881770	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2797441	ENSG00000198626:ENST00000542537:exon72:c.C10455T:p.T3485T,ENSG00000198626:ENST00000366574:exon73:c.C10503T:p.T3501T,ENSG00000198626:ENST00000360064:exon74:c.C10497T:p.T3499T	RYR2:NM_001035:exon73:c.C10503T:p.T3501T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9886	0.9616	0.960463	0.9623	.	.	.	.	.	.	.	.	RYR2:uc010pxz.1:exon12:c.C1368T:p.T456T,RYR2:uc001hyl.1:exon73:c.C10503T:p.T3501T	.	AFR:0.8678,AMR:0.9964,EAS:1,FIN:1,NFE:0.9995,OTH:0.9949,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724767	hom
1	237890437	237890437	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2685301	ENSG00000198626:ENST00000542537:exon75:c.C10728T:p.S3576S,ENSG00000198626:ENST00000366574:exon76:c.C10776T:p.S3592S,ENSG00000198626:ENST00000360064:exon77:c.C10770T:p.S3590S	RYR2:NM_001035:exon76:c.C10776T:p.S3592S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9885	0.9608	0.960264	0.9625	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon76:c.C10776T:p.S3592S	.	AFR:0.8687,AMR:0.9964,EAS:1,FIN:1,NFE:0.9995,OTH:0.9949,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724775	hom
1	237893674	237893674	C	T	RYR2	intronic	.	ENSG00000198626	rs2797445	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9954	0.9854	0.985224	0.9853	.	.	.	.	.	.	.	.	.	.	AFR:0.9485,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724780	hom
1	241663902	241663902	-	GAGTGA	FH	intronic	.	ENSG00000091483	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	136850	150800;606812;	24;523;	24|Fumarase deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|606812 ~523|Familial leiomyomatosis and renal cell cancer<br>Familial leiomyomatosis cutis et uteri<br>Familial leiomyomatosis with renal carcinoma<br>Familial multiple cutaneous leiomyomas<br>HLRCC<br>Hereditary leiomyomatosis<br>Hereditary leiomyomatosis with renal carcinoma<br>Hereditary multiple cutaneous leiomyomas<br>MCUL<br>Multiple cutaneous and uterine leiomyomas<br>Reed syndrome|Unknown|Autosomal dominant|Adolescent<br>Adult<br>Elderly|150800 ~	~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko00720 Carbon fixation pathways in prokaryotes~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04934 Cushing syndrome~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma~~M00009 Citrate cycle (TCA cycle, Krebs cycle)~M00011 Citrate cycle, second carbon oxidation, 2-oxoglutarate =>~~M00173 Reductive citrate cycle (Arnon-Buchanan cycle)~M00376 3-Hydroxypropionate bi-cycle ~	.	.	.	.	.	.	.	1	.	hom
1	242042301	242042301	G	A	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs1047840	ENSG00000174371:ENST00000348581:exon11:c.G1765A:p.E589K,ENSG00000174371:ENST00000518483:exon11:c.G1765A:p.E589K,ENSG00000174371:ENST00000366548:exon13:c.G1765A:p.E589K	EXO1:NM_003686:exon11:c.G1765A:p.E589K,EXO1:NM_006027:exon11:c.G1765A:p.E589K,EXO1:NM_001319224:exon12:c.G1762A:p.E588K,EXO1:NM_130398:exon13:c.G1765A:p.E589K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3610	0.4087	0.351637	1(haematopoietic_and_lymphoid_tissue)	-0.283	0.727	1.0	-3.34	0.000	.	.	.	EXO1:uc021plj.1:exon11:c.G1765A:p.E589K,EXO1:uc021plk.1:exon11:c.G1765A:p.E589K,EXO1:uc009xgq.3:exon12:c.G1762A:p.E588K,EXO1:uc001hzh.3:exon13:c.G1765A:p.E589K	-0.938	AFR:1(skin),AMR:MU581675,EAS:0.4007,FIN:0.4647,NFE:0.3720,OTH:0.3808,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|4|205|0.0195122,COCA-CN|2|321|0.00623053	606063	.	.	.	.	.	.	.	0.0	1.24	0.000	-0.6	1	1(prostate)	0.1951
1	242042545	242042545	A	G	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs1776148	ENSG00000174371:ENST00000348581:exon11:c.A2009G:p.E670G,ENSG00000174371:ENST00000518483:exon11:c.A2009G:p.E670G,ENSG00000174371:ENST00000366548:exon13:c.A2009G:p.E670G	EXO1:NM_003686:exon11:c.A2009G:p.E670G,EXO1:NM_006027:exon11:c.A2009G:p.E670G,EXO1:NM_001319224:exon12:c.A2006G:p.E669G,EXO1:NM_130398:exon13:c.A2009G:p.E670G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6573	0.6550	0.681909	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	-0.519	0.197	0.382	-5.51	0.000	.	.	.	EXO1:uc021plj.1:exon11:c.A2009G:p.E670G,EXO1:uc021plk.1:exon11:c.A2009G:p.E670G,EXO1:uc009xgq.3:exon12:c.A2006G:p.E669G,EXO1:uc001hzh.3:exon13:c.A2009G:p.E670G	-1.000	AFR:0.6669,AMR:0.6913,EAS:0.6722,FIN:0.8226,NFE:0.6128,OTH:0.6491,ASJ:0.6885	606063	.	.	.	.	.	.	.	0.0	1.44	0.000	0.41	1	1(thyroid)	0.6373
1	242045275	242045275	C	T	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs1635498	ENSG00000174371:ENST00000348581:exon12:c.C2167T:p.R723C,ENSG00000174371:ENST00000518483:exon12:c.C2167T:p.R723C,ENSG00000174371:ENST00000366548:exon14:c.C2167T:p.R723C	EXO1:NM_003686:exon12:c.C2167T:p.R723C,EXO1:NM_006027:exon12:c.C2167T:p.R723C,EXO1:NM_001319224:exon13:c.C2164T:p.R722C,EXO1:NM_130398:exon14:c.C2167T:p.R723C	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9564	0.9452	0.915335	0.9462	3.117	22.6	0.188	1.84	0.565	.	.	.	EXO1:uc021plj.1:exon12:c.C2167T:p.R723C,EXO1:uc021plk.1:exon12:c.C2167T:p.R723C,EXO1:uc009xgq.3:exon13:c.C2164T:p.R722C,EXO1:uc001hzh.3:exon14:c.C2167T:p.R723C	-0.976	AFR:0.8801,AMR:0.9712,EAS:0.8691,FIN:0.9954,NFE:0.9780,OTH:0.9744,ASJ:0.9669	606063	.	.	.	.	.	.	.	0.85	1.35	0.000	0.345	1	MU18036633	hom
1	247582080	247582080	C	T	NLRP3	UTR5	.	ENSG00000162711	rs866137462	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606416	120100;191900;607115;	1451;575;47045;	1451|Chronic infantile neurological cutaneous articular syndrome<br>IOMID syndrome<br>Infantile-onset multisystem inflammatory disease<br>NOMID syndrome<br>Neonatal-onset multisystem inflammatory disease<br>Prieur-Griscelli syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|607115 ~575|Neutrophilic urticaria|Unknown|Autosomal dominant|Childhood<br>Neonatal<br>Infancy|191900 ~47045|FCAS<br>FCU<br>Familial cold autoinflammatory syndrome|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|120100 616115 ~	.	.	.	.	.	.	.	.	1	.	hom
1	247587477	247587477	G	A	NLRP3	exonic	synonymous SNV	ENSG00000162711	rs3806268	ENSG00000162711:ENST00000336119:exon3:c.G732A:p.A244A,ENSG00000162711:ENST00000348069:exon3:c.G732A:p.A244A,ENSG00000162711:ENST00000366496:exon3:c.G732A:p.A244A,ENSG00000162711:ENST00000391827:exon3:c.G732A:p.A244A,ENSG00000162711:ENST00000366497:exon4:c.G732A:p.A244A,ENSG00000162711:ENST00000391828:exon5:c.G732A:p.A244A	NLRP3:NM_001127462:exon3:c.G732A:p.A244A,NLRP3:NM_001243133:exon3:c.G726A:p.A242A,NLRP3:NM_004895:exon3:c.G732A:p.A244A,NLRP3:NM_183395:exon3:c.G732A:p.A244A,NLRP3:NM_001127461:exon4:c.G732A:p.A244A,NLRP3:NM_001079821:exon5:c.G732A:p.A244A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4996	0.4060	0.38738	2(stomach)	.	.	.	.	.	.	.	.	NLRP3:uc001ict.1:exon3:c.G726A:p.A242A,NLRP3:uc001icu.3:exon3:c.G732A:p.A244A,NLRP3:uc001icv.3:exon3:c.G732A:p.A244A,NLRP3:uc001icw.3:exon3:c.G732A:p.A244A,NLRP3:uc010pyw.2:exon3:c.G726A:p.A242A,NLRP3:uc001ics.3:exon4:c.G732A:p.A244A,NLRP3:uc001icr.3:exon5:c.G732A:p.A244A	.	AFR:MU581687,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|5|321|0.0155763,EAS:0.1151,FIN:0.4177,NFE:0.5333,OTH:0.5286,ASJ:0.4313	606416	120100;191900;607115;	1451;575;47045;	1451|Chronic infantile neurological cutaneous articular syndrome<br>IOMID syndrome<br>Infantile-onset multisystem inflammatory disease<br>NOMID syndrome<br>Neonatal-onset multisystem inflammatory disease<br>Prieur-Griscelli syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|607115 ~575|Neutrophilic urticaria|Unknown|Autosomal dominant|Childhood<br>Neonatal<br>Infancy|191900 ~47045|FCAS<br>FCU<br>Familial cold autoinflammatory syndrome|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|120100 616115 ~	.	.	.	.	.	.	.	.	1	2(haematopoietic_and_lymphoid_tissue)	0.5387
1	247587531	247587531	A	G	NLRP3	exonic	synonymous SNV	ENSG00000162711	rs4925543	ENSG00000162711:ENST00000336119:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000348069:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000366496:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000391827:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000366497:exon4:c.A786G:p.R262R,ENSG00000162711:ENST00000391828:exon5:c.A786G:p.R262R	NLRP3:NM_001127462:exon3:c.A786G:p.R262R,NLRP3:NM_001243133:exon3:c.A780G:p.R260R,NLRP3:NM_004895:exon3:c.A786G:p.R262R,NLRP3:NM_183395:exon3:c.A786G:p.R262R,NLRP3:NM_001127461:exon4:c.A786G:p.R262R,NLRP3:NM_001079821:exon5:c.A786G:p.R262R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9426	0.9188	0.919928	0.9332	.	.	.	.	.	.	.	.	NLRP3:uc001ict.1:exon3:c.A780G:p.R260R,NLRP3:uc001icu.3:exon3:c.A786G:p.R262R,NLRP3:uc001icv.3:exon3:c.A786G:p.R262R,NLRP3:uc001icw.3:exon3:c.A786G:p.R262R,NLRP3:uc010pyw.2:exon3:c.A780G:p.R260R,NLRP3:uc001ics.3:exon4:c.A786G:p.R262R,NLRP3:uc001icr.3:exon5:c.A786G:p.R262R	.	AFR:0.8519,AMR:0.9737,EAS:0.9975,FIN:0.9522,NFE:0.9645,OTH:0.9562,ASJ:0.9735	606416	120100;191900;607115;	1451;575;47045;	1451|Chronic infantile neurological cutaneous articular syndrome<br>IOMID syndrome<br>Infantile-onset multisystem inflammatory disease<br>NOMID syndrome<br>Neonatal-onset multisystem inflammatory disease<br>Prieur-Griscelli syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|607115 ~575|Neutrophilic urticaria|Unknown|Autosomal dominant|Childhood<br>Neonatal<br>Infancy|191900 ~47045|FCAS<br>FCU<br>Familial cold autoinflammatory syndrome|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|120100 616115 ~	.	.	.	.	.	.	.	.	1	MU81725544	hom
1	247587795	247587795	G	A	NLRP3	exonic	synonymous SNV	ENSG00000162711	rs143140947	ENSG00000162711:ENST00000336119:exon3:c.G1050A:p.T350T,ENSG00000162711:ENST00000348069:exon3:c.G1050A:p.T350T,ENSG00000162711:ENST00000366496:exon3:c.G1050A:p.T350T,ENSG00000162711:ENST00000391827:exon3:c.G1050A:p.T350T,ENSG00000162711:ENST00000366497:exon4:c.G1050A:p.T350T,ENSG00000162711:ENST00000391828:exon5:c.G1050A:p.T350T	NLRP3:NM_001127462:exon3:c.G1050A:p.T350T,NLRP3:NM_001243133:exon3:c.G1044A:p.T348T,NLRP3:NM_004895:exon3:c.G1050A:p.T350T,NLRP3:NM_183395:exon3:c.G1050A:p.T350T,NLRP3:NM_001127461:exon4:c.G1050A:p.T350T,NLRP3:NM_001079821:exon5:c.G1050A:p.T350T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 2, 0, 0, 0] 	0.0061	7.7e-05	0.0115815	0.0001	.	.	.	.	.	.	.	.	NLRP3:uc001ict.1:exon3:c.G1044A:p.T348T,NLRP3:uc001icu.3:exon3:c.G1050A:p.T350T,NLRP3:uc001icv.3:exon3:c.G1050A:p.T350T,NLRP3:uc001icw.3:exon3:c.G1050A:p.T350T,NLRP3:uc010pyw.2:exon3:c.G1044A:p.T348T,NLRP3:uc001ics.3:exon4:c.G1050A:p.T350T,NLRP3:uc001icr.3:exon5:c.G1050A:p.T350T	.	AFR:0.0001,AMR:0,EAS:0.0006,FIN:0,NFE:0,OTH:0.0020,ASJ:0	606416	120100;191900;607115;	1451;575;47045;	1451|Chronic infantile neurological cutaneous articular syndrome<br>IOMID syndrome<br>Infantile-onset multisystem inflammatory disease<br>NOMID syndrome<br>Neonatal-onset multisystem inflammatory disease<br>Prieur-Griscelli syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|607115 ~575|Neutrophilic urticaria|Unknown|Autosomal dominant|Childhood<br>Neonatal<br>Infancy|191900 ~47045|FCAS<br>FCU<br>Familial cold autoinflammatory syndrome|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|120100 616115 ~	.	.	.	.	.	.	.	.	1	MU82388961	hom
2	17942775	17942775	T	A	GEN1	exonic	nonsynonymous SNV	ENSG00000178295	rs1812152	ENSG00000178295:ENST00000317402:exon3:c.T274A:p.S92T,ENSG00000178295:ENST00000381254:exon3:c.T274A:p.S92T,ENSG00000178295:ENST00000524465:exon3:c.T274A:p.S92T,ENSG00000178295:ENST00000532257:exon3:c.T274A:p.S92T	GEN1:NM_001130009:exon3:c.T274A:p.S92T,GEN1:NM_182625:exon3:c.T274A:p.S92T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7138	0.6712	0.813698	0.6849	0.082	3.418	1.0	0.326	0.953	.	.	PIN domain-like|XPG N-terminal	GEN1:uc002rct.2:exon3:c.T274A:p.S92T,GEN1:uc002rcu.2:exon3:c.T274A:p.S92T,GEN1:uc010yjs.1:exon3:c.T274A:p.S92T	-1.005	AFR:0.7717,AMR:0.7912,EAS:0.9790,FIN:0.5835,NFE:0.6234,OTH:0.6493,ASJ:0.6376	612449	.	.	.	.	.	.	.	0.0	-0.01	0.000	-0.86	2	MU31230816	hom
2	17946243	17946243	A	G	GEN1	exonic	nonsynonymous SNV	ENSG00000178295	rs16981869	ENSG00000178295:ENST00000317402:exon4:c.A428G:p.N143S,ENSG00000178295:ENST00000381254:exon4:c.A428G:p.N143S	GEN1:NM_001130009:exon4:c.A428G:p.N143S,GEN1:NM_182625:exon4:c.A428G:p.N143S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1045	0.1454	0.127995	2(haematopoietic_and_lymphoid_tissue)	3.262	22.8	0.03	3.32	0.625	.	.	PIN domain-like|XPG-I domain	GEN1:uc002rct.2:exon4:c.A428G:p.N143S,GEN1:uc002rcu.2:exon4:c.A428G:p.N143S,GEN1:uc010yjs.1:exon4:c.A428G:p.N143S	-1.083	AFR:MU13382169,AMR:LUSC-KR|1|170|0.00588235,EAS:0.2383,FIN:0.0919,NFE:0.1126,OTH:0.0334,ASJ:0.1391	612449	.	.	.	.	.	.	.	0.812	-0.45	0.000	2.21	2	1(stomach)	0.0784
2	17954027	17954027	G	A	GEN1	exonic	nonsynonymous SNV	ENSG00000178295	rs300175	ENSG00000178295:ENST00000528873:exon3:c.G242A:p.S81N,ENSG00000178295:ENST00000317402:exon8:c.G929A:p.S310N,ENSG00000178295:ENST00000381254:exon8:c.G929A:p.S310N	GEN1:NM_001130009:exon8:c.G929A:p.S310N,GEN1:NM_182625:exon8:c.G929A:p.S310N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9932	0.9835	0.977037	0.9882	-3.164	0.001	0.706	-11.3	0.001	.	.	.	GEN1:uc002rct.2:exon8:c.G929A:p.S310N,GEN1:uc002rcu.2:exon8:c.G929A:p.S310N,GEN1:uc010yjs.1:exon8:c.G929A:p.S310N	-0.973	AFR:0.9588,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9949,ASJ:1	612449	.	.	.	.	.	.	.	0.001	0.81	0.000	-0.66	2	MU81728351	hom
2	17962518	17962518	C	T	GEN1	exonic	nonsynonymous SNV	ENSG00000178295	rs300169	ENSG00000178295:ENST00000317402:exon14:c.C2039T:p.T680I,ENSG00000178295:ENST00000381254:exon14:c.C2039T:p.T680I	GEN1:NM_001130009:exon14:c.C2039T:p.T680I,GEN1:NM_182625:exon14:c.C2039T:p.T680I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6981	0.6187	0.757987	0.6392	-0.073	1.943	1.0	1.16	0.862	.	.	.	GEN1:uc002rct.2:exon14:c.C2039T:p.T680I,GEN1:uc002rcu.2:exon14:c.C2039T:p.T680I,GEN1:uc010yjs.1:exon14:c.C2039T:p.T680I	-0.997	AFR:0.6127,AMR:0.7721,EAS:0.9783,FIN:0.5833,NFE:0.6234,OTH:0.6442,ASJ:0.63	612449	.	.	.	.	.	.	.	0.0	2.01	0.000	-1.845	2	MU31230939	hom
2	21226219	21226219	A	-	APOB	intronic	.	ENSG00000084674	rs751121092	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0206	0.0187	.	0.0067	.	.	.	.	.	.	.	.	.	.	AFR:0.0027,AMR:0.0036,EAS:0.0547,FIN:0.0084,NFE:0.0028,OTH:0.0080,ASJ:0.0081	107730	144010;615558;	.	.	.	.	.	.	.	.	.	.	2	MU43765859	het
2	21231524	21231524	G	A	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs676210	ENSG00000084674:ENST00000233242:exon26:c.C8216T:p.P2739L	APOB:NM_000384:exon26:c.C8216T:p.P2739L	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.2928	0.1965	0.366214	MU156045	5.787	27.1	0.0	5.22	1.000	.	.	.	APOB:uc002red.3:exon26:c.C8216T:p.P2739L	-1.071	AFR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.2347,EAS:0.2153,FIN:0.1424,NFE:0.7298,OTH:0.2563,ASJ:0.1459	107730	144010;615558;	.	.	.	.	.	.	1.0	5.21	0.000	2.785	2	1(large_intestine)	0.2276
2	21235475	21235475	T	C	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs568413	ENSG00000084674:ENST00000233242:exon26:c.A4265G:p.Y1422C	APOB:NM_000384:exon26:c.A4265G:p.Y1422C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9999	0.9997	1	0.9997	.	.	.	.	.	.	.	.	APOB:uc002red.3:exon26:c.A4265G:p.Y1422C	.	AFR:0.9997,AMR:1,EAS:1,FIN:1,NFE:0.9997,OTH:0.9990,ASJ:1	107730	144010;615558;	.	.	.	.	.	.	.	.	.	.	2	MU81728579	hom
2	21250914	21250914	G	A	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs679899	ENSG00000084674:ENST00000233242:exon14:c.C1853T:p.A618V,ENSG00000084674:ENST00000399256:exon14:c.C1853T:p.A618V	APOB:NM_000384:exon14:c.C1853T:p.A618V	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.4857	0.3655	0.485024	0.4190	5.620	26.6	0.005	5.73	0.712	.	.	Lipid transport protein, N-terminal|Vitellinogen, superhelical	APOB:uc002red.3:exon14:c.C1853T:p.A618V	-0.928	AFR:0.1710,AMR:0.3926,EAS:0.8424,FIN:0.5479,NFE:0.4846,OTH:0.5061,ASJ:0.3576	107730	144010;615558;	.	.	.	.	.	.	1.0	-0.62	0.000	2.695	2	MU4129271	hom
2	24905927	24905927	G	C	NCOA1	exonic	synonymous SNV	ENSG00000084676	rs11125744	ENSG00000084676:ENST00000288599:exon6:c.G462C:p.T154T,ENSG00000084676:ENST00000348332:exon6:c.G462C:p.T154T,ENSG00000084676:ENST00000395856:exon6:c.G462C:p.T154T,ENSG00000084676:ENST00000407230:exon6:c.G9C:p.T3T,ENSG00000084676:ENST00000538539:exon7:c.G462C:p.T154T,ENSG00000084676:ENST00000406961:exon8:c.G462C:p.T154T,ENSG00000084676:ENST00000405141:exon9:c.G462C:p.T154T	NCOA1:NM_147233:exon6:c.G462C:p.T154T,NCOA1:NM_147223:exon7:c.G462C:p.T154T,NCOA1:NM_001362950:exon8:c.G462C:p.T154T,NCOA1:NM_001362952:exon8:c.G462C:p.T154T,NCOA1:NM_001362954:exon8:c.G462C:p.T154T,NCOA1:NM_001362955:exon8:c.G462C:p.T154T,NCOA1:NM_003743:exon8:c.G462C:p.T154T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8689	0.7864	0.80651	0.8160	.	.	.	.	.	.	.	.	NCOA1:uc002rfi.3:exon6:c.G9C:p.T3T,NCOA1:uc002rfj.3:exon6:c.G462C:p.T154T,NCOA1:uc002rfk.3:exon6:c.G462C:p.T154T,NCOA1:uc002rfl.3:exon6:c.G462C:p.T154T,NCOA1:uc010eye.3:exon7:c.G462C:p.T154T	.	AFR:0.5729,AMR:0.9306,EAS:0.9957,FIN:0.9123,NFE:0.9034,OTH:0.8724,ASJ:0.9040	602691	.	.	.	~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	2	MU4558267	hom
2	24974945	24974945	T	G	NCOA1	exonic	synonymous SNV	ENSG00000084676	rs11125763	ENSG00000084676:ENST00000288599:exon18:c.T3801G:p.L1267L,ENSG00000084676:ENST00000348332:exon18:c.T3801G:p.L1267L,ENSG00000084676:ENST00000395856:exon18:c.T3801G:p.L1267L,ENSG00000084676:ENST00000407230:exon18:c.T3348G:p.L1116L,ENSG00000084676:ENST00000538539:exon19:c.T3801G:p.L1267L,ENSG00000084676:ENST00000406961:exon20:c.T3801G:p.L1267L,ENSG00000084676:ENST00000405141:exon21:c.T3801G:p.L1267L	NCOA1:NM_147233:exon18:c.T3801G:p.L1267L,NCOA1:NM_147223:exon19:c.T3801G:p.L1267L,NCOA1:NM_001362950:exon20:c.T3801G:p.L1267L,NCOA1:NM_001362952:exon20:c.T3801G:p.L1267L,NCOA1:NM_001362954:exon20:c.T3801G:p.L1267L,NCOA1:NM_001362955:exon20:c.T3801G:p.L1267L,NCOA1:NM_003743:exon20:c.T3801G:p.L1267L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8784	0.8189	0.836062	0.8444	.	.	.	.	.	.	.	.	NCOA1:uc010eyf.3:exon2:c.T480G:p.L160L,NCOA1:uc002rfi.3:exon18:c.T3348G:p.L1116L,NCOA1:uc002rfj.3:exon18:c.T3801G:p.L1267L,NCOA1:uc002rfk.3:exon18:c.T3801G:p.L1267L,NCOA1:uc002rfl.3:exon18:c.T3801G:p.L1267L,NCOA1:uc010eye.3:exon19:c.T3801G:p.L1267L	.	AFR:0.6732,AMR:0.9368,EAS:0.9957,FIN:0.9118,NFE:0.9033,OTH:0.8763,ASJ:0.9040	602691	.	.	.	~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	2	MU81728834	hom
2	25469913	25469913	C	T	DNMT3A	intronic	.	ENSG00000119772	rs2276599	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7167	0.6863	0.614018	ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|6|321|0.0186916	.	.	.	.	.	0	0	.	.	.	AFR:0.7006,AMR:0.5654,EAS:0.6656,FIN:0.6001,NFE:0.8238,OTH:0.7565,ASJ:0.7363	602769	615879;	404443;	404443|DNMT3A-related overgrowth syndrome|<1 / 1 000 000|Unknown|Neonatal|615879 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.7525
2	25536800	25536800	C	T	DNMT3A	exonic	synonymous SNV	ENSG00000119772	.	ENSG00000119772:ENST00000264709:exon2:c.G54A:p.E18E,ENSG00000119772:ENST00000321117:exon2:c.G54A:p.E18E,ENSG00000119772:ENST00000380756:exon2:c.G54A:p.E18E,ENSG00000119772:ENST00000406659:exon2:c.G54A:p.E18E	DNMT3A:NM_001320892:exon2:c.G54A:p.E18E,DNMT3A:NM_022552:exon2:c.G54A:p.E18E,DNMT3A:NM_175629:exon2:c.G54A:p.E18E,DNMT3A:NM_175630:exon2:c.G54A:p.E18E	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 1, 0, 1, 0, 1, 1] 	.	.	.	.	.	.	.	.	.	.	.	.	DNMT3A:uc002rgc.4:exon2:c.G54A:p.E18E,DNMT3A:uc002rgd.4:exon2:c.G54A:p.E18E,DNMT3A:uc002rgf.3:exon2:c.G54A:p.E18E	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602769	615879;	404443;	404443|DNMT3A-related overgrowth syndrome|<1 / 1 000 000|Unknown|Neonatal|615879 ~	.	,2229,2225,2236,2228,2233,2226	.	,2234,2230,2235,2232,2227,2231	.	.	.	.	2	.	hom
2	27440785	27440785	C	T	CAD	exonic	synonymous SNV	ENSG00000084774	rs1275536	ENSG00000084774:ENST00000264705:exon2:c.C123T:p.T41T,ENSG00000084774:ENST00000403525:exon2:c.C123T:p.T41T	CAD:NM_001306079:exon2:c.C123T:p.T41T,CAD:NM_004341:exon2:c.C123T:p.T41T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9986	0.9958	0.995807	0.9947	.	.	.	.	.	.	.	.	CAD:uc002rji.3:exon2:c.C123T:p.T41T,CAD:uc010eyw.3:exon2:c.C123T:p.T41T	.	AFR:0.9815,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	114010	616457;	448010;	448010|CDG syndrome type IZ<br>CDG-IZ<br>CDG1Z<br>Carbohydrate deficient glycoprotein syndrome type IZ<br>Congenital disorder of glycosylation type 1Z|<1 / 1 000 000|Autosomal recessive|Infancy|616457 ~	.	.	.	.	.	.	.	.	2	MU81729819	hom
2	27454948	27454948	G	A	CAD	exonic	nonsynonymous SNV	ENSG00000084774	rs761503191	ENSG00000084774:ENST00000403525:exon16:c.G2312A:p.R771H,ENSG00000084774:ENST00000264705:exon17:c.G2501A:p.R834H	CAD:NM_001306079:exon16:c.G2312A:p.R771H,CAD:NM_004341:exon17:c.G2501A:p.R834H	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	8.237e-06	.	.	.	4.027	23.6	0.072	4.51	0.996	.	.	Carbamoyl-phosphate synthetase, large subunit oligomerisation domain	CAD:uc010eyw.3:exon16:c.G2312A:p.R771H,CAD:uc002rji.3:exon17:c.G2501A:p.R834H	0.728	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	114010	616457;	448010;	448010|CDG syndrome type IZ<br>CDG-IZ<br>CDG1Z<br>Carbohydrate deficient glycoprotein syndrome type IZ<br>Congenital disorder of glycosylation type 1Z|<1 / 1 000 000|Autosomal recessive|Infancy|616457 ~	.	.	.	.	0.007	-4.08	0.858	2.03	2	.	hom
2	29416572	29416572	T	C	ALK	exonic	nonsynonymous SNV	ENSG00000171094	rs1670283	ENSG00000171094:ENST00000431873:exon4:c.A871G:p.I291V,ENSG00000171094:ENST00000389048:exon29:c.A4381G:p.I1461V	ALK:NM_001353765:exon10:c.A1177G:p.I393V,ALK:NM_004304:exon29:c.A4381G:p.I1461V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.9972	0.9903	0.992212	COCA-CN|5|321|0.0155763	-2.014	0.001	1.0	-0.134	0.001	.	.	.	ALK:uc010ymo.3:exon10:c.A1177G:p.I393V,ALK:uc031rnw.1:exon11:c.A1177G:p.I393V,ALK:uc002rmy.3:exon29:c.A4381G:p.I1461V	-0.987	AFR:0.9907,AMR:0.9680,EAS:0.9934,FIN:1,NFE:1,OTH:0.9999,ASJ:0.9940	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	617,,621,623,619,622,624,616,618,620	.	.	0.0	-0.89	0.000	-1.1	2	30(lung)	0.9990
2	29444076	29444076	G	T	ALK	intronic	.	ENSG00000171094	rs1534545	ENSG00000171094:ENST00000453137:exon4:c.C237A:p.F79L	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3087	.	0.374601	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	-0.053	2.104	0.0	2.44	0.034	.	.	.	.	-0.916	AFR:0.2385,AMR:0.1525,EAS:0.2119,FIN:0.7398,NFE:0.2981,OTH:0.2032,ASJ:0.5274	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	-0.83	0.000	.	2	5(meninges)	0.2643
2	29444095	29444095	C	T	ALK	intronic	.	ENSG00000171094	rs1569156	ENSG00000171094:ENST00000453137:exon4:c.G218A:p.W73X	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9757	.	0.914736	0.9329	0.034	2.916	.	-1.17	0.003	.	.	.	.	.	AFR:0.7762,AMR:0.9833,EAS:0.9414,FIN:1,NFE:0.9995,OTH:0.9898,ASJ:0.9934	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	MU23036355	hom
2	29445458	29445458	G	T	ALK	exonic	synonymous SNV	ENSG00000171094	rs3795850	ENSG00000171094:ENST00000453137:exon2:c.C69A:p.G23G,ENSG00000171094:ENST00000389048:exon21:c.C3375A:p.G1125G	ALK:NM_001353765:exon2:c.C171A:p.G57G,ALK:NM_004304:exon21:c.C3375A:p.G1125G	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3271	0.2214	0.415935	MU18066530	.	.	.	.	.	.	.	.	ALK:uc010ymo.3:exon2:c.C171A:p.G57G,ALK:uc031rnw.1:exon3:c.C171A:p.G57G,ALK:uc002rmy.3:exon21:c.C3375A:p.G1125G	.	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|4|321|0.0124611,AMR:0.2742,EAS:0.5383,FIN:0.2119,NFE:0.7426,OTH:0.3158,ASJ:0.2537	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	617,,621,623,619,622,624,616,618,620	.	.	.	.	.	.	2	6(meninges)	0.2119
2	29445798	29445798	T	C	ALK	intronic	.	ENSG00000171094	rs4666182	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.922923	0.9371	.	.	.	.	.	.	.	.	.	.	AFR:0.7909,AMR:0.9868,EAS:0.9426,FIN:1,NFE:0.9995,OTH:0.9898,ASJ:0.9934	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	hom
2	29446184	29446184	C	G	ALK	intronic	.	ENSG00000171094	rs2276550	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3312	0.2234	0.420727	0.2763	.	.	.	.	.	.	.	.	.	.	AFR:0.2548,AMR:0.5418,EAS:0.7584,FIN:0.3162,NFE:0.2133,OTH:0.2844,ASJ:0.2185	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	MU21150305	hom
2	29447108	29447108	G	A	ALK	intronic	.	ENSG00000171094	rs4387740	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.727436	0.7086	.	.	.	.	.	.	.	.	.	.	AFR:0.6098,AMR:0.7947,EAS:0.7670,FIN:0.8268,NFE:0.7242,OTH:0.7495,ASJ:0.7152	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	MU114075717	hom
2	29449005	29449005	G	T	ALK	intronic	.	ENSG00000171094	rs1317902	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.129593	0.1288	.	.	.	.	.	.	.	.	.	.	AFR:0.1719,AMR:0.0621,EAS:0.1359,FIN:0.0960,NFE:0.1143,OTH:0.1245,ASJ:0.1457	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	MU22244224	hom
2	29449819	29449819	C	T	ALK	exonic	synonymous SNV	ENSG00000171094	rs2293563	ENSG00000171094:ENST00000389048:exon18:c.G3036A:p.T1012T	ALK:NM_004304:exon18:c.G3036A:p.T1012T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1591	0.1896	0.169928	1(stomach)	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon18:c.G3036A:p.T1012T	.	AFR:5(soft_tissue),AMR:2(lung),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,FIN:0.1686,NFE:0.2114,OTH:0.1122,ASJ:MU584959	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	617,,621,623,619,622,624,616,618,620	.	.	.	.	.	.	2	2(haematopoietic_and_lymphoid_tissue)	0.2550
2	29543663	29543663	T	C	ALK	exonic	synonymous SNV	ENSG00000171094	rs2293564	ENSG00000171094:ENST00000389048:exon7:c.A1500G:p.Q500Q	ALK:NM_004304:exon7:c.A1500G:p.Q500Q	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8716	0.7909	0.776558	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon7:c.A1500G:p.Q500Q	.	AFR:0.8023,AMR:0.5071,EAS:0.8808,FIN:0.9086,NFE:0.9241,OTH:0.9216,ASJ:0.8771	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	617,,621,623,619,622,624,616,618,620	.	.	.	.	.	.	2	18(meninges)	0.8939
2	29940529	29940529	A	T	ALK	exonic	synonymous SNV	ENSG00000171094	rs2246745	ENSG00000171094:ENST00000389048:exon2:c.T702A:p.P234P,ENSG00000171094:ENST00000431873:exon2:c.T702A:p.P234P	ALK:NM_004304:exon2:c.T702A:p.P234P	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7335	0.6270	0.589257	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon2:c.T702A:p.P234P	.	AFR:0.6361,AMR:0.2397,EAS:0.7881,FIN:0.7342,NFE:0.7362,OTH:0.8163,ASJ:0.7224	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	617,,621,623,619,622,624,616,618,620	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.7633
2	44200855	44200855	T	A	LRPPRC	splicing	.	ENSG00000138095	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	4.728	24.6	.	6.05	0.985	1.0000	0.93	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	.	.	.	.	2	.	hom
2	44209477	44209477	C	T	LRPPRC	exonic	synonymous SNV	ENSG00000138095	rs6741066	ENSG00000138095:ENST00000260665:exon2:c.G246A:p.Q82Q,ENSG00000138095:ENST00000409659:exon2:c.G246A:p.Q82Q,ENSG00000138095:ENST00000409946:exon2:c.G246A:p.Q82Q,ENSG00000138095:ENST00000447246:exon2:c.G168A:p.Q56Q	LRPPRC:NM_133259:exon2:c.G246A:p.Q82Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6240	0.7243	0.503994	2(large_intestine)	.	.	.	.	.	.	.	.	LRPPRC:uc002rtr.2:exon2:c.G246A:p.Q82Q,LRPPRC:uc010faw.1:exon2:c.G168A:p.Q56Q	.	AFR:MU108002,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,EAS:0.7029,FIN:0.5347,NFE:0.7550,OTH:0.0222,ASJ:0.6781	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	.	.	.	.	2	1(stomach)	0.7353
2	46603671	46603671	C	G	EPAS1	intronic	.	ENSG00000116016	rs7557402	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4104	0.4291	0.3125	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	0.0217	0.11	.	.	.	AFR:0.3909,AMR:0.2780,EAS:0.47,FIN:0.1968,NFE:0.4450,OTH:0.4659,ASJ:0.2703	603349	611783;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.4539
2	47601106	47601106	T	C	EPCAM	exonic	nonsynonymous SNV	ENSG00000119888	rs1126497	ENSG00000119888:ENST00000263735:exon3:c.T344C:p.M115T,ENSG00000119888:ENST00000419334:exon3:c.T572C:p.M191T,ENSG00000119888:ENST00000405271:exon4:c.T428C:p.M143T,ENSG00000119888:ENST00000456133:exon4:c.T428C:p.M143T	EPCAM:NM_002354:exon3:c.T344C:p.M115T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5198	0.5667	0.666134	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	-0.486	0.238	1.0	1.71	0.815	.	.	Thyroglobulin type-1	EPCAM:uc002rvx.3:exon3:c.T344C:p.M115T	-0.934	AFR:0.6033,AMR:0.8316,EAS:0.3775,FIN:0.8403,NFE:0.6001,OTH:0.4616,ASJ:0.4557	185535	613217;613244;	144;92050;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~92050|Congenital familial intractable diarrhea with epithelial or epithelium abnormalities<br>IED<br>Tufting enteropathy|Unknown|Autosomal recessive|All ages|613217 ~	.	.	.	.	0.0	0.05	0.000	-1.4	2	2(prostate)	0.5545
2	48023115	48023115	T	C	MSH6	exonic	synonymous SNV	ENSG00000116062	rs1800935	ENSG00000116062:ENST00000234420:exon3:c.T540C:p.D180D,ENSG00000116062:ENST00000411819:exon3:c.T243C:p.D81D,ENSG00000116062:ENST00000420813:exon3:c.T243C:p.D81D,ENSG00000116062:ENST00000455383:exon3:c.T243C:p.D81D	MSH6:NM_000179:exon3:c.T540C:p.D180D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2144	0.2507	0.135184	.	.	.	.	.	.	.	.	.	MSH6:uc002rwc.2:exon3:c.T540C:p.D180D,MSH6:uc002rwd.4:exon3:c.T540C:p.D180D	.	AFR:0.2281,AMR:0.1767,EAS:0.1755,FIN:0.0019,NFE:0.2689,OTH:0.2787,ASJ:0.1456	600678	276300;608089;614350;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	,7600	.	.	.	.	.	2	9(meninges)	0.2279
2	48025764	48025764	C	T	MSH6	exonic	synonymous SNV	ENSG00000116062	rs1800937	ENSG00000116062:ENST00000445503:exon3:c.C472T:p.R158C	MSH6:NM_001281492:exon2:c.C252T:p.Y84Y,MSH6:NM_000179:exon4:c.C642T:p.Y214Y	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0735	0.0691	0.0285543	MU28749005	.	.	.	.	.	.	.	.	MSH6:uc002rwc.2:exon4:c.C642T:p.Y214Y,MSH6:uc002rwd.4:exon4:c.C642T:p.Y214Y	.	AFR:LAML-KR|1|205|0.00487805,AMR:0.0807,EAS:0.0418,FIN:0.0298,NFE:0,OTH:0.1440,ASJ:0.0205	600678	276300;608089;614350;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	,7600	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.1115
2	58388696	58388696	A	G	FANCL	exonic	synonymous SNV	ENSG00000115392	rs848291	ENSG00000115392:ENST00000403676:exon8:c.T630C:p.S210S,ENSG00000115392:ENST00000449070:exon9:c.T804C:p.S268S,ENSG00000115392:ENST00000403295:exon11:c.T897C:p.S299S,ENSG00000115392:ENST00000233741:exon12:c.T981C:p.S327S,ENSG00000115392:ENST00000402135:exon12:c.T996C:p.S332S	FANCL:NM_001114636:exon12:c.T996C:p.S332S,FANCL:NM_018062:exon12:c.T981C:p.S327S	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.6487	0.7041	0.70647	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FANCL:uc010fcf.1:exon9:c.T804C:p.S268S,FANCL:uc010fce.3:exon11:c.T897C:p.S299S,FANCL:uc002rzw.4:exon12:c.T981C:p.S327S,FANCL:uc002rzx.4:exon12:c.T996C:p.S332S	.	AFR:0.6976,AMR:0.8947,EAS:0.5430,FIN:0.5789,NFE:0.6272,OTH:0.6195,ASJ:0.6751	608111	614083;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	,4922	.	.	.	.	.	.	2	2(haematopoietic_and_lymphoid_tissue)	0.6442
2	60687959	60687959	A	G	BCL11A	exonic	synonymous SNV	ENSG00000119866	rs7569946	ENSG00000119866:ENST00000358510:exon3:c.T1986C:p.S662S,ENSG00000119866:ENST00000538214:exon3:c.T1986C:p.S662S,ENSG00000119866:ENST00000335712:exon4:c.T2088C:p.S696S,ENSG00000119866:ENST00000356842:exon4:c.T2088C:p.S696S,ENSG00000119866:ENST00000537768:exon6:c.T1095C:p.S365S	BCL11A:NM_001363864:exon3:c.T1986C:p.S662S,BCL11A:NM_001365609:exon3:c.T1986C:p.S662S,BCL11A:NM_018014:exon4:c.T2088C:p.S696S,BCL11A:NM_022893:exon4:c.T2088C:p.S696S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6977	0.7125	0.830072	0.7089	.	.	.	.	.	.	.	.	BCL11A:uc002sad.1:exon3:c.T1632C:p.S544S,BCL11A:uc002saf.1:exon3:c.T1986C:p.S662S,BCL11A:uc010ypj.2:exon3:c.T1986C:p.S662S,BCL11A:uc002sab.3:exon4:c.T2088C:p.S696S,BCL11A:uc002sae.1:exon4:c.T2088C:p.S696S,BCL11A:uc010ypi.2:exon6:c.T1095C:p.S365S	.	AFR:0.9088,AMR:0.8118,EAS:0.9994,FIN:0.5992,NFE:0.5886,OTH:0.6311,ASJ:0.5530	606557	617101;	.	.	.	.	.	.	.	.	.	.	2	MU68453	hom
2	60689522	60689522	G	A	BCL11A	exonic	synonymous SNV	ENSG00000119866	rs61748090	ENSG00000119866:ENST00000358510:exon3:c.C423T:p.C141C,ENSG00000119866:ENST00000538214:exon3:c.C423T:p.C141C,ENSG00000119866:ENST00000335712:exon4:c.C525T:p.C175C,ENSG00000119866:ENST00000356842:exon4:c.C525T:p.C175C,ENSG00000119866:ENST00000359629:exon4:c.C525T:p.C175C,ENSG00000119866:ENST00000537768:exon5:c.C69T:p.C23C	BCL11A:NM_001363864:exon3:c.C423T:p.C141C,BCL11A:NM_001365609:exon3:c.C423T:p.C141C,BCL11A:NM_018014:exon4:c.C525T:p.C175C,BCL11A:NM_022893:exon4:c.C525T:p.C175C,BCL11A:NM_138559:exon4:c.C525T:p.C175C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0180	0.0192	0.00778754	0.0160	.	.	.	.	.	.	.	.	BCL11A:uc002sad.1:exon3:c.C69T:p.C23C,BCL11A:uc002saf.1:exon3:c.C423T:p.C141C,BCL11A:uc010ypj.2:exon3:c.C423T:p.C141C,BCL11A:uc002sab.3:exon4:c.C525T:p.C175C,BCL11A:uc002sac.3:exon4:c.C525T:p.C175C,BCL11A:uc002sae.1:exon4:c.C525T:p.C175C,BCL11A:uc010ypi.2:exon5:c.C69T:p.C23C	.	AFR:0.0044,AMR:0.0167,EAS:0,FIN:0.0275,NFE:0.0216,OTH:0.0163,ASJ:0.0265	606557	617101;	.	.	.	.	.	.	.	.	.	.	2	.	het
2	74087290	74087290	T	C	STAMBP	intronic	.	ENSG00000124356	rs1025424	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1776	0.2291	0.158546	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	.	.	AFR:0.2026,AMR:0.2813,EAS:0.1788,FIN:0.0049,NFE:0.1245,OTH:0.2008,ASJ:0.1790	606247	614261;	294016;	294016|MIC-CAP syndrome<br>MIC-CM syndrome<br>Microcephaly-cutaneous capillary malformation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614261 ~	.	.	.	.	.	.	.	.	2	1(lung)	0.1640
2	85536415	85536415	G	A	TCF7L1	exonic	nonsynonymous SNV	ENSG00000152284	rs11547160	ENSG00000152284:ENST00000282111:exon12:c.G1597A:p.G533R	TCF7L1:NM_031283:exon12:c.G1597A:p.G533R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0427	0.0456	0.0291534	0.0342	2.417	18.93	0.01	0.084	0.308	.	.	.	TCF7L1:uc002soy.3:exon12:c.G1597A:p.G533R	-0.137	AFR:0.0129,AMR:0.0251,EAS:0,FIN:0.0172,NFE:0.0555,OTH:0.0265,ASJ:0.0232	604652	.	.	.	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04916 Melanogenesis~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	0.119	-4.95	0.331	0	2	.	hom
2	85625222	85625222	T	G	CAPG	exonic	synonymous SNV	ENSG00000042493	rs6885	ENSG00000042493:ENST00000453973:exon2:c.A78C:p.P26P,ENSG00000042493:ENST00000263867:exon8:c.A813C:p.P271P,ENSG00000042493:ENST00000409670:exon8:c.A813C:p.P271P,ENSG00000042493:ENST00000409724:exon8:c.A813C:p.P271P,ENSG00000042493:ENST00000409921:exon8:c.A768C:p.P256P	CAPG:NM_001320734:exon7:c.A720C:p.P240P,CAPG:NM_001256139:exon8:c.A813C:p.P271P,CAPG:NM_001256140:exon8:c.A768C:p.P256P,CAPG:NM_001320732:exon8:c.A813C:p.P271P,CAPG:NM_001320733:exon8:c.A813C:p.P271P,CAPG:NM_001747:exon8:c.A813C:p.P271P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2239	0.2880	0.251597	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	CAPG:uc010fgj.1:exon5:c.A495C:p.P165P,CAPG:uc002spl.2:exon8:c.A813C:p.P271P,CAPG:uc002spm.2:exon8:c.A768C:p.P256P,CAPG:uc010fgi.2:exon8:c.A813C:p.P271P	.	AFR:0.2682,AMR:0.3776,EAS:0.1788,FIN:0.0797,NFE:0.2134,OTH:0.2507,ASJ:0.1169	153615	.	.	.	.	.	.	.	.	.	.	.	2	1(breast)	0.2251
2	85628983	85628983	C	T	CAPG	exonic	nonsynonymous SNV	ENSG00000042493	rs2229668	ENSG00000042493:ENST00000263867:exon3:c.G121A:p.V41I,ENSG00000042493:ENST00000409275:exon3:c.G121A:p.V41I,ENSG00000042493:ENST00000409670:exon3:c.G121A:p.V41I,ENSG00000042493:ENST00000409724:exon3:c.G121A:p.V41I,ENSG00000042493:ENST00000409921:exon3:c.G121A:p.V41I,ENSG00000042493:ENST00000439385:exon3:c.G121A:p.V41I,ENSG00000042493:ENST00000449030:exon3:c.G121A:p.V41I,ENSG00000042493:ENST00000447219:exon4:c.G121A:p.V41I	CAPG:NM_001256139:exon3:c.G121A:p.V41I,CAPG:NM_001256140:exon3:c.G121A:p.V41I,CAPG:NM_001320732:exon3:c.G121A:p.V41I,CAPG:NM_001320733:exon3:c.G121A:p.V41I,CAPG:NM_001320734:exon3:c.G121A:p.V41I,CAPG:NM_001747:exon3:c.G121A:p.V41I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1083	0.1264	0.0920527	0.1120	-0.437	0.314	0.364	-9.84	0.013	.	.	ADF-H/Gelsolin-like domain|Gelsolin-like domain	CAPG:uc002spl.2:exon3:c.G121A:p.V41I,CAPG:uc002spm.2:exon3:c.G121A:p.V41I,CAPG:uc010fgi.2:exon3:c.G121A:p.V41I	-1.067	AFR:0.0959,AMR:0.0632,EAS:0.0471,FIN:0.0871,NFE:0.1382,OTH:0.1012,ASJ:0.0828	153615	.	.	.	.	.	.	.	0.0	0.56	0.001	0.33	2	MU154844	het
2	88913273	88913273	G	C	EIF2AK3	exonic	nonsynonymous SNV	ENSG00000172071	rs867529	ENSG00000172071:ENST00000303236:exon2:c.C407G:p.S136C	EIF2AK3:NM_004836:exon2:c.C407G:p.S136C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2983	0.1984	0.280551	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	2.316	18.27	0.134	5.38	0.950	.	.	Quinoprotein alcohol dehydrogenase-like superfamily	EIF2AK3:uc002stc.4:exon2:c.C407G:p.S136C	-0.898	AFR:0.2313,AMR:0.0559,EAS:0.2167,FIN:0.4832,NFE:0.3419,OTH:0.2732,ASJ:0.2950	604032	226980;	1667;	1667|Early-onset diabetes mellitus with multiple epiphyseal dysplasia<br>WRS|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226980 ~	.	.	.	.	0.002	1.51	0.000	1.295	2	4(lung)	0.2949
2	96919206	96919206	C	T	TMEM127	UTR3	.	ENSG00000135956	rs1032246352	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	613403	171300;	29072;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~	.	.	.	.	.	.	.	.	2	.	hom
2	100055506	100055506	A	G	REV1	exonic	nonsynonymous SNV	ENSG00000135945	rs3087386	ENSG00000135945:ENST00000258428:exon6:c.T770C:p.F257S,ENSG00000135945:ENST00000393445:exon6:c.T770C:p.F257S	REV1:NM_001037872:exon6:c.T770C:p.F257S,REV1:NM_001321454:exon6:c.T770C:p.F257S,REV1:NM_016316:exon6:c.T770C:p.F257S,REV1:NM_001321455:exon7:c.T560C:p.F187S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5755	0.6015	0.580272	1(stomach)	-1.561	0.002	0.465	-0.027	0.333	.	.	.	REV1:uc002tae.1:exon4:c.T707C:p.F236S,REV1:uc002tac.3:exon6:c.T770C:p.F257S,REV1:uc002tad.3:exon6:c.T770C:p.F257S	-0.979	AFR:1(breast),AMR:3(haematopoietic_and_lymphoid_tissue),EAS:MU754754,FIN:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,NFE:0.6019,OTH:0.7121,ASJ:1(oesophagus)	606134	.	.	.	.	.	.	.	0.0	1.8	0.000	-2.045	2	1(thyroid)	0.6874
2	100288931	100288931	G	A	AFF3	intronic	.	ENSG00000144218	rs4851222	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	0.5469	0.599241	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.5578,AMR:0.6906,EAS:0.4106,FIN:0.6371,NFE:0.5146,OTH:0.4844,ASJ:0.6038	601464	.	.	.	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.5298
2	100343557	100343557	C	T	AFF3	exonic	nonsynonymous SNV	ENSG00000144218	rs4851223	ENSG00000144218:ENST00000409236:exon9:c.G1073A:p.S358N,ENSG00000144218:ENST00000317233:exon10:c.G1073A:p.S358N,ENSG00000144218:ENST00000356421:exon10:c.G1148A:p.S383N,ENSG00000144218:ENST00000409579:exon11:c.G1148A:p.S383N	AFF3:NM_001025108:exon10:c.G1148A:p.S383N,AFF3:NM_002285:exon10:c.G1073A:p.S358N	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	AFF3:uc010fiq.1:exon9:c.G1073A:p.S358N,AFF3:uc002taf.3:exon10:c.G1148A:p.S383N,AFF3:uc002tag.3:exon10:c.G1073A:p.S358N,AFF3:uc002tah.1:exon11:c.G1148A:p.S383N,AFF3:uc010fir.1:exon11:c.G1304A:p.S435N,AFF3:uc010yvr.1:exon11:c.G1535A:p.S512N	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	601464	.	.	.	.	.	.	.	.	.	.	.	2	MU81737770	hom
2	109389463	109389463	G	A	RANBP2	exonic	synonymous SNV	ENSG00000153201	rs826580	ENSG00000153201:ENST00000283195:exon23:c.G8253A:p.E2751E	RANBP2:NM_006267:exon23:c.G8253A:p.E2751E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9959	0.9842	0.98722	0.9884	.	.	.	.	.	.	.	.	RANBP2:uc002tem.4:exon23:c.G8253A:p.E2751E	.	AFR:0.9595,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	.	.	.	.	2	MU81738486	hom
2	112751928	112751928	G	A	MERTK	exonic	nonsynonymous SNV	ENSG00000153208	rs7604639	ENSG00000153208:ENST00000409780:exon8:c.G869A:p.R290K,ENSG00000153208:ENST00000295408:exon9:c.G1397A:p.R466K,ENSG00000153208:ENST00000421804:exon9:c.G1397A:p.R466K	MERTK:NM_006343:exon9:c.G1397A:p.R466K	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5972	0.6340	0.561502	73(lung)	-1.256	0.005	1.0	-3.17	0.328	.	.	Fibronectin type III|Immunoglobulin-like fold	MERTK:uc002thk.1:exon9:c.G1397A:p.R466K,MERTK:uc002thl.1:exon9:c.G869A:p.R290K	-0.967	AFR:MU755143,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.6596,FIN:0.6340,NFE:0.6887,OTH:0.2466,ASJ:0.6217	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	0.0	0.65	0.000	-1.685	2	5(haematopoietic_and_lymphoid_tissue)	0.6623
2	112754880	112754880	G	A	MERTK	intronic	.	ENSG00000153208	rs3811633	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2384	0.2495	0.190096	MU755152	.	.	.	.	.	.	.	.	.	.	AFR:COCA-CN|2|321|0.00623053,AMR:0.2197,EAS:0.1874,FIN:0.3278,NFE:0.1409,OTH:0.2021,ASJ:0.1392	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.2791
2	112754943	112754943	C	T	MERTK	exonic	synonymous SNV	ENSG00000153208	rs3811634	ENSG00000153208:ENST00000409780:exon9:c.C966T:p.N322N,ENSG00000153208:ENST00000295408:exon10:c.C1494T:p.N498N,ENSG00000153208:ENST00000421804:exon10:c.C1494T:p.N498N	MERTK:NM_006343:exon10:c.C1494T:p.N498N	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2385	0.2497	0.190495	0.2198	1.865	15.37	.	1.35	0.913	.	.	.	MERTK:uc002thk.1:exon10:c.C1494T:p.N498N,MERTK:uc002thl.1:exon10:c.C966T:p.N322N	-1.042	AFR:0.1394,AMR:0.1878,EAS:0.1413,FIN:0.2022,NFE:0.2791,OTH:0.2153,ASJ:0.3278	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	0.000	.	2	MU755155	het
2	112755001	112755001	A	G	MERTK	exonic	nonsynonymous SNV	ENSG00000153208	rs2230515	ENSG00000153208:ENST00000409780:exon9:c.A1024G:p.I342V,ENSG00000153208:ENST00000295408:exon10:c.A1552G:p.I518V,ENSG00000153208:ENST00000421804:exon10:c.A1552G:p.I518V	MERTK:NM_006343:exon10:c.A1552G:p.I518V	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5973	0.6339	0.561502	73(lung)	-1.806	0.002	0.795	-2.03	0.431	.	.	.	MERTK:uc002thk.1:exon10:c.A1552G:p.I518V,MERTK:uc002thl.1:exon10:c.A1024G:p.I342V	-0.960	AFR:1(large_intestine),AMR:MU755158,EAS:0.6218,FIN:0.6603,NFE:0.6340,OTH:0.6887,ASJ:LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	0.001	-0.81	0.000	-0.085	2	4(haematopoietic_and_lymphoid_tissue)	0.2469
2	112765973	112765973	A	G	MERTK	exonic	synonymous SNV	ENSG00000153208	rs1131244	ENSG00000153208:ENST00000409780:exon13:c.A1353G:p.S451S,ENSG00000153208:ENST00000295408:exon14:c.A1881G:p.S627S,ENSG00000153208:ENST00000421804:exon14:c.A1881G:p.S627S	MERTK:NM_006343:exon14:c.A1881G:p.S627S	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5825	0.5878	0.515176	LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	MERTK:uc002thk.1:exon14:c.A1881G:p.S627S,MERTK:uc002thl.1:exon14:c.A1353G:p.S451S	.	AFR:0.5805,AMR:0.5181,EAS:0.6887,FIN:0.2469,NFE:0.6615,OTH:0.6273,ASJ:0.6223	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	2(lung)	0.6090
2	121713022	121713022	C	G	GLI2	intronic	.	ENSG00000074047	rs6718382	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9999	.	1	1.0000	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	2	MU81739801	unknown
2	121726447	121726447	G	A	GLI2	exonic	synonymous SNV	ENSG00000074047	rs2592595	ENSG00000074047:ENST00000360874:exon3:c.G388A:p.G130S	GLI2:NM_001371271:exon6:c.G801A:p.S267S,GLI2:NM_005270:exon6:c.G801A:p.S267S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9401	0.8092	0.827276	0.8415	0.628	8.346	0.994	-9.82	0.535	.	.	.	GLI2:uc002tmv.1:exon3:c.G412A:p.G138S	-0.987	AFR:0.4716,AMR:0.9582,EAS:0.9988,FIN:0.9954,NFE:0.9864,OTH:0.9633,ASJ:0.9570	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.006	.	0.000	.	2	MU81739854	hom
2	127808772	127808772	T	C	BIN1	exonic	synonymous SNV	ENSG00000136717	rs749531373	ENSG00000136717:ENST00000409400:exon11:c.A957G:p.G319G,ENSG00000136717:ENST00000352848:exon12:c.A1002G:p.G334G,ENSG00000136717:ENST00000393040:exon12:c.A1086G:p.G362G,ENSG00000136717:ENST00000393041:exon12:c.A1065G:p.G355G,ENSG00000136717:ENST00000259238:exon13:c.A1131G:p.G377G,ENSG00000136717:ENST00000346226:exon13:c.A1194G:p.G398G,ENSG00000136717:ENST00000351659:exon13:c.A1158G:p.G386G,ENSG00000136717:ENST00000357970:exon15:c.A1290G:p.G430G,ENSG00000136717:ENST00000316724:exon16:c.A1419G:p.G473G	BIN1:NM_139350:exon11:c.A957G:p.G319G,BIN1:NM_001320633:exon12:c.A1050G:p.G350G,BIN1:NM_004305:exon12:c.A1002G:p.G334G,BIN1:NM_139348:exon12:c.A1086G:p.G362G,BIN1:NM_139349:exon12:c.A1065G:p.G355G,BIN1:NM_001320640:exon13:c.A1179G:p.G393G,BIN1:NM_139345:exon13:c.A1158G:p.G386G,BIN1:NM_139346:exon13:c.A1131G:p.G377G,BIN1:NM_139347:exon13:c.A1194G:p.G398G,BIN1:NM_001320641:exon15:c.A1326G:p.G442G,BIN1:NM_139344:exon15:c.A1290G:p.G430G,BIN1:NM_001320642:exon16:c.A1338G:p.G446G,BIN1:NM_139343:exon16:c.A1419G:p.G473G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0001	.	.	.	.	.	.	.	.	.	.	.	BIN1:uc002tob.2:exon11:c.A957G:p.G319G,BIN1:uc002tnx.2:exon12:c.A1002G:p.G334G,BIN1:uc002toa.2:exon12:c.A1086G:p.G362G,BIN1:uc002toc.2:exon12:c.A1065G:p.G355G,BIN1:uc010yzg.2:exon12:c.A1050G:p.G350G,BIN1:uc002tnw.2:exon13:c.A1131G:p.G377G,BIN1:uc002tny.2:exon13:c.A1158G:p.G386G,BIN1:uc002tnz.2:exon13:c.A1194G:p.G398G,BIN1:uc002tnv.2:exon15:c.A1290G:p.G430G,BIN1:uc002tns.2:exon16:c.A1419G:p.G473G	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601248	255200;	169186;	169186|AR-CNM|Unknown|Autosomal recessive|Childhood|255200 615959 ~	.	.	.	.	.	.	.	.	2	.	hom
2	140992337	140992337	C	A	LRP1B	intronic	.	ENSG00000168702	rs13387241	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5495	0.5303	0.467452	0.5345	.	.	.	.	.	.	.	.	.	.	AFR:0.3965,AMR:0.4940,EAS:0.5443,FIN:0.6355,NFE:0.5916,OTH:0.5849,ASJ:0.4106	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU735230	hom
2	141027926	141027926	A	G	LRP1B	intronic	.	ENSG00000168702	rs3748865	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1767	0.1296	0.167732	0.1411	.	.	.	.	.	0.0003	0.018	.	.	.	AFR:0.0346,AMR:0.1918,EAS:0.3342,FIN:0.1777,NFE:0.1706,OTH:0.1636,ASJ:0.1258	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU13320520	het
2	141032088	141032088	C	T	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs1386356	ENSG00000168702:ENST00000389484:exon85:c.G13047A:p.T4349T	LRP1B:NM_018557:exon85:c.G13047A:p.T4349T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6037	0.5320	0.486222	0.5412	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon85:c.G13047A:p.T4349T	.	AFR:0.2389,AMR:0.5469,EAS:0.7081,FIN:0.6794,NFE:0.6628,OTH:0.6222,ASJ:0.4967	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU26066624	hom
2	141298674	141298674	T	C	LRP1B	intronic	.	ENSG00000168702	rs13013854	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3911	0.3490	0.329473	0.3494	.	.	.	.	.	0	0	.	.	.	AFR:0.1858,AMR:0.3621,EAS:0.3510,FIN:0.4485,NFE:0.4165,OTH:0.4083,ASJ:0.3742	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU585211	unknown
2	141298682	141298682	G	C	LRP1B	intronic	.	ENSG00000168702	rs11694934	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5084	0.4952	0.504792	0.4973	.	.	.	.	.	.	.	.	.	.	AFR:0.4414,AMR:0.4233,EAS:0.5985,FIN:0.5407,NFE:0.5137,OTH:0.5092,ASJ:0.4338	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU13320946	unknown
2	141528592	141528592	T	C	LRP1B	intronic	.	ENSG00000168702	rs7599219	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8727	0.8384	.	0.8586	.	.	.	.	.	.	.	.	.	.	AFR:0.7653,AMR:0.9111,EAS:1,FIN:0.8989,NFE:0.8841,OTH:0.8755,ASJ:0.8676	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU81741507	hom
2	141533662	141533662	T	C	LRP1B	intronic	.	ENSG00000168702	rs996361	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8732	0.8384	0.855232	0.8591	.	.	.	.	.	0.0002	0.01	.	.	.	AFR:0.7660,AMR:0.9117,EAS:1,FIN:0.8985,NFE:0.8846,OTH:0.8758,ASJ:0.8676	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU81741515	hom
2	141571329	141571329	T	C	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs3749010	ENSG00000168702:ENST00000389484:exon32:c.A5256G:p.S1752S	LRP1B:NM_018557:exon32:c.A5256G:p.S1752S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8708	0.8370	0.845248	0.8491	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon32:c.A5256G:p.S1752S	.	AFR:0.7260,AMR:0.8098,EAS:0.9932,FIN:0.8967,NFE:0.8937,OTH:0.8809,ASJ:0.8642	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU4547566	hom
2	141751592	141751592	G	A	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs13007735	ENSG00000168702:ENST00000389484:exon16:c.C2616T:p.D872D	LRP1B:NM_018557:exon16:c.C2616T:p.D872D	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.3880	0.3987	0.509585	0.3874	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon16:c.C2616T:p.D872D	.	AFR:0.5551,AMR:0.3553,EAS:0.5853,FIN:0.2413,NFE:0.3080,OTH:0.3145,ASJ:0.4834	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU26807821	het
2	142567910	142567910	T	C	LRP1B	exonic	nonsynonymous SNV	ENSG00000168702	rs12990449	ENSG00000168702:ENST00000389484:exon2:c.A143G:p.Q48R,ENSG00000168702:ENST00000434794:exon2:c.A143G:p.Q48R	LRP1B:NM_018557:exon2:c.A143G:p.Q48R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.2338	0.1752	0.217452	0.1856	1.379	12.68	0.329	4.45	1.000	.	.	EGF-like domain;Low-density lipoprotein (LDL) receptor class A, conserved site	LRP1B:uc002tvj.1:exon2:c.A143G:p.Q48R,LRP1B:uc010fnl.1:exon2:c.A254G:p.Q85R	-1.072	AFR:0.0954,AMR:0.1986,EAS:0.4038,FIN:0.1832,NFE:0.2105,OTH:0.2010,ASJ:0.3477	608766	.	.	.	.	,7092	.	.	0.001	-3.68	0.000	-0.31	2	MU760781	hom
2	152404053	152404053	-	A	NEB	intronic	.	ENSG00000183091	rs763008896	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0015	0.0066	.	0.0002	.	.	.	.	.	.	.	.	.	.	AFR:0.0007,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	.	het
2	152425775	152425775	G	A	NEB	intronic	.	ENSG00000183091	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.0001	0.01	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	.	hom
2	152432311	152432311	T	C	NEB	exonic	synonymous SNV	ENSG00000183091	rs33988153	ENSG00000183091:ENST00000413693:exon7:c.A1101G:p.P367P,ENSG00000183091:ENST00000172853:exon79:c.A11808G:p.P3936P,ENSG00000183091:ENST00000409198:exon80:c.A11808G:p.P3936P,ENSG00000183091:ENST00000603639:exon105:c.A16911G:p.P5637P,ENSG00000183091:ENST00000604864:exon105:c.A16911G:p.P5637P,ENSG00000183091:ENST00000397345:exon107:c.A16911G:p.P5637P,ENSG00000183091:ENST00000427231:exon107:c.A16911G:p.P5637P	NEB:NM_004543:exon80:c.A11808G:p.P3936P,NEB:NM_001164507:exon107:c.A16911G:p.P5637P,NEB:NM_001164508:exon107:c.A16911G:p.P5637P,NEB:NM_001271208:exon107:c.A16911G:p.P5637P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1984	0.1894	0.110224	.	.	.	.	.	.	.	.	.	NEB:uc002txr.3:exon7:c.A1206G:p.P402P,NEB:uc021vrb.1:exon78:c.A11808G:p.P3936P,NEB:uc010fnx.3:exon79:c.A11772G:p.P3924P,NEB:uc021vrd.1:exon80:c.A11808G:p.P3936P,NEB:uc002txu.3:exon107:c.A16911G:p.P5637P,NEB:uc021vrc.1:exon107:c.A16911G:p.P5637P,NEB:uc031rpp.1:exon107:c.A16911G:p.P5637P	.	AFR:0.1751,AMR:0.0473,EAS:0.2748,FIN:0.0012,NFE:0.2520,OTH:0.2476,ASJ:0.1283	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.2290
2	152490458	152490458	A	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs6710212	ENSG00000183091:ENST00000603639:exon63:c.T9124C:p.C3042R,ENSG00000183091:ENST00000604864:exon63:c.T9124C:p.C3042R,ENSG00000183091:ENST00000397345:exon65:c.T9124C:p.C3042R,ENSG00000183091:ENST00000427231:exon65:c.T9124C:p.C3042R	NEB:NM_001164507:exon65:c.T9124C:p.C3042R,NEB:NM_001164508:exon65:c.T9124C:p.C3042R,NEB:NM_001271208:exon65:c.T9124C:p.C3042R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9928	0.9757	0.972045	0.9771	0.806	9.498	0.971	6.02	0.994	.	.	.	NEB:uc002txu.3:exon65:c.T9124C:p.C3042R,NEB:uc021vrc.1:exon65:c.T9124C:p.C3042R,NEB:uc031rpp.1:exon65:c.T9124C:p.C3042R	-0.915	AFR:0.9192,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	3.85	0.000	.	2	MU81742117	hom
2	152500449	152500449	C	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs13013209	ENSG00000183091:ENST00000603639:exon55:c.G7839C:p.K2613N,ENSG00000183091:ENST00000604864:exon55:c.G7839C:p.K2613N,ENSG00000183091:ENST00000172853:exon57:c.G7839C:p.K2613N,ENSG00000183091:ENST00000397345:exon57:c.G7839C:p.K2613N,ENSG00000183091:ENST00000409198:exon57:c.G7839C:p.K2613N,ENSG00000183091:ENST00000427231:exon57:c.G7839C:p.K2613N	NEB:NM_001164507:exon57:c.G7839C:p.K2613N,NEB:NM_001164508:exon57:c.G7839C:p.K2613N,NEB:NM_001271208:exon57:c.G7839C:p.K2613N,NEB:NM_004543:exon57:c.G7839C:p.K2613N	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.4150	0.3498	0.293331	1(urinary_tract)	6.495	31	0.026	5.77	1.000	.	.	.	NEB:uc021vrb.1:exon55:c.G7839C:p.K2613N,NEB:uc002txu.3:exon57:c.G7839C:p.K2613N,NEB:uc010fnx.3:exon57:c.G7839C:p.K2613N,NEB:uc021vrc.1:exon57:c.G7839C:p.K2613N,NEB:uc021vrd.1:exon57:c.G7839C:p.K2613N,NEB:uc031rpp.1:exon57:c.G7839C:p.K2613N	-0.977	AFR:MU4546905,AMR:COCA-CN|3|321|0.00934579,EAS:0.0874,FIN:0.4448,NFE:0.4007,OTH:0.2562,ASJ:0.3553	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.999	1.13	0.000	3.455	2	1(bone)	0.4464
2	152527572	152527572	C	T	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs7426114	ENSG00000183091:ENST00000603639:exon36:c.G4471A:p.V1491M,ENSG00000183091:ENST00000604864:exon36:c.G4471A:p.V1491M,ENSG00000183091:ENST00000172853:exon38:c.G4471A:p.V1491M,ENSG00000183091:ENST00000397345:exon38:c.G4471A:p.V1491M,ENSG00000183091:ENST00000409198:exon38:c.G4471A:p.V1491M,ENSG00000183091:ENST00000427231:exon38:c.G4471A:p.V1491M	NEB:NM_001164507:exon38:c.G4471A:p.V1491M,NEB:NM_001164508:exon38:c.G4471A:p.V1491M,NEB:NM_001271208:exon38:c.G4471A:p.V1491M,NEB:NM_004543:exon38:c.G4471A:p.V1491M	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.7386	0.6615	0.533147	MU761016	5.308	25.8	0.03	5.42	0.996	.	.	.	NEB:uc021vrb.1:exon36:c.G4471A:p.V1491M,NEB:uc002txu.3:exon38:c.G4471A:p.V1491M,NEB:uc010fnx.3:exon38:c.G4471A:p.V1491M,NEB:uc021vrc.1:exon38:c.G4471A:p.V1491M,NEB:uc021vrd.1:exon38:c.G4471A:p.V1491M,NEB:uc031rpp.1:exon38:c.G4471A:p.V1491M	-1.161	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.6642,EAS:0.8609,FIN:0.7450,NFE:0.4091,OTH:0.8606,ASJ:0.2882	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.82	3.22	0.000	2.325	2	1(large_intestine)	0.8429
2	152531077	152531077	A	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs6711382	ENSG00000183091:ENST00000603639:exon34:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000604864:exon34:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000172853:exon36:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000397345:exon36:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000409198:exon36:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000427231:exon36:c.T3901C:p.Y1301H	NEB:NM_001164507:exon36:c.T3901C:p.Y1301H,NEB:NM_001164508:exon36:c.T3901C:p.Y1301H,NEB:NM_001271208:exon36:c.T3901C:p.Y1301H,NEB:NM_004543:exon36:c.T3901C:p.Y1301H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8265	0.8178	0.716054	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	1.671	14.24	0.456	5.52	0.994	.	.	.	NEB:uc021vrb.1:exon34:c.T3901C:p.Y1301H,NEB:uc002txu.3:exon36:c.T3901C:p.Y1301H,NEB:uc010fnx.3:exon36:c.T3901C:p.Y1301H,NEB:uc021vrc.1:exon36:c.T3901C:p.Y1301H,NEB:uc021vrd.1:exon36:c.T3901C:p.Y1301H,NEB:uc031rpp.1:exon36:c.T3901C:p.Y1301H	-0.984	AFR:0.8055,AMR:0.6410,EAS:0.8510,FIN:0.5892,NFE:0.8883,OTH:0.8950,ASJ:0.9055	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.0	0.91	0.000	-1.385	2	1(haematopoietic_and_lymphoid_tissue)	0.8605
2	152536498	152536498	T	A	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs6735208	ENSG00000183091:ENST00000603639:exon29:c.A3081T:p.K1027N,ENSG00000183091:ENST00000604864:exon29:c.A3081T:p.K1027N,ENSG00000183091:ENST00000172853:exon31:c.A3081T:p.K1027N,ENSG00000183091:ENST00000397345:exon31:c.A3081T:p.K1027N,ENSG00000183091:ENST00000409198:exon31:c.A3081T:p.K1027N,ENSG00000183091:ENST00000427231:exon31:c.A3081T:p.K1027N	NEB:NM_001164507:exon31:c.A3081T:p.K1027N,NEB:NM_001164508:exon31:c.A3081T:p.K1027N,NEB:NM_001271208:exon31:c.A3081T:p.K1027N,NEB:NM_004543:exon31:c.A3081T:p.K1027N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7499	0.6986	0.583466	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	3.606	23.2	0.131	-1.62	0.997	.	.	.	NEB:uc021vrb.1:exon29:c.A3081T:p.K1027N,NEB:uc002txu.3:exon31:c.A3081T:p.K1027N,NEB:uc010fnx.3:exon31:c.A3081T:p.K1027N,NEB:uc021vrc.1:exon31:c.A3081T:p.K1027N,NEB:uc021vrd.1:exon31:c.A3081T:p.K1027N,NEB:uc031rpp.1:exon31:c.A3081T:p.K1027N	-1.010	AFR:0.6939,AMR:0.3867,EAS:0.7318,FIN:0.4932,NFE:0.8647,OTH:0.8361,ASJ:0.8711	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.982	3.22	0.000	1.65	2	1(breast)	0.8043
2	152573981	152573981	A	G	NEB	exonic	synonymous SNV	ENSG00000183091	rs4611637	ENSG00000183091:ENST00000603639:exon8:c.T771C:p.A257A,ENSG00000183091:ENST00000604864:exon8:c.T771C:p.A257A,ENSG00000183091:ENST00000172853:exon10:c.T771C:p.A257A,ENSG00000183091:ENST00000397345:exon10:c.T771C:p.A257A,ENSG00000183091:ENST00000409198:exon10:c.T771C:p.A257A,ENSG00000183091:ENST00000427231:exon10:c.T771C:p.A257A	NEB:NM_001164507:exon10:c.T771C:p.A257A,NEB:NM_001164508:exon10:c.T771C:p.A257A,NEB:NM_001271208:exon10:c.T771C:p.A257A,NEB:NM_004543:exon10:c.T771C:p.A257A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7438	0.6861	0.569289	LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	NEB:uc021vrb.1:exon8:c.T771C:p.A257A,NEB:uc002txu.3:exon10:c.T771C:p.A257A,NEB:uc010fnx.3:exon10:c.T771C:p.A257A,NEB:uc021vrc.1:exon10:c.T771C:p.A257A,NEB:uc021vrd.1:exon10:c.T771C:p.A257A,NEB:uc031rpp.1:exon10:c.T771C:p.A257A	.	AFR:0.6784,AMR:0.3451,EAS:0.7351,FIN:0.4548,NFE:0.8545,OTH:0.8362,ASJ:0.8604	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	1(breast)	0.7965
2	169830328	169830328	A	G	ABCB11	exonic	nonsynonymous SNV	ENSG00000073734	rs2287622	ENSG00000073734:ENST00000263817:exon13:c.T1331C:p.V444A	ABCB11:NM_003742:exon13:c.T1331C:p.V444A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5794	0.5958	0.588658	MU13370497	1.830	15.16	0.25	4.62	0.998	.	.	ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	ABCB11:uc002ueo.1:exon13:c.T1331C:p.V444A	-0.896	AFR:COCA-CN|5|321|0.0155763,AMR:0.5706,EAS:0.4185,FIN:0.5497,NFE:0.7126,OTH:0.5115,ASJ:0.5576	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	0.001	-3.2	0.000	0.145	2	1(haematopoietic_and_lymphoid_tissue)	0.5895
2	169842809	169842809	T	C	ABCB11	intronic	.	ENSG00000073734	rs2287618	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7053	0.7396	0.774161	0.7312	.	.	.	.	.	.	.	.	.	.	AFR:0.8273,AMR:0.5203,EAS:0.7994,FIN:0.6964,NFE:0.6929,OTH:0.6701,ASJ:0.6887	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	MU23484908	hom
2	169874650	169874650	A	G	ABCB11	UTR5	.	ENSG00000073734	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	.	hom
2	173292709	173292709	A	G	ITGA6	intronic	.	ENSG00000226963	rs6744873	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3560	0.3208	0.500599	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EOPC-DE|1|202|0.0049505	.	.	.	.	.	.	.	.	.	.	AFR:0.3607,AMR:0.4865,EAS:0.2416,FIN:0.8855,NFE:0.3204,OTH:0.2360,ASJ:0.4988	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.3509
2	173292713	173292713	C	T	ITGA6	intronic	.	ENSG00000226963	rs6716540	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3463	0.3175	0.489018	0.3521	.	.	.	.	.	.	.	.	.	.	AFR:0.4824,AMR:0.4730,EAS:0.8664,FIN:0.2892,NFE:0.2327,OTH:0.3306,ASJ:0.2384	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	2	MU16475346	hom
2	173344474	173344474	A	G	ITGA6	intronic	.	ENSG00000091409	rs1920979	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3710	0.4081	0.407149	LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	0.0002	0	.	.	.	AFR:0.3839,AMR:0.5102,EAS:0.3433,FIN:0.3661,NFE:0.3025,OTH:0.3347,ASJ:0.3663	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	2	1(lung)	0.3624
2	173451074	173451074	T	C	PDK1	exonic	synonymous SNV	ENSG00000152256	rs36014095	ENSG00000152256:ENST00000282077:exon9:c.T1014C:p.T338T,ENSG00000152256:ENST00000410055:exon9:c.T1014C:p.T338T,ENSG00000152256:ENST00000543905:exon9:c.T786C:p.T262T,ENSG00000152256:ENST00000392571:exon10:c.T1074C:p.T358T,ENSG00000152256:ENST00000544863:exon10:c.T549C:p.T183T	PDK1:NM_002610:exon9:c.T1014C:p.T338T,PDK1:NM_001278549:exon10:c.T1074C:p.T358T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0191	0.0151	0.0201677	0.0144	.	.	.	.	.	.	.	.	PDK1:uc002uhs.3:exon9:c.T1014C:p.T338T,PDK1:uc002uhq.1:exon10:c.T1074C:p.T358T,PDK1:uc010zdz.1:exon10:c.T549C:p.T183T,PDK1:uc010zeb.2:exon10:c.T1074C:p.T358T	.	AFR:0.0075,AMR:0.0084,EAS:0,FIN:0.0126,NFE:0.0206,OTH:0.0174,ASJ:0.0099	602524	.	.	.	~ko04066 HIF-1 signaling pathway~ko04360 Axon guidance~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	2	.	het
2	175436940	175436940	G	A	WIPF1	exonic	nonsynonymous SNV	ENSG00000115935	rs4972450	ENSG00000115935:ENST00000272746:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000359761:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000392547:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000409415:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000409891:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000392546:exon6:c.C593T:p.P198L	WIPF1:NM_001077269:exon5:c.C593T:p.P198L,WIPF1:NM_003387:exon5:c.C593T:p.P198L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9411	0.923	0.907947	0.9292	0.950	10.37	1.0	5.02	0.942	.	.	.	WIPF1:uc002uiz.3:exon5:c.C593T:p.P198L,WIPF1:uc002uja.3:exon5:c.C593T:p.P198L,WIPF1:uc002ujb.2:exon5:c.C593T:p.P198L,WIPF1:uc002ujc.1:exon5:c.C593T:p.P198L,WIPF1:uc010fqt.1:exon5:c.C593T:p.P198L,WIPF1:uc010zep.1:exon5:c.C593T:p.P198L	-0.966	AFR:0.8450,AMR:0.9558,EAS:0.9926,FIN:0.9774,NFE:0.9571,OTH:0.9612,ASJ:0.8940	602357	614493;	906;	906|Eczema-thrombocytopenia-immunodeficiency syndrome<br>WAS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|277970 301000 600903 614493 ~	.	.	.	.	0.0	1.68	0.000	-2.28	2	MU26801477	hom
2	187487160	187487160	G	A	ITGAV	intronic	.	ENSG00000138448	rs9333288	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7458	0.7575	0.76258	0.7530	.	.	.	.	.	0	0.004	.	.	.	AFR:0.7741,AMR:0.7291,EAS:0.8623,FIN:0.7467,NFE:0.7342,OTH:0.7295,ASJ:0.7119	193210	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	2	MU26816650	hom
2	187532417	187532417	G	A	ITGAV	exonic	nonsynonymous SNV	ENSG00000138448	rs2230616	ENSG00000138448:ENST00000374907:exon22:c.G2239A:p.V747I,ENSG00000138448:ENST00000261023:exon24:c.G2347A:p.V783I,ENSG00000138448:ENST00000433736:exon24:c.G2209A:p.V737I	ITGAV:NM_001145000:exon22:c.G2239A:p.V747I,ITGAV:NM_001144999:exon24:c.G2209A:p.V737I,ITGAV:NM_002210:exon24:c.G2347A:p.V783I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9978	0.9909	0.992212	0.9923	2.394	18.78	0.694	3.39	1.000	.	.	Integrin alpha-2|Integrin domain	ITGAV:uc010frs.4:exon22:c.G2239A:p.V747I,ITGAV:uc002upq.4:exon24:c.G2347A:p.V783I,ITGAV:uc010zfv.3:exon24:c.G2209A:p.V737I	-0.948	AFR:0.9732,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:1,ASJ:1	193210	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.002	0.62	0.000	0.39	2	MU81747102	hom
2	189864080	189864080	G	A	COL3A1	exonic	nonsynonymous SNV	ENSG00000168542	rs1800255	ENSG00000168542:ENST00000304636:exon30:c.G2092A:p.A698T,ENSG00000168542:ENST00000317840:exon30:c.G2092A:p.A698T	COL3A1:NM_000090:exon30:c.G2092A:p.A698T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3204	0.2139	0.21845	0.2118	3.334	22.9	0.231	0.873	0.906	.	.	.	COL3A1:uc002uqj.1:exon30:c.G2092A:p.A698T	-1.057	AFR:0.1219,AMR:0.2368,EAS:0.2178,FIN:0.2579,NFE:0.2463,OTH:0.2485,ASJ:0.3411	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	0.0	-3.23	0.000	0.975	2	MU121280	hom
2	189875421	189875421	T	G	COL3A1	exonic	nonsynonymous SNV	ENSG00000168542	rs1516446	ENSG00000168542:ENST00000317840:exon41:c.T3150G:p.H1050Q,ENSG00000168542:ENST00000304636:exon50:c.T4059G:p.H1353Q	COL3A1:NM_000090:exon50:c.T4059G:p.H1353Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9985	0.9949	0.996605	0.9958	0.421	6.799	1.0	1.42	0.979	.	.	Fibrillar collagen, C-terminal|Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1	COL3A1:uc002uqj.1:exon50:c.T4059G:p.H1353Q	-0.950	AFR:0.9852,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:0.9967	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	0.0	0.36	0.000	-3.715	2	MU81747200	hom
2	190738296	190738296	T	C	PMS1	exonic	synonymous SNV	ENSG00000064933	.	ENSG00000064933:ENST00000452382:exon4:c.T712C:p.L238L,ENSG00000064933:ENST00000409593:exon6:c.T1417C:p.L473L,ENSG00000064933:ENST00000432292:exon10:c.T2020C:p.L674L,ENSG00000064933:ENST00000409823:exon11:c.T2431C:p.L811L,ENSG00000064933:ENST00000418224:exon11:c.T2020C:p.L674L,ENSG00000064933:ENST00000447232:exon11:c.T2062C:p.L688L,ENSG00000064933:ENST00000441310:exon12:c.T2548C:p.L850L	PMS1:NM_001289409:exon10:c.T2020C:p.L674L,PMS1:NM_001321044:exon10:c.T1945C:p.L649L,PMS1:NM_001128143:exon11:c.T2431C:p.L811L,PMS1:NM_001128144:exon11:c.T2062C:p.L688L,PMS1:NM_001289408:exon11:c.T2020C:p.L674L,PMS1:NM_001321046:exon11:c.T2365C:p.L789L,PMS1:NM_000534:exon12:c.T2548C:p.L850L,PMS1:NM_001321047:exon12:c.T2548C:p.L850L,PMS1:NM_001321045:exon13:c.T2548C:p.L850L,PMS1:NM_001321048:exon13:c.T2548C:p.L850L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	PMS1:uc002url.3:exon6:c.T1417C:p.L473L,PMS1:uc010zgd.2:exon10:c.T2020C:p.L674L,PMS1:uc002uri.4:exon11:c.T2062C:p.L688L,PMS1:uc002urk.4:exon11:c.T2431C:p.L811L,PMS1:uc010zgc.2:exon11:c.T2020C:p.L674L,PMS1:uc002urh.4:exon12:c.T2548C:p.L850L	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600258	.	.	.	.	.	.	.	.	.	.	.	2	.	hom
2	198257795	198257795	T	C	SF3B1	exonic	synonymous SNV	ENSG00000115524	rs4685	ENSG00000115524:ENST00000335508:exon24:c.A3657G:p.V1219V	SF3B1:NM_012433:exon24:c.A3657G:p.V1219V	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6717	0.7360	0.71845	0.6804	.	.	.	.	.	.	.	.	SF3B1:uc002uue.3:exon24:c.A3657G:p.V1219V	.	AFR:0.8292,AMR:0.5299,EAS:0.5310,FIN:0.5539,NFE:0.6499,OTH:0.6245,ASJ:0.7517	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	9683,,9684,9685	.	9679,9675,,9677,9678,9680,9676,9681	.	.	.	.	2	MU137937	hom
2	198283305	198283305	T	C	SF3B1	exonic	synonymous SNV	ENSG00000115524	rs788023	ENSG00000115524:ENST00000335508:exon5:c.A423G:p.K141K	SF3B1:NM_012433:exon5:c.A423G:p.K141K	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6725	0.7394	0.720647	0.6838	.	.	.	.	.	.	.	.	SF3B1:uc002uue.3:exon5:c.A423G:p.K141K	.	AFR:0.8395,AMR:0.5311,EAS:0.5273,FIN:0.5554,NFE:0.6508,OTH:0.6281,ASJ:0.7450	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	9683,,9684,9685	.	9679,9675,,9677,9678,9680,9676,9681	.	.	.	.	2	MU137962	hom
2	202122995	202122995	A	G	CASP8	exonic	nonsynonymous SNV	ENSG00000064012	rs3769823	ENSG00000064012:ENST00000358485:exon1:c.A41G:p.K14R,ENSG00000064012:ENST00000437283:exon1:c.A41G:p.K14R	CASP8:NM_001080125:exon1:c.A41G:p.K14R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6673	0.6695	0.646366	LAML-KR|1|205|0.00487805,COCA-CN|6|321|0.0186916	-0.732	0.061	1.0	2.78	0.001	.	.	Death effector domain|Death-like domain	CASP8:uc002uxt.1:exon1:c.A41G:p.K14R	-0.995	AFR:0.6618,AMR:0.5774,EAS:0.6167,FIN:0.7326,NFE:0.6444,OTH:0.7127,ASJ:0.5658	601763	114480;114550;211980;607271;	275517;449;88673;227535;	275517|ALPS with recurrent viral infections<br>CEDS<br>Caspase 8 deficiency syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|607271 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05130 Pathogenic Escherichia coli infection~ko05134 Legionellosis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05416 Viral myocarditis ~	.	.	.	0.008	4.26	0.000	.	2	1(thyroid)	0.6714
2	202149696	202149696	G	A	CASP8	exonic	synonymous SNV	ENSG00000064012	rs1045487	ENSG00000064012:ENST00000444430:exon2:c.G297A:p.K99K,ENSG00000064012:ENST00000264274:exon6:c.G708A:p.K236K,ENSG00000064012:ENST00000323492:exon7:c.G915A:p.K305K,ENSG00000064012:ENST00000358485:exon8:c.G1137A:p.K379K,ENSG00000064012:ENST00000392263:exon8:c.G915A:p.K305K,ENSG00000064012:ENST00000264275:exon9:c.G1011A:p.K337K,ENSG00000064012:ENST00000432109:exon9:c.G960A:p.K320K	CASP8:NM_033356:exon7:c.G915A:p.K305K,CASP8:NM_001080124:exon8:c.G915A:p.K305K,CASP8:NM_001080125:exon8:c.G1137A:p.K379K,CASP8:NM_001228:exon9:c.G1011A:p.K337K,CASP8:NM_033355:exon9:c.G960A:p.K320K	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1020	0.1062	0.175319	LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	CASP8:uc010ftf.2:exon4:c.G708A:p.K236K,CASP8:uc002uxw.1:exon7:c.G915A:p.K305K,CASP8:uc002uxq.1:exon8:c.G915A:p.K305K,CASP8:uc002uxt.1:exon8:c.G1137A:p.K379K,CASP8:uc002uxp.1:exon9:c.G1011A:p.K337K,CASP8:uc002uxr.1:exon9:c.G960A:p.K320K	.	AFR:0.0977,AMR:0.2068,EAS:0.0828,FIN:0.1938,NFE:0.0475,OTH:0.0418,ASJ:0.0358	601763	114480;114550;211980;607271;	275517;449;88673;227535;	275517|ALPS with recurrent viral infections<br>CEDS<br>Caspase 8 deficiency syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|607271 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05130 Pathogenic Escherichia coli infection~ko05134 Legionellosis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	2	2(lung)	0.0644
2	203421199	203421199	G	A	BMPR2	exonic	synonymous SNV	ENSG00000204217	rs1061157	ENSG00000204217:ENST00000374580:exon12:c.G2811A:p.R937R	BMPR2:NM_001204:exon12:c.G2811A:p.R937R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1203	0.0917	0.116414	BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	BMPR2:uc002uzf.4:exon12:c.G2811A:p.R937R	.	AFR:0.0915,AMR:0.0218,EAS:0.0667,FIN:0.0980,NFE:0.1231,OTH:0.1239,ASJ:0.0931	600799	178600;265450;	31837;422;	31837|-|-|Autosomal recessive<br>or&nbsp;Not applicable|All ages|265450 ~422|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable<br>or&nbsp;Autosomal recessive|All ages|178600 265400 615342 615343 615344 ~	.	.	.	.	.	.	.	.	2	1(breast)	0.0980
2	203424617	203424617	G	T	BMPR2	exonic	nonsynonymous SNV	ENSG00000204217	.	ENSG00000204217:ENST00000374580:exon13:c.G3065T:p.G1022V	BMPR2:NM_001204:exon13:c.G3065T:p.G1022V	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 2, 0, 0] 	.	.	.	.	5.681	26.7	0.002	5.65	1.000	.	.	.	BMPR2:uc002uzf.4:exon13:c.G3065T:p.G1022V	0.899	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600799	178600;265450;	31837;422;	31837|-|-|Autosomal recessive<br>or&nbsp;Not applicable|All ages|265450 ~422|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable<br>or&nbsp;Autosomal recessive|All ages|178600 265400 615342 615343 615344 ~	.	.	.	.	0.976	-3.84	0.857	2.045	2	.	hom
2	209101906	209101906	A	-	IDH1	intronic	.	ENSG00000138413	rs57383668	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9898	.	0.982628	0.9861	.	.	.	.	.	.	.	.	.	.	AFR:0.9526,AMR:0.9964,EAS:1,FIN:1,NFE:0.9994,OTH:0.9938,ASJ:1	147700	137800;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko00020 Citrate cycle (TCA cycle)~ko00480 Glutathione metabolism~ko00720 Carbon fixation pathways in prokaryotes~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko01210 2-Oxocarboxylic acid metabolism~ko01230 Biosynthesis of amino acids~ko04146 Peroxisome~~M00009 Citrate cycle (TCA cycle, Krebs cycle)~M00010 Citrate cycle, first carbon oxidation, oxaloacetate =>~~M00173 Reductive citrate cycle (Arnon-Buchanan cycle)~M00740 Methylaspartate cycle ~	.	.	.	.	.	.	.	2	.	het
2	211521228	211521229	TT	-	CPS1	intronic	.	ENSG00000021826	rs200838660	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2389	.	.	0.0135	.	.	.	.	.	.	.	.	.	.	AFR:0.0080,AMR:0.0392,EAS:0.0009,FIN:0.0716,NFE:0.0103,OTH:0.0213,ASJ:0.0174	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	.	.	.	.	2	.	het
2	211527828	211527828	T	-	CPS1	intronic	.	ENSG00000021826	rs397703682	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.7547	.	0.77476	0.8552	.	.	.	.	.	.	.	.	.	.	AFR:0.7533,AMR:0.8290,EAS:0.9375,FIN:0.9002,NFE:0.8987,OTH:0.9048,ASJ:0.9190	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	.	.	.	.	2	.	hom
2	211540507	211540507	C	A	CPS1	exonic	nonsynonymous SNV	ENSG00000021826	rs1047891	ENSG00000021826:ENST00000451903:exon26:c.C2864A:p.T955N,ENSG00000021826:ENST00000233072:exon36:c.C4217A:p.T1406N,ENSG00000021826:ENST00000430249:exon37:c.C4235A:p.T1412N	CPS1:NM_001875:exon36:c.C4217A:p.T1406N,CPS1:NM_001122633:exon37:c.C4217A:p.T1406N,CPS1:NM_001369256:exon37:c.C4250A:p.T1417N,CPS1:NM_001369257:exon38:c.C4217A:p.T1406N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3034	0.3292	0.288538	0.3275	2.953	22.1	0.237	5.2	1.000	.	.	Carbamoyl-phosphate synthetase, large subunit oligomerisation domain;Methylglyoxal synthase-like domain	CPS1:uc010fus.3:exon26:c.C2864A:p.T955N,CPS1:uc002vee.4:exon36:c.C4217A:p.T1406N,CPS1:uc010fur.3:exon37:c.C4235A:p.T1412N	-1.073	AFR:0.3725,AMR:0.3138,EAS:0.1578,FIN:0.3426,NFE:0.3171,OTH:0.3289,ASJ:0.3146	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	0.009	-1.67	0.000	1.695	2	MU816614	hom
2	211542676	211542676	C	T	CPS1	exonic	synonymous SNV	ENSG00000021826	rs780901179	ENSG00000021826:ENST00000451903:exon28:c.C3117T:p.H1039H,ENSG00000021826:ENST00000233072:exon38:c.C4470T:p.H1490H,ENSG00000021826:ENST00000430249:exon39:c.C4488T:p.H1496H	CPS1:NM_001875:exon38:c.C4470T:p.H1490H,CPS1:NM_001122633:exon39:c.C4470T:p.H1490H,CPS1:NM_001369256:exon39:c.C4503T:p.H1501H,CPS1:NM_001369257:exon40:c.C4470T:p.H1490H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	1.652e-05	.	.	.	.	.	.	.	.	.	.	.	CPS1:uc010fus.3:exon28:c.C3117T:p.H1039H,CPS1:uc002vee.4:exon38:c.C4470T:p.H1490H,CPS1:uc010fur.3:exon39:c.C4488T:p.H1496H	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	.	.	.	.	2	.	het
2	215632255	215632255	C	T	BARD1	exonic	nonsynonymous SNV	ENSG00000138376	rs2070094	ENSG00000138376:ENST00000449967:exon5:c.G1087A:p.V363M,ENSG00000138376:ENST00000260947:exon6:c.G1519A:p.V507M	BARD1:NM_001282543:exon5:c.G1462A:p.V488M,BARD1:NM_000465:exon6:c.G1519A:p.V507M	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3783	0.2806	0.366214	0.3845	0.209	4.771	0.269	-11.3	0.313	.	.	Ankyrin repeat-containing domain	BARD1:uc021vwf.1:exon4:c.G1228A:p.V410M,BARD1:uc010zjm.1:exon5:c.G1087A:p.V363M,BARD1:uc021vwd.1:exon5:c.G217A:p.V73M,BARD1:uc021vwe.1:exon5:c.G1462A:p.V488M,BARD1:uc002veu.2:exon6:c.G1519A:p.V507M,BARD1:uc021vwj.1:exon6:c.G1111A:p.V371M	-1.097	AFR:0.3705,AMR:0.3103,EAS:0.3806,FIN:0.4676,NFE:0.3741,OTH:0.4286,ASJ:0.4238	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.001	-0.17	0.000	1.23	2	MU152802	unknown
2	215632256	215632256	A	G	BARD1	exonic	synonymous SNV	ENSG00000138376	rs2070093	ENSG00000138376:ENST00000449967:exon5:c.T1086C:p.H362H,ENSG00000138376:ENST00000260947:exon6:c.T1518C:p.H506H	BARD1:NM_001282543:exon5:c.T1461C:p.H487H,BARD1:NM_000465:exon6:c.T1518C:p.H506H	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8134	0.7138	0.770567	0.7658	.	.	.	.	.	.	.	.	BARD1:uc021vwf.1:exon4:c.T1227C:p.H409H,BARD1:uc010zjm.1:exon5:c.T1086C:p.H362H,BARD1:uc021vwd.1:exon5:c.T216C:p.H72H,BARD1:uc021vwe.1:exon5:c.T1461C:p.H487H,BARD1:uc002veu.2:exon6:c.T1518C:p.H506H,BARD1:uc021vwj.1:exon6:c.T1110C:p.H370H	.	AFR:0.6055,AMR:0.7883,EAS:0.9543,FIN:0.8947,NFE:0.8028,OTH:0.8286,ASJ:0.7848	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	MU31491380	unknown
2	215645464	215645464	C	G	BARD1	exonic	nonsynonymous SNV	ENSG00000138376	rs2229571	ENSG00000138376:ENST00000449967:exon3:c.G702C:p.R234S,ENSG00000138376:ENST00000260947:exon4:c.G1134C:p.R378S	BARD1:NM_001282543:exon3:c.G1077C:p.R359S,BARD1:NM_000465:exon4:c.G1134C:p.R378S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5487	0.5318	0.459265	0.5519	0.673	8.652	0.174	-1.03	0.050	.	.	.	BARD1:uc021vwf.1:exon2:c.G843C:p.R281S,BARD1:uc010zjm.1:exon3:c.G702C:p.R234S,BARD1:uc021vwe.1:exon3:c.G1077C:p.R359S,BARD1:uc002veu.2:exon4:c.G1134C:p.R378S	-0.921	AFR:0.4006,AMR:0.4376,EAS:0.3851,FIN:0.6827,NFE:0.6283,OTH:0.6214,ASJ:0.5894	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.024	-0.67	0.000	1.67	2	MU152809	hom
2	216226642	216226642	A	C	FN1	intronic	.	ENSG00000115414	rs13394662	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2935	0.3255	0.185503	0.3171	.	.	.	.	.	.	.	.	.	.	AFR:0.1958,AMR:0.2285,EAS:0.0037,FIN:0.4470,NFE:0.3926,OTH:0.3837,ASJ:0.31	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU87917989	het
2	216229692	216229692	A	G	FN1	exonic	synonymous SNV	ENSG00000115414	rs11651	ENSG00000115414:ENST00000456923:exon19:c.T3039C:p.Y1013Y,ENSG00000115414:ENST00000345488:exon41:c.T6282C:p.Y2094Y,ENSG00000115414:ENST00000346544:exon42:c.T6363C:p.Y2121Y,ENSG00000115414:ENST00000356005:exon42:c.T6618C:p.Y2206Y,ENSG00000115414:ENST00000357867:exon42:c.T6258C:p.Y2086Y,ENSG00000115414:ENST00000359671:exon43:c.T6888C:p.Y2296Y,ENSG00000115414:ENST00000421182:exon43:c.T6450C:p.Y2150Y,ENSG00000115414:ENST00000432072:exon43:c.T6531C:p.Y2177Y,ENSG00000115414:ENST00000443816:exon43:c.T6525C:p.Y2175Y,ENSG00000115414:ENST00000336916:exon44:c.T6795C:p.Y2265Y,ENSG00000115414:ENST00000354785:exon44:c.T7161C:p.Y2387Y,ENSG00000115414:ENST00000446046:exon44:c.T6720C:p.Y2240Y,ENSG00000115414:ENST00000323926:exon45:c.T7068C:p.Y2356Y	FN1:NM_001365523:exon42:c.T6543C:p.Y2181Y,FN1:NM_212474:exon42:c.T6258C:p.Y2086Y,FN1:NM_212476:exon42:c.T6618C:p.Y2206Y,FN1:NM_001306130:exon43:c.T6531C:p.Y2177Y,FN1:NM_001306131:exon43:c.T6525C:p.Y2175Y,FN1:NM_001306132:exon43:c.T6450C:p.Y2150Y,FN1:NM_001365517:exon43:c.T6891C:p.Y2297Y,FN1:NM_001365518:exon43:c.T6888C:p.Y2296Y,FN1:NM_001365519:exon43:c.T6816C:p.Y2272Y,FN1:NM_001365520:exon43:c.T6813C:p.Y2271Y,FN1:NM_001365524:exon43:c.T6528C:p.Y2176Y,FN1:NM_001365521:exon44:c.T6798C:p.Y2266Y,FN1:NM_001365522:exon44:c.T6723C:p.Y2241Y,FN1:NM_002026:exon44:c.T6795C:p.Y2265Y,FN1:NM_212478:exon44:c.T6720C:p.Y2240Y,FN1:NM_212482:exon44:c.T7161C:p.Y2387Y,FN1:NM_001306129:exon45:c.T7068C:p.Y2356Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4079	0.2481	0.282748	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	FN1:uc002vez.3:exon17:c.T1650C:p.Y550Y,FN1:uc010zjp.2:exon19:c.T2772C:p.Y924Y,FN1:uc002vfg.3:exon42:c.T6618C:p.Y2206Y,FN1:uc002vfh.3:exon42:c.T6258C:p.Y2086Y,FN1:uc002vfb.3:exon43:c.T6525C:p.Y2175Y,FN1:uc002vfc.3:exon43:c.T6450C:p.Y2150Y,FN1:uc002vfj.3:exon43:c.T6531C:p.Y2177Y,FN1:uc002vfa.3:exon44:c.T7161C:p.Y2387Y,FN1:uc002vfe.3:exon44:c.T6795C:p.Y2265Y,FN1:uc002vff.3:exon44:c.T6720C:p.Y2240Y,FN1:uc002vfi.3:exon45:c.T7068C:p.Y2356Y	.	AFR:0.2534,AMR:0.0982,EAS:0.3940,FIN:0.2816,NFE:0.2758,OTH:0.3266,ASJ:0.3369	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	1(large_intestine)	0.2751
2	216235089	216235089	C	T	FN1	exonic	nonsynonymous SNV	ENSG00000115414	rs1250209	ENSG00000115414:ENST00000456923:exon16:c.G2659A:p.V887I,ENSG00000115414:ENST00000356005:exon39:c.G6238A:p.V2080I,ENSG00000115414:ENST00000357867:exon39:c.G5878A:p.V1960I,ENSG00000115414:ENST00000346544:exon40:c.G6148A:p.V2050I,ENSG00000115414:ENST00000359671:exon40:c.G6508A:p.V2170I,ENSG00000115414:ENST00000421182:exon40:c.G6070A:p.V2024I,ENSG00000115414:ENST00000432072:exon40:c.G6151A:p.V2051I,ENSG00000115414:ENST00000443816:exon40:c.G6145A:p.V2049I,ENSG00000115414:ENST00000336916:exon41:c.G6415A:p.V2139I,ENSG00000115414:ENST00000354785:exon41:c.G6781A:p.V2261I,ENSG00000115414:ENST00000446046:exon41:c.G6340A:p.V2114I,ENSG00000115414:ENST00000323926:exon42:c.G6688A:p.V2230I	FN1:NM_001365523:exon39:c.G6163A:p.V2055I,FN1:NM_212474:exon39:c.G5878A:p.V1960I,FN1:NM_212476:exon39:c.G6238A:p.V2080I,FN1:NM_001306130:exon40:c.G6151A:p.V2051I,FN1:NM_001306131:exon40:c.G6145A:p.V2049I,FN1:NM_001306132:exon40:c.G6070A:p.V2024I,FN1:NM_001365517:exon40:c.G6511A:p.V2171I,FN1:NM_001365518:exon40:c.G6508A:p.V2170I,FN1:NM_001365519:exon40:c.G6436A:p.V2146I,FN1:NM_001365520:exon40:c.G6433A:p.V2145I,FN1:NM_001365524:exon40:c.G6148A:p.V2050I,FN1:NM_001365521:exon41:c.G6418A:p.V2140I,FN1:NM_001365522:exon41:c.G6343A:p.V2115I,FN1:NM_002026:exon41:c.G6415A:p.V2139I,FN1:NM_212478:exon41:c.G6340A:p.V2114I,FN1:NM_212482:exon41:c.G6781A:p.V2261I,FN1:NM_001306129:exon42:c.G6688A:p.V2230I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	1.0000	0.9998	0.9998	0.9998	3.072	22.4	1.0	5.6	0.999	.	.	Fibronectin type III|Immunoglobulin-like fold;Fibronectin, type I	FN1:uc010fvd.1:exon7:c.G961A:p.V321I,FN1:uc010fvc.1:exon11:c.G1507A:p.V503I,FN1:uc002vez.3:exon14:c.G1270A:p.V424I,FN1:uc010zjp.2:exon16:c.G2392A:p.V798I,FN1:uc002vfg.3:exon39:c.G6238A:p.V2080I,FN1:uc002vfh.3:exon39:c.G5878A:p.V1960I,FN1:uc002vfb.3:exon40:c.G6145A:p.V2049I,FN1:uc002vfc.3:exon40:c.G6070A:p.V2024I,FN1:uc002vfj.3:exon40:c.G6151A:p.V2051I,FN1:uc002vfa.3:exon41:c.G6781A:p.V2261I,FN1:uc002vfe.3:exon41:c.G6415A:p.V2139I,FN1:uc002vff.3:exon41:c.G6340A:p.V2114I,FN1:uc002vfi.3:exon42:c.G6688A:p.V2230I	-0.928	AFR:0.9994,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.0	0.29	0.000	-0.455	2	MU81750207	hom
2	216249587	216249587	C	T	FN1	exonic	synonymous SNV	ENSG00000115414	rs13652	ENSG00000115414:ENST00000456923:exon5:c.G873A:p.E291E,ENSG00000115414:ENST00000336916:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000345488:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000346544:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000356005:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000357009:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000357867:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000359671:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000421182:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000443816:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000446046:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000323926:exon29:c.G4725A:p.E1575E,ENSG00000115414:ENST00000354785:exon29:c.G4725A:p.E1575E,ENSG00000115414:ENST00000432072:exon29:c.G4725A:p.E1575E	FN1:NM_001306131:exon28:c.G4452A:p.E1484E,FN1:NM_001306132:exon28:c.G4452A:p.E1484E,FN1:NM_001365518:exon28:c.G4452A:p.E1484E,FN1:NM_001365520:exon28:c.G4452A:p.E1484E,FN1:NM_001365523:exon28:c.G4452A:p.E1484E,FN1:NM_001365524:exon28:c.G4452A:p.E1484E,FN1:NM_002026:exon28:c.G4452A:p.E1484E,FN1:NM_212474:exon28:c.G4452A:p.E1484E,FN1:NM_212476:exon28:c.G4452A:p.E1484E,FN1:NM_212478:exon28:c.G4452A:p.E1484E,FN1:NM_001306129:exon29:c.G4725A:p.E1575E,FN1:NM_001306130:exon29:c.G4725A:p.E1575E,FN1:NM_001365517:exon29:c.G4725A:p.E1575E,FN1:NM_001365519:exon29:c.G4725A:p.E1575E,FN1:NM_001365521:exon29:c.G4725A:p.E1575E,FN1:NM_001365522:exon29:c.G4725A:p.E1575E,FN1:NM_212482:exon29:c.G4725A:p.E1575E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8752	0.8493	0.86861	0.8734	.	.	.	.	.	.	.	.	FN1:uc010zjp.2:exon5:c.G606A:p.E202E,FN1:uc002vfb.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfc.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfe.3:exon28:c.G4452A:p.E1484E,FN1:uc002vff.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfg.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfh.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfa.3:exon29:c.G4725A:p.E1575E,FN1:uc002vfi.3:exon29:c.G4725A:p.E1575E,FN1:uc002vfj.3:exon29:c.G4725A:p.E1575E	.	AFR:0.8131,AMR:0.8890,EAS:1,FIN:0.9270,NFE:0.8818,OTH:0.8890,ASJ:0.8046	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU81750265	hom
2	216253039	216253039	G	C	FN1	intronic	.	ENSG00000115414	rs1250215	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5491	0.5241	0.411741	0.5267	.	.	.	.	.	.	.	.	.	.	AFR:0.3086,AMR:0.4880,EAS:0.2151,FIN:0.6778,NFE:0.6522,OTH:0.5939,ASJ:0.4073	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU25472968	hom
2	216272900	216272900	T	G	FN1	exonic	nonsynonymous SNV	ENSG00000115414	rs2577301	ENSG00000115414:ENST00000323926:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000336916:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000345488:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000346544:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000354785:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000356005:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000357009:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000357867:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000359671:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000421182:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000432072:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000443816:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000446046:exon17:c.A2449C:p.T817P	FN1:NM_001306129:exon17:c.A2449C:p.T817P,FN1:NM_001306130:exon17:c.A2449C:p.T817P,FN1:NM_001306131:exon17:c.A2449C:p.T817P,FN1:NM_001306132:exon17:c.A2449C:p.T817P,FN1:NM_001365517:exon17:c.A2449C:p.T817P,FN1:NM_001365518:exon17:c.A2449C:p.T817P,FN1:NM_001365519:exon17:c.A2449C:p.T817P,FN1:NM_001365520:exon17:c.A2449C:p.T817P,FN1:NM_001365521:exon17:c.A2449C:p.T817P,FN1:NM_001365522:exon17:c.A2449C:p.T817P,FN1:NM_001365523:exon17:c.A2449C:p.T817P,FN1:NM_001365524:exon17:c.A2449C:p.T817P,FN1:NM_002026:exon17:c.A2449C:p.T817P,FN1:NM_212474:exon17:c.A2449C:p.T817P,FN1:NM_212476:exon17:c.A2449C:p.T817P,FN1:NM_212478:exon17:c.A2449C:p.T817P,FN1:NM_212482:exon17:c.A2449C:p.T817P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	1.0000	0.9999	0.9998	0.9998	1.626	14.00	0.314	5.93	0.070	.	.	Fibronectin type III|Immunoglobulin-like fold	FN1:uc002vfa.3:exon17:c.A2449C:p.T817P,FN1:uc002vfb.3:exon17:c.A2449C:p.T817P,FN1:uc002vfc.3:exon17:c.A2449C:p.T817P,FN1:uc002vfe.3:exon17:c.A2449C:p.T817P,FN1:uc002vff.3:exon17:c.A2449C:p.T817P,FN1:uc002vfg.3:exon17:c.A2449C:p.T817P,FN1:uc002vfh.3:exon17:c.A2449C:p.T817P,FN1:uc002vfi.3:exon17:c.A2449C:p.T817P,FN1:uc002vfj.3:exon17:c.A2449C:p.T817P	-0.957	AFR:0.9995,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.0	0.51	0.000	-0.69	2	MU81750388	hom
2	216274441	216274441	G	A	FN1	exonic	nonsynonymous SNV	ENSG00000115414	rs144664306	ENSG00000115414:ENST00000323926:exon15:c.C2144T:p.T715M,ENSG00000115414:ENST00000336916:exon15:c.C2144T:p.T715M,ENSG00000115414:ENST00000345488:exon15:c.C2144T:p.T715M,ENSG00000115414:ENST00000346544:exon15:c.C2144T:p.T715M,ENSG00000115414:ENST00000354785:exon15:c.C2144T:p.T715M,ENSG00000115414:ENST00000356005:exon15:c.C2144T:p.T715M,ENSG00000115414:ENST00000357009:exon15:c.C2144T:p.T715M,ENSG00000115414:ENST00000357867:exon15:c.C2144T:p.T715M,ENSG00000115414:ENST00000359671:exon15:c.C2144T:p.T715M,ENSG00000115414:ENST00000421182:exon15:c.C2144T:p.T715M,ENSG00000115414:ENST00000432072:exon15:c.C2144T:p.T715M,ENSG00000115414:ENST00000443816:exon15:c.C2144T:p.T715M,ENSG00000115414:ENST00000446046:exon15:c.C2144T:p.T715M	FN1:NM_001306129:exon15:c.C2144T:p.T715M,FN1:NM_001306130:exon15:c.C2144T:p.T715M,FN1:NM_001306131:exon15:c.C2144T:p.T715M,FN1:NM_001306132:exon15:c.C2144T:p.T715M,FN1:NM_001365517:exon15:c.C2144T:p.T715M,FN1:NM_001365518:exon15:c.C2144T:p.T715M,FN1:NM_001365519:exon15:c.C2144T:p.T715M,FN1:NM_001365520:exon15:c.C2144T:p.T715M,FN1:NM_001365521:exon15:c.C2144T:p.T715M,FN1:NM_001365522:exon15:c.C2144T:p.T715M,FN1:NM_001365523:exon15:c.C2144T:p.T715M,FN1:NM_001365524:exon15:c.C2144T:p.T715M,FN1:NM_002026:exon15:c.C2144T:p.T715M,FN1:NM_212474:exon15:c.C2144T:p.T715M,FN1:NM_212476:exon15:c.C2144T:p.T715M,FN1:NM_212478:exon15:c.C2144T:p.T715M,FN1:NM_212482:exon15:c.C2144T:p.T715M	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 1, 0] 	0.0008	0.0007	0.00119808	MU1333940	5.715	26.8	0.002	3.94	0.172	.	.	Immunoglobulin-like fold	FN1:uc002vfa.3:exon15:c.C2144T:p.T715M,FN1:uc002vfb.3:exon15:c.C2144T:p.T715M,FN1:uc002vfc.3:exon15:c.C2144T:p.T715M,FN1:uc002vfe.3:exon15:c.C2144T:p.T715M,FN1:uc002vff.3:exon15:c.C2144T:p.T715M,FN1:uc002vfg.3:exon15:c.C2144T:p.T715M,FN1:uc002vfh.3:exon15:c.C2144T:p.T715M,FN1:uc002vfi.3:exon15:c.C2144T:p.T715M,FN1:uc002vfj.3:exon15:c.C2144T:p.T715M	-0.602	AFR:COCA-CN|1|321|0.00311526,GACA-JP|1|585|0.0017094,LUSC-US|1|485|0.00206186,READ-US|1|143|0.00699301,AMR:0.0001,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.999	0.67	0.254	2.19	2	1(lung)	0.0003
2	216300482	216300482	T	A	FN1	exonic	nonsynonymous SNV	ENSG00000115414	rs1250259	ENSG00000115414:ENST00000323926:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000336916:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000345488:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000346544:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000354785:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000356005:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000357009:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000357867:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000359671:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000421182:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000426059:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000432072:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000443816:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000446046:exon1:c.A44T:p.Q15L	FN1:NM_001306129:exon1:c.A44T:p.Q15L,FN1:NM_001306130:exon1:c.A44T:p.Q15L,FN1:NM_001306131:exon1:c.A44T:p.Q15L,FN1:NM_001306132:exon1:c.A44T:p.Q15L,FN1:NM_001365517:exon1:c.A44T:p.Q15L,FN1:NM_001365518:exon1:c.A44T:p.Q15L,FN1:NM_001365519:exon1:c.A44T:p.Q15L,FN1:NM_001365520:exon1:c.A44T:p.Q15L,FN1:NM_001365521:exon1:c.A44T:p.Q15L,FN1:NM_001365522:exon1:c.A44T:p.Q15L,FN1:NM_001365523:exon1:c.A44T:p.Q15L,FN1:NM_001365524:exon1:c.A44T:p.Q15L,FN1:NM_002026:exon1:c.A44T:p.Q15L,FN1:NM_054034:exon1:c.A44T:p.Q15L,FN1:NM_212474:exon1:c.A44T:p.Q15L,FN1:NM_212476:exon1:c.A44T:p.Q15L,FN1:NM_212478:exon1:c.A44T:p.Q15L,FN1:NM_212482:exon1:c.A44T:p.Q15L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7691	0.7885	0.795128	COCA-CN|5|321|0.0155763	1.570	13.69	1.0	5.35	0.947	.	.	.	FN1:uc002vfa.3:exon1:c.A44T:p.Q15L,FN1:uc002vfb.3:exon1:c.A44T:p.Q15L,FN1:uc002vfc.3:exon1:c.A44T:p.Q15L,FN1:uc002vfe.3:exon1:c.A44T:p.Q15L,FN1:uc002vff.3:exon1:c.A44T:p.Q15L,FN1:uc002vfg.3:exon1:c.A44T:p.Q15L,FN1:uc002vfh.3:exon1:c.A44T:p.Q15L,FN1:uc002vfi.3:exon1:c.A44T:p.Q15L,FN1:uc002vfj.3:exon1:c.A44T:p.Q15L,FN1:uc002vfl.3:exon1:c.A44T:p.Q15L	-0.961	AFR:0.7912,AMR:0.8614,EAS:0.8013,FIN:0.9302,NFE:0.7946,OTH:0.7365,ASJ:0.7613	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.0	1.28	0.000	-0.895	2	1(thyroid)	0.7811
2	217012901	217012901	A	G	XRCC5	exonic	synonymous SNV	ENSG00000079246	rs207906	ENSG00000079246:ENST00000392132:exon14:c.A1572G:p.T524T,ENSG00000079246:ENST00000392133:exon16:c.A1572G:p.T524T	XRCC5:NM_021141:exon14:c.A1572G:p.T524T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8710	0.8732	0.882788	0.8815	.	.	.	.	.	.	.	.	XRCC5:uc002vfz.3:exon11:c.A1230G:p.T410T,XRCC5:uc002vfy.3:exon14:c.A1572G:p.T524T	.	AFR:0.8683,AMR:0.9093,EAS:0.9220,FIN:0.9187,NFE:0.8729,OTH:0.9083,ASJ:0.8742	194364	.	.	.	.	.	.	.	.	.	.	.	2	MU26214825	hom
2	219301973	219301973	C	T	VIL1	exonic	stopgain	ENSG00000127831	.	ENSG00000127831:ENST00000392114:exon12:c.C1165T:p.Q389X,ENSG00000127831:ENST00000248444:exon17:c.C2098T:p.Q700X	VIL1:NM_007127:exon17:c.C2098T:p.Q700X	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	12.997	40	.	4.87	0.999	.	.	ADF-H/Gelsolin-like domain|Gelsolin-like domain	VIL1:uc010zke.2:exon12:c.C1165T:p.Q389X,VIL1:uc002vib.3:exon16:c.C2098T:p.Q700X,VIL1:uc002via.3:exon17:c.C2098T:p.Q700X	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	193040	.	.	.	.	.	.	.	.	.	.	.	2	.	hom
2	220022176	220022176	C	T	NHEJ1	intronic	.	ENSG00000187736;ENSG00000213901	rs6436120	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9646	0.9163	0.902356	0.9324	.	.	.	.	.	.	.	.	.	.	AFR:0.7672,AMR:0.9785,EAS:1,FIN:1,NFE:0.9984,OTH:0.9827,ASJ:0.9868	611290	611291;	169079;	169079|Cernunnos XLFD<br>Cernunnos deficiency<br>Combined immunodeficiency-microcephaly-growth retardation-sensitivity to ionizing radiation syndrome<br>NHEJ1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|611291 ~	.	.	.	.	.	.	.	.	2	MU81751416	hom
2	220470343	220470343	T	C	STK11IP	exonic	nonsynonymous SNV	ENSG00000144589	.	ENSG00000144589:ENST00000295641:exon8:c.T665C:p.L222P,ENSG00000144589:ENST00000456909:exon8:c.T632C:p.L211P	STK11IP:NM_052902:exon8:c.T632C:p.L211P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	5.363	25.9	0.0	4.21	0.502	.	.	Leucine-rich repeat domain, L domain-like	STK11IP:uc002vmm.1:exon7:c.T632C:p.L211P,STK11IP:uc002vml.3:exon8:c.T665C:p.L222P,STK11IP:uc010zlk.2:exon8:c.T632C:p.L211P,STK11IP:uc010zll.2:exon8:c.T632C:p.L211P	0.225	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607172	.	.	.	.	.	.	.	1.0	0.56	0.493	3.77	2	.	hom
2	220476443	220476443	C	T	STK11IP	exonic	nonsynonymous SNV	ENSG00000144589	rs627530	ENSG00000144589:ENST00000295641:exon18:c.C2255T:p.S752F,ENSG00000144589:ENST00000456909:exon18:c.C2222T:p.S741F	STK11IP:NM_052902:exon18:c.C2222T:p.S741F	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9376	0.8398	0.839058	0.8456	1.670	14.24	0.054	1.31	0.000	.	.	.	STK11IP:uc002vml.3:exon18:c.C2255T:p.S752F	-1.018	AFR:0.5283,AMR:0.9642,EAS:0.9975,FIN:0.9547,NFE:0.9720,OTH:0.9517,ASJ:0.9570	607172	.	.	.	.	.	.	.	0.004	3.48	0.000	1.6	2	MU81752072	hom
2	223161889	223161889	A	G	PAX3	exonic	synonymous SNV	ENSG00000135903	rs12623857	ENSG00000135903:ENST00000258387:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000336840:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000344493:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000350526:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000392069:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000392070:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000409551:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000409828:exon2:c.T129C:p.G43G	PAX3:NM_000438:exon2:c.T129C:p.G43G,PAX3:NM_001127366:exon2:c.T129C:p.G43G,PAX3:NM_013942:exon2:c.T129C:p.G43G,PAX3:NM_181457:exon2:c.T129C:p.G43G,PAX3:NM_181458:exon2:c.T129C:p.G43G,PAX3:NM_181459:exon2:c.T129C:p.G43G,PAX3:NM_181460:exon2:c.T129C:p.G43G,PAX3:NM_181461:exon2:c.T129C:p.G43G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8872	0.8465	0.904353	0.8514	.	.	.	.	.	.	.	.	PAX3:uc002vmt.2:exon2:c.T129C:p.G43G,PAX3:uc002vmv.2:exon2:c.T129C:p.G43G,PAX3:uc002vmw.2:exon2:c.T129C:p.G43G,PAX3:uc002vmx.2:exon2:c.T129C:p.G43G,PAX3:uc002vmy.2:exon2:c.T129C:p.G43G,PAX3:uc002vmz.2:exon2:c.T129C:p.G43G,PAX3:uc002vna.2:exon2:c.T129C:p.G43G,PAX3:uc010fwo.3:exon2:c.T129C:p.G43G	.	AFR:0.8433,AMR:0.9165,EAS:1,FIN:0.8283,NFE:0.8402,OTH:0.8523,ASJ:0.9305	606597	122880;148820;193500;268220;	780;99756;3440;894;3440;896;1529;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~894|WS1<br>Waardenburg syndrome type I|1-9 / 100 000|Autosomal dominant|Neonatal|193500 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~896|Klein-Waardenburg syndrome<br>WS3<br>Waardenburg syndrome type III<br>Waardenburg syndrome with limb anomalies|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|148820 ~1529|CDHS<br>Sommer-Young-Wee-Frye syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|122880 ~	 ~	.	.	.	.	.	.	.	2	MU81752201	hom
2	228102752	228102752	C	A	LOC654841	ncRNA_intronic	.	ENSG00000236432	rs1882435	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3078	0.2848	0.305112	0.2982	.	.	.	.	.	.	.	.	.	.	AFR:0.2605,AMR:0.2995,EAS:0.4509,FIN:0.2605,NFE:0.3118,OTH:0.3074,ASJ:0.3013	.	.	.	.	.	.	.	.	.	.	.	.	2	MU585375	hom
2	228111435	228111435	T	C	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs10178458	ENSG00000169031:ENST00000396578:exon7:c.T422C:p.L141P	COL4A3:NM_000091:exon7:c.T422C:p.L141P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8302	0.7704	0.796725	0.7805	-0.830	0.037	1.0	3.62	0.029	.	.	.	COL4A3:uc002vom.2:exon7:c.T422C:p.L141P	-0.919	AFR:0.6284,AMR:0.8720,EAS:0.9280,FIN:0.8270,NFE:0.8347,OTH:0.8180,ASJ:0.7781	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.004	-3.4	0.000	-1.39	2	MU18207837	het
2	228128540	228128540	C	T	COL4A3	exonic	synonymous SNV	ENSG00000169031	rs10205042	ENSG00000169031:ENST00000396578:exon21:c.C1195T:p.L399L	COL4A3:NM_000091:exon21:c.C1195T:p.L399L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7667	0.7180	0.767572	0.7419	.	.	.	.	.	.	.	.	COL4A3:uc002vom.2:exon21:c.C1195T:p.L399L	.	AFR:0.6775,AMR:0.8242,EAS:0.8912,FIN:0.8013,NFE:0.7453,OTH:0.7597,ASJ:0.6589	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU18208390	hom
2	232879694	232879694	T	A	DIS3L2	intronic	.	ENSG00000227033	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0	0.014	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	614184	267000;	2849;	2849|Nephroblastomatosis-fetal ascites-macrosomia-Wilms tumor syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267000 ~	.	.	.	.	.	.	.	.	2	.	hom
2	240003870	240003870	G	A	HDAC4	exonic	synonymous SNV	ENSG00000068024	rs1063639	ENSG00000068024:ENST00000543185:exon15:c.C1317T:p.P439P,ENSG00000068024:ENST00000345617:exon21:c.C2565T:p.P855P	HDAC4:NM_006037:exon21:c.C2565T:p.P855P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5333	0.5061	0.595248	0.5092	.	.	.	.	.	.	.	.	HDAC4:uc010fyy.3:exon18:c.C2436T:p.P812P,HDAC4:uc002vyk.4:exon21:c.C2565T:p.P855P	.	AFR:0.5783,AMR:0.6277,EAS:0.7295,FIN:0.4685,NFE:0.4490,OTH:0.5092,ASJ:0.4667	605314	.	.	.	~ko04371 Apelin signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	2	MU792285	hom
2	240066417	240066417	A	G	HDAC4	intronic	.	ENSG00000068024	rs2290087	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8616	0.8947	0.88778	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	.	.	.	.	.	0.0001	0.048	.	.	.	AFR:0.8949,AMR:0.9678,EAS:0.7980,FIN:0.8407,NFE:0.9032,OTH:0.8698,ASJ:0.6914	605314	.	.	.	~ko04371 Apelin signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.8931
2	242793273	242793273	A	G	PDCD1	exonic	synonymous SNV	ENSG00000188389	rs2227981	ENSG00000188389:ENST00000334409:exon5:c.T804C:p.A268A	PDCD1:NM_005018:exon5:c.T804C:p.A268A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6284	0.5864	0.647963	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PDCD1:uc010fzs.3:exon3:c.T441C:p.A147A,PDCD1:uc002wcq.4:exon5:c.T804C:p.A268A	.	AFR:0.6047,AMR:0.5763,EAS:0.5894,FIN:0.7311,NFE:0.7071,OTH:0.5808,ASJ:0.6124	600244	126200;605218;	.	.	.	.	.	.	.	.	.	.	2	1(large_intestine)	0.6462
3	8955389	8955389	C	T	RAD18	exonic	nonsynonymous SNV	ENSG00000070950	rs373572	ENSG00000070950:ENST00000264926:exon8:c.G905A:p.R302Q	RAD18:NM_020165:exon8:c.G905A:p.R302Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6951	0.7043	0.647564	0.6904	3.782	23.4	0.617	4.47	0.998	.	.	SAP domain	RAD18:uc003brd.3:exon8:c.G905A:p.R302Q	-0.988	AFR:0.6630,AMR:0.6631,EAS:0.3531,FIN:0.7584,NFE:0.7244,OTH:0.7270,ASJ:0.7550	605256	.	.	.	.	.	.	.	0.001	1.85	0.000	-1.61	3	MU17638060	hom
3	9005078	9005078	C	T	RAD18	UTR5	.	ENSG00000070950	rs615967	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7529	0.6622	0.597644	LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.6503,AMR:0.3926,EAS:0.8046,FIN:0.3831,NFE:0.7921,OTH:0.7830,ASJ:0.6914	605256	.	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.7561
3	9824651	9824651	C	T	TADA3	intronic	.	ENSG00000114026;ENSG00000171148	rs6443265	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.65016	0.6563	.	.	.	.	.	.	.	.	.	.	AFR:0.5406,AMR:0.6340,EAS:0.7360,FIN:0.6966,NFE:0.7027,OTH:0.6708,ASJ:0.8146	602945	.	.	.	.	.	.	.	.	.	.	.	3	.	hom
3	10106443	10106443	C	T	FANCD2	exonic	synonymous SNV	ENSG00000144554	rs776906387	ENSG00000144554:ENST00000287647:exon23:c.C2052T:p.Y684Y,ENSG00000144554:ENST00000383806:exon23:c.C2052T:p.Y684Y,ENSG00000144554:ENST00000383807:exon23:c.C2052T:p.Y684Y,ENSG00000144554:ENST00000419585:exon23:c.C2052T:p.Y684Y	FANCD2:NM_001018115:exon23:c.C2052T:p.Y684Y,FANCD2:NM_001319984:exon23:c.C2052T:p.Y684Y,FANCD2:NM_033084:exon23:c.C2052T:p.Y684Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	8.237e-06	.	.	.	.	.	.	.	.	.	.	.	FANCD2:uc003buw.3:exon23:c.C2052T:p.Y684Y,FANCD2:uc003bux.1:exon23:c.C2052T:p.Y684Y,FANCD2:uc003buy.1:exon23:c.C2052T:p.Y684Y	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	.	hom
3	14175262	14175262	T	C	TMEM43	exonic	nonsynonymous SNV	ENSG00000170876	rs2340917	ENSG00000170876:ENST00000306077:exon7:c.T536C:p.M179T	TMEM43:NM_024334:exon7:c.T536C:p.M179T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3724	0.3328	0.463259	0.3565	0.428	6.855	1.0	5.32	0.297	.	.	.	TMEM43:uc003byl.1:exon5:c.T176C:p.M59T,TMEM43:uc003byk.2:exon7:c.T536C:p.M179T	-0.943	AFR:0.4188,AMR:0.5095,EAS:0.6592,FIN:0.3033,NFE:0.2967,OTH:0.3037,ASJ:0.2682	612048	604400;614302;	261;98853;217656;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.0	1.6	0.000	-2.25	3	MU124112	het
3	14187449	14187449	G	T	XPC	exonic	nonsynonymous SNV	ENSG00000154767	rs2228001	ENSG00000154767:ENST00000285021:exon16:c.C2815A:p.Q939K,ENSG00000154767:ENST00000449060:exon16:c.C2704A:p.Q902K	XPC:NM_001354726:exon15:c.C2236A:p.Q746K,XPC:NM_001354727:exon16:c.C2809A:p.Q937K,XPC:NM_001354729:exon16:c.C2797A:p.Q933K,XPC:NM_001354730:exon16:c.C2569A:p.Q857K,XPC:NM_004628:exon16:c.C2815A:p.Q939K	clinvar: drug_response 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6325	0.6421	0.684704	0.6556	1.250	12.01	1.0	4.24	0.998	.	.	.	XPC:uc011avf.2:exon15:c.C2236A:p.Q746K,XPC:uc011ave.2:exon16:c.C2815A:p.Q939K,XPC:uc011avg.2:exon16:c.C2704A:p.Q902K	-0.955	AFR:0.7228,AMR:0.7057,EAS:0.6382,FIN:0.6985,NFE:0.6087,OTH:0.6337,ASJ:0.5629	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.0	1.93	0.000	-2.455	3	MU11483739	hom
3	14193889	14193889	C	T	XPC	exonic	synonymous SNV	ENSG00000154767	rs2227998	ENSG00000154767:ENST00000285021:exon11:c.G2061A:p.R687R,ENSG00000154767:ENST00000449060:exon11:c.G1950A:p.R650R	XPC:NM_001354726:exon10:c.G1482A:p.R494R,XPC:NM_001354727:exon11:c.G2055A:p.R685R,XPC:NM_001354729:exon11:c.G2043A:p.R681R,XPC:NM_001354730:exon11:c.G1815A:p.R605R,XPC:NM_004628:exon11:c.G2061A:p.R687R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2734	0.2658	0.235423	1(lung)	.	.	.	.	.	.	.	.	XPC:uc021wtm.1:exon2:c.G364A:p.G122R	.	AFR:MU131806,AMR:LUSC-KR|1|170|0.00588235,EAS:0.2989,FIN:0.3022,NFE:0.2649,OTH:0.0358,ASJ:0.2561	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	3	1(thyroid)	0.2282
3	14197987	14197987	A	T	XPC	exonic	synonymous SNV	ENSG00000154767	rs2958057	ENSG00000154767:ENST00000285021:exon10:c.T1881A:p.A627A,ENSG00000154767:ENST00000449060:exon10:c.T1770A:p.A590A	XPC:NM_001354726:exon9:c.T1302A:p.A434A,XPC:NM_001354729:exon10:c.T1863A:p.A621A,XPC:NM_001354730:exon10:c.T1635A:p.A545A,XPC:NM_004628:exon10:c.T1881A:p.A627A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	1	.	1	1	.	.	.	.	.	.	.	.	XPC:uc021wtl.1:exon2:c.T99A:p.A33A,XPC:uc011avf.2:exon9:c.T1302A:p.A434A,XPC:uc011ave.2:exon10:c.T1881A:p.A627A,XPC:uc011avg.2:exon10:c.T1770A:p.A590A	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	3	MU81758228	hom
3	14199887	14199887	G	A	XPC	exonic	nonsynonymous SNV	ENSG00000154767	rs2228000	ENSG00000154767:ENST00000285021:exon9:c.C1496T:p.A499V,ENSG00000154767:ENST00000449060:exon9:c.C1385T:p.A462V	XPC:NM_001354726:exon8:c.C917T:p.A306V,XPC:NM_001354727:exon9:c.C1496T:p.A499V,XPC:NM_001354729:exon9:c.C1478T:p.A493V,XPC:NM_001354730:exon9:c.C1496T:p.A499V,XPC:NM_004628:exon9:c.C1496T:p.A499V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2378	0.2006	0.233027	66(meninges)	0.061	3.201	0.331	-1.03	0.000	.	.	.	XPC:uc011avf.2:exon8:c.C917T:p.A306V,XPC:uc011ave.2:exon9:c.C1496T:p.A499V,XPC:uc011avg.2:exon9:c.C1385T:p.A462V	-0.924	AFR:1(skin),AMR:MU11484076,EAS:0.2220,FIN:0.0901,NFE:0.2596,OTH:0.2133,ASJ:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.081	1.24	0.000	1.14	3	1(lung)	0.3601
3	14199908	14199908	C	T	XPC	exonic	nonsynonymous SNV	ENSG00000154767	rs2227999	ENSG00000154767:ENST00000285021:exon9:c.G1475A:p.R492H,ENSG00000154767:ENST00000449060:exon9:c.G1364A:p.R455H	XPC:NM_001354726:exon8:c.G896A:p.R299H,XPC:NM_001354727:exon9:c.G1475A:p.R492H,XPC:NM_001354729:exon9:c.G1457A:p.R486H,XPC:NM_001354730:exon9:c.G1475A:p.R492H,XPC:NM_004628:exon9:c.G1475A:p.R492H	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0425	0.0465	0.0231629	3(soft_tissue)	-0.282	0.730	0.225	-4.51	0.000	.	.	.	XPC:uc011avf.2:exon8:c.G896A:p.R299H,XPC:uc011ave.2:exon9:c.G1475A:p.R492H,XPC:uc011avg.2:exon9:c.G1364A:p.R455H	-1.068	AFR:1(lung),AMR:MU67350061,EAS:0.0375,FIN:0.0097,NFE:0.0346,OTH:0.08,ASJ:LUSC-KR|1|170|0.00588235	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.0	1.24	0.006	0.895	3	1(haematopoietic_and_lymphoid_tissue)	0
3	24184995	24184995	G	A	THRB	exonic	synonymous SNV	ENSG00000151090	rs3752874	ENSG00000151090:ENST00000280696:exon4:c.C780T:p.F260F,ENSG00000151090:ENST00000356447:exon7:c.C735T:p.F245F,ENSG00000151090:ENST00000396671:exon8:c.C735T:p.F245F,ENSG00000151090:ENST00000416420:exon9:c.C735T:p.F245F	THRB:NM_001354714:exon6:c.C642T:p.F214F,THRB:NM_001354715:exon6:c.C642T:p.F214F,THRB:NM_000461:exon7:c.C735T:p.F245F,THRB:NM_001354708:exon7:c.C735T:p.F245F,THRB:NM_001354711:exon7:c.C735T:p.F245F,THRB:NM_001354713:exon7:c.C735T:p.F245F,THRB:NM_001128176:exon8:c.C735T:p.F245F,THRB:NM_001128177:exon8:c.C735T:p.F245F,THRB:NM_001354709:exon8:c.C735T:p.F245F,THRB:NM_001354710:exon8:c.C735T:p.F245F,THRB:NM_001354712:exon8:c.C735T:p.F245F,THRB:NM_001252634:exon9:c.C735T:p.F245F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1555	0.1536	0.157548	0.1340	.	.	.	.	.	.	.	.	THRB:uc003ccy.4:exon7:c.C735T:p.F245F,THRB:uc003ccx.4:exon8:c.C735T:p.F245F,THRB:uc010hfe.3:exon8:c.C735T:p.F245F,THRB:uc003ccz.4:exon9:c.C735T:p.F245F	.	AFR:0.1371,AMR:0.1456,EAS:0.0347,FIN:0.1202,NFE:0.1416,OTH:0.1598,ASJ:0.2450	190160	145650;188570;274300;	3221;3221;165994;	3221|Deafness-thyroid hormone resistance syndrome<br>Refetoff syndrome|-|-|-|188570 274300 ~3221|Deafness-thyroid hormone resistance syndrome<br>Refetoff syndrome|-|-|-|188570 274300 ~165994|-|-|Autosomal dominant|-|145650 ~	.	.	.	.	.	.	.	.	3	MU113459927	hom
3	24270412	24270412	-	A	THRB	intronic	.	ENSG00000151090	.	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0141	.	.	0.0109	.	.	.	.	.	.	.	.	.	.	AFR:0.0313,AMR:0.0048,EAS:0.0082,FIN:0.0049,NFE:0.0005,OTH:0.0041,ASJ:0	190160	145650;188570;274300;	3221;3221;165994;	3221|Deafness-thyroid hormone resistance syndrome<br>Refetoff syndrome|-|-|-|188570 274300 ~3221|Deafness-thyroid hormone resistance syndrome<br>Refetoff syndrome|-|-|-|188570 274300 ~165994|-|-|Autosomal dominant|-|145650 ~	.	.	.	.	.	.	.	.	3	.	het
3	30656168	30656168	G	A	TGFBR2	intronic	.	ENSG00000163513	rs6791557	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.502995	0.4614	.	.	.	.	.	.	.	.	.	.	AFR:0.3984,AMR:0.4117,EAS:0.7776,FIN:0.5140,NFE:0.4560,OTH:0.4826,ASJ:0.3154	190182	133239;610168;614331;	144;284973;558;60030;91387;99977;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~284973|MFS2|-|Autosomal dominant|All ages|610168 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~60030|Aortic aneurysm syndrome due to TGF-beta receptors anomalies|Unknown|Autosomal dominant|Infancy<br>Neonatal|609192 610168 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04659 Th17 cell differentiation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05142 Chagas disease (American trypanosomiasis)~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	3	MU86952688	hom
3	37053568	37053568	A	G	MLH1	exonic	nonsynonymous SNV	ENSG00000076242	rs1799977	ENSG00000076242:ENST00000231790:exon8:c.A655G:p.I219V,ENSG00000076242:ENST00000435176:exon8:c.A361G:p.I121V	MLH1:NM_001354629:exon7:c.A556G:p.I186V,MLH1:NM_000249:exon8:c.A655G:p.I219V,MLH1:NM_001167617:exon8:c.A361G:p.I121V,MLH1:NM_001258271:exon8:c.A655G:p.I219V,MLH1:NM_001354620:exon8:c.A361G:p.I121V,MLH1:NM_001354628:exon8:c.A655G:p.I219V,MLH1:NM_001354630:exon8:c.A655G:p.I219V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2325	0.2430	0.129593	12(soft_tissue)	1.609	13.90	0.338	4.61	1.000	.	.	DNA mismatch repair protein, C-terminal|Histidine kinase-like ATPase, C-terminal domain|Ribosomal protein S5 domain 2-type fold;Histidine kinase-like ATPase, C-terminal domain	MLH1:uc003cgl.3:exon8:c.A655G:p.I219V,MLH1:uc010hge.3:exon8:c.A655G:p.I219V,MLH1:uc011ayc.2:exon8:c.A361G:p.I121V	-1.077	AFR:5(prostate),AMR:35(lung),EAS:8(meninges),FIN:MU114937856,NFE:COCA-CN|1|321|0.00311526,OTH:0.2281,ASJ:1(haematopoietic_and_lymphoid_tissue)	120436	158320;276300;609310;	144;252202;587;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~587|Multiple keratoacanthoma, Muir-Torre type|Unknown|Autosomal dominant|Adult|158320 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05226 Gastric cancer ~	.	.	.	0.018	-1.74	0.000	1.03	3	8(large_intestine)	0.0826
3	38180409	38180409	G	A	MYD88	exonic	nonsynonymous SNV	ENSG00000172936	.	ENSG00000172936:ENST00000396334:exon1:c.G257A:p.R86K,ENSG00000172936:ENST00000417037:exon1:c.G257A:p.R86K,ENSG00000172936:ENST00000421516:exon1:c.G254A:p.R85K,ENSG00000172936:ENST00000424893:exon1:c.G257A:p.R86K,ENSG00000172936:ENST00000443433:exon1:c.G257A:p.R86K,ENSG00000172936:ENST00000495303:exon1:c.G257A:p.R86K	MYD88:NM_001172566:exon1:c.G218A:p.R73K,MYD88:NM_001172567:exon1:c.G218A:p.R73K,MYD88:NM_001172568:exon1:c.G218A:p.R73K,MYD88:NM_001172569:exon1:c.G218A:p.R73K,MYD88:NM_001365876:exon1:c.G218A:p.R73K,MYD88:NM_001365877:exon1:c.G218A:p.R73K,MYD88:NM_002468:exon1:c.G218A:p.R73K	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 1, 0, 1, 0, 0, 1, 0, 1, -1, 1, 1] 	.	.	.	.	-0.551	0.164	1.0	2.21	0.178	.	.	Death domain|Death-like domain|MyD88, death domain	MYD88:uc003chx.3:exon1:c.G257A:p.R86K,MYD88:uc011ayh.2:exon1:c.G257A:p.R86K,MYD88:uc011ayi.2:exon1:c.G257A:p.R86K,MYD88:uc011ayj.2:exon1:c.G257A:p.R86K,MYD88:uc011ayk.2:exon1:c.G257A:p.R86K,MYD88:uc011ayl.2:exon1:c.G257A:p.R86K	-0.828	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602170	153600;612260;	183713;33226;	183713|MyD88 deficiency|Unknown|Autosomal recessive|Childhood|612260 ~33226|-|1-9 / 100 000|Multigenic/multifactorial|Elderly|153600 610430 ~	.	,7648	7662,,7663,7664	.	0.0	-1.9	0.257	0.49	3	.	hom
3	38607904	38607904	A	G	SCN5A	exonic	nonsynonymous SNV	ENSG00000183873	.	ENSG00000183873:ENST00000449557:exon19:c.T3674C:p.V1225A,ENSG00000183873:ENST00000450102:exon19:c.T3674C:p.V1225A,ENSG00000183873:ENST00000414099:exon20:c.T3836C:p.V1279A,ENSG00000183873:ENST00000423572:exon20:c.T3833C:p.V1278A,ENSG00000183873:ENST00000451551:exon20:c.T3674C:p.V1225A,ENSG00000183873:ENST00000455624:exon20:c.T3833C:p.V1278A,ENSG00000183873:ENST00000333535:exon21:c.T3836C:p.V1279A,ENSG00000183873:ENST00000413689:exon21:c.T3836C:p.V1279A,ENSG00000183873:ENST00000425664:exon21:c.T3836C:p.V1279A,ENSG00000183873:ENST00000443581:exon21:c.T3833C:p.V1278A	SCN5A:NM_001160161:exon20:c.T3674C:p.V1225A,SCN5A:NM_000335:exon21:c.T3833C:p.V1278A,SCN5A:NM_001099404:exon21:c.T3836C:p.V1279A,SCN5A:NM_001099405:exon21:c.T3836C:p.V1279A,SCN5A:NM_001160160:exon21:c.T3833C:p.V1278A,SCN5A:NM_001354701:exon21:c.T3833C:p.V1278A,SCN5A:NM_198056:exon21:c.T3836C:p.V1279A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 2, 0, 0] 	.	.	.	.	5.151	25.4	0.0	4.79	0.977	.	.	Ion transport domain	SCN5A:uc021wvw.1:exon12:c.T2666C:p.V889A,SCN5A:uc021wvj.1:exon17:c.T3272C:p.V1091A,SCN5A:uc021wvi.1:exon18:c.T3434C:p.V1145A,SCN5A:uc021wvl.1:exon19:c.T3674C:p.V1225A,SCN5A:uc021wvk.1:exon20:c.T3833C:p.V1278A,SCN5A:uc021wvm.1:exon20:c.T3836C:p.V1279A,SCN5A:uc021wvn.1:exon20:c.T3833C:p.V1278A,SCN5A:uc021wvo.1:exon20:c.T3836C:p.V1279A,SCN5A:uc021wvp.1:exon20:c.T3836C:p.V1279A,SCN5A:uc021wvu.1:exon20:c.T3674C:p.V1225A,SCN5A:uc021wvq.1:exon21:c.T3833C:p.V1278A,SCN5A:uc021wvr.1:exon21:c.T3836C:p.V1279A,SCN5A:uc021wvs.1:exon21:c.T3836C:p.V1279A,SCN5A:uc021wvt.1:exon21:c.T3833C:p.V1278A,SCN5A:uc021wvv.1:exon21:c.T3836C:p.V1279A	0.985	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	0.941	-5.34	0.987	3.99	3	.	hom
3	38620993	38620993	A	T	SCN5A	intronic	.	ENSG00000183873	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.9982	0.782	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	.	.	.	.	3	.	hom
3	38622467	38622467	T	C	SCN5A	exonic	synonymous SNV	ENSG00000183873	rs7430407	ENSG00000183873:ENST00000414099:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000423572:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000449557:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000450102:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000455624:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000333535:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000413689:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000425664:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000443581:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000451551:exon17:c.A3183G:p.E1061E	SCN5A:NM_000335:exon17:c.A3183G:p.E1061E,SCN5A:NM_001099404:exon17:c.A3183G:p.E1061E,SCN5A:NM_001099405:exon17:c.A3183G:p.E1061E,SCN5A:NM_001160160:exon17:c.A3183G:p.E1061E,SCN5A:NM_001160161:exon17:c.A3183G:p.E1061E,SCN5A:NM_001354701:exon17:c.A3183G:p.E1061E,SCN5A:NM_198056:exon17:c.A3183G:p.E1061E	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9128	0.8850	0.923123	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SCN5A:uc021wvw.1:exon8:c.A2016G:p.E672E,SCN5A:uc021wvi.1:exon14:c.A2781G:p.E927E,SCN5A:uc021wvj.1:exon14:c.A2781G:p.E927E,SCN5A:uc021wvk.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvl.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvm.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvn.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvo.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvp.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvq.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvr.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvs.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvt.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvu.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvv.1:exon17:c.A3183G:p.E1061E	.	AFR:0.9032,AMR:0.8836,EAS:0.8742,FIN:0.9994,NFE:0.9242,OTH:0.8978,ASJ:0.9284	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	.	.	.	.	3	1(thyroid)	0.9155
3	38674712	38674712	T	C	SCN5A	exonic	synonymous SNV	ENSG00000183873	rs6599230	ENSG00000183873:ENST00000414099:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000423572:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000449557:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000450102:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000455624:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000327956:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000333535:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000413689:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000425664:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000443581:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000451551:exon2:c.A87G:p.A29A	SCN5A:NM_000335:exon2:c.A87G:p.A29A,SCN5A:NM_001099404:exon2:c.A87G:p.A29A,SCN5A:NM_001099405:exon2:c.A87G:p.A29A,SCN5A:NM_001160160:exon2:c.A87G:p.A29A,SCN5A:NM_001160161:exon2:c.A87G:p.A29A,SCN5A:NM_001354701:exon2:c.A87G:p.A29A,SCN5A:NM_198056:exon2:c.A87G:p.A29A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7737	0.8360	0.781749	0.7947	.	.	.	.	.	.	.	.	SCN5A:uc021wvx.1:exon2:c.A95G:p.Q32R	.	AFR:0.8943,AMR:0.7255,EAS:0.7012,FIN:0.6997,NFE:0.7774,OTH:0.7398,ASJ:0.7417	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	.	.	.	.	3	MU24669512	hom
3	47125385	47125385	G	A	SETD2	exonic	nonsynonymous SNV	ENSG00000181555	rs4082155	ENSG00000181555:ENST00000409792:exon12:c.C5885T:p.P1962L	SETD2:NM_001349370:exon11:c.C5753T:p.P1918L,SETD2:NM_014159:exon12:c.C5885T:p.P1962L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.5342	0.4713	0.469848	0.4931	1.276	12.14	0.311	2.94	0.998	.	.	.	SETD2:uc003cqs.3:exon12:c.C5885T:p.P1962L,SETD2:uc003cqv.3:exon13:c.C6086T:p.P2029L	-0.947	AFR:0.2820,AMR:0.4771,EAS:0.5424,FIN:0.6158,NFE:0.5774,OTH:0.5767,ASJ:0.4933	612778	616831;	.	.	.	,9653,9650,9651	.	.	0.001	1.98	0.000	0.895	3	MU585924	het
3	47447298	47447298	G	A	PTPN23	intronic	.	ENSG00000076201	rs749541946	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	9.372e-06	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606584	.	.	.	.	.	.	.	.	.	.	.	3	.	hom
3	47449058	47449058	T	C	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs900688	ENSG00000076201:ENST00000431726:exon11:c.T609C:p.T203T,ENSG00000076201:ENST00000265562:exon12:c.T987C:p.T329T	PTPN23:NM_001304482:exon11:c.T609C:p.T203T,PTPN23:NM_015466:exon12:c.T987C:p.T329T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9863	0.9493	0.953874	0.9584	.	.	.	.	.	.	.	.	PTPN23:uc011baw.1:exon11:c.T882C:p.T294T,PTPN23:uc011bay.1:exon11:c.T597C:p.T199T,PTPN23:uc003crf.1:exon12:c.T987C:p.T329T	.	AFR:0.8548,AMR:0.9928,EAS:1,FIN:1,NFE:0.9993,OTH:0.9959,ASJ:0.9901	606584	.	.	.	.	.	.	.	.	.	.	.	3	MU81761996	hom
3	47452087	47452087	G	A	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs900689	ENSG00000076201:ENST00000431726:exon19:c.G2421A:p.P807P,ENSG00000076201:ENST00000265562:exon20:c.G2799A:p.P933P	PTPN23:NM_001304482:exon19:c.G2421A:p.P807P,PTPN23:NM_015466:exon20:c.G2799A:p.P933P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9867	0.9511	0.954872	0.9600	.	.	.	.	.	.	.	.	PTPN23:uc011baw.1:exon19:c.G2694A:p.P898P,PTPN23:uc011bay.1:exon19:c.G2409A:p.P803P,PTPN23:uc003crf.1:exon20:c.G2799A:p.P933P	.	AFR:0.8595,AMR:0.9928,EAS:1,FIN:1,NFE:0.9994,OTH:0.9959,ASJ:0.99	606584	.	.	.	.	.	.	.	.	.	.	.	3	MU4555978	hom
3	47454399	47454399	G	A	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs6789730	ENSG00000076201:ENST00000431726:exon24:c.G4257A:p.P1419P,ENSG00000076201:ENST00000265562:exon25:c.G4635A:p.P1545P	PTPN23:NM_001304482:exon24:c.G4257A:p.P1419P,PTPN23:NM_015466:exon25:c.G4635A:p.P1545P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9872	0.9547	0.954673	0.9077	.	.	.	.	.	.	.	.	PTPN23:uc011bay.1:exon24:c.G4245A:p.P1415P,PTPN23:uc003crf.1:exon25:c.G4635A:p.P1545P	.	AFR:0.8071,AMR:0.9365,EAS:0.9812,FIN:0.9173,NFE:0.9510,OTH:0.9412,ASJ:0.9458	606584	.	.	.	.	.	.	.	.	.	.	.	3	MU4564936	hom
3	48602523	48602523	-	GGC	COL7A1	intronic	.	ENSG00000114270	rs138595277	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9999	0.9998	0.999401	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	120120	131705;131750;131850;132000;226600;604129;607523;	89843;79408;79409;79410;231568;79411;	89843|DEB, pruriginosa<br>DEB-Pr<br>Pruriginous dystrophic epidermolysis bullosa|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604129 ~79408|Autosomal recessive dystrophic epidermolysis bullosa generalisata gravis<br>Autosomal recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type<br>RDEB generalisata gravis<br>RDEB, Hallopeau-Siemens type<br>RDEB-sev gen<br>Severe generalized RDEB|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79409|Dystrophic epidermolysis bullosa inversa<br>Inverse RDEB<br>Inverse recessive dystrophic epidermolysis bullosa<br>RDEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79410|DEB-Pt<br>Pretibial DEB|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131850 ~231568|Autosomal dominant dystrophic epidermolysis bullosa, Pasini and Cockayne-Touraine types<br>DDEB, Pasini and Cockayne-Touraine types<br>DDEB, generalized<br>DDEB-gen|Unknown|Autosomal dominant|Infancy<br>Neonatal|131750 ~79411|DEB, bullous dermolysis of the newborn<br>DEB-BDN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131705 ~	.	.	.	.	.	.	.	.	3	.	hom
3	49724808	49724808	T	C	MST1	exonic	synonymous SNV	ENSG00000173531	rs3020779	ENSG00000173531:ENST00000383728:exon3:c.A234G:p.P78P,ENSG00000173531:ENST00000449682:exon4:c.A459G:p.P153P	MST1:NM_020998:exon4:c.A459G:p.P153P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8574	0.7876	0.860224	0.8201	.	.	.	.	.	.	.	.	MST1:uc003cxg.3:exon4:c.A459G:p.P153P,MST1:uc010hkx.2:exon4:c.A222G:p.P74P,MST1:uc011bcs.1:exon4:c.A459G:p.P153P,MST1:uc011bct.1:exon4:c.A459G:p.P153P	.	AFR:0.7258,AMR:0.8819,EAS:0.9963,FIN:0.8986,NFE:0.8320,OTH:0.8599,ASJ:0.8079	142408	.	.	.	.	.	.	.	.	.	.	.	3	MU81762505	het
3	49760039	49760039	T	C	GMPPB	exonic	nonsynonymous SNV	ENSG00000173540	rs1466685	ENSG00000173540:ENST00000308375:exon5:c.A551G:p.Q184R,ENSG00000173540:ENST00000308388:exon5:c.A551G:p.Q184R,ENSG00000173540:ENST00000480687:exon6:c.A551G:p.Q184R	GMPPB:NM_013334:exon5:c.A551G:p.Q184R,GMPPB:NM_021971:exon5:c.A551G:p.Q184R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9967	0.9892	0.989018	0.9889	0.422	6.799	0.071	-2.63	0.913	.	.	Nucleotide-diphospho-sugar transferases|Nucleotidyl transferase domain	GMPPB:uc003cxk.1:exon5:c.A551G:p.Q184R,GMPPB:uc003cxl.1:exon5:c.A551G:p.Q184R	-0.902	AFR:0.9620,AMR:0.9952,EAS:1,FIN:1,NFE:0.9997,OTH:0.9949,ASJ:1	615320	615350;615351;615352;	363623;370959;370968;588;	363623|LGMD2T|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615352 ~370959|CMD with cerebellar involvement<br>CMD-CRB|-|-|-|606612 613151 613155 613156 615351 ~370968|CMD with intellectual disability<br>CMD-MR|-|-|-|606612 608840 613155 613156 615351 ~588|MEB syndrome<br>Muscle-eye-brain syndrome<br>Santavuori congenital muscular dystrophy|Unknown|Autosomal recessive|Infancy<br>Neonatal|236670 253280 253800 613150 613153 613154 615181 615350 ~	.	.	.	.	0.0	-3.29	0.000	-0.49	3	MU81762601	hom
3	49928691	49928691	T	C	MST1R	exonic	nonsynonymous SNV	ENSG00000164078	rs7433231	ENSG00000164078:ENST00000344206:exon16:c.A3436G:p.S1146G,ENSG00000164078:ENST00000296474:exon17:c.A3583G:p.S1195G	MST1R:NM_001318913:exon15:c.A3265G:p.S1089G,MST1R:NM_001244937:exon16:c.A3436G:p.S1146G,MST1R:NM_002447:exon17:c.A3583G:p.S1195G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MST1R:uc031rzv.1:exon6:c.A220G:p.S74G,MST1R:uc031rzw.1:exon15:c.A3265G:p.S1089G,MST1R:uc011bdc.2:exon16:c.A3436G:p.S1146G,MST1R:uc003cxy.4:exon17:c.A3583G:p.S1195G	.	AFR:1.0000,AMR:0.9999,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	.	.	.	.	3	23(upper_aerodigestive_tract)	1
3	49933423	49933423	G	A	MST1R	exonic	stopgain	ENSG00000164078	.	ENSG00000164078:ENST00000296474:exon11:c.C2767T:p.Q923X,ENSG00000164078:ENST00000411578:exon11:c.C2767T:p.Q923X	MST1R:NM_001318913:exon9:c.C2449T:p.Q817X,MST1R:NM_002447:exon11:c.C2767T:p.Q923X	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	8.143	35	.	-1.27	0.974	.	.	Immunoglobulin-like fold	MST1R:uc031rzw.1:exon9:c.C2449T:p.Q817X,MST1R:uc003cxy.4:exon11:c.C2767T:p.Q923X	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	.	.	.	.	3	.	hom
3	50378840	50378840	C	A	ZMYND10	UTR3	.	ENSG00000235058	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607070	615444;	244;	244|PCD|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Neonatal|215518 215520 242670 242680 244400 606763 608644 608646 608647 610852 611884 612274 612444 612518 612649 612650 613193 613807 613808 614017 614679 614874 614935 615067 615294 615444 615451 615481 615482 615500 615504 615505 615872 616037 616481 616726 617091 617092 ~	.	.	.	.	.	.	.	.	3	.	hom
3	51978220	51978220	A	G	PARP3	exonic	nonsynonymous SNV	ENSG00000041880	rs28547534	ENSG00000041880:ENST00000498510:exon2:c.A299G:p.H100R,ENSG00000041880:ENST00000398755:exon3:c.A320G:p.H107R,ENSG00000041880:ENST00000431474:exon3:c.A299G:p.H100R,ENSG00000041880:ENST00000417220:exon4:c.A299G:p.H100R	PARP3:NM_001003931:exon3:c.A320G:p.H107R,PARP3:NM_001370240:exon3:c.A299G:p.H100R,PARP3:NM_005485:exon3:c.A299G:p.H100R,PARP3:NM_001370239:exon4:c.A299G:p.H100R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9927	0.9920	0.997604	0.9937	.	.	.	.	.	.	.	.	PARP3:uc003dby.3:exon3:c.A299G:p.H100R,PARP3:uc003dbz.3:exon3:c.A320G:p.H107R	.	AFR:0.9977,AMR:0.9928,EAS:1,FIN:0.9946,NFE:0.9907,OTH:0.9908,ASJ:1	607726	.	.	.	.	.	.	.	.	.	.	.	3	MU4565297	hom
3	52584786	52584786	C	A	PBRM1	exonic	nonsynonymous SNV	ENSG00000163939	rs769978319	ENSG00000163939:ENST00000337303:exon26:c.G4336T:p.G1446C,ENSG00000163939:ENST00000356770:exon26:c.G4396T:p.G1466C,ENSG00000163939:ENST00000409057:exon27:c.G4492T:p.G1498C,ENSG00000163939:ENST00000409767:exon27:c.G4381T:p.G1461C,ENSG00000163939:ENST00000410007:exon27:c.G4417T:p.G1473C,ENSG00000163939:ENST00000296302:exon28:c.G4657T:p.G1553C,ENSG00000163939:ENST00000394830:exon28:c.G4336T:p.G1446C,ENSG00000163939:ENST00000409114:exon28:c.G4546T:p.G1516C	PBRM1:NM_001350075:exon28:c.G4492T:p.G1498C,PBRM1:NM_001366072:exon28:c.G4399T:p.G1467C,PBRM1:NM_001366073:exon28:c.G4390T:p.G1464C,PBRM1:NM_001366076:exon28:c.G4339T:p.G1447C,PBRM1:NM_018313:exon28:c.G4336T:p.G1446C,PBRM1:NM_181042:exon28:c.G4336T:p.G1446C,PBRM1:NM_001350079:exon29:c.G4324T:p.G1442C,PBRM1:NM_001366070:exon29:c.G4444T:p.G1482C,PBRM1:NM_001366071:exon29:c.G4564T:p.G1522C,PBRM1:NM_001366074:exon29:c.G4387T:p.G1463C,PBRM1:NM_001366075:exon29:c.G4369T:p.G1457C,PBRM1:NM_001350074:exon30:c.G4444T:p.G1482C,PBRM1:NM_001350076:exon30:c.G4441T:p.G1481C,PBRM1:NM_001350078:exon30:c.G4444T:p.G1482C,PBRM1:NM_001350077:exon31:c.G4435T:p.G1479C	clinvar: UNK 	 CancerVar: 8#Tier_II_potential EVS=[1, 0, 1, 1, 0, 0, 1, 0, 1, 1, 1, 1] 	4.125e-05	.	.	.	5.042	25.2	0.004	5.06	1.000	.	.	High mobility group box domain	PBRM1:uc003deq.2:exon26:c.G4336T:p.G1446C,PBRM1:uc003der.2:exon26:c.G4396T:p.G1466C,PBRM1:uc003det.2:exon27:c.G4381T:p.G1461C,PBRM1:uc003dew.2:exon27:c.G4492T:p.G1498C,PBRM1:uc010hmk.1:exon27:c.G4417T:p.G1473C,PBRM1:uc003des.2:exon28:c.G4657T:p.G1553C,PBRM1:uc003deu.2:exon28:c.G4546T:p.G1516C,PBRM1:uc003dey.2:exon28:c.G4336T:p.G1446C	-0.924	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606083	.	.	.	.	,8453,8456	.	,8455,8454	0.997	1.2	0.145	1.7	3	.	het
3	53222761	53222761	C	T	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs2306574	ENSG00000163932:ENST00000394729:exon15:c.C1441T:p.L481L,ENSG00000163932:ENST00000330452:exon16:c.C1441T:p.L481L	PRKCD:NM_001354676:exon15:c.C1498T:p.L500L,PRKCD:NM_001354678:exon15:c.C1489T:p.L497L,PRKCD:NM_212539:exon15:c.C1441T:p.L481L,PRKCD:NM_001316327:exon16:c.C1441T:p.L481L,PRKCD:NM_001354679:exon16:c.C1441T:p.L481L,PRKCD:NM_006254:exon16:c.C1441T:p.L481L,PRKCD:NM_001354680:exon17:c.C1441T:p.L481L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7480	0.7583	0.713458	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PRKCD:uc003dgm.3:exon15:c.C1441T:p.L481L,PRKCD:uc003dgl.3:exon16:c.C1441T:p.L481L	.	AFR:0.7580,AMR:0.7198,EAS:0.7667,FIN:0.7833,NFE:0.7338,OTH:0.7843,ASJ:0.7356	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	1(urinary_tract)	0.7556
3	53223927	53223927	C	G	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs1075865	ENSG00000163932:ENST00000394729:exon17:c.C1782G:p.T594T,ENSG00000163932:ENST00000330452:exon18:c.C1782G:p.T594T	PRKCD:NM_001354676:exon17:c.C1839G:p.T613T,PRKCD:NM_001354678:exon17:c.C1830G:p.T610T,PRKCD:NM_212539:exon17:c.C1782G:p.T594T,PRKCD:NM_001316327:exon18:c.C1782G:p.T594T,PRKCD:NM_001354679:exon18:c.C1782G:p.T594T,PRKCD:NM_006254:exon18:c.C1782G:p.T594T,PRKCD:NM_001354680:exon19:c.C1782G:p.T594T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9655	0.9335	0.901957	0.9428	.	.	.	.	.	.	.	.	PRKCD:uc003dgm.3:exon17:c.C1782G:p.T594T,PRKCD:uc003dgl.3:exon18:c.C1782G:p.T594T	.	AFR:0.8065,AMR:0.9905,EAS:0.9728,FIN:1,NFE:0.9993,OTH:0.9806,ASJ:0.9967	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	MU81763707	hom
3	53224002	53224002	T	C	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs900495	ENSG00000163932:ENST00000394729:exon17:c.T1857C:p.P619P,ENSG00000163932:ENST00000330452:exon18:c.T1857C:p.P619P	PRKCD:NM_001354676:exon17:c.T1914C:p.P638P,PRKCD:NM_001354678:exon17:c.T1905C:p.P635P,PRKCD:NM_212539:exon17:c.T1857C:p.P619P,PRKCD:NM_001316327:exon18:c.T1857C:p.P619P,PRKCD:NM_001354679:exon18:c.T1857C:p.P619P,PRKCD:NM_006254:exon18:c.T1857C:p.P619P,PRKCD:NM_001354680:exon19:c.T1857C:p.P619P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9835	0.9393	0.940495	0.9481	.	.	.	.	.	.	.	.	PRKCD:uc003dgm.3:exon17:c.T1857C:p.P619P,PRKCD:uc003dgl.3:exon18:c.T1857C:p.P619P	.	AFR:0.8192,AMR:0.9905,EAS:1,FIN:1,NFE:0.9993,OTH:0.9888,ASJ:0.9967	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	MU81763716	hom
3	53699667	53699667	T	-	CACNA1D	intronic	.	ENSG00000157388	rs773797504	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0027	0.0007	.	0.0003	.	.	.	.	.	.	.	.	.	.	AFR:0.0001,AMR:0,EAS:0.0012,FIN:0.0009,NFE:0.0002,OTH:0,ASJ:0	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU77367820	het
3	53700550	53700550	T	C	CACNA1D	exonic	synonymous SNV	ENSG00000157388	rs2250736	ENSG00000157388:ENST00000481478:exon1:c.T123C:p.D41D,ENSG00000157388:ENST00000288139:exon7:c.T1104C:p.D368D,ENSG00000157388:ENST00000350061:exon7:c.T1104C:p.D368D,ENSG00000157388:ENST00000422281:exon7:c.T1104C:p.D368D	CACNA1D:NM_000720:exon7:c.T1104C:p.D368D,CACNA1D:NM_001128839:exon7:c.T1104C:p.D368D,CACNA1D:NM_001128840:exon7:c.T1104C:p.D368D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5945	0.6475	0.70647	0.6466	.	.	.	.	.	.	.	.	CACNA1D:uc003dgw.4:exon1:c.T45C:p.D15D,CACNA1D:uc003dgu.5:exon7:c.T1104C:p.D368D,CACNA1D:uc003dgv.5:exon7:c.T1104C:p.D368D,CACNA1D:uc003dgy.5:exon7:c.T1104C:p.D368D	.	AFR:0.8772,AMR:0.6026,EAS:0.6200,FIN:0.5856,NFE:0.5390,OTH:0.5833,ASJ:0.4967	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU19620305	hom
3	53769479	53769479	C	T	CACNA1D	exonic	synonymous SNV	ENSG00000157388	rs1045958	ENSG00000157388:ENST00000481478:exon15:c.C1779T:p.S593S,ENSG00000157388:ENST00000350061:exon20:c.C2700T:p.S900S,ENSG00000157388:ENST00000422281:exon20:c.C2700T:p.S900S,ENSG00000157388:ENST00000288139:exon21:c.C2760T:p.S920S	CACNA1D:NM_001128839:exon20:c.C2700T:p.S900S,CACNA1D:NM_001128840:exon20:c.C2700T:p.S900S,CACNA1D:NM_000720:exon21:c.C2760T:p.S920S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2994	0.2545	0.192292	0.2681	.	.	.	.	.	.	.	.	CACNA1D:uc003dgx.1:exon4:c.C144T:p.S48S,CACNA1D:uc003dgw.4:exon15:c.C1701T:p.S567S,CACNA1D:uc003dgv.5:exon20:c.C2700T:p.S900S,CACNA1D:uc003dgy.5:exon20:c.C2700T:p.S900S,CACNA1D:uc003dgu.5:exon21:c.C2760T:p.S920S	.	AFR:0.0693,AMR:0.3313,EAS:0.2042,FIN:0.3673,NFE:0.3585,OTH:0.3374,ASJ:0.3377	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU4565454	hom
3	57132200	57132200	A	G	IL17RD	exonic	synonymous SNV	ENSG00000144730	rs2291462	ENSG00000144730:ENST00000296318:exon12:c.T1531C:p.L511L,ENSG00000144730:ENST00000427856:exon12:c.T1459C:p.L487L,ENSG00000144730:ENST00000463523:exon12:c.T1099C:p.L367L,ENSG00000144730:ENST00000320057:exon13:c.T1099C:p.L367L	IL17RD:NM_017563:exon12:c.T1531C:p.L511L,IL17RD:NM_001318864:exon13:c.T1099C:p.L367L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8239	0.7910	0.736222	0.7820	.	.	.	.	.	.	.	.	IL17RD:uc003dik.3:exon12:c.T1459C:p.L487L,IL17RD:uc003dil.3:exon12:c.T1531C:p.L511L,IL17RD:uc011bex.1:exon12:c.T1099C:p.L367L,IL17RD:uc010hna.3:exon13:c.T1099C:p.L367L	.	AFR:0.6457,AMR:0.8377,EAS:0.4777,FIN:0.8980,NFE:0.8579,OTH:0.8405,ASJ:0.8841	606807	615267;	478;	478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	.	.	.	.	.	.	.	.	3	MU21327509	hom
3	57138419	57138419	G	A	IL17RD	exonic	nonsynonymous SNV	ENSG00000144730	rs6780995	ENSG00000144730:ENST00000296318:exon8:c.C764T:p.T255M,ENSG00000144730:ENST00000427856:exon8:c.C692T:p.T231M,ENSG00000144730:ENST00000463523:exon8:c.C332T:p.T111M,ENSG00000144730:ENST00000320057:exon9:c.C332T:p.T111M	IL17RD:NM_017563:exon8:c.C764T:p.T255M,IL17RD:NM_001318864:exon9:c.C332T:p.T111M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6490	0.6661	0.530152	ESAD-UK|1|409|0.00244499,LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053	2.678	20.7	0.094	-0.521	0.999	.	.	Interleukin 17 receptor D, N-terminal	IL17RD:uc003dik.3:exon8:c.C692T:p.T231M,IL17RD:uc003dil.3:exon8:c.C764T:p.T255M,IL17RD:uc011bex.1:exon8:c.C332T:p.T111M,IL17RD:uc010hna.3:exon9:c.C332T:p.T111M	-1.079	AFR:0.6306,AMR:0.5815,EAS:0.6921,FIN:0.1156,NFE:0.7376,OTH:0.6926,ASJ:0.5180	606807	615267;	478;	478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	.	.	.	.	0.943	2.89	0.000	1.245	3	1(bone)	0.6633
3	59997112	59997112	G	A	FHIT	exonic	synonymous SNV	ENSG00000189283	rs1130972	ENSG00000189283:ENST00000341848:exon3:c.C264T:p.A88A,ENSG00000189283:ENST00000468189:exon7:c.C264T:p.A88A,ENSG00000189283:ENST00000476844:exon7:c.C264T:p.A88A,ENSG00000189283:ENST00000492590:exon7:c.C264T:p.A88A	FHIT:NM_001320901:exon5:c.C96T:p.A32A,FHIT:NM_001166243:exon7:c.C264T:p.A88A,FHIT:NM_001320899:exon7:c.C264T:p.A88A,FHIT:NM_001354589:exon7:c.C264T:p.A88A,FHIT:NM_001354590:exon7:c.C264T:p.A88A,FHIT:NM_002012:exon7:c.C264T:p.A88A,FHIT:NM_001320900:exon8:c.C264T:p.A88A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1287	0.1313	0.0820687	0.1358	.	.	.	.	.	.	.	.	FHIT:uc003dkx.4:exon7:c.C264T:p.A88A,FHIT:uc003dky.3:exon7:c.C264T:p.A88A,FHIT:uc010hnn.1:exon7:c.C264T:p.A88A	.	AFR:0.0789,AMR:0.1751,EAS:0.0012,FIN:0.1821,NFE:0.1701,OTH:0.1619,ASJ:0.0629	601153	.	.	.	.	.	.	.	.	.	.	.	3	.	hom
3	78676467	78676467	A	G	ROBO1	intronic	.	ENSG00000169855	rs7636043	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9648	0.9735	0.969848	0.9692	.	.	.	.	.	0	0	.	.	.	AFR:0.9787,AMR:0.9881,EAS:0.9926,FIN:0.9648,NFE:0.9616,OTH:0.9541,ASJ:0.9901	602430	.	.	.	.	.	.	.	.	.	.	.	3	MU18278522	hom
3	78685024	78685024	C	T	ROBO1	exonic	nonsynonymous SNV	ENSG00000169855	rs35456279	ENSG00000169855:ENST00000436010:exon21:c.G3155A:p.S1052N,ENSG00000169855:ENST00000467549:exon21:c.G2972A:p.S991N,ENSG00000169855:ENST00000495273:exon21:c.G3137A:p.S1046N,ENSG00000169855:ENST00000464233:exon23:c.G3272A:p.S1091N	ROBO1:NM_001145845:exon21:c.G2972A:p.S991N,ROBO1:NM_133631:exon21:c.G3137A:p.S1046N,ROBO1:NM_002941:exon23:c.G3272A:p.S1091N	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0375	0.0447	0.0291534	0.0399	2.702	20.8	0.015	4.24	0.965	.	.	.	ROBO1:uc011bgl.1:exon13:c.G1988A:p.S663N,ROBO1:uc010hoh.2:exon15:c.G848A:p.S283N,ROBO1:uc003dqb.2:exon21:c.G3155A:p.S1052N,ROBO1:uc003dqc.2:exon21:c.G2972A:p.S991N,ROBO1:uc003dqd.2:exon21:c.G3137A:p.S1046N,ROBO1:uc003dqe.2:exon23:c.G3272A:p.S1091N	-1.032	AFR:0.0428,AMR:0.0239,EAS:0.0006,FIN:0.0160,NFE:0.0486,OTH:0.0469,ASJ:0.0298	602430	.	.	.	.	.	.	.	0.032	0.18	0.027	1.04	3	.	het
3	100467018	100467018	T	C	TFG	exonic	synonymous SNV	ENSG00000114354	rs11353	ENSG00000114354:ENST00000240851:exon8:c.T846C:p.P282P,ENSG00000114354:ENST00000418917:exon8:c.T834C:p.P278P,ENSG00000114354:ENST00000476228:exon8:c.T834C:p.P278P,ENSG00000114354:ENST00000490574:exon8:c.T846C:p.P282P	TFG:NM_001007565:exon8:c.T846C:p.P282P,TFG:NM_001195478:exon8:c.T846C:p.P282P,TFG:NM_001195479:exon8:c.T834C:p.P278P,TFG:NM_006070:exon8:c.T846C:p.P282P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6993	0.6551	0.713059	MU760146	-0.585	0.136	.	4.77	0.997	.	.	.	TFG:uc003due.3:exon8:c.T846C:p.P282P,TFG:uc003duf.3:exon8:c.T846C:p.P282P,TFG:uc003dug.3:exon8:c.T834C:p.P278P,TFG:uc003dui.3:exon8:c.T846C:p.P282P	-1.026	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.6676,EAS:0.7792,FIN:0.6192,NFE:0.5946,OTH:0.6703,ASJ:0.6560	602498	604484;615658;	431329;90117;	431329|SPG57<br>Spastic paraplegia due to partial TFG deficiency|<1 / 1 000 000|Autosomal recessive|Infancy|615658 ~90117|HMSNP<br>Hereditary motor and sensory neuropathy, proximal type|Unknown|Autosomal dominant|-|604484 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	0.000	.	3	2(haematopoietic_and_lymphoid_tissue)	0.6739
3	121154974	121154974	T	C	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs1381057	ENSG00000051341:ENST00000264233:exon28:c.A7538G:p.Q2513R	POLQ:NM_199420:exon28:c.A7538G:p.Q2513R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7217	0.6696	0.745208	0.6799	-1.556	0.002	1.0	-0.307	0.086	.	.	DNA-directed DNA polymerase, family A, palm domain	POLQ:uc003eed.3:exon13:c.A5054G:p.Q1685R,POLQ:uc003eee.4:exon28:c.A7538G:p.Q2513R	-0.965	AFR:0.6569,AMR:0.6957,EAS:0.9017,FIN:0.7032,NFE:0.6616,OTH:0.7031,ASJ:0.6767	604419	.	.	.	.	.	.	.	0.0	0.85	0.000	-1.14	3	MU13963964	hom
3	121208176	121208176	T	C	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs3218651	ENSG00000051341:ENST00000264233:exon16:c.A3602G:p.H1201R	POLQ:NM_199420:exon16:c.A3602G:p.H1201R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.2325	0.1325	0.289736	0.1807	-1.287	0.005	0.275	4.24	0.020	.	.	.	POLQ:uc003eed.3:exon1:c.A1118G:p.H373R,POLQ:uc003eee.4:exon16:c.A3602G:p.H1201R	-0.947	AFR:0.1205,AMR:0.3091,EAS:0.5717,FIN:0.2207,NFE:0.1576,OTH:0.1935,ASJ:0.1159	604419	.	.	.	.	.	.	.	0.048	0.9	0.000	0	3	MU13964063	hom
3	121238749	121238749	G	A	POLQ	exonic	synonymous SNV	ENSG00000051341	rs702018	ENSG00000051341:ENST00000264233:exon9:c.C1437T:p.G479G	POLQ:NM_199420:exon9:c.C1437T:p.G479G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9995	0.9985	0.997404	0.9983	.	.	.	.	.	.	.	.	POLQ:uc003eee.4:exon9:c.C1437T:p.G479G	.	AFR:0.9940,AMR:1,EAS:1,FIN:1,NFE:1,OTH:0.9990,ASJ:1	604419	.	.	.	.	.	.	.	.	.	.	.	3	MU81768041	hom
3	121263720	121263720	C	A	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs702017	ENSG00000051341:ENST00000264233:exon2:c.G197T:p.R66I	POLQ:NM_199420:exon2:c.G197T:p.R66I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9964	0.9886	0.988618	0.9896	0.494	7.389	0.525	-2.11	0.374	.	.	.	POLQ:uc003eee.4:exon2:c.G197T:p.R66I	-0.988	AFR:0.9637,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	604419	.	.	.	.	.	.	.	0.0	0.86	0.000	-1.67	3	MU81768070	hom
3	121264693	121264693	C	T	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	.	ENSG00000051341:ENST00000264233:exon1:c.G32A:p.R11Q	POLQ:NM_199420:exon1:c.G32A:p.R11Q	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 1, 1, 0] 	.	.	.	.	6.678	32	0.016	5.16	0.998	.	.	.	POLQ:uc003eee.4:exon1:c.G32A:p.R11Q	-0.710	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604419	.	.	.	.	.	.	.	1.0	0.61	0.215	2.28	3	MU125618406	hom
3	121981070	121981070	A	T	CASR	exonic	synonymous SNV	ENSG00000036828	.	ENSG00000036828:ENST00000296154:exon3:c.A1188T:p.T396T,ENSG00000036828:ENST00000490131:exon4:c.A1188T:p.T396T,ENSG00000036828:ENST00000498619:exon4:c.A1188T:p.T396T	CASR:NM_000388:exon4:c.A1188T:p.T396T,CASR:NM_001178065:exon4:c.A1188T:p.T396T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	CASR:uc003eev.4:exon4:c.A1188T:p.T396T,CASR:uc003eew.4:exon4:c.A1188T:p.T396T	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	.	.	.	.	3	.	hom
3	122003769	122003769	A	G	CASR	exonic	nonsynonymous SNV	ENSG00000036828	rs1042636	ENSG00000036828:ENST00000296154:exon6:c.A2968G:p.R990G,ENSG00000036828:ENST00000490131:exon7:c.A2968G:p.R990G,ENSG00000036828:ENST00000498619:exon7:c.A2998G:p.R1000G	CASR:NM_000388:exon7:c.A2968G:p.R990G,CASR:NM_001178065:exon7:c.A2998G:p.R1000G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.1451	0.0629	0.20647	LIRI-JP|1|258|0.00387597,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	2.338	18.42	0.002	3.26	0.340	.	.	.	CASR:uc003eev.4:exon7:c.A2968G:p.R990G,CASR:uc003eew.4:exon7:c.A2998G:p.R1000G	-0.936	AFR:0.1041,AMR:0.0461,EAS:0.0596,FIN:0.5093,NFE:0.1093,OTH:0.0851,ASJ:0.2339	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	0.319	-2.56	0.000	1.735	3	1(liver)	0.1255
3	122003832	122003832	G	C	CASR	exonic	nonsynonymous SNV	ENSG00000036828	rs1801726	ENSG00000036828:ENST00000296154:exon6:c.G3031C:p.E1011Q,ENSG00000036828:ENST00000490131:exon7:c.G3031C:p.E1011Q,ENSG00000036828:ENST00000498619:exon7:c.G3061C:p.E1021Q	CASR:NM_000388:exon7:c.G3031C:p.E1011Q,CASR:NM_001178065:exon7:c.G3061C:p.E1021Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9446	0.9178	0.924121	0.9148	-0.624	0.109	1.0	5.79	0.342	.	.	.	CASR:uc003eev.4:exon7:c.G3031C:p.E1011Q,CASR:uc003eew.4:exon7:c.G3061C:p.E1021Q	-0.937	AFR:0.8274,AMR:0.9785,EAS:0.9809,FIN:0.9190,NFE:0.9516,OTH:0.9264,ASJ:0.9934	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	0.0	-2.35	0.000	.	3	MU81768527	hom
3	124515491	124515491	G	T	ITGB5	exonic	nonsynonymous SNV	ENSG00000082781	.	ENSG00000082781:ENST00000488466:exon4:c.C621A:p.S207R,ENSG00000082781:ENST00000296181:exon10:c.C1437A:p.S479R	ITGB5:NM_001354766:exon9:c.C978A:p.S326R,ITGB5:NM_001354764:exon10:c.C1113A:p.S371R,ITGB5:NM_001354765:exon10:c.C1113A:p.S371R,ITGB5:NM_002213:exon10:c.C1437A:p.S479R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	0.416	6.749	0.03	-5.09	0.005	.	.	.	ITGB5:uc003eho.3:exon10:c.C1437A:p.S479R	-0.716	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	147561	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	0.045	-2.65	0.305	-1.01	3	.	hom
3	128205860	128205860	G	C	GATA2	exonic	synonymous SNV	ENSG00000179348	rs1573858	ENSG00000179348:ENST00000341105:exon2:c.C15G:p.P5P,ENSG00000179348:ENST00000430265:exon2:c.C15G:p.P5P,ENSG00000179348:ENST00000492608:exon2:c.C15G:p.P5P,ENSG00000179348:ENST00000487848:exon3:c.C15G:p.P5P,ENSG00000179348:ENST00000498200:exon3:c.C15G:p.P5P	GATA2:NM_001145662:exon2:c.C15G:p.P5P,GATA2:NM_032638:exon2:c.C15G:p.P5P,GATA2:NM_001145661:exon3:c.C15G:p.P5P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6943	0.6934	0.709864	1(prostate)	.	.	.	.	.	.	.	.	GATA2:uc003ekn.3:exon2:c.C15G:p.P5P,GATA2:uc003eko.2:exon2:c.C15G:p.P5P,GATA2:uc003ekm.3:exon3:c.C15G:p.P5P	.	AFR:MU77941,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.7816,FIN:0.7236,NFE:0.7318,OTH:0.7293,ASJ:0.6532	137295	601626;614038;614172;614286;	52688;228423;3226;519;	52688|-|1-9 / 100 000|-|All ages|614286 ~228423|Combined immunodeficiency with susceptibility to mycobacterial, viral and fungal infections<br>Dendritic cell, monocyte, B and NK lymphoid deficiency<br>MonoMAC<br>Monocyte-B-natural killer-dendritic cell deficiency syndrome<br>Monocytopenia and mycobacterial infection syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|614172 ~3226|Emberger syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614038 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	,5843	.	,5844	.	.	.	.	3	4(large_intestine)	0.5255
3	129020778	129020778	A	G	HMCES	intronic	.	ENSG00000183624	rs6765930	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7957	0.8211	0.809704	0.8190	.	.	.	.	.	.	.	.	.	.	AFR:0.9009,AMR:0.7524,EAS:0.7009,FIN:0.8328,NFE:0.7859,OTH:0.7984,ASJ:0.8278	.	.	.	.	.	.	.	.	.	.	.	.	3	MU18309036	hom
3	133329943	133329943	G	A	TOPBP1	exonic	synonymous SNV	ENSG00000163781	rs1444601	ENSG00000163781:ENST00000260810:exon25:c.C4078T:p.L1360L	TOPBP1:NM_001363889:exon25:c.C4063T:p.L1355L,TOPBP1:NM_007027:exon25:c.C4078T:p.L1360L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6905	0.7468	0.682109	0.7131	.	.	.	.	.	.	.	.	TOPBP1:uc003eps.3:exon25:c.C4078T:p.L1360L	.	AFR:0.7736,AMR:0.6842,EAS:0.5854,FIN:0.6523,NFE:0.7102,OTH:0.6811,ASJ:0.6788	607760	.	.	.	.	.	.	.	.	.	.	.	3	MU4134346	het
3	133356790	133356790	G	A	TOPBP1	exonic	nonsynonymous SNV	ENSG00000163781	rs17301766	ENSG00000163781:ENST00000260810:exon14:c.C2450T:p.S817L	TOPBP1:NM_001363889:exon14:c.C2435T:p.S812L,TOPBP1:NM_007027:exon14:c.C2450T:p.S817L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1411	0.1553	0.0810703	0.1396	3.906	23.5	0.004	5.16	0.977	.	.	BRCT domain	TOPBP1:uc003eps.3:exon14:c.C2450T:p.S817L	-1.047	AFR:0.0739,AMR:0.1077,EAS:0,FIN:0.1622,NFE:0.1883,OTH:0.1548,ASJ:0.1490	607760	.	.	.	.	.	.	.	0.372	2.02	0.000	2.745	3	MU144370	het
3	134670524	134670524	C	T	EPHB1	exonic	synonymous SNV	ENSG00000154928	rs7644369	ENSG00000154928:ENST00000398015:exon3:c.C435T:p.S145S,ENSG00000154928:ENST00000474732:exon3:c.C369T:p.S123S,ENSG00000154928:ENST00000482618:exon3:c.C435T:p.S145S	EPHB1:NM_004441:exon3:c.C435T:p.S145S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4628	0.4879	0.48143	2(lung)	.	.	.	.	.	.	.	.	EPHB1:uc003eqt.3:exon3:c.C435T:p.S145S,EPHB1:uc011bly.2:exon3:c.C435T:p.S145S	.	AFR:MU150981,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.6072,FIN:0.5359,NFE:0.5430,OTH:0.1963,ASJ:0.4687	600600	.	.	.	.	.	.	.	.	.	.	.	3	1(large_intestine)	0.3564
3	134884880	134884880	C	T	EPHB1	exonic	synonymous SNV	ENSG00000154928	rs56372452	ENSG00000154928:ENST00000493838:exon6:c.C339T:p.F113F,ENSG00000154928:ENST00000398015:exon8:c.C1656T:p.F552F	EPHB1:NM_004441:exon8:c.C1656T:p.F552F	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0034	0.0030	0.00259585	0.0024	.	.	.	.	.	.	.	.	EPHB1:uc003equ.3:exon6:c.C339T:p.F113F,EPHB1:uc003eqt.3:exon8:c.C1656T:p.F552F	.	AFR:0.0010,AMR:0.0036,EAS:0,FIN:0.0006,NFE:0.0035,OTH:0.0051,ASJ:0.0066	600600	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	134898742	134898742	C	T	EPHB1	exonic	synonymous SNV	ENSG00000154928	rs1042787	ENSG00000154928:ENST00000493838:exon8:c.C483T:p.Y161Y,ENSG00000154928:ENST00000398015:exon10:c.C1800T:p.Y600Y	EPHB1:NM_004441:exon10:c.C1800T:p.Y600Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4494	0.4166	0.537939	0.4358	.	.	.	.	.	.	.	.	EPHB1:uc003equ.3:exon8:c.C483T:p.Y161Y,EPHB1:uc003eqt.3:exon10:c.C1800T:p.Y600Y	.	AFR:0.5083,AMR:0.4653,EAS:0.7172,FIN:0.3184,NFE:0.3933,OTH:0.4206,ASJ:0.2748	600600	.	.	.	.	.	.	.	.	.	.	.	3	MU4133192	het
3	142168331	142168331	C	T	ATR	exonic	synonymous SNV	ENSG00000175054	rs1802904	ENSG00000175054:ENST00000383101:exon46:c.G7683A:p.Q2561Q,ENSG00000175054:ENST00000350721:exon47:c.G7875A:p.Q2625Q	ATR:NM_001354579:exon46:c.G7683A:p.Q2561Q,ATR:NM_001184:exon47:c.G7875A:p.Q2625Q	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8646	0.8978	0.916334	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ATR:uc003eux.4:exon47:c.G7875A:p.Q2625Q	.	AFR:0.8880,AMR:0.9702,EAS:0.8079,FIN:0.9420,NFE:0.7995,OTH:0.8651,ASJ:0.7775	601215	210600;614564;	313846;808;	313846|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614564 ~808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	926,,925	.	.	.	.	.	.	3	17(meninges)	0.8510
3	142274740	142274740	T	-	ATR	exonic	frameshift deletion	ENSG00000175054	rs757500301	ENSG00000175054:ENST00000383101:exon9:c.2128delA:p.I710fs,ENSG00000175054:ENST00000350721:exon10:c.2320delA:p.I774fs	ATR:NM_001354579:exon9:c.2128delA:p.I710fs,ATR:NM_001184:exon10:c.2320delA:p.I774fs	clinvar: not_provided 	 CancerVar: 8#Tier_II_potential EVS=[1, 0, 1, 1, 0, 0, 1, 0, 2, 0, 1, 1] 	0.0053	.	.	6.653e-05	.	.	.	.	.	.	.	.	ATR:uc003eux.4:exon10:c.2320delA:p.I774fs	.	AFR:0.0002,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	601215	210600;614564;	313846;808;	313846|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614564 ~808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	926,,925	.	,924	.	.	.	.	3	MU4350843	het
3	142281124	142281124	T	A	ATR	exonic	nonsynonymous SNV	ENSG00000175054	.	ENSG00000175054:ENST00000515149:exon1:c.A163T:p.N55Y,ENSG00000175054:ENST00000350721:exon4:c.A1120T:p.N374Y,ENSG00000175054:ENST00000383101:exon4:c.A1120T:p.N374Y	ATR:NM_001184:exon4:c.A1120T:p.N374Y,ATR:NM_001354579:exon4:c.A1120T:p.N374Y	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 1] 	.	.	.	.	2.685	20.7	0.051	4.48	0.999	.	.	Armadillo-like helical	ATR:uc003eux.4:exon4:c.A1120T:p.N374Y	-0.963	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601215	210600;614564;	313846;808;	313846|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614564 ~808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	926,,925	.	.	0.845	-0.22	0.135	1.39	3	.	hom
3	148759325	148759325	T	C	HLTF	exonic	synonymous SNV	ENSG00000071794	rs2290725	ENSG00000071794:ENST00000467858:exon6:c.A732G:p.A244A,ENSG00000071794:ENST00000310053:exon20:c.A2328G:p.A776A,ENSG00000071794:ENST00000392912:exon20:c.A2328G:p.A776A,ENSG00000071794:ENST00000465259:exon20:c.A2325G:p.A775A,ENSG00000071794:ENST00000494055:exon20:c.A2328G:p.A776A	HLTF:NM_001318934:exon20:c.A2325G:p.A775A,HLTF:NM_001318935:exon20:c.A2328G:p.A776A,HLTF:NM_003071:exon20:c.A2328G:p.A776A,HLTF:NM_139048:exon20:c.A2328G:p.A776A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3187	0.3052	0.315695	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	HLTF:uc003ewq.1:exon20:c.A2328G:p.A776A,HLTF:uc003ewr.1:exon20:c.A2328G:p.A776A,HLTF:uc003ews.1:exon20:c.A2325G:p.A775A,HLTF:uc010hve.1:exon20:c.A2325G:p.A775A	.	AFR:1(large_intestine),AMR:1(breast),EAS:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,FIN:0.3153,NFE:0.3025,OTH:0.3565,ASJ:MU106674	603257	.	.	.	.	.	.	.	.	.	.	.	3	1(stomach)	0.2980
3	148786108	148786108	C	T	HLTF	exonic	synonymous SNV	ENSG00000071794	rs812249	ENSG00000071794:ENST00000310053:exon8:c.G909A:p.T303T,ENSG00000071794:ENST00000392912:exon8:c.G909A:p.T303T,ENSG00000071794:ENST00000465259:exon8:c.G909A:p.T303T,ENSG00000071794:ENST00000494055:exon8:c.G909A:p.T303T	HLTF:NM_001318934:exon8:c.G909A:p.T303T,HLTF:NM_001318935:exon8:c.G909A:p.T303T,HLTF:NM_003071:exon8:c.G909A:p.T303T,HLTF:NM_139048:exon8:c.G909A:p.T303T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7161	0.7527	0.742412	MU16602666	.	.	.	.	.	.	.	.	HLTF:uc003ewq.1:exon8:c.G909A:p.T303T,HLTF:uc003ewr.1:exon8:c.G909A:p.T303T,HLTF:uc003ews.1:exon8:c.G909A:p.T303T,HLTF:uc010hve.1:exon8:c.G909A:p.T303T	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,AMR:0.7369,EAS:0.8289,FIN:0.7980,NFE:0.7213,OTH:0.7109,ASJ:0.8307	603257	.	.	.	.	.	.	.	.	.	.	.	3	1(prostate)	0.6853
3	154832888	154832888	G	A	MME	exonic	nonsynonymous SNV	ENSG00000196549	.	ENSG00000196549:ENST00000360490:exon4:c.G302A:p.S101N,ENSG00000196549:ENST00000460393:exon4:c.G302A:p.S101N,ENSG00000196549:ENST00000462745:exon4:c.G302A:p.S101N,ENSG00000196549:ENST00000462837:exon4:c.G302A:p.S101N,ENSG00000196549:ENST00000481828:exon4:c.G302A:p.S101N,ENSG00000196549:ENST00000491026:exon4:c.G302A:p.S101N,ENSG00000196549:ENST00000492661:exon4:c.G302A:p.S101N,ENSG00000196549:ENST00000493237:exon4:c.G302A:p.S101N	MME:NM_000902:exon4:c.G302A:p.S101N,MME:NM_001354642:exon4:c.G302A:p.S101N,MME:NM_001354643:exon4:c.G302A:p.S101N,MME:NM_007287:exon4:c.G302A:p.S101N,MME:NM_007288:exon4:c.G302A:p.S101N,MME:NM_007289:exon4:c.G302A:p.S101N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	1.579	13.73	0.547	4.72	0.747	.	.	Metallopeptidase, catalytic domain|Peptidase M13, N-terminal domain;Peptidase M13, N-terminal domain	MME:uc003fab.1:exon4:c.G302A:p.S101N,MME:uc003fac.1:exon4:c.G302A:p.S101N,MME:uc003fad.1:exon4:c.G302A:p.S101N,MME:uc003fae.1:exon4:c.G302A:p.S101N,MME:uc010hvr.1:exon4:c.G302A:p.S101N	-0.806	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	120520	617017;617018;	443950;	443950|AR-CMT2T<br>Autosomal recessive axonal Charcot-Marie-Tooth disease type 2T<br>CMT2T|<1 / 1 000 000|Autosomal recessive|Adult|616233 617017 ~	.	.	.	.	0.253	-0.8	0.222	1.26	3	.	hom
3	156396331	156396331	T	C	TIPARP	exonic	nonsynonymous SNV	ENSG00000163659	.	ENSG00000163659:ENST00000295924:exon2:c.T845C:p.F282S,ENSG00000163659:ENST00000461166:exon2:c.T845C:p.F282S,ENSG00000163659:ENST00000473702:exon2:c.T845C:p.F282S,ENSG00000163659:ENST00000481853:exon2:c.T845C:p.F282S,ENSG00000163659:ENST00000486483:exon2:c.T845C:p.F282S,ENSG00000163659:ENST00000542783:exon2:c.T845C:p.F282S	TIPARP:NM_001184717:exon2:c.T845C:p.F282S,TIPARP:NM_001184718:exon2:c.T845C:p.F282S,TIPARP:NM_015508:exon2:c.T845C:p.F282S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	0.013	2.716	1.0	4.3	0.997	.	.	Zinc finger, CCCH-type	TIPARP:uc003fav.3:exon2:c.T845C:p.F282S,TIPARP:uc003faw.3:exon2:c.T845C:p.F282S,TIPARP:uc021xgg.1:exon2:c.T845C:p.F282S	-0.963	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	612480	.	.	.	.	.	.	.	0.0	3.12	0.012	-1.955	3	.	hom
3	156870816	156870816	A	G	CCNL1	intronic	.	ENSG00000163660	rs41272613	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2546	0.1954	0.23722	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.2035,AMR:0.0990,EAS:0.1821,FIN:0.3578,NFE:0.1823,OTH:0.2377,ASJ:0.4580	613384	.	.	.	.	.	.	.	.	.	.	.	3	2(haematopoietic_and_lymphoid_tissue)	0.2219
3	158306627	158306627	A	G	MLF1	intronic	.	ENSG00000178053	rs1075551	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5630	.	0.571286	0.5541	.	.	.	.	.	.	.	.	.	.	AFR:0.7255,AMR:0.5407,EAS:0.3040,FIN:0.4707,NFE:0.5063,OTH:0.4856,ASJ:0.5430	601402	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	3	MU14910846	het
3	168806987	168806987	G	A	MECOM	intronic	.	ENSG00000085276	rs1981745	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1770	0.1433	0.0874601	0.1615	.	.	.	.	.	.	.	.	.	.	AFR:0.0340,AMR:0.0955,EAS:0.0553,FIN:0.3025,NFE:0.2145,OTH:0.2177,ASJ:0.1623	165215	616738;	71289;	71289|ATRUS syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|605432 616738 ~	~ko04010 MAPK signaling pathway~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	3	MU61980520	hom
3	168810874	168810874	C	T	MECOM	exonic	synonymous SNV	ENSG00000085276	rs17466625	ENSG00000085276:ENST00000460814:exon11:c.G2445A:p.S815S,ENSG00000085276:ENST00000464456:exon12:c.G2445A:p.S815S,ENSG00000085276:ENST00000392736:exon13:c.G2472A:p.S824S,ENSG00000085276:ENST00000468789:exon13:c.G2472A:p.S824S,ENSG00000085276:ENST00000472280:exon13:c.G2475A:p.S825S,ENSG00000085276:ENST00000494292:exon13:c.G3009A:p.S1003S,ENSG00000085276:ENST00000264674:exon14:c.G2667A:p.S889S,ENSG00000085276:ENST00000433243:exon14:c.G2475A:p.S825S	MECOM:NM_001163999:exon12:c.G2448A:p.S816S,MECOM:NM_001164000:exon12:c.G2445A:p.S815S,MECOM:NM_001366470:exon12:c.G2448A:p.S816S,MECOM:NM_001366471:exon12:c.G2445A:p.S815S,MECOM:NM_001366472:exon12:c.G2445A:p.S815S,MECOM:NM_001366474:exon12:c.G1473A:p.S491S,MECOM:NM_001105078:exon13:c.G2472A:p.S824S,MECOM:NM_001205194:exon13:c.G2472A:p.S824S,MECOM:NM_001366466:exon13:c.G3009A:p.S1003S,MECOM:NM_001366467:exon13:c.G2475A:p.S825S,MECOM:NM_001366468:exon13:c.G2475A:p.S825S,MECOM:NM_001366469:exon13:c.G2472A:p.S824S,MECOM:NM_001366473:exon13:c.G2037A:p.S679S,MECOM:NM_005241:exon13:c.G2472A:p.S824S,MECOM:NM_001105077:exon14:c.G2667A:p.S889S,MECOM:NM_004991:exon14:c.G3036A:p.S1012S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1671	0.1504	0.0908546	0.1650	.	.	.	.	.	.	.	.	MECOM:uc010hwk.1:exon11:c.G2514A:p.S838S,MECOM:uc003ffk.2:exon12:c.G2445A:p.S815S,MECOM:uc003ffl.2:exon12:c.G2925A:p.S975S,MECOM:uc011bpi.1:exon12:c.G2448A:p.S816S,MECOM:uc003ffi.3:exon13:c.G2472A:p.S824S,MECOM:uc003ffn.3:exon13:c.G2472A:p.S824S,MECOM:uc011bpk.1:exon13:c.G2472A:p.S824S,MECOM:uc003ffj.3:exon14:c.G2667A:p.S889S,MECOM:uc011bpj.1:exon14:c.G3036A:p.S1012S	.	AFR:0.0433,AMR:0.0988,EAS:0.0550,FIN:0.3019,NFE:0.2160,OTH:0.2178,ASJ:0.1623	165215	616738;	71289;	71289|ATRUS syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|605432 616738 ~	~ko04010 MAPK signaling pathway~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	3	.	het
3	185155430	185155430	-	T	MAP3K13	intronic	.	ENSG00000073803	rs5855064	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5905	.	0.616214	0.7684	.	.	.	.	.	.	.	.	.	.	AFR:0.6852,AMR:0.7870,EAS:0.7418,FIN:0.7263,NFE:0.8259,OTH:0.7861,ASJ:0.8433	604915	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	185191191	185191191	-	GCCCGGCTCGA	MAP3K13	exonic	frameshift insertion	ENSG00000073803	.	ENSG00000073803:ENST00000446828:exon10:c.1451_1452insGCCCGGCTCGA:p.L484fs,ENSG00000073803:ENST00000535426:exon10:c.1640_1641insGCCCGGCTCGA:p.L547fs,ENSG00000073803:ENST00000265026:exon11:c.2072_2073insGCCCGGCTCGA:p.L691fs,ENSG00000073803:ENST00000443863:exon11:c.1640_1641insGCCCGGCTCGA:p.L547fs,ENSG00000073803:ENST00000424227:exon12:c.2072_2073insGCCCGGCTCGA:p.L691fs	MAP3K13:NM_001242317:exon10:c.1451_1452insGCCCGGCTCGA:p.L484fs,MAP3K13:NM_004721:exon11:c.2072_2073insGCCCGGCTCGA:p.L691fs,MAP3K13:NM_001242314:exon12:c.2072_2073insGCCCGGCTCGA:p.L691fs	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	MAP3K13:uc010hyg.3:exon9:c.1142_1143insGCCCGGCTCGA:p.L381fs,MAP3K13:uc011brt.2:exon10:c.1451_1452insGCCCGGCTCGA:p.L484fs,MAP3K13:uc003fpi.3:exon11:c.2072_2073insGCCCGGCTCGA:p.L691fs,MAP3K13:uc011bru.2:exon11:c.1640_1641insGCCCGGCTCGA:p.L547fs,MAP3K13:uc010hyf.3:exon12:c.2072_2073insGCCCGGCTCGA:p.L691fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604915	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	186509517	186509517	G	A	RFC4	exonic	synonymous SNV	ENSG00000163918	rs187868	ENSG00000163918:ENST00000417876:exon1:c.C123T:p.A41A,ENSG00000163918:ENST00000433496:exon7:c.C798T:p.A266A,ENSG00000163918:ENST00000296273:exon8:c.C798T:p.A266A,ENSG00000163918:ENST00000392481:exon8:c.C798T:p.A266A	RFC4:NM_002916:exon8:c.C798T:p.A266A,RFC4:NM_181573:exon8:c.C798T:p.A266A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4918	0.4748	0.483826	MU18338543	.	.	.	.	.	.	.	.	RFC4:uc003fqz.3:exon8:c.C798T:p.A266A,RFC4:uc011bsc.2:exon8:c.C798T:p.A266A,RFC4:uc011bsd.2:exon8:c.C798T:p.A266A	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.5062,EAS:0.5215,FIN:0.4172,NFE:0.4684,OTH:0.6110,ASJ:0.4608	102577	.	.	.	.	.	.	.	.	.	.	.	3	1(stomach)	0.5122
3	187451491	187451491	A	G	BCL6	UTR5	.	ENSG00000228804	rs764849942	ENSG00000228804:ENST00000449623:exon3:c.A309G:p.S103S	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	1.714e-05	.	.	.	.	.	.	.	.	0.0002	0.028	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	109565	.	.	.	~ko04068 FoxO signaling pathway~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	3	.	hom
3	191888452	191888452	-	A	FGF12	intronic	.	ENSG00000114279	rs201475598	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0028	.	0.00239617	0.0018	.	.	.	.	.	.	.	.	.	.	AFR:0.0003,AMR:0,EAS:0.0139,FIN:0.0059,NFE:0.0007,OTH:0.0029,ASJ:0	601513	.	.	.	.	.	.	.	.	.	.	.	3	MU112217309	het
3	195594494	195594494	C	T	TNK2	exonic	nonsynonymous SNV	ENSG00000061938	rs112384084	ENSG00000061938:ENST00000416152:exon4:c.G1331A:p.R444H,ENSG00000061938:ENST00000333602:exon12:c.G2630A:p.R877H,ENSG00000061938:ENST00000392400:exon12:c.G2630A:p.R877H,ENSG00000061938:ENST00000428187:exon12:c.G2726A:p.R909H,ENSG00000061938:ENST00000381916:exon13:c.G2864A:p.R955H	TNK2:NM_001308046:exon12:c.G2726A:p.R909H,TNK2:NM_005781:exon12:c.G2630A:p.R877H,TNK2:NM_001010938:exon13:c.G2747A:p.R916H	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, -1, 0, 0] 	0.0154	0.0125	0.0123802	0.0117	2.901	21.9	0.023	0.166	0.709	.	.	.	TNK2:uc003fvq.1:exon1:c.G851A:p.R284H,TNK2:uc003fvr.1:exon4:c.G1205A:p.R402H,TNK2:uc003fvs.1:exon12:c.G2726A:p.R909H,TNK2:uc003fvu.1:exon12:c.G2630A:p.R877H,TNK2:uc003fvt.1:exon13:c.G2864A:p.R955H	-0.871	AFR:0.0037,AMR:0.0072,EAS:0.0241,FIN:0.0066,NFE:0.0166,OTH:0.0133,ASJ:0	606994	.	.	.	.	.	.	.	0.814	2.58	0.108	1.75	3	MU80672199	hom
3	195595089	195595089	G	A	TNK2	exonic	nonsynonymous SNV	ENSG00000061938	.	ENSG00000061938:ENST00000416152:exon4:c.C736T:p.P246S,ENSG00000061938:ENST00000333602:exon12:c.C2035T:p.P679S,ENSG00000061938:ENST00000392400:exon12:c.C2035T:p.P679S,ENSG00000061938:ENST00000428187:exon12:c.C2131T:p.P711S,ENSG00000061938:ENST00000381916:exon13:c.C2269T:p.P757S	TNK2:NM_001308046:exon12:c.C2131T:p.P711S,TNK2:NM_005781:exon12:c.C2035T:p.P679S,TNK2:NM_001010938:exon13:c.C2152T:p.P718S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	-1.044	0.013	0.706	4.31	0.004	.	.	.	TNK2:uc003fvq.1:exon1:c.C256T:p.P86S,TNK2:uc003fvr.1:exon4:c.C610T:p.P204S,TNK2:uc003fvs.1:exon12:c.C2131T:p.P711S,TNK2:uc003fvu.1:exon12:c.C2035T:p.P679S,TNK2:uc003fvt.1:exon13:c.C2269T:p.P757S	-0.985	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606994	.	.	.	.	.	.	.	0.002	0.77	0.069	1.1	3	.	hom
3	195596354	195596354	G	A	TNK2	intronic	.	ENSG00000061938	rs921067558	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606994	.	.	.	.	.	.	.	.	.	.	.	3	.	hom
3	195605109	195605109	C	T	TNK2	intronic	.	ENSG00000061938	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	3.233e-05	.	.	.	.	.	.	.	.	.	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	606994	.	.	.	.	.	.	.	.	.	.	.	3	.	hom
3	195798258	195798258	T	C	TFRC	intronic	.	ENSG00000072274	rs480760	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9497	0.8857	0.894169	0.9015	.	.	.	.	.	.	.	.	.	.	AFR:0.7292,AMR:0.9606,EAS:1,FIN:0.9657,NFE:0.9670,OTH:0.9654,ASJ:0.9768	190010	616740;	.	.	.	.	.	.	.	.	.	.	3	MU81776721	hom
3	196199204	196199204	G	T	RNF168	exonic	nonsynonymous SNV	ENSG00000163961	rs3796129	ENSG00000163961:ENST00000318037:exon6:c.C1202A:p.P401Q	RNF168:NM_152617:exon6:c.C1202A:p.P401Q	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.5405	0.5172	0.402356	0.5038	2.051	16.54	0.058	4.29	0.713	.	.	.	RNF168:uc010iah.3:exon5:c.C701A:p.P234Q,RNF168:uc003fwq.3:exon6:c.C1202A:p.P401Q	-1.041	AFR:0.2989,AMR:0.4306,EAS:0.1776,FIN:0.6676,NFE:0.6172,OTH:0.5706,ASJ:0.6225	612688	611943;	420741;	420741|RNF168 deficiency<br>Radiosensitivity-immunodeficiency-dysmorphic features-learning difficulties syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Adolescent|611943 ~	.	.	.	.	0.8	3.18	0.000	2.38	3	MU27951640	hom
3	196229894	196229894	A	G	RNF168	exonic	nonsynonymous SNV	ENSG00000163961	.	ENSG00000163961:ENST00000318037:exon1:c.T151C:p.C51R,ENSG00000163961:ENST00000437070:exon1:c.T151C:p.C51R	RNF168:NM_152617:exon1:c.T151C:p.C51R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 2, 0, 0] 	.	.	.	.	4.992	25.1	0.0	6.0	0.756	.	.	Zinc finger, RING-type|Zinc finger, RING/FYVE/PHD-type	RNF168:uc003fwq.3:exon1:c.T151C:p.C51R	0.893	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	612688	611943;	420741;	420741|RNF168 deficiency<br>Radiosensitivity-immunodeficiency-dysmorphic features-learning difficulties syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Adolescent|611943 ~	.	.	.	.	1.0	-7.24	0.997	4.16	3	.	hom
4	1346120	1346120	-	ACCCCAGATCCTTCTCCTGACAGACTGTGGTCCCAGGTGTGGG	UVSSA	intronic	.	ENSG00000163945	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	.	het
4	1346903	1346903	G	A	UVSSA	exonic	synonymous SNV	ENSG00000163945	rs77892061	ENSG00000163945:ENST00000389851:exon5:c.G636A:p.P212P,ENSG00000163945:ENST00000507531:exon5:c.G636A:p.P212P,ENSG00000163945:ENST00000511216:exon5:c.G636A:p.P212P	UVSSA:NM_001317934:exon5:c.G636A:p.P212P,UVSSA:NM_001317935:exon5:c.G636A:p.P212P,UVSSA:NM_020894:exon5:c.G636A:p.P212P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0421	0.0394	0.0265575	0.0332	.	.	.	.	.	.	.	.	UVSSA:uc003gde.4:exon5:c.G636A:p.P212P	.	AFR:0.0093,AMR:0.0274,EAS:0.0006,FIN:0.0309,NFE:0.0504,OTH:0.0377,ASJ:0.0762	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	.	het
4	1350256	1350256	C	T	UVSSA	intronic	.	ENSG00000163945	rs527408349	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.00698882	0.0003	.	.	.	.	.	.	.	.	.	.	AFR:0.0003,AMR:0.0012,EAS:0,FIN:0,NFE:0.0002,OTH:0.0010,ASJ:0	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	.	hom
4	1350322	1350322	C	T	UVSSA	intronic	.	ENSG00000163945	rs2336081	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.779952	0.7631	.	.	.	.	.	.	.	.	.	.	AFR:0.9337,AMR:0.8457,EAS:0.7097,FIN:0.7048,NFE:0.6859,OTH:0.6980,ASJ:0.6060	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	.	hom
4	1377615	1377615	A	G	UVSSA	exonic	synonymous SNV	ENSG00000163945	rs9996817	ENSG00000163945:ENST00000511563:exon6:c.A576G:p.S192S,ENSG00000163945:ENST00000512728:exon6:c.A576G:p.S192S,ENSG00000163945:ENST00000389851:exon13:c.A1923G:p.S641S,ENSG00000163945:ENST00000507531:exon13:c.A1923G:p.S641S,ENSG00000163945:ENST00000511216:exon13:c.A1923G:p.S641S	UVSSA:NM_001317934:exon13:c.A1923G:p.S641S,UVSSA:NM_001317935:exon13:c.A1923G:p.S641S,UVSSA:NM_020894:exon13:c.A1923G:p.S641S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7195	0.7205	0.717252	0.7205	.	.	.	.	.	.	.	.	UVSSA:uc010ibv.3:exon6:c.A576G:p.S192S,UVSSA:uc003gde.4:exon13:c.A1923G:p.S641S	.	AFR:0.7138,AMR:0.8481,EAS:0.7077,FIN:0.7226,NFE:0.7205,OTH:0.7156,ASJ:0.6225	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	.	.	.	.	4	MU4566462	het
4	1806043	1806043	C	T	FGFR3	intronic	.	ENSG00000068078	rs752649130	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	9.027e-06	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	134934	100800;109800;114500;146000;149730;162900;187600;187601;273300;602849;603956;610474;612247;616482;	85165;93262;85164;53271;363483;363494;363504;842;876;99865;2655;93274;1860;2655;79414;2363;429;15;	85165|SADDAN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|616482 ~93262|Crouzon-dermoskeletal syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|612247 ~85164|CATSHL syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610474 ~53271|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|602849 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~93274|Cloverleaf skull-micromelic bone dysplasia syndrome<br>TD2<br>Thanatophoric dwarfism type 2<br>Thanatophoric dwarfism-cloverleaf skull syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|156830 187601 ~1860|TD1<br>Thanatophoric dwarfism type 1|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal|187600 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~429|-|1-9 / 100 000|Autosomal dominant|Childhood|146000 ~15|-|1-9 / 100 000|Autosomal dominant|Neonatal|100800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05219 Bladder cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	4	.	hom
4	25678199	25678199	A	G	SLC34A2	exonic	nonsynonymous SNV	ENSG00000157765	rs6448389	ENSG00000157765:ENST00000382051:exon13:c.A1901G:p.D634G,ENSG00000157765:ENST00000503434:exon13:c.A1898G:p.D633G,ENSG00000157765:ENST00000504570:exon13:c.A1898G:p.D633G	SLC34A2:NM_001177998:exon13:c.A1898G:p.D633G,SLC34A2:NM_001177999:exon13:c.A1898G:p.D633G,SLC34A2:NM_006424:exon13:c.A1901G:p.D634G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8643	0.8760	0.910743	0.8992	0.576	7.988	1.0	4.99	0.264	.	.	.	SLC34A2:uc003grr.3:exon13:c.A1901G:p.D634G,SLC34A2:uc003grs.3:exon13:c.A1898G:p.D633G,SLC34A2:uc010iev.3:exon13:c.A1898G:p.D633G	-0.970	AFR:0.9638,AMR:0.8612,EAS:0.9994,FIN:0.9121,NFE:0.8528,OTH:0.8824,ASJ:0.8113	604217	265100;	60025;	60025|-|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|All ages|265100 ~	.	.	.	.	0.0	2.17	0.000	-2.62	4	MU81781878	hom
4	55161391	55161391	T	C	PDGFRA	exonic	synonymous SNV	ENSG00000134853;ENSG00000145216	rs7685117	ENSG00000134853:ENST00000257290:exon23:c.T3222C:p.D1074D,ENSG00000145216:ENST00000507166:exon24:c.T2502C:p.D834D	PDGFRA:NM_001347829:exon23:c.T3222C:p.D1074D,PDGFRA:NM_001347830:exon23:c.T3261C:p.D1087D,PDGFRA:NM_006206:exon23:c.T3222C:p.D1074D,PDGFRA:NM_001347828:exon24:c.T3297C:p.D1099D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9990	0.9968	0.997204	0.9980	.	.	.	.	.	.	.	.	PDGFRA:uc003han.4:exon23:c.T3222C:p.D1074D,PDGFRA:uc003haa.3:exon24:c.T2502C:p.D834D	.	AFR:0.9929,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	,8557,8564	,8558	.	.	.	.	.	4	MU81784009	hom
4	55948108	55948108	A	G	KDR	intronic	.	ENSG00000250646	rs2412617	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9986	0.9976	0.996805	0.9975	.	.	.	.	.	.	.	.	.	.	AFR:0.9923,AMR:1,EAS:1,FIN:1,NFE:0.9995,OTH:0.9980,ASJ:0.9967	191306	602089;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	MU81784046	hom
4	55979558	55979558	C	T	KDR	exonic	nonsynonymous SNV	ENSG00000128052	rs2305948	ENSG00000128052:ENST00000263923:exon7:c.G889A:p.V297I	KDR:NM_002253:exon7:c.G889A:p.V297I	clinvar: not_provided 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.1089	0.1427	0.152556	5(meninges)	5.248	25.6	0.059	4.63	0.113	.	.	Immunoglobulin|Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	KDR:uc003has.3:exon7:c.G889A:p.V297I,KDR:uc003hat.1:exon7:c.G889A:p.V297I,KDR:uc011bzx.2:exon7:c.G889A:p.V297I	-1.133	AFR:1(autonomic_ganglia),AMR:2(large_intestine),EAS:LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053,FIN:0.1406,NFE:0.2455,OTH:0.0740,ASJ:MU23090618	191306	602089;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,6301,6300,6302,6303	.	.	0.998	-0.23	0.000	2.99	4	10(soft_tissue)	0.0993
4	66197804	66197804	C	T	EPHA5	exonic	synonymous SNV	ENSG00000145242	rs7349683	ENSG00000145242:ENST00000432638:exon15:c.G2406A:p.G802G,ENSG00000145242:ENST00000354839:exon16:c.G2829A:p.G943G,ENSG00000145242:ENST00000273854:exon17:c.G2895A:p.G965G,ENSG00000145242:ENST00000511294:exon17:c.G2898A:p.G966G	EPHA5:NM_001281766:exon16:c.G2832A:p.G944G,EPHA5:NM_182472:exon16:c.G2829A:p.G943G,EPHA5:NM_001281765:exon17:c.G2898A:p.G966G,EPHA5:NM_001281767:exon17:c.G2898A:p.G966G,EPHA5:NM_001318761:exon17:c.G2691A:p.G897G,EPHA5:NM_004439:exon17:c.G2895A:p.G965G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3465	0.2829	0.326677	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	EPHA5:uc003hcz.3:exon16:c.G2829A:p.G943G,EPHA5:uc011cai.2:exon16:c.G2832A:p.G944G,EPHA5:uc003hcx.3:exon17:c.G2691A:p.G897G,EPHA5:uc003hcy.3:exon17:c.G2895A:p.G965G,EPHA5:uc003hda.2:exon17:c.G2898A:p.G966G,EPHA5:uc011cah.2:exon17:c.G2898A:p.G966G	.	AFR:0.2977,AMR:0.1274,EAS:0.3411,FIN:0.4289,NFE:0.3329,OTH:0.3694,ASJ:0.2888	600004	.	.	.	.	.	.	.	.	.	.	.	4	1(breast)	0.3796
4	66218765	66218765	A	G	EPHA5	exonic	synonymous SNV	ENSG00000145242	.	ENSG00000145242:ENST00000432638:exon11:c.T1804C:p.L602L,ENSG00000145242:ENST00000354839:exon12:c.T2227C:p.L743L,ENSG00000145242:ENST00000273854:exon13:c.T2293C:p.L765L,ENSG00000145242:ENST00000511294:exon13:c.T2296C:p.L766L	EPHA5:NM_001281766:exon12:c.T2230C:p.L744L,EPHA5:NM_182472:exon12:c.T2227C:p.L743L,EPHA5:NM_001281765:exon13:c.T2296C:p.L766L,EPHA5:NM_001281767:exon13:c.T2296C:p.L766L,EPHA5:NM_001318761:exon13:c.T2089C:p.L697L,EPHA5:NM_004439:exon13:c.T2293C:p.L765L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	EPHA5:uc003hcz.3:exon12:c.T2227C:p.L743L,EPHA5:uc011cai.2:exon12:c.T2230C:p.L744L,EPHA5:uc003hcx.3:exon13:c.T2089C:p.L697L,EPHA5:uc003hcy.3:exon13:c.T2293C:p.L765L,EPHA5:uc003hda.2:exon13:c.T2296C:p.L766L,EPHA5:uc011cah.2:exon13:c.T2296C:p.L766L	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600004	.	.	.	.	.	.	.	.	.	.	.	4	.	hom
4	66535284	66535284	G	A	EPHA5	exonic	synonymous SNV	ENSG00000145242	rs55860557	ENSG00000145242:ENST00000273854:exon1:c.C177T:p.N59N,ENSG00000145242:ENST00000354839:exon1:c.C177T:p.N59N,ENSG00000145242:ENST00000432638:exon1:c.C177T:p.N59N,ENSG00000145242:ENST00000511294:exon1:c.C177T:p.N59N	EPHA5:NM_001281765:exon1:c.C177T:p.N59N,EPHA5:NM_001281766:exon1:c.C177T:p.N59N,EPHA5:NM_001281767:exon1:c.C177T:p.N59N,EPHA5:NM_004439:exon1:c.C177T:p.N59N,EPHA5:NM_182472:exon1:c.C177T:p.N59N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2093	0.1673	0.115016	0.1888	.	.	.	.	.	.	.	.	EPHA5:uc003hcy.3:exon1:c.C177T:p.N59N,EPHA5:uc003hcz.3:exon1:c.C177T:p.N59N,EPHA5:uc003hda.2:exon1:c.C177T:p.N59N,EPHA5:uc011cah.2:exon1:c.C177T:p.N59N,EPHA5:uc011cai.2:exon1:c.C177T:p.N59N	.	AFR:0.1123,AMR:0.0913,EAS:0.0148,FIN:0.2768,NFE:0.2341,OTH:0.2254,ASJ:0.2152	600004	.	.	.	.	.	.	.	.	.	.	.	4	MU159232	hom
4	83791474	83791474	A	G	SEC31A	intronic	.	ENSG00000138674	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.0001	0.01	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	610257	.	.	.	.	.	.	.	.	.	.	.	4	.	hom
4	84364751	84364751	A	G	HELQ	exonic	synonymous SNV	ENSG00000163312	rs7665103	ENSG00000163312:ENST00000510985:exon5:c.T1281C:p.I427I,ENSG00000163312:ENST00000295488:exon6:c.T1482C:p.I494I	HELQ:NM_001297755:exon5:c.T1281C:p.I427I,HELQ:NM_133636:exon6:c.T1482C:p.I494I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4668	0.4197	0.507788	0.4518	.	.	.	.	.	.	.	.	HELQ:uc010ikb.3:exon5:c.T1281C:p.I427I,HELQ:uc003hom.3:exon6:c.T1482C:p.I494I	.	AFR:0.4436,AMR:0.5513,EAS:0.6749,FIN:0.4522,NFE:0.4286,OTH:0.4817,ASJ:0.2715	606769	.	.	.	.	.	.	.	.	.	.	.	4	MU105612	hom
4	84370091	84370091	A	G	HELQ	exonic	synonymous SNV	ENSG00000163312	rs13141136	ENSG00000163312:ENST00000295488:exon3:c.T1036C:p.L346L,ENSG00000163312:ENST00000508591:exon3:c.T1036C:p.L346L,ENSG00000163312:ENST00000510985:exon3:c.T1036C:p.L346L	HELQ:NM_001297755:exon3:c.T1036C:p.L346L,HELQ:NM_133636:exon3:c.T1036C:p.L346L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4336	0.3225	0.414537	MU4568051	.	.	.	.	.	.	.	.	HELQ:uc003hom.3:exon3:c.T1036C:p.L346L,HELQ:uc003hon.1:exon3:c.T718C:p.L240L,HELQ:uc010ikb.3:exon3:c.T1036C:p.L346L	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.3675,EAS:0.5443,FIN:0.2781,NFE:0.6743,OTH:0.4523,ASJ:0.1501	606769	.	.	.	.	.	.	.	.	.	.	.	4	1(haematopoietic_and_lymphoid_tissue)	0.4274
4	84376743	84376743	A	T	HELQ	exonic	nonsynonymous SNV	ENSG00000163312	rs6831595	ENSG00000163312:ENST00000295488:exon1:c.T104A:p.V35E,ENSG00000163312:ENST00000508591:exon1:c.T104A:p.V35E,ENSG00000163312:ENST00000510985:exon1:c.T104A:p.V35E	HELQ:NM_001297755:exon1:c.T104A:p.V35E,HELQ:NM_001297758:exon1:c.T104A:p.V35E,HELQ:NM_001297759:exon1:c.T104A:p.V35E,HELQ:NM_133636:exon1:c.T104A:p.V35E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	1.0000	0.9999	1	1.0000	-1.530	0.002	1.0	-3.44	0.000	.	.	.	HELQ:uc003hom.3:exon1:c.T104A:p.V35E,HELQ:uc003hoo.1:exon1:c.T104A:p.V35E,HELQ:uc003hoq.1:exon1:c.T104A:p.V35E,HELQ:uc010ikb.3:exon1:c.T104A:p.V35E	-0.964	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	606769	.	.	.	.	.	.	.	0.0	0.53	0.000	-1.24	4	MU81786772	hom
4	84383810	84383810	C	T	ABRAXAS1	exonic	nonsynonymous SNV	ENSG00000163322	rs12642536	ENSG00000163322:ENST00000321945:exon9:c.G1042A:p.A348T,ENSG00000163322:ENST00000506553:exon9:c.G895A:p.A299T	ABRAXAS1:NM_001345962:exon8:c.G715A:p.A239T,ABRAXAS1:NM_139076:exon9:c.G1042A:p.A348T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.4308	0.3272	0.41893	1(stomach)	2.475	19.31	0.011	2.75	0.057	.	.	.	FAM175A:uc003hov.2:exon8:c.G715A:p.A239T,FAM175A:uc003hou.2:exon9:c.G1042A:p.A348T	-0.934	AFR:MU159712,AMR:MELA-AU|1|183|0.00546448,ESAD-UK|1|409|0.00244499,COCA-CN|4|321|0.0124611,EAS:0.1635,FIN:0.5432,NFE:0.2781,OTH:0.6768,ASJ:0.3720	611143	.	.	.	.	.	.	.	0.822	0.81	0.000	1.95	4	1(large_intestine)	0.4516
4	88048164	88048164	T	-	AFF1	intronic	.	ENSG00000172493	rs572828739	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0061	0.0144	0.00259585	0.0010	.	.	.	.	.	.	.	.	.	.	AFR:0.0032,AMR:0,EAS:0,FIN:0,NFE:6.824e-05,OTH:0.0011,ASJ:0	159557	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	4	.	het
4	103514658	103514658	T	C	NFKB1	exonic	synonymous SNV	ENSG00000109320	rs1609993	ENSG00000109320:ENST00000600343:exon5:c.T600C:p.A200A,ENSG00000109320:ENST00000508584:exon6:c.T522C:p.A174A,ENSG00000109320:ENST00000226574:exon12:c.T1143C:p.A381A,ENSG00000109320:ENST00000394820:exon12:c.T1140C:p.A380A,ENSG00000109320:ENST00000505458:exon12:c.T1140C:p.A380A	NFKB1:NM_001165412:exon12:c.T1140C:p.A380A,NFKB1:NM_001319226:exon12:c.T1140C:p.A380A,NFKB1:NM_003998:exon12:c.T1143C:p.A381A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9401	0.9420	0.969848	0.9425	.	.	.	.	.	.	.	.	NFKB1:uc011cer.2:exon5:c.T600C:p.A200A,NFKB1:uc011cep.2:exon12:c.T1143C:p.A381A,NFKB1:uc011ceq.2:exon12:c.T1140C:p.A380A	.	AFR:0.9856,AMR:0.9402,EAS:1,FIN:0.9250,NFE:0.9179,OTH:0.9173,ASJ:0.9040	164011	616576;	1572;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~	~ko01523 Antifolate resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04623 Cytosolic DNA-sensing pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04926 Relaxin signaling pathway~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05030 Cocaine addiction~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05132 Salmonella infection~ko05133 Pertussis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	MU81788168	hom
4	104061993	104061993	C	G	CENPE	exonic	nonsynonymous SNV	ENSG00000138778	rs1381657	ENSG00000138778:ENST00000380026:exon35:c.G5657C:p.S1886T,ENSG00000138778:ENST00000265148:exon36:c.G5732C:p.S1911T	CENPE:NM_001286734:exon35:c.G5657C:p.S1886T,CENPE:NM_001813:exon36:c.G5732C:p.S1911T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1932	0.1815	0.210863	2(haematopoietic_and_lymphoid_tissue)	-1.564	0.002	0.501	-1.34	0.001	.	.	.	CENPE:uc003hxc.1:exon35:c.G5657C:p.S1886T,CENPE:uc003hxb.1:exon36:c.G5732C:p.S1911T	-1.099	AFR:MU77894,AMR:BRCA-KR|1|50|0.02,EAS:0.1713,FIN:0.1874,NFE:0.2185,OTH:0.1307,ASJ:0.1679	117143	616051;	808;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	.	.	.	0.247	-0.65	0.000	0.11	4	1(thyroid)	0.1195
4	104072508	104072508	T	C	CENPE	exonic	synonymous SNV	ENSG00000138778	.	ENSG00000138778:ENST00000380026:exon25:c.A3189G:p.R1063R,ENSG00000138778:ENST00000265148:exon26:c.A3264G:p.R1088R,ENSG00000138778:ENST00000503705:exon26:c.A3264G:p.R1088R	CENPE:NM_001286734:exon25:c.A3189G:p.R1063R,CENPE:NM_001813:exon26:c.A3264G:p.R1088R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	CENPE:uc003hxc.1:exon25:c.A3189G:p.R1063R,CENPE:uc003hxb.1:exon26:c.A3264G:p.R1088R	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	117143	616051;	808;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	.	.	.	.	.	.	.	4	.	hom
4	106197454	106197454	G	C	TET2	exonic	nonsynonymous SNV	ENSG00000168769	.	ENSG00000168769:ENST00000380013:exon11:c.G5787C:p.E1929D,ENSG00000168769:ENST00000513237:exon11:c.G5850C:p.E1950D,ENSG00000168769:ENST00000540549:exon11:c.G5787C:p.E1929D	TET2:NM_001127208:exon11:c.G5787C:p.E1929D	clinvar: UNK 	 CancerVar: 8#Tier_II_potential EVS=[1, 0, 1, 1, 0, 0, 1, 0, 1, 1, 1, 1] 	.	.	.	.	3.666	23.2	0.007	2.89	0.983	.	.	.	TET2:uc003hxk.3:exon11:c.G5787C:p.E1929D,TET2:uc011cez.2:exon11:c.G5850C:p.E1950D	-1.169	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	612839	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	,9975,9974	.	,9977,9980,9976,9981,9979,9978	0.997	4.03	0.028	2.32	4	.	hom
4	122739240	122739240	C	A	CCNA2	exonic	nonsynonymous SNV	ENSG00000145386	rs568350890	ENSG00000145386:ENST00000274026:exon7:c.G1209T:p.Q403H	CCNA2:NM_001237:exon7:c.G1209T:p.Q403H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0003	.	0.000599042	.	0.820	9.588	0.961	0.089	0.997	.	.	Cyclin, C-terminal domain|Cyclin-like	CCNA2:uc003iec.4:exon7:c.G1209T:p.Q403H	-1.039	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	123835	.	.	.	~ko04110 Cell cycle~ko04152 AMPK signaling pathway~ko04218 Cellular senescence~ko04914 Progesterone-mediated oocyte maturation~ko05161 Hepatitis B~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	0.0	1.91	0.033	1.385	4	.	het
4	122742217	122742217	T	C	CCNA2	exonic	nonsynonymous SNV	ENSG00000145386	rs769242	ENSG00000145386:ENST00000274026:exon3:c.A487G:p.I163V	CCNA2:NM_001237:exon3:c.A487G:p.I163V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9629	0.9691	0.96865	0.9672	0.665	8.596	1.0	4.14	0.999	.	.	Cyclin-A, N-terminal	CCNA2:uc003iec.4:exon3:c.A487G:p.I163V	-0.995	AFR:0.9913,AMR:0.9760,EAS:0.9382,FIN:0.9453,NFE:0.9605,OTH:0.9664,ASJ:0.9901	123835	.	.	.	~ko04110 Cell cycle~ko04152 AMPK signaling pathway~ko04218 Cellular senescence~ko04914 Progesterone-mediated oocyte maturation~ko05161 Hepatitis B~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	0.0	2.65	0.000	-2.175	4	MU27950768	hom
4	126240510	126240510	T	C	FAT4	exonic	synonymous SNV	ENSG00000196159	rs2940779	ENSG00000196159:ENST00000394329:exon1:c.T2944C:p.L982L	FAT4:NM_001291285:exon1:c.T2944C:p.L982L,FAT4:NM_001291303:exon1:c.T2944C:p.L982L,FAT4:NM_024582:exon1:c.T2944C:p.L982L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7012	0.7660	0.721046	0.7296	.	.	.	.	.	.	.	.	FAT4:uc003ifj.4:exon1:c.T2944C:p.L982L	.	AFR:0.8901,AMR:0.7243,EAS:0.4728,FIN:0.5910,NFE:0.7007,OTH:0.6646,ASJ:0.7285	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU23614382	hom
4	126241253	126241253	G	C	FAT4	exonic	synonymous SNV	ENSG00000196159	rs7657251	ENSG00000196159:ENST00000394329:exon1:c.G3687C:p.V1229V	FAT4:NM_001291285:exon1:c.G3687C:p.V1229V,FAT4:NM_001291303:exon1:c.G3687C:p.V1229V,FAT4:NM_024582:exon1:c.G3687C:p.V1229V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0921	0.1124	0.0642971	0.0919	.	.	.	.	.	.	.	.	FAT4:uc003ifj.4:exon1:c.G3687C:p.V1229V	.	AFR:0.0714,AMR:0.0644,EAS:0,FIN:0.0544,NFE:0.1217,OTH:0.0973,ASJ:0.1954	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU626652	het
4	126241871	126241871	C	T	FAT4	exonic	synonymous SNV	ENSG00000196159	rs2710555	ENSG00000196159:ENST00000394329:exon1:c.C4305T:p.I1435I	FAT4:NM_001291285:exon1:c.C4305T:p.I1435I,FAT4:NM_001291303:exon1:c.C4305T:p.I1435I,FAT4:NM_024582:exon1:c.C4305T:p.I1435I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6974	0.7544	0.711262	0.7203	.	.	.	.	.	.	.	.	FAT4:uc003ifj.4:exon1:c.C4305T:p.I1435I	.	AFR:0.8596,AMR:0.7196,EAS:0.4617,FIN:0.5917,NFE:0.7007,OTH:0.6612,ASJ:0.7285	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU23614425	hom
4	126329789	126329789	T	C	FAT4	exonic	synonymous SNV	ENSG00000196159	rs958415	ENSG00000196159:ENST00000335110:exon4:c.T654C:p.D218D,ENSG00000196159:ENST00000394329:exon4:c.T5760C:p.D1920D	FAT4:NM_001291285:exon4:c.T5760C:p.D1920D,FAT4:NM_001291303:exon4:c.T5760C:p.D1920D,FAT4:NM_024582:exon4:c.T5760C:p.D1920D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9966	0.9905	0.988419	0.9917	.	.	.	.	.	.	.	.	FAT4:uc003ifj.4:exon4:c.T5760C:p.D1920D,FAT4:uc011cgp.2:exon4:c.T654C:p.D218D	.	AFR:0.9728,AMR:0.9952,EAS:1,FIN:1,NFE:0.9991,OTH:0.9959,ASJ:1	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU81789789	hom
4	126371814	126371814	C	T	FAT4	exonic	nonsynonymous SNV	ENSG00000196159	rs73849225	ENSG00000196159:ENST00000335110:exon9:c.C4537T:p.H1513Y,ENSG00000196159:ENST00000394329:exon9:c.C9643T:p.H3215Y	FAT4:NM_001291285:exon9:c.C9649T:p.H3217Y,FAT4:NM_001291303:exon9:c.C9649T:p.H3217Y,FAT4:NM_024582:exon9:c.C9643T:p.H3215Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 1, 0] 	0.0803	0.1376	0.117812	0.1226	3.301	22.9	0.08	3.77	0.871	.	.	Cadherin|Cadherin-like	FAT4:uc003ifi.1:exon1:c.C2077T:p.H693Y,FAT4:uc003ifj.4:exon9:c.C9643T:p.H3215Y,FAT4:uc011cgp.2:exon9:c.C4537T:p.H1513Y	-1.017	AFR:0.2633,AMR:0.0610,EAS:0.0012,FIN:0.0808,NFE:0.0710,OTH:0.0746,ASJ:0.0861	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	0.728	0.67	0.000	0.65	4	.	hom
4	126373789	126373789	G	A	FAT4	exonic	nonsynonymous SNV	ENSG00000196159	rs12650153	ENSG00000196159:ENST00000335110:exon9:c.G6512A:p.S2171N,ENSG00000196159:ENST00000394329:exon9:c.G11618A:p.S3873N	FAT4:NM_001291285:exon9:c.G11624A:p.S3875N,FAT4:NM_001291303:exon9:c.G11624A:p.S3875N,FAT4:NM_024582:exon9:c.G11618A:p.S3873N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9978	0.9925	0.991014	0.9931	1.631	14.02	0.671	5.27	0.994	.	.	Cadherin|Cadherin-like;EGF-like calcium-binding domain|EGF-like domain|Growth factor receptor cysteine-rich domain	FAT4:uc003ifi.1:exon1:c.G4052A:p.S1351N,FAT4:uc003ifj.4:exon9:c.G11618A:p.S3873N,FAT4:uc011cgp.2:exon9:c.G6512A:p.S2171N	-0.924	AFR:0.9760,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	0.0	-2.26	0.000	-2.215	4	MU81789855	hom
4	126397321	126397321	C	T	FAT4	intronic	.	ENSG00000196159	rs17009761	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3745	0.3960	0.337859	0.3952	.	.	.	.	.	0	0.004	.	.	.	AFR:0.3859,AMR:0.2751,EAS:0.2744,FIN:0.4394,NFE:0.4083,OTH:0.4252,ASJ:0.3907	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU11839003	hom
4	126412575	126412575	A	G	FAT4	exonic	synonymous SNV	ENSG00000196159	rs1014866	ENSG00000196159:ENST00000335110:exon15:c.A9321G:p.R3107R,ENSG00000196159:ENST00000394329:exon17:c.A14598G:p.R4866R	FAT4:NM_001291285:exon17:c.A14601G:p.R4867R,FAT4:NM_001291303:exon17:c.A14604G:p.R4868R,FAT4:NM_024582:exon17:c.A14598G:p.R4866R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7569	0.7442	0.740615	0.7566	.	.	.	.	.	.	.	.	FAT4:uc003ifi.1:exon9:c.A7029G:p.R2343R,FAT4:uc011cgp.2:exon15:c.A9321G:p.R3107R,FAT4:uc003ifj.4:exon17:c.A14598G:p.R4866R	.	AFR:0.7063,AMR:0.7321,EAS:0.8694,FIN:0.7915,NFE:0.7663,OTH:0.7673,ASJ:0.7567	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU21902856	het
4	143235865	143235865	C	G	INPP4B	exonic	synonymous SNV	ENSG00000109452	rs3756122	ENSG00000109452:ENST00000308502:exon5:c.G423C:p.G141G,ENSG00000109452:ENST00000262992:exon6:c.G423C:p.G141G,ENSG00000109452:ENST00000508116:exon7:c.G423C:p.G141G,ENSG00000109452:ENST00000510812:exon7:c.G423C:p.G141G,ENSG00000109452:ENST00000512630:exon7:c.G423C:p.G141G,ENSG00000109452:ENST00000509777:exon8:c.G423C:p.G141G,ENSG00000109452:ENST00000513000:exon9:c.G423C:p.G141G	INPP4B:NM_001101669:exon8:c.G423C:p.G141G,INPP4B:NM_001331040:exon8:c.G423C:p.G141G,INPP4B:NM_003866:exon9:c.G423C:p.G141G	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 1] 	0.1844	0.0884	0.199481	MU109191	.	.	.	.	.	0.9836	0.634	.	INPP4B:uc003iiw.4:exon8:c.G423C:p.G141G,INPP4B:uc003iix.4:exon9:c.G423C:p.G141G	.	AFR:COCA-CN|4|321|0.0124611,AMR:0.1385,EAS:0.2464,FIN:0.1026,NFE:0.4863,OTH:0.2483,ASJ:0.0241	607494	.	.	.	.	,6189	.	.	.	.	.	.	4	10(soft_tissue)	0.1339
4	169428733	169428733	T	C	PALLD	intronic	.	ENSG00000129116	rs1962362	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.402356	0.4093	.	.	.	.	.	.	.	.	.	.	AFR:0.2371,AMR:0.4260,EAS:0.6077,FIN:0.4851,NFE:0.4693,OTH:0.4376,ASJ:0.3344	608092	606856;	1333;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~	.	.	.	.	.	.	.	.	4	MU18750111	hom
4	178274835	178274835	A	C	NEIL3	exonic	nonsynonymous SNV	ENSG00000109674	rs13112390	ENSG00000109674:ENST00000264596:exon8:c.A1413C:p.Q471H	NEIL3:NM_018248:exon8:c.A1413C:p.Q471H	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7337	0.7711	0.66254	1(liver)	-0.597	0.127	0.642	-1.15	0.022	.	.	.	NEIL3:uc003iut.2:exon8:c.A1413C:p.Q471H	-1.063	AFR:1(large_intestine),AMR:MU122675,EAS:0.7413,FIN:0.7233,NFE:0.7691,OTH:0.8013,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	608934	.	.	.	.	.	.	.	0.0	3.81	0.000	-2.515	4	1(prostate)	0.4387
4	178281795	178281795	T	C	NEIL3	exonic	synonymous SNV	ENSG00000109674	.	ENSG00000109674:ENST00000264596:exon9:c.T1599C:p.C533C	NEIL3:NM_018248:exon9:c.T1599C:p.C533C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	NEIL3:uc003iut.2:exon9:c.T1599C:p.C533C	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608934	.	.	.	.	.	.	.	.	.	.	.	4	.	hom
4	185587165	185587165	A	G	PRIMPOL	exonic	nonsynonymous SNV	ENSG00000164306	rs2463447	ENSG00000164306:ENST00000515774:exon5:c.A116G:p.Q39R,ENSG00000164306:ENST00000314970:exon6:c.A503G:p.Q168R,ENSG00000164306:ENST00000503752:exon6:c.A503G:p.Q168R,ENSG00000164306:ENST00000512834:exon6:c.A503G:p.Q168R	PRIMPOL:NM_001300767:exon5:c.A116G:p.Q39R,PRIMPOL:NM_001300768:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345891:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345892:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345893:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345895:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345896:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345899:exon6:c.A503G:p.Q168R,PRIMPOL:NM_152683:exon6:c.A503G:p.Q168R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9873	0.9592	0.966853	0.9642	.	.	.	.	.	.	.	.	CCDC111:uc003iwm.2:exon5:c.A116G:p.Q39R,CCDC111:uc003iwj.2:exon6:c.A503G:p.Q168R,CCDC111:uc003iwk.2:exon6:c.A503G:p.Q168R	.	AFR:0.8792,AMR:0.9893,EAS:1,FIN:0.9977,NFE:0.9981,OTH:0.9919,ASJ:1	615421	615420;	.	.	.	.	.	.	.	.	.	.	4	MU81793151	hom
4	187516880	187516880	A	G	FAT1	exonic	synonymous SNV	ENSG00000083857	rs1298865	ENSG00000083857:ENST00000509927:exon1:c.T75C:p.S25S,ENSG00000083857:ENST00000441802:exon26:c.T13101C:p.S4367S	FAT1:NM_005245:exon26:c.T13101C:p.S4367S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4212	0.4541	0.491813	1(thyroid)	.	.	.	.	.	.	.	.	FAT1:uc003izf.3:exon26:c.T13101C:p.S4367S	.	AFR:MU4567056,AMR:ESAD-UK|2|409|0.00488998,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.6638,FIN:0.5299,NFE:0.4172,OTH:0.6185,ASJ:0.4742	600976	.	.	.	.	,4923	.	.	.	.	.	.	4	1(lung)	0.3804
4	187521037	187521037	C	A	FAT1	intronic	.	ENSG00000083857	rs10009030	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3225	0.2838	0.284744	ESAD-UK|2|409|0.00488998,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.2971,AMR:0.2302,EAS:0.3967,FIN:0.4142,NFE:0.2841,OTH:0.3191,ASJ:0.3592	600976	.	.	.	.	.	.	.	.	.	.	.	4	1(upper_aerodigestive_tract)	0.3269
4	187525020	187525020	A	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs2637777	ENSG00000083857:ENST00000441802:exon19:c.T10660G:p.S3554A	FAT1:NM_005245:exon19:c.T10660G:p.S3554A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4276	0.4716	0.51278	1(breast)	-0.348	0.515	0.43	2.19	0.761	.	.	Cadherin-like	FAT1:uc003izf.3:exon19:c.T10660G:p.S3554A	-1.002	AFR:MU14006115,AMR:ESAD-UK|1|409|0.00244499,PACA-CA|1|268|0.00373134,COCA-CN|4|321|0.0124611,EAS:0.7324,FIN:0.5371,NFE:0.4172,OTH:0.6255,ASJ:0.4939	600976	.	.	.	.	,4923	.	.	0.0	1.2	0.000	0.425	4	1(haematopoietic_and_lymphoid_tissue)	0.3789
4	187538330	187538330	G	A	FAT1	exonic	synonymous SNV	ENSG00000083857	rs1280099	ENSG00000083857:ENST00000441802:exon11:c.C8904T:p.A2968A	FAT1:NM_005245:exon11:c.C8904T:p.A2968A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4398	0.4755	0.416134	MU18454834	.	.	.	.	.	.	.	.	FAT1:uc003izf.3:exon11:c.C8904T:p.A2968A	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.4575,EAS:0.4820,FIN:0.4636,NFE:0.25,OTH:0.4446,ASJ:0.5317	600976	.	.	.	.	,4923	.	.	.	.	.	.	4	1(stomach)	0.4388
4	187538942	187538942	T	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs1280098	ENSG00000083857:ENST00000441802:exon10:c.A8798C:p.Q2933P	FAT1:NM_005245:exon10:c.A8798C:p.Q2933P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5554	0.6234	0.592053	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BLCA-CN|1|103|0.00970874	-1.112	0.009	1.0	4.04	0.044	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon10:c.A8798C:p.Q2933P	-0.940	AFR:0.5898,AMR:0.7045,EAS:0.5298,FIN:0.6355,NFE:0.5183,OTH:0.5375,ASJ:0.5871	600976	.	.	.	.	,4923	.	.	0.0	0.79	0.000	-2.575	4	1(haematopoietic_and_lymphoid_tissue)	0.5682
4	187557893	187557893	T	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs328418	ENSG00000083857:ENST00000441802:exon5:c.A3818G:p.H1273R	FAT1:NM_005245:exon5:c.A3818G:p.H1273R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5876	0.6338	0.645767	1(kidney)	-1.030	0.014	1.0	4.99	0.003	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon5:c.A3818G:p.H1273R	-0.954	AFR:MU14006434,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,RECA-EU|1|422|0.00236967,EAS:0.8076,FIN:0.6471,NFE:0.6060,OTH:0.6689,ASJ:0.6358	600976	.	.	.	.	,4923	.	.	0.0	0.84	0.000	-2.11	4	1(urinary_tract)	0.5607
4	187584771	187584771	C	G	FAT1	intronic	.	ENSG00000083857	rs172903	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9673	0.9625	0.983427	0.9714	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.9888,AMR:0.9666,EAS:1,FIN:0.9720,NFE:0.9585,OTH:0.9705,ASJ:0.9702	600976	.	.	.	.	.	.	.	.	.	.	.	4	MU81793736	hom
4	187627792	187627792	T	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs11939575	ENSG00000083857:ENST00000441802:exon2:c.A3190G:p.R1064G	FAT1:NM_005245:exon2:c.A3190G:p.R1064G	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.7609	0.8272	0.745807	LAML-KR|5|205|0.0243902,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	0.930	10.26	1.0	4.6	0.007	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.A3190G:p.R1064G,FAT1:uc010iso.1:exon2:c.A3190G:p.R1064G	-0.947	AFR:0.7963,AMR:0.8886,EAS:0.7517,FIN:0.5136,NFE:0.7496,OTH:0.7913,ASJ:0.6790	600976	.	.	.	.	,4923	.	.	0.0	0.54	0.000	-3.06	4	1(breast)	0.7959
4	187629140	187629140	G	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs367863	ENSG00000083857:ENST00000441802:exon2:c.C1842G:p.F614L	FAT1:NM_005245:exon2:c.C1842G:p.F614L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.7476	0.7801	0.690495	MU11955600	-0.701	0.071	1.0	3.53	0.206	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.C1842G:p.F614L,FAT1:uc010iso.1:exon2:c.C1842G:p.F614L	-0.980	AFR:LAML-KR|5|205|0.0243902,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.7519,EAS:0.6659,FIN:0.7517,NFE:0.5111,OTH:0.7499,ASJ:0.7350	600976	.	.	.	.	,4923	.	.	0.0	1.35	0.000	-1.85	4	3(lung)	0.7907
5	224656	224656	C	T	SDHA	intronic	.	ENSG00000073578	rs111533078	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0374	.	.	MU16272486	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|5|205|0.0243902,LUSC-KR|2|170|0.0117647,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	3(soft_tissue)	0
5	254861	254861	C	G	SDHA	intronic	.	ENSG00000073578	rs2241600	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.652756	0.7383	.	.	.	.	.	.	.	.	.	.	AFR:0.7851,AMR:0.6516,EAS:0.3348,FIN:0.7478,NFE:0.7577,OTH:0.7418,ASJ:0.6987	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	MU1256647	hom
5	6600150	6600150	G	A	NSUN2	exonic	synonymous SNV	ENSG00000037474	rs3822434	ENSG00000037474:ENST00000506139:exon18:c.C2088T:p.D696D,ENSG00000037474:ENST00000539938:exon18:c.C1485T:p.D495D,ENSG00000037474:ENST00000264670:exon19:c.C2193T:p.D731D	NSUN2:NM_001193455:exon18:c.C2088T:p.D696D,NSUN2:NM_017755:exon19:c.C2193T:p.D731D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1743	0.1299	0.173522	MU122540	.	.	.	.	.	.	.	.	NSUN2:uc003jdt.3:exon13:c.C1485T:p.D495D,NSUN2:uc003jdv.3:exon18:c.C1485T:p.D495D,NSUN2:uc011cmk.2:exon18:c.C2088T:p.D696D,NSUN2:uc003jdu.3:exon19:c.C2193T:p.D731D	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.1567,EAS:0.2208,FIN:0.1093,NFE:0.2189,OTH:0.2471,ASJ:0.0906	610916	611091;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	5	2(large_intestine)	0.1621
5	10256161	10256161	T	C	CCT5	exonic	synonymous SNV	ENSG00000150753	rs1042392	ENSG00000150753:ENST00000506600:exon3:c.T147C:p.R49R,ENSG00000150753:ENST00000515390:exon3:c.T261C:p.R87R,ENSG00000150753:ENST00000280326:exon4:c.T426C:p.R142R,ENSG00000150753:ENST00000503026:exon4:c.T363C:p.R121R,ENSG00000150753:ENST00000515676:exon4:c.T312C:p.R104R	CCT5:NM_001306154:exon3:c.T261C:p.R87R,CCT5:NM_001306155:exon3:c.T147C:p.R49R,CCT5:NM_001306153:exon4:c.T363C:p.R121R,CCT5:NM_001306156:exon4:c.T312C:p.R104R,CCT5:NM_012073:exon4:c.T426C:p.R142R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7948	0.7274	0.692492	0.7493	.	.	.	.	.	.	.	.	CCT5:uc011cmr.2:exon3:c.T261C:p.R87R,CCT5:uc011cmt.2:exon3:c.T147C:p.R49R,CCT5:uc003jeq.3:exon4:c.T426C:p.R142R,CCT5:uc011cms.2:exon4:c.T312C:p.R104R	.	AFR:0.4732,AMR:0.7983,EAS:0.8465,FIN:0.8612,NFE:0.8637,OTH:0.8177,ASJ:0.8576	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU44187827	hom
5	10262740	10262740	C	A	CCT5	intronic	.	ENSG00000150753	rs2578642	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7894	0.7187	0.685903	0.7416	.	.	.	.	.	.	.	.	.	.	AFR:0.4589,AMR:0.7971,EAS:0.8337,FIN:0.8603,NFE:0.8580,OTH:0.8153,ASJ:0.8576	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU81795401	het
5	14368975	14368975	C	T	TRIO	exonic	synonymous SNV	ENSG00000038382	rs13189406	ENSG00000038382:ENST00000513206:exon13:c.C2232T:p.N744N,ENSG00000038382:ENST00000344204:exon17:c.C3033T:p.N1011N,ENSG00000038382:ENST00000509967:exon17:c.C2886T:p.N962N,ENSG00000038382:ENST00000512070:exon17:c.C2856T:p.N952N,ENSG00000038382:ENST00000537187:exon17:c.C3033T:p.N1011N	TRIO:NM_007118:exon17:c.C3033T:p.N1011N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2508	0.2317	0.176518	0.2064	.	.	.	.	.	.	.	.	TRIO:uc003jfh.1:exon12:c.C1980T:p.N660N,TRIO:uc003jff.3:exon17:c.C3033T:p.N1011N,TRIO:uc011cna.1:exon17:c.C2886T:p.N962N	.	AFR:0.1072,AMR:0.2900,EAS:0.0432,FIN:0.1974,NFE:0.2714,OTH:0.2714,ASJ:0.3808	601893	617061;	.	.	.	.	.	.	.	.	.	.	5	MU67363617	hom
5	14397238	14397238	T	C	TRIO	exonic	synonymous SNV	ENSG00000038382	rs30774	ENSG00000038382:ENST00000513206:exon25:c.T3597C:p.D1199D,ENSG00000038382:ENST00000344204:exon29:c.T4398C:p.D1466D,ENSG00000038382:ENST00000509967:exon29:c.T4251C:p.D1417D,ENSG00000038382:ENST00000512070:exon29:c.T4221C:p.D1407D,ENSG00000038382:ENST00000537187:exon29:c.T4398C:p.D1466D	TRIO:NM_007118:exon29:c.T4398C:p.D1466D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3826	0.4421	0.393371	1(thyroid)	.	.	.	.	.	.	.	.	TRIO:uc003jfh.1:exon24:c.T3345C:p.D1115D,TRIO:uc003jff.3:exon29:c.T4398C:p.D1466D,TRIO:uc011cna.1:exon29:c.T4251C:p.D1417D	.	AFR:MU4552563,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,EAS:0.6575,FIN:0.4129,NFE:0.4172,OTH:0.0858,ASJ:0.3992	601893	617061;	.	.	.	.	.	.	.	.	.	.	5	1(lung)	0.2722
5	38950776	38950776	G	A	RICTOR	exonic	synonymous SNV	ENSG00000164327	rs2115949	ENSG00000164327:ENST00000296782:exon31:c.C3174T:p.S1058S,ENSG00000164327:ENST00000357387:exon31:c.C3174T:p.S1058S	RICTOR:NM_001285439:exon31:c.C3174T:p.S1058S,RICTOR:NM_001285440:exon31:c.C2319T:p.S773S,RICTOR:NM_152756:exon31:c.C3174T:p.S1058S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9658	0.9521	0.949481	0.9624	.	.	.	.	.	.	.	.	RICTOR:uc003jlo.2:exon31:c.C3174T:p.S1058S,RICTOR:uc003jlp.2:exon31:c.C3174T:p.S1058S,RICTOR:uc010ivf.2:exon31:c.C2319T:p.S773S	.	AFR:0.9120,AMR:0.9665,EAS:0.9926,FIN:0.9914,NFE:0.9802,OTH:0.9755,ASJ:0.9834	609022	.	.	.	.	.	.	.	.	.	.	.	5	MU81796672	hom
5	38960606	38960606	T	A	RICTOR	exonic	nonsynonymous SNV	ENSG00000164327	.	ENSG00000164327:ENST00000296782:exon20:c.A1745T:p.K582M,ENSG00000164327:ENST00000357387:exon20:c.A1745T:p.K582M	RICTOR:NM_001285439:exon20:c.A1745T:p.K582M,RICTOR:NM_001285440:exon20:c.A890T:p.K297M,RICTOR:NM_152756:exon20:c.A1745T:p.K582M	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	6.343	29.3	0.005	5.52	0.996	.	.	Armadillo-like helical|Rapamycin-insensitive companion of mTOR, middle domain	RICTOR:uc003jlo.2:exon20:c.A1745T:p.K582M,RICTOR:uc003jlp.2:exon20:c.A1745T:p.K582M,RICTOR:uc010ivf.2:exon20:c.A890T:p.K297M	-0.399	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	609022	.	.	.	.	.	.	.	1.0	0.73	0.308	2.365	5	.	hom
5	44388615	44388615	-	AGG	FGF10	exonic	nonframeshift insertion	ENSG00000070193	.	ENSG00000070193:ENST00000264664:exon1:c.169_170insCCT:p.F57delinsSF,ENSG00000070193:ENST00000513107:exon2:c.169_170insCCT:p.F57delinsSF	FGF10:NM_004465:exon1:c.169_170insCCT:p.F57delinsSF	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	FGF10:uc003jog.1:exon1:c.169_170insCCT:p.F57delinsSF	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602115	149730;180920;	86815;2363;	86815|ALSG<br>Congenital absence of lacrimal puncta and salivary glands|-|Autosomal dominant|-|180920 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	5	.	het
5	56152416	56152416	C	A	MAP3K1	intronic	.	ENSG00000237705	rs832567	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6132	0.6989	0.526158	0.6521	.	.	.	.	.	0.0006	0.018	.	.	.	AFR:0.6500,AMR:0.4618,EAS:0.2040,FIN:0.7156,NFE:0.6929,OTH:0.6793,ASJ:0.7748	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	MU767397	hom
5	56177443	56177443	G	A	MAP3K1	exonic	nonsynonymous SNV	ENSG00000095015	rs702689	ENSG00000095015:ENST00000399503:exon14:c.G2416A:p.D806N	MAP3K1:NM_005921:exon14:c.G2416A:p.D806N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.5984	0.6501	0.476438	MU12351955	2.329	18.36	0.195	5.56	1.000	.	.	.	MAP3K1:uc003jqw.4:exon14:c.G2416A:p.D806N	-0.975	AFR:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579,AMR:0.6061,EAS:0.4555,FIN:0.7748,NFE:0.2011,OTH:0.7146,ASJ:0.4892	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	0.999	0.82	0.000	2.085	5	76(lung)	0.6930
5	56178217	56178217	A	C	MAP3K1	exonic	synonymous SNV	ENSG00000095015	rs832583	ENSG00000095015:ENST00000399503:exon14:c.A3190C:p.R1064R	MAP3K1:NM_005921:exon14:c.A3190C:p.R1064R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7653	0.7995	0.708267	1(thyroid)	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon14:c.A3190C:p.R1064R	.	AFR:2(breast),AMR:MU4558542,EAS:0.7764,FIN:0.7465,NFE:0.6089,OTH:0.8477,ASJ:LICA-CN|2|402|0.00497512,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	1(haematopoietic_and_lymphoid_tissue)	0.5897
5	57751443	57751443	A	G	PLK2	exonic	synonymous SNV	ENSG00000145632	rs1042994	ENSG00000145632:ENST00000274289:exon11:c.T1548C:p.F516F	PLK2:NM_006622:exon11:c.T1548C:p.F516F,PLK2:NM_001252226:exon12:c.T1506C:p.F502F	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1249	0.1379	0.121206	0.1463	.	.	.	.	.	.	.	.	PLK2:uc003jrn.3:exon11:c.T1548C:p.F516F,PLK2:uc021xyx.1:exon12:c.T1506C:p.F502F	.	AFR:0.1967,AMR:0.2327,EAS:0,FIN:0.1671,NFE:0.1250,OTH:0.1462,ASJ:0.0596	607023	.	.	.	.	.	.	.	.	.	.	.	5	.	het
5	57754004	57754004	C	T	PLK2	intronic	.	ENSG00000145632	rs697135	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4229	0.5076	0.422324	0.5019	.	.	.	.	.	0.0001	0.162	.	.	.	AFR:0.6283,AMR:0.4317,EAS:0.2460,FIN:0.4819,NFE:0.4702,OTH:0.4561,ASJ:0.3691	607023	.	.	.	.	.	.	.	.	.	.	.	5	MU27120297	unknown
5	57754007	57754007	T	G	PLK2	intronic	.	ENSG00000145632	rs59135347	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1241	0.1324	0.118411	0.1423	.	.	.	.	.	0	0	.	.	.	AFR:0.1829,AMR:0.2337,EAS:0,FIN:0.1672,NFE:0.1247,OTH:0.1449,ASJ:0.0596	607023	.	.	.	.	.	.	.	.	.	.	.	5	.	unknown
5	57754808	57754808	G	A	PLK2	intronic	.	ENSG00000145632	rs697133	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6662	0.6373	0.740216	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0.0013	0.062	.	.	.	AFR:0.6426,AMR:0.7164,EAS:0.62,FIN:0.8881,NFE:0.6009,OTH:0.5763,ASJ:0.7780	607023	.	.	.	.	.	.	.	.	.	.	.	5	1(liver)	0.6322
5	60170513	60170513	A	-	ERCC8	intronic	.	ENSG00000049167	rs769301124	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3391	0.2235	.	0.0111	.	.	.	.	.	.	.	.	.	.	AFR:0.0038,AMR:0.0368,EAS:0,FIN:0.1183,NFE:0.0068,OTH:0.0274,ASJ:0.0216	609412	216400;614621;	178338;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	.	.	.	.	.	.	.	5	MU43782654	het
5	64926104	64926104	A	G	SHLD3	exonic	synonymous SNV	ENSG00000253251	rs6874425	ENSG00000253251:ENST00000510585:exon2:c.A690G:p.R230R	SHLD3:NM_001365341:exon2:c.A690G:p.R230R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0723	.	0.0778754	0.0434	.	.	.	.	.	.	.	.	TRAPPC13:uc010iwu.1:exon2:c.A690G:p.R230R	.	AFR:0.0951,AMR:0.0239,EAS:0.0785,FIN:0.0054,NFE:0.0196,OTH:0.0367,ASJ:0.0596	.	.	.	.	.	.	.	.	.	.	.	.	5	MU24960183	hom
5	64926174	64926174	C	T	SHLD3	UTR3	.	ENSG00000253251	rs35217736	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1227	.	0.061901	0.0285	.	.	.	.	.	.	.	.	.	.	AFR:0.0434,AMR:0.0215,EAS:0.0784,FIN:0.0054,NFE:0.0196,OTH:0.0286,ASJ:0.0596	.	.	.	.	.	.	.	.	.	.	.	.	5	MU67364734	hom
5	67522722	67522722	C	T	PIK3R1	exonic	synonymous SNV	ENSG00000145675	rs706713	ENSG00000145675:ENST00000274335:exon1:c.C219T:p.Y73Y,ENSG00000145675:ENST00000396611:exon1:c.C219T:p.Y73Y,ENSG00000145675:ENST00000521381:exon2:c.C219T:p.Y73Y,ENSG00000145675:ENST00000521657:exon2:c.C219T:p.Y73Y	PIK3R1:NM_181523:exon2:c.C219T:p.Y73Y	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3129	0.2933	0.419329	1(liver)	.	.	.	.	.	.	.	.	PIK3R1:uc003jva.3:exon2:c.C219T:p.Y73Y	.	AFR:MU10857398,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.4091,FIN:0.3690,NFE:0.2351,OTH:0.6857,ASJ:0.3176	171833	269880;615214;616005;	397596;229717;33110;3163;	397596|APDS<br>Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adult|615513 616005 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~3163|Aarskog-Ose-Pande syndrome<br>Lipodystrophy-Rieger anomaly-diabetes syndrome<br>Rieger anomaly-partial lipodystrophy syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|269880 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,9068,9069,9067	.	.	.	.	.	.	5	1(breast)	0.2703
5	67576747	67576747	T	A	PIK3R1	intronic	.	ENSG00000145675	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	0.0012	0.116	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	171833	269880;615214;616005;	397596;229717;33110;3163;	397596|APDS<br>Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adult|615513 616005 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~3163|Aarskog-Ose-Pande syndrome<br>Lipodystrophy-Rieger anomaly-diabetes syndrome<br>Rieger anomaly-partial lipodystrophy syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|269880 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	5	.	hom
5	70338109	70338109	T	C	GTF2H2	exonic	nonsynonymous SNV	ENSG00000145736	.	ENSG00000145736:ENST00000425596:exon12:c.A653G:p.H218R,ENSG00000145736:ENST00000274400:exon13:c.A824G:p.H275R,ENSG00000145736:ENST00000330280:exon14:c.A824G:p.H275R	GTF2H2:NM_001364572:exon12:c.A653G:p.H218R,GTF2H2:NM_001364568:exon13:c.A824G:p.H275R,GTF2H2:NM_001364569:exon13:c.A824G:p.H275R,GTF2H2:NM_001364570:exon13:c.A824G:p.H275R,GTF2H2:NM_001515:exon13:c.A824G:p.H275R,GTF2H2:NM_001364567:exon14:c.A824G:p.H275R,GTF2H2:NM_001364571:exon14:c.A824G:p.H275R,GTF2H2:NM_001364573:exon14:c.A656G:p.H219R	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 1, 0] 	.	.	.	.	3.308	22.9	0.035	2.84	0.857	.	.	.	GTF2H2:uc011crt.2:exon12:c.A653G:p.H218R,GTF2H2:uc003kav.4:exon13:c.A824G:p.H275R,GTF2H2:uc003kau.4:exon14:c.A824G:p.H275R	-0.732	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601748	.	.	.	~ko03022 Basal transcription factors~ko03420 Nucleotide excision repair~ko05203 Viral carcinogenesis ~	.	.	.	0.865	1.38	0.184	3.26	5	.	hom
5	74889743	74889743	A	G	POLK	exonic	nonsynonymous SNV	ENSG00000122008	.	ENSG00000122008:ENST00000241436:exon12:c.A1397G:p.E466G,ENSG00000122008:ENST00000380481:exon12:c.A1127G:p.E376G	POLK:NM_001345921:exon11:c.A1199G:p.E400G,POLK:NM_016218:exon12:c.A1397G:p.E466G,POLK:NM_001345922:exon13:c.A1127G:p.E376G	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 1, 0] 	.	.	.	.	6.575	31	0.003	5.82	1.000	.	.	DNA polymerase, Y-family, little finger domain	POLK:uc003kdw.3:exon12:c.A1397G:p.E466G,POLK:uc003kec.3:exon12:c.A1127G:p.E376G	-0.570	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605650	.	.	.	~ko03460 Fanconi anemia pathway~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	1.0	1.44	0.231	3.83	5	.	hom
5	79960955	79960955	G	A	MSH3	intronic	.	ENSG00000113318	rs1382543	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2654	0.3045	0.249401	0.2645	.	.	.	.	.	0.0005	0.016	.	.	.	AFR:0.3377,AMR:0.1587,EAS:0.0512,FIN:0.2316,NFE:0.2586,OTH:0.2531,ASJ:0.2980	600887	608089;617100;	.	.	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	5	.	hom
5	112162854	112162854	T	C	APC	exonic	synonymous SNV	ENSG00000134982	rs2229992	ENSG00000134982:ENST00000504915:exon3:c.T147C:p.Y49Y,ENSG00000134982:ENST00000507379:exon10:c.T1404C:p.Y468Y,ENSG00000134982:ENST00000257430:exon12:c.T1458C:p.Y486Y,ENSG00000134982:ENST00000457016:exon12:c.T1458C:p.Y486Y,ENSG00000134982:ENST00000512211:exon12:c.T1458C:p.Y486Y,ENSG00000134982:ENST00000508376:exon13:c.T1458C:p.Y486Y	APC:NM_001127511:exon10:c.T1404C:p.Y468Y,APC:NM_001354897:exon11:c.T1488C:p.Y496Y,APC:NM_001354899:exon11:c.T1374C:p.Y458Y,APC:NM_001354901:exon11:c.T1281C:p.Y427Y,APC:NM_001354902:exon11:c.T1185C:p.Y395Y,APC:NM_001354905:exon11:c.T978C:p.Y326Y,APC:NM_000038:exon12:c.T1458C:p.Y486Y,APC:NM_001354895:exon12:c.T1458C:p.Y486Y,APC:NM_001354898:exon12:c.T1383C:p.Y461Y,APC:NM_001354900:exon12:c.T1335C:p.Y445Y,APC:NM_001354903:exon12:c.T1155C:p.Y385Y,APC:NM_001354904:exon12:c.T1080C:p.Y360Y,APC:NM_001127510:exon13:c.T1458C:p.Y486Y,APC:NM_001354896:exon13:c.T1512C:p.Y504Y,APC:NM_001354906:exon13:c.T609C:p.Y203Y	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5780	0.4622	0.509984	0.4692	.	.	.	.	.	.	.	.	APC:uc011cvt.2:exon10:c.T1404C:p.Y468Y,APC:uc003kpy.4:exon12:c.T1458C:p.Y486Y,APC:uc003kpz.4:exon13:c.T1458C:p.Y486Y,APC:uc010jbz.3:exon13:c.T609C:p.Y203Y	.	AFR:0.2085,AMR:0.6579,EAS:0.6538,FIN:0.5003,NFE:0.5762,OTH:0.5430,ASJ:0.5894	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,742,737,745,738,743,739,740	.	,741	.	.	.	.	5	MU151723	het
5	112175770	112175770	G	A	APC	exonic	synonymous SNV	ENSG00000134982	rs41115	ENSG00000134982:ENST00000257430:exon16:c.G4479A:p.T1493T,ENSG00000134982:ENST00000457016:exon16:c.G4479A:p.T1493T,ENSG00000134982:ENST00000508376:exon17:c.G4479A:p.T1493T	APC:NM_001127511:exon14:c.G4425A:p.T1475T,APC:NM_001354897:exon15:c.G4509A:p.T1503T,APC:NM_001354899:exon15:c.G4395A:p.T1465T,APC:NM_001354901:exon15:c.G4302A:p.T1434T,APC:NM_001354902:exon15:c.G4206A:p.T1402T,APC:NM_001354905:exon15:c.G3999A:p.T1333T,APC:NM_000038:exon16:c.G4479A:p.T1493T,APC:NM_001354895:exon16:c.G4479A:p.T1493T,APC:NM_001354898:exon16:c.G4404A:p.T1468T,APC:NM_001354900:exon16:c.G4356A:p.T1452T,APC:NM_001354903:exon16:c.G4176A:p.T1392T,APC:NM_001354904:exon16:c.G4101A:p.T1367T,APC:NM_001127510:exon17:c.G4479A:p.T1493T,APC:NM_001354896:exon17:c.G4533A:p.T1511T,APC:NM_001354906:exon17:c.G3630A:p.T1210T	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6486	0.5862	0.665535	0.5933	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.G2379A:p.T793T,APC:uc011cvt.2:exon14:c.G4425A:p.T1475T,APC:uc003kpy.4:exon16:c.G4479A:p.T1493T,APC:uc003kpz.4:exon17:c.G4479A:p.T1493T,APC:uc010jbz.3:exon17:c.G3630A:p.T1210T	.	AFR:0.5356,AMR:0.6918,EAS:0.8082,FIN:0.5563,NFE:0.6050,OTH:0.6209,ASJ:0.5927	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,742,737,745,738,743,739,740	.	,741	.	.	.	.	5	MU62815	hom
5	112177171	112177171	G	A	APC	exonic	synonymous SNV	ENSG00000134982	rs465899	ENSG00000134982:ENST00000257430:exon16:c.G5880A:p.P1960P,ENSG00000134982:ENST00000457016:exon16:c.G5880A:p.P1960P,ENSG00000134982:ENST00000508376:exon17:c.G5880A:p.P1960P	APC:NM_001127511:exon14:c.G5826A:p.P1942P,APC:NM_001354897:exon15:c.G5910A:p.P1970P,APC:NM_001354899:exon15:c.G5796A:p.P1932P,APC:NM_001354901:exon15:c.G5703A:p.P1901P,APC:NM_001354902:exon15:c.G5607A:p.P1869P,APC:NM_001354905:exon15:c.G5400A:p.P1800P,APC:NM_000038:exon16:c.G5880A:p.P1960P,APC:NM_001354895:exon16:c.G5880A:p.P1960P,APC:NM_001354898:exon16:c.G5805A:p.P1935P,APC:NM_001354900:exon16:c.G5757A:p.P1919P,APC:NM_001354903:exon16:c.G5577A:p.P1859P,APC:NM_001354904:exon16:c.G5502A:p.P1834P,APC:NM_001127510:exon17:c.G5880A:p.P1960P,APC:NM_001354896:exon17:c.G5934A:p.P1978P,APC:NM_001354906:exon17:c.G5031A:p.P1677P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6488	0.5869	0.666534	0.5952	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.G3780A:p.P1260P,APC:uc011cvt.2:exon14:c.G5826A:p.P1942P,APC:uc003kpy.4:exon16:c.G5880A:p.P1960P,APC:uc003kpz.4:exon17:c.G5880A:p.P1960P,APC:uc010jbz.3:exon17:c.G5031A:p.P1677P	.	AFR:0.5409,AMR:0.6938,EAS:0.8097,FIN:0.5564,NFE:0.6055,OTH:0.6224,ASJ:0.5927	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,742,737,745,738,743,739,740	.	,741	.	.	.	.	5	MU62778	het
5	112179160	112179160	A	G	APC	exonic	synonymous SNV	ENSG00000134982	.	ENSG00000134982:ENST00000257430:exon16:c.A7869G:p.T2623T,ENSG00000134982:ENST00000457016:exon16:c.A7869G:p.T2623T,ENSG00000134982:ENST00000508376:exon17:c.A7869G:p.T2623T	APC:NM_001127511:exon14:c.A7815G:p.T2605T,APC:NM_001354897:exon15:c.A7899G:p.T2633T,APC:NM_001354899:exon15:c.A7785G:p.T2595T,APC:NM_001354901:exon15:c.A7692G:p.T2564T,APC:NM_001354902:exon15:c.A7596G:p.T2532T,APC:NM_001354905:exon15:c.A7389G:p.T2463T,APC:NM_000038:exon16:c.A7869G:p.T2623T,APC:NM_001354895:exon16:c.A7869G:p.T2623T,APC:NM_001354898:exon16:c.A7794G:p.T2598T,APC:NM_001354900:exon16:c.A7746G:p.T2582T,APC:NM_001354903:exon16:c.A7566G:p.T2522T,APC:NM_001354904:exon16:c.A7491G:p.T2497T,APC:NM_001127510:exon17:c.A7869G:p.T2623T,APC:NM_001354896:exon17:c.A7923G:p.T2641T,APC:NM_001354906:exon17:c.A7020G:p.T2340T	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 1, 0, 1, 0, 1, 1] 	.	.	.	.	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.A5769G:p.T1923T,APC:uc011cvt.2:exon14:c.A7815G:p.T2605T,APC:uc003kpy.4:exon16:c.A7869G:p.T2623T,APC:uc003kpz.4:exon17:c.A7869G:p.T2623T,APC:uc010jbz.3:exon17:c.A7020G:p.T2340T	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,742,737,745,738,743,739,740	.	,741	.	.	.	.	5	.	hom
5	127685135	127685135	C	T	FBN2	exonic	nonsynonymous SNV	ENSG00000138829	rs154001	ENSG00000138829:ENST00000508989:exon22:c.G2794A:p.V932I,ENSG00000138829:ENST00000262464:exon23:c.G2893A:p.V965I,ENSG00000138829:ENST00000508053:exon29:c.G2893A:p.V965I	FBN2:NM_001999:exon23:c.G2893A:p.V965I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7234	0.6622	0.73103	COCA-CN|5|321|0.0155763	3.009	22.3	0.331	3.32	1.000	.	.	EGF-like calcium-binding domain|EGF-like calcium-binding, conserved site|EGF-like domain|TB domain	FBN2:uc003kuv.2:exon22:c.G2794A:p.V932I,FBN2:uc003kuu.3:exon23:c.G2893A:p.V965I	-0.947	AFR:0.6947,AMR:0.6250,EAS:0.7682,FIN:0.9442,NFE:0.7234,OTH:0.6936,ASJ:0.7655	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	0.118	-3.01	0.000	-0.39	5	1(haematopoietic_and_lymphoid_tissue)	0.7357
5	131719999	131719999	A	G	SLC22A5	intronic	.	ENSG00000197375	rs4551059	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	1	.	1	1	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	603377	212140;	158;	158|CDSP<br>CUD<br>Carnitine transporter defect<br>Carnitine uptake deficiency<br>Deficiency of plasma-membrane carnitine transporter<br>SPCD|-|Autosomal recessive|Infancy<br>Neonatal|212140 ~	~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	MU81802464	hom
5	137717265	137717265	G	A	KDM3B	exonic	nonsynonymous SNV	ENSG00000120733	rs6865472	ENSG00000120733:ENST00000510866:exon5:c.G574A:p.A192T,ENSG00000120733:ENST00000314358:exon6:c.G766A:p.A256T	KDM3B:NM_016604:exon6:c.G766A:p.A256T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9951	0.9823	0.978435	0.9828	-0.332	0.561	0.773	-2.75	0.029	.	.	.	KDM3B:uc003lcy.1:exon6:c.G766A:p.A256T	-1.016	AFR:0.9396,AMR:0.9988,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	609373	.	.	.	.	.	.	.	0.0	0.15	0.000	0.69	5	MU81803283	hom
5	137733891	137733891	A	G	KDM3B	exonic	synonymous SNV	ENSG00000120733	rs17294563	ENSG00000120733:ENST00000394866:exon5:c.A1824G:p.V608V,ENSG00000120733:ENST00000314358:exon10:c.A2856G:p.V952V	KDM3B:NM_016604:exon10:c.A2856G:p.V952V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1563	0.1338	0.111621	LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	KDM3B:uc003lcy.1:exon10:c.A2856G:p.V952V,KDM3B:uc010jew.1:exon10:c.A1824G:p.V608V	.	AFR:0.1287,AMR:0.0348,EAS:0.1424,FIN:0.0123,NFE:0.1719,OTH:0.1851,ASJ:0.0931	609373	.	.	.	.	.	.	.	.	.	.	.	5	1(urinary_tract)	0.1673
5	138266546	138266546	G	A	CTNNA1	exonic	synonymous SNV	ENSG00000044115	rs1059110	ENSG00000044115:ENST00000520520:exon2:c.G45A:p.S15S,ENSG00000044115:ENST00000540387:exon10:c.G1110A:p.S370S,ENSG00000044115:ENST00000355078:exon15:c.G1911A:p.S637S,ENSG00000044115:ENST00000518825:exon15:c.G2220A:p.S740S,ENSG00000044115:ENST00000302763:exon16:c.G2220A:p.S740S	CTNNA1:NM_001324010:exon7:c.G771A:p.S257S,CTNNA1:NM_001324012:exon8:c.G867A:p.S289S,CTNNA1:NM_001290312:exon10:c.G1110A:p.S370S,CTNNA1:NM_001323987:exon10:c.G1110A:p.S370S,CTNNA1:NM_001323994:exon10:c.G1110A:p.S370S,CTNNA1:NM_001324001:exon10:c.G1110A:p.S370S,CTNNA1:NM_001324002:exon10:c.G1110A:p.S370S,CTNNA1:NM_001324004:exon10:c.G1110A:p.S370S,CTNNA1:NM_001323989:exon11:c.G1110A:p.S370S,CTNNA1:NM_001323991:exon11:c.G1110A:p.S370S,CTNNA1:NM_001324000:exon11:c.G1110A:p.S370S,CTNNA1:NM_001324008:exon11:c.G771A:p.S257S,CTNNA1:NM_001324009:exon11:c.G771A:p.S257S,CTNNA1:NM_001324013:exon11:c.G867A:p.S289S,CTNNA1:NM_001323990:exon12:c.G1110A:p.S370S,CTNNA1:NM_001324003:exon12:c.G1110A:p.S370S,CTNNA1:NM_001324011:exon12:c.G1017A:p.S339S,CTNNA1:NM_001323988:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323992:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323993:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323995:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323996:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323997:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323998:exon13:c.G1110A:p.S370S,CTNNA1:NM_001323999:exon13:c.G1110A:p.S370S,CTNNA1:NM_001324005:exon13:c.G1110A:p.S370S,CTNNA1:NM_001324007:exon13:c.G771A:p.S257S,CTNNA1:NM_001324006:exon14:c.G771A:p.S257S,CTNNA1:NM_001290309:exon15:c.G1911A:p.S637S,CTNNA1:NM_001323986:exon15:c.G2127A:p.S709S,CTNNA1:NM_001290307:exon16:c.G2220A:p.S740S,CTNNA1:NM_001290310:exon16:c.G1851A:p.S617S,CTNNA1:NM_001323983:exon16:c.G2220A:p.S740S,CTNNA1:NM_001323985:exon16:c.G2220A:p.S740S,CTNNA1:NM_001903:exon16:c.G2220A:p.S740S,CTNNA1:NM_001323982:exon17:c.G2220A:p.S740S,CTNNA1:NM_001323984:exon17:c.G2220A:p.S740S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2796	0.3348	0.249002	0.3223	.	.	.	.	.	.	.	.	CTNNA1:uc003ldl.3:exon10:c.G1110A:p.S370S,CTNNA1:uc003ldi.3:exon13:c.G1314A:p.S438S,CTNNA1:uc003ldj.3:exon15:c.G2220A:p.S740S,CTNNA1:uc011cyx.2:exon15:c.G1911A:p.S637S,CTNNA1:uc003ldh.3:exon16:c.G2220A:p.S740S,CTNNA1:uc011cyy.2:exon16:c.G1851A:p.S617S	.	AFR:0.4084,AMR:0.2704,EAS:0.0006,FIN:0.2952,NFE:0.3176,OTH:0.3,ASJ:0.3179	116805	608970;	99001;	99001|Butterfly-shaped pattern dystrophy<br>Butterfly-shaped pigmentary macular dystrophy|-|Autosomal dominant|Adult|169150 608970 610125 ~	~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04670 Leukocyte transendothelial migration~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05213 Endometrial cancer~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	5	.	het
5	141014494	141014494	T	C	HDAC3	exonic	synonymous SNV	ENSG00000171720	rs2530223	ENSG00000171720:ENST00000305264:exon3:c.A165G:p.Q55Q	HDAC3:NM_001355039:exon3:c.A165G:p.Q55Q,HDAC3:NM_003883:exon3:c.A165G:p.Q55Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6253	0.6832	0.639776	0.6716	.	.	.	.	.	.	.	.	HDAC3:uc003llf.2:exon3:c.A165G:p.Q55Q	.	AFR:0.8538,AMR:0.7303,EAS:0.3067,FIN:0.6067,NFE:0.6193,OTH:0.6582,ASJ:0.5927	605166	.	.	.	~ko04919 Thyroid hormone signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	5	MU105200	hom
5	142150942	142150942	T	C	ARHGAP26	splicing	.	ENSG00000145819	rs10042074	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.39996	0.3053	.	.	.	.	.	.	.	.	.	.	AFR:0.7692,AMR:0.2625,EAS:0.3792,FIN:0.1354,NFE:0.0816,OTH:0.1612,ASJ:0.13	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	.	hom
5	142254679	142254679	A	G	ARHGAP26	exonic	synonymous SNV	ENSG00000145819	rs185200	ENSG00000145819:ENST00000274498:exon3:c.A255G:p.R85R,ENSG00000145819:ENST00000378004:exon3:c.A255G:p.R85R,ENSG00000145819:ENST00000378013:exon3:c.A171G:p.R57R	ARHGAP26:NM_001135608:exon3:c.A255G:p.R85R,ARHGAP26:NM_001349547:exon3:c.A147G:p.R49R,ARHGAP26:NM_015071:exon3:c.A255G:p.R85R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4468	0.4620	0.673722	0.4728	.	.	.	.	.	.	.	.	ARHGAP26:uc003lmt.3:exon3:c.A255G:p.R85R,ARHGAP26:uc003lmw.3:exon3:c.A255G:p.R85R,ARHGAP26:uc011dbj.2:exon3:c.A255G:p.R85R	.	AFR:0.8006,AMR:0.5084,EAS:0.8806,FIN:0.2917,NFE:0.2887,OTH:0.3640,ASJ:0.3079	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	MU24874862	het
5	142416741	142416741	T	C	ARHGAP26	intronic	.	ENSG00000145819	rs192194	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7071	0.7795	0.644768	0.7523	.	.	.	.	.	.	.	.	.	.	AFR:0.7955,AMR:0.5621,EAS:0.3362,FIN:0.7196,NFE:0.7903,OTH:0.7474,ASJ:0.7649	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	MU15244426	hom
5	142421415	142421415	T	G	ARHGAP26	exonic	synonymous SNV	ENSG00000145819	rs2270068	ENSG00000145819:ENST00000274498:exon14:c.T1245G:p.G415G,ENSG00000145819:ENST00000378004:exon14:c.T1245G:p.G415G	ARHGAP26:NM_001135608:exon14:c.T1245G:p.G415G,ARHGAP26:NM_001349547:exon14:c.T1137G:p.G379G,ARHGAP26:NM_015071:exon14:c.T1245G:p.G415G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9619	0.9983	0.888179	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ARHGAP26:uc003lmt.3:exon14:c.T1245G:p.G415G,ARHGAP26:uc003lmw.3:exon14:c.T1245G:p.G415G,ARHGAP26:uc011dbj.2:exon14:c.T1245G:p.G415G	.	AFR:0.9698,AMR:0.9969,EAS:1,FIN:0.5162,NFE:0.9885,OTH:0.9983,ASJ:0.9414	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	1(breast)	0.9827
5	142779585	142779585	G	A	NR3C1	exonic	nonsynonymous SNV	ENSG00000113580	.	ENSG00000113580:ENST00000424646:exon1:c.C820T:p.P274S,ENSG00000113580:ENST00000231509:exon2:c.C820T:p.P274S,ENSG00000113580:ENST00000343796:exon2:c.C820T:p.P274S,ENSG00000113580:ENST00000394464:exon2:c.C820T:p.P274S,ENSG00000113580:ENST00000394466:exon2:c.C820T:p.P274S,ENSG00000113580:ENST00000415690:exon2:c.C820T:p.P274S,ENSG00000113580:ENST00000503201:exon2:c.C820T:p.P274S,ENSG00000113580:ENST00000504572:exon3:c.C820T:p.P274S	NR3C1:NM_000176:exon2:c.C820T:p.P274S,NR3C1:NM_001018074:exon2:c.C820T:p.P274S,NR3C1:NM_001018075:exon2:c.C820T:p.P274S,NR3C1:NM_001018076:exon2:c.C820T:p.P274S,NR3C1:NM_001018077:exon2:c.C820T:p.P274S,NR3C1:NM_001020825:exon2:c.C820T:p.P274S,NR3C1:NM_001024094:exon2:c.C820T:p.P274S,NR3C1:NM_001204258:exon2:c.C742T:p.P248S,NR3C1:NM_001204259:exon2:c.C565T:p.P189S,NR3C1:NM_001204260:exon2:c.C553T:p.P185S,NR3C1:NM_001204261:exon2:c.C529T:p.P177S,NR3C1:NM_001204265:exon2:c.C820T:p.P274S,NR3C1:NM_001364180:exon2:c.C820T:p.P274S,NR3C1:NM_001364181:exon2:c.C820T:p.P274S,NR3C1:NM_001364182:exon2:c.C820T:p.P274S,NR3C1:NM_001364184:exon2:c.C820T:p.P274S,NR3C1:NM_001364185:exon2:c.C820T:p.P274S,NR3C1:NM_001364183:exon3:c.C820T:p.P274S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	1.661	14.19	0.087	5.46	0.994	.	.	.	NR3C1:uc021yfa.1:exon1:c.C820T:p.P274S,NR3C1:uc031slp.1:exon1:c.C820T:p.P274S,NR3C1:uc003lmy.3:exon2:c.C820T:p.P274S,NR3C1:uc003lna.3:exon2:c.C820T:p.P274S,NR3C1:uc003lnb.3:exon2:c.C820T:p.P274S,NR3C1:uc003lnc.3:exon2:c.C820T:p.P274S,NR3C1:uc003lnd.3:exon2:c.C820T:p.P274S,NR3C1:uc003lne.3:exon2:c.C820T:p.P274S,NR3C1:uc003lng.2:exon2:c.C820T:p.P274S,NR3C1:uc003lni.2:exon2:c.C820T:p.P274S,NR3C1:uc021yfb.1:exon2:c.C820T:p.P274S,NR3C1:uc003lnf.3:exon3:c.C820T:p.P274S	-0.781	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	138040	615962;	786;	786|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|615962 ~	.	.	.	.	0.549	1.2	0.218	1.885	5	.	hom
5	149457678	149457678	G	A	CSF1R	exonic	synonymous SNV	ENSG00000182578	rs2228422	ENSG00000182578:ENST00000504875:exon4:c.C726T:p.T242T,ENSG00000182578:ENST00000543093:exon4:c.C726T:p.T242T,ENSG00000182578:ENST00000286301:exon5:c.C726T:p.T242T	CSF1R:NM_001288705:exon4:c.C726T:p.T242T,CSF1R:NM_005211:exon5:c.C726T:p.T242T,CSF1R:NM_001349736:exon6:c.C726T:p.T242T	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5153	0.4807	0.38738	4(lung)	.	.	.	.	.	.	.	.	CSF1R:uc011dcd.2:exon3:c.C282T:p.T94T,CSF1R:uc003lrl.3:exon4:c.C726T:p.T242T,CSF1R:uc011dce.1:exon4:c.C726T:p.T242T,CSF1R:uc011dcf.2:exon4:c.C726T:p.T242T,CSF1R:uc003lrm.3:exon5:c.C726T:p.T242T	.	AFR:1(stomach),AMR:1(breast),EAS:1(thyroid),FIN:MU586881,NFE:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,OTH:0.4998,ASJ:1(liver)	164770	221820;	313808;	313808|ALSP<br>Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia<br>Autosomal dominant leukoencephalopathy with neuroaxonal spheroids<br>FPSG<br>Familial dementia, Neumann type<br>Familial progressive subcortical gliosis<br>GPSC<br>HDLS<br>Hereditary diffuse leukoencephalopathy with spheroids<br>POLD<br>Pigmentary orthochromatic leukodystrophy<br>Subcortical gliosis of Neumann|<1 / 1 000 000|Autosomal dominant|Adult|221820 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	2067,,2068,2070	.	,2069	.	.	.	.	5	14(meninges)	0.3213
5	149515384	149515384	A	T	PDGFRB	exonic	nonsynonymous SNV	ENSG00000113721	.	ENSG00000113721:ENST00000261799:exon3:c.T98A:p.L33Q,ENSG00000113721:ENST00000517957:exon3:c.T98A:p.L33Q,ENSG00000113721:ENST00000520579:exon3:c.T98A:p.L33Q	PDGFRB:NM_002609:exon3:c.T98A:p.L33Q	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 0] 	.	.	.	.	5.480	26.2	0.032	5.42	0.093	.	.	Immunoglobulin-like domain|Immunoglobulin-like fold	PDGFRB:uc011dcg.1:exon2:c.T98A:p.L33Q,PDGFRB:uc003lro.3:exon3:c.T98A:p.L33Q	0.151	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	173410	131440;228550;601812;615007;616592;	1980;363665;2591;86830;	1980|BSPDC<br>Cerebrovascular ferrocalcinosis<br>Idiopathic basal ganglia calcification<br>PFBC<br>Primary familial brain calcification|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Adult|213600 606656 615007 615483 616413 ~363665|Premature aging syndrome, Penttinen type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|601812 ~2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~86830|CMPD-U<br>Undifferentiated myeloproliferative disease|-|-|-|131440 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	.	.	.	0.999	-1.08	0.549	2.36	5	.	hom
5	151054165	151054165	C	A	SPARC	intronic	.	ENSG00000113140	rs199756185	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0039	0.0002	0.0115815	0.0007	.	.	.	.	.	0	0.002	.	.	.	AFR:0.0003,AMR:0,EAS:0.0086,FIN:0.0006,NFE:6.66e-05,OTH:0.0020,ASJ:0	182120	616507;	216820;666;	216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~	.	.	.	.	.	.	.	.	5	.	hom
5	161113004	161113004	G	A	GABRA6	exonic	synonymous SNV	ENSG00000145863	rs13188991	ENSG00000145863:ENST00000274545:exon1:c.G9A:p.S3S,ENSG00000145863:ENST00000523217:exon1:c.G9A:p.S3S	GABRA6:NM_000811:exon1:c.G9A:p.S3S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1893	0.1877	0.0992412	1(thyroid)	.	.	.	.	.	.	.	.	GABRA6:uc003lyu.2:exon1:c.G9A:p.S3S	.	AFR:1(liver),AMR:MU4567513,EAS:0.1857,FIN:0.0473,NFE:0.1235,OTH:0.2848,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647	137143	.	.	.	.	.	.	.	.	.	.	.	5	1(central_nervous_system)	0.0895
5	161119071	161119071	G	T	GABRA6	exonic	synonymous SNV	ENSG00000145863	rs12522663	ENSG00000145863:ENST00000274545:exon8:c.G951T:p.A317A,ENSG00000145863:ENST00000523217:exon8:c.G921T:p.A307A	GABRA6:NM_000811:exon8:c.G951T:p.A317A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9902	0.9655	0.968251	0.9699	.	.	.	.	.	.	.	.	GABRA6:uc003lyv.2:exon2:c.G264T:p.A88A,GABRA6:uc003lyu.2:exon8:c.G951T:p.A317A	.	AFR:0.8962,AMR:0.9881,EAS:1,FIN:1,NFE:0.9997,OTH:0.9878,ASJ:1	137143	.	.	.	.	.	.	.	.	.	.	.	5	MU81806764	hom
5	161119125	161119125	C	G	GABRA6	exonic	synonymous SNV	ENSG00000145863	rs13184586	ENSG00000145863:ENST00000274545:exon8:c.C1005G:p.A335A,ENSG00000145863:ENST00000523217:exon8:c.C975G:p.A325A	GABRA6:NM_000811:exon8:c.C1005G:p.A335A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4854	0.4881	0.401158	MU12248552	.	.	.	.	.	.	.	.	GABRA6:uc003lyv.2:exon2:c.C318G:p.A106A,GABRA6:uc003lyu.2:exon8:c.C1005G:p.A335A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.4862,EAS:0.3801,FIN:0.5695,NFE:0.3021,OTH:0.5499,ASJ:0.3513	137143	.	.	.	.	.	.	.	.	.	.	.	5	2(haematopoietic_and_lymphoid_tissue)	0.5715
5	162909687	162909687	G	A	HMMR	exonic	synonymous SNV	ENSG00000072571	rs17600938	ENSG00000072571:ENST00000432118:exon10:c.G1164A:p.K388K,ENSG00000072571:ENST00000353866:exon12:c.G1377A:p.K459K,ENSG00000072571:ENST00000358715:exon13:c.G1422A:p.K474K,ENSG00000072571:ENST00000393915:exon13:c.G1425A:p.K475K	HMMR:NM_001142557:exon10:c.G1164A:p.K388K,HMMR:NM_012485:exon12:c.G1377A:p.K459K,HMMR:NM_001142556:exon13:c.G1425A:p.K475K,HMMR:NM_012484:exon13:c.G1422A:p.K474K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1138	0.1192	0.11242	0.1187	.	.	.	.	.	.	.	.	HMMR:uc011dem.2:exon10:c.G1164A:p.K388K,HMMR:uc003lzg.3:exon12:c.G1377A:p.K459K,HMMR:uc003lzf.3:exon13:c.G1422A:p.K474K,HMMR:uc003lzh.3:exon13:c.G1425A:p.K475K	.	AFR:0.1331,AMR:0.1014,EAS:0.0507,FIN:0.1368,NFE:0.1145,OTH:0.1227,ASJ:0.1060	600936	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	5	.	hom
5	162909716	162909716	C	T	HMMR	exonic	nonsynonymous SNV	ENSG00000072571	rs299295	ENSG00000072571:ENST00000432118:exon10:c.C1193T:p.A398V,ENSG00000072571:ENST00000353866:exon12:c.C1406T:p.A469V,ENSG00000072571:ENST00000358715:exon13:c.C1451T:p.A484V,ENSG00000072571:ENST00000393915:exon13:c.C1454T:p.A485V	HMMR:NM_001142557:exon10:c.C1193T:p.A398V,HMMR:NM_012485:exon12:c.C1406T:p.A469V,HMMR:NM_001142556:exon13:c.C1454T:p.A485V,HMMR:NM_012484:exon13:c.C1451T:p.A484V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2326	0.2556	0.215655	LAML-KR|1|205|0.00487805	0.773	9.295	1.0	4.27	0.039	.	.	.	HMMR:uc011dem.2:exon10:c.C1193T:p.A398V,HMMR:uc003lzg.3:exon12:c.C1406T:p.A469V,HMMR:uc003lzf.3:exon13:c.C1451T:p.A484V,HMMR:uc003lzh.3:exon13:c.C1454T:p.A485V	-0.957	AFR:0.2549,AMR:0.3007,EAS:0.2433,FIN:0.0593,NFE:0.2849,OTH:0.2474,ASJ:0.1671	600936	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.0	3.83	0.000	-2.455	5	1(haematopoietic_and_lymphoid_tissue)	0.2597
5	169127097	169127097	C	A	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs2112703	ENSG00000134516:ENST00000256935:exon13:c.C1212A:p.T404T,ENSG00000134516:ENST00000524185:exon13:c.C1212A:p.T404T	DOCK2:NM_004946:exon13:c.C1212A:p.T404T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1695	0.1619	0.121605	0.1472	.	.	.	.	.	.	.	.	DOCK2:uc003maf.3:exon13:c.C1212A:p.T404T	.	AFR:0.0610,AMR:0.0859,EAS:0.1227,FIN:0.1722,NFE:0.1962,OTH:0.1578,ASJ:0.1821	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU29854221	hom
5	169435713	169435713	A	C	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs2287727	ENSG00000134516:ENST00000520908:exon18:c.A1671C:p.L557L,ENSG00000134516:ENST00000540750:exon18:c.A378C:p.L126L,ENSG00000134516:ENST00000256935:exon32:c.A3195C:p.L1065L	DOCK2:NM_004946:exon32:c.A3195C:p.L1065L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2919	0.2207	0.243011	0.2467	.	.	.	.	.	.	.	.	DOCK2:uc010jjm.3:exon18:c.A1671C:p.L557L,DOCK2:uc003maf.3:exon32:c.A3195C:p.L1065L	.	AFR:0.0696,AMR:0.3517,EAS:0.4252,FIN:0.3768,NFE:0.2895,OTH:0.3129,ASJ:0.2781	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU137499	hom
5	170837514	170837515	TT	-	NPM1	intronic	.	ENSG00000181163	rs766749752	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	0.0073	.	.	4.077e-05	.	.	.	.	.	.	.	.	.	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	164040	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	5	.	het
5	180035137	180035137	C	T	FLT4	exonic	nonsynonymous SNV	ENSG00000037280	.	ENSG00000037280:ENST00000502649:exon30:c.G3916A:p.A1306T	FLT4:NM_001354989:exon30:c.G3916A:p.A1306T	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	-0.489	0.234	0.0	-0.218	0.001	.	.	.	.	-0.721	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	-1.02	0.316	.	5	.	hom
5	180046344	180046344	G	C	FLT4	exonic	nonsynonymous SNV	ENSG00000037280	rs448012	ENSG00000037280:ENST00000261937:exon19:c.C2670G:p.H890Q,ENSG00000037280:ENST00000393347:exon19:c.C2670G:p.H890Q,ENSG00000037280:ENST00000502649:exon19:c.C2670G:p.H890Q	FLT4:NM_001354989:exon19:c.C2670G:p.H890Q,FLT4:NM_002020:exon19:c.C2670G:p.H890Q,FLT4:NM_182925:exon19:c.C2670G:p.H890Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6247	0.5970	0.582668	1(urinary_tract)	5.326	25.8	0.045	1.22	1.000	.	.	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase, catalytic domain|Tyrosine-protein kinase, catalytic domain	FLT4:uc003mlz.4:exon19:c.C2670G:p.H890Q,FLT4:uc003mma.4:exon19:c.C2670G:p.H890Q	-0.907	AFR:79(lung),AMR:MU678928,EAS:0.6216,FIN:0.5506,NFE:0.7367,OTH:0.5233,ASJ:SKCA-BR|1|100|0.01,LUSC-KR|3|170|0.0176471,COCA-CN|7|321|0.0218069,BLCA-CN|1|103|0.00970874	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	0.18	-1.54	0.000	0.04	5	1(thyroid)	0.4763
5	180047863	180047863	C	G	FLT4	intronic	.	ENSG00000037280	rs423086	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9876	0.9531	0.960064	0.9627	.	.	.	.	.	.	.	.	.	.	AFR:0.8699,AMR:0.9940,EAS:1,FIN:1,NFE:0.9993,OTH:0.9929,ASJ:1	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	5	MU81809230	hom
5	180072102	180072102	C	A	FLT4	intronic	.	ENSG00000037280	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	5	.	hom
6	325126	325126	A	G	DUSP22	intronic	.	ENSG00000112679	rs2757553	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.996805	0.9836	.	.	.	.	.	.	.	.	.	.	AFR:0.9701,AMR:0.9817,EAS:0.9950,FIN:0.9786,NFE:0.9909,OTH:0.9896,ASJ:0.9966	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	325403	325403	G	A	DUSP22	intronic	.	ENSG00000112679	rs28517601	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.448882	SKCA-BR|1|100|0.01	.	.	.	.	.	.	.	.	.	.	AFR:0.4451,AMR:0.4021,EAS:0.4362,FIN:0.4699,NFE:0.4720,OTH:0.4602,ASJ:0.4648	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(skin)	0.448
6	325544	325544	A	G	DUSP22	intronic	.	ENSG00000112679	rs28733103	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	SKCA-BR|1|100|0.01,PRAD-CA|1|306|0.00326797	.	.	.	.	.	.	.	.	.	.	AFR:0.4135,AMR:0.4588,EAS:0.2794,FIN:0.4791,NFE:0.3795,OTH:0.3840,ASJ:0.4074	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(prostate)	0.3932
6	325549	325549	G	A	DUSP22	intronic	.	ENSG00000112679	rs2488422	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	0.1463	.	.	.	.	.	.	.	.	.	.	AFR:0.2011,AMR:0.1741,EAS:0.2748,FIN:0.1402,NFE:0.1075,OTH:0.1175,ASJ:0.0481	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU43698069	het
6	325557	325557	G	T	DUSP22	intronic	.	ENSG00000112679	rs2797328	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	0.1947	.	.	.	.	.	.	.	.	.	.	AFR:0.2682,AMR:0.2135,EAS:0.3047,FIN:0.2377,NFE:0.1407,OTH:0.1202,ASJ:0.0612	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU43698139	het
6	325873	325873	T	C	DUSP22	intronic	.	ENSG00000112679	rs2797329	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.997804	0.9956	.	.	.	.	.	.	.	.	.	.	AFR:0.9902,AMR:0.9986,EAS:0.9992,FIN:0.9932,NFE:0.9986,OTH:0.9974,ASJ:1	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	325901	325901	G	A	DUSP22	intronic	.	ENSG00000112679	rs59192834	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	LICA-CN|3|402|0.00746269,NKTL-SG|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.0036,AMR:0.0053,EAS:0,FIN:0.0194,NFE:0.0029,OTH:0.0013,ASJ:0.0107	616778	.	.	.	.	.	.	.	.	.	.	.	6	2(liver)	0.0075
6	325961	325961	T	C	DUSP22	intronic	.	ENSG00000112679	rs2797330	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.971046	0.9765	.	.	.	.	.	.	.	.	.	.	AFR:0.9660,AMR:0.9744,EAS:0.9888,FIN:0.9693,NFE:0.9835,OTH:0.9676,ASJ:0.9795	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU80942806	hom
6	326134	326134	G	A	DUSP22	intronic	.	ENSG00000112679	rs2757557	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.996805	0.9956	.	.	.	.	.	.	.	.	.	.	AFR:0.9887,AMR:0.9913,EAS:1,FIN:0.9949,NFE:0.9992,OTH:0.9978,ASJ:1	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	326491	326553	GGTGCCTGGAGAGTCATCTGCCCTGGGCTTCCGCGTCCTGGTGTGTGCAGTGCTGTATCTGCT	-	DUSP22	intronic	.	ENSG00000112679	.	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.0903	.	.	.	.	.	.	.	.	.	.	AFR:0.0661,AMR:0.0572,EAS:0.1625,FIN:0.1314,NFE:0.0858,OTH:0.1062,ASJ:0.0569	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	348906	348906	G	A	DUSP22	exonic	synonymous SNV	ENSG00000112679	rs11242812	ENSG00000112679:ENST00000604971:exon4:c.G264A:p.P88P,ENSG00000112679:ENST00000605315:exon4:c.G264A:p.P88P,ENSG00000112679:ENST00000603453:exon6:c.G264A:p.P88P,ENSG00000112679:ENST00000419235:exon7:c.G573A:p.P191P	DUSP22:NM_001286555:exon7:c.G573A:p.P191P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4882	.	.	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	DUSP22:uc003msy.1:exon6:c.G444A:p.P148P,DUSP22:uc011dhn.1:exon7:c.G573A:p.P191P	.	AFR:MU4553881,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,EAS:0.4929,FIN:0.4795,NFE:0.4567,OTH:0.4781,ASJ:0.4800	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.4698
6	398826	398826	A	G	IRF4	splicing	.	ENSG00000137265	.	.	.	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	5.108	25.3	.	5.4	1.000	1.0000	0.944	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601900	611724;	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	7563983	7563983	T	G	DSP	exonic	synonymous SNV	ENSG00000096696	rs2806234	ENSG00000096696:ENST00000379802:exon6:c.T741G:p.A247A,ENSG00000096696:ENST00000418664:exon6:c.T741G:p.A247A	DSP:NM_001008844:exon6:c.T741G:p.A247A,DSP:NM_001319034:exon6:c.T741G:p.A247A,DSP:NM_004415:exon6:c.T741G:p.A247A	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9991	0.9985	1	0.9995	.	.	.	.	.	.	.	.	DSP:uc003mxp.1:exon6:c.T741G:p.A247A,DSP:uc003mxq.1:exon6:c.T741G:p.A247A,DSP:uc021yle.1:exon6:c.T741G:p.A247A	.	AFR:0.9999,AMR:1,EAS:1,FIN:0.9991,NFE:0.9992,OTH:0.9990,ASJ:1	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	MU81810273	hom
6	7585967	7585967	G	C	DSP	exonic	synonymous SNV	ENSG00000096696	rs2744380	ENSG00000096696:ENST00000379802:exon24:c.G8472C:p.G2824G,ENSG00000096696:ENST00000418664:exon24:c.G6675C:p.G2225G	DSP:NM_001008844:exon24:c.G6675C:p.G2225G,DSP:NM_001319034:exon24:c.G7143C:p.G2381G,DSP:NM_004415:exon24:c.G8472C:p.G2824G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7117	0.6881	0.709465	0.6718	.	.	.	.	.	.	.	.	DSP:uc003mxp.1:exon24:c.G8472C:p.G2824G,DSP:uc003mxq.1:exon24:c.G6675C:p.G2225G,DSP:uc021yle.1:exon24:c.G7143C:p.G2381G	.	AFR:0.6315,AMR:0.7398,EAS:0.7978,FIN:0.6403,NFE:0.6820,OTH:0.6875,ASJ:0.7781	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	MU14034520	hom
6	18139214	18139214	G	A	TPMT	exonic	synonymous SNV	ENSG00000137364	rs2842934	ENSG00000137364:ENST00000309983:exon6:c.C474T:p.I158I	TPMT:NM_000367:exon6:c.C474T:p.I158I,TPMT:NM_001346818:exon6:c.C474T:p.I158I,TPMT:NM_001346817:exon7:c.C474T:p.I158I	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7633	0.7943	0.752995	LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	TPMT:uc003ncm.3:exon6:c.C474T:p.I158I,TPMT:uc010jpm.1:exon6:c.C474T:p.I158I	.	AFR:0.7849,AMR:0.8096,EAS:0.7053,FIN:0.7670,NFE:0.7666,OTH:0.7819,ASJ:0.7596	187680	610460;	413687;	413687|-|-|-|-|610460 616903 ~	.	.	.	.	.	.	.	.	6	1(stomach)	0.7515
6	28872446	28872446	T	C	TRIM27	intronic	.	ENSG00000204713	rs209126	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5675	0.6261	0.680911	0.6037	.	.	.	.	.	0.0011	0.018	.	.	.	AFR:0.8643,AMR:0.5683,EAS:0.6902,FIN:0.4335,NFE:0.4924,OTH:0.4990,ASJ:0.5464	602165	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	30672390	30672390	C	G	MDC1	exonic	nonsynonymous SNV	ENSG00000137337	rs201813097	ENSG00000137337:ENST00000376405:exon9:c.G3778C:p.V1260L,ENSG00000137337:ENST00000376406:exon10:c.G4570C:p.V1524L	MDC1:NM_014641:exon10:c.G4570C:p.V1524L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	0.0009	.	0.000998403	6.545e-05	0.014	2.724	0.205	-1.02	0.034	.	.	.	MDC1:uc003nrg.4:exon10:c.G4570C:p.V1524L,MDC1:uc011dmp.1:exon10:c.G3391C:p.V1131L	-1.012	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0021,ASJ:0	607593	.	.	.	.	.	.	.	0.923	2.85	0.019	2.165	6	.	het
6	30857072	30857072	G	C	DDR1	exonic	synonymous SNV	ENSG00000204580	rs2229933	ENSG00000204580:ENST00000376567:exon3:c.G282C:p.L94L,ENSG00000204580:ENST00000513240:exon3:c.G282C:p.L94L,ENSG00000204580:ENST00000376568:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000396342:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000418800:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000421124:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000460944:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000482873:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000503495:exon4:c.G360C:p.L120L,ENSG00000204580:ENST00000504679:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000504927:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000505066:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000508312:exon4:c.G336C:p.L112L,ENSG00000204580:ENST00000511510:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000512694:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000512725:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000515233:exon4:c.G282C:p.L94L,ENSG00000204580:ENST00000376569:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000428153:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000437124:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000452441:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000505534:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000508317:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000509639:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000512336:exon5:c.G282C:p.L94L,ENSG00000204580:ENST00000324771:exon6:c.G282C:p.L94L,ENSG00000204580:ENST00000376570:exon6:c.G282C:p.L94L,ENSG00000204580:ENST00000376575:exon6:c.G282C:p.L94L,ENSG00000204580:ENST00000446312:exon6:c.G282C:p.L94L,ENSG00000204580:ENST00000454612:exon8:c.G282C:p.L94L	DDR1:NM_001202521:exon3:c.G282C:p.L94L,DDR1:NM_001202522:exon3:c.G282C:p.L94L,DDR1:NM_013994:exon3:c.G282C:p.L94L,DDR1:NM_001202523:exon4:c.G336C:p.L112L,DDR1:NM_001297652:exon4:c.G282C:p.L94L,DDR1:NM_001297653:exon4:c.G282C:p.L94L,DDR1:NM_001297654:exon4:c.G282C:p.L94L,DDR1:NM_013993:exon5:c.G282C:p.L94L,DDR1:NM_001954:exon6:c.G282C:p.L94L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3051	0.2076	0.415335	0.2548	.	.	.	.	.	.	.	.	DDR1:uc003nru.3:exon3:c.G282C:p.L94L,DDR1:uc003nrv.3:exon3:c.G282C:p.L94L,DDR1:uc003nrx.2:exon3:c.G282C:p.L94L,DDR1:uc003nry.2:exon3:c.G282C:p.L94L,DDR1:uc011dmu.1:exon3:c.G282C:p.L94L,DDR1:uc003nrs.3:exon4:c.G282C:p.L94L,DDR1:uc003nrt.3:exon4:c.G282C:p.L94L,DDR1:uc010jse.3:exon4:c.G282C:p.L94L,DDR1:uc011dms.2:exon4:c.G336C:p.L112L,DDR1:uc011dmt.2:exon4:c.G360C:p.L120L,DDR1:uc003nrr.3:exon5:c.G282C:p.L94L,DDR1:uc003nrq.3:exon6:c.G282C:p.L94L	.	AFR:0.2781,AMR:0.4594,EAS:0.5861,FIN:0.2629,NFE:0.1910,OTH:0.2776,ASJ:0.2384	600408	.	.	.	.	.	.	.	.	.	.	.	6	MU640884	het
6	30858857	30858857	C	T	DDR1	exonic	synonymous SNV	ENSG00000204580	rs1049622	ENSG00000204580:ENST00000515219:exon3:c.C51T:p.S17S,ENSG00000204580:ENST00000376567:exon4:c.C525T:p.S175S,ENSG00000204580:ENST00000513240:exon4:c.C525T:p.S175S,ENSG00000204580:ENST00000376568:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000418800:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000421124:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000460944:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000482873:exon5:c.C525T:p.S175S,ENSG00000204580:ENST00000508312:exon5:c.C579T:p.S193S,ENSG00000204580:ENST00000376569:exon6:c.C525T:p.S175S,ENSG00000204580:ENST00000428153:exon6:c.C525T:p.S175S,ENSG00000204580:ENST00000452441:exon6:c.C525T:p.S175S,ENSG00000204580:ENST00000324771:exon7:c.C525T:p.S175S,ENSG00000204580:ENST00000376570:exon7:c.C525T:p.S175S,ENSG00000204580:ENST00000376575:exon7:c.C525T:p.S175S,ENSG00000204580:ENST00000446312:exon7:c.C525T:p.S175S,ENSG00000204580:ENST00000454612:exon9:c.C525T:p.S175S	DDR1:NM_001202521:exon4:c.C525T:p.S175S,DDR1:NM_001202522:exon4:c.C525T:p.S175S,DDR1:NM_013994:exon4:c.C525T:p.S175S,DDR1:NM_001202523:exon5:c.C579T:p.S193S,DDR1:NM_001297652:exon5:c.C525T:p.S175S,DDR1:NM_001297653:exon5:c.C525T:p.S175S,DDR1:NM_001297654:exon5:c.C525T:p.S175S,DDR1:NM_013993:exon6:c.C525T:p.S175S,DDR1:NM_001954:exon7:c.C525T:p.S175S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3051	0.2080	0.415535	LAML-KR|1|205|0.00487805	.	.	.	.	.	.	.	.	DDR1:uc003nru.3:exon4:c.C525T:p.S175S,DDR1:uc003nrv.3:exon4:c.C525T:p.S175S,DDR1:uc003nrx.2:exon4:c.C525T:p.S175S,DDR1:uc003nry.2:exon4:c.C525T:p.S175S,DDR1:uc011dmu.1:exon4:c.C525T:p.S175S,DDR1:uc003nrs.3:exon5:c.C525T:p.S175S,DDR1:uc003nrt.3:exon5:c.C525T:p.S175S,DDR1:uc010jse.3:exon5:c.C525T:p.S175S,DDR1:uc011dms.2:exon5:c.C579T:p.S193S,DDR1:uc011dmt.2:exon5:c.C603T:p.S201S,DDR1:uc003nrr.3:exon6:c.C525T:p.S175S,DDR1:uc003nrq.3:exon7:c.C525T:p.S175S	.	AFR:0.2552,AMR:0.2786,EAS:0.2384,FIN:0.5855,NFE:0.2630,OTH:0.1914,ASJ:0.4594	600408	.	.	.	.	.	.	.	.	.	.	.	6	52(meninges)	0.2770
6	30864829	30864829	T	C	DDR1	exonic	synonymous SNV	ENSG00000204580	rs1049623	ENSG00000204580:ENST00000361741:exon9:c.T909C:p.V303V,ENSG00000204580:ENST00000417521:exon9:c.T1104C:p.V368V,ENSG00000204580:ENST00000376567:exon12:c.T1797C:p.V599V,ENSG00000204580:ENST00000418800:exon13:c.T1797C:p.V599V,ENSG00000204580:ENST00000508312:exon13:c.T1851C:p.V617V,ENSG00000204580:ENST00000513240:exon13:c.T1908C:p.V636V,ENSG00000204580:ENST00000376568:exon14:c.T1908C:p.V636V,ENSG00000204580:ENST00000376569:exon14:c.T1797C:p.V599V,ENSG00000204580:ENST00000376570:exon15:c.T1797C:p.V599V,ENSG00000204580:ENST00000452441:exon15:c.T1908C:p.V636V,ENSG00000204580:ENST00000324771:exon16:c.T1908C:p.V636V,ENSG00000204580:ENST00000376575:exon16:c.T1908C:p.V636V,ENSG00000204580:ENST00000454612:exon17:c.T1797C:p.V599V	DDR1:NM_001202522:exon11:c.T1470C:p.V490V,DDR1:NM_001202523:exon13:c.T1851C:p.V617V,DDR1:NM_001297652:exon13:c.T1797C:p.V599V,DDR1:NM_001297653:exon13:c.T1797C:p.V599V,DDR1:NM_013994:exon13:c.T1908C:p.V636V,DDR1:NM_001297654:exon14:c.T1908C:p.V636V,DDR1:NM_001954:exon15:c.T1797C:p.V599V,DDR1:NM_013993:exon15:c.T1908C:p.V636V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4631	0.4071	0.535743	1(large_intestine)	.	.	.	.	.	.	.	.	DDR1:uc003nrw.1:exon9:c.T1113C:p.V371V,DDR1:uc003nrx.2:exon11:c.T1470C:p.V490V,DDR1:uc003nru.3:exon12:c.T1797C:p.V599V,DDR1:uc003nrt.3:exon13:c.T1797C:p.V599V,DDR1:uc003nrv.3:exon13:c.T1908C:p.V636V,DDR1:uc010jse.3:exon13:c.T1797C:p.V599V,DDR1:uc011dms.2:exon13:c.T1851C:p.V617V,DDR1:uc003nrs.3:exon14:c.T1908C:p.V636V,DDR1:uc003nrq.3:exon15:c.T1797C:p.V599V,DDR1:uc003nrr.3:exon15:c.T1908C:p.V636V	.	AFR:MU157872,AMR:LAML-KR|1|205|0.00487805,EAS:0.4650,FIN:0.5692,NFE:0.3808,OTH:0.6677,ASJ:0.4341	600408	.	.	.	.	.	.	.	.	.	.	.	6	1(prostate)	0.4067
6	30877202	30877202	T	C	GTF2H4	intronic	.	ENSG00000213780	rs916920	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3007	0.2074	0.407748	0.2543	.	.	.	.	.	0	0	.	.	.	AFR:0.2780,AMR:0.4581,EAS:0.5821,FIN:0.2637,NFE:0.1909,OTH:0.2751,ASJ:0.2285	601760	.	.	.	~ko03022 Basal transcription factors~ko03420 Nucleotide excision repair~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	6	.	hom
6	30877760	30877760	A	C	GTF2H4	exonic	synonymous SNV	ENSG00000213780	rs1419693	ENSG00000213780:ENST00000539324:exon3:c.A126C:p.T42T,ENSG00000213780:ENST00000259895:exon4:c.A294C:p.T98T,ENSG00000213780:ENST00000376316:exon4:c.A294C:p.T98T,ENSG00000213780:ENST00000453897:exon4:c.A294C:p.T98T	GTF2H4:NM_001517:exon4:c.A294C:p.T98T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3002	0.2076	0.407748	0.2544	.	.	.	.	.	.	.	.	GTF2H4:uc011dmv.1:exon3:c.A126C:p.T42T,GTF2H4:uc003nsa.1:exon4:c.A294C:p.T98T,GTF2H4:uc010jsf.2:exon4:c.A294C:p.T98T	.	AFR:0.2780,AMR:0.4581,EAS:0.5797,FIN:0.2629,NFE:0.1915,OTH:0.2765,ASJ:0.2285	601760	.	.	.	~ko03022 Basal transcription factors~ko03420 Nucleotide excision repair~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	6	MU16197142	het
6	31729359	31729359	A	G	MSH5	exonic	synonymous SNV	ENSG00000204410;ENSG00000255152	rs707938	ENSG00000204410:ENST00000429846:exon2:c.A162G:p.Q54Q,ENSG00000204410:ENST00000484309:exon4:c.A372G:p.Q124Q,ENSG00000204410:ENST00000395853:exon11:c.A1170G:p.Q390Q,ENSG00000204410:ENST00000431848:exon14:c.A1245G:p.Q415Q,ENSG00000204410:ENST00000375703:exon22:c.A2151G:p.Q717Q,ENSG00000204410:ENST00000375740:exon22:c.A2202G:p.Q734Q,ENSG00000204410:ENST00000375742:exon22:c.A2199G:p.Q733Q,ENSG00000204410:ENST00000375750:exon22:c.A2148G:p.Q716Q,ENSG00000204410:ENST00000375755:exon22:c.A2148G:p.Q716Q,ENSG00000255152:ENST00000493662:exon22:c.A2199G:p.Q733Q,ENSG00000204410:ENST00000534153:exon22:c.A2199G:p.Q733Q	MSH5:NM_002441:exon22:c.A2148G:p.Q716Q,MSH5:NM_025259:exon22:c.A2202G:p.Q734Q,MSH5:NM_172165:exon22:c.A2151G:p.Q717Q,MSH5:NM_172166:exon22:c.A2148G:p.Q716Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3854	0.4283	0.467252	1(kidney)	.	.	.	.	.	.	.	.	MSH5-SAPCD1:uc003nwy.1:exon10:c.A1170G:p.Q390Q,MSH5-SAPCD1:uc011dof.1:exon14:c.A1245G:p.Q415Q,MSH5-SAPCD1:uc003nwu.2:exon22:c.A2151G:p.Q717Q,MSH5-SAPCD1:uc003nwv.2:exon22:c.A2148G:p.Q716Q,MSH5-SAPCD1:uc003nww.2:exon22:c.A2148G:p.Q716Q,MSH5-SAPCD1:uc003nwx.2:exon22:c.A2202G:p.Q734Q	.	AFR:MU616434,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,EAS:0.6417,FIN:0.3866,NFE:0.3113,OTH:0.3181,ASJ:0.4219	603382	.	.	.	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.4344
6	32172065	32172065	T	G	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs1044506	ENSG00000204301:ENST00000375023:exon19:c.A2967C:p.G989G	NOTCH4:NM_004557:exon19:c.A2967C:p.G989G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9165	0.9034	0.963259	0.9054	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon19:c.A2967C:p.G989G	.	AFR:0.9704,AMR:0.9427,EAS:0.9957,FIN:0.8716,NFE:0.8629,OTH:0.8988,ASJ:0.9603	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	.	hom
6	32190390	32190390	T	G	NOTCH4	exonic	nonsynonymous SNV	ENSG00000204301	rs915894	ENSG00000204301:ENST00000375023:exon3:c.A349C:p.K117Q	NOTCH4:NM_004557:exon3:c.A349C:p.K117Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3584	0.3722	0.398762	1(lung)	-0.306	0.643	0.399	2.36	0.002	.	.	.	NOTCH4:uc003obb.3:exon3:c.A349C:p.K117Q,NOTCH4:uc003obc.3:exon3:c.A349C:p.K117Q	-0.758	AFR:1(urinary_tract),AMR:MU12600545,EAS:0.3603,FIN:0.3721,NFE:0.2542,OTH:0.3609,ASJ:LUSC-KR|2|170|0.0117647,BRCA-KR|1|50|0.02	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	0.0	-2.92	0.370	0.04	6	1(haematopoietic_and_lymphoid_tissue)	0.4819
6	32190406	32190406	A	G	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs443198	ENSG00000204301:ENST00000375023:exon3:c.T333C:p.G111G	NOTCH4:NM_004557:exon3:c.T333C:p.G111G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3804	0.4040	0.460663	2(lung)	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon3:c.T333C:p.G111G,NOTCH4:uc003obc.3:exon3:c.T333C:p.G111G	.	AFR:2(breast),AMR:MU713734,EAS:0.3795,FIN:0.4611,NFE:0.3225,OTH:0.4338,ASJ:LUSC-KR|2|170|0.0117647,BRCA-KR|1|50|0.02	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	1(urinary_tract)	0.5261
6	32190484	32190484	G	A	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs8192569	ENSG00000204301:ENST00000375023:exon3:c.C255T:p.P85P	NOTCH4:NM_004557:exon3:c.C255T:p.P85P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1414	0.1555	0.215056	1(large_intestine)	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon3:c.C255T:p.P85P,NOTCH4:uc003obc.3:exon3:c.C255T:p.P85P	.	AFR:1(breast),AMR:MU116684,EAS:0.1588,FIN:0.2985,NFE:0.1196,OTH:0.09,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	5(soft_tissue)	0.2807
6	32191643	32191643	G	A	NOTCH4	exonic	synonymous SNV	ENSG00000204301	.	ENSG00000204301:ENST00000375023:exon1:c.C63T:p.V21V	NOTCH4:NM_004557:exon1:c.C63T:p.V21V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon1:c.C63T:p.V21V,NOTCH4:uc003obc.3:exon1:c.C63T:p.V21V	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	.	hom
6	33287796	33287796	G	C	DAXX	exonic	nonsynonymous SNV	ENSG00000204209	rs146304558	ENSG00000204209:ENST00000414083:exon4:c.C1232G:p.A411G,ENSG00000204209:ENST00000266000:exon5:c.C1457G:p.A486G,ENSG00000204209:ENST00000374542:exon5:c.C1457G:p.A486G	DAXX:NM_001254717:exon4:c.C1232G:p.A411G,DAXX:NM_001141969:exon5:c.C1457G:p.A486G,DAXX:NM_001141970:exon5:c.C1493G:p.A498G,DAXX:NM_001350:exon5:c.C1457G:p.A486G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0093	0.0068	0.00858626	MU80599446	-0.816	0.039	0.119	-1.84	0.503	.	.	Leucine-rich repeat domain, L domain-like	DAXX:uc011drd.2:exon4:c.C1232G:p.A411G,DAXX:uc021ywn.1:exon4:c.C1457G:p.A486G,DAXX:uc021ywo.1:exon4:c.C1457G:p.A486G,DAXX:uc003oec.3:exon5:c.C1457G:p.A486G,DAXX:uc003oed.3:exon5:c.C1457G:p.A486G,DAXX:uc011dre.2:exon5:c.C1493G:p.A498G	-0.911	AFR:BRCA-KR|1|50|0.02,AMR:0.0046,EAS:0.0024,FIN:0.0033,NFE:0.0006,OTH:0.0014,ASJ:0.0014	603186	.	.	.	.	.	.	.	0.033	3.55	0.003	0.69	6	1(haematopoietic_and_lymphoid_tissue)	0.0076
6	33288271	33288271	A	G	DAXX	exonic	synonymous SNV	ENSG00000204209	rs1059231	ENSG00000204209:ENST00000414083:exon3:c.T912C:p.Y304Y,ENSG00000204209:ENST00000266000:exon4:c.T1137C:p.Y379Y,ENSG00000204209:ENST00000374542:exon4:c.T1137C:p.Y379Y	DAXX:NM_001254717:exon3:c.T912C:p.Y304Y,DAXX:NM_001141969:exon4:c.T1137C:p.Y379Y,DAXX:NM_001141970:exon4:c.T1173C:p.Y391Y,DAXX:NM_001350:exon4:c.T1137C:p.Y379Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2955	0.2189	0.220847	MU25113587	.	.	.	.	.	.	.	.	DAXX:uc010juw.2:exon3:c.T912C:p.Y304Y,DAXX:uc011drd.2:exon3:c.T912C:p.Y304Y,DAXX:uc021ywn.1:exon3:c.T1137C:p.Y379Y,DAXX:uc021ywo.1:exon3:c.T1137C:p.Y379Y,DAXX:uc003oec.3:exon4:c.T1137C:p.Y379Y,DAXX:uc003oed.3:exon4:c.T1137C:p.Y379Y,DAXX:uc011dre.2:exon4:c.T1173C:p.Y391Y	.	AFR:ESAD-UK|1|409|0.00244499,AMR:0.2464,EAS:0.3699,FIN:0.2450,NFE:0.2519,OTH:0.3484,ASJ:0.0532	603186	.	.	.	.	.	.	.	.	.	.	.	6	10(meninges)	0.3226
6	33288324	33288324	G	A	DAXX	exonic	nonsynonymous SNV	ENSG00000204209	rs749468991	ENSG00000204209:ENST00000414083:exon3:c.C859T:p.R287W,ENSG00000204209:ENST00000266000:exon4:c.C1084T:p.R362W,ENSG00000204209:ENST00000374542:exon4:c.C1084T:p.R362W	DAXX:NM_001254717:exon3:c.C859T:p.R287W,DAXX:NM_001141969:exon4:c.C1084T:p.R362W,DAXX:NM_001141970:exon4:c.C1120T:p.R374W,DAXX:NM_001350:exon4:c.C1084T:p.R362W	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 1, 0] 	3.319e-05	.	.	.	4.451	24.2	0.001	3.68	0.999	.	.	Leucine-rich repeat domain, L domain-like	DAXX:uc010juw.2:exon3:c.C859T:p.R287W,DAXX:uc011drd.2:exon3:c.C859T:p.R287W,DAXX:uc021ywn.1:exon3:c.C1084T:p.R362W,DAXX:uc021ywo.1:exon3:c.C1084T:p.R362W,DAXX:uc003oec.3:exon4:c.C1084T:p.R362W,DAXX:uc003oed.3:exon4:c.C1084T:p.R362W,DAXX:uc011dre.2:exon4:c.C1120T:p.R374W	-0.343	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603186	.	.	.	.	.	.	.	0.999	.	0.319	1.935	6	.	hom
6	35420483	35420483	G	A	FANCE	exonic	nonsynonymous SNV	ENSG00000112039	.	ENSG00000112039:ENST00000229769:exon1:c.G161A:p.G54D	FANCE:NM_021922:exon1:c.G161A:p.G54D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	0.011	2.693	0.519	2.35	0.638	.	.	.	FANCE:uc003oko.1:exon1:c.G161A:p.G54D,FANCE:uc010jvw.1:exon1:c.G161A:p.G54D	-1.030	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	613976	600901;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.005	0.9	0.035	0.55	6	.	hom
6	35423662	35423662	A	C	FANCE	exonic	synonymous SNV	ENSG00000112039	rs4713867	ENSG00000112039:ENST00000229769:exon2:c.A387C:p.P129P	FANCE:NM_021922:exon2:c.A387C:p.P129P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7211	0.7357	0.777955	0.7433	.	.	.	.	.	.	.	.	FANCE:uc003oko.1:exon2:c.A387C:p.P129P,FANCE:uc010jvw.1:exon2:c.A387C:p.P129P	.	AFR:0.8741,AMR:0.7995,EAS:0.6605,FIN:0.6994,NFE:0.6843,OTH:0.7255,ASJ:0.7417	613976	600901;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	6	MU18657626	hom
6	42931205	42931205	G	-	CNPY3-GNMT;GNMT	intronic	.	ENSG00000124713	rs4987175	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0980	0.1630	0.152556	0.1433	.	.	.	.	.	.	.	.	.	.	AFR:0.3305,AMR:0.0668,EAS:0.0820,FIN:0.0533,NFE:0.0732,OTH:0.0777,ASJ:0.0333	606628	606664;	289891;	289891|Glycine N-methyltransferase deficiency<br>Hypermethioninemia due to GNMT deficiency|-|-|-|606664 ~	.	.	.	.	.	.	.	.	6	.	hom
6	42931261	42931261	C	G	CNPY3-GNMT;GNMT	intronic	.	ENSG00000124713	rs2296804	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5897	0.6896	0.647364	0.6479	.	.	.	.	.	0.0014	0.014	.	.	.	AFR:0.9126,AMR:0.5574,EAS:0.3269,FIN:0.5114,NFE:0.5733,OTH:0.5758,ASJ:0.48	606628	606664;	289891;	289891|Glycine N-methyltransferase deficiency<br>Hypermethioninemia due to GNMT deficiency|-|-|-|606664 ~	.	.	.	.	.	.	.	.	6	MU20718783	hom
6	44268371	44268371	T	C	AARS2	exonic	synonymous SNV	ENSG00000124608	rs325008	ENSG00000124608:ENST00000244571:exon22:c.A2871G:p.S957S	AARS2:NM_020745:exon22:c.A2871G:p.S957S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9426	0.8711	0.869409	0.8912	.	.	.	.	.	.	.	.	AARS2:uc010jza.1:exon22:c.A2871G:p.S957S	.	AFR:0.6787,AMR:0.9606,EAS:0.9975,FIN:0.9954,NFE:0.9709,OTH:0.9469,ASJ:0.9139	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	MU4546910	hom
6	44275011	44275011	T	C	AARS2	exonic	nonsynonymous SNV	ENSG00000124608	rs324136	ENSG00000124608:ENST00000244571:exon6:c.A1015G:p.I339V	AARS2:NM_020745:exon6:c.A1015G:p.I339V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9469	0.8866	0.888978	0.9059	-0.555	0.161	0.378	2.88	0.879	.	.	Alanine-tRNA ligase, class IIc, anti-codon-binding domain|Alanyl-tRNA synthetase, class IIc, N-terminal|Alanyl-tRNA synthetase, class IIc, core domain	AARS2:uc010jza.1:exon6:c.A1015G:p.I339V	-1.086	AFR:0.7292,AMR:0.9618,EAS:0.9975,FIN:0.9954,NFE:0.9716,OTH:0.9497,ASJ:0.9139	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	0.0	-0.43	0.033	-1.04	6	MU81815212	hom
6	93967851	93967851	C	T	EPHA7	exonic	synonymous SNV	ENSG00000135333	rs345730	ENSG00000135333:ENST00000369303:exon11:c.G2076A:p.P692P	EPHA7:NM_001288629:exon11:c.G2061A:p.P687P,EPHA7:NM_004440:exon11:c.G2076A:p.P692P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7226	0.6783	0.73123	0.6823	.	.	.	.	.	.	.	.	EPHA7:uc003poe.3:exon11:c.G2076A:p.P692P,EPHA7:uc003pof.3:exon11:c.G2061A:p.P687P,EPHA7:uc011eac.2:exon11:c.G2064A:p.P688P	.	AFR:0.6010,AMR:0.6930,EAS:0.7868,FIN:0.7228,NFE:0.7056,OTH:0.7035,ASJ:0.7550	602190	.	.	.	.	.	.	.	.	.	.	.	6	MU20730318	hom
6	93982124	93982124	A	G	EPHA7	exonic	synonymous SNV	ENSG00000135333	rs345713	ENSG00000135333:ENST00000369303:exon6:c.T1341C:p.S447S	EPHA7:NM_001288629:exon6:c.T1341C:p.S447S,EPHA7:NM_004440:exon6:c.T1341C:p.S447S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8735	0.9151	0.900359	0.8912	.	.	.	.	.	.	.	.	EPHA7:uc003poe.3:exon6:c.T1341C:p.S447S,EPHA7:uc003pof.3:exon6:c.T1341C:p.S447S,EPHA7:uc011eac.2:exon6:c.T1341C:p.S447S	.	AFR:0.9733,AMR:0.8070,EAS:0.7869,FIN:0.8502,NFE:0.8689,OTH:0.8686,ASJ:0.9437	602190	.	.	.	.	.	.	.	.	.	.	.	6	MU721640	hom
6	94120192	94120192	G	A	EPHA7	UTR3	.	ENSG00000135333	rs474809	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5384	0.5549	0.632987	ESAD-UK|1|409|0.00244499,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.5908,AMR:0.7911,EAS:0.26,FIN:0.6793,NFE:0.5762,OTH:0.4763,ASJ:0.6112	602190	.	.	.	.	.	.	.	.	.	.	.	6	4(large_intestine)	0.5469
6	97000342	97000344	TTT	-	UFL1	intronic	.	ENSG00000014123	rs746589180	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0006	0.0012	.	8.335e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0002,OTH:0,ASJ:0	613372	.	.	.	.	.	.	.	.	.	.	.	6	.	unknown
6	105300262	105300262	-	AG	HACE1	intronic	.	ENSG00000085382	rs10635352	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.6682	0.6597	0.620008	0.6452	.	.	.	.	.	.	.	.	.	.	AFR:0.5858,AMR:0.6190,EAS:0.5638,FIN:0.6368,NFE:0.6865,OTH:0.6902,ASJ:0.7633	610876	616756;	464282;	464282|SPPRS syndrome<br>Spastic paraplegia-psychomotor retardation-seizures syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616756 ~	.	.	.	.	.	.	.	.	6	.	hom
6	106535813	106535815	TTT	-	PRDM1	intronic	.	ENSG00000057657	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603423	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	111695073	111695073	C	T	REV3L	exonic	synonymous SNV	ENSG00000009413	rs455645	ENSG00000009413:ENST00000368802:exon13:c.G4485A:p.S1495S,ENSG00000009413:ENST00000358835:exon14:c.G4485A:p.S1495S,ENSG00000009413:ENST00000368805:exon14:c.G4485A:p.S1495S,ENSG00000009413:ENST00000435970:exon15:c.G4251A:p.S1417S	REV3L:NM_002912:exon14:c.G4485A:p.S1495S,REV3L:NM_001286432:exon15:c.G4251A:p.S1417S,REV3L:NM_001286431:exon16:c.G4251A:p.S1417S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7159	0.6862	0.586462	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.G4485A:p.S1495S,REV3L:uc003pux.4:exon15:c.G4251A:p.S1417S,REV3L:uc003puz.4:exon15:c.G4251A:p.S1417S	.	AFR:0.6670,AMR:0.4393,EAS:0.7682,FIN:0.4651,NFE:0.6989,OTH:0.8072,ASJ:0.6826	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.7169
6	111695887	111695887	G	A	REV3L	exonic	nonsynonymous SNV	ENSG00000009413	rs462779	ENSG00000009413:ENST00000368802:exon13:c.C3671T:p.T1224I,ENSG00000009413:ENST00000358835:exon14:c.C3671T:p.T1224I,ENSG00000009413:ENST00000368805:exon14:c.C3671T:p.T1224I,ENSG00000009413:ENST00000435970:exon15:c.C3437T:p.T1146I	REV3L:NM_002912:exon14:c.C3671T:p.T1224I,REV3L:NM_001286432:exon15:c.C3437T:p.T1146I,REV3L:NM_001286431:exon16:c.C3437T:p.T1146I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7165	0.6866	0.586462	0.6672	0.396	6.577	1.0	1.45	0.417	.	.	.	REV3L:uc003puy.4:exon13:c.C3671T:p.T1224I,REV3L:uc003pux.4:exon15:c.C3437T:p.T1146I,REV3L:uc003puz.4:exon15:c.C3437T:p.T1146I	-0.991	AFR:0.4399,AMR:0.6818,EAS:0.4652,FIN:0.6987,NFE:0.8075,OTH:0.7172,ASJ:0.7667	602776	.	.	.	.	.	.	.	0.0	5.02	0.001	-1.355	6	MU4714890	hom
6	111696091	111696091	T	C	REV3L	exonic	nonsynonymous SNV	ENSG00000009413	rs458017	ENSG00000009413:ENST00000368802:exon13:c.A3467G:p.Y1156C,ENSG00000009413:ENST00000358835:exon14:c.A3467G:p.Y1156C,ENSG00000009413:ENST00000368805:exon14:c.A3467G:p.Y1156C,ENSG00000009413:ENST00000435970:exon15:c.A3233G:p.Y1078C	REV3L:NM_002912:exon14:c.A3467G:p.Y1156C,REV3L:NM_001286432:exon15:c.A3233G:p.Y1078C,REV3L:NM_001286431:exon16:c.A3233G:p.Y1078C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0572	0.0607	0.0403355	0.0558	-1.271	0.005	0.261	-4.51	0.006	.	.	Domain of unknown function DUF4683	REV3L:uc003puy.4:exon13:c.A3467G:p.Y1156C,REV3L:uc003pux.4:exon15:c.A3233G:p.Y1078C,REV3L:uc003puz.4:exon15:c.A3233G:p.Y1078C	-0.936	AFR:0.0477,AMR:0.0597,EAS:0,FIN:0.0639,NFE:0.0636,OTH:0.0562,ASJ:0.0927	602776	.	.	.	.	.	.	.	0.002	4.83	0.001	0.57	6	MU152420	hom
6	111696257	111696257	G	A	REV3L	exonic	synonymous SNV	ENSG00000009413	rs461646	ENSG00000009413:ENST00000368802:exon13:c.C3301T:p.L1101L,ENSG00000009413:ENST00000358835:exon14:c.C3301T:p.L1101L,ENSG00000009413:ENST00000368805:exon14:c.C3301T:p.L1101L,ENSG00000009413:ENST00000435970:exon15:c.C3067T:p.L1023L	REV3L:NM_002912:exon14:c.C3301T:p.L1101L,REV3L:NM_001286432:exon15:c.C3067T:p.L1023L,REV3L:NM_001286431:exon16:c.C3067T:p.L1023L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7161	0.6859	0.586661	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.C3301T:p.L1101L,REV3L:uc003pux.4:exon15:c.C3067T:p.L1023L,REV3L:uc003puz.4:exon15:c.C3067T:p.L1023L	.	AFR:MU4714901,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.4403,FIN:0.6859,NFE:0.7682,OTH:0.4633,ASJ:0.6671	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(liver)	0.6988
6	112015838	112015838	G	A	FYN	exonic	nonsynonymous SNV	ENSG00000010810	.	ENSG00000010810:ENST00000229471:exon8:c.C947T:p.A316V,ENSG00000010810:ENST00000538466:exon8:c.C1103T:p.A368V,ENSG00000010810:ENST00000229470:exon10:c.C956T:p.A319V,ENSG00000010810:ENST00000356013:exon10:c.C947T:p.A316V,ENSG00000010810:ENST00000368667:exon10:c.C1112T:p.A371V,ENSG00000010810:ENST00000368678:exon10:c.C1103T:p.A368V,ENSG00000010810:ENST00000354650:exon11:c.C1112T:p.A371V,ENSG00000010810:ENST00000368682:exon11:c.C1103T:p.A368V	FYN:NM_153048:exon8:c.C947T:p.A316V,FYN:NM_001370529:exon9:c.C1112T:p.A371V,FYN:NM_002037:exon11:c.C1112T:p.A371V,FYN:NM_153047:exon11:c.C1103T:p.A368V	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	7.280	34	0.001	5.95	0.996	.	.	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase, catalytic domain|Tyrosine-protein kinase, catalytic domain	FYN:uc010kdy.1:exon2:c.C185T:p.A62V,FYN:uc003pvh.3:exon8:c.C1103T:p.A368V,FYN:uc003pvi.3:exon8:c.C947T:p.A316V,FYN:uc003pvj.3:exon10:c.C1112T:p.A371V,FYN:uc003pvk.3:exon11:c.C1112T:p.A371V	-1.075	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	137025	.	.	.	.	.	.	.	1.0	2.63	0.092	1.5	6	.	hom
6	117678083	117678083	A	G	ROS1	intronic	.	ENSG00000047936	rs2243384	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4657	0.4254	0.394569	MU687081	.	.	.	.	.	0	0	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.4054,EAS:0.4093,FIN:0.5033,NFE:0.4882,OTH:0.4413,ASJ:0.2292	165020	.	.	.	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.4875
6	128312033	128312033	A	G	PTPRK	intronic	.	ENSG00000152894	rs12055782	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2965	0.2202	0.263179	MU806746	.	.	.	.	.	0.0002	0.024	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.2552,EAS:0.3795,FIN:0.2947,NFE:0.4038,OTH:0.3626,ASJ:0.0855	602545	.	.	.	.	.	.	.	.	.	.	.	6	1(lung)	0.3026
6	128403745	128403745	A	G	PTPRK	exonic	synonymous SNV	ENSG00000152894	rs17828130	ENSG00000152894:ENST00000368207:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368210:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368213:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368215:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368226:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368227:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000532331:exon10:c.T1614C:p.V538V	PTPRK:NM_001291983:exon9:c.T1227C:p.V409V,PTPRK:NM_001135648:exon10:c.T1614C:p.V538V,PTPRK:NM_001291981:exon10:c.T1614C:p.V538V,PTPRK:NM_001291982:exon10:c.T1614C:p.V538V,PTPRK:NM_001291984:exon10:c.T1614C:p.V538V,PTPRK:NM_002844:exon10:c.T1614C:p.V538V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5892	0.4865	0.481829	0.4893	.	.	.	.	.	.	.	.	PTPRK:uc003qbl.1:exon8:c.T1224C:p.V408V,PTPRK:uc003qbj.3:exon10:c.T1614C:p.V538V,PTPRK:uc003qbk.3:exon10:c.T1614C:p.V538V,PTPRK:uc010kfc.3:exon10:c.T1614C:p.V538V,PTPRK:uc011ebu.2:exon10:c.T1614C:p.V538V,PTPRK:uc011ebv.1:exon10:c.T1614C:p.V538V	.	AFR:0.1828,AMR:0.6918,EAS:0.5370,FIN:0.5369,NFE:0.6335,OTH:0.5806,ASJ:0.5232	602545	.	.	.	.	.	.	.	.	.	.	.	6	MU14046683	hom
6	128505559	128505559	T	C	PTPRK	intronic	.	ENSG00000152894	rs7754321	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0403	0.0694	0.0778754	0.0749	.	.	.	.	.	.	.	.	.	.	AFR:0.1912,AMR:0.0143,EAS:0.0452,FIN:0.0914,NFE:0.0136,OTH:0.0418,ASJ:0.0066	602545	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	129381026	129381026	C	A	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs4404787	ENSG00000196569:ENST00000421865:exon3:c.C381A:p.T127T	LAMA2:NM_000426:exon3:c.C381A:p.T127T,LAMA2:NM_001079823:exon3:c.C381A:p.T127T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9578	0.9473	0.936701	0.9540	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon3:c.C381A:p.T127T,LAMA2:uc003qbo.3:exon3:c.C381A:p.T127T,LAMA2:uc021zfb.1:exon3:c.C381A:p.T127T	.	AFR:0.9027,AMR:0.9773,EAS:0.9759,FIN:0.9840,NFE:0.9723,OTH:0.9644,ASJ:0.9636	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU81821229	het
6	129571330	129571330	G	A	LAMA2	exonic	nonsynonymous SNV	ENSG00000196569	rs3816665	ENSG00000196569:ENST00000421865:exon13:c.G1856A:p.R619H	LAMA2:NM_000426:exon13:c.G1856A:p.R619H,LAMA2:NM_001079823:exon13:c.G1856A:p.R619H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.1828	0.2697	0.270966	0.2530	-0.271	0.771	0.287	-5.14	0.001	.	.	Laminin IV	LAMA2:uc003qbn.3:exon13:c.G1856A:p.R619H,LAMA2:uc003qbo.3:exon13:c.G1856A:p.R619H,LAMA2:uc021zfb.1:exon13:c.G1856A:p.R619H	-1.045	AFR:0.5371,AMR:0.1089,EAS:0.0803,FIN:0.1869,NFE:0.1374,OTH:0.1762,ASJ:0.1490	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	0.004	1.26	0.036	0.895	6	MU82190846	hom
6	129612808	129612808	A	G	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs1027199	ENSG00000196569:ENST00000421865:exon20:c.A2799G:p.Q933Q	LAMA2:NM_000426:exon20:c.A2799G:p.Q933Q,LAMA2:NM_001079823:exon20:c.A2799G:p.Q933Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2683	0.2584	0.313898	0.2719	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon20:c.A2799G:p.Q933Q,LAMA2:uc003qbo.3:exon20:c.A2799G:p.Q933Q,LAMA2:uc021zfb.1:exon20:c.A2799G:p.Q933Q	.	AFR:0.3228,AMR:0.2524,EAS:0.4294,FIN:0.2984,NFE:0.2232,OTH:0.2459,ASJ:0.2067	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU105678	hom
6	129670548	129670548	C	T	LAMA2	intronic	.	ENSG00000196569	rs17057158	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0859	0.0800	0.0970447	0.0725	.	.	.	.	.	.	.	.	.	.	AFR:0.1101,AMR:0.1611,EAS:0.0284,FIN:0.0529,NFE:0.0544,OTH:0.0735,ASJ:0.1	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	.	het
6	129722389	129722389	A	G	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs3749877	ENSG00000196569:ENST00000421865:exon38:c.A5466G:p.E1822E	LAMA2:NM_000426:exon38:c.A5466G:p.E1822E,LAMA2:NM_001079823:exon38:c.A5466G:p.E1822E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4978	0.5161	0.544529	0.5112	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon38:c.A5466G:p.E1822E,LAMA2:uc003qbo.3:exon38:c.A5466G:p.E1822E,LAMA2:uc021zfb.1:exon38:c.A5466G:p.E1822E	.	AFR:0.6206,AMR:0.4845,EAS:0.5824,FIN:0.4613,NFE:0.4523,OTH:0.5051,ASJ:0.5705	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU12472152	hom
6	129722425	129722425	G	A	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs3749878	ENSG00000196569:ENST00000421865:exon38:c.G5502A:p.E1834E	LAMA2:NM_000426:exon38:c.G5502A:p.E1834E,LAMA2:NM_001079823:exon38:c.G5502A:p.E1834E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4963	0.5150	0.543331	0.5089	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon38:c.G5502A:p.E1834E,LAMA2:uc003qbo.3:exon38:c.G5502A:p.E1834E,LAMA2:uc021zfb.1:exon38:c.G5502A:p.E1834E	.	AFR:0.6208,AMR:0.4784,EAS:0.5815,FIN:0.4559,NFE:0.4496,OTH:0.5020,ASJ:0.5667	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU4554300	hom
6	129807629	129807629	C	T	LAMA2	exonic	nonsynonymous SNV	ENSG00000196569	rs2229848	ENSG00000196569:ENST00000421865:exon56:c.C7760T:p.A2587V	LAMA2:NM_001079823:exon55:c.C7748T:p.A2583V,LAMA2:NM_000426:exon56:c.C7760T:p.A2587V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.6678	0.6386	0.583866	0.6270	7.378	34	0.056	5.6	0.894	.	.	Concanavalin A-like lectin/glucanase domain|Laminin G domain	LAMA2:uc003qbo.3:exon54:c.C7742T:p.A2581V,LAMA2:uc003qbn.3:exon55:c.C7754T:p.A2585V,LAMA2:uc021zfb.1:exon56:c.C7760T:p.A2587V	0.056	AFR:0.4529,AMR:0.6878,EAS:0.6160,FIN:0.6464,NFE:0.7152,OTH:0.6851,ASJ:0.7384	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	0.998	-1.2	0.584	2.395	6	MU687237	hom
6	129807699	129807699	G	C	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs2229849	ENSG00000196569:ENST00000421865:exon56:c.G7830C:p.V2610V	LAMA2:NM_001079823:exon55:c.G7818C:p.V2606V,LAMA2:NM_000426:exon56:c.G7830C:p.V2610V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6682	0.6400	0.584265	0.6279	.	.	.	.	.	.	.	.	LAMA2:uc003qbo.3:exon54:c.G7812C:p.V2604V,LAMA2:uc003qbn.3:exon55:c.G7824C:p.V2608V,LAMA2:uc021zfb.1:exon56:c.G7830C:p.V2610V	.	AFR:0.4568,AMR:0.6894,EAS:0.6113,FIN:0.6461,NFE:0.7153,OTH:0.6857,ASJ:0.7384	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU20737955	hom
6	138195991	138195991	A	G	TNFAIP3	exonic	nonsynonymous SNV	ENSG00000118503	rs146534657	ENSG00000118503:ENST00000237289:exon3:c.A305G:p.N102S,ENSG00000118503:ENST00000420009:exon3:c.A305G:p.N102S	TNFAIP3:NM_001270507:exon3:c.A305G:p.N102S,TNFAIP3:NM_001270508:exon3:c.A305G:p.N102S,TNFAIP3:NM_006290:exon3:c.A305G:p.N102S	clinvar: not_provided 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0] 	0.0107	0.0011	0.0129792	0.0031	5.465	26.1	0.0	5.97	0.992	.	.	OTU domain	TNFAIP3:uc003qhr.4:exon3:c.A305G:p.N102S,TNFAIP3:uc003qhs.4:exon3:c.A305G:p.N102S,TNFAIP3:uc031spv.1:exon3:c.A305G:p.N102S,TNFAIP3:uc031spw.1:exon3:c.A305G:p.N102S	-0.643	AFR:0.0007,AMR:0.0549,EAS:0.0129,FIN:0.0031,NFE:0.0004,OTH:0.0051,ASJ:0	191163	616744;	.	.	.	.	.	.	1.0	1.25	0.199	2.705	6	MU81821999	hom
6	146234644	146234644	G	A	SHPRH	exonic	synonymous SNV	ENSG00000146414	rs9497426	ENSG00000146414:ENST00000275233:exon24:c.C4296T:p.C1432C,ENSG00000146414:ENST00000367503:exon24:c.C4308T:p.C1436C,ENSG00000146414:ENST00000367505:exon24:c.C4296T:p.C1432C,ENSG00000146414:ENST00000438092:exon24:c.C4308T:p.C1436C	SHPRH:NM_001042683:exon24:c.C4296T:p.C1432C,SHPRH:NM_001370327:exon24:c.C4296T:p.C1432C,SHPRH:NM_173082:exon24:c.C4308T:p.C1436C,SHPRH:NM_001370328:exon26:c.C2853T:p.C951C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7804	0.8120	0.836262	0.8023	.	.	.	.	.	.	.	.	SHPRH:uc003qlg.1:exon23:c.C2964T:p.C988C,SHPRH:uc003qle.3:exon24:c.C4308T:p.C1436C,SHPRH:uc003qlf.3:exon24:c.C4296T:p.C1432C	.	AFR:0.9376,AMR:0.8950,EAS:0.8269,FIN:0.6485,NFE:0.7536,OTH:0.7688,ASJ:0.7980	608048	.	.	.	.	.	.	.	.	.	.	.	6	MU800391	hom
6	149983216	149983216	G	A	LATS1	exonic	synonymous SNV	ENSG00000131023	rs3924871	ENSG00000131023:ENST00000253339:exon7:c.C3042T:p.D1014D,ENSG00000131023:ENST00000543571:exon8:c.C3042T:p.D1014D	LATS1:NM_001350392:exon7:c.C2202T:p.D734D,LATS1:NM_004690:exon8:c.C3042T:p.D1014D,LATS1:NM_001350340:exon9:c.C2727T:p.D909D,LATS1:NM_001350339:exon10:c.C2826T:p.D942D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4492	0.4227	0.550719	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LATS1:uc003qmu.2:exon8:c.C3042T:p.D1014D,LATS1:uc010kif.2:exon9:c.C2727T:p.D909D	.	AFR:0.4418,AMR:0.5405,EAS:0.3742,FIN:0.8296,NFE:0.3674,OTH:0.3535,ASJ:0.6346	603473	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.3998
6	150004779	150004779	A	G	LATS1	exonic	synonymous SNV	ENSG00000131023	rs3798761	ENSG00000131023:ENST00000253339:exon3:c.T1446C:p.S482S,ENSG00000131023:ENST00000392273:exon4:c.T1446C:p.S482S,ENSG00000131023:ENST00000543571:exon4:c.T1446C:p.S482S	LATS1:NM_001350392:exon3:c.T606C:p.S202S,LATS1:NM_001270519:exon4:c.T1446C:p.S482S,LATS1:NM_004690:exon4:c.T1446C:p.S482S,LATS1:NM_001350339:exon5:c.T1131C:p.S377S,LATS1:NM_001350340:exon5:c.T1131C:p.S377S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4493	0.4243	0.552316	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LATS1:uc003qmv.2:exon3:c.T1446C:p.S482S,LATS1:uc003qmu.2:exon4:c.T1446C:p.S482S,LATS1:uc003qmw.3:exon4:c.T1446C:p.S482S,LATS1:uc010kif.2:exon5:c.T1131C:p.S377S,LATS1:uc010kig.1:exon5:c.T1131C:p.S377S	.	AFR:0.4425,AMR:0.5429,EAS:0.3742,FIN:0.8317,NFE:0.3673,OTH:0.3535,ASJ:0.6376	603473	.	.	.	.	.	.	.	.	.	.	.	6	1(urinary_tract)	0.3949
6	152201875	152201875	T	C	ESR1	exonic	synonymous SNV	ENSG00000091831	rs4986934	ENSG00000091831:ENST00000415488:exon1:c.T84C:p.R28R,ENSG00000091831:ENST00000206249:exon3:c.T729C:p.R243R,ENSG00000091831:ENST00000427531:exon3:c.T210C:p.R70R,ENSG00000091831:ENST00000338799:exon4:c.T729C:p.R243R,ENSG00000091831:ENST00000443427:exon4:c.T729C:p.R243R,ENSG00000091831:ENST00000456483:exon4:c.T729C:p.R243R,ENSG00000091831:ENST00000440973:exon5:c.T729C:p.R243R	ESR1:NM_000125:exon3:c.T729C:p.R243R,ESR1:NM_001328100:exon3:c.T210C:p.R70R,ESR1:NM_001122740:exon4:c.T729C:p.R243R,ESR1:NM_001122741:exon4:c.T729C:p.R243R,ESR1:NM_001291230:exon4:c.T735C:p.R245R,ESR1:NM_001291241:exon4:c.T729C:p.R243R,ESR1:NM_001122742:exon5:c.T729C:p.R243R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9707	0.9708	0.985623	0.9679	.	.	.	.	.	.	.	.	ESR1:uc011eex.2:exon1:c.T72C:p.R24R,ESR1:uc010kis.3:exon2:c.T210C:p.R70R,ESR1:uc003qoo.4:exon3:c.T729C:p.R243R,ESR1:uc003qon.4:exon4:c.T729C:p.R243R,ESR1:uc010kin.3:exon4:c.T729C:p.R243R,ESR1:uc010kio.3:exon4:c.T735C:p.R245R,ESR1:uc010kip.3:exon4:c.T729C:p.R243R,ESR1:uc003qom.4:exon5:c.T729C:p.R243R	.	AFR:0.9929,AMR:0.9845,EAS:1,FIN:0.9562,NFE:0.9525,OTH:0.9633,ASJ:0.9437	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05224 Breast cancer ~	,4804,4803,4805	.	.	.	.	.	.	6	MU81823068	hom
6	152265522	152265522	G	C	ESR1	exonic	synonymous SNV	ENSG00000091831	rs1801132	ENSG00000091831:ENST00000206249:exon4:c.G975C:p.P325P,ENSG00000091831:ENST00000427531:exon4:c.G456C:p.P152P,ENSG00000091831:ENST00000338799:exon5:c.G975C:p.P325P,ENSG00000091831:ENST00000443427:exon5:c.G975C:p.P325P,ENSG00000091831:ENST00000440973:exon6:c.G975C:p.P325P	ESR1:NM_000125:exon4:c.G975C:p.P325P,ESR1:NM_001328100:exon4:c.G456C:p.P152P,ESR1:NM_001122740:exon5:c.G975C:p.P325P,ESR1:NM_001122741:exon5:c.G975C:p.P325P,ESR1:NM_001291230:exon5:c.G981C:p.P327P,ESR1:NM_001291241:exon5:c.G972C:p.P324P,ESR1:NM_001122742:exon6:c.G975C:p.P325P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.7362	0.8144	0.717652	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	ESR1:uc010kit.1:exon1:c.G186C:p.P62P,ESR1:uc011eey.2:exon1:c.G186C:p.P62P,ESR1:uc011eex.2:exon2:c.G318C:p.P106P,ESR1:uc003qoo.4:exon4:c.G975C:p.P325P,ESR1:uc003qon.4:exon5:c.G975C:p.P325P,ESR1:uc010kin.3:exon5:c.G975C:p.P325P,ESR1:uc010kio.3:exon5:c.G981C:p.P327P,ESR1:uc010kip.3:exon5:c.G972C:p.P324P,ESR1:uc003qom.4:exon6:c.G975C:p.P325P	.	AFR:0.7877,AMR:0.8925,EAS:0.7781,FIN:0.4950,NFE:0.7264,OTH:0.7793,ASJ:0.7124	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05224 Breast cancer ~	,4804,4803,4805	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.7505
6	152420095	152420095	G	A	ESR1	exonic	synonymous SNV	ENSG00000091831	rs2228480	ENSG00000091831:ENST00000406599:exon4:c.G999A:p.T333T,ENSG00000091831:ENST00000206249:exon8:c.G1782A:p.T594T,ENSG00000091831:ENST00000456483:exon8:c.G1446A:p.T482T,ENSG00000091831:ENST00000338799:exon9:c.G1782A:p.T594T,ENSG00000091831:ENST00000443427:exon9:c.G1782A:p.T594T,ENSG00000091831:ENST00000440973:exon10:c.G1782A:p.T594T	ESR1:NM_000125:exon8:c.G1782A:p.T594T,ESR1:NM_001122740:exon9:c.G1782A:p.T594T,ESR1:NM_001122741:exon9:c.G1782A:p.T594T,ESR1:NM_001291230:exon9:c.G1788A:p.T596T,ESR1:NM_001291241:exon9:c.G1779A:p.T593T,ESR1:NM_001122742:exon10:c.G1782A:p.T594T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.1893	0.1720	0.188698	1(lung)	.	.	.	.	.	.	.	.	ESR1:uc011eev.2:exon3:c.G537A:p.T179T,ESR1:uc021zha.1:exon3:c.G411A:p.T137T,ESR1:uc010kir.3:exon4:c.G999A:p.T333T,ESR1:uc011eex.2:exon4:c.G807A:p.T269T,ESR1:uc010kiq.3:exon5:c.G576A:p.T192T,ESR1:uc003qoo.4:exon8:c.G1782A:p.T594T,ESR1:uc003qon.4:exon9:c.G1782A:p.T594T,ESR1:uc010kin.3:exon9:c.G1782A:p.T594T,ESR1:uc010kio.3:exon9:c.G1788A:p.T596T,ESR1:uc010kip.3:exon9:c.G1779A:p.T593T,ESR1:uc003qom.4:exon10:c.G1782A:p.T594T	.	AFR:10(soft_tissue),AMR:1(stomach),EAS:LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,GACA-JP|1|585|0.0017094,FIN:0.1801,NFE:0.1520,OTH:0.2644,ASJ:MU159359	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05224 Breast cancer ~	,4804,4803,4805	.	.	.	.	.	.	6	1(breast)	0.1291
6	152464839	152464839	A	G	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs2256135	ENSG00000131018:ENST00000539504:exon9:c.T1503C:p.R501R,ENSG00000131018:ENST00000354674:exon10:c.T1572C:p.R524R,ENSG00000131018:ENST00000367257:exon18:c.T2976C:p.R992R,ENSG00000131018:ENST00000367251:exon24:c.T3873C:p.R1291R,ENSG00000131018:ENST00000356820:exon53:c.T8610C:p.R2870R,ENSG00000131018:ENST00000265368:exon138:c.T25038C:p.R8346R,ENSG00000131018:ENST00000367255:exon138:c.T25038C:p.R8346R,ENSG00000131018:ENST00000423061:exon138:c.T24894C:p.R8298R,ENSG00000131018:ENST00000341594:exon139:c.T23874C:p.R7958R,ENSG00000131018:ENST00000448038:exon139:c.T24894C:p.R8298R	SYNE1:NM_001347702:exon10:c.T1572C:p.R524R,SYNE1:NM_001347701:exon11:c.T1644C:p.R548R,SYNE1:NM_033071:exon138:c.T24894C:p.R8298R,SYNE1:NM_182961:exon138:c.T25038C:p.R8346R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6109	0.6235	0.689696	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SYNE1:uc003qoq.4:exon11:c.T1644C:p.R548R,SYNE1:uc011eez.2:exon11:c.T1644C:p.R548R,SYNE1:uc003qor.4:exon24:c.T3807C:p.R1269R,SYNE1:uc003qos.4:exon53:c.T8610C:p.R2870R,SYNE1:uc003qot.4:exon138:c.T24894C:p.R8298R,SYNE1:uc003qou.4:exon138:c.T25038C:p.R8346R	.	AFR:0.6144,AMR:0.7548,EAS:0.5927,FIN:0.6994,NFE:0.4963,OTH:0.5468,ASJ:0.7069	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.6071
6	152489294	152489294	T	C	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs998147	ENSG00000131018:ENST00000354674:exon1:c.A46G:p.S16G,ENSG00000131018:ENST00000539504:exon1:c.A46G:p.S16G	SYNE1:NM_001347702:exon1:c.A46G:p.S16G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8278	0.8572	0.867013	0.8364	2.090	16.79	0.75	2.24	0.979	.	.	.	.	-0.952	AFR:0.9369,AMR:0.8361,EAS:0.8813,FIN:0.7483,NFE:0.7964,OTH:0.8101,ASJ:0.7833	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	4.66	0.001	.	6	MU81823126	het
6	152540278	152540278	A	C	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs2147377	ENSG00000131018:ENST00000367251:exon5:c.T670G:p.F224V,ENSG00000131018:ENST00000356820:exon35:c.T5476G:p.F1826V,ENSG00000131018:ENST00000423061:exon119:c.T21691G:p.F7231V,ENSG00000131018:ENST00000265368:exon120:c.T21904G:p.F7302V,ENSG00000131018:ENST00000367255:exon120:c.T21904G:p.F7302V,ENSG00000131018:ENST00000448038:exon120:c.T21691G:p.F7231V,ENSG00000131018:ENST00000341594:exon121:c.T20740G:p.F6914V	SYNE1:NM_033071:exon119:c.T21691G:p.F7231V,SYNE1:NM_182961:exon120:c.T21904G:p.F7302V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9923	0.9931	0.995607	0.9922	-0.224	0.977	1.0	3.99	0.127	.	.	.	SYNE1:uc003qor.4:exon5:c.T604G:p.F202V,SYNE1:uc003qos.4:exon35:c.T5476G:p.F1826V,SYNE1:uc003qot.4:exon119:c.T21691G:p.F7231V,SYNE1:uc003qou.4:exon120:c.T21904G:p.F7302V	-0.974	AFR:0.9984,AMR:0.9905,EAS:1,FIN:0.9877,NFE:0.9892,OTH:0.9878,ASJ:0.9868	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.0	0.82	0.009	-2.32	6	MU81823155	hom
6	152577752	152577752	T	C	SYNE1	intronic	.	ENSG00000131018	rs17082389	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0703	0.0612	0.0764776	MU9450689	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,AMR:0.0539,EAS:0.0465,FIN:0.0960,NFE:0.1108,OTH:0.0232,ASJ:0.0637	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(upper_aerodigestive_tract)	0.0500
6	152650903	152650903	G	A	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs35085679	ENSG00000131018:ENST00000423061:exon77:c.C14704T:p.L4902L,ENSG00000131018:ENST00000265368:exon78:c.C14917T:p.L4973L,ENSG00000131018:ENST00000367255:exon78:c.C14917T:p.L4973L,ENSG00000131018:ENST00000448038:exon78:c.C14704T:p.L4902L,ENSG00000131018:ENST00000341594:exon81:c.C14158T:p.L4720L	SYNE1:NM_033071:exon77:c.C14704T:p.L4902L,SYNE1:NM_182961:exon78:c.C14917T:p.L4973L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0342	0.0394	0.033746	0.0310	.	.	.	.	.	.	.	.	SYNE1:uc010kiz.4:exon2:c.C2182T:p.L728L,SYNE1:uc003qot.4:exon77:c.C14704T:p.L4902L,SYNE1:uc003qou.4:exon78:c.C14917T:p.L4973L	.	AFR:0.0274,AMR:0.0191,EAS:0.0247,FIN:0.0135,NFE:0.0382,OTH:0.0296,ASJ:0.0497	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	MU114435003	hom
6	152665261	152665261	C	A	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs4645434	ENSG00000131018:ENST00000423061:exon73:c.G11967T:p.E3989D,ENSG00000131018:ENST00000265368:exon74:c.G12180T:p.E4060D,ENSG00000131018:ENST00000367255:exon74:c.G12180T:p.E4060D,ENSG00000131018:ENST00000448038:exon74:c.G11967T:p.E3989D,ENSG00000131018:ENST00000341594:exon76:c.G11775T:p.E3925D	SYNE1:NM_033071:exon73:c.G11967T:p.E3989D,SYNE1:NM_182961:exon74:c.G12180T:p.E4060D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5761	0.5673	0.545527	1(central_nervous_system)	0.235	5.046	0.071	-1.25	0.019	.	.	.	SYNE1:uc010kja.2:exon17:c.G2295T:p.E765D,SYNE1:uc003qot.4:exon73:c.G11967T:p.E3989D,SYNE1:uc003qou.4:exon74:c.G12180T:p.E4060D	-0.976	AFR:2(large_intestine),AMR:MU588841,EAS:0.5601,FIN:0.4517,NFE:0.6160,OTH:0.66,ASJ:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.203	1.33	0.015	0.345	6	1(skin)	0.6582
6	152675854	152675854	A	G	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs9397102	ENSG00000131018:ENST00000265368:exon67:c.T10866C:p.S3622S,ENSG00000131018:ENST00000367255:exon67:c.T10866C:p.S3622S,ENSG00000131018:ENST00000341594:exon70:c.T10779C:p.S3593S	SYNE1:NM_182961:exon67:c.T10866C:p.S3622S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5799	0.5812	0.568291	MU26896631	.	.	.	.	.	.	.	.	SYNE1:uc010kja.2:exon10:c.T981C:p.S327S,SYNE1:uc003qou.4:exon67:c.T10866C:p.S3622S	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.5777,EAS:0.6169,FIN:0.6567,NFE:0.6256,OTH:0.5568,ASJ:0.5229	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.6074
6	152694184	152694184	T	C	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs6913579	ENSG00000131018:ENST00000265368:exon59:c.A9495G:p.E3165E,ENSG00000131018:ENST00000367255:exon59:c.A9495G:p.E3165E,ENSG00000131018:ENST00000423061:exon59:c.A9516G:p.E3172E,ENSG00000131018:ENST00000448038:exon60:c.A9516G:p.E3172E,ENSG00000131018:ENST00000341594:exon62:c.A9612G:p.E3204E	SYNE1:NM_033071:exon59:c.A9516G:p.E3172E,SYNE1:NM_182961:exon59:c.A9495G:p.E3165E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4993	0.5288	0.468251	3(lung)	.	.	.	.	.	.	.	.	SYNE1:uc003qov.3:exon4:c.A729G:p.E243E,SYNE1:uc003qot.4:exon59:c.A9516G:p.E3172E,SYNE1:uc003qou.4:exon59:c.A9495G:p.E3165E	.	AFR:MU29885722,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,COCA-CN|1|321|0.00311526,EAS:0.4821,FIN:0.5276,NFE:0.5298,OTH:0.4532,ASJ:0.5133	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	2(large_intestine)	0.5040
6	152711395	152711395	T	A	SYNE1	intronic	.	ENSG00000131018	rs214943	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4440	0.4833	0.561901	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4900,AMR:0.6936,EAS:0.4305,FIN:0.7853,NFE:0.3829,OTH:0.3795,ASJ:0.3209	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(upper_aerodigestive_tract)	0.4223
6	152765727	152765727	A	-	SYNE1	intronic	.	ENSG00000131018	rs111322292	.	.	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2126	0.1541	.	0.0364	.	.	.	.	.	.	.	.	.	.	AFR:0.0220,AMR:0.0296,EAS:0.0038,FIN:0.0581,NFE:0.0478,OTH:0.0352,ASJ:0.0312	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	MU43566314	het
6	152772264	152772264	A	G	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs214976	ENSG00000131018:ENST00000367253:exon24:c.T3104C:p.V1035A,ENSG00000131018:ENST00000413186:exon24:c.T3104C:p.V1035A,ENSG00000131018:ENST00000367248:exon25:c.T3074C:p.V1025A,ENSG00000131018:ENST00000265368:exon26:c.T3104C:p.V1035A,ENSG00000131018:ENST00000367255:exon26:c.T3104C:p.V1035A,ENSG00000131018:ENST00000423061:exon26:c.T3125C:p.V1042A,ENSG00000131018:ENST00000448038:exon27:c.T3125C:p.V1042A,ENSG00000131018:ENST00000341594:exon29:c.T3302C:p.V1101A	SYNE1:NM_033071:exon26:c.T3125C:p.V1042A,SYNE1:NM_182961:exon26:c.T3104C:p.V1035A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4811	0.5325	0.607228	MU18833080	3.767	23.4	0.006	5.84	0.998	.	.	.	SYNE1:uc003qow.3:exon7:c.T989C:p.V330A,SYNE1:uc003qox.1:exon13:c.T1652C:p.V551A,SYNE1:uc010kjb.1:exon24:c.T3053C:p.V1018A,SYNE1:uc003qot.4:exon26:c.T3125C:p.V1042A,SYNE1:uc003qou.4:exon26:c.T3104C:p.V1035A	0.108	AFR:COCA-CN|5|321|0.0155763,AMR:0.5270,EAS:0.3565,FIN:0.5302,NFE:0.7779,OTH:0.3912,ASJ:0.7437	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.033	0.55	0.536	1.905	6	1(pancreas)	0.4198
6	152809527	152809527	A	T	SYNE1	intronic	.	ENSG00000131018	rs9397106	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4810	0.5072	0.589257	0.5097	.	.	.	.	.	0	0.028	.	.	.	AFR:0.6693,AMR:0.3537,EAS:0.7736,FIN:0.4046,NFE:0.4250,OTH:0.4551,ASJ:0.5232	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	MU18839010	hom
6	159188128	159188128	A	G	EZR	intronic	.	ENSG00000092820	rs2242318	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6369	0.6978	0.522963	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.6788,AMR:0.6095,EAS:0.5993,FIN:0.1592,NFE:0.8257,OTH:0.7540,ASJ:0.4149	123900	.	.	.	~ko04530 Tight junction~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko04971 Gastric acid secretion~ko05130 Pathogenic Escherichia coli infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	6	2(lung)	0.7296
6	159188282	159188282	T	G	EZR	intronic	.	ENSG00000092820	rs9364994	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1778	0.1448	0.127995	0.1478	.	.	.	.	.	.	.	.	.	.	AFR:0.0413,AMR:0.1062,EAS:0.0611,FIN:0.2310,NFE:0.1986,OTH:0.2051,ASJ:0.1457	123900	.	.	.	~ko04530 Tight junction~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko04971 Gastric acid secretion~ko05130 Pathogenic Escherichia coli infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	6	MU25189207	hom
6	159191788	159191788	C	T	EZR	intronic	.	ENSG00000092820	rs3212308	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4051	0.4257	0.33127	0.4118	.	.	.	.	.	0.0003	0.004	.	.	.	AFR:0.3299,AMR:0.2811,EAS:0.1406,FIN:0.5043,NFE:0.4736,OTH:0.4458,ASJ:0.34	123900	.	.	.	~ko04530 Tight junction~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko04971 Gastric acid secretion~ko05130 Pathogenic Escherichia coli infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	6	MU800661	het
6	160113872	160113872	A	G	SOD2	exonic	nonsynonymous SNV	ENSG00000112096	rs4880	ENSG00000112096:ENST00000337404:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000367054:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000367055:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000444946:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000452684:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000535561:exon2:c.T116C:p.V39A,ENSG00000112096:ENST00000538183:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000545162:exon2:c.T116C:p.V39A,ENSG00000112096:ENST00000546260:exon2:c.T47C:p.V16A	SOD2:NM_000636:exon2:c.T47C:p.V16A,SOD2:NM_001024465:exon2:c.T47C:p.V16A,SOD2:NM_001024466:exon2:c.T47C:p.V16A,SOD2:NM_001322814:exon2:c.T47C:p.V16A,SOD2:NM_001322815:exon2:c.T47C:p.V16A,SOD2:NM_001322816:exon2:c.T47C:p.V16A	clinvar: drug_response 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5024	0.4731	0.410743	MU140155	-0.079	1.894	0.926	3.08	0.004	.	.	.	SOD2:uc003qsg.3:exon2:c.T47C:p.V16A,SOD2:uc003qsh.3:exon2:c.T47C:p.V16A,SOD2:uc003qsi.1:exon2:c.T47C:p.V16A,SOD2:uc003qsj.3:exon2:c.T47C:p.V16A,SOD2:uc011efu.1:exon2:c.T47C:p.V16A,SOD2:uc011efv.1:exon2:c.T47C:p.V16A	-0.931	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,AMR:0.4676,EAS:0.6062,FIN:0.5397,NFE:0.1510,OTH:0.4716,ASJ:0.4235	147460	612634;	.	.	.	.	.	.	0.0	2.8	0.008	.	6	3(lung)	0.5131
6	160464289	160464289	G	A	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs894817	ENSG00000197081:ENST00000356956:exon12:c.G1590A:p.G530G	IGF2R:NM_000876:exon12:c.G1590A:p.G530G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3553	0.2971	0.423722	0.3197	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon12:c.G1590A:p.G530G	.	AFR:0.2720,AMR:0.4402,EAS:0.7655,FIN:0.2564,NFE:0.3095,OTH:0.3067,ASJ:0.2550	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	MU9524266	hom
6	160468278	160468278	A	G	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs998075	ENSG00000197081:ENST00000356956:exon16:c.A2139G:p.T713T	IGF2R:NM_000876:exon16:c.A2139G:p.T713T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5299	0.5167	0.577476	0.5485	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon16:c.A2139G:p.T713T	.	AFR:0.6179,AMR:0.5217,EAS:0.6582,FIN:0.5868,NFE:0.4919,OTH:0.5205,ASJ:0.4834	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	MU23691521	hom
6	160468383	160468383	T	C	IGF2R	intronic	.	ENSG00000197081	rs998074	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5357	0.5080	0.573083	1(liver)	.	.	.	.	.	.	.	.	.	.	AFR:MU9524334,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.6046,FIN:0.5179,NFE:0.4735,OTH:0.6611,ASJ:0.5441	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.5873
6	160494409	160494409	A	G	IGF2R	exonic	nonsynonymous SNV	ENSG00000197081	rs629849	ENSG00000197081:ENST00000356956:exon34:c.A4855G:p.R1619G	IGF2R:NM_000876:exon34:c.A4855G:p.R1619G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8963	0.9107	0.903155	0.9115	-0.274	0.760	1.0	4.43	0.492	.	.	Mannose-6-phosphate receptor binding domain	IGF2R:uc003qta.3:exon34:c.A4855G:p.R1619G	-0.945	AFR:0.9723,AMR:0.9391,EAS:0.8269,FIN:0.9097,NFE:0.8832,OTH:0.9114,ASJ:0.9570	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	0.0	4.55	0.001	.	6	MU23691754	hom
6	160505199	160505199	C	G	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs614754	ENSG00000197081:ENST00000356956:exon40:c.C6051G:p.L2017L	IGF2R:NM_000876:exon40:c.C6051G:p.L2017L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9918	0.9897	0.996006	0.9896	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon40:c.C6051G:p.L2017L	.	AFR:0.9954,AMR:0.9916,EAS:0.9994,FIN:0.9906,NFE:0.9845,OTH:0.9919,ASJ:1	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	MU81824095	hom
6	160517481	160517481	C	T	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs1803989	ENSG00000197081:ENST00000356956:exon45:c.C6666T:p.L2222L	IGF2R:NM_000876:exon45:c.C6666T:p.L2222L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1492	0.1157	0.229433	MU16856501	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon45:c.C6666T:p.L2222L	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.1453,EAS:0.2828,FIN:0.0066,NFE:0.4101,OTH:0.0844,ASJ:0.2395	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	1(lung)	0.0735
6	160524773	160524773	T	A	IGF2R	intronic	.	ENSG00000197081	rs2297370	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2408	0.1781	0.222444	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	.	.	.	.	.	0	0.016	.	.	.	AFR:0.2029,AMR:0.1047,EAS:0.1523,FIN:0.4019,NFE:0.2385,OTH:0.2235,ASJ:0.3357	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	9(soft_tissue)	0.2150
6	161807855	161807855	C	G	PRKN	exonic	nonsynonymous SNV	ENSG00000185345	rs1801582	ENSG00000185345:ENST00000366896:exon7:c.G691C:p.V231L,ENSG00000185345:ENST00000338468:exon9:c.G565C:p.V189L,ENSG00000185345:ENST00000366894:exon9:c.G565C:p.V189L,ENSG00000185345:ENST00000366897:exon9:c.G1054C:p.V352L,ENSG00000185345:ENST00000366898:exon10:c.G1138C:p.V380L	PRKN:NM_013988:exon7:c.G691C:p.V231L,PRKN:NM_013987:exon9:c.G1054C:p.V352L,PRKN:NM_004562:exon10:c.G1138C:p.V380L	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1646	0.1758	0.172125	0.1610	0.084	3.433	0.377	2.74	0.001	.	.	IBR domain	PARK2:uc011egf.2:exon5:c.G160C:p.V54L,PARK2:uc003qtz.4:exon7:c.G691C:p.V231L,PARK2:uc003qtw.4:exon8:c.G565C:p.V189L,PARK2:uc010kkd.3:exon8:c.G565C:p.V189L,PARK2:uc021zhs.1:exon8:c.G904C:p.V302L,PARK2:uc003qty.4:exon9:c.G1054C:p.V352L,PARK2:uc021zhw.1:exon9:c.G565C:p.V189L,PARK2:uc021zhy.1:exon9:c.G988C:p.V330L,PARK2:uc003qtx.4:exon10:c.G1138C:p.V380L,PARK2:uc021zhu.1:exon11:c.G1279C:p.V427L,PARK2:uc021zhv.1:exon11:c.G901C:p.V301L,PARK2:uc031sqz.1:exon12:c.G1333C:p.V445L	-1.065	AFR:0.1788,AMR:0.1304,EAS:0.0877,FIN:0.1554,NFE:0.1615,OTH:0.1439,ASJ:0.2219	602544	167000;211980;600116;607572;	548;2828;	548|-|Unknown|Multigenic/multifactorial|All ages|246300 607572 609888 610988 613223 613407 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	0.0	-2.73	0.268	-1.1	6	MU26226992	het
6	162622304	162622304	A	G	PRKN	intronic	.	ENSG00000185345	rs4709583	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9329	0.9403	0.950479	0.9475	.	.	.	.	.	.	.	.	.	.	AFR:0.9849,AMR:0.9642,EAS:0.9920,FIN:0.9473,NFE:0.9217,OTH:0.9206,ASJ:0.9536	602544	167000;211980;600116;607572;	548;2828;	548|-|Unknown|Multigenic/multifactorial|All ages|246300 607572 609888 610988 613223 613407 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	.	.	.	.	6	MU81824308	hom
6	167271716	167271716	T	C	RPS6KA2	exonic	nonsynonymous SNV	ENSG00000071242;ENSG00000249141	rs9347162	ENSG00000071242:ENST00000503859:exon2:c.A95G:p.E32G,ENSG00000071242:ENST00000510118:exon2:c.A95G:p.E32G,ENSG00000071242:ENST00000506565:exon3:c.A95G:p.E32G	RPS6KA2:NM_001006932:exon2:c.A95G:p.E32G,RPS6KA2:NM_001318936:exon2:c.A95G:p.E32G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7054	0.5814	0.607628	0.6165	0.605	8.191	0.335	3.56	0.007	.	.	.	RPS6KA2:uc003qvc.1:exon2:c.A95G:p.E32G,RPS6KA2:uc003qvd.1:exon2:c.A95G:p.E32G	-1.027	AFR:0.2480,AMR:0.7912,EAS:0.8784,FIN:0.7153,NFE:0.7601,OTH:0.7357,ASJ:0.6854	601685	.	.	.	.	.	.	.	0.0	-0.5	0.024	.	6	MU19401625	hom
6	167453519	167453519	-	TT	FGFR1OP	UTR3	.	ENSG00000272980	rs61189196	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0378	0.0167	0.0153754	0.0096	.	.	.	.	.	.	.	.	.	.	AFR:0.0197,AMR:0.0171,EAS:0.0006,FIN:0.0210,NFE:0.0025,OTH:0.0074,ASJ:0.0115	605392	.	.	.	.	.	.	.	.	.	.	.	6	.	het
7	2054273	2054273	C	T	MAD1L1	exonic	nonsynonymous SNV	ENSG00000002822	rs774196409	ENSG00000002822:ENST00000438959:exon3:c.G224A:p.R75Q,ENSG00000002822:ENST00000402746:exon11:c.G947A:p.R316Q,ENSG00000002822:ENST00000265854:exon12:c.G1223A:p.R408Q,ENSG00000002822:ENST00000399654:exon13:c.G1223A:p.R408Q,ENSG00000002822:ENST00000406869:exon13:c.G1223A:p.R408Q	MAD1L1:NM_001304524:exon11:c.G947A:p.R316Q,MAD1L1:NM_001304523:exon12:c.G1223A:p.R408Q,MAD1L1:NM_001013836:exon13:c.G1223A:p.R408Q,MAD1L1:NM_001013837:exon13:c.G1223A:p.R408Q,MAD1L1:NM_003550:exon13:c.G1223A:p.R408Q	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 0] 	8.758e-06	.	.	.	6.897	33	0.0	5.39	0.929	.	.	.	MAD1L1:uc003sle.1:exon5:c.G410A:p.R137Q,MAD1L1:uc003sli.1:exon11:c.G947A:p.R316Q,MAD1L1:uc010ksi.1:exon11:c.G1082A:p.R361Q,MAD1L1:uc010ksh.1:exon12:c.G1223A:p.R408Q,MAD1L1:uc003slf.1:exon13:c.G1223A:p.R408Q,MAD1L1:uc003slg.1:exon13:c.G1223A:p.R408Q,MAD1L1:uc003slh.1:exon13:c.G1223A:p.R408Q,MAD1L1:uc010ksj.3:exon13:c.G1223A:p.R408Q	-0.747	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602686	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04114 Oocyte meiosis~ko04914 Progesterone-mediated oocyte maturation~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	1.0	1.63	0.225	2.98	7	.	hom
7	2259055	2259055	G	A	MAD1L1	exonic	stopgain	ENSG00000002822	.	ENSG00000002822:ENST00000429625:exon3:c.C295T:p.Q99X,ENSG00000002822:ENST00000445959:exon3:c.C139T:p.Q47X,ENSG00000002822:ENST00000402746:exon4:c.C232T:p.Q78X,ENSG00000002822:ENST00000455998:exon4:c.C367T:p.Q123X,ENSG00000002822:ENST00000265854:exon5:c.C508T:p.Q170X,ENSG00000002822:ENST00000399654:exon6:c.C508T:p.Q170X,ENSG00000002822:ENST00000406869:exon6:c.C508T:p.Q170X	MAD1L1:NM_001304524:exon4:c.C232T:p.Q78X,MAD1L1:NM_001304523:exon5:c.C508T:p.Q170X,MAD1L1:NM_001013836:exon6:c.C508T:p.Q170X,MAD1L1:NM_001013837:exon6:c.C508T:p.Q170X,MAD1L1:NM_003550:exon6:c.C508T:p.Q170X	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	10.777	36	.	5.29	0.475	.	.	.	MAD1L1:uc003sli.1:exon4:c.C232T:p.Q78X,MAD1L1:uc010ksi.1:exon4:c.C367T:p.Q123X,MAD1L1:uc010ksh.1:exon5:c.C508T:p.Q170X,MAD1L1:uc003slf.1:exon6:c.C508T:p.Q170X,MAD1L1:uc003slg.1:exon6:c.C508T:p.Q170X,MAD1L1:uc003slh.1:exon6:c.C508T:p.Q170X,MAD1L1:uc010ksj.3:exon6:c.C508T:p.Q170X	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602686	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04114 Oocyte meiosis~ko04914 Progesterone-mediated oocyte maturation~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	7	.	hom
7	2290522	2290522	C	T	NUDT1	exonic	synonymous SNV	ENSG00000106268	rs1799832	ENSG00000106268:ENST00000339737:exon4:c.C357T:p.D119D,ENSG00000106268:ENST00000343985:exon4:c.C426T:p.D142D,ENSG00000106268:ENST00000356714:exon4:c.C357T:p.D119D,ENSG00000106268:ENST00000397046:exon5:c.C357T:p.D119D,ENSG00000106268:ENST00000397048:exon5:c.C426T:p.D142D,ENSG00000106268:ENST00000397049:exon5:c.C426T:p.D142D	NUDT1:NM_002452:exon4:c.C357T:p.D119D,NUDT1:NM_198953:exon4:c.C357T:p.D119D,NUDT1:NM_198954:exon4:c.C426T:p.D142D,NUDT1:NM_001367553:exon5:c.C357T:p.D119D,NUDT1:NM_198948:exon5:c.C357T:p.D119D,NUDT1:NM_198949:exon5:c.C426T:p.D142D,NUDT1:NM_198950:exon5:c.C357T:p.D119D,NUDT1:NM_198952:exon5:c.C426T:p.D142D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1767	0.1641	0.148962	0.1501	.	.	.	.	.	.	.	.	NUDT1:uc003slr.1:exon4:c.C357T:p.D119D,NUDT1:uc003slu.1:exon4:c.C426T:p.D142D,NUDT1:uc003slv.1:exon4:c.C357T:p.D119D,NUDT1:uc003slp.1:exon5:c.C426T:p.D142D,NUDT1:uc003slq.1:exon5:c.C357T:p.D119D,NUDT1:uc003sls.1:exon5:c.C426T:p.D142D,NUDT1:uc003slt.1:exon5:c.C357T:p.D119D	.	AFR:0.1077,AMR:0.2069,EAS:0.0617,FIN:0.1663,NFE:0.1751,OTH:0.1670,ASJ:0.2185	600312	.	.	.	.	.	.	.	.	.	.	.	7	MU4568734	hom
7	2962753	2962753	G	A	CARD11	intronic	.	ENSG00000198286	rs2527509	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6795	0.6346	0.505391	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.6370,AMR:0.3526,EAS:0.7550,FIN:0.3714,NFE:0.8256,OTH:0.7775,ASJ:0.6444	607210	615206;616452;	464336;357237;	464336|B-cell expansion with NF-kB and T-cell anergy disease|-|Autosomal dominant|-|616452 ~357237|SCID due to CARD11 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615206 ~	.	.	.	.	.	.	.	.	7	1(lung)	0.7383
7	2966445	2966445	T	G	CARD11	intronic	.	ENSG00000198286	rs1182136	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5711	.	0.560503	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.5294,AMR:0.3676,EAS:0.4967,FIN:0.2041,NFE:0.7129,OTH:0.6081,ASJ:0.5644	607210	615206;616452;	464336;357237;	464336|B-cell expansion with NF-kB and T-cell anergy disease|-|Autosomal dominant|-|616452 ~357237|SCID due to CARD11 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615206 ~	.	.	.	.	.	.	.	.	7	12(soft_tissue)	0.6276
7	2969680	2969680	G	A	CARD11	exonic	synonymous SNV	ENSG00000198286	rs1621509	ENSG00000198286:ENST00000355508:exon1:c.C15T:p.D5D,ENSG00000198286:ENST00000396946:exon12:c.C1599T:p.D533D	CARD11:NM_032415:exon12:c.C1599T:p.D533D,CARD11:NM_001324281:exon13:c.C1599T:p.D533D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1879	0.1715	0.102037	LUSC-KR|3|170|0.0176471	.	.	.	.	.	.	.	.	CARD11:uc003smv.3:exon12:c.C1599T:p.D533D	.	AFR:0.1820,AMR:0.0782,EAS:0.1887,FIN:0.0049,NFE:0.2924,OTH:0.2304,ASJ:0.2321	607210	615206;616452;	464336;357237;	464336|B-cell expansion with NF-kB and T-cell anergy disease|-|Autosomal dominant|-|616452 ~357237|SCID due to CARD11 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615206 ~	.	.	.	.	.	.	.	.	7	8(soft_tissue)	0.2218
7	6026775	6026775	T	C	PMS2	exonic	nonsynonymous SNV	ENSG00000122512	rs2228006	ENSG00000122512:ENST00000441476:exon8:c.A1303G:p.K435E,ENSG00000122512:ENST00000265849:exon11:c.A1621G:p.K541E,ENSG00000122512:ENST00000406569:exon11:c.A1621G:p.K541E	PMS2:NM_001322008:exon9:c.A1303G:p.K435E,PMS2:NM_001322010:exon9:c.A1060G:p.K354E,PMS2:NM_001322004:exon10:c.A1216G:p.K406E,PMS2:NM_001322006:exon10:c.A1465G:p.K489E,PMS2:NM_001322007:exon10:c.A1303G:p.K435E,PMS2:NM_001322013:exon10:c.A1048G:p.K350E,PMS2:NM_000535:exon11:c.A1621G:p.K541E,PMS2:NM_001322003:exon11:c.A1216G:p.K406E,PMS2:NM_001322005:exon11:c.A1216G:p.K406E,PMS2:NM_001322009:exon11:c.A1216G:p.K406E,PMS2:NM_001322011:exon11:c.A688G:p.K230E,PMS2:NM_001322012:exon11:c.A688G:p.K230E,PMS2:NM_001322014:exon11:c.A1621G:p.K541E,PMS2:NM_001322015:exon11:c.A1312G:p.K438E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8514	0.8704	0.883187	0.8722	-0.586	0.135	1.0	4.66	0.013	.	.	.	PMS2:uc003spj.3:exon8:c.A1303G:p.K435E,PMS2:uc011jwl.2:exon10:c.A1216G:p.K406E,PMS2:uc003spk.3:exon11:c.A1216G:p.K406E,PMS2:uc003spl.3:exon11:c.A1621G:p.K541E,PMS2:uc010ktf.2:exon11:c.A1621G:p.K541E,PMS2:uc010ktg.3:exon11:c.A688G:p.K230E	-0.949	AFR:0.9248,AMR:0.7213,EAS:0.9202,FIN:0.8447,NFE:0.8522,OTH:0.8507,ASJ:0.8974	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	0.0	1.0	0.000	-1.87	7	MU784023	hom
7	6036980	6036980	G	C	PMS2	exonic	synonymous SNV	ENSG00000122512	rs1805319	ENSG00000122512:ENST00000441476:exon4:c.C462G:p.S154S,ENSG00000122512:ENST00000265849:exon7:c.C780G:p.S260S,ENSG00000122512:ENST00000382321:exon7:c.C780G:p.S260S,ENSG00000122512:ENST00000406569:exon7:c.C780G:p.S260S	PMS2:NM_001322008:exon5:c.C462G:p.S154S,PMS2:NM_001322004:exon6:c.C375G:p.S125S,PMS2:NM_001322007:exon6:c.C462G:p.S154S,PMS2:NM_001322010:exon6:c.C375G:p.S125S,PMS2:NM_001322013:exon6:c.C207G:p.S69S,PMS2:NM_000535:exon7:c.C780G:p.S260S,PMS2:NM_001322003:exon7:c.C375G:p.S125S,PMS2:NM_001322005:exon7:c.C375G:p.S125S,PMS2:NM_001322006:exon7:c.C780G:p.S260S,PMS2:NM_001322009:exon7:c.C375G:p.S125S,PMS2:NM_001322014:exon7:c.C780G:p.S260S,PMS2:NM_001322015:exon7:c.C471G:p.S157S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8109	0.8238	0.83127	0.8205	.	.	.	.	.	.	.	.	PMS2:uc003spj.3:exon4:c.C462G:p.S154S,PMS2:uc011jwl.2:exon6:c.C375G:p.S125S,PMS2:uc003spk.3:exon7:c.C375G:p.S125S,PMS2:uc003spl.3:exon7:c.C780G:p.S260S,PMS2:uc010kte.3:exon7:c.C780G:p.S260S,PMS2:uc010ktf.2:exon7:c.C780G:p.S260S	.	AFR:0.8433,AMR:0.7031,EAS:0.9180,FIN:0.7911,NFE:0.8107,OTH:0.8010,ASJ:0.8444	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	.	.	.	.	7	MU4565970	hom
7	6431690	6431690	C	T	RAC1	intronic	.	ENSG00000136238	rs836478	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5603	0.5425	0.691494	0.5664	.	.	.	.	.	.	.	.	.	.	AFR:0.7118,AMR:0.6439,EAS:0.9142,FIN:0.4745,NFE:0.4697,OTH:0.4949,ASJ:0.3874	602048	.	.	.	~ko04010 MAPK signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04071 Sphingolipid signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04310 Wnt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko04620 Toll-like receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04972 Pancreatic secretion~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05132 Salmonella infection~ko05135 Yersinia infection~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05231 Choline metabolism in cancer~ko05416 Viral myocarditis~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	7	MU18753436	hom
7	24742436	24742436	T	C	GSDME	exonic	synonymous SNV	ENSG00000105928	rs17149912	ENSG00000105928:ENST00000430096:exon2:c.A60G:p.A20A,ENSG00000105928:ENST00000409970:exon8:c.A708G:p.A236A,ENSG00000105928:ENST00000419307:exon8:c.A708G:p.A236A,ENSG00000105928:ENST00000342947:exon9:c.A1200G:p.A400A,ENSG00000105928:ENST00000409775:exon9:c.A1200G:p.A400A,ENSG00000105928:ENST00000545231:exon11:c.A708G:p.A236A	GSDME:NM_001127454:exon8:c.A708G:p.A236A,GSDME:NM_001127453:exon9:c.A1200G:p.A400A,GSDME:NM_004403:exon9:c.A1200G:p.A400A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1961	0.1480	0.201877	MU587359	.	.	.	.	.	.	.	.	DFNA5:uc010kut.1:exon8:c.A708G:p.A236A,DFNA5:uc003sxa.1:exon9:c.A1200G:p.A400A,DFNA5:uc010kus.1:exon9:c.A1200G:p.A400A	.	AFR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.1698,EAS:0.2828,FIN:0.1755,NFE:0.2695,OTH:0.2065,ASJ:0.1289	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	7	1(lung)	0.1667
7	44112873	44112873	G	T	POLM	exonic	nonsynonymous SNV	ENSG00000122678	rs3218660	ENSG00000122678:ENST00000395831:exon9:c.C1315A:p.H439N	POLM:NM_001284330:exon9:c.C1315A:p.H439N,POLM:NM_001362683:exon11:c.C1555A:p.H519N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2448	0.2560	0.231629	0.2665	-0.151	1.381	0.0	-3.99	0.000	.	.	DNA polymerase beta, thumb domain|DNA-directed DNA polymerase X	POLM:uc003tjx.2:exon9:c.C1315A:p.H439N	-0.964	AFR:0.3080,AMR:0.2931,EAS:0.1165,FIN:0.3040,NFE:0.2494,OTH:0.2562,ASJ:0.2450	606344	.	.	.	.	.	.	.	0.0	1.71	0.000	.	7	MU67378315	hom
7	45703971	45703971	G	A	ADCY1	exonic	synonymous SNV	ENSG00000164742	rs1042009	ENSG00000164742:ENST00000432715:exon10:c.G1014A:p.T338T	ADCY1:NM_001281768:exon10:c.G1014A:p.T338T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6815	.	0.472644	MU5454033	.	.	.	.	.	.	.	.	ADCY1:uc003tnd.3:exon10:c.G1014A:p.T338T	.	AFR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.5516,EAS:0.6229,FIN:0.6490,NFE:0.2954,OTH:0.7317,ASJ:0.2343	103072	610154;	90636;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~	~ko00230 Purine metabolism~ko01100 Metabolic pathways~ko01522 Endocrine resistance~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04072 Phospholipase D signaling pathway~ko04114 Oocyte meiosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04713 Circadian entrainment~ko04714 Thermogenesis~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04727 GABAergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04913 Ovarian steroidogenesis~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04921 Oxytocin signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04976 Bile secretion~ko05032 Morphine addiction~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	7	2(breast)	0.7067
7	48008802	48008802	A	T	HUS1	intronic	.	ENSG00000136273	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603760	.	.	.	.	.	.	.	.	.	.	.	7	.	hom
7	55214348	55214348	C	T	EGFR	exonic	synonymous SNV	ENSG00000146648	rs2072454	ENSG00000146648:ENST00000275493:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000342916:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000344576:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000420316:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000442591:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000450046:exon4:c.C315T:p.N105N,ENSG00000146648:ENST00000454757:exon4:c.C315T:p.N105N	EGFR:NM_001346898:exon4:c.C474T:p.N158N,EGFR:NM_001346900:exon4:c.C315T:p.N105N,EGFR:NM_005228:exon4:c.C474T:p.N158N,EGFR:NM_201282:exon4:c.C474T:p.N158N,EGFR:NM_201283:exon4:c.C474T:p.N158N,EGFR:NM_201284:exon4:c.C474T:p.N158N	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5090	0.5151	0.475439	2(central_nervous_system)	.	.	.	.	.	.	.	.	EGFR:uc003tqh.3:exon4:c.C474T:p.N158N,EGFR:uc003tqi.3:exon4:c.C474T:p.N158N,EGFR:uc003tqj.3:exon4:c.C474T:p.N158N,EGFR:uc003tqk.3:exon4:c.C474T:p.N158N,EGFR:uc011kco.2:exon4:c.C315T:p.N105N,EGFR:uc022adm.1:exon4:c.C474T:p.N158N	.	AFR:18(soft_tissue),AMR:1(prostate),EAS:1(large_intestine),FIN:MU4807633,NFE:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205,OTH:0.5053,ASJ:1(lung)	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	3259,3212,3242,3265,,3218,3228,3216,3264,2509,2510,3244,3261,3267,3225,3227,3241,3256,3235,3229,3248,3268,3263,3245,3255,3214,3258,3213,3260,3224,3215,3231,3220,3236,3239,3222,2507,3221,2506,3247,3211,3266,3232,3223,3254,3234,3240,3251,3262,3269,3238,3252,3226,3230,2508,3219,3217,3233,3243,3237,3257,3253,3246	.	,3249,3250	.	.	.	.	7	3(haematopoietic_and_lymphoid_tissue)	0.5028
7	55229255	55229255	G	A	EGFR	exonic	nonsynonymous SNV	ENSG00000146648	rs2227983	ENSG00000146648:ENST00000455089:exon12:c.G1427A:p.R476K,ENSG00000146648:ENST00000275493:exon13:c.G1562A:p.R521K,ENSG00000146648:ENST00000342916:exon13:c.G1562A:p.R521K,ENSG00000146648:ENST00000344576:exon13:c.G1562A:p.R521K,ENSG00000146648:ENST00000442591:exon13:c.G1562A:p.R521K,ENSG00000146648:ENST00000454757:exon13:c.G1403A:p.R468K	EGFR:NM_001346941:exon7:c.G761A:p.R254K,EGFR:NM_001346897:exon12:c.G1427A:p.R476K,EGFR:NM_001346899:exon12:c.G1427A:p.R476K,EGFR:NM_001346898:exon13:c.G1562A:p.R521K,EGFR:NM_001346900:exon13:c.G1403A:p.R468K,EGFR:NM_005228:exon13:c.G1562A:p.R521K,EGFR:NM_201282:exon13:c.G1562A:p.R521K,EGFR:NM_201284:exon13:c.G1562A:p.R521K	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.2870	0.2027	0.292133	1(upper_aerodigestive_tract)	-0.782	0.047	0.927	-5.79	0.247	.	.	Growth factor receptor cysteine-rich domain|Growth factor receptor domain 4	EGFR:uc010kzg.2:exon12:c.G1427A:p.R476K,EGFR:uc022adn.1:exon12:c.G1427A:p.R476K,EGFR:uc003tqi.3:exon13:c.G1562A:p.R521K,EGFR:uc003tqj.3:exon13:c.G1562A:p.R521K,EGFR:uc003tqk.3:exon13:c.G1562A:p.R521K,EGFR:uc011kco.2:exon13:c.G1403A:p.R468K,EGFR:uc022adm.1:exon13:c.G1562A:p.R521K	-0.907	AFR:2(central_nervous_system),AMR:1(autonomic_ganglia),EAS:1(pleura),FIN:64(meninges),NFE:MU150493,OTH:LAML-KR|1|205|0.00487805,LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611,ASJ:1(haematopoietic_and_lymphoid_tissue)	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	3259,3212,3242,3265,,3218,3228,3216,3264,2509,2510,3244,3261,3267,3225,3227,3241,3256,3235,3229,3248,3268,3263,3245,3255,3214,3258,3213,3260,3224,3215,3231,3220,3236,3239,3222,2507,3221,2506,3247,3211,3266,3232,3223,3254,3234,3240,3251,3262,3269,3238,3252,3226,3230,2508,3219,3217,3233,3243,3237,3257,3253,3246	.	,3249,3250	0.0	1.63	0.000	0.23	7	1(thyroid)	0.2326
7	55249063	55249063	G	A	EGFR	exonic	synonymous SNV	ENSG00000146648	rs1050171	ENSG00000146648:ENST00000455089:exon19:c.G2226A:p.Q742Q,ENSG00000146648:ENST00000275493:exon20:c.G2361A:p.Q787Q,ENSG00000146648:ENST00000454757:exon20:c.G2202A:p.Q734Q	EGFR:NM_001346941:exon14:c.G1560A:p.Q520Q,EGFR:NM_001346897:exon19:c.G2226A:p.Q742Q,EGFR:NM_001346899:exon19:c.G2226A:p.Q742Q,EGFR:NM_001346898:exon20:c.G2361A:p.Q787Q,EGFR:NM_001346900:exon20:c.G2202A:p.Q734Q,EGFR:NM_005228:exon20:c.G2361A:p.Q787Q	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5228	0.5424	0.432708	2(breast)	.	.	.	.	.	.	.	.	EGFR:uc022ado.1:exon1:c.G66A:p.Q22Q,EGFR:uc010kzg.2:exon19:c.G2226A:p.Q742Q,EGFR:uc022adn.1:exon19:c.G2226A:p.Q742Q,EGFR:uc003tqk.3:exon20:c.G2361A:p.Q787Q,EGFR:uc011kco.2:exon20:c.G2202A:p.Q734Q,EGFR:uc022adm.1:exon20:c.G2361A:p.Q787Q	.	AFR:2(biliary_tract),AMR:MU13012522,EAS:0.5005,FIN:0.4162,NFE:0.5692,OTH:0.6589,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	3259,3212,3242,3370,3265,,3218,3228,3216,3264,2509,2510,3244,3261,3267,3225,3227,3241,3256,3235,3229,3248,3268,3263,3245,3255,3214,3258,3213,2682,3260,3224,3215,3231,3220,3236,3239,3222,2507,3221,2506,3247,3211,3266,3232,3223,3254,3234,3240,3251,3262,3269,3238,3252,3226,3230,2508,3219,2712,3217,3233,3237,3243,3257,3253,3246	.	,3249,3250	.	.	.	.	7	15(meninges)	0.1743
7	55266417	55266417	T	C	EGFR	exonic	synonymous SNV	ENSG00000146648	rs1140475	ENSG00000146648:ENST00000455089:exon22:c.T2574C:p.T858T,ENSG00000146648:ENST00000275493:exon23:c.T2709C:p.T903T,ENSG00000146648:ENST00000454757:exon23:c.T2550C:p.T850T	EGFR:NM_001346941:exon17:c.T1908C:p.T636T,EGFR:NM_001346897:exon22:c.T2574C:p.T858T,EGFR:NM_001346899:exon22:c.T2574C:p.T858T,EGFR:NM_001346898:exon23:c.T2709C:p.T903T,EGFR:NM_001346900:exon23:c.T2550C:p.T850T,EGFR:NM_005228:exon23:c.T2709C:p.T903T	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8957	0.8891	0.916733	SKCA-BR|1|100|0.01,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	EGFR:uc010kzg.2:exon22:c.T2574C:p.T858T,EGFR:uc022adn.1:exon22:c.T2574C:p.T858T,EGFR:uc003tqk.3:exon23:c.T2709C:p.T903T,EGFR:uc011kco.2:exon23:c.T2550C:p.T850T,EGFR:uc022adm.1:exon23:c.T2709C:p.T903T	.	AFR:0.8922,AMR:0.9260,EAS:0.9139,FIN:0.9228,NFE:0.8832,OTH:0.8703,ASJ:0.9103	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	3259,3212,3242,3265,,3218,3228,3216,3264,2509,2510,3244,3261,3267,3225,3227,3241,3256,3235,3229,3248,3268,3263,3245,3255,3214,3258,3213,3260,3224,3215,3231,3220,3236,3239,3222,2507,3221,2506,3247,3211,3266,3232,3223,3254,3234,3240,3251,3262,3269,3238,3252,3226,3230,2508,3219,3217,3233,3243,3237,3257,3253,3246	.	,3249,3250	.	.	.	.	7	3(lung)	0.8878
7	73470782	73470782	C	T	ELN	intronic	.	ENSG00000049540	rs2856728	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7895	0.7932	0.756589	0.7980	.	.	.	.	.	.	.	.	.	.	AFR:0.7664,AMR:0.7739,EAS:0.6866,FIN:0.8373,NFE:0.8203,OTH:0.7898,ASJ:0.8377	130160	123700;185500;	3193;90348;	3193|SVAS|1-5 / 10 000|Autosomal dominant|All ages|185500 ~90348|ADCL|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123700 614434 616603 ~	.	.	.	.	.	.	.	.	7	MU81832477	hom
7	75145411	75145411	T	C	PMS2P3	ncRNA_intronic	.	ENSG00000127957	rs794378	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9744	.	0.975839	0.9805	.	.	.	.	.	.	.	.	.	.	AFR:0.9886,AMR:0.9592,EAS:0.9507,FIN:0.9616,NFE:0.9844,OTH:0.9774,ASJ:0.9966	.	.	.	.	.	.	.	.	.	.	.	.	7	.	hom
7	75610877	75610877	G	T	POR	exonic	synonymous SNV	ENSG00000127948	.	ENSG00000127948:ENST00000454934:exon5:c.G559T:p.G187C	POR:NM_000941:exon7:c.G684T:p.P228P,POR:NM_001367562:exon8:c.G684T:p.P228P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	POR:uc011kgc.2:exon2:c.G108T:p.P36P,POR:uc003udy.3:exon7:c.G684T:p.P228P	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	.	.	.	.	7	.	hom
7	75615075	75615075	A	T	POR	exonic	nonsynonymous SNV	ENSG00000127948	.	ENSG00000127948:ENST00000439269:exon7:c.A791T:p.K264M,ENSG00000127948:ENST00000545601:exon8:c.A1001T:p.K334M,ENSG00000127948:ENST00000450476:exon9:c.A1274T:p.K425M,ENSG00000127948:ENST00000394893:exon13:c.A1577T:p.K526M,ENSG00000127948:ENST00000461988:exon13:c.A1577T:p.K526M	POR:NM_000941:exon13:c.A1577T:p.K526M,POR:NM_001367562:exon14:c.A1577T:p.K526M	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	4.249	23.9	0.001	4.5	0.993	.	.	.	POR:uc011kge.2:exon7:c.A791T:p.K264M,POR:uc011kgc.2:exon8:c.A1001T:p.K334M,POR:uc003udy.3:exon13:c.A1577T:p.K526M	-0.310	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	0.024	-1.05	0.369	2.94	7	.	hom
7	77756580	77756580	T	C	MAGI2	exonic	synonymous SNV	ENSG00000187391	rs2074641	ENSG00000187391:ENST00000419488:exon18:c.A3315G:p.L1105L,ENSG00000187391:ENST00000354212:exon19:c.A3357G:p.L1119L,ENSG00000187391:ENST00000522391:exon19:c.A3357G:p.L1119L	MAGI2:NM_001301128:exon18:c.A3315G:p.L1105L,MAGI2:NM_012301:exon19:c.A3357G:p.L1119L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8248	0.8840	0.786542	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	MAGI2:uc010ldx.1:exon14:c.A2136G:p.L712L,MAGI2:uc003ugy.3:exon18:c.A3315G:p.L1105L,MAGI2:uc003ugx.3:exon19:c.A3357G:p.L1119L	.	AFR:0.8715,AMR:0.9082,EAS:0.8013,FIN:0.6043,NFE:0.8788,OTH:0.8868,ASJ:0.7362	606382	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.8615
7	77756724	77756724	C	T	MAGI2	exonic	synonymous SNV	ENSG00000187391	rs7812015	ENSG00000187391:ENST00000419488:exon18:c.G3171A:p.S1057S,ENSG00000187391:ENST00000354212:exon19:c.G3213A:p.S1071S,ENSG00000187391:ENST00000522391:exon19:c.G3213A:p.S1071S	MAGI2:NM_001301128:exon18:c.G3171A:p.S1057S,MAGI2:NM_012301:exon19:c.G3213A:p.S1071S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8244	0.8840	0.786342	MU116389	.	.	.	.	.	.	.	.	MAGI2:uc010ldx.1:exon14:c.G1992A:p.S664S,MAGI2:uc003ugy.3:exon18:c.G3171A:p.S1057S,MAGI2:uc003ugx.3:exon19:c.G3213A:p.S1071S	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.8715,EAS:0.7380,FIN:0.8013,NFE:0.6032,OTH:0.8789,ASJ:0.9082	606382	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.8869
7	80300353	80300353	T	C	CD36	exonic	synonymous SNV	ENSG00000135218	rs188717259	ENSG00000135218:ENST00000433696:exon6:c.T762C:p.F254F,ENSG00000135218:ENST00000538969:exon7:c.T699C:p.F233F,ENSG00000135218:ENST00000419819:exon8:c.T879C:p.F293F,ENSG00000135218:ENST00000534394:exon8:c.T651C:p.F217F,ENSG00000135218:ENST00000432207:exon9:c.T879C:p.F293F,ENSG00000135218:ENST00000309881:exon10:c.T879C:p.F293F,ENSG00000135218:ENST00000394788:exon10:c.T879C:p.F293F,ENSG00000135218:ENST00000447544:exon10:c.T879C:p.F293F,ENSG00000135218:ENST00000435819:exon13:c.T879C:p.F293F	CD36:NM_001289908:exon6:c.T762C:p.F254F,CD36:NM_001371080:exon7:c.T414C:p.F138F,CD36:NM_001127444:exon8:c.T879C:p.F293F,CD36:NM_001289909:exon8:c.T699C:p.F233F,CD36:NM_001289911:exon8:c.T651C:p.F217F,CD36:NM_001127443:exon9:c.T879C:p.F293F,CD36:NM_000072:exon10:c.T879C:p.F293F,CD36:NM_001001547:exon10:c.T879C:p.F293F,CD36:NM_001001548:exon10:c.T879C:p.F293F,CD36:NM_001371074:exon10:c.T879C:p.F293F,CD36:NM_001371075:exon10:c.T879C:p.F293F,CD36:NM_001371077:exon10:c.T879C:p.F293F,CD36:NM_001371078:exon10:c.T879C:p.F293F,CD36:NM_001371079:exon10:c.T777C:p.F259F,CD36:NM_001371081:exon10:c.T414C:p.F138F	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0065	0.0003	0.0111821	0.0011	.	.	.	.	.	.	.	.	CD36:uc022agu.1:exon6:c.T762C:p.F254F,CD36:uc022agv.1:exon7:c.T699C:p.F233F,CD36:uc003uhh.4:exon8:c.T879C:p.F293F,CD36:uc011kgv.2:exon8:c.T651C:p.F217F,CD36:uc003uhg.4:exon9:c.T879C:p.F293F,CD36:uc003uhd.4:exon10:c.T879C:p.F293F,CD36:uc003uhe.4:exon10:c.T879C:p.F293F,CD36:uc003uhf.4:exon10:c.T879C:p.F293F,CD36:uc003uhc.3:exon13:c.T879C:p.F293F	.	AFR:0.0002,AMR:0,EAS:0.0074,FIN:0.0011,NFE:0.0008,OTH:0.0051,ASJ:0	173510	608404;610938;611162;	673;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~	.	.	.	.	.	.	.	.	7	.	hom
7	81346685	81346685	T	C	HGF	intronic	.	ENSG00000019991	rs1800793	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8053	0.7530	0.798323	0.7671	.	.	.	.	.	0.0002	0.044	.	.	.	AFR:0.6746,AMR:0.8675,EAS:0.8335,FIN:0.7857,NFE:0.7983,OTH:0.8136,ASJ:0.8825	142409	608265;	90636;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05144 Malaria~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	7	MU26259331	hom
7	87032613	87032613	A	G	ABCB4	intronic	.	ENSG00000005471	rs31653	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8775	0.9234	0.879992	0.9026	.	.	.	.	.	.	.	.	.	.	AFR:0.9733,AMR:0.8361,EAS:0.7247,FIN:0.8706,NFE:0.8926,OTH:0.8878,ASJ:0.9139	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	MU20973608	hom
7	87053206	87053206	G	A	ABCB4	intronic	.	ENSG00000005471	rs31668	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8990	0.9260	0.873602	0.9132	.	.	.	.	.	.	.	.	.	.	AFR:0.9313,AMR:0.8840,EAS:0.7120,FIN:0.9407,NFE:0.9191,OTH:0.9224,ASJ:0.9139	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	MU20974205	het
7	87081037	87081037	-	A	ABCB4	exonic	frameshift insertion	ENSG00000005471	.	ENSG00000005471:ENST00000453593:exon6:c.609dupT:p.A204fs,ENSG00000005471:ENST00000545634:exon6:c.609dupT:p.A204fs,ENSG00000005471:ENST00000265723:exon7:c.609dupT:p.A204fs,ENSG00000005471:ENST00000358400:exon7:c.609dupT:p.A204fs,ENSG00000005471:ENST00000359206:exon7:c.609dupT:p.A204fs	ABCB4:NM_000443:exon7:c.609dupT:p.A204fs,ABCB4:NM_018849:exon7:c.609dupT:p.A204fs,ABCB4:NM_018850:exon7:c.609dupT:p.A204fs	clinvar: Pathogenic 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 1, 2, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	ABCB4:uc003uiv.1:exon7:c.609dupT:p.A204fs,ABCB4:uc003uiw.1:exon7:c.609dupT:p.A204fs,ABCB4:uc003uix.1:exon7:c.609dupT:p.A204fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	MU115180530	hom
7	87082292	87082292	G	A	ABCB4	exonic	synonymous SNV	ENSG00000005471	rs1202283	ENSG00000005471:ENST00000453593:exon5:c.C504T:p.N168N,ENSG00000005471:ENST00000545634:exon5:c.C504T:p.N168N,ENSG00000005471:ENST00000265723:exon6:c.C504T:p.N168N,ENSG00000005471:ENST00000358400:exon6:c.C504T:p.N168N,ENSG00000005471:ENST00000359206:exon6:c.C504T:p.N168N	ABCB4:NM_000443:exon6:c.C504T:p.N168N,ABCB4:NM_018849:exon6:c.C504T:p.N168N,ABCB4:NM_018850:exon6:c.C504T:p.N168N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4765	0.4041	0.347843	MU149931	.	.	.	.	.	.	.	.	ABCB4:uc003uiy.3:exon5:c.C504T:p.N168N,ABCB4:uc003uiv.1:exon6:c.C504T:p.N168N,ABCB4:uc003uiw.1:exon6:c.C504T:p.N168N,ABCB4:uc003uix.1:exon6:c.C504T:p.N168N	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.4295,EAS:0.4356,FIN:0.4267,NFE:0.3747,OTH:0.6479,ASJ:0.1106	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	1(urinary_tract)	0.5617
7	87092185	87092185	G	A	ABCB4	exonic	synonymous SNV	ENSG00000005471	rs2302387	ENSG00000005471:ENST00000453593:exon3:c.C175T:p.L59L,ENSG00000005471:ENST00000545634:exon3:c.C175T:p.L59L,ENSG00000005471:ENST00000265723:exon4:c.C175T:p.L59L,ENSG00000005471:ENST00000358400:exon4:c.C175T:p.L59L,ENSG00000005471:ENST00000359206:exon4:c.C175T:p.L59L,ENSG00000005471:ENST00000417608:exon7:c.C175T:p.L59L	ABCB4:NM_000443:exon4:c.C175T:p.L59L,ABCB4:NM_018849:exon4:c.C175T:p.L59L,ABCB4:NM_018850:exon4:c.C175T:p.L59L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1752	0.2420	0.252396	0.2271	.	.	.	.	.	.	.	.	ABCB4:uc003uiy.3:exon3:c.C175T:p.L59L,ABCB4:uc003uiv.1:exon4:c.C175T:p.L59L,ABCB4:uc003uiw.1:exon4:c.C175T:p.L59L,ABCB4:uc003uix.1:exon4:c.C175T:p.L59L	.	AFR:0.4392,AMR:0.1635,EAS:0.1898,FIN:0.1370,NFE:0.1380,OTH:0.1578,ASJ:0.1788	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	MU749307	hom
7	87105276	87105276	G	C	ABCB4	upstream	.	ENSG00000005471	rs2071645	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.340655	0.2938	.	.	.	.	.	.	.	.	.	.	AFR:0.5594,AMR:0.2248,EAS:0.2562,FIN:0.1926,NFE:0.1793,OTH:0.2058,ASJ:0.1854	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	.	het
7	91632306	91632306	C	T	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs1989779	ENSG00000127914:ENST00000356239:exon8:c.C3075T:p.T1025T,ENSG00000127914:ENST00000358100:exon9:c.C3111T:p.T1037T,ENSG00000127914:ENST00000359028:exon9:c.C3111T:p.T1037T	AKAP9:NM_005751:exon8:c.C3075T:p.T1025T,AKAP9:NM_147185:exon8:c.C3075T:p.T1025T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8924	0.9064	0.935903	0.8912	.	.	.	.	.	.	.	.	AKAP9:uc003uli.3:exon1:c.C1950T:p.T650T,AKAP9:uc003ulf.3:exon8:c.C3075T:p.T1025T,AKAP9:uc003ulg.3:exon8:c.C3075T:p.T1025T,AKAP9:uc003ule.2:exon9:c.C3111T:p.T1037T	.	AFR:0.9731,AMR:0.9284,EAS:0.9728,FIN:0.8373,NFE:0.8471,OTH:0.8678,ASJ:0.8676	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	MU81834056	hom
7	91714911	91714911	C	T	AKAP9	exonic	nonsynonymous SNV	ENSG00000127914	rs1063242	ENSG00000127914:ENST00000394534:exon10:c.C2473T:p.P825S,ENSG00000127914:ENST00000358100:exon35:c.C8785T:p.P2929S,ENSG00000127914:ENST00000356239:exon36:c.C8935T:p.P2979S,ENSG00000127914:ENST00000359028:exon36:c.C8947T:p.P2983S	AKAP9:NM_005751:exon36:c.C8935T:p.P2979S,AKAP9:NM_147185:exon36:c.C8911T:p.P2971S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9962	0.9974	0.998802	0.9959	-0.130	1.518	1.0	2.47	0.977	.	.	.	AKAP9:uc003ulk.3:exon4:c.C760T:p.P254S,AKAP9:uc003ulj.3:exon10:c.C2245T:p.P749S,AKAP9:uc003uli.3:exon29:c.C7804T:p.P2602S,AKAP9:uc003ulf.3:exon36:c.C8911T:p.P2971S,AKAP9:uc003ulg.3:exon36:c.C8935T:p.P2979S	-1.027	AFR:0.9997,AMR:1,EAS:1,FIN:0.9920,NFE:0.9942,OTH:0.9908,ASJ:1	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.0	4.21	0.000	-2.075	7	MU81834100	hom
7	95800820	95800820	T	C	SLC25A13	exonic	synonymous SNV	ENSG00000004864	rs2301629	ENSG00000004864:ENST00000542654:exon11:c.A870G:p.L290L,ENSG00000004864:ENST00000265631:exon12:c.A1194G:p.L398L,ENSG00000004864:ENST00000416240:exon12:c.A1197G:p.L399L	SLC25A13:NM_001160210:exon12:c.A1197G:p.L399L,SLC25A13:NM_014251:exon12:c.A1194G:p.L398L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3958	0.3202	0.409145	0.3492	.	.	.	.	.	.	.	.	SLC25A13:uc011kik.2:exon11:c.A870G:p.L290L,SLC25A13:uc003uof.4:exon12:c.A1194G:p.L398L,SLC25A13:uc003uog.4:exon12:c.A1197G:p.L399L	.	AFR:0.2530,AMR:0.3612,EAS:0.5739,FIN:0.3732,NFE:0.3748,OTH:0.3806,ASJ:0.2450	603859	603471;605814;	247598;247585;	247598|NICCD<br>Neonatal intrahepatic cholestasis caused by citrin deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|605814 ~247585|Adult-onset citrin deficiency<br>Adult-onset type 2 citrullinemia<br>Adult-onset type II citrullinemia<br>CTLN2<br>Citrullinemia type 2|Unknown|Autosomal recessive|Adult|603471 ~	.	.	.	.	.	.	.	.	7	MU138872	hom
7	98490098	98490098	C	T	TRRAP	exonic	nonsynonymous SNV	ENSG00000196367	rs782635647	ENSG00000196367:ENST00000446306:exon4:c.C313T:p.H105Y,ENSG00000196367:ENST00000355540:exon5:c.C313T:p.H105Y,ENSG00000196367:ENST00000359863:exon5:c.C313T:p.H105Y	TRRAP:NM_001244580:exon5:c.C313T:p.H105Y,TRRAP:NM_003496:exon5:c.C313T:p.H105Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	8.241e-06	.	.	.	2.097	16.83	1.0	5.97	0.994	.	.	Armadillo-like helical|Armadillo-type fold	TRRAP:uc003upp.3:exon5:c.C313T:p.H105Y,TRRAP:uc011kis.2:exon5:c.C313T:p.H105Y	-0.829	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603015	.	.	.	.	.	.	.	0.908	3.57	0.266	0.805	7	.	hom
7	98558880	98558880	G	C	TRRAP	intronic	.	ENSG00000196367	rs160384	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9007	0.9160	0.886981	0.9051	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.9094,AMR:0.8616,EAS:0.7432,FIN:0.9255,NFE:0.9166,OTH:0.9175,ASJ:0.9139	603015	.	.	.	.	.	.	.	.	.	.	.	7	MU18827407	hom
7	103202363	103202363	A	T	RELN	exonic	nonsynonymous SNV	ENSG00000189056	rs200364591	ENSG00000189056:ENST00000343529:exon35:c.T5248A:p.Y1750N,ENSG00000189056:ENST00000424685:exon35:c.T5248A:p.Y1750N,ENSG00000189056:ENST00000428762:exon35:c.T5248A:p.Y1750N	RELN:NM_005045:exon35:c.T5248A:p.Y1750N,RELN:NM_173054:exon35:c.T5248A:p.Y1750N	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	8.374e-06	.	0.000199681	.	4.695	24.6	0.184	5.78	0.962	.	.	Galactose-binding domain-like|Sialidases	RELN:uc010liz.3:exon35:c.T5248A:p.Y1750N,RELN:uc022ajq.1:exon35:c.T5248A:p.Y1750N,RELN:uc022ajr.1:exon35:c.T5248A:p.Y1750N	-1.052	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	0.997	2.05	0.123	2.085	7	.	hom
7	103389954	103389954	A	G	RELN	intronic	.	ENSG00000189056	rs607755	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4960	0.5108	0.465455	2(breast)	.	.	.	.	.	0	0	.	.	.	AFR:MU44519711,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.4444,FIN:0.4093,NFE:0.5265,OTH:0.3883,ASJ:0.4905	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	2(haematopoietic_and_lymphoid_tissue)	0.4585
7	106508978	106508978	A	G	PIK3CG	exonic	synonymous SNV	ENSG00000105851	rs849389	ENSG00000105851:ENST00000359195:exon2:c.A972G:p.P324P,ENSG00000105851:ENST00000440650:exon2:c.A972G:p.P324P,ENSG00000105851:ENST00000496166:exon2:c.A972G:p.P324P	PIK3CG:NM_001282426:exon2:c.A972G:p.P324P,PIK3CG:NM_001282427:exon2:c.A972G:p.P324P,PIK3CG:NM_002649:exon2:c.A972G:p.P324P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9490	0.9174	0.939497	0.9283	.	.	.	.	.	.	.	.	PIK3CG:uc003vdu.3:exon2:c.A972G:p.P324P,PIK3CG:uc003vdv.4:exon2:c.A972G:p.P324P,PIK3CG:uc003vdw.3:exon2:c.A972G:p.P324P	.	AFR:0.8501,AMR:0.9664,EAS:0.9981,FIN:0.9607,NFE:0.9549,OTH:0.9389,ASJ:0.9636	601232	.	.	.	.	.	.	.	.	.	.	.	7	MU81838218	unknown
7	106508987	106508987	T	C	PIK3CG	exonic	synonymous SNV	ENSG00000105851	rs849390	ENSG00000105851:ENST00000359195:exon2:c.T981C:p.D327D,ENSG00000105851:ENST00000440650:exon2:c.T981C:p.D327D,ENSG00000105851:ENST00000496166:exon2:c.T981C:p.D327D	PIK3CG:NM_001282426:exon2:c.T981C:p.D327D,PIK3CG:NM_001282427:exon2:c.T981C:p.D327D,PIK3CG:NM_002649:exon2:c.T981C:p.D327D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9502	0.9187	0.940895	0.9295	.	.	.	.	.	.	.	.	PIK3CG:uc003vdu.3:exon2:c.T981C:p.D327D,PIK3CG:uc003vdv.4:exon2:c.T981C:p.D327D,PIK3CG:uc003vdw.3:exon2:c.T981C:p.D327D	.	AFR:0.8507,AMR:0.9665,EAS:0.9981,FIN:0.9613,NFE:0.9568,OTH:0.9420,ASJ:0.9636	601232	.	.	.	.	.	.	.	.	.	.	.	7	MU81838233	unknown
7	106509331	106509331	C	A	PIK3CG	exonic	nonsynonymous SNV	ENSG00000105851	rs17847825	ENSG00000105851:ENST00000359195:exon2:c.C1325A:p.S442Y,ENSG00000105851:ENST00000440650:exon2:c.C1325A:p.S442Y,ENSG00000105851:ENST00000496166:exon2:c.C1325A:p.S442Y	PIK3CG:NM_001282426:exon2:c.C1325A:p.S442Y,PIK3CG:NM_001282427:exon2:c.C1325A:p.S442Y,PIK3CG:NM_002649:exon2:c.C1325A:p.S442Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1176	0.0797	0.116014	1(thyroid)	3.635	23.2	0.013	5.51	0.150	.	.	C2 domain|Phosphatidylinositol 3-kinase, C2 domain	PIK3CG:uc003vdu.3:exon2:c.C1325A:p.S442Y,PIK3CG:uc003vdv.4:exon2:c.C1325A:p.S442Y,PIK3CG:uc003vdw.3:exon2:c.C1325A:p.S442Y	-1.151	AFR:MU130656,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,EAS:0.0215,FIN:0.0549,NFE:0.1325,OTH:0.1706,ASJ:0.0853	601232	.	.	.	.	.	.	.	0.984	-1.12	0.001	1.935	7	1(large_intestine)	0.1151
7	107414419	107414419	A	G	SLC26A3	exonic	synonymous SNV	ENSG00000091138	rs41669	ENSG00000091138:ENST00000340010:exon17:c.T1953C:p.L651L	SLC26A3:NM_000111:exon17:c.T1953C:p.L651L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9936	0.9916	0.998003	0.9937	.	.	.	.	.	.	.	.	SLC26A3:uc003ver.2:exon17:c.T1953C:p.L651L	.	AFR:0.9974,AMR:0.9928,EAS:1,FIN:0.9977,NFE:0.9899,OTH:0.9939,ASJ:1	126650	214700;	53689;	53689|-|-|Autosomal recessive|-|214700 ~	.	.	.	.	.	.	.	.	7	MU81838359	hom
7	107545799	107545799	T	C	DLD	intronic	.	ENSG00000091140	rs10263341	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6182	0.6485	0.716054	0.6630	.	.	.	.	.	0.0308	0.07	.	.	.	AFR:0.7964,AMR:0.5635,EAS:0.8418,FIN:0.6017,NFE:0.5913,OTH:0.6053,ASJ:0.5728	238331	246900;	2394;765;	2394|DLD deficiency<br>Dihydrolipoamide dehydrogenase deficiency<br>E3-deficient maple syrup urine disease|<1 / 1 000 000|Autosomal recessive|Childhood|246900 ~765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~	.	.	.	.	.	.	.	.	7	MU713564	hom
7	116397572	116397572	A	G	MET	exonic	synonymous SNV	ENSG00000105976	rs13223756	ENSG00000105976:ENST00000436117:exon6:c.A1944G:p.Q648Q,ENSG00000105976:ENST00000318493:exon7:c.A1944G:p.Q648Q,ENSG00000105976:ENST00000397752:exon7:c.A1944G:p.Q648Q	MET:NM_001324402:exon6:c.A654G:p.Q218Q,MET:NM_000245:exon7:c.A1944G:p.Q648Q,MET:NM_001127500:exon7:c.A1944G:p.Q648Q,MET:NM_001324401:exon7:c.A1944G:p.Q648Q	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1878	0.1687	0.187899	1(lung)	.	.	.	.	.	.	.	.	MET:uc011knd.2:exon6:c.A1944G:p.Q648Q,MET:uc011kne.2:exon6:c.A1860G:p.Q620Q,MET:uc011knf.2:exon6:c.A1944G:p.Q648Q,MET:uc011kng.1:exon6:c.A1944G:p.Q648Q,MET:uc011knh.1:exon6:c.A1944G:p.Q648Q,MET:uc011kni.2:exon6:c.A1944G:p.Q648Q,MET:uc003vij.3:exon7:c.A1944G:p.Q648Q,MET:uc010lkh.3:exon7:c.A1944G:p.Q648Q,MET:uc011knj.2:exon7:c.A654G:p.Q218Q,MET:uc022akk.1:exon7:c.A1944G:p.Q648Q	.	AFR:61(meninges),AMR:3(haematopoietic_and_lymphoid_tissue),EAS:LAML-KR|3|205|0.0146341,COCA-CN|1|321|0.00311526,FIN:0.1720,NFE:0.1247,OTH:0.0993,ASJ:MU12805326	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05144 Malaria~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,7488,7489,7500,7490,7495,7503,7486,7497,7487,7491,7498,7496,7485,7502,7492,7493,7504,7501,7499	.	.	.	.	.	.	7	1(biliary_tract)	0.2318
7	116436022	116436022	G	A	MET	exonic	synonymous SNV	ENSG00000105976	rs2023748	ENSG00000105976:ENST00000539704:exon7:c.G627A:p.A209A,ENSG00000105976:ENST00000318493:exon21:c.G4071A:p.A1357A,ENSG00000105976:ENST00000397752:exon21:c.G4017A:p.A1339A	MET:NM_001324402:exon20:c.G2727A:p.A909A,MET:NM_000245:exon21:c.G4017A:p.A1339A,MET:NM_001127500:exon21:c.G4071A:p.A1357A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4245	0.3225	0.353834	3(lung)	.	.	.	.	.	.	.	.	MET:uc003vij.3:exon21:c.G4017A:p.A1339A,MET:uc010lkh.3:exon21:c.G4071A:p.A1357A,MET:uc011knj.2:exon21:c.G2727A:p.A909A	.	AFR:1(prostate),AMR:19(soft_tissue),EAS:1(breast),FIN:2(large_intestine),NFE:MU118166,OTH:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763,EOPC-DE|1|202|0.0049505,BRCA-KR|1|50|0.02,ASJ:2(stomach)	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05144 Malaria~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,7488,7489,7500,7490,7495,7503,7486,7497,7487,7491,7498,7496,7485,7502,7492,7493,7504,7501,7499	.	.	.	.	.	.	7	12(meninges)	0.3420
7	116436097	116436097	G	A	MET	exonic	synonymous SNV	ENSG00000105976	rs41737	ENSG00000105976:ENST00000539704:exon7:c.G702A:p.P234P,ENSG00000105976:ENST00000318493:exon21:c.G4146A:p.P1382P,ENSG00000105976:ENST00000397752:exon21:c.G4092A:p.P1364P	MET:NM_001324402:exon20:c.G2802A:p.P934P,MET:NM_000245:exon21:c.G4092A:p.P1364P,MET:NM_001127500:exon21:c.G4146A:p.P1382P	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4248	0.3210	0.354633	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	MET:uc003vij.3:exon21:c.G4092A:p.P1364P,MET:uc010lkh.3:exon21:c.G4146A:p.P1382P,MET:uc011knj.2:exon21:c.G2802A:p.P934P	.	AFR:12(meninges),AMR:2(large_intestine),EAS:MU118189,FIN:COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,NFE:0.3428,OTH:0.1030,ASJ:1(breast)	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05144 Malaria~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,7488,7489,7500,7490,7495,7503,7486,7497,7487,7491,7498,7496,7485,7502,7492,7493,7504,7501,7499	.	.	.	.	.	.	7	19(soft_tissue)	0.4761
7	117305531	117305531	A	G	CFTR	exonic	synonymous SNV	ENSG00000001626	.	ENSG00000001626:ENST00000426809:exon25:c.A4065G:p.R1355R,ENSG00000001626:ENST00000454343:exon25:c.A3972G:p.R1324R,ENSG00000001626:ENST00000003084:exon26:c.A4155G:p.R1385R	CFTR:NM_000492:exon26:c.A4155G:p.R1385R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	CFTR:uc003vjd.3:exon26:c.A4155G:p.R1385R,CFTR:uc011knq.2:exon26:c.A2373G:p.R791R	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602421	167800;211400;219700;277180;	48;586;60033;676;	48|Congenital bilateral agenesis of vas deferens<br>Congenital bilateral aplasia of vas deferens|1-5 / 10 000|X-linked recessive<br>or&nbsp;Autosomal recessive|Adolescent<br>Adult|277180 300985 ~586|CF<br>Mucoviscidosis|1-9 / 100 000|Autosomal recessive|All ages|219700 ~60033|-|-|-|-|211400 613021 613071 ~676|-|1-9 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent|167800 ~	.	.	.	.	.	.	.	.	7	MU129900148	hom
7	127250907	127250907	T	C	PAX4	exonic	stoploss	ENSG00000106331	rs712700	ENSG00000106331:ENST00000378740:exon10:c.A1022G:p.X341W	PAX4:NM_001366111:exon10:c.A1046G:p.X349W	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7632	.	0.669329	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	0.746	9.126	.	1.4	0.731	.	.	.	PAX4:uc003vmg.1:exon10:c.A1022G:p.X341W	.	AFR:0.7255,AMR:0.7065,EAS:0.8676,FIN:0.3628,NFE:0.7340,OTH:0.7704,ASJ:0.7220	167413	125853;612225;612227;	552;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~	.	.	.	.	.	.	.	.	7	1(thyroid)	0.7362
7	128846328	128846328	G	C	SMO	exonic	synonymous SNV	ENSG00000128602	rs2228617	ENSG00000128602:ENST00000462420:exon3:c.G246C:p.G82G,ENSG00000128602:ENST00000249373:exon6:c.G1164C:p.G388G	SMO:NM_005631:exon6:c.G1164C:p.G388G	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7975	0.7896	0.75619	0.7929	.	.	.	.	.	.	.	.	SMO:uc003vos.3:exon2:c.G189C:p.G63G,SMO:uc003vor.3:exon6:c.G1164C:p.G388G	.	AFR:0.6895,AMR:0.7721,EAS:0.7674,FIN:0.8099,NFE:0.8520,OTH:0.7837,ASJ:0.8709	601500	601707;605462;	1553;	1553|Corpus callosum agenesis-polysyndactyly syndrome|<1 / 1 000 000|Not applicable|Neonatal|601707 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	,9748,9805,9806,9804	.	.	.	.	.	.	7	MU802754	hom
7	137600690	137600690	C	T	CREB3L2	exonic	nonsynonymous SNV	ENSG00000182158	rs273957	ENSG00000182158:ENST00000330387:exon3:c.G388A:p.V130I,ENSG00000182158:ENST00000420629:exon3:c.G367A:p.V123I,ENSG00000182158:ENST00000452463:exon3:c.G388A:p.V130I,ENSG00000182158:ENST00000456390:exon3:c.G388A:p.V130I,ENSG00000182158:ENST00000458726:exon3:c.G199A:p.V67I	CREB3L2:NM_001253775:exon3:c.G388A:p.V130I,CREB3L2:NM_001318246:exon3:c.G199A:p.V67I,CREB3L2:NM_194071:exon3:c.G388A:p.V130I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6893	0.7151	0.804313	0.7149	-0.089	1.817	1.0	5.01	0.525	.	.	.	CREB3L2:uc003vtv.3:exon3:c.G199A:p.V67I,CREB3L2:uc003vtw.3:exon3:c.G388A:p.V130I,CREB3L2:uc003vtx.2:exon3:c.G388A:p.V130I,CREB3L2:uc003vty.4:exon3:c.G388A:p.V130I,CREB3L2:uc031szf.1:exon4:c.G199A:p.V67I	-0.976	AFR:0.9201,AMR:0.7662,EAS:0.9227,FIN:0.5615,NFE:0.6136,OTH:0.6268,ASJ:0.6093	608834	.	.	.	~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04668 TNF signaling pathway~ko04714 Thermogenesis~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04911 Insulin secretion~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04922 Glucagon signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04931 Insulin resistance~ko04934 Cushing syndrome~ko04962 Vasopressin-regulated water reabsorption~ko05016 Huntington disease~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05034 Alcoholism~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis~ko05215 Prostate cancer ~	.	.	.	0.0	0.42	0.000	-1.67	7	MU641291	hom
7	142561370	142561370	C	A	EPHB6	intronic	.	ENSG00000106123	rs887855865	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602757	.	.	.	.	.	.	.	.	.	.	.	7	.	hom
7	142566408	142566408	C	T	EPHB6	exonic	nonsynonymous SNV	ENSG00000106123	rs143932854	ENSG00000106123:ENST00000411471:exon10:c.C1366T:p.R456W,ENSG00000106123:ENST00000392957:exon15:c.C2197T:p.R733W,ENSG00000106123:ENST00000442129:exon15:c.C2197T:p.R733W	EPHB6:NM_001280795:exon11:c.C1321T:p.R441W,EPHB6:NM_001280794:exon14:c.C1321T:p.R441W,EPHB6:NM_004445:exon15:c.C2197T:p.R733W	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0] 	3.374e-05	0.0003	.	0.0002	7.597	34	.	4.1	1.000	.	.	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase, catalytic domain	EPHB6:uc003wbv.3:exon2:c.C349T:p.R117W,EPHB6:uc003wbu.3:exon11:c.C1321T:p.R441W,EPHB6:uc003wbs.3:exon14:c.C1321T:p.R441W,EPHB6:uc003wbt.3:exon14:c.C619T:p.R207W,EPHB6:uc011kst.2:exon15:c.C2197T:p.R733W,EPHB6:uc011ksu.2:exon15:c.C2197T:p.R733W	0.231	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0.0003,OTH:0,ASJ:0	602757	.	.	.	.	.	.	.	1.0	.	0.518	3.385	7	.	hom
7	142640685	142640685	T	A	KEL	splicing	.	ENSG00000197993	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	3.762	23.3	.	4.88	0.159	1.0000	0.842	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	613883	110900;	.	.	.	.	.	.	.	.	.	.	7	.	hom
7	147092861	147092861	G	A	CNTNAP2	exonic	unknown	ENSG00000174469	rs34592169	ENSG00000174469:ENST00000361727:exon10:c.G1659A:p.A553A	UNKNOWN	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1875	0.1743	0.0936502	0.1717	.	.	.	.	.	.	.	.	CNTNAP2:uc003weu.2:exon10:c.G1659A:p.A553A	.	AFR:0.0534,AMR:0.1859,EAS:0.0031,FIN:0.2712,NFE:0.2330,OTH:0.2035,ASJ:0.1556	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	MU156507	hom
7	147183143	147183143	A	G	CNTNAP2	intronic	.	ENSG00000174469	rs2286127	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2255	0.1897	0.274561	MU587631	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|4|205|0.0195122,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.2054,EAS:0.3289,FIN:0.1192,NFE:0.3758,OTH:0.1778,ASJ:0.2401	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	1(stomach)	0.1689
7	148523560	148523560	C	T	EZH2;EZH2	exonic;splicing	nonsynonymous SNV	ENSG00000106462;ENSG00000106462	.	ENSG00000106462:ENST00000320356:exon8:c.G893A:p.R298H	EZH2:NM_004456:exon8:c.G893A:p.R298H	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 1, 0, 2, 1, 0, 1] 	.	.	.	.	6.328	29.3	0.006	5.28	1.000	.	.	.	EZH2:uc003wfb.2:exon8:c.G893A:p.R298H	0.404	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	.	.	.	.	.	,4880,4873,4882,4871,4878	.	,4874,4879,4881,4876,4875,4877	0.999	-2.18	0.703	.	7	MU129945222	hom
7	148525904	148525904	C	G	EZH2	exonic	nonsynonymous SNV	ENSG00000106462	rs2302427	ENSG00000106462:ENST00000350995:exon5:c.G436C:p.D146H,ENSG00000106462:ENST00000320356:exon6:c.G553C:p.D185H,ENSG00000106462:ENST00000460911:exon6:c.G553C:p.D185H,ENSG00000106462:ENST00000476773:exon6:c.G526C:p.D176H,ENSG00000106462:ENST00000483967:exon6:c.G526C:p.D176H,ENSG00000106462:ENST00000492143:exon6:c.G553C:p.D185H,ENSG00000106462:ENST00000541220:exon6:c.G526C:p.D176H,ENSG00000106462:ENST00000478654:exon7:c.G526C:p.D176H,ENSG00000106462:ENST00000536783:exon7:c.G226C:p.D76H	EZH2:NM_152998:exon5:c.G436C:p.D146H,EZH2:NM_001203247:exon6:c.G553C:p.D185H,EZH2:NM_001203248:exon6:c.G526C:p.D176H,EZH2:NM_001203249:exon6:c.G526C:p.D176H,EZH2:NM_004456:exon6:c.G553C:p.D185H	clinvar: Benign 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 1, 1, 1] 	0.0786	0.0604	0.0798722	1(haematopoietic_and_lymphoid_tissue)	4.555	24.4	0.011	5.69	0.993	.	.	SANT/Myb domain	EZH2:uc022aov.1:exon4:c.G436C:p.D146H,EZH2:uc003wfc.2:exon5:c.G436C:p.D146H,EZH2:uc003wfb.2:exon6:c.G553C:p.D185H,EZH2:uc003wfd.2:exon6:c.G553C:p.D185H,EZH2:uc011kug.2:exon6:c.G526C:p.D176H,EZH2:uc011kuh.2:exon6:c.G526C:p.D176H,EZH2:uc011kui.2:exon6:c.G553C:p.D185H	-0.751	AFR:3(meninges),AMR:1(central_nervous_system),EAS:47(prostate),FIN:1(lung),NFE:MU151646,OTH:LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,ASJ:3(soft_tissue)	601573	277590;	3447;	3447|Camptodactyly-overgrowth-unusual facies syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|277590 ~	.	,4880,4873,4882,4871,4878	.	,4874,4879,4881,4876,4875,4877	0.898	-3.46	0.022	0.895	7	1(large_intestine)	0.0635
7	150648198	150648198	A	G	KCNH2	exonic	synonymous SNV	ENSG00000055118	rs1137617	ENSG00000055118:ENST00000330883:exon4:c.T936C:p.Y312Y,ENSG00000055118:ENST00000392968:exon6:c.T1668C:p.Y556Y,ENSG00000055118:ENST00000262186:exon8:c.T1956C:p.Y652Y,ENSG00000055118:ENST00000430723:exon8:c.T1956C:p.Y652Y	KCNH2:NM_001204798:exon4:c.T936C:p.Y312Y,KCNH2:NM_172057:exon4:c.T936C:p.Y312Y,KCNH2:NM_000238:exon8:c.T1956C:p.Y652Y,KCNH2:NM_172056:exon8:c.T1956C:p.Y652Y	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6658	0.6905	0.772165	0.7031	.	.	.	.	.	.	.	.	KCNH2:uc003wib.3:exon4:c.T936C:p.Y312Y,KCNH2:uc003wid.3:exon4:c.T936C:p.Y312Y,KCNH2:uc011kux.2:exon6:c.T1668C:p.Y556Y,KCNH2:uc003wic.3:exon8:c.T1956C:p.Y652Y,KCNH2:uc003wie.3:exon8:c.T1956C:p.Y652Y	.	AFR:0.8883,AMR:0.6766,EAS:0.9021,FIN:0.6263,NFE:0.6004,OTH:0.6222,ASJ:0.61	152427	609620;613688;	101016;768;51083;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~	.	.	.	.	.	.	.	.	7	MU4567794	hom
7	151873853	151873853	C	T	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs6464211	ENSG00000055609:ENST00000262189:exon38:c.G8685A:p.Q2895Q,ENSG00000055609:ENST00000355193:exon38:c.G8685A:p.Q2895Q	KMT2C:NM_170606:exon38:c.G8685A:p.Q2895Q	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.2494	0.3412	0.382788	SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	KMT2C:uc003wky.3:exon1:c.G1212A:p.Q404Q,KMT2C:uc003wkz.3:exon24:c.G5868A:p.Q1956Q,KMT2C:uc003wla.3:exon38:c.G8685A:p.Q2895Q	.	AFR:0.3452,AMR:0.6988,EAS:0.2384,FIN:0.2983,NFE:0.2690,OTH:0.1798,ASJ:0.2188	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	6(large_intestine)	0.2281
7	151927025	151927025	A	G	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs77735469	ENSG00000055609:ENST00000262189:exon18:c.T2959C:p.Y987H,ENSG00000055609:ENST00000355193:exon18:c.T2959C:p.Y987H	KMT2C:NM_170606:exon18:c.T2959C:p.Y987H	clinvar: UNK 	 CancerVar: 8#Tier_II_potential EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, 2, 1, 1] 	0.4728	.	.	19(central_nervous_system)	6.190	28.6	0.001	4.67	0.996	.	.	Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, RING-type|Zinc finger, RING/FYVE/PHD-type	KMT2C:uc003wkz.3:exon4:c.T142C:p.Y48H,KMT2C:uc003wla.3:exon18:c.T2959C:p.Y987H	0.656	AFR:1(thyroid),AMR:1(large_intestine),EAS:COCA-CN|5|321|0.0155763,BLCA-CN|1|103|0.00970874,FIN:0.2021,NFE:0.3091,OTH:0.2654,ASJ:MU4563013	606833	.	.	.	.	.	.	,6806	1.0	-2.28	0.754	2.22	7	2(urinary_tract)	0.2062
7	151932897	151932897	C	A	KMT2C	intronic	.	ENSG00000055609	rs73728782	.	.	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1450	.	.	1(lung)	.	.	.	.	.	0.9999	0.978	.	.	.	AFR:MU44683266,AMR:PACA-CA|1|268|0.00373134,LICA-CN|4|402|0.00995025,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,EAS:0.0001,FIN:0,NFE:0,OTH:0,ASJ:0.0002	606833	.	.	.	.	.	.	.	.	.	.	.	7	3(biliary_tract)	0.0018
7	151932965	151932965	C	T	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs78472109	ENSG00000055609:ENST00000262189:exon16:c.G2706A:p.S902S,ENSG00000055609:ENST00000355193:exon16:c.G2706A:p.S902S	KMT2C:NM_170606:exon16:c.G2706A:p.S902S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.3211	.	.	1(thyroid)	.	.	.	.	.	.	.	.	KMT2C:uc003wla.3:exon16:c.G2706A:p.S902S	.	AFR:MU4556521,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,EAS:0.3219,FIN:0.4336,NFE:0.4651,OTH:0.4080,ASJ:0.4117	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	1(liver)	0.4344
7	151945007	151945007	C	T	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs2479172	ENSG00000055609:ENST00000262189:exon14:c.G2512A:p.G838S,ENSG00000055609:ENST00000355193:exon14:c.G2512A:p.G838S	KMT2C:NM_170606:exon14:c.G2512A:p.G838S	clinvar: UNK 	 CancerVar: 8#Tier_II_potential EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, 2, 1, 1] 	0.4944	.	.	1(large_intestine)	6.636	32	0.003	5.67	1.000	.	.	.	KMT2C:uc003wla.3:exon14:c.G2512A:p.G838S	-0.835	AFR:3(bone),AMR:MU31381223,EAS:0.4950,FIN:0.4995,NFE:0.5,OTH:0.4927,ASJ:SKCA-BR|1|100|0.01,COCA-CN|6|321|0.0186916	606833	.	.	.	.	.	.	,6806	1.0	-2.3	0.230	2.075	7	3(prostate)	0.4981
7	151945140	151945140	C	T	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs2537263	ENSG00000055609:ENST00000262189:exon14:c.G2379A:p.S793S,ENSG00000055609:ENST00000355193:exon14:c.G2379A:p.S793S,ENSG00000055609:ENST00000558084:exon14:c.G2379A:p.S793S	KMT2C:NM_170606:exon14:c.G2379A:p.S793S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4564	.	.	4(central_nervous_system)	.	.	.	.	.	.	.	.	KMT2C:uc003wla.3:exon14:c.G2379A:p.S793S	.	AFR:1(upper_aerodigestive_tract),AMR:1(stomach),EAS:1(haematopoietic_and_lymphoid_tissue),FIN:MU22082,NFE:MELA-AU|1|183|0.00546448,LAML-KR|1|205|0.00487805,COCA-CN|7|321|0.0218069,GACA-JP|1|585|0.0017094,OTH:0.4617,ASJ:1(skin)	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	1(thyroid)	0.4870
7	151945167	151945167	G	T	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs2537264	ENSG00000055609:ENST00000262189:exon14:c.C2352A:p.S784S,ENSG00000055609:ENST00000355193:exon14:c.C2352A:p.S784S,ENSG00000055609:ENST00000558084:exon14:c.C2352A:p.S784S	KMT2C:NM_170606:exon14:c.C2352A:p.S784S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4776	.	.	1(prostate)	.	.	.	.	.	.	.	.	KMT2C:uc003wla.3:exon14:c.C2352A:p.S784S	.	AFR:MU4548885,AMR:COCA-CN|7|321|0.0218069,PRAD-CA|1|306|0.00326797,EAS:0.4972,FIN:0.4852,NFE:0.4530,OTH:0.4924,ASJ:0.4815	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	2(large_intestine)	0.4671
7	151962309	151962309	G	A	KMT2C	intronic	.	ENSG00000055609	rs201948579	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0003	.	0.000399361	LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.0316,AMR:0.0274,EAS:0.0099,FIN:0.0502,NFE:0.0792,OTH:0.0210,ASJ:0.0714	606833	.	.	.	.	.	.	.	.	.	.	.	7	1(meninges)	0.0243
7	154752736	154752736	G	A	PAXIP1	exonic	synonymous SNV	ENSG00000157212	rs61752008	ENSG00000157212:ENST00000397192:exon12:c.C2301T:p.V767V,ENSG00000157212:ENST00000404141:exon12:c.C2301T:p.V767V	PAXIP1:NM_007349:exon12:c.C2301T:p.V767V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0074	0.0031	0.0109824	0.0027	.	.	.	.	.	.	.	.	PAXIP1:uc022aqi.1:exon10:c.C2193T:p.V731V,PAXIP1:uc022aqf.1:exon12:c.C2301T:p.V767V,PAXIP1:uc022aqg.1:exon12:c.C2301T:p.V767V,PAXIP1:uc022aqh.1:exon13:c.C2199T:p.V733V	.	AFR:0.0078,AMR:0.0143,EAS:0,FIN:0,NFE:0,OTH:0.0031,ASJ:0	608254	.	.	.	.	.	.	.	.	.	.	.	7	.	hom
7	154760369	154760369	A	G	PAXIP1	exonic	synonymous SNV	ENSG00000157212	rs935037	ENSG00000157212:ENST00000397192:exon7:c.T1542C:p.L514L,ENSG00000157212:ENST00000404141:exon7:c.T1542C:p.L514L	PAXIP1:NM_007349:exon7:c.T1542C:p.L514L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5995	0.5959	0.615415	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PAXIP1:uc003wlr.1:exon3:c.T1269C:p.L423L,PAXIP1:uc022aqi.1:exon5:c.T1434C:p.L478L,PAXIP1:uc022aqf.1:exon7:c.T1542C:p.L514L,PAXIP1:uc022aqg.1:exon7:c.T1542C:p.L514L,PAXIP1:uc022aqh.1:exon8:c.T1440C:p.L480L	.	AFR:0.5835,AMR:0.5346,EAS:0.6324,FIN:0.5944,NFE:0.6474,OTH:0.5861,ASJ:0.7356	608254	.	.	.	.	.	.	.	.	.	.	.	7	1(thyroid)	0.5869
7	154767793	154767793	T	A	PAXIP1	exonic	synonymous SNV	ENSG00000157212	.	ENSG00000157212:ENST00000397192:exon6:c.A687T:p.S229S,ENSG00000157212:ENST00000404141:exon6:c.A687T:p.S229S	PAXIP1:NM_007349:exon6:c.A687T:p.S229S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	PAXIP1:uc003wlr.1:exon2:c.A414T:p.S138S,PAXIP1:uc022aqi.1:exon4:c.A579T:p.S193S,PAXIP1:uc022aqf.1:exon6:c.A687T:p.S229S,PAXIP1:uc022aqg.1:exon6:c.A687T:p.S229S,PAXIP1:uc022aqh.1:exon7:c.A585T:p.S195S	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608254	.	.	.	.	.	.	.	.	.	.	.	7	.	hom
8	6296550	6296550	G	T	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs2442513	ENSG00000147316:ENST00000344683:exon6:c.G513T:p.R171S,ENSG00000147316:ENST00000519480:exon6:c.G513T:p.R171S	MCPH1:NM_001172574:exon6:c.G513T:p.R171S,MCPH1:NM_001322042:exon6:c.G513T:p.R171S,MCPH1:NM_001322043:exon6:c.G507T:p.R169S,MCPH1:NM_001322045:exon6:c.G411T:p.R137S,MCPH1:NM_001363979:exon6:c.G513T:p.R171S,MCPH1:NM_001363980:exon6:c.G513T:p.R171S,MCPH1:NM_024596:exon6:c.G513T:p.R171S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9662	0.9251	0.916933	0.9276	-1.150	0.008	0.857	-4.59	0.012	.	.	BRCT domain	MCPH1:uc003wqh.3:exon6:c.G513T:p.R171S,MCPH1:uc003wqi.3:exon6:c.G513T:p.R171S	-1.032	AFR:0.7806,AMR:0.9797,EAS:0.9889,FIN:0.9865,NFE:0.9859,OTH:0.9695,ASJ:0.9768	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	0.0	3.78	0.000	-1.355	8	MU81846801	hom
8	6302418	6302418	A	G	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs2515569	ENSG00000147316:ENST00000522905:exon7:c.A1031G:p.D344G,ENSG00000147316:ENST00000344683:exon8:c.A1175G:p.D392G,ENSG00000147316:ENST00000519480:exon8:c.A1175G:p.D392G	MCPH1:NM_001172575:exon7:c.A1031G:p.D344G,MCPH1:NM_001172574:exon8:c.A1175G:p.D392G,MCPH1:NM_001322042:exon8:c.A1175G:p.D392G,MCPH1:NM_001322043:exon8:c.A1169G:p.D390G,MCPH1:NM_001322045:exon8:c.A1073G:p.D358G,MCPH1:NM_001363979:exon8:c.A1175G:p.D392G,MCPH1:NM_001363980:exon8:c.A1175G:p.D392G,MCPH1:NM_024596:exon8:c.A1175G:p.D392G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9980	0.9927	0.994409	0.9918	-1.735	0.002	0.573	-11.5	0.000	.	.	.	MCPH1:uc011kwl.2:exon7:c.A1031G:p.D344G,MCPH1:uc003wqh.3:exon8:c.A1175G:p.D392G,MCPH1:uc003wqi.3:exon8:c.A1175G:p.D392G	-0.923	AFR:0.9711,AMR:1,EAS:1,FIN:1,NFE:1,OTH:0.9990,ASJ:1	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	0.0	2.99	0.000	-1.355	8	MU81846820	hom
8	6303025	6303025	G	A	MCPH1	exonic	synonymous SNV	ENSG00000147316	rs2584	ENSG00000147316:ENST00000522905:exon7:c.G1638A:p.T546T,ENSG00000147316:ENST00000344683:exon8:c.G1782A:p.T594T,ENSG00000147316:ENST00000519480:exon8:c.G1782A:p.T594T	MCPH1:NM_001172575:exon7:c.G1638A:p.T546T,MCPH1:NM_001172574:exon8:c.G1782A:p.T594T,MCPH1:NM_001322042:exon8:c.G1782A:p.T594T,MCPH1:NM_001322043:exon8:c.G1776A:p.T592T,MCPH1:NM_001322045:exon8:c.G1680A:p.T560T,MCPH1:NM_001363979:exon8:c.G1782A:p.T594T,MCPH1:NM_001363980:exon8:c.G1782A:p.T594T,MCPH1:NM_024596:exon8:c.G1782A:p.T594T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2616	0.2472	0.132188	0.2566	.	.	.	.	.	.	.	.	MCPH1:uc011kwl.2:exon7:c.G1638A:p.T546T,MCPH1:uc003wqh.3:exon8:c.G1782A:p.T594T,MCPH1:uc003wqi.3:exon8:c.G1782A:p.T594T	.	AFR:0.0630,AMR:0.2680,EAS:0.0154,FIN:0.3471,NFE:0.3689,OTH:0.3452,ASJ:0.2020	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	.	.	.	.	8	MU20999920	het
8	6402992	6402992	A	G	ANGPT2;MCPH1	intronic	.	ENSG00000091879;ENSG00000147316	rs2442596	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.995807	0.9936	.	.	.	.	.	.	.	.	.	.	AFR:0.9777,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	.	.	.	.	.	.	.	.	.	.	.	.	8	.	hom
8	6478986	6478986	C	T	MCPH1	exonic	synonymous SNV	ENSG00000147316	rs2912010	ENSG00000147316:ENST00000344683:exon13:c.C2226T:p.S742S	MCPH1:NM_001363980:exon10:c.C1947T:p.S649S,MCPH1:NM_001322042:exon13:c.C2226T:p.S742S,MCPH1:NM_001363979:exon13:c.C2226T:p.S742S,MCPH1:NM_024596:exon13:c.C2226T:p.S742S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4292	0.3746	0.452875	0.4154	.	.	.	.	.	.	.	.	MCPH1:uc003wqi.3:exon13:c.C2226T:p.S742S	.	AFR:0.3650,AMR:0.3876,EAS:0.6557,FIN:0.4321,NFE:0.4187,OTH:0.4139,ASJ:0.3013	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	.	.	.	.	8	MU117658	het
8	6479042	6479042	C	T	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs1057090	ENSG00000147316:ENST00000344683:exon13:c.C2282T:p.A761V	MCPH1:NM_001363980:exon10:c.C2003T:p.A668V,MCPH1:NM_001322042:exon13:c.C2282T:p.A761V,MCPH1:NM_001363979:exon13:c.C2282T:p.A761V,MCPH1:NM_024596:exon13:c.C2282T:p.A761V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4362	0.4098	0.482029	LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	0.693	8.779	1.0	-8.27	0.024	.	.	BRCT domain	MCPH1:uc003wqi.3:exon13:c.C2282T:p.A761V	-1.003	AFR:0.4424,AMR:0.4784,EAS:0.3079,FIN:0.6510,NFE:0.4015,OTH:0.4167,ASJ:0.3880	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	.	-2.34	0.000	.	8	1(soft_tissue)	0.4047
8	6483586	6483586	C	T	MCPH1-AS1	ncRNA_intronic	.	ENSG00000249898	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	.	.	.	.	.	.	.	.	.	.	.	.	8	.	hom
8	6500544	6500544	C	T	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs1057091	ENSG00000147316:ENST00000344683:exon14:c.C2482T:p.P828S	MCPH1:NM_001363980:exon11:c.C2203T:p.P735S,MCPH1:NM_024596:exon14:c.C2482T:p.P828S,MCPH1:NM_001322042:exon15:c.C2624T:p.P875L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2917	0.2649	0.24361	0.2661	-0.618	0.113	0.407	-1.42	0.228	.	.	BRCT domain	MCPH1:uc003wqi.3:exon14:c.C2482T:p.P828S	-1.034	AFR:0.1867,AMR:0.1974,EAS:0.1900,FIN:0.2756,NFE:0.3180,OTH:0.3098,ASJ:0.3233	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	0.0	-2.55	0.000	-0.51	8	MU23365881	hom
8	11614575	11614575	A	G	GATA4	exonic	nonsynonymous SNV	ENSG00000136574	rs3729856	ENSG00000136574:ENST00000526716:exon5:c.A511G:p.S171G,ENSG00000136574:ENST00000532059:exon5:c.A1132G:p.S378G,ENSG00000136574:ENST00000335135:exon6:c.A1129G:p.S377G,ENSG00000136574:ENST00000528712:exon6:c.A511G:p.S171G	GATA4:NM_001308093:exon5:c.A1132G:p.S378G,GATA4:NM_001308094:exon6:c.A511G:p.S171G,GATA4:NM_002052:exon6:c.A1129G:p.S377G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0962	0.1006	0.0429313	LUSC-KR|2|170|0.0117647	0.793	9.418	0.417	0.906	0.884	.	.	.	GATA4:uc011kxc.1:exon5:c.A1132G:p.S378G,GATA4:uc003wub.1:exon6:c.A511G:p.S171G,GATA4:uc003wuc.2:exon6:c.A1129G:p.S377G	-0.395	AFR:0.1060,AMR:0.0196,EAS:0.1788,FIN:0.0006,NFE:0.1382,OTH:0.1595,ASJ:0.0501	600576	187500;607941;614429;614430;615542;	98722;1480;1478;3303;	98722|AVSD<br>Atrioventricular septal defect|-|-|-|600309 606215 606217 614430 614474 615779 ~1480|Interventricular communication<br>VSD|-|-|-|614429 614431 614432 ~1478|ASD<br>Atrial septal defect<br>Interauricular communication|1-9 / 100 000|-|Childhood|108800 607941 611363 612794 613087 614089 614433 614475 ~3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~	.	.	.	.	0.0	-5.31	0.047	-0.205	8	2(soft_tissue)	0.1436
8	11637102	11637102	T	C	NEIL2	intronic	.	ENSG00000154328	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.0004	0.016	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608933	.	.	.	.	.	.	.	.	.	.	.	8	.	hom
8	12948951	12948951	A	G	DLC1	intronic	.	ENSG00000164741	rs609020	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5562	0.6111	0.571486	MU587710	.	.	.	.	.	0.0002	0.034	.	.	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.5898,EAS:0.3735,FIN:0.6623,NFE:0.4107,OTH:0.5433,ASJ:0.7230	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	1(stomach)	0.5541
8	12950110	12950110	G	A	DLC1	intronic	.	ENSG00000164741	rs7829535	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4475	0.4115	0.336861	0.4052	.	.	.	.	.	.	.	.	.	.	AFR:0.2205,AMR:0.2990,EAS:0.3412,FIN:0.4662,NFE:0.5021,OTH:0.4908,ASJ:0.5762	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU32417843	hom
8	12957475	12957475	C	T	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs532841	ENSG00000164741:ENST00000358919:exon5:c.G1060A:p.V354M,ENSG00000164741:ENST00000512044:exon5:c.G1162A:p.V388M,ENSG00000164741:ENST00000520226:exon5:c.G838A:p.V280M,ENSG00000164741:ENST00000276297:exon9:c.G2371A:p.V791M	DLC1:NM_001348084:exon4:c.G838A:p.V280M,DLC1:NM_001164271:exon5:c.G838A:p.V280M,DLC1:NM_001316668:exon5:c.G1162A:p.V388M,DLC1:NM_001348083:exon5:c.G838A:p.V280M,DLC1:NM_006094:exon5:c.G1060A:p.V354M,DLC1:NM_001348082:exon8:c.G838A:p.V280M,DLC1:NM_001348081:exon9:c.G2371A:p.V791M,DLC1:NM_182643:exon9:c.G2371A:p.V791M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4935	0.5252	0.496605	28(soft_tissue)	-0.212	1.034	0.322	-6.1	0.746	.	.	.	DLC1:uc003wwk.1:exon5:c.G1060A:p.V354M,DLC1:uc003wwl.1:exon5:c.G1162A:p.V388M,DLC1:uc011kxx.1:exon5:c.G838A:p.V280M,DLC1:uc003wwm.2:exon9:c.G2371A:p.V791M	-0.963	AFR:1(pancreas),AMR:1(thyroid),EAS:MU55000,FIN:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,NFE:0.5114,OTH:0.6111,ASJ:4(large_intestine)	604258	114500;	.	.	.	.	.	.	0.0	3.64	0.000	0.11	8	1(stomach)	0.3246
8	12957528	12957528	C	T	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	.	ENSG00000164741:ENST00000358919:exon5:c.G1007A:p.G336D,ENSG00000164741:ENST00000512044:exon5:c.G1109A:p.G370D,ENSG00000164741:ENST00000520226:exon5:c.G785A:p.G262D,ENSG00000164741:ENST00000276297:exon9:c.G2318A:p.G773D	DLC1:NM_001348084:exon4:c.G785A:p.G262D,DLC1:NM_001164271:exon5:c.G785A:p.G262D,DLC1:NM_001316668:exon5:c.G1109A:p.G370D,DLC1:NM_001348083:exon5:c.G785A:p.G262D,DLC1:NM_006094:exon5:c.G1007A:p.G336D,DLC1:NM_001348082:exon8:c.G785A:p.G262D,DLC1:NM_001348081:exon9:c.G2318A:p.G773D,DLC1:NM_182643:exon9:c.G2318A:p.G773D	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	5.849	27.3	0.001	4.33	0.999	.	.	.	DLC1:uc003wwk.1:exon5:c.G1007A:p.G336D,DLC1:uc003wwl.1:exon5:c.G1109A:p.G370D,DLC1:uc011kxx.1:exon5:c.G785A:p.G262D,DLC1:uc003wwm.2:exon9:c.G2318A:p.G773D	-0.862	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604258	114500;	.	.	.	.	.	.	1.0	2.96	0.123	2.88	8	.	hom
8	13356621	13356621	T	G	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs34591797	ENSG00000164741:ENST00000276297:exon2:c.A960C:p.Q320H,ENSG00000164741:ENST00000316609:exon2:c.A960C:p.Q320H,ENSG00000164741:ENST00000511869:exon2:c.A960C:p.Q320H	DLC1:NM_001348081:exon2:c.A960C:p.Q320H,DLC1:NM_024767:exon2:c.A960C:p.Q320H,DLC1:NM_182643:exon2:c.A960C:p.Q320H	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0219	0.0434	0.0587061	0.0390	-1.766	0.002	1.0	1.12	0.267	.	.	.	DLC1:uc003wwm.2:exon2:c.A960C:p.Q320H,DLC1:uc003wwn.3:exon2:c.A960C:p.Q320H,DLC1:uc011kxy.2:exon2:c.A960C:p.Q320H	-0.964	AFR:0.1337,AMR:0.0131,EAS:0,FIN:0,NFE:0.0009,OTH:0.0173,ASJ:0	604258	114500;	.	.	.	.	.	.	0.0	3.85	0.000	-1.59	8	.	het
8	13356802	13356802	G	A	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs3816747	ENSG00000164741:ENST00000276297:exon2:c.C779T:p.T260I,ENSG00000164741:ENST00000316609:exon2:c.C779T:p.T260I,ENSG00000164741:ENST00000511869:exon2:c.C779T:p.T260I	DLC1:NM_001348081:exon2:c.C779T:p.T260I,DLC1:NM_024767:exon2:c.C779T:p.T260I,DLC1:NM_182643:exon2:c.C779T:p.T260I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8777	0.9101	0.815096	0.8937	-3.066	0.001	0.193	-9.96	0.001	.	.	.	DLC1:uc003wwm.2:exon2:c.C779T:p.T260I,DLC1:uc003wwn.3:exon2:c.C779T:p.T260I,DLC1:uc011kxy.2:exon2:c.C779T:p.T260I	-0.942	AFR:0.8611,AMR:0.7470,EAS:0.6101,FIN:0.9408,NFE:0.9387,OTH:0.9083,ASJ:0.9272	604258	114500;	.	.	.	.	.	.	0.0	3.65	0.000	-1.245	8	MU18918835	hom
8	13356818	13356818	T	C	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs11203494	ENSG00000164741:ENST00000276297:exon2:c.A763G:p.N255D,ENSG00000164741:ENST00000316609:exon2:c.A763G:p.N255D,ENSG00000164741:ENST00000511869:exon2:c.A763G:p.N255D	DLC1:NM_001348081:exon2:c.A763G:p.N255D,DLC1:NM_024767:exon2:c.A763G:p.N255D,DLC1:NM_182643:exon2:c.A763G:p.N255D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9673	0.9461	0.958067	0.9540	-2.148	0.001	1.0	1.93	0.003	.	.	.	DLC1:uc003wwm.2:exon2:c.A763G:p.N255D,DLC1:uc003wwn.3:exon2:c.A763G:p.N255D,DLC1:uc011kxy.2:exon2:c.A763G:p.N255D	-0.998	AFR:0.9099,AMR:0.9761,EAS:1,FIN:0.9785,NFE:0.9664,OTH:0.9715,ASJ:0.9636	604258	114500;	.	.	.	.	.	.	0.0	3.92	0.000	-0.955	8	MU81847893	unknown
8	13356819	13356819	T	G	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs11203495	ENSG00000164741:ENST00000276297:exon2:c.A762C:p.Q254H,ENSG00000164741:ENST00000316609:exon2:c.A762C:p.Q254H,ENSG00000164741:ENST00000511869:exon2:c.A762C:p.Q254H	DLC1:NM_001348081:exon2:c.A762C:p.Q254H,DLC1:NM_024767:exon2:c.A762C:p.Q254H,DLC1:NM_182643:exon2:c.A762C:p.Q254H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8558	0.8644	0.758387	0.8541	-1.363	0.004	0.208	-5.59	0.000	.	.	.	DLC1:uc003wwm.2:exon2:c.A762C:p.Q254H,DLC1:uc003wwn.3:exon2:c.A762C:p.Q254H,DLC1:uc011kxy.2:exon2:c.A762C:p.Q254H	-1.018	AFR:0.7255,AMR:0.7345,EAS:0.6110,FIN:0.9408,NFE:0.9375,OTH:0.8910,ASJ:0.9272	604258	114500;	.	.	.	.	.	.	0.005	3.38	0.000	1.055	8	MU18918882	unknown
8	13357587	13357587	G	A	DLC1	UTR5	.	ENSG00000164741	rs1383942	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8562	0.8371	0.741613	0.8287	.	.	.	.	.	.	.	.	.	.	AFR:0.6355,AMR:0.7279,EAS:0.6098,FIN:0.9408,NFE:0.9376,OTH:0.8951,ASJ:0.9267	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU18918940	hom
8	15978063	15978063	C	T	MSR1	exonic	synonymous SNV	ENSG00000038945	rs4338104	ENSG00000038945:ENST00000262101:exon9:c.G1086A:p.R362R,ENSG00000038945:ENST00000445506:exon9:c.G1140A:p.R380R	MSR1:NM_001363744:exon9:c.G1140A:p.R380R,MSR1:NM_138715:exon9:c.G1086A:p.R362R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9992	0.9975	0.997404	0.9982	.	.	.	.	.	.	.	.	MSR1:uc003wwz.3:exon9:c.G1086A:p.R362R,MSR1:uc010lsu.3:exon9:c.G1140A:p.R380R	.	AFR:0.9936,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	8	MU81848037	hom
8	16043667	16043667	C	T	MSR1	splicing	.	ENSG00000038945	rs435815	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2588	.	0.398163	MU5477370	-0.071	1.954	.	0.054	0.016	0	0.002	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.2426,EAS:0.4593,FIN:0.1556,NFE:0.5336,OTH:0.0656,ASJ:0.4661	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	8	1(lung)	0.1171
8	16043686	16043686	G	C	MSR1	exonic	nonsynonymous SNV	ENSG00000038945	rs76917531	ENSG00000038945:ENST00000445506:exon1:c.C32G:p.S11C	MSR1:NM_001363744:exon1:c.C32G:p.S11C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1226	.	0.142572	0.0522	0.238	5.075	0.0	-1.41	0.059	.	.	.	MSR1:uc010lsu.3:exon1:c.C32G:p.S11C	-1.075	AFR:0.0233,AMR:0.2105,EAS:0.3093,FIN:0.0143,NFE:0.0417,OTH:0.0489,ASJ:0.0430	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	0.003	-2.13	0.000	.	8	MU19603427	unknown
8	17796382	17796382	A	G	PCM1	exonic	nonsynonymous SNV	ENSG00000078674	rs412750	ENSG00000078674:ENST00000523055:exon4:c.A476G:p.N159S,ENSG00000078674:ENST00000524226:exon4:c.A476G:p.N159S,ENSG00000078674:ENST00000325083:exon5:c.A476G:p.N159S,ENSG00000078674:ENST00000517730:exon5:c.A476G:p.N159S,ENSG00000078674:ENST00000518537:exon5:c.A476G:p.N159S,ENSG00000078674:ENST00000519253:exon5:c.A476G:p.N159S	PCM1:NM_001352647:exon4:c.A476G:p.N159S,PCM1:NM_001352651:exon4:c.A476G:p.N159S,PCM1:NM_001352652:exon4:c.A476G:p.N159S,PCM1:NM_001315507:exon5:c.A476G:p.N159S,PCM1:NM_001315508:exon5:c.A476G:p.N159S,PCM1:NM_001352632:exon5:c.A476G:p.N159S,PCM1:NM_001352634:exon5:c.A476G:p.N159S,PCM1:NM_001352636:exon5:c.A476G:p.N159S,PCM1:NM_001352637:exon5:c.A476G:p.N159S,PCM1:NM_001352639:exon5:c.A476G:p.N159S,PCM1:NM_001352640:exon5:c.A476G:p.N159S,PCM1:NM_001352641:exon5:c.A476G:p.N159S,PCM1:NM_001352643:exon5:c.A476G:p.N159S,PCM1:NM_001352644:exon5:c.A476G:p.N159S,PCM1:NM_001352646:exon5:c.A476G:p.N159S,PCM1:NM_001352649:exon5:c.A476G:p.N159S,PCM1:NM_001352654:exon5:c.A476G:p.N159S,PCM1:NM_001352658:exon5:c.A476G:p.N159S,PCM1:NM_001352659:exon5:c.A476G:p.N159S,PCM1:NM_006197:exon5:c.A476G:p.N159S,PCM1:NM_001352638:exon6:c.A476G:p.N159S,PCM1:NM_001352655:exon6:c.A476G:p.N159S,PCM1:NM_001352633:exon7:c.A476G:p.N159S,PCM1:NM_001352635:exon7:c.A476G:p.N159S,PCM1:NM_001352642:exon7:c.A476G:p.N159S,PCM1:NM_001352645:exon7:c.A476G:p.N159S,PCM1:NM_001352648:exon7:c.A476G:p.N159S,PCM1:NM_001352650:exon7:c.A476G:p.N159S,PCM1:NM_001352653:exon7:c.A476G:p.N159S,PCM1:NM_001352656:exon7:c.A476G:p.N159S,PCM1:NM_001352657:exon7:c.A476G:p.N159S,PCM1:NM_001352660:exon7:c.A476G:p.N159S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7324	0.8139	0.690495	0.7933	-1.468	0.003	1.0	4.85	0.007	.	.	.	PCM1:uc022asj.1:exon3:c.A476G:p.N159S,PCM1:uc003wyg.2:exon4:c.A476G:p.N159S,PCM1:uc003wyj.4:exon4:c.A476G:p.N159S,PCM1:uc003wyh.3:exon5:c.A476G:p.N159S,PCM1:uc003wyi.4:exon5:c.A476G:p.N159S,PCM1:uc010lta.1:exon5:c.A476G:p.N159S,PCM1:uc011kyh.2:exon5:c.A476G:p.N159S	-0.976	AFR:0.8326,AMR:0.5493,EAS:0.6044,FIN:0.8153,NFE:0.8004,OTH:0.7920,ASJ:0.7351	600299	.	.	.	.	.	.	.	0.0	3.99	0.000	.	8	MU18922720	unknown
8	17796383	17796383	C	T	PCM1	exonic	synonymous SNV	ENSG00000078674	rs454755	ENSG00000078674:ENST00000523055:exon4:c.C477T:p.N159N,ENSG00000078674:ENST00000524226:exon4:c.C477T:p.N159N,ENSG00000078674:ENST00000325083:exon5:c.C477T:p.N159N,ENSG00000078674:ENST00000517730:exon5:c.C477T:p.N159N,ENSG00000078674:ENST00000518537:exon5:c.C477T:p.N159N,ENSG00000078674:ENST00000519253:exon5:c.C477T:p.N159N	PCM1:NM_001352647:exon4:c.C477T:p.N159N,PCM1:NM_001352651:exon4:c.C477T:p.N159N,PCM1:NM_001352652:exon4:c.C477T:p.N159N,PCM1:NM_001315507:exon5:c.C477T:p.N159N,PCM1:NM_001315508:exon5:c.C477T:p.N159N,PCM1:NM_001352632:exon5:c.C477T:p.N159N,PCM1:NM_001352634:exon5:c.C477T:p.N159N,PCM1:NM_001352636:exon5:c.C477T:p.N159N,PCM1:NM_001352637:exon5:c.C477T:p.N159N,PCM1:NM_001352639:exon5:c.C477T:p.N159N,PCM1:NM_001352640:exon5:c.C477T:p.N159N,PCM1:NM_001352641:exon5:c.C477T:p.N159N,PCM1:NM_001352643:exon5:c.C477T:p.N159N,PCM1:NM_001352644:exon5:c.C477T:p.N159N,PCM1:NM_001352646:exon5:c.C477T:p.N159N,PCM1:NM_001352649:exon5:c.C477T:p.N159N,PCM1:NM_001352654:exon5:c.C477T:p.N159N,PCM1:NM_001352658:exon5:c.C477T:p.N159N,PCM1:NM_001352659:exon5:c.C477T:p.N159N,PCM1:NM_006197:exon5:c.C477T:p.N159N,PCM1:NM_001352638:exon6:c.C477T:p.N159N,PCM1:NM_001352655:exon6:c.C477T:p.N159N,PCM1:NM_001352633:exon7:c.C477T:p.N159N,PCM1:NM_001352635:exon7:c.C477T:p.N159N,PCM1:NM_001352642:exon7:c.C477T:p.N159N,PCM1:NM_001352645:exon7:c.C477T:p.N159N,PCM1:NM_001352648:exon7:c.C477T:p.N159N,PCM1:NM_001352650:exon7:c.C477T:p.N159N,PCM1:NM_001352653:exon7:c.C477T:p.N159N,PCM1:NM_001352656:exon7:c.C477T:p.N159N,PCM1:NM_001352657:exon7:c.C477T:p.N159N,PCM1:NM_001352660:exon7:c.C477T:p.N159N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7324	0.8139	0.690495	0.7932	.	.	.	.	.	.	.	.	PCM1:uc022asj.1:exon3:c.C477T:p.N159N,PCM1:uc003wyg.2:exon4:c.C477T:p.N159N,PCM1:uc003wyj.4:exon4:c.C477T:p.N159N,PCM1:uc003wyh.3:exon5:c.C477T:p.N159N,PCM1:uc003wyi.4:exon5:c.C477T:p.N159N,PCM1:uc010lta.1:exon5:c.C477T:p.N159N,PCM1:uc011kyh.2:exon5:c.C477T:p.N159N	.	AFR:0.8327,AMR:0.5478,EAS:0.6039,FIN:0.8148,NFE:0.8004,OTH:0.7920,ASJ:0.7351	600299	.	.	.	.	.	.	.	.	.	.	.	8	MU803684	unknown
8	17799172	17799172	T	G	PCM1	intronic	.	ENSG00000078674	rs2467076	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	1	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600299	.	.	.	.	.	.	.	.	.	.	.	8	.	hom
8	17799241	17799241	T	C	PCM1	intronic	.	ENSG00000078674	rs10108545	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.297125	0.4425	.	.	.	.	.	.	.	.	.	.	AFR:0.2216,AMR:0.2812,EAS:0.1253,FIN:0.5743,NFE:0.5776,OTH:0.5328,ASJ:0.4633	600299	.	.	.	.	.	.	.	.	.	.	.	8	.	het
8	21964802	21964802	C	T	NUDT18	UTR3	.	ENSG00000173566	rs1552286	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9048	0.8733	0.920527	0.8847	.	.	.	.	.	.	.	.	.	.	AFR:0.8719,AMR:0.9305,EAS:0.9944,FIN:0.9147,NFE:0.8698,OTH:0.8953,ASJ:0.8940	615791	.	.	.	.	.	.	.	.	.	.	.	8	MU81848854	hom
8	21965113	21965113	T	C	NUDT18	exonic	nonsynonymous SNV	ENSG00000173566	rs3739435	ENSG00000173566:ENST00000522405:exon3:c.A439G:p.M147V,ENSG00000173566:ENST00000309188:exon5:c.A670G:p.M224V	NUDT18:NM_024815:exon5:c.A670G:p.M224V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5141	0.4747	0.554113	0.5037	-3.587	0.001	.	-2.23	0.553	.	.	.	NUDT18:uc003xaq.1:exon4:c.A670G:p.M224V	-0.939	AFR:0.5174,AMR:0.6938,EAS:0.6354,FIN:0.5838,NFE:0.4534,OTH:0.5154,ASJ:0.4033	615791	.	.	.	.	.	.	.	.	.	0.000	1.185	8	MU18563877	hom
8	23049292	23049292	C	T	TNFRSF10A	exonic	nonsynonymous SNV	ENSG00000104689	rs2230229	ENSG00000104689:ENST00000221132:exon10:c.G1322A:p.R441K	TNFRSF10A:NM_003844:exon10:c.G1322A:p.R441K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8782	0.8493	0.91254	0.8540	-1.070	0.011	1.0	-2.61	0.001	.	.	Death domain|Death-like domain|Tumour necrosis factor receptor 10A/B, death domain	TNFRSF10A:uc003xda.3:exon10:c.G1322A:p.R441K	-0.992	AFR:0.8633,AMR:0.9342,EAS:0.9808,FIN:0.8049,NFE:0.8418,OTH:0.8480,ASJ:0.8742	603611	.	.	.	.	.	.	.	0.0	-2.0	0.000	-1.345	8	MU81849571	hom
8	23059324	23059324	C	G	TNFRSF10A	exonic	nonsynonymous SNV	ENSG00000104689	rs20575	ENSG00000104689:ENST00000221132:exon4:c.G626C:p.R209T,ENSG00000104689:ENST00000524158:exon4:c.G20C:p.R7T	TNFRSF10A:NM_003844:exon4:c.G626C:p.R209T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5279	0.4103	0.579473	0.4435	-1.605	0.002	1.0	0.222	0.000	.	.	TNFR/NGFR cysteine-rich region;TNFR/NGFR cysteine-rich region|Tumor necrosis factor receptor 10, N-terminal	TNFRSF10A:uc003xda.3:exon4:c.G626C:p.R209T	-0.966	AFR:0.3146,AMR:0.6432,EAS:0.9735,FIN:0.4050,NFE:0.4544,OTH:0.4867,ASJ:0.4636	603611	.	.	.	.	.	.	.	0.0	-2.7	0.000	-1.105	8	MU64437	hom
8	23060256	23060256	T	C	TNFRSF10A	exonic	nonsynonymous SNV	ENSG00000104689	rs17620	ENSG00000104689:ENST00000221132:exon3:c.A422G:p.H141R	TNFRSF10A:NM_003844:exon3:c.A422G:p.H141R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5254	0.4000	0.571685	0.4325	-3.114	0.001	0.419	-6.96	0.000	.	.	Tumor necrosis factor receptor 10, N-terminal	TNFRSF10A:uc003xda.3:exon3:c.A422G:p.H141R	-0.910	AFR:0.2767,AMR:0.6435,EAS:0.9735,FIN:0.4044,NFE:0.4554,OTH:0.4847,ASJ:0.4636	603611	.	.	.	.	.	.	.	0.824	0.99	0.000	1.15	8	MU144012	hom
8	26227640	26227640	A	G	PPP2R2A	intronic	.	ENSG00000221914	rs3808565	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0863	0.0593	0.144569	LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0	.	.	.	AFR:0.0868,AMR:0.1007,EAS:0.0530,FIN:0.4068,NFE:0.0778,OTH:0.0481,ASJ:0.0752	604941	.	.	.	.	.	.	.	.	.	.	.	8	1(breast)	0.0835
8	29197672	29197672	A	G	DUSP4	exonic	synonymous SNV	ENSG00000120875	rs583034	ENSG00000120875:ENST00000240100:exon2:c.T522C:p.S174S,ENSG00000120875:ENST00000240101:exon3:c.T249C:p.S83S	DUSP4:NM_001394:exon2:c.T522C:p.S174S,DUSP4:NM_057158:exon3:c.T249C:p.S83S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5589	0.5339	0.622404	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	DUSP4:uc003xhm.3:exon2:c.T522C:p.S174S,DUSP4:uc003xhl.3:exon3:c.T249C:p.S83S	.	AFR:0.5519,AMR:0.7727,EAS:0.55,FIN:0.6425,NFE:0.4768,OTH:0.4305,ASJ:0.6523	602747	.	.	.	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.4775
8	30436507	30436507	G	T	GTF2E2	exonic	synonymous SNV	ENSG00000197265	.	ENSG00000197265:ENST00000355904:exon8:c.C807A:p.R269R	GTF2E2:NM_002095:exon8:c.C807A:p.R269R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	GTF2E2:uc003xig.3:exon8:c.C807A:p.R269R	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	189964	616943;	33364;	33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~	~ko03022 Basal transcription factors~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	8	.	hom
8	30958354	30958354	T	-	WRN	intronic	.	ENSG00000165392	rs397723919	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.9943	0.9784	0.98123	0.9825	.	.	.	.	.	.	.	.	.	.	AFR:0.9388,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	.	hom
8	30973957	30973957	G	T	WRN	exonic	synonymous SNV	ENSG00000165392	rs1800392	ENSG00000165392:ENST00000298139:exon20:c.G2361T:p.L787L	WRN:NM_000553:exon20:c.G2361T:p.L787L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4466	0.4482	0.471246	0.4285	.	.	.	.	.	.	.	.	WRN:uc010lvk.3:exon8:c.G762T:p.L254L,WRN:uc003xio.4:exon20:c.G2361T:p.L787L	.	AFR:0.4064,AMR:0.5598,EAS:0.6073,FIN:0.3639,NFE:0.4294,OTH:0.4255,ASJ:0.4570	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU131479	het
8	30999280	30999280	G	T	WRN	exonic	nonsynonymous SNV	ENSG00000165392	rs1801195	ENSG00000165392:ENST00000298139:exon26:c.G3222T:p.L1074F	WRN:NM_000553:exon26:c.G3222T:p.L1074F	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4492	0.4669	0.496006	0.4457	-0.691	0.076	0.764	1.4	0.007	.	.	Winged helix-turn-helix DNA-binding domain	WRN:uc010lvk.3:exon14:c.G1623T:p.L541F,WRN:uc003xio.4:exon26:c.G3222T:p.L1074F	-0.938	AFR:0.4802,AMR:0.5504,EAS:0.6186,FIN:0.3607,NFE:0.4221,OTH:0.4262,ASJ:0.4536	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	0.0	1.48	0.000	-1.24	8	MU131494	hom
8	31024654	31024654	T	C	WRN	exonic	nonsynonymous SNV	ENSG00000165392	rs1346044	ENSG00000165392:ENST00000298139:exon34:c.T4099C:p.C1367R	WRN:NM_000553:exon34:c.T4099C:p.C1367R	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.2416	0.2274	0.192692	0.2282	1.231	11.91	0.035	2.45	0.273	.	.	.	WRN:uc010lvk.3:exon22:c.T2500C:p.C834R,WRN:uc003xio.4:exon34:c.T4099C:p.C1367R	-1.067	AFR:0.1610,AMR:0.1659,EAS:0.1239,FIN:0.2821,NFE:0.2679,OTH:0.2664,ASJ:0.1788	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	0.744	0.93	0.000	1.87	8	MU804166	hom
8	32505910	32505911	AG	-	NRG1	intronic	.	ENSG00000157168	rs146965117	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2264	.	.	0.0015	.	.	.	.	.	.	.	.	.	.	AFR:0.0002,AMR:0.0047,EAS:0,FIN:0.0113,NFE:0.0007,OTH:0.0024,ASJ:0	142445	603013;	.	.	.	.	.	.	.	.	.	.	8	MU53212306	het
8	37689071	37689071	G	A	ADGRA2	exonic	nonsynonymous SNV	ENSG00000020181	rs148701575	ENSG00000020181:ENST00000315215:exon8:c.G1063A:p.A355T,ENSG00000020181:ENST00000412232:exon8:c.G1063A:p.A355T	ADGRA2:NM_032777:exon8:c.G1063A:p.A355T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.0053	0.0052	0.00419329	.	3.117	22.6	0.049	5.22	0.048	.	.	GPCR, family 2, extracellular hormone receptor domain	GPR124:uc003xkj.3:exon8:c.G1063A:p.A355T,GPR124:uc010lvy.3:exon8:c.G1063A:p.A355T	-0.883	AFR:0.0030,AMR:0.0015,EAS:0,FIN:0,NFE:0.0029,OTH:0.0046,ASJ:0.0012	606823	.	.	.	.	.	.	.	0.993	0.59	0.157	2.045	8	1(central_nervous_system)	0.0010
8	37693302	37693302	T	C	ADGRA2	intronic	.	ENSG00000020181	rs10101560	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9539	0.9521	0.978834	0.9606	.	.	.	.	.	.	.	.	.	.	AFR:0.9885,AMR:0.9797,EAS:1,FIN:0.9613,NFE:0.9393,OTH:0.9488,ASJ:0.9768	606823	.	.	.	.	.	.	.	.	.	.	.	8	MU81850840	hom
8	41525914	41525914	C	T	ANK1	exonic	synonymous SNV	ENSG00000029534	rs750625	ENSG00000029534:ENST00000289734:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000347528:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000352337:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000379758:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000396942:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000396945:exon39:c.G5265A:p.V1755V,ENSG00000029534:ENST00000265709:exon40:c.G5388A:p.V1796V	ANK1:NM_000037:exon39:c.G5265A:p.V1755V,ANK1:NM_020475:exon39:c.G5265A:p.V1755V,ANK1:NM_020476:exon39:c.G5265A:p.V1755V,ANK1:NM_020477:exon39:c.G4779A:p.V1593V,ANK1:NM_001142446:exon40:c.G5388A:p.V1796V	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2134	0.2312	0.194688	1(lung)	.	.	.	.	.	.	.	.	ANK1:uc003xoh.3:exon23:c.G2727A:p.V909V,ANK1:uc003xoi.3:exon39:c.G5265A:p.V1755V,ANK1:uc003xoj.3:exon39:c.G5265A:p.V1755V,ANK1:uc003xok.3:exon39:c.G5265A:p.V1755V,ANK1:uc003xol.3:exon39:c.G4779A:p.V1593V,ANK1:uc003xom.3:exon40:c.G5388A:p.V1796V	.	AFR:MU156389,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,EAS:0.1994,FIN:0.2148,NFE:0.3742,OTH:0.1194,ASJ:0.2180	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	1(large_intestine)	0.2054
8	41585438	41585438	G	A	ANK1	exonic	synonymous SNV	ENSG00000029534	rs2304871	ENSG00000029534:ENST00000265709:exon4:c.C414T:p.N138N,ENSG00000029534:ENST00000289734:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000347528:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000352337:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000379758:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000396942:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000396945:exon4:c.C315T:p.N105N	ANK1:NM_000037:exon4:c.C315T:p.N105N,ANK1:NM_001142446:exon4:c.C414T:p.N138N,ANK1:NM_020475:exon4:c.C315T:p.N105N,ANK1:NM_020476:exon4:c.C315T:p.N105N,ANK1:NM_020477:exon4:c.C315T:p.N105N	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2443	0.2497	0.228435	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	ANK1:uc003xoi.3:exon4:c.C315T:p.N105N,ANK1:uc003xoj.3:exon4:c.C315T:p.N105N,ANK1:uc003xok.3:exon4:c.C315T:p.N105N,ANK1:uc003xol.3:exon4:c.C315T:p.N105N,ANK1:uc003xom.3:exon4:c.C414T:p.N138N	.	AFR:0.2346,AMR:0.1844,EAS:0.3477,FIN:0.2208,NFE:0.2199,OTH:0.2695,ASJ:0.1615	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	1(large_intestine)	0.2490
8	41814574	41814574	G	A	KAT6A	intronic	.	ENSG00000083168	rs28510452	ENSG00000083168:ENST00000418721:exon1:c.C215T:p.P72L	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0440	0.0363	0.0640974	0.0395	-0.003	2.562	0.502	-1.06	0.006	.	.	.	.	-0.999	AFR:0.1125,AMR:0.0131,EAS:0.0673,FIN:0.0026,NFE:0.0055,OTH:0.0235,ASJ:0.0199	601408	616268;	457193;	457193|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|616268 ~	.	.	.	.	.	.	0.003	.	8	.	hom
8	48732075	48732075	A	-	PRKDC	intronic	.	ENSG00000253729	rs11311765	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1835	.	.	0.1462	.	.	.	.	.	.	.	.	.	.	AFR:0.2992,AMR:0.1952,EAS:0.0707,FIN:0.0225,NFE:0.0647,OTH:0.1089,ASJ:0.1092	600899	615966;	317425;	317425|SCID due to DNA-PKcs deficiency|-|-|-|615966 ~	.	.	.	.	.	.	.	.	8	.	het
8	48846519	48846519	T	C	PRKDC	intronic	.	ENSG00000253729	rs1231202	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9598	0.9623	0.983626	0.9656	.	.	.	.	.	.	.	.	.	.	AFR:0.9926,AMR:0.9785,EAS:0.9994,FIN:0.9528,NFE:0.9498,OTH:0.9561,ASJ:0.9338	600899	615966;	317425;	317425|SCID due to DNA-PKcs deficiency|-|-|-|615966 ~	.	.	.	.	.	.	.	.	8	MU81851562	hom
8	48885436	48885436	T	A	MCM4	exonic	nonsynonymous SNV	ENSG00000104738	rs762679	ENSG00000104738:ENST00000262105:exon13:c.T1948A:p.L650M,ENSG00000104738:ENST00000523944:exon14:c.T1948A:p.L650M	MCM4:NM_005914:exon13:c.T1948A:p.L650M,MCM4:NM_182746:exon14:c.T1948A:p.L650M	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8669	0.8730	0.914137	0.8783	1.663	14.20	1.0	5.32	1.000	.	.	MCM domain|P-loop containing nucleoside triphosphate hydrolase	MCM4:uc003xql.2:exon13:c.T1948A:p.L650M,MCM4:uc003xqk.2:exon14:c.T1948A:p.L650M,MCM4:uc011ldi.2:exon15:c.T1909A:p.L637M	-0.942	AFR:0.9223,AMR:0.9308,EAS:0.9994,FIN:0.8306,NFE:0.8494,OTH:0.8635,ASJ:0.8444	602638	609981;	75391;	75391|Primary immunodeficiency due to MCM4 deficiency|<1 / 1 000 000|Autosomal recessive|Childhood|609981 ~	.	.	.	.	0.002	2.56	0.000	0.04	8	MU81851575	hom
8	56792159	56792159	T	C	LYN	upstream	.	ENSG00000254087	rs1450741	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.715655	0.6942	.	.	.	.	.	.	.	.	.	.	AFR:0.6917,AMR:0.7267,EAS:0.7954,FIN:0.6894,NFE:0.6821,OTH:0.6916,ASJ:0.7980	165120	.	.	.	~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04611 Platelet activation~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04730 Long-term depression~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	8	.	hom
8	103307533	103307533	T	C	UBR5	exonic	synonymous SNV	ENSG00000104517	rs9650002	ENSG00000104517:ENST00000220959:exon31:c.A3957G:p.L1319L,ENSG00000104517:ENST00000520539:exon31:c.A3957G:p.L1319L,ENSG00000104517:ENST00000521922:exon31:c.A3939G:p.L1313L	UBR5:NM_001282873:exon31:c.A3957G:p.L1319L,UBR5:NM_015902:exon31:c.A3957G:p.L1319L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0990	0.1209	0.052516	0.1059	.	.	.	.	.	.	.	.	UBR5:uc003ykr.2:exon31:c.A3957G:p.L1319L,UBR5:uc003yks.2:exon31:c.A3957G:p.L1319L	.	AFR:0.0548,AMR:0.0526,EAS:0.0204,FIN:0.1329,NFE:0.1408,OTH:0.1082,ASJ:0.1424	608413	.	.	.	.	.	.	.	.	.	.	.	8	MU118082617	hom
8	103311667	103311667	T	G	UBR5	intronic	.	ENSG00000104517	rs36178006	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1010	0.1243	0.0569089	0.1102	.	.	.	.	.	.	.	.	.	.	AFR:0.0687,AMR:0.0561,EAS:0.0199,FIN:0.1332,NFE:0.1408,OTH:0.1133,ASJ:0.1424	608413	.	.	.	.	.	.	.	.	.	.	.	8	MU118406517	hom
8	108970367	108970367	A	G	RSPO2	exonic	nonsynonymous SNV	ENSG00000147655	rs601558	ENSG00000147655:ENST00000378439:exon4:c.T365C:p.L122P,ENSG00000147655:ENST00000517781:exon4:c.T365C:p.L122P,ENSG00000147655:ENST00000517939:exon4:c.T356C:p.L119P,ENSG00000147655:ENST00000521502:exon4:c.T356C:p.L119P,ENSG00000147655:ENST00000276659:exon5:c.T557C:p.L186P	RSPO2:NM_001282863:exon4:c.T365C:p.L122P,RSPO2:NM_001317942:exon4:c.T356C:p.L119P,RSPO2:NM_178565:exon5:c.T557C:p.L186P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5784	0.4729	0.490216	COCA-CN|6|321|0.0186916	2.545	19.76	0.655	4.95	0.759	.	.	Growth factor receptor cysteine-rich domain	RSPO2:uc003ymq.3:exon4:c.T356C:p.L119P,RSPO2:uc003ymr.3:exon4:c.T365C:p.L122P,RSPO2:uc003yms.3:exon5:c.T557C:p.L186P	-0.958	AFR:0.4824,AMR:0.1523,EAS:0.5894,FIN:0.7177,NFE:0.5967,OTH:0.6087,ASJ:0.6145	610575	.	.	.	.	.	.	.	0.0	-0.89	0.000	-1.44	8	1(large_intestine)	0.5543
8	109094747	109094747	C	T	RSPO2	intronic	.	ENSG00000147655	rs10955475	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2121	0.1575	0.195088	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841	.	.	.	.	.	.	.	.	.	.	AFR:0.1799,AMR:0.0557,EAS:0.1854,FIN:0.4333,NFE:0.2109,OTH:0.2170,ASJ:0.1563	610575	.	.	.	.	.	.	.	.	.	.	.	8	1(biliary_tract)	0.2098
8	109094803	109094803	G	A	RSPO2	exonic	stopgain	ENSG00000147655	.	ENSG00000147655:ENST00000521956:exon1:c.C64T:p.Q22X,ENSG00000147655:ENST00000276659:exon2:c.C64T:p.Q22X,ENSG00000147655:ENST00000378439:exon2:c.C64T:p.Q22X,ENSG00000147655:ENST00000517781:exon2:c.C64T:p.Q22X,ENSG00000147655:ENST00000522333:exon2:c.C64T:p.Q22X	RSPO2:NM_001282863:exon2:c.C64T:p.Q22X,RSPO2:NM_178565:exon2:c.C64T:p.Q22X	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	12.089	38	.	5.57	1.000	.	.	.	RSPO2:uc003ymr.3:exon2:c.C64T:p.Q22X,RSPO2:uc003yms.3:exon2:c.C64T:p.Q22X	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	610575	.	.	.	.	.	.	.	.	.	.	.	8	.	hom
8	117864217	117864217	A	G	RAD21	exonic	synonymous SNV	ENSG00000164754	rs1050838	ENSG00000164754:ENST00000518055:exon1:c.T75C:p.A25A,ENSG00000164754:ENST00000297338:exon11:c.T1440C:p.A480A	RAD21:NM_006265:exon11:c.T1440C:p.A480A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1728	0.1241	0.133187	1(large_intestine)	.	.	.	.	.	.	.	.	RAD21:uc003yod.3:exon11:c.T1440C:p.A480A	.	AFR:MU134726,AMR:LAML-KR|3|205|0.0146341,COCA-CN|4|321|0.0124611,EAS:0.0303,FIN:0.2363,NFE:0.2450,OTH:0.1735,ASJ:0.1372	606462	614701;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	,9365	.	.	.	.	.	.	8	8(soft_tissue)	0.1703
8	117868531	117868531	-	AA	RAD21	intronic	.	ENSG00000164754	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606462	614701;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	.	.	.	.	.	.	.	8	.	hom
8	128750681	128750681	C	A	MYC	exonic	nonsynonymous SNV	ENSG00000136997	.	ENSG00000136997:ENST00000259523:exon2:c.C173A:p.T58N,ENSG00000136997:ENST00000377970:exon2:c.C218A:p.T73N,ENSG00000136997:ENST00000520751:exon2:c.C139A:p.P47T,ENSG00000136997:ENST00000524013:exon2:c.C215A:p.T72N,ENSG00000136997:ENST00000517291:exon3:c.C215A:p.T72N	MYC:NM_001354870:exon2:c.C215A:p.T72N,MYC:NM_002467:exon2:c.C218A:p.T73N	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 2, 1, 1, 0] 	.	.	.	.	5.783	27.1	0.013	4.78	1.000	.	.	Transcription regulator Myc, N-terminal	MYC:uc003ysi.3:exon2:c.C218A:p.T73N,MYC:uc022bbe.1:exon2:c.C173A:p.T58N,MYC:uc003ysh.1:exon3:c.C173A:p.T58N	-0.525	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	190080	113970;	543;	543|Small non-cleaved cell lymphoma|Unknown|Not applicable|All ages|113970 ~	~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04110 Cell cycle~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04310 Wnt signaling pathway~ko04350 TGF-beta signaling pathway~ko04390 Hippo signaling pathway~ko04391 Hippo signaling pathway - fly~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05216 Thyroid cancer~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	0.997	1.55	0.239	3.195	8	MU69532170	hom
8	144991176	144991176	T	C	PLEC	exonic	synonymous SNV	ENSG00000178209	rs6558405	ENSG00000178209:ENST00000322810:exon32:c.A13224G:p.S4408S,ENSG00000178209:ENST00000345136:exon32:c.A12813G:p.S4271S,ENSG00000178209:ENST00000354589:exon32:c.A12813G:p.S4271S,ENSG00000178209:ENST00000354958:exon32:c.A12747G:p.S4249S,ENSG00000178209:ENST00000356346:exon32:c.A12771G:p.S4257S,ENSG00000178209:ENST00000357649:exon32:c.A12825G:p.S4275S,ENSG00000178209:ENST00000398774:exon32:c.A12717G:p.S4239S,ENSG00000178209:ENST00000527096:exon32:c.A12882G:p.S4294S,ENSG00000178209:ENST00000436759:exon33:c.A12894G:p.S4298S	PLEC:NM_201378:exon32:c.A12771G:p.S4257S,PLEC:NM_201379:exon32:c.A12747G:p.S4249S,PLEC:NM_201380:exon32:c.A13224G:p.S4408S,PLEC:NM_201381:exon32:c.A12717G:p.S4239S,PLEC:NM_201382:exon32:c.A12813G:p.S4271S,PLEC:NM_201383:exon32:c.A12825G:p.S4275S,PLEC:NM_201384:exon32:c.A12813G:p.S4271S,PLEC:NM_000445:exon33:c.A12894G:p.S4298S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4190	0.5655	0.478435	MU99304	.	.	.	.	.	.	.	.	PLEC:uc003zab.1:exon32:c.A12813G:p.S4271S,PLEC:uc003zac.1:exon32:c.A12825G:p.S4275S,PLEC:uc003zad.2:exon32:c.A12813G:p.S4271S,PLEC:uc003zae.1:exon32:c.A12717G:p.S4239S,PLEC:uc003zaf.1:exon32:c.A13224G:p.S4408S,PLEC:uc003zag.1:exon32:c.A12747G:p.S4249S,PLEC:uc003zah.2:exon32:c.A12771G:p.S4257S,PLEC:uc003zaj.2:exon33:c.A12894G:p.S4298S	.	AFR:LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,AMR:0.5197,EAS:0.3577,FIN:0.4667,NFE:0.1434,OTH:0.4102,ASJ:0.8382	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	.	.	.	.	8	1(large_intestine)	0.4164
8	144996408	144996408	T	G	PLEC	exonic	synonymous SNV	ENSG00000178209	rs11778026	ENSG00000178209:ENST00000322810:exon32:c.A7992C:p.A2664A,ENSG00000178209:ENST00000345136:exon32:c.A7581C:p.A2527A,ENSG00000178209:ENST00000354589:exon32:c.A7581C:p.A2527A,ENSG00000178209:ENST00000354958:exon32:c.A7515C:p.A2505A,ENSG00000178209:ENST00000356346:exon32:c.A7539C:p.A2513A,ENSG00000178209:ENST00000357649:exon32:c.A7593C:p.A2531A,ENSG00000178209:ENST00000398774:exon32:c.A7485C:p.A2495A,ENSG00000178209:ENST00000527096:exon32:c.A7650C:p.A2550A,ENSG00000178209:ENST00000436759:exon33:c.A7662C:p.A2554A	PLEC:NM_201378:exon32:c.A7539C:p.A2513A,PLEC:NM_201379:exon32:c.A7515C:p.A2505A,PLEC:NM_201380:exon32:c.A7992C:p.A2664A,PLEC:NM_201381:exon32:c.A7485C:p.A2495A,PLEC:NM_201382:exon32:c.A7581C:p.A2527A,PLEC:NM_201383:exon32:c.A7593C:p.A2531A,PLEC:NM_201384:exon32:c.A7581C:p.A2527A,PLEC:NM_000445:exon33:c.A7662C:p.A2554A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4297	0.2950	0.23103	MU119760	.	.	.	.	.	.	.	.	PLEC:uc003zab.1:exon32:c.A7581C:p.A2527A,PLEC:uc003zac.1:exon32:c.A7593C:p.A2531A,PLEC:uc003zad.2:exon32:c.A7581C:p.A2527A,PLEC:uc003zae.1:exon32:c.A7485C:p.A2495A,PLEC:uc003zaf.1:exon32:c.A7992C:p.A2664A,PLEC:uc003zag.1:exon32:c.A7515C:p.A2505A,PLEC:uc003zah.2:exon32:c.A7539C:p.A2513A,PLEC:uc003zaj.2:exon33:c.A7662C:p.A2554A	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841,AMR:0.2961,EAS:0.2990,FIN:0.4603,NFE:0.1401,OTH:0.4014,ASJ:0.0856	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	.	.	.	.	8	1(kidney)	0.4022
8	144999417	144999417	C	T	PLEC	exonic	synonymous SNV	ENSG00000178209	rs55836855	ENSG00000178209:ENST00000322810:exon31:c.G5091A:p.A1697A,ENSG00000178209:ENST00000345136:exon31:c.G4680A:p.A1560A,ENSG00000178209:ENST00000354589:exon31:c.G4680A:p.A1560A,ENSG00000178209:ENST00000354958:exon31:c.G4614A:p.A1538A,ENSG00000178209:ENST00000356346:exon31:c.G4638A:p.A1546A,ENSG00000178209:ENST00000357649:exon31:c.G4692A:p.A1564A,ENSG00000178209:ENST00000398774:exon31:c.G4584A:p.A1528A,ENSG00000178209:ENST00000527096:exon31:c.G4749A:p.A1583A,ENSG00000178209:ENST00000436759:exon32:c.G4761A:p.A1587A	PLEC:NM_201378:exon31:c.G4638A:p.A1546A,PLEC:NM_201379:exon31:c.G4614A:p.A1538A,PLEC:NM_201380:exon31:c.G5091A:p.A1697A,PLEC:NM_201381:exon31:c.G4584A:p.A1528A,PLEC:NM_201382:exon31:c.G4680A:p.A1560A,PLEC:NM_201383:exon31:c.G4692A:p.A1564A,PLEC:NM_201384:exon31:c.G4680A:p.A1560A,PLEC:NM_000445:exon32:c.G4761A:p.A1587A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3759	0.2681	0.230831	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PLEC:uc003zab.1:exon31:c.G4680A:p.A1560A,PLEC:uc003zac.1:exon31:c.G4692A:p.A1564A,PLEC:uc003zad.2:exon31:c.G4680A:p.A1560A,PLEC:uc003zae.1:exon31:c.G4584A:p.A1528A,PLEC:uc003zaf.1:exon31:c.G5091A:p.A1697A,PLEC:uc003zag.1:exon31:c.G4614A:p.A1538A,PLEC:uc003zah.2:exon31:c.G4638A:p.A1546A,PLEC:uc003zaj.2:exon32:c.G4761A:p.A1587A	.	AFR:0.2960,AMR:0.0861,EAS:0.4633,FIN:0.1395,NFE:0.4021,OTH:0.4017,ASJ:0.2993	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	.	.	.	.	8	1(liver)	0.3804
8	145001031	145001031	T	C	PLEC	exonic	nonsynonymous SNV	ENSG00000178209	rs55895668	ENSG00000178209:ENST00000322810:exon30:c.A4376G:p.H1459R,ENSG00000178209:ENST00000345136:exon30:c.A3965G:p.H1322R,ENSG00000178209:ENST00000354589:exon30:c.A3965G:p.H1322R,ENSG00000178209:ENST00000354958:exon30:c.A3899G:p.H1300R,ENSG00000178209:ENST00000356346:exon30:c.A3923G:p.H1308R,ENSG00000178209:ENST00000357649:exon30:c.A3977G:p.H1326R,ENSG00000178209:ENST00000398774:exon30:c.A3869G:p.H1290R,ENSG00000178209:ENST00000527096:exon30:c.A4034G:p.H1345R,ENSG00000178209:ENST00000436759:exon31:c.A4046G:p.H1349R	PLEC:NM_201378:exon30:c.A3923G:p.H1308R,PLEC:NM_201379:exon30:c.A3899G:p.H1300R,PLEC:NM_201380:exon30:c.A4376G:p.H1459R,PLEC:NM_201381:exon30:c.A3869G:p.H1290R,PLEC:NM_201382:exon30:c.A3965G:p.H1322R,PLEC:NM_201383:exon30:c.A3977G:p.H1326R,PLEC:NM_201384:exon30:c.A3965G:p.H1322R,PLEC:NM_000445:exon31:c.A4046G:p.H1349R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4128	0.5616	0.466653	1(stomach)	-0.096	1.761	1.0	3.9	0.417	.	.	.	PLEC:uc003zab.1:exon30:c.A3965G:p.H1322R,PLEC:uc003zac.1:exon30:c.A3977G:p.H1326R,PLEC:uc003zad.2:exon30:c.A3965G:p.H1322R,PLEC:uc003zae.1:exon30:c.A3869G:p.H1290R,PLEC:uc003zaf.1:exon30:c.A4376G:p.H1459R,PLEC:uc003zag.1:exon30:c.A3899G:p.H1300R,PLEC:uc003zah.2:exon30:c.A3923G:p.H1308R,PLEC:uc003zaj.2:exon31:c.A4046G:p.H1349R	-1.000	AFR:3(large_intestine),AMR:MU146324,EAS:0.5112,FIN:0.8231,NFE:0.3568,OTH:0.4702,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	0.0	1.71	0.000	-1.7	8	3(lung)	0.1383
8	145004546	145004546	G	A	PLEC	intronic	.	ENSG00000178209	rs11780911	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7411	0.6988	0.571885	0.6622	.	.	.	.	.	0	0.004	.	.	.	AFR:0.3862,AMR:0.6411,EAS:0.6188,FIN:0.7603,NFE:0.7994,OTH:0.7162,ASJ:0.78	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	.	.	.	.	8	MU81858392	hom
8	145006790	145006790	T	C	PLEC	intronic	.	ENSG00000178209	rs10866916	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3598	0.3815	0.327476	0.3795	.	.	.	.	.	.	.	.	.	.	AFR:0.4187,AMR:0.3098,EAS:0.1439,FIN:0.3917,NFE:0.3815,OTH:0.3834,ASJ:0.4570	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	.	.	.	.	8	MU81858402	hom
8	145007187	145007187	G	A	PLEC	exonic	nonsynonymous SNV	ENSG00000178209	rs11136336	ENSG00000178209:ENST00000322810:exon14:c.C1922T:p.A641V,ENSG00000178209:ENST00000345136:exon14:c.C1511T:p.A504V,ENSG00000178209:ENST00000354589:exon14:c.C1511T:p.A504V,ENSG00000178209:ENST00000354958:exon14:c.C1445T:p.A482V,ENSG00000178209:ENST00000356346:exon14:c.C1469T:p.A490V,ENSG00000178209:ENST00000357649:exon14:c.C1523T:p.A508V,ENSG00000178209:ENST00000398774:exon14:c.C1415T:p.A472V,ENSG00000178209:ENST00000527096:exon14:c.C1580T:p.A527V,ENSG00000178209:ENST00000436759:exon15:c.C1592T:p.A531V,ENSG00000178209:ENST00000528025:exon16:c.C1643T:p.A548V	PLEC:NM_201378:exon14:c.C1469T:p.A490V,PLEC:NM_201379:exon14:c.C1445T:p.A482V,PLEC:NM_201380:exon14:c.C1922T:p.A641V,PLEC:NM_201381:exon14:c.C1415T:p.A472V,PLEC:NM_201382:exon14:c.C1511T:p.A504V,PLEC:NM_201383:exon14:c.C1523T:p.A508V,PLEC:NM_201384:exon14:c.C1511T:p.A504V,PLEC:NM_000445:exon15:c.C1592T:p.A531V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3669	0.2896	0.23143	MU146334	1.450	13.05	0.569	3.92	0.906	.	.	.	PLEC:uc003zab.1:exon14:c.C1511T:p.A504V,PLEC:uc003zac.1:exon14:c.C1523T:p.A508V,PLEC:uc003zad.2:exon14:c.C1511T:p.A504V,PLEC:uc003zae.1:exon14:c.C1415T:p.A472V,PLEC:uc003zaf.1:exon14:c.C1922T:p.A641V,PLEC:uc003zag.1:exon14:c.C1445T:p.A482V,PLEC:uc003zah.2:exon14:c.C1469T:p.A490V,PLEC:uc003zaj.2:exon15:c.C1592T:p.A531V	-1.073	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841,AMR:0.2890,EAS:0.2843,FIN:0.4570,NFE:0.1512,OTH:0.3921,ASJ:0.1043	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	0.0	-1.03	0.000	1.04	8	1(liver)	0.3792
8	145007534	145007534	C	T	PLEC	intronic	.	ENSG00000178209	rs7003580	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3804	0.4671	0.398363	0.4430	.	.	.	.	.	.	.	.	.	.	AFR:0.6291,AMR:0.3254,EAS:0.1518,FIN:0.3937,NFE:0.3873,OTH:0.3938,ASJ:0.4570	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	.	.	.	.	8	MU32515755	hom
8	145008560	145008560	A	G	PLEC	exonic	synonymous SNV	ENSG00000178209	rs11783799	ENSG00000178209:ENST00000322810:exon11:c.T1506C:p.D502D,ENSG00000178209:ENST00000345136:exon11:c.T1095C:p.D365D,ENSG00000178209:ENST00000354589:exon11:c.T1095C:p.D365D,ENSG00000178209:ENST00000354958:exon11:c.T1029C:p.D343D,ENSG00000178209:ENST00000356346:exon11:c.T1053C:p.D351D,ENSG00000178209:ENST00000357649:exon11:c.T1107C:p.D369D,ENSG00000178209:ENST00000398774:exon11:c.T999C:p.D333D,ENSG00000178209:ENST00000527096:exon11:c.T1164C:p.D388D,ENSG00000178209:ENST00000436759:exon12:c.T1176C:p.D392D,ENSG00000178209:ENST00000528025:exon13:c.T1227C:p.D409D	PLEC:NM_201378:exon11:c.T1053C:p.D351D,PLEC:NM_201379:exon11:c.T1029C:p.D343D,PLEC:NM_201380:exon11:c.T1506C:p.D502D,PLEC:NM_201381:exon11:c.T999C:p.D333D,PLEC:NM_201382:exon11:c.T1095C:p.D365D,PLEC:NM_201383:exon11:c.T1107C:p.D369D,PLEC:NM_201384:exon11:c.T1095C:p.D365D,PLEC:NM_000445:exon12:c.T1176C:p.D392D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3302	0.2925	0.23143	1(liver)	.	.	.	.	.	.	.	.	PLEC:uc003zab.1:exon11:c.T1095C:p.D365D,PLEC:uc003zac.1:exon11:c.T1107C:p.D369D,PLEC:uc003zad.2:exon11:c.T1095C:p.D365D,PLEC:uc003zae.1:exon11:c.T999C:p.D333D,PLEC:uc003zaf.1:exon11:c.T1506C:p.D502D,PLEC:uc003zag.1:exon11:c.T1029C:p.D343D,PLEC:uc003zah.2:exon11:c.T1053C:p.D351D,PLEC:uc003zaj.2:exon12:c.T1176C:p.D392D	.	AFR:MU146346,AMR:LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841,ESCA-CN|1|332|0.00301205,EAS:0.1067,FIN:0.2876,NFE:0.4570,OTH:0.1528,ASJ:0.2904	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	.	.	.	.	8	1(oesophagus)	0.3924
8	145011204	145011204	A	G	PLEC	exonic	synonymous SNV	ENSG00000178209	rs6993938	ENSG00000178209:ENST00000322810:exon5:c.T789C:p.A263A,ENSG00000178209:ENST00000345136:exon5:c.T378C:p.A126A,ENSG00000178209:ENST00000354589:exon5:c.T378C:p.A126A,ENSG00000178209:ENST00000354958:exon5:c.T312C:p.A104A,ENSG00000178209:ENST00000356346:exon5:c.T336C:p.A112A,ENSG00000178209:ENST00000357649:exon5:c.T390C:p.A130A,ENSG00000178209:ENST00000398774:exon5:c.T282C:p.A94A,ENSG00000178209:ENST00000526416:exon5:c.T309C:p.A103A,ENSG00000178209:ENST00000527096:exon5:c.T459C:p.A153A,ENSG00000178209:ENST00000527816:exon5:c.T96C:p.A32A,ENSG00000178209:ENST00000528131:exon5:c.T429C:p.A143A,ENSG00000178209:ENST00000436759:exon6:c.T459C:p.A153A,ENSG00000178209:ENST00000528025:exon7:c.T510C:p.A170A	PLEC:NM_201378:exon5:c.T336C:p.A112A,PLEC:NM_201379:exon5:c.T312C:p.A104A,PLEC:NM_201380:exon5:c.T789C:p.A263A,PLEC:NM_201381:exon5:c.T282C:p.A94A,PLEC:NM_201382:exon5:c.T378C:p.A126A,PLEC:NM_201383:exon5:c.T390C:p.A130A,PLEC:NM_201384:exon5:c.T378C:p.A126A,PLEC:NM_000445:exon6:c.T459C:p.A153A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3303	0.2923	0.232428	1(large_intestine)	.	.	.	.	.	.	.	.	PLEC:uc003zab.1:exon5:c.T378C:p.A126A,PLEC:uc003zac.1:exon5:c.T390C:p.A130A,PLEC:uc003zad.2:exon5:c.T378C:p.A126A,PLEC:uc003zae.1:exon5:c.T282C:p.A94A,PLEC:uc003zaf.1:exon5:c.T789C:p.A263A,PLEC:uc003zag.1:exon5:c.T312C:p.A104A,PLEC:uc003zah.2:exon5:c.T336C:p.A112A,PLEC:uc003zaj.2:exon6:c.T459C:p.A153A	.	AFR:MU146351,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.1065,FIN:0.2876,NFE:0.4564,OTH:0.1562,ASJ:0.2898	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	.	.	.	.	8	1(stomach)	0.3923
8	145737636	145737636	A	G	RECQL4	exonic	synonymous SNV	ENSG00000160957	rs4925828	ENSG00000160957:ENST00000428558:exon19:c.T3127C:p.L1043L	RECQL4:NM_004260:exon19:c.T3127C:p.L1043L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9728	0.9984	0.946086	0.9838	.	.	.	.	.	.	.	.	RECQL4:uc003zdj.3:exon19:c.T3127C:p.L1043L	.	AFR:0.9944,AMR:0.9224,EAS:0.7879,FIN:0.9960,NFE:0.9989,OTH:0.9878,ASJ:1	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU4561850	hom
8	145738582	145738583	GG	-	RECQL4	intronic	.	ENSG00000265393	rs565544396	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.4121	.	0.539537	0.4380	.	.	.	.	.	.	.	.	.	.	AFR:0.2800,AMR:0.4963,EAS:0.5041,FIN:0.4776,NFE:0.5102,OTH:0.4876,ASJ:0.4936	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	.	hom
9	390512	390512	C	T	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs2297075	ENSG00000107099:ENST00000382331:exon10:c.C822T:p.T274T,ENSG00000107099:ENST00000382329:exon11:c.C1317T:p.T439T,ENSG00000107099:ENST00000469391:exon22:c.C2616T:p.T872T,ENSG00000107099:ENST00000432829:exon24:c.C2712T:p.T904T,ENSG00000107099:ENST00000453981:exon24:c.C2916T:p.T972T	DOCK8:NM_001190458:exon22:c.C2616T:p.T872T,DOCK8:NM_001193536:exon23:c.C2712T:p.T904T,DOCK8:NM_203447:exon24:c.C2916T:p.T972T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2344	0.2850	0.254992	6(lung)	.	.	.	.	.	.	.	.	DOCK8:uc010mgw.2:exon10:c.C822T:p.T274T,DOCK8:uc003zgk.2:exon11:c.C1290T:p.T430T,DOCK8:uc010mgu.3:exon22:c.C822T:p.T274T,DOCK8:uc010mgv.3:exon22:c.C2616T:p.T872T,DOCK8:uc022bcu.1:exon23:c.C2712T:p.T904T,DOCK8:uc003zgf.2:exon24:c.C2916T:p.T972T	.	AFR:MU137638,AMR:PACA-CA|1|268|0.00373134,LUSC-KR|6|170|0.0352941,EAS:0.3682,FIN:0.2017,NFE:0.2086,OTH:0.0641,ASJ:0.2589	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	1(large_intestine)	0.1989
9	421032	421032	C	G	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs2297079	ENSG00000107099:ENST00000382329:exon19:c.C2508G:p.L836L,ENSG00000107099:ENST00000469391:exon30:c.C3807G:p.L1269L,ENSG00000107099:ENST00000432829:exon32:c.C3903G:p.L1301L,ENSG00000107099:ENST00000453981:exon32:c.C4107G:p.L1369L	DOCK8:NM_001190458:exon30:c.C3807G:p.L1269L,DOCK8:NM_001193536:exon31:c.C3903G:p.L1301L,DOCK8:NM_203447:exon32:c.C4107G:p.L1369L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5094	0.4626	0.391773	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	DOCK8:uc003zgk.2:exon19:c.C2481G:p.L827L,DOCK8:uc010mgu.3:exon30:c.C2013G:p.L671L,DOCK8:uc010mgv.3:exon30:c.C3807G:p.L1269L,DOCK8:uc022bcu.1:exon31:c.C3903G:p.L1301L,DOCK8:uc003zgf.2:exon32:c.C4107G:p.L1369L	.	AFR:0.4491,AMR:0.1521,EAS:0.4801,FIN:0.5155,NFE:0.4814,OTH:0.6050,ASJ:0.4354	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	1(large_intestine)	0.4837
9	429719	429719	T	C	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs7854035	ENSG00000107099:ENST00000382329:exon23:c.T2892C:p.F964F,ENSG00000107099:ENST00000469391:exon34:c.T4191C:p.F1397F,ENSG00000107099:ENST00000432829:exon36:c.T4287C:p.F1429F,ENSG00000107099:ENST00000453981:exon36:c.T4491C:p.F1497F	DOCK8:NM_001190458:exon34:c.T4191C:p.F1397F,DOCK8:NM_001193536:exon35:c.T4287C:p.F1429F,DOCK8:NM_203447:exon36:c.T4491C:p.F1497F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9978	0.9968	0.999401	0.9979	.	.	.	.	.	.	.	.	DOCK8:uc003zgk.2:exon23:c.T2865C:p.F955F,DOCK8:uc010mgu.3:exon34:c.T2397C:p.F799F,DOCK8:uc010mgv.3:exon34:c.T4191C:p.F1397F,DOCK8:uc022bcu.1:exon35:c.T4287C:p.F1429F,DOCK8:uc003zgf.2:exon36:c.T4491C:p.F1497F	.	AFR:0.9993,AMR:0.9928,EAS:1,FIN:0.9997,NFE:0.9965,OTH:1,ASJ:1	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU81859376	hom
9	432330	432330	C	G	DOCK8	intronic	.	ENSG00000107099	rs7036567	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7577	0.6692	0.714257	0.7017	.	.	.	.	.	0.0001	0.042	.	.	.	AFR:0.4865,AMR:0.8305,EAS:0.9870,FIN:0.8003,NFE:0.7628,OTH:0.7351,ASJ:0.7417	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU81859387	hom
9	433978	433978	A	G	DOCK8	intronic	.	ENSG00000107099	rs2360712	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7588	0.6749	0.721046	0.7071	.	.	.	.	.	0.0041	0.204	.	.	.	AFR:0.5078,AMR:0.8313,EAS:0.9871,FIN:0.7994,NFE:0.7610,OTH:0.7383,ASJ:0.7417	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU81859414	hom
9	441952	441952	G	A	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs1887957	ENSG00000107099:ENST00000382329:exon29:c.G3834A:p.E1278E,ENSG00000107099:ENST00000469391:exon40:c.G5133A:p.E1711E,ENSG00000107099:ENST00000432829:exon42:c.G5229A:p.E1743E,ENSG00000107099:ENST00000453981:exon42:c.G5433A:p.E1811E	DOCK8:NM_001190458:exon40:c.G5133A:p.E1711E,DOCK8:NM_001193536:exon41:c.G5229A:p.E1743E,DOCK8:NM_203447:exon42:c.G5433A:p.E1811E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8201	0.7429	0.803914	0.7641	.	.	.	.	.	.	.	.	DOCK8:uc003zgk.2:exon29:c.G3807A:p.E1269E,DOCK8:uc010mgu.3:exon40:c.G3339A:p.E1113E,DOCK8:uc010mgv.3:exon40:c.G5133A:p.E1711E,DOCK8:uc022bcu.1:exon41:c.G5229A:p.E1743E,DOCK8:uc003zgf.2:exon42:c.G5433A:p.E1811E	.	AFR:0.5880,AMR:0.8795,EAS:0.9981,FIN:0.8293,NFE:0.8162,OTH:0.8020,ASJ:0.8013	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU4566310	hom
9	446352	446352	G	C	DOCK8	intronic	.	ENSG00000107099	rs10814952	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6887	0.5583	0.632987	0.5990	.	.	.	.	.	.	.	.	.	.	AFR:0.2953,AMR:0.7852,EAS:0.9858,FIN:0.7018,NFE:0.6930,OTH:0.6837,ASJ:0.6457	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU32516518	hom
9	732536	732536	T	C	KANK1	exonic	nonsynonymous SNV	ENSG00000107104	rs34832656	ENSG00000107104:ENST00000382289:exon1:c.T95C:p.I32T,ENSG00000107104:ENST00000382293:exon5:c.T2690C:p.I897T,ENSG00000107104:ENST00000382297:exon6:c.T3164C:p.I1055T,ENSG00000107104:ENST00000382303:exon10:c.T3164C:p.I1055T	KANK1:NM_001354335:exon5:c.T2690C:p.I897T,KANK1:NM_001354337:exon5:c.T2690C:p.I897T,KANK1:NM_001354338:exon5:c.T2636C:p.I879T,KANK1:NM_001354340:exon5:c.T2636C:p.I879T,KANK1:NM_001354341:exon5:c.T2690C:p.I897T,KANK1:NM_001354344:exon5:c.T2636C:p.I879T,KANK1:NM_153186:exon5:c.T2690C:p.I897T,KANK1:NM_001354332:exon6:c.T3110C:p.I1037T,KANK1:NM_001354333:exon6:c.T2690C:p.I897T,KANK1:NM_015158:exon6:c.T3164C:p.I1055T,KANK1:NM_001256877:exon7:c.T3164C:p.I1055T,KANK1:NM_001354334:exon7:c.T3164C:p.I1055T,KANK1:NM_001256876:exon10:c.T3164C:p.I1055T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1539	0.1801	0.125998	0.1612	-0.554	0.162	0.572	0.228	0.999	.	.	Ankyrin repeat-containing domain	KANK1:uc010mgx.2:exon1:c.T29C:p.I10T,KANK1:uc003zgs.2:exon5:c.T2690C:p.I897T,KANK1:uc003zgn.2:exon6:c.T3164C:p.I1055T,KANK1:uc031tct.1:exon7:c.T3164C:p.I1055T,KANK1:uc003zgl.2:exon10:c.T3164C:p.I1055T	-1.033	AFR:0.1808,AMR:0.2249,EAS:0.0006,FIN:0.1395,NFE:0.1688,OTH:0.1551,ASJ:0.1689	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	0.004	0.91	0.000	0.76	9	MU13487669	het
9	740770	740775	TTTTTT	-	KANK1	intronic	.	ENSG00000107104	rs368007873	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.3271	.	0.417732	0.3401	.	.	.	.	.	.	.	.	.	.	AFR:0.3280,AMR:0.2619,EAS:0.1738,FIN:0.4033,NFE:0.3595,OTH:0.3548,ASJ:0.2581	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	.	hom
9	740901	740901	C	T	KANK1	exonic	synonymous SNV	ENSG00000107104	rs2296049	ENSG00000107104:ENST00000382286:exon4:c.C420T:p.F140F,ENSG00000107104:ENST00000382289:exon5:c.C663T:p.F221F,ENSG00000107104:ENST00000382293:exon8:c.C3189T:p.F1063F,ENSG00000107104:ENST00000382297:exon9:c.C3663T:p.F1221F,ENSG00000107104:ENST00000382303:exon13:c.C3663T:p.F1221F	KANK1:NM_001354336:exon7:c.C2895T:p.F965F,KANK1:NM_001354339:exon7:c.C2949T:p.F983F,KANK1:NM_001354342:exon7:c.C2949T:p.F983F,KANK1:NM_001354343:exon7:c.C2949T:p.F983F,KANK1:NM_001354331:exon8:c.C3423T:p.F1141F,KANK1:NM_001354335:exon8:c.C3189T:p.F1063F,KANK1:NM_001354337:exon8:c.C3189T:p.F1063F,KANK1:NM_001354338:exon8:c.C3135T:p.F1045F,KANK1:NM_001354340:exon8:c.C3135T:p.F1045F,KANK1:NM_001354341:exon8:c.C3189T:p.F1063F,KANK1:NM_001354344:exon8:c.C3135T:p.F1045F,KANK1:NM_153186:exon8:c.C3189T:p.F1063F,KANK1:NM_001354332:exon9:c.C3609T:p.F1203F,KANK1:NM_001354333:exon9:c.C3189T:p.F1063F,KANK1:NM_015158:exon9:c.C3663T:p.F1221F,KANK1:NM_001256877:exon10:c.C3663T:p.F1221F,KANK1:NM_001354334:exon10:c.C3663T:p.F1221F,KANK1:NM_001256876:exon13:c.C3663T:p.F1221F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2418	0.2793	0.265974	0.2654	.	.	.	.	.	.	.	.	KANK1:uc003zgt.1:exon3:c.C399T:p.F133F,KANK1:uc010mgy.2:exon3:c.C399T:p.F133F,KANK1:uc010mgx.2:exon5:c.C597T:p.F199F,KANK1:uc003zgs.2:exon8:c.C3189T:p.F1063F,KANK1:uc003zgn.2:exon9:c.C3663T:p.F1221F,KANK1:uc031tct.1:exon10:c.C3663T:p.F1221F,KANK1:uc003zgl.2:exon13:c.C3663T:p.F1221F	.	AFR:0.3983,AMR:0.3732,EAS:0.2206,FIN:0.1804,NFE:0.2117,OTH:0.2086,ASJ:0.2020	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	MU587925	het
9	742342	742342	A	G	KANK1	exonic	synonymous SNV	ENSG00000107104	rs10733535	ENSG00000107104:ENST00000382286:exon5:c.A591G:p.G197G,ENSG00000107104:ENST00000382289:exon6:c.A834G:p.G278G,ENSG00000107104:ENST00000382293:exon9:c.A3360G:p.G1120G,ENSG00000107104:ENST00000382297:exon10:c.A3834G:p.G1278G,ENSG00000107104:ENST00000382303:exon14:c.A3834G:p.G1278G	KANK1:NM_001354336:exon8:c.A3066G:p.G1022G,KANK1:NM_001354339:exon8:c.A3120G:p.G1040G,KANK1:NM_001354342:exon8:c.A3120G:p.G1040G,KANK1:NM_001354343:exon8:c.A3120G:p.G1040G,KANK1:NM_001354331:exon9:c.A3594G:p.G1198G,KANK1:NM_001354335:exon9:c.A3360G:p.G1120G,KANK1:NM_001354337:exon9:c.A3360G:p.G1120G,KANK1:NM_001354338:exon9:c.A3306G:p.G1102G,KANK1:NM_001354340:exon9:c.A3306G:p.G1102G,KANK1:NM_001354341:exon9:c.A3360G:p.G1120G,KANK1:NM_001354344:exon9:c.A3306G:p.G1102G,KANK1:NM_153186:exon9:c.A3360G:p.G1120G,KANK1:NM_001354332:exon10:c.A3780G:p.G1260G,KANK1:NM_001354333:exon10:c.A3360G:p.G1120G,KANK1:NM_015158:exon10:c.A3834G:p.G1278G,KANK1:NM_001256877:exon11:c.A3834G:p.G1278G,KANK1:NM_001354334:exon11:c.A3834G:p.G1278G,KANK1:NM_001256876:exon14:c.A3834G:p.G1278G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9953	0.9934	0.997604	0.9934	.	.	.	.	.	.	.	.	KANK1:uc003zgt.1:exon4:c.A570G:p.G190G,KANK1:uc010mgy.2:exon4:c.A570G:p.G190G,KANK1:uc010mgx.2:exon6:c.A768G:p.G256G,KANK1:uc003zgs.2:exon9:c.A3360G:p.G1120G,KANK1:uc003zgn.2:exon10:c.A3834G:p.G1278G,KANK1:uc031tct.1:exon11:c.A3834G:p.G1278G,KANK1:uc003zgl.2:exon14:c.A3834G:p.G1278G	.	AFR:0.9989,AMR:0.9916,EAS:1,FIN:0.9989,NFE:0.9887,OTH:0.9878,ASJ:1	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	MU93460	hom
9	2081838	2081838	G	T	SMARCA2	exonic	nonsynonymous SNV	ENSG00000080503	.	ENSG00000080503:ENST00000382194:exon14:c.G2191T:p.G731C,ENSG00000080503:ENST00000349721:exon15:c.G2191T:p.G731C,ENSG00000080503:ENST00000357248:exon15:c.G2191T:p.G731C,ENSG00000080503:ENST00000382203:exon15:c.G2191T:p.G731C	SMARCA2:NM_001289396:exon15:c.G2191T:p.G731C,SMARCA2:NM_001289397:exon15:c.G2191T:p.G731C,SMARCA2:NM_003070:exon15:c.G2191T:p.G731C,SMARCA2:NM_139045:exon15:c.G2191T:p.G731C	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 2, 0, 0] 	.	.	.	.	6.744	32	0.0	5.52	1.000	.	.	Helicase superfamily 1/2, ATP-binding domain|P-loop containing nucleoside triphosphate hydrolase	SMARCA2:uc003zhc.3:exon15:c.G2191T:p.G731C,SMARCA2:uc003zhd.3:exon15:c.G2191T:p.G731C,SMARCA2:uc010mha.3:exon15:c.G2164T:p.G722C	1.080	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600014	601358;	3051;	3051|Nicolaides-Baraitser syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|601358 ~	.	.	.	.	1.0	-3.41	0.934	4.025	9	.	hom
9	2191388	2191388	G	A	SMARCA2	exonic	nonsynonymous SNV	ENSG00000080503	rs61736899	ENSG00000080503:ENST00000382183:exon6:c.G655A:p.D219N,ENSG00000080503:ENST00000302401:exon7:c.G781A:p.D261N,ENSG00000080503:ENST00000417599:exon7:c.G775A:p.D259N,ENSG00000080503:ENST00000324954:exon8:c.G655A:p.D219N,ENSG00000080503:ENST00000382185:exon8:c.G655A:p.D219N,ENSG00000080503:ENST00000382186:exon8:c.G709A:p.D237N,ENSG00000080503:ENST00000382194:exon31:c.G4663A:p.D1555N,ENSG00000080503:ENST00000357248:exon32:c.G4663A:p.D1555N,ENSG00000080503:ENST00000349721:exon33:c.G4717A:p.D1573N,ENSG00000080503:ENST00000382203:exon33:c.G4717A:p.D1573N	SMARCA2:NM_001289398:exon6:c.G691A:p.D231N,SMARCA2:NM_001289399:exon7:c.G775A:p.D259N,SMARCA2:NM_001289400:exon7:c.G781A:p.D261N,SMARCA2:NM_001289397:exon32:c.G4489A:p.D1497N,SMARCA2:NM_139045:exon32:c.G4663A:p.D1555N,SMARCA2:NM_001289396:exon33:c.G4717A:p.D1573N,SMARCA2:NM_003070:exon33:c.G4717A:p.D1573N	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, 1, 0, 0] 	0.0008	0.0012	0.000199681	0.0008	6.072	28.1	0.005	5.82	0.993	.	.	.	SMARCA2:uc010mhb.3:exon6:c.G727A:p.D243N,SMARCA2:uc003zhe.3:exon7:c.G781A:p.D261N,SMARCA2:uc011llw.2:exon7:c.G775A:p.D259N,SMARCA2:uc011llx.2:exon8:c.G655A:p.D219N,SMARCA2:uc003zhd.3:exon32:c.G4663A:p.D1555N,SMARCA2:uc010mha.3:exon32:c.G4462A:p.D1488N,SMARCA2:uc003zhc.3:exon33:c.G4717A:p.D1573N	0.048	AFR:0.0005,AMR:0,EAS:0,FIN:0.0006,NFE:0.0012,OTH:0,ASJ:0	600014	601358;	3051;	3051|Nicolaides-Baraitser syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|601358 ~	.	.	.	.	0.327	-2.32	0.548	1.845	9	.	het
9	5054765	5054765	A	G	JAK2	exonic	nonsynonymous SNV	ENSG00000096968	.	ENSG00000096968:ENST00000544510:exon4:c.A370G:p.K124E,ENSG00000096968:ENST00000539801:exon6:c.A817G:p.K273E,ENSG00000096968:ENST00000381652:exon7:c.A817G:p.K273E	JAK2:NM_001322204:exon4:c.A370G:p.K124E,JAK2:NM_001322195:exon6:c.A817G:p.K273E,JAK2:NM_001322196:exon6:c.A817G:p.K273E,JAK2:NM_001322194:exon7:c.A817G:p.K273E,JAK2:NM_004972:exon7:c.A817G:p.K273E	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 1] 	.	.	.	.	1.133	11.39	0.65	5.53	1.000	.	.	FERM domain	JAK2:uc010mhm.3:exon6:c.A817G:p.K273E,JAK2:uc003ziw.3:exon7:c.A817G:p.K273E	-0.933	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	147796	133100;254450;263300;600800;601626;614521;	3318;71493;519;729;824;90042;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~729|Acquired primary erythrocytosis<br>Osler-Vaquez disease<br>PV<br>Polycythemia rubra vera<br>Vaquez disease|1-5 / 10 000|Not applicable|All ages|263300 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~90042|Congenital erythrocytosis due to erythropoietin receptor mutation<br>Congenital polycythemia due to erythropoietin receptor mutation<br>Familial erythrocytosis<br>PFCP<br>Primary congenital erythrocytosis<br>Primary familial and congenital polycythemia|Unknown|Autosomal dominant|All ages|133100 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04725 Cholinergic synapse~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,6214	.	.	0.704	0.44	0.097	2.295	9	.	hom
9	5073682	5073682	T	-	JAK2	intronic	.	ENSG00000096968	rs750624043	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0062	0.0187	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	147796	133100;254450;263300;600800;601626;614521;	3318;71493;519;729;824;90042;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~729|Acquired primary erythrocytosis<br>Osler-Vaquez disease<br>PV<br>Polycythemia rubra vera<br>Vaquez disease|1-5 / 10 000|Not applicable|All ages|263300 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~90042|Congenital erythrocytosis due to erythropoietin receptor mutation<br>Congenital polycythemia due to erythropoietin receptor mutation<br>Familial erythrocytosis<br>PFCP<br>Primary congenital erythrocytosis<br>Primary familial and congenital polycythemia|Unknown|Autosomal dominant|All ages|133100 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04725 Cholinergic synapse~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	9	MU43993940	het
9	5557672	5557672	T	C	PDCD1LG2	exonic	nonsynonymous SNV	ENSG00000197646	rs7854303	ENSG00000197646:ENST00000397745:exon4:c.T416C:p.F139S,ENSG00000197646:ENST00000397747:exon5:c.T686C:p.F229S	PDCD1LG2:NM_025239:exon5:c.T686C:p.F229S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9992	0.9988	0.997804	0.9989	-0.047	2.158	0.552	0.724	0.021	.	.	.	PDCD1LG2:uc010mho.1:exon3:c.T416C:p.F139S,PDCD1LG2:uc003zjg.4:exon5:c.T686C:p.F229S,PDCD1LG2:uc011lmc.2:exon5:c.T686C:p.F229S	-1.036	AFR:0.9975,AMR:0.9964,EAS:1,FIN:1,NFE:0.9995,OTH:0.9980,ASJ:1	605723	.	.	.	.	.	.	.	0.0	5.16	0.000	.	9	MU81859703	hom
9	5557688	5557688	C	A	PDCD1LG2	exonic	nonsynonymous SNV	ENSG00000197646	.	ENSG00000197646:ENST00000397745:exon4:c.C432A:p.F144L,ENSG00000197646:ENST00000397747:exon5:c.C702A:p.F234L	PDCD1LG2:NM_025239:exon5:c.C702A:p.F234L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	-1.933	0.001	1.0	-9.28	0.001	.	.	.	PDCD1LG2:uc010mho.1:exon3:c.C432A:p.F144L,PDCD1LG2:uc010mhp.1:exon3:c.C427A:p.H143N,PDCD1LG2:uc003zjg.4:exon5:c.C702A:p.F234L,PDCD1LG2:uc011lmc.2:exon5:c.C702A:p.F234L,PDCD1LG2:uc011lmd.2:exon5:c.C697A:p.H233N	-0.961	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605723	.	.	.	.	.	.	.	0.0	5.46	0.004	.	9	.	hom
9	8389364	8389364	C	G	PTPRD	exonic	synonymous SNV	ENSG00000153707	rs2279776	ENSG00000153707:ENST00000397606:exon20:c.G3033C:p.G1011G,ENSG00000153707:ENST00000397617:exon20:c.G3033C:p.G1011G,ENSG00000153707:ENST00000537002:exon20:c.G3024C:p.G1008G,ENSG00000153707:ENST00000397611:exon21:c.G3024C:p.G1008G,ENSG00000153707:ENST00000355233:exon22:c.G3036C:p.G1012G,ENSG00000153707:ENST00000358503:exon22:c.G4188C:p.G1396G,ENSG00000153707:ENST00000486161:exon22:c.G3033C:p.G1011G,ENSG00000153707:ENST00000360074:exon23:c.G4215C:p.G1405G,ENSG00000153707:ENST00000356435:exon26:c.G4254C:p.G1418G,ENSG00000153707:ENST00000540109:exon26:c.G4254C:p.G1418G,ENSG00000153707:ENST00000381196:exon34:c.G4254C:p.G1418G	PTPRD:NM_001171025:exon20:c.G3033C:p.G1011G,PTPRD:NM_130393:exon20:c.G3006C:p.G1002G,PTPRD:NM_001040712:exon21:c.G3024C:p.G1008G,PTPRD:NM_130391:exon22:c.G3033C:p.G1011G,PTPRD:NM_130392:exon22:c.G3036C:p.G1012G,PTPRD:NM_002839:exon37:c.G4254C:p.G1418G	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.4992	0.4847	0.55631	0.4920	.	.	.	.	.	.	.	.	PTPRD:uc003zkr.3:exon20:c.G3006C:p.G1002G,PTPRD:uc003zks.3:exon20:c.G3033C:p.G1011G,PTPRD:uc022bdj.1:exon21:c.G3024C:p.G1008G,PTPRD:uc003zkp.3:exon22:c.G3036C:p.G1012G,PTPRD:uc003zkq.3:exon22:c.G3033C:p.G1011G,PTPRD:uc003zkk.3:exon37:c.G4254C:p.G1418G	.	AFR:0.5735,AMR:0.5072,EAS:0.6897,FIN:0.4948,NFE:0.4231,OTH:0.4691,ASJ:0.5066	601598	.	.	.	.	,9360,9359	.	.	.	.	.	.	9	MU733175	hom
9	8436674	8436674	G	A	PTPRD	exonic	nonsynonymous SNV	ENSG00000153707	.	ENSG00000153707:ENST00000397606:exon18:c.C2783T:p.P928L,ENSG00000153707:ENST00000397617:exon18:c.C2783T:p.P928L,ENSG00000153707:ENST00000537002:exon18:c.C2774T:p.P925L,ENSG00000153707:ENST00000397611:exon19:c.C2774T:p.P925L,ENSG00000153707:ENST00000355233:exon20:c.C2786T:p.P929L,ENSG00000153707:ENST00000358503:exon20:c.C3938T:p.P1313L,ENSG00000153707:ENST00000486161:exon20:c.C2783T:p.P928L,ENSG00000153707:ENST00000360074:exon21:c.C3965T:p.P1322L,ENSG00000153707:ENST00000356435:exon24:c.C4004T:p.P1335L,ENSG00000153707:ENST00000540109:exon24:c.C4004T:p.P1335L,ENSG00000153707:ENST00000381196:exon32:c.C4004T:p.P1335L	PTPRD:NM_001171025:exon18:c.C2783T:p.P928L,PTPRD:NM_130393:exon18:c.C2756T:p.P919L,PTPRD:NM_001040712:exon19:c.C2774T:p.P925L,PTPRD:NM_130391:exon20:c.C2783T:p.P928L,PTPRD:NM_130392:exon20:c.C2786T:p.P929L,PTPRD:NM_002839:exon35:c.C4004T:p.P1335L	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 1] 	.	.	.	.	6.613	32	0.0	6.03	1.000	.	.	Fibronectin type III;Protein-tyrosine phosphatase-like	PTPRD:uc003zkr.3:exon18:c.C2756T:p.P919L,PTPRD:uc003zks.3:exon18:c.C2783T:p.P928L,PTPRD:uc022bdj.1:exon19:c.C2774T:p.P925L,PTPRD:uc003zkp.3:exon20:c.C2786T:p.P929L,PTPRD:uc003zkq.3:exon20:c.C2783T:p.P928L,PTPRD:uc003zkk.3:exon35:c.C4004T:p.P1335L	-0.251	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601598	.	.	.	.	,9360,9359	.	.	0.999	0.53	0.416	3.005	9	.	hom
9	8454566	8454566	T	C	PTPRD	intronic	.	ENSG00000153707	rs7031287	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4198	0.4580	0.502995	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.4591,AMR:0.6408,EAS:0.4669,FIN:0.3696,NFE:0.3666,OTH:0.3878,ASJ:0.4459	601598	.	.	.	.	.	.	.	.	.	.	.	9	1(liver)	0.4199
9	27183463	27183463	A	C	TEK	exonic	nonsynonymous SNV	ENSG00000120156	rs682632	ENSG00000120156:ENST00000519080:exon5:c.A467C:p.Q156P,ENSG00000120156:ENST00000519097:exon6:c.A596C:p.Q199P,ENSG00000120156:ENST00000406359:exon7:c.A908C:p.Q303P,ENSG00000120156:ENST00000380036:exon8:c.A1037C:p.Q346P	TEK:NM_001290078:exon6:c.A596C:p.Q199P,TEK:NM_001290077:exon7:c.A908C:p.Q303P,TEK:NM_000459:exon8:c.A1037C:p.Q346P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9733	0.9727	0.989816	0.9758	1.658	14.17	0.411	5.52	0.985	.	.	Immunoglobulin-like fold	TEK:uc003zqj.1:exon6:c.A839C:p.Q280P,TEK:uc011lnp.2:exon6:c.A596C:p.Q199P,TEK:uc011lno.2:exon7:c.A908C:p.Q303P,TEK:uc003zqi.4:exon8:c.A1037C:p.Q346P	-0.934	AFR:0.9924,AMR:0.9905,EAS:1,FIN:0.9720,NFE:0.9639,OTH:0.9674,ASJ:0.9834	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	0.0	-0.81	0.000	-0.345	9	MU81860880	hom
9	27202870	27202870	A	G	TEK	exonic	synonymous SNV	ENSG00000120156	rs639225	ENSG00000120156:ENST00000519080:exon10:c.A1392G:p.S464S,ENSG00000120156:ENST00000519097:exon11:c.A1521G:p.S507S,ENSG00000120156:ENST00000406359:exon12:c.A1833G:p.S611S,ENSG00000120156:ENST00000380036:exon13:c.A1962G:p.S654S	TEK:NM_001290078:exon11:c.A1521G:p.S507S,TEK:NM_001290077:exon12:c.A1833G:p.S611S,TEK:NM_000459:exon13:c.A1962G:p.S654S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4649	0.4463	0.414337	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	TEK:uc003zqj.1:exon11:c.A1764G:p.S588S,TEK:uc011lnp.2:exon11:c.A1521G:p.S507S,TEK:uc011lno.2:exon12:c.A1833G:p.S611S,TEK:uc003zqi.4:exon13:c.A1962G:p.S654S	.	AFR:0.4777,AMR:0.3685,EAS:0.4033,FIN:0.4114,NFE:0.6298,OTH:0.5107,ASJ:0.5024	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	.	.	.	.	9	1(lung)	0.5132
9	27203134	27203134	A	G	TEK	intronic	.	ENSG00000120156	rs638203	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4657	0.4471	0.414936	LAML-KR|1|205|0.00487805,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.4779,AMR:0.3706,EAS:0.4007,FIN:0.4084,NFE:0.6302,OTH:0.5101,ASJ:0.5012	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	.	.	.	.	9	1(liver)	0.5133
9	32542204	32542204	A	G	TOPORS	exonic	synonymous SNV	ENSG00000197579	rs10971019	ENSG00000197579:ENST00000379858:exon2:c.T2124C:p.S708S,ENSG00000197579:ENST00000360538:exon3:c.T2319C:p.S773S	TOPORS:NM_001195622:exon2:c.T2124C:p.S708S,TOPORS:NM_005802:exon3:c.T2319C:p.S773S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2075	0.1794	0.179113	LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	TOPORS:uc003zrc.3:exon2:c.T2124C:p.S708S,TOPORS:uc003zrb.3:exon3:c.T2319C:p.S773S	.	AFR:0.1688,AMR:0.0925,EAS:0.27,FIN:0.0761,NFE:0.1603,OTH:0.2208,ASJ:0.1647	609507	609923;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	9	1(stomach)	0.2082
9	32630472	32630472	T	C	TAF1L	exonic	synonymous SNV	ENSG00000122728	rs10758145	ENSG00000122728:ENST00000242310:exon1:c.A5106G:p.K1702K	TAF1L:NM_153809:exon1:c.A5106G:p.K1702K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2810	0.3147	0.346046	0.3276	.	.	.	.	.	.	.	.	TAF1L:uc003zrg.1:exon1:c.A5106G:p.K1702K	.	AFR:0.4882,AMR:0.2267,EAS:0.3814,FIN:0.2693,NFE:0.2532,OTH:0.2749,ASJ:0.2285	607798	.	.	.	.	.	.	.	.	.	.	.	9	MU18619976	het
9	32891930	32891930	T	C	TMEM215;APTX	intergenic	.	ENSG00000236796;ENSG00000223807	rs10115224	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.602436	0.6777	.	.	.	.	.	.	.	.	.	.	AFR:0.6434,AMR:0.5502,EAS:0.2880,FIN:0.6624,NFE:0.7488,OTH:0.7168,ASJ:0.6391	.	.	.	.	.	.	.	.	.	.	.	.	9	MU10673410	het
9	35074917	35074917	T	C	FANCG	intronic	.	ENSG00000221829	rs587118	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3957	0.3621	0.220248	0.3611	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.0939,AMR:0.4952,EAS:0.0006,FIN:0.5063,NFE:0.5084,OTH:0.4481,ASJ:0.3808	602956	614082;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	9	MU10698616	hom
9	35078352	35078353	AC	-	FANCG	intronic	.	ENSG00000221829	rs780427355	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	4.288e-05	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602956	614082;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	9	.	het
9	71820148	71820148	G	A	TJP2	exonic	nonsynonymous SNV	ENSG00000119139	rs4493966	ENSG00000119139:ENST00000535702:exon1:c.G71A:p.R24H,ENSG00000119139:ENST00000539225:exon1:c.G71A:p.R24H	TJP2:NM_001170415:exon1:c.G71A:p.R24H,TJP2:NM_001170416:exon1:c.G71A:p.R24H,TJP2:NM_001369874:exon1:c.G71A:p.R24H,TJP2:NM_001369875:exon1:c.G71A:p.R24H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0382	0.0309	0.0623003	0.0345	1.103	11.23	0.286	-2.56	0.946	.	.	.	TJP2:uc011lru.2:exon1:c.G71A:p.R24H,TJP2:uc011lrv.2:exon1:c.G71A:p.R24H	-0.947	AFR:0.0112,AMR:0.2351,EAS:0.0556,FIN:0.0258,NFE:0.0365,OTH:0.0378,ASJ:0.0232	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	0.0	3.06	0.000	.	9	MU10854577	het
9	71843023	71843023	C	A	TJP2	exonic	nonsynonymous SNV	ENSG00000119139	rs2309428	ENSG00000119139:ENST00000265384:exon9:c.C1446A:p.D482E,ENSG00000119139:ENST00000348208:exon9:c.C1446A:p.D482E,ENSG00000119139:ENST00000377245:exon9:c.C1446A:p.D482E,ENSG00000119139:ENST00000535702:exon9:c.C1458A:p.D486E,ENSG00000119139:ENST00000539225:exon9:c.C1539A:p.D513E,ENSG00000119139:ENST00000453658:exon10:c.C1377A:p.D459E	TJP2:NM_001170415:exon9:c.C1458A:p.D486E,TJP2:NM_001170416:exon9:c.C1539A:p.D513E,TJP2:NM_001369872:exon9:c.C1446A:p.D482E,TJP2:NM_001369873:exon9:c.C1446A:p.D482E,TJP2:NM_001369874:exon9:c.C1458A:p.D486E,TJP2:NM_001369875:exon9:c.C1458A:p.D486E,TJP2:NM_004817:exon9:c.C1446A:p.D482E,TJP2:NM_201629:exon9:c.C1446A:p.D482E,TJP2:NM_001170414:exon10:c.C1377A:p.D459E,TJP2:NM_001369870:exon10:c.C1371A:p.D457E,TJP2:NM_001369871:exon11:c.C1377A:p.D459E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8115	0.7580	0.772165	0.7864	-0.778	0.048	1.0	-1.25	0.390	.	.	PDZ domain	TJP2:uc004ahd.3:exon9:c.C1446A:p.D482E,TJP2:uc004ahe.3:exon9:c.C1446A:p.D482E,TJP2:uc004ahf.3:exon9:c.C1446A:p.D482E,TJP2:uc011lru.2:exon9:c.C1458A:p.D486E,TJP2:uc011lrv.2:exon9:c.C1539A:p.D513E,TJP2:uc011lrs.2:exon10:c.C1377A:p.D459E,TJP2:uc011lrt.1:exon11:c.C1377A:p.D459E	-0.968	AFR:0.6611,AMR:0.8616,EAS:0.8906,FIN:0.8698,NFE:0.8210,OTH:0.8310,ASJ:0.7947	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	0.0	3.13	0.000	-0.485	9	MU10854686	hom
9	71862975	71862975	C	T	TJP2	exonic	synonymous SNV	ENSG00000119139	rs2282336	ENSG00000119139:ENST00000265384:exon19:c.C2715T:p.T905T,ENSG00000119139:ENST00000348208:exon19:c.C2715T:p.T905T,ENSG00000119139:ENST00000377245:exon19:c.C2715T:p.T905T,ENSG00000119139:ENST00000535702:exon19:c.C2727T:p.T909T,ENSG00000119139:ENST00000539225:exon19:c.C2808T:p.T936T,ENSG00000119139:ENST00000453658:exon20:c.C2646T:p.T882T	TJP2:NM_001170415:exon19:c.C2727T:p.T909T,TJP2:NM_001170416:exon19:c.C2808T:p.T936T,TJP2:NM_001369872:exon19:c.C2715T:p.T905T,TJP2:NM_001369874:exon19:c.C2727T:p.T909T,TJP2:NM_001369875:exon19:c.C2727T:p.T909T,TJP2:NM_004817:exon19:c.C2715T:p.T905T,TJP2:NM_201629:exon19:c.C2715T:p.T905T,TJP2:NM_001170414:exon20:c.C2646T:p.T882T,TJP2:NM_001369870:exon20:c.C2640T:p.T880T,TJP2:NM_001369871:exon21:c.C2646T:p.T882T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2614	0.1975	0.284145	MU10854788	.	.	.	.	.	.	.	.	TJP2:uc010mom.1:exon2:c.C195T:p.T65T,TJP2:uc004ahd.3:exon19:c.C2715T:p.T905T,TJP2:uc004ahe.3:exon19:c.C2715T:p.T905T,TJP2:uc004ahf.3:exon19:c.C2715T:p.T905T,TJP2:uc011lru.2:exon19:c.C2727T:p.T909T,TJP2:uc011lrv.2:exon19:c.C2808T:p.T936T,TJP2:uc011lrs.2:exon20:c.C2646T:p.T882T	.	AFR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.2233,EAS:0.4856,FIN:0.1523,NFE:0.4249,OTH:0.2242,ASJ:0.1776	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	.	.	.	.	9	2(haematopoietic_and_lymphoid_tissue)	0.2139
9	71862987	71862987	G	A	TJP2	exonic	synonymous SNV	ENSG00000119139	rs2095876	ENSG00000119139:ENST00000265384:exon19:c.G2727A:p.A909A,ENSG00000119139:ENST00000348208:exon19:c.G2727A:p.A909A,ENSG00000119139:ENST00000377245:exon19:c.G2727A:p.A909A,ENSG00000119139:ENST00000535702:exon19:c.G2739A:p.A913A,ENSG00000119139:ENST00000539225:exon19:c.G2820A:p.A940A,ENSG00000119139:ENST00000453658:exon20:c.G2658A:p.A886A	TJP2:NM_001170415:exon19:c.G2739A:p.A913A,TJP2:NM_001170416:exon19:c.G2820A:p.A940A,TJP2:NM_001369872:exon19:c.G2727A:p.A909A,TJP2:NM_001369874:exon19:c.G2739A:p.A913A,TJP2:NM_001369875:exon19:c.G2739A:p.A913A,TJP2:NM_004817:exon19:c.G2727A:p.A909A,TJP2:NM_201629:exon19:c.G2727A:p.A909A,TJP2:NM_001170414:exon20:c.G2658A:p.A886A,TJP2:NM_001369870:exon20:c.G2652A:p.A884A,TJP2:NM_001369871:exon21:c.G2658A:p.A886A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2606	0.1974	0.284145	ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TJP2:uc010mom.1:exon2:c.G207A:p.A69A,TJP2:uc004ahd.3:exon19:c.G2727A:p.A909A,TJP2:uc004ahe.3:exon19:c.G2727A:p.A909A,TJP2:uc004ahf.3:exon19:c.G2727A:p.A909A,TJP2:uc011lru.2:exon19:c.G2739A:p.A913A,TJP2:uc011lrv.2:exon19:c.G2820A:p.A940A,TJP2:uc011lrs.2:exon20:c.G2658A:p.A886A	.	AFR:0.2231,AMR:0.1773,EAS:0.1533,FIN:0.4200,NFE:0.2241,OTH:0.2140,ASJ:0.4868	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	.	.	.	.	9	1(liver)	0.2367
9	72897434	72897434	G	A	SMC5	exonic	nonsynonymous SNV	ENSG00000198887	rs1180116	ENSG00000198887:ENST00000361138:exon7:c.G916A:p.V306I	SMC5:NM_015110:exon7:c.G916A:p.V306I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8824	0.8558	0.855032	0.8686	0.072	3.315	0.655	-1.31	0.909	.	.	RecF/RecN/SMC, N-terminal	SMC5:uc004ahr.2:exon7:c.G916A:p.V306I	-1.035	AFR:0.7743,AMR:0.8849,EAS:0.8476,FIN:0.9321,NFE:0.9100,OTH:0.8845,ASJ:0.8146	609386	.	.	.	.	.	.	.	0.0	2.34	0.000	0	9	MU25197989	hom
9	86617265	86617265	A	G	RMI1	exonic	nonsynonymous SNV	ENSG00000178966	rs1982151	ENSG00000178966:ENST00000325875:exon3:c.A1364G:p.N455S	RMI1:NM_001358291:exon3:c.A1364G:p.N455S,RMI1:NM_001358294:exon3:c.A1364G:p.N455S,RMI1:NM_024945:exon3:c.A1364G:p.N455S,RMI1:NM_001358292:exon4:c.A1364G:p.N455S,RMI1:NM_001358293:exon4:c.A1364G:p.N455S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7152	0.6857	0.671126	0.6902	-3.981	0.001	1.0	-2.97	0.162	.	.	.	RMI1:uc022bjb.1:exon1:c.A1364G:p.N455S,RMI1:uc004ans.4:exon2:c.A1364G:p.N455S,RMI1:uc004anp.4:exon3:c.A1364G:p.N455S,RMI1:uc004anq.4:exon3:c.A1364G:p.N455S,RMI1:uc004anr.4:exon4:c.A1364G:p.N455S	-0.986	AFR:0.5670,AMR:0.8381,EAS:0.7447,FIN:0.7441,NFE:0.7344,OTH:0.6944,ASJ:0.7119	610404	.	.	.	.	.	.	.	0.0	1.57	0.000	-1.15	9	MU14191257	hom
9	90265015	90265015	C	T	DAPK1	exonic	synonymous SNV	ENSG00000196730	rs3818584	ENSG00000196730:ENST00000491893:exon15:c.C1608T:p.D536D,ENSG00000196730:ENST00000358077:exon16:c.C1608T:p.D536D,ENSG00000196730:ENST00000408954:exon16:c.C1608T:p.D536D,ENSG00000196730:ENST00000469640:exon16:c.C1608T:p.D536D,ENSG00000196730:ENST00000472284:exon16:c.C1608T:p.D536D	DAPK1:NM_001288729:exon16:c.C1608T:p.D536D,DAPK1:NM_001288730:exon16:c.C1608T:p.D536D,DAPK1:NM_001288731:exon16:c.C1608T:p.D536D,DAPK1:NM_004938:exon16:c.C1608T:p.D536D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3895	0.3067	0.354034	LIRI-JP|1|258|0.00387597,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,PBCA-DE|1|499|0.00200401	.	.	.	.	.	.	.	.	DAPK1:uc004apf.1:exon2:c.C270T:p.D90D,DAPK1:uc011lth.2:exon14:c.C819T:p.D273D,DAPK1:uc011ltg.2:exon15:c.C1608T:p.D536D,DAPK1:uc004apc.3:exon16:c.C1608T:p.D536D,DAPK1:uc004apd.3:exon16:c.C1608T:p.D536D,DAPK1:uc004ape.3:exon16:c.C1608T:p.D536D	.	AFR:0.3442,AMR:0.1615,EAS:0.2848,FIN:0.6390,NFE:0.4332,OTH:0.3804,ASJ:0.5873	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	1(lung)	0.4255
9	90318112	90318112	C	-	DAPK1	exonic	frameshift deletion	ENSG00000196730	.	ENSG00000196730:ENST00000491893:exon23:c.2842delC:p.Q948fs,ENSG00000196730:ENST00000358077:exon25:c.3040delC:p.Q1014fs,ENSG00000196730:ENST00000408954:exon25:c.3040delC:p.Q1014fs,ENSG00000196730:ENST00000472284:exon25:c.3040delC:p.Q1014fs,ENSG00000196730:ENST00000469640:exon26:c.3115delC:p.Q1039fs	DAPK1:NM_001288729:exon25:c.3040delC:p.Q1014fs,DAPK1:NM_001288730:exon25:c.3040delC:p.Q1014fs,DAPK1:NM_001288731:exon25:c.3040delC:p.Q1014fs,DAPK1:NM_004938:exon25:c.3040delC:p.Q1014fs	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	DAPK1:uc011ltg.2:exon23:c.2842delC:p.Q948fs,DAPK1:uc011lth.2:exon23:c.2251delC:p.Q751fs,DAPK1:uc004apc.3:exon25:c.3040delC:p.Q1014fs,DAPK1:uc004apd.3:exon25:c.3040delC:p.Q1014fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	.	hom
9	93637015	93637015	C	T	SYK	exonic	synonymous SNV	ENSG00000165025	rs2290890	ENSG00000165025:ENST00000375747:exon8:c.C996T:p.P332P,ENSG00000165025:ENST00000375751:exon8:c.C996T:p.P332P,ENSG00000165025:ENST00000375746:exon9:c.C1065T:p.P355P,ENSG00000165025:ENST00000375754:exon9:c.C1065T:p.P355P	SYK:NM_001135052:exon8:c.C996T:p.P332P,SYK:NM_001174168:exon8:c.C996T:p.P332P,SYK:NM_001174167:exon9:c.C1065T:p.P355P,SYK:NM_003177:exon9:c.C1065T:p.P355P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1833	0.1641	0.195887	MU13514284	.	.	.	.	.	.	.	.	SYK:uc004ara.3:exon8:c.C996T:p.P332P,SYK:uc004arb.3:exon8:c.C996T:p.P332P,SYK:uc004aqz.3:exon9:c.C1065T:p.P355P,SYK:uc004arc.3:exon9:c.C1065T:p.P355P	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.1801,EAS:0.3513,FIN:0.2053,NFE:0.2587,OTH:0.1891,ASJ:0.2121	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	7(soft_tissue)	0.1410
9	93639973	93639973	G	C	SYK	exonic	synonymous SNV	ENSG00000165025	rs2290888	ENSG00000165025:ENST00000375747:exon9:c.G1233C:p.R411R,ENSG00000165025:ENST00000375751:exon9:c.G1233C:p.R411R,ENSG00000165025:ENST00000375746:exon10:c.G1302C:p.R434R,ENSG00000165025:ENST00000375754:exon10:c.G1302C:p.R434R	SYK:NM_001135052:exon9:c.G1233C:p.R411R,SYK:NM_001174168:exon9:c.G1233C:p.R411R,SYK:NM_001174167:exon10:c.G1302C:p.R434R,SYK:NM_003177:exon10:c.G1302C:p.R434R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1835	0.1652	0.196486	7(soft_tissue)	.	.	.	.	.	.	.	.	SYK:uc004ara.3:exon9:c.G1233C:p.R411R,SYK:uc004arb.3:exon9:c.G1233C:p.R411R,SYK:uc004aqz.3:exon10:c.G1302C:p.R434R,SYK:uc004arc.3:exon10:c.G1302C:p.R434R	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU93007,EAS:0.1812,FIN:0.2152,NFE:0.3532,OTH:0.2053,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	1(urinary_tract)	0.2553
9	93640009	93640009	G	A	SYK	exonic	synonymous SNV	ENSG00000165025	rs2290887	ENSG00000165025:ENST00000375747:exon9:c.G1269A:p.L423L,ENSG00000165025:ENST00000375751:exon9:c.G1269A:p.L423L,ENSG00000165025:ENST00000375746:exon10:c.G1338A:p.L446L,ENSG00000165025:ENST00000375754:exon10:c.G1338A:p.L446L	SYK:NM_001135052:exon9:c.G1269A:p.L423L,SYK:NM_001174168:exon9:c.G1269A:p.L423L,SYK:NM_001174167:exon10:c.G1338A:p.L446L,SYK:NM_003177:exon10:c.G1338A:p.L446L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1833	0.1648	0.196086	3(lung)	.	.	.	.	.	.	.	.	SYK:uc004ara.3:exon9:c.G1269A:p.L423L,SYK:uc004arb.3:exon9:c.G1269A:p.L423L,SYK:uc004aqz.3:exon10:c.G1338A:p.L446L,SYK:uc004arc.3:exon10:c.G1338A:p.L446L	.	AFR:MU93027,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053,EAS:0.2134,FIN:0.3532,NFE:0.2053,OTH:0.2565,ASJ:0.1807	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	2(haematopoietic_and_lymphoid_tissue)	0.1899
9	93641175	93641175	C	T	SYK	exonic	synonymous SNV	ENSG00000165025	rs2306041	ENSG00000165025:ENST00000375747:exon10:c.C1452T:p.Y484Y,ENSG00000165025:ENST00000375751:exon10:c.C1452T:p.Y484Y,ENSG00000165025:ENST00000375746:exon11:c.C1521T:p.Y507Y,ENSG00000165025:ENST00000375754:exon11:c.C1521T:p.Y507Y	SYK:NM_001135052:exon10:c.C1452T:p.Y484Y,SYK:NM_001174168:exon10:c.C1452T:p.Y484Y,SYK:NM_001174167:exon11:c.C1521T:p.Y507Y,SYK:NM_003177:exon11:c.C1521T:p.Y507Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1844	0.1678	0.198283	4(lung)	.	.	.	.	.	.	.	.	SYK:uc004ara.3:exon10:c.C1452T:p.Y484Y,SYK:uc004arb.3:exon10:c.C1452T:p.Y484Y,SYK:uc004aqz.3:exon11:c.C1521T:p.Y507Y,SYK:uc004arc.3:exon11:c.C1521T:p.Y507Y	.	AFR:1(urinary_tract),AMR:MU93054,EAS:0.1841,FIN:0.2252,NFE:0.3517,OTH:0.2053,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|5|170|0.0294118,COCA-CN|2|321|0.00623053	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	2(haematopoietic_and_lymphoid_tissue)	0.2577
9	93641199	93641199	T	C	SYK	exonic	synonymous SNV	ENSG00000165025	rs2306040	ENSG00000165025:ENST00000375747:exon10:c.T1476C:p.L492L,ENSG00000165025:ENST00000375751:exon10:c.T1476C:p.L492L,ENSG00000165025:ENST00000375746:exon11:c.T1545C:p.L515L,ENSG00000165025:ENST00000375754:exon11:c.T1545C:p.L515L	SYK:NM_001135052:exon10:c.T1476C:p.L492L,SYK:NM_001174168:exon10:c.T1476C:p.L492L,SYK:NM_001174167:exon11:c.T1545C:p.L515L,SYK:NM_003177:exon11:c.T1545C:p.L515L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1097	0.0666	0.130791	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	SYK:uc004ara.3:exon10:c.T1476C:p.L492L,SYK:uc004arb.3:exon10:c.T1476C:p.L492L,SYK:uc004aqz.3:exon11:c.T1545C:p.L515L,SYK:uc004arc.3:exon11:c.T1545C:p.L515L	.	AFR:MU13514305,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.0745,FIN:0.2852,NFE:0.0927,OTH:0.2559,ASJ:0.0830	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	4(soft_tissue)	0.0742
9	96000622	96000622	C	T	WNK2	intronic	.	ENSG00000165238	rs1539670	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9482	0.9682	0.94349	0.9599	.	.	.	.	.	.	.	.	.	.	AFR:0.9757,AMR:0.9773,EAS:0.8938,FIN:0.9550,NFE:0.9595,OTH:0.95,ASJ:0.9205	606249	.	.	.	.	.	.	.	.	.	.	.	9	MU82109719	hom
9	96030127	96030127	G	A	WNK2	exonic	nonsynonymous SNV	ENSG00000165238	.	ENSG00000165238:ENST00000297954:exon16:c.G3796A:p.D1266N,ENSG00000165238:ENST00000349097:exon16:c.G2632A:p.D878N,ENSG00000165238:ENST00000395477:exon16:c.G3796A:p.D1266N,ENSG00000165238:ENST00000427277:exon16:c.G2632A:p.D878N	WNK2:NM_001282394:exon16:c.G3796A:p.D1266N,WNK2:NM_006648:exon16:c.G3796A:p.D1266N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	4.189	23.8	0.052	5.47	0.028	.	.	.	WNK2:uc004atk.3:exon13:c.G2707A:p.D903N,WNK2:uc004ati.1:exon16:c.G3796A:p.D1266N,WNK2:uc004atj.3:exon16:c.G3796A:p.D1266N,WNK2:uc011lud.1:exon16:c.G3796A:p.D1266N	-0.945	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606249	.	.	.	.	.	.	.	0.999	1.02	0.146	2.4	9	.	hom
9	97879579	97879579	A	T	FANCC	intronic	.	ENSG00000158169	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	613899	227645;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	9	.	hom
9	98209594	98209594	G	A	PTCH1	exonic	nonsynonymous SNV	ENSG00000185920	rs357564	ENSG00000185920:ENST00000331920:exon23:c.C3944T:p.P1315L,ENSG00000185920:ENST00000375274:exon23:c.C3941T:p.P1314L,ENSG00000185920:ENST00000418258:exon23:c.C3491T:p.P1164L,ENSG00000185920:ENST00000421141:exon23:c.C3491T:p.P1164L,ENSG00000185920:ENST00000429896:exon23:c.C3491T:p.P1164L,ENSG00000185920:ENST00000430669:exon23:c.C3746T:p.P1249L,ENSG00000185920:ENST00000437951:exon23:c.C3746T:p.P1249L	PTCH1:NM_001354918:exon22:c.C3788T:p.P1263L,PTCH1:NM_000264:exon23:c.C3944T:p.P1315L,PTCH1:NM_001083602:exon23:c.C3746T:p.P1249L,PTCH1:NM_001083603:exon23:c.C3941T:p.P1314L,PTCH1:NM_001083604:exon23:c.C3491T:p.P1164L,PTCH1:NM_001083605:exon23:c.C3491T:p.P1164L,PTCH1:NM_001083606:exon23:c.C3491T:p.P1164L,PTCH1:NM_001083607:exon23:c.C3491T:p.P1164L	clinvar: Benign 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, 2, 1, 1] 	0.3855	0.2993	0.396765	1(biliary_tract)	6.218	28.8	0.025	4.83	0.995	.	.	.	PTCH1:uc010mrn.3:exon2:c.C320T:p.P107L,PTCH1:uc004avk.4:exon23:c.C3944T:p.P1315L,PTCH1:uc004avl.4:exon23:c.C3491T:p.P1164L,PTCH1:uc004avm.4:exon23:c.C3941T:p.P1314L,PTCH1:uc010mro.3:exon23:c.C3491T:p.P1164L,PTCH1:uc010mrp.3:exon23:c.C3491T:p.P1164L,PTCH1:uc010mrq.3:exon23:c.C3491T:p.P1164L,PTCH1:uc010mrr.3:exon23:c.C3746T:p.P1249L	-1.000	AFR:1(bone),AMR:2(pancreas),EAS:2(lung),FIN:11(soft_tissue),NFE:1(large_intestine),OTH:MU148935,ASJ:3(penis)	601309	109400;605462;610828;	2162;377;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	,9110,9111,9113,9112,9114	.	.	0.944	-2.76	0.000	2.295	9	3(haematopoietic_and_lymphoid_tissue)	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,BOCA-UK|1|130|0.00769231,BRCA-KR|1|50|0.02
9	102594972	102594972	G	A	NR4A3	exonic	nonsynonymous SNV	ENSG00000119508	.	ENSG00000119508:ENST00000330847:exon3:c.G986A:p.R329K,ENSG00000119508:ENST00000338488:exon4:c.G953A:p.R318K,ENSG00000119508:ENST00000395097:exon4:c.G953A:p.R318K	NR4A3:NM_006981:exon4:c.G953A:p.R318K,NR4A3:NM_173199:exon4:c.G953A:p.R318K,NR4A3:NM_173200:exon5:c.G986A:p.R329K	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 1, 0] 	.	.	.	.	5.554	26.4	0.0	5.6	1.000	0.9862	0.86	Zinc finger, NHR/GATA-type|Zinc finger, nuclear hormone receptor-type	NR4A3:uc004bae.3:exon4:c.G953A:p.R318K,NR4A3:uc004baf.1:exon4:c.G953A:p.R318K,NR4A3:uc022bky.1:exon5:c.G986A:p.R329K	0.994	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600542	612237;	209916;	209916|-|1-9 / 1 000 000|Not applicable|Adult|612237 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.996	-5.19	0.987	3.885	9	.	hom
9	110084328	110084328	C	T	RAD23B	exonic	nonsynonymous SNV	ENSG00000119318	rs1805329	ENSG00000119318:ENST00000358015:exon7:c.C746T:p.A249V,ENSG00000119318:ENST00000416373:exon7:c.C530T:p.A177V	RAD23B:NM_001244713:exon7:c.C683T:p.A228V,RAD23B:NM_001244724:exon7:c.C530T:p.A177V,RAD23B:NM_002874:exon7:c.C746T:p.A249V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1953	0.1379	0.152756	ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	3.759	23.3	0.226	5.28	0.822	.	.	UBA-like	RAD23B:uc004bde.3:exon7:c.C746T:p.A249V,RAD23B:uc011lwa.2:exon7:c.C746T:p.A249V,RAD23B:uc011lwb.2:exon7:c.C683T:p.A228V,RAD23B:uc022blj.1:exon7:c.C530T:p.A177V	-0.913	AFR:0.1748,AMR:0.0396,EAS:0.0927,FIN:0.1739,NFE:0.2484,OTH:0.2293,ASJ:0.2685	600062	.	.	.	.	.	.	.	0.005	2.08	0.000	2.045	9	1(bone)	0.2306
9	111653574	111653574	C	G	ELP1	exonic	synonymous SNV	ENSG00000070061	rs1063110	ENSG00000070061:ENST00000537196:exon21:c.G2022C:p.L674L,ENSG00000070061:ENST00000374647:exon28:c.G3069C:p.L1023L	ELP1:NM_001330749:exon26:c.G2022C:p.L674L,ELP1:NM_001318360:exon28:c.G2727C:p.L909L,ELP1:NM_003640:exon28:c.G3069C:p.L1023L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3913	0.3389	0.315495	1(breast)	.	.	.	.	.	.	.	.	IKBKAP:uc004bdk.3:exon1:c.G81C:p.L27L,IKBKAP:uc004bdl.3:exon20:c.G2022C:p.L674L,IKBKAP:uc010mtq.3:exon21:c.G2022C:p.L674L,IKBKAP:uc004bdm.4:exon28:c.G3069C:p.L1023L,IKBKAP:uc011lwc.2:exon28:c.G2727C:p.L909L	.	AFR:1(liver),AMR:1(large_intestine),EAS:MU91232,FIN:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,NFE:0.3421,OTH:0.1048,ASJ:2(thyroid)	603722	223900;	1764;	1764|HSAN3<br>Hereditary sensory and autonomic neuropathy type 3<br>Riley-Day syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|223900 ~	.	.	.	.	.	.	.	.	9	2(lung)	0.4209
9	111688828	111688828	C	T	ELP1	exonic	synonymous SNV	ENSG00000070061	rs2230788	ENSG00000070061:ENST00000374647:exon5:c.G441A:p.Q147Q	ELP1:NM_001318360:exon5:c.G99A:p.Q33Q,ELP1:NM_003640:exon5:c.G441A:p.Q147Q	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0936	0.0733	0.0798722	MU4567391	.	.	.	.	.	.	.	.	IKBKAP:uc004bdm.4:exon5:c.G441A:p.Q147Q,IKBKAP:uc011lwc.2:exon5:c.G99A:p.Q33Q	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.0864,EAS:0.1205,FIN:0.1589,NFE:0.1171,OTH:0.1113,ASJ:0.0396	603722	223900;	1764;	1764|HSAN3<br>Hereditary sensory and autonomic neuropathy type 3<br>Riley-Day syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|223900 ~	.	.	.	.	.	.	.	.	9	1(stomach)	0.1001
9	131095785	131095785	C	A	COQ4	exonic	nonsynonymous SNV	ENSG00000167113	.	ENSG00000167113:ENST00000300452:exon7:c.C659A:p.P220Q	COQ4:NM_016035:exon7:c.C659A:p.P220Q	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	6.597	31	0.001	5.76	0.919	.	.	.	COQ4:uc010mxy.3:exon6:c.C587A:p.P196Q,COQ4:uc004bur.4:exon7:c.C659A:p.P220Q	0.066	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	612898	616276;	457185;	457185|COQ4-related neonatal encephalomyopathy|<1 / 1 000 000|Autosomal recessive|Neonatal|616276 ~	.	.	.	.	1.0	0.41	0.473	3.93	9	.	hom
9	131346218	131346218	A	C	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs10760566	ENSG00000197694:ENST00000358161:exon16:c.A2163C:p.A721A,ENSG00000197694:ENST00000372731:exon16:c.A2163C:p.A721A,ENSG00000197694:ENST00000372739:exon16:c.A2163C:p.A721A	SPTAN1:NM_001130438:exon16:c.A2163C:p.A721A,SPTAN1:NM_001195532:exon16:c.A2163C:p.A721A,SPTAN1:NM_001363759:exon16:c.A2163C:p.A721A,SPTAN1:NM_001363765:exon16:c.A2163C:p.A721A,SPTAN1:NM_003127:exon16:c.A2163C:p.A721A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9914	0.9701	0.969848	0.9713	.	.	.	.	.	.	.	.	SPTAN1:uc004bvl.4:exon16:c.A2163C:p.A721A,SPTAN1:uc004bvm.4:exon16:c.A2163C:p.A721A,SPTAN1:uc004bvn.4:exon16:c.A2163C:p.A721A,SPTAN1:uc011mbg.2:exon16:c.A2163C:p.A721A,SPTAN1:uc011mbh.2:exon17:c.A2199C:p.A733A	.	AFR:0.8996,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9939,ASJ:1	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	MU81869219	hom
9	131360750	131360750	C	T	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs2227864	ENSG00000197694:ENST00000358161:exon25:c.C3486T:p.L1162L,ENSG00000197694:ENST00000372731:exon25:c.C3486T:p.L1162L,ENSG00000197694:ENST00000372739:exon25:c.C3486T:p.L1162L	SPTAN1:NM_001195532:exon24:c.C3426T:p.L1142L,SPTAN1:NM_001363765:exon24:c.C3426T:p.L1142L,SPTAN1:NM_001130438:exon25:c.C3486T:p.L1162L,SPTAN1:NM_001363759:exon25:c.C3486T:p.L1162L,SPTAN1:NM_003127:exon25:c.C3486T:p.L1162L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8064	0.7604	0.642772	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SPTAN1:uc004bvn.4:exon24:c.C3426T:p.L1142L,SPTAN1:uc011mbg.2:exon24:c.C3426T:p.L1142L,SPTAN1:uc004bvl.4:exon25:c.C3486T:p.L1162L,SPTAN1:uc004bvm.4:exon25:c.C3486T:p.L1162L,SPTAN1:uc011mbh.2:exon26:c.C3522T:p.L1174L	.	AFR:0.7491,AMR:0.4777,EAS:0.9172,FIN:0.5161,NFE:0.8242,OTH:0.9048,ASJ:0.7828	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	1(salivary_gland)	0.8160
9	131375701	131375701	A	G	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs1415568	ENSG00000197694:ENST00000372731:exon39:c.A5070G:p.L1690L,ENSG00000197694:ENST00000358161:exon40:c.A5085G:p.L1695L,ENSG00000197694:ENST00000372739:exon40:c.A5085G:p.L1695L	SPTAN1:NM_001195532:exon38:c.A5010G:p.L1670L,SPTAN1:NM_001363765:exon39:c.A5025G:p.L1675L,SPTAN1:NM_003127:exon39:c.A5070G:p.L1690L,SPTAN1:NM_001130438:exon40:c.A5085G:p.L1695L,SPTAN1:NM_001363759:exon40:c.A5085G:p.L1695L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9959	0.9854	0.984824	0.9846	.	.	.	.	.	.	.	.	SPTAN1:uc004bvn.4:exon38:c.A5010G:p.L1670L,SPTAN1:uc004bvl.4:exon39:c.A5070G:p.L1690L,SPTAN1:uc004bvm.4:exon40:c.A5085G:p.L1695L	.	AFR:0.9466,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9939,ASJ:1	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	MU81869234	hom
9	131379967	131379967	C	T	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs2227862	ENSG00000197694:ENST00000372731:exon41:c.C5391T:p.T1797T,ENSG00000197694:ENST00000358161:exon42:c.C5406T:p.T1802T,ENSG00000197694:ENST00000372739:exon42:c.C5406T:p.T1802T	SPTAN1:NM_001195532:exon40:c.C5331T:p.T1777T,SPTAN1:NM_001363765:exon41:c.C5346T:p.T1782T,SPTAN1:NM_003127:exon41:c.C5391T:p.T1797T,SPTAN1:NM_001130438:exon42:c.C5406T:p.T1802T,SPTAN1:NM_001363759:exon42:c.C5406T:p.T1802T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7913	0.7328	0.617013	MU4566604	.	.	.	.	.	.	.	.	SPTAN1:uc004bvn.4:exon40:c.C5331T:p.T1777T,SPTAN1:uc004bvl.4:exon41:c.C5391T:p.T1797T,SPTAN1:uc004bvm.4:exon42:c.C5406T:p.T1802T	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.7233,EAS:0.7709,FIN:0.9133,NFE:0.5099,OTH:0.8235,ASJ:0.3892	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	1(thyroid)	0.9049
9	131455903	131455903	C	T	SET	intronic	.	ENSG00000119335	rs4836618	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9465	0.8600	0.845248	0.8698	.	.	.	.	.	.	.	.	.	.	AFR:0.5824,AMR:0.9570,EAS:0.9068,FIN:0.9719,NFE:0.9959,OTH:0.9593,ASJ:0.9801	600960	.	.	.	.	.	.	.	.	.	.	.	9	MU21478277	hom
9	131456385	131456385	-	TA	SET	intronic	.	ENSG00000119335	rs10637043	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	.	0.8278	.	.	.	.	.	.	.	.	.	.	AFR:0.6190,AMR:0.7987,EAS:0.8946,FIN:0.7615,NFE:0.9507,OTH:0.8894,ASJ:0.9126	600960	.	.	.	.	.	.	.	.	.	.	.	9	.	hom
9	134021630	134021630	A	G	NUP214	exonic	synonymous SNV	ENSG00000126883	rs2296710	ENSG00000126883:ENST00000359428:exon13:c.A1884G:p.T628T,ENSG00000126883:ENST00000411637:exon13:c.A1851G:p.T617T,ENSG00000126883:ENST00000451030:exon13:c.A1884G:p.T628T	NUP214:NM_001318324:exon13:c.A1851G:p.T617T,NUP214:NM_005085:exon13:c.A1884G:p.T628T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3309	0.3022	0.346446	0.3227	.	.	.	.	.	.	.	.	NUP214:uc004cai.3:exon2:c.A171G:p.T57T,NUP214:uc004caf.1:exon13:c.A1851G:p.T617T,NUP214:uc004cag.3:exon13:c.A1884G:p.T628T,NUP214:uc004cah.3:exon13:c.A1851G:p.T617T	.	AFR:0.2908,AMR:0.2416,EAS:0.4250,FIN:0.3437,NFE:0.3280,OTH:0.3299,ASJ:0.3833	114350	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	9	MU588209	hom
9	134062770	134062770	-	T	NUP214	intronic	.	ENSG00000126883	rs762584920	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0535	.	.	0.1108	.	.	.	.	.	.	.	.	.	.	AFR:0.0708,AMR:0.1273,EAS:0.2088,FIN:0.0212,NFE:0.1283,OTH:0.0906,ASJ:0.1465	114350	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	9	.	unknown
9	136637177	136637177	-	CACACGGCCCCGGCGGTCACTGCGTGAGGGC	VAV2	intronic	.	ENSG00000160293	rs367642598	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	0.3902	0.22524	0.3475	.	.	.	.	.	.	.	.	.	.	AFR:0.2947,AMR:0.2852,EAS:0.0377,FIN:0.3645,NFE:0.4099,OTH:0.3690,ASJ:0.3767	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	MU112597187	het
9	136645079	136645079	G	C	VAV2	intronic	.	ENSG00000160293	rs540626	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2969	0.3162	0.241613	0.3013	.	.	.	.	.	.	.	.	.	.	AFR:0.2653,AMR:0.2249,EAS:0.0086,FIN:0.3247,NFE:0.3507,OTH:0.3143,ASJ:0.3675	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	.	het
9	136648606	136648606	G	A	VAV2	intronic	.	ENSG00000160293	rs1468128	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7246	0.6048	0.690096	0.6390	.	.	.	.	.	.	.	.	.	.	AFR:0.4276,AMR:0.7222,EAS:0.9639,FIN:0.6866,NFE:0.7070,OTH:0.6936,ASJ:0.7207	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	MU81871689	hom
9	136648611	136648611	-	G	VAV2	intronic	.	ENSG00000160293	rs56145872	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.8287	0.7097	0.131789	0.7542	.	.	.	.	.	.	.	.	.	.	AFR:0.4406,AMR:0.8017,EAS:0.9682,FIN:0.8421,NFE:0.8711,OTH:0.8333,ASJ:0.8699	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	.	hom
9	136804211	136804211	G	A	VAV2	intronic	.	ENSG00000160293	rs2073886	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7450	0.7196	0.702676	0.7217	.	.	.	.	.	.	.	.	.	.	AFR:0.6228,AMR:0.7041,EAS:0.7892,FIN:0.7327,NFE:0.7658,OTH:0.7658,ASJ:0.8046	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	MU19104859	hom
9	139391636	139391636	G	A	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs2229974	ENSG00000148400:ENST00000277541:exon34:c.C6555T:p.D2185D	NOTCH1:NM_017617:exon34:c.C6555T:p.D2185D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6187	0.5813	0.695088	1(breast)	.	.	.	.	.	.	.	.	NOTCH1:uc004chz.3:exon34:c.C6555T:p.D2185D	.	AFR:1(large_intestine),AMR:MU123836,EAS:0.5914,FIN:0.6176,NFE:0.6734,OTH:0.5232,ASJ:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7818,7816,7823,7811,7815,7817,7822,7812,7820,7810,7821	.	,7814,7813,7819	.	.	.	.	9	2(skin)	0.9635
9	139396926	139396926	G	A	NOTCH1	exonic	nonsynonymous SNV	ENSG00000148400	.	ENSG00000148400:ENST00000277541:exon28:c.C5182T:p.P1728S	NOTCH1:NM_017617:exon28:c.C5182T:p.P1728S	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 1, 0, 1, -1, 1, 1] 	.	.	.	.	2.066	16.64	0.097	3.53	0.831	.	.	Notch, NODP domain	NOTCH1:uc004chz.3:exon28:c.C5182T:p.P1728S	-1.033	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7818,7816,7823,7811,7815,7817,7822,7812,7820,7810,7821	.	,7814,7813,7819	0.004	1.37	0.059	1.365	9	.	hom
9	139397707	139397707	G	A	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs10521	ENSG00000148400:ENST00000277541:exon27:c.C5094T:p.D1698D	NOTCH1:NM_017617:exon27:c.C5094T:p.D1698D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4443	0.4080	0.553514	13(soft_tissue)	.	.	.	.	.	.	.	.	NOTCH1:uc004cia.1:exon14:c.C2784T:p.D928D,NOTCH1:uc004chz.3:exon27:c.C5094T:p.D1698D	.	AFR:1(lung),AMR:12(haematopoietic_and_lymphoid_tissue),EAS:MU58034,FIN:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,NFE:0.4460,OTH:0.5089,ASJ:12(meninges)	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7818,7816,7823,7811,7815,7817,7822,7812,7820,7810,7821	.	,7814,7813,7819	.	.	.	.	9	1(liver)	0.5240
9	139407932	139407932	A	G	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs2229971	ENSG00000148400:ENST00000277541:exon14:c.T2265C:p.N755N	NOTCH1:NM_017617:exon14:c.T2265C:p.N755N	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3977	0.3975	0.527756	MU123856	.	.	.	.	.	.	.	.	NOTCH1:uc004chz.3:exon14:c.T2265C:p.N755N	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.4428,EAS:0.5024,FIN:0.2152,NFE:0.8152,OTH:0.4293,ASJ:0.6200	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7818,7816,7823,7811,7815,7817,7822,7812,7820,7810,7821	.	,7814,7813,7819	.	.	.	.	9	1(skin)	0.3095
9	139418260	139418260	A	G	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs4489420	ENSG00000148400:ENST00000277541:exon3:c.T312C:p.N104N	NOTCH1:NM_017617:exon3:c.T312C:p.N104N	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5970	0.6087	0.740016	1(salivary_gland)	.	.	.	.	.	.	.	.	NOTCH1:uc004chz.3:exon3:c.T312C:p.N104N	.	AFR:MU4624948,AMR:COCA-CN|4|321|0.0124611,BLCA-CN|1|103|0.00970874,EAS:0.8853,FIN:0.6388,NFE:0.46,OTH:0.8547,ASJ:0.6424	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7818,7816,7823,7811,7815,7817,7822,7812,7820,7810,7821	.	,7814,7813,7819	.	.	.	.	9	13(meninges)	0.6006
10	14941233	14941233	C	T	DCLRE1C	UTR3	.	ENSG00000152457	rs60006238	ENSG00000152457:ENST00000378289:exon14:c.G1235A:p.R412Q	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1941	.	0.103035	0.0771	1.577	13.73	0.0	0.819	0.295	.	.	.	DCLRE1C:uc010qbx.2:exon14:c.G1235A:p.R412Q	-1.061	AFR:0.1123,AMR:0.1184,EAS:0.0444,FIN:0.0321,NFE:0.0661,OTH:0.0820,ASJ:0.1722	605988	602450;603554;	39041;275;	39041|Combined immunodeficiency with hypereosinophilia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|603554 ~275|SCID due to ARTEMIS deficiency<br>SCID due to DCLRE1C deficiency<br>SCID, Athabascan type<br>SCID, Athabaskan type<br>Severe combined immunodeficiency due to ARTEMIS deficiency<br>Severe combined immunodeficiency, Athabascan type<br>Severe combined immunodeficiency, Athabaskan type|Unknown|Autosomal recessive|Infancy<br>Neonatal|602450 ~	.	.	.	.	0.665	1.02	0.002	.	10	MU4563635	hom
10	21970272	21970272	C	T	MLLT10	exonic	stopgain	ENSG00000078403	.	ENSG00000078403:ENST00000438473:exon4:c.C562T:p.Q188X,ENSG00000078403:ENST00000377059:exon11:c.C1633T:p.Q545X,ENSG00000078403:ENST00000307729:exon12:c.C1633T:p.Q545X,ENSG00000078403:ENST00000377072:exon12:c.C1633T:p.Q545X,ENSG00000078403:ENST00000446906:exon12:c.C1633T:p.Q545X	MLLT10:NM_001195626:exon12:c.C1633T:p.Q545X,MLLT10:NM_004641:exon12:c.C1633T:p.Q545X,MLLT10:NM_001324297:exon14:c.C898T:p.Q300X	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	14.011	44	.	4.67	1.000	.	.	.	MLLT10:uc001ira.3:exon5:c.C4T:p.Q2X,MLLT10:uc021pny.1:exon11:c.C1633T:p.Q545X,MLLT10:uc001iqs.3:exon12:c.C1633T:p.Q545X,MLLT10:uc001iqt.3:exon12:c.C1633T:p.Q545X	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602409	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	10	.	hom
10	27303605	27303605	A	T	ANKRD26	exonic	nonsynonymous SNV	ENSG00000107890	rs2274741	ENSG00000107890:ENST00000376070:exon16:c.T3213A:p.F1071L,ENSG00000107890:ENST00000376087:exon31:c.T4542A:p.F1514L,ENSG00000107890:ENST00000436985:exon31:c.T4590A:p.F1530L	ANKRD26:NM_001256053:exon31:c.T4539A:p.F1513L,ANKRD26:NM_014915:exon31:c.T4542A:p.F1514L	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2258	0.1717	0.317292	0.2050	0.365	6.303	1.0	1.33	0.834	.	.	.	ANKRD26:uc001itg.2:exon25:c.T3600A:p.F1200L,ANKRD26:uc001ith.2:exon31:c.T4539A:p.F1513L,ANKRD26:uc009xku.1:exon31:c.T4542A:p.F1514L	-0.964	AFR:0.2263,AMR:0.1675,EAS:0.5643,FIN:0.2329,NFE:0.1498,OTH:0.2147,ASJ:0.1623	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	0.0	1.91	0.000	-3.085	10	MU794304	hom
10	27317840	27317840	C	T	ANKRD26	exonic	nonsynonymous SNV	ENSG00000107890	rs10829163	ENSG00000107890:ENST00000376070:exon12:c.G2584A:p.V862I,ENSG00000107890:ENST00000376087:exon27:c.G3913A:p.V1305I,ENSG00000107890:ENST00000436985:exon27:c.G3961A:p.V1321I	ANKRD26:NM_001256053:exon27:c.G3910A:p.V1304I,ANKRD26:NM_014915:exon27:c.G3913A:p.V1305I	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2217	0.1723	0.317292	0.2051	-0.852	0.033	1.0	-4.39	0.007	.	.	.	ANKRD26:uc001itg.2:exon21:c.G2971A:p.V991I,ANKRD26:uc001ith.2:exon27:c.G3910A:p.V1304I,ANKRD26:uc009xku.1:exon27:c.G3913A:p.V1305I	-1.016	AFR:0.2260,AMR:0.1683,EAS:0.5649,FIN:0.2339,NFE:0.1498,OTH:0.2137,ASJ:0.1623	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	0.0	-0.9	0.000	-0.63	10	MU794298	hom
10	27319465	27319465	T	C	ANKRD26	intronic	.	ENSG00000107890	rs10829165	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.857628	0.8220	.	.	.	.	.	.	.	.	.	.	AFR:0.8599,AMR:0.7133,EAS:0.9932,FIN:0.8683,NFE:0.7763,OTH:0.8378,ASJ:0.7833	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	hom
10	27319546	27319546	T	C	ANKRD26	intronic	.	ENSG00000107890	rs34844053	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.317292	0.2052	.	.	.	.	.	.	.	.	.	.	AFR:0.2264,AMR:0.1671,EAS:0.5665,FIN:0.2332,NFE:0.1499,OTH:0.2143,ASJ:0.1623	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	hom
10	27326950	27326954	TCTTC	-	ANKRD26	exonic	frameshift deletion	ENSG00000107890	rs764011194	ENSG00000107890:ENST00000376070:exon7:c.1076_1080del:p.R359fs,ENSG00000107890:ENST00000376087:exon22:c.2405_2409del:p.R802fs,ENSG00000107890:ENST00000436985:exon22:c.2453_2457del:p.R818fs	ANKRD26:NM_001256053:exon22:c.2402_2406del:p.R801fs,ANKRD26:NM_014915:exon22:c.2405_2409del:p.R802fs	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	6.46e-05	.	.	.	.	.	.	.	.	ANKRD26:uc001itg.2:exon16:c.1463_1467del:p.R488fs,ANKRD26:uc001ith.2:exon22:c.2402_2406del:p.R801fs,ANKRD26:uc009xku.1:exon22:c.2405_2409del:p.R802fs	.	AFR:0.0002,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	het
10	27326999	27326999	T	C	ANKRD26	intronic	.	ENSG00000107890	rs7096505	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8408	0.8289	0.865216	0.8452	.	.	.	.	.	.	.	.	.	.	AFR:0.8609,AMR:0.7321,EAS:0.9932,FIN:0.9057,NFE:0.8121,OTH:0.8612,ASJ:0.8067	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	MU19136977	hom
10	27341090	27341090	C	T	ANKRD26	intronic	.	ENSG00000107890	rs12762165	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.129992	0.0794	.	.	.	.	.	.	.	.	.	.	AFR:0.0207,AMR:0.1041,EAS:0.2965,FIN:0.1097,NFE:0.0809,OTH:0.0920,ASJ:0.0861	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	hom
10	27349268	27349268	A	G	ANKRD26	intronic	.	ENSG00000107890	rs149655759	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0192	0.0188	0.00958466	0.0206	.	.	.	.	.	0.0315	0.226	.	.	.	AFR:0.0044,AMR:0.0048,EAS:0.0012,FIN:0.0258,NFE:0.0313,OTH:0.0275,ASJ:0.0232	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	hom
10	27350056	27350056	G	T	ANKRD26	intronic	.	ENSG00000107890	rs11015496	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0709	0.0810	0.0972444	0.0858	.	.	.	.	.	.	.	.	.	.	AFR:0.1327,AMR:0.0346,EAS:0.1205,FIN:0.0668,NFE:0.0629,OTH:0.0784,ASJ:0.0695	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	MU794284	hom
10	27381349	27381349	T	C	ANKRD26	exonic	synonymous SNV	ENSG00000107890	rs2297145	ENSG00000107890:ENST00000376087:exon4:c.A624G:p.V208V,ENSG00000107890:ENST00000436985:exon4:c.A624G:p.V208V	ANKRD26:NM_001256053:exon4:c.A624G:p.V208V,ANKRD26:NM_014915:exon4:c.A624G:p.V208V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2571	0.2101	0.346645	0.2429	.	.	.	.	.	.	.	.	ANKRD26:uc001ith.2:exon4:c.A624G:p.V208V,ANKRD26:uc009xku.1:exon4:c.A624G:p.V208V	.	AFR:0.3237,AMR:0.1830,EAS:0.5597,FIN:0.2497,NFE:0.1657,OTH:0.2352,ASJ:0.1722	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	MU16245236	hom
10	27389197	27389197	T	C	ANKRD26	exonic	nonsynonymous SNV	ENSG00000107890	rs7897309	ENSG00000107890:ENST00000376087:exon1:c.A59G:p.Q20R,ENSG00000107890:ENST00000436985:exon1:c.A59G:p.Q20R	ANKRD26:NM_001256053:exon1:c.A59G:p.Q20R,ANKRD26:NM_014915:exon1:c.A59G:p.Q20R	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8977	0.8935	0.944688	0.9039	-1.524	0.002	1.0	-1.08	0.003	.	.	.	ANKRD26:uc001ith.2:exon1:c.A59G:p.Q20R,ANKRD26:uc009xku.1:exon1:c.A59G:p.Q20R	-0.984	AFR:0.9727,AMR:0.9010,EAS:1,FIN:0.9275,NFE:0.8493,OTH:0.9043,ASJ:0.8477	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	0.0	1.63	0.000	-1.355	10	MU71687	hom
10	31810840	31810840	A	G	ZEB1	exonic	synonymous SNV	ENSG00000148516	.	ENSG00000148516:ENST00000542815:exon6:c.A2376G:p.K792K,ENSG00000148516:ENST00000560721:exon6:c.A2517G:p.K839K,ENSG00000148516:ENST00000320985:exon7:c.A2577G:p.K859K,ENSG00000148516:ENST00000361642:exon7:c.A2580G:p.K860K,ENSG00000148516:ENST00000446923:exon7:c.A2529G:p.K843K	ZEB1:NM_001323674:exon5:c.A2355G:p.K785K,ZEB1:NM_001323675:exon5:c.A2313G:p.K771K,ZEB1:NM_001323678:exon5:c.A2304G:p.K768K,ZEB1:NM_001174093:exon6:c.A2517G:p.K839K,ZEB1:NM_001174095:exon6:c.A2376G:p.K792K,ZEB1:NM_001323644:exon6:c.A1923G:p.K641K,ZEB1:NM_001128128:exon7:c.A2529G:p.K843K,ZEB1:NM_001174094:exon7:c.A2526G:p.K842K,ZEB1:NM_001174096:exon7:c.A2580G:p.K860K,ZEB1:NM_001323641:exon7:c.A1923G:p.K641K,ZEB1:NM_001323648:exon7:c.A1923G:p.K641K,ZEB1:NM_001323656:exon7:c.A1923G:p.K641K,ZEB1:NM_001323657:exon7:c.A1923G:p.K641K,ZEB1:NM_001323658:exon7:c.A1923G:p.K641K,ZEB1:NM_001323659:exon7:c.A1923G:p.K641K,ZEB1:NM_001323660:exon7:c.A1923G:p.K641K,ZEB1:NM_001323666:exon7:c.A1923G:p.K641K,ZEB1:NM_001323676:exon7:c.A2538G:p.K846K,ZEB1:NM_001323677:exon7:c.A2535G:p.K845K,ZEB1:NM_030751:exon7:c.A2577G:p.K859K,ZEB1:NM_001323645:exon8:c.A1923G:p.K641K,ZEB1:NM_001323647:exon8:c.A1923G:p.K641K,ZEB1:NM_001323649:exon8:c.A1923G:p.K641K,ZEB1:NM_001323651:exon8:c.A1923G:p.K641K,ZEB1:NM_001323661:exon8:c.A1923G:p.K641K,ZEB1:NM_001323665:exon8:c.A1923G:p.K641K,ZEB1:NM_001323671:exon8:c.A1923G:p.K641K,ZEB1:NM_001323673:exon8:c.A1923G:p.K641K,ZEB1:NM_001323642:exon9:c.A1923G:p.K641K,ZEB1:NM_001323643:exon9:c.A1923G:p.K641K,ZEB1:NM_001323652:exon9:c.A1923G:p.K641K,ZEB1:NM_001323653:exon9:c.A1923G:p.K641K,ZEB1:NM_001323654:exon9:c.A1923G:p.K641K,ZEB1:NM_001323655:exon9:c.A1923G:p.K641K,ZEB1:NM_001323662:exon9:c.A1923G:p.K641K,ZEB1:NM_001323664:exon9:c.A1923G:p.K641K,ZEB1:NM_001323672:exon9:c.A1923G:p.K641K,ZEB1:NM_001323646:exon10:c.A1923G:p.K641K,ZEB1:NM_001323650:exon10:c.A1923G:p.K641K,ZEB1:NM_001323663:exon10:c.A1923G:p.K641K,ZEB1:NM_001323638:exon11:c.A1923G:p.K641K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	ZEB1:uc010qeg.1:exon4:c.A2154G:p.K718K,ZEB1:uc009xlj.1:exon5:c.A2355G:p.K785K,ZEB1:uc001ivv.4:exon6:c.A2517G:p.K839K,ZEB1:uc010qeh.2:exon6:c.A2376G:p.K792K,ZEB1:uc001ivs.4:exon7:c.A2577G:p.K859K,ZEB1:uc001ivu.4:exon7:c.A2580G:p.K860K,ZEB1:uc009xlo.2:exon7:c.A2526G:p.K842K,ZEB1:uc009xlp.3:exon7:c.A2529G:p.K843K,ZEB1:uc010qef.2:exon7:c.A1923G:p.K641K,ZEB1:uc009xlk.1:exon8:c.A1923G:p.K641K,ZEB1:uc001ivt.4:exon9:c.A1923G:p.K641K,ZEB1:uc001ivr.4:exon11:c.A1923G:p.K641K	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	189909	609141;613270;	98974;98973;	98974|Endoepithelial corneal dystrophy<br>FECD<br>Late hereditary endothelial dystrophy|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|136800 610158 613267 613268 613269 613270 613271 615523 ~98973|PPCD<br>Posterior polymorphous dystrophy<br>Schlichting dystrophy|Unknown|Autosomal dominant|Childhood|122000 609140 609141 ~	~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	10	.	hom
10	32311969	32311969	A	G	KIF5B	intronic	.	ENSG00000170759	rs176924	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9914	0.9677	0.967053	0.9753	.	.	.	.	.	0.0002	0.006	.	.	.	AFR:0.9135,AMR:0.9940,EAS:1,FIN:1,NFE:1,OTH:0.9939,ASJ:1	602809	.	.	.	.	.	.	.	.	.	.	.	10	MU81878086	hom
10	43595968	43595968	A	G	RET	exonic	synonymous SNV	ENSG00000165731	rs1800858	ENSG00000165731:ENST00000340058:exon2:c.A135G:p.A45A,ENSG00000165731:ENST00000355710:exon2:c.A135G:p.A45A	RET:NM_020630:exon2:c.A135G:p.A45A,RET:NM_020975:exon2:c.A135G:p.A45A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7365	0.8092	0.753594	1(breast)	.	.	.	.	.	.	.	.	RET:uc001jak.1:exon2:c.A135G:p.A45A,RET:uc001jal.3:exon2:c.A135G:p.A45A	.	AFR:17(meninges),AMR:MU4562096,EAS:0.7726,FIN:0.9506,NFE:0.7787,OTH:0.6656,ASJ:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	,9510,9512,9513,9509,9508,9514,9511,9507,9506	.	.	.	.	.	.	10	1(large_intestine)	0.5790
10	43600399	43600399	G	A	RET	splicing	.	ENSG00000165731	.	.	.	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	4.594	24.4	.	4.3	0.695	0.9999	0.954	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	43604950	43604950	A	G	RET	intronic	.	ENSG00000165731	rs1864403	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.754193	0.7729	.	.	.	.	.	.	.	.	.	.	AFR:0.9488,AMR:0.7792,EAS:0.5774,FIN:0.6494,NFE:0.7265,OTH:0.7041,ASJ:0.6755	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	43605247	43605249	AAA	-	RET	intronic	.	ENSG00000165731	rs57979030	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.309904	0.3186	.	.	.	.	.	.	.	.	.	.	AFR:0.2101,AMR:0.4689,EAS:0.3306,FIN:0.3449,NFE:0.3626,OTH:0.3663,ASJ:0.3377	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	43605392	43605392	G	A	RET	intronic	.	ENSG00000165731	rs2251674	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.72484	0.7456	.	.	.	.	.	.	.	.	.	.	AFR:0.8580,AMR:0.7745,EAS:0.5737,FIN:0.6429,NFE:0.7254,OTH:0.6973,ASJ:0.6755	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	43605860	43605860	T	G	RET	intronic	.	ENSG00000165731	rs1864402	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.742412	0.7599	.	.	.	.	.	.	.	.	.	.	AFR:0.9029,AMR:0.7769,EAS:0.5978,FIN:0.6426,NFE:0.7258,OTH:0.7029,ASJ:0.6767	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	43605902	43605902	A	G	RET	intronic	.	ENSG00000165731	rs1864401	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.743011	0.7603	.	.	.	.	.	.	.	.	.	.	AFR:0.9015,AMR:0.7799,EAS:0.5972,FIN:0.6460,NFE:0.7263,OTH:0.7100,ASJ:0.6755	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	43610366	43610366	G	A	RET	intronic	.	ENSG00000165731	rs1864400	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.7498	0.8143	.	.	.	.	.	.	.	.	.	.	AFR:0.9094,AMR:0.8115,EAS:0.5405,FIN:0.7994,NFE:0.7951,OTH:0.7735,ASJ:0.7914	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	MU17394467	hom
10	43610455	43610455	T	C	RET	intronic	.	ENSG00000165731	rs1864399	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.717851	0.7822	.	.	.	.	.	.	.	.	.	.	AFR:0.8892,AMR:0.7888,EAS:0.5442,FIN:0.7656,NFE:0.7523,OTH:0.7392,ASJ:0.7483	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	43611708	43611708	A	G	RET	intronic	.	ENSG00000165731	rs741968	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.752995	0.8220	.	.	.	.	.	.	.	.	.	.	AFR:0.9157,AMR:0.8138,EAS:0.5377,FIN:0.8102,NFE:0.8049,OTH:0.7796,ASJ:0.7914	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	43612609	43612609	C	T	RET	intronic	.	ENSG00000165731	rs2742234	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.690895	0.7585	.	.	.	.	.	.	.	.	.	.	AFR:0.8088,AMR:0.7864,EAS:0.5366,FIN:0.7662,NFE:0.7517,OTH:0.7372,ASJ:0.7351	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	50701156	50701156	G	A	ERCC6	intronic	.	ENSG00000225830	rs4253132	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8887	0.8322	0.876997	0.8456	.	.	.	.	.	0.0003	0.004	.	.	.	AFR:0.7220,AMR:0.9269,EAS:0.9994,FIN:0.9026,NFE:0.8787,OTH:0.9057,ASJ:0.8642	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	.	.	.	.	.	.	.	10	MU81879491	hom
10	50723684	50723684	G	A	ERCC6;PGBD3	exonic	synonymous SNV	ENSG00000243251;ENSG00000258838	rs4253073	ENSG00000243251:ENST00000508005:exon1:c.C1477T:p.L493L,ENSG00000243251:ENST00000374127:exon2:c.C1477T:p.L493L,ENSG00000258838:ENST00000447839:exon6:c.C2881T:p.L961L,ENSG00000258838:ENST00000515869:exon6:c.C2881T:p.L961L,ENSG00000243251:ENST00000603152:exon6:c.C2881T:p.L961L	PGBD3:NM_170753:exon2:c.C1477T:p.L493L,ERCC6:NM_001277058:exon6:c.C2881T:p.L961L,ERCC6:NM_001277059:exon6:c.C2881T:p.L961L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.9070	0.8491	0.893371	0.8616	.	.	.	.	.	.	.	.	PGBD3:uc021pqe.1:exon1:c.C1477T:p.L493L,ERCC6-PGBD3:uc001jhu.3:exon6:c.C2881T:p.L961L,ERCC6-PGBD3:uc009xoe.4:exon6:c.C2881T:p.L961L	.	AFR:0.7277,AMR:0.9368,EAS:0.9994,FIN:0.9319,NFE:0.8994,OTH:0.9196,ASJ:0.8974	.	.	.	.	.	,4781	.	.	.	.	.	.	10	MU81879509	hom
10	50724016	50724016	C	T	ERCC6;PGBD3	exonic	nonsynonymous SNV	ENSG00000243251;ENSG00000258838	rs4253072	ENSG00000243251:ENST00000508005:exon1:c.G1145A:p.R382K,ENSG00000243251:ENST00000374127:exon2:c.G1145A:p.R382K,ENSG00000258838:ENST00000447839:exon6:c.G2549A:p.R850K,ENSG00000258838:ENST00000515869:exon6:c.G2549A:p.R850K,ENSG00000243251:ENST00000603152:exon6:c.G2549A:p.R850K	PGBD3:NM_170753:exon2:c.G1145A:p.R382K,ERCC6:NM_001277058:exon6:c.G2549A:p.R850K,ERCC6:NM_001277059:exon6:c.G2549A:p.R850K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 1] 	0.9983	0.9939	0.996206	0.9951	0.120	3.819	1.0	0.699	0.923	.	.	PiggyBac transposable element-derived protein	PGBD3:uc021pqe.1:exon1:c.G1145A:p.R382K,ERCC6-PGBD3:uc001jhu.3:exon6:c.G2549A:p.R850K,ERCC6-PGBD3:uc009xoe.4:exon6:c.G2549A:p.R850K	-1.056	AFR:0.9835,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:0.9959,ASJ:1	.	.	.	.	.	,4781	.	.	0.0	2.35	0.000	-0.75	10	MU81879516	hom
10	50724393	50724393	T	A	ERCC6;PGBD3	exonic	nonsynonymous SNV	ENSG00000243251;ENSG00000258838	rs774749613	ENSG00000243251:ENST00000508005:exon1:c.A768T:p.R256S,ENSG00000243251:ENST00000374127:exon2:c.A768T:p.R256S,ENSG00000258838:ENST00000447839:exon6:c.A2172T:p.R724S,ENSG00000258838:ENST00000515869:exon6:c.A2172T:p.R724S,ENSG00000243251:ENST00000603152:exon6:c.A2172T:p.R724S	PGBD3:NM_170753:exon2:c.A768T:p.R256S,ERCC6:NM_001277058:exon6:c.A2172T:p.R724S,ERCC6:NM_001277059:exon6:c.A2172T:p.R724S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 1] 	8.303e-06	.	.	.	1.287	12.20	0.1	0.468	0.959	.	.	PiggyBac transposable element-derived protein	PGBD3:uc021pqe.1:exon1:c.A768T:p.R256S,ERCC6-PGBD3:uc001jhu.3:exon6:c.A2172T:p.R724S,ERCC6-PGBD3:uc009xoe.4:exon6:c.A2172T:p.R724S	-0.981	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	.	.	.	.	.	,4781	.	.	0.534	2.18	0.022	0.2	10	.	hom
10	50740876	50740876	G	C	ERCC6	exonic	synonymous SNV	ENSG00000225830;ENSG00000243251;ENSG00000258838	rs2228524	ENSG00000225830:ENST00000355832:exon2:c.C135G:p.L45L,ENSG00000258838:ENST00000447839:exon2:c.C135G:p.L45L,ENSG00000225830:ENST00000462247:exon2:c.C135G:p.L45L,ENSG00000258838:ENST00000515869:exon2:c.C135G:p.L45L,ENSG00000243251:ENST00000603152:exon2:c.C135G:p.L45L	ERCC6:NM_000124:exon2:c.C135G:p.L45L,ERCC6:NM_001277058:exon2:c.C135G:p.L45L,ERCC6:NM_001277059:exon2:c.C135G:p.L45L,ERCC6:NM_001346440:exon2:c.C135G:p.L45L	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.6946	0.6276	0.590855	0.6264	.	.	.	.	.	.	.	.	ERCC6:uc001jhs.5:exon2:c.C135G:p.L45L,ERCC6-PGBD3:uc001jhu.3:exon2:c.C135G:p.L45L,ERCC6-PGBD3:uc009xoe.4:exon2:c.C135G:p.L45L	.	AFR:0.3820,AMR:0.6595,EAS:0.5217,FIN:0.7570,NFE:0.7389,OTH:0.7286,ASJ:0.7219	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	.	.	.	.	10	MU786536	hom
10	61828881	61828882	TG	-	ANK3	exonic	frameshift deletion	ENSG00000151150	.	ENSG00000151150:ENST00000280772:exon37:c.11757_11758del:p.H3919fs	ANK3:NM_020987:exon37:c.11757_11758del:p.H3919fs	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	ANK3:uc001jky.3:exon37:c.11757_11758del:p.H3919fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600465	615493;	356996;	356996|-|<1 / 1 000 000|Autosomal recessive|Childhood|615493 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	10	.	het
10	64573312	64573312	T	G	EGR2	exonic	synonymous SNV	ENSG00000122877	rs45602133	ENSG00000122877:ENST00000242480:exon2:c.A1086C:p.R362R,ENSG00000122877:ENST00000411732:exon3:c.A936C:p.R312R,ENSG00000122877:ENST00000439032:exon4:c.A1086C:p.R362R	EGR2:NM_000399:exon2:c.A1086C:p.R362R,EGR2:NM_001136177:exon3:c.A1086C:p.R362R,EGR2:NM_001136179:exon3:c.A936C:p.R312R,EGR2:NM_001321037:exon3:c.A936C:p.R312R,EGR2:NM_001136178:exon4:c.A1086C:p.R362R	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0401	0.0381	0.076877	MU11724516	.	.	.	.	.	.	.	.	EGR2:uc001jmi.3:exon2:c.A1086C:p.R362R,EGR2:uc010qim.2:exon3:c.A1086C:p.R362R,EGR2:uc010qin.2:exon3:c.A936C:p.R312R,EGR2:uc010qio.2:exon3:c.A1125C:p.R375R,EGR2:uc009xph.3:exon4:c.A1086C:p.R362R	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|6|170|0.0352941,COCA-CN|2|321|0.00623053,AMR:0.0438,EAS:0.0483,FIN:0.0072,NFE:0.0879,OTH:0.0319,ASJ:0.0905	129010	145900;605253;607678;	101084;99951;64748;	101084|CMT1D|-|Autosomal dominant|Adolescent<br>Infancy<br>Childhood<br>Adult|607678 ~99951|Autosomal recessive congenital hypomyelinating neuropathy<br>CMT4E|-|Autosomal recessive|Infancy<br>Neonatal|605253 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	~ko04625 C-type lectin receptor signaling pathway~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	10	6(lung)	0.0157
10	64573771	64573771	C	T	EGR2	exonic	synonymous SNV	ENSG00000122877	rs224083	ENSG00000122877:ENST00000242480:exon2:c.G627A:p.P209P,ENSG00000122877:ENST00000411732:exon3:c.G477A:p.P159P,ENSG00000122877:ENST00000439032:exon4:c.G627A:p.P209P	EGR2:NM_000399:exon2:c.G627A:p.P209P,EGR2:NM_001136177:exon3:c.G627A:p.P209P,EGR2:NM_001136179:exon3:c.G477A:p.P159P,EGR2:NM_001321037:exon3:c.G477A:p.P159P,EGR2:NM_001136178:exon4:c.G627A:p.P209P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9953	0.9822	0.986022	0.9847	.	.	.	.	.	.	.	.	EGR2:uc001jmi.3:exon2:c.G627A:p.P209P,EGR2:uc010qim.2:exon3:c.G627A:p.P209P,EGR2:uc010qin.2:exon3:c.G477A:p.P159P,EGR2:uc010qio.2:exon3:c.G666A:p.P222P,EGR2:uc009xph.3:exon4:c.G627A:p.P209P	.	AFR:0.9457,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	129010	145900;605253;607678;	101084;99951;64748;	101084|CMT1D|-|Autosomal dominant|Adolescent<br>Infancy<br>Childhood<br>Adult|607678 ~99951|Autosomal recessive congenital hypomyelinating neuropathy<br>CMT4E|-|Autosomal recessive|Infancy<br>Neonatal|605253 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	~ko04625 C-type lectin receptor signaling pathway~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	10	MU81880257	hom
10	70406747	70406747	A	G	TET1	exonic	nonsynonymous SNV	ENSG00000138336	rs144156611	ENSG00000138336:ENST00000373644:exon4:c.A4261G:p.T1421A	TET1:NM_030625:exon4:c.A4261G:p.T1421A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0099	0.0033	0.00858626	.	0.359	6.251	0.111	-10.4	0.004	.	.	.	TET1:uc001jok.4:exon4:c.A4261G:p.T1421A	-1.047	AFR:0.0038,AMR:0.0021,EAS:0,FIN:0,NFE:0.0023,OTH:0.0027,ASJ:0.0585	607790	.	.	.	.	.	.	.	0.009	2.04	0.005	0.345	10	1(haematopoietic_and_lymphoid_tissue)	0.0031
10	73104056	73104056	A	G	SLC29A3	intronic	.	ENSG00000198246	rs2243540	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8674	0.8794	0.814297	0.8696	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.8539,AMR:0.8640,EAS:0.7043,FIN:0.8585,NFE:0.8980,OTH:0.8806,ASJ:0.91	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	.	.	.	.	10	MU14180483	hom
10	73111408	73111408	C	T	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs780668	ENSG00000198246:ENST00000373189:exon4:c.C473T:p.S158F	SLC29A3:NM_001174098:exon4:c.C473T:p.S158F,SLC29A3:NM_001363518:exon4:c.C239T:p.S80F,SLC29A3:NM_018344:exon4:c.C473T:p.S158F	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.6384	0.6183	0.479832	MU139025	6.297	29.1	0.062	4.62	0.992	.	.	.	SLC29A3:uc010qjq.2:exon3:c.C35T:p.S12F,SLC29A3:uc001jrr.4:exon4:c.C473T:p.S158F,SLC29A3:uc001jrs.4:exon4:c.C473T:p.S158F	-0.969	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.6241,EAS:0.5227,FIN:0.7417,NFE:0.4472,OTH:0.7288,ASJ:0.3520	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.656	0.33	0.000	3.085	10	1(liver)	0.7743
10	73115941	73115941	T	C	SLC29A3	exonic	synonymous SNV	ENSG00000198246	rs2252997	ENSG00000198246:ENST00000373189:exon5:c.T714C:p.T238T	SLC29A3:NM_001174098:exon5:c.T714C:p.T238T,SLC29A3:NM_001363518:exon5:c.T480C:p.T160T,SLC29A3:NM_018344:exon5:c.T714C:p.T238T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8294	0.8891	0.780751	0.8679	.	.	.	.	.	.	.	.	SLC29A3:uc001jrt.4:exon3:c.T96C:p.T32T,SLC29A3:uc010qjq.2:exon4:c.T276C:p.T92T,SLC29A3:uc001jrr.4:exon5:c.T714C:p.T238T,SLC29A3:uc001jrs.4:exon5:c.T714C:p.T238T	.	AFR:0.8897,AMR:0.6885,EAS:0.6926,FIN:0.8490,NFE:0.8879,OTH:0.8551,ASJ:0.93	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	.	.	.	.	10	MU14239655	unknown
10	73115942	73115942	G	A	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs2252996	ENSG00000198246:ENST00000373189:exon5:c.G715A:p.V239I	SLC29A3:NM_001174098:exon5:c.G715A:p.V239I,SLC29A3:NM_001363518:exon5:c.G481A:p.V161I,SLC29A3:NM_018344:exon5:c.G715A:p.V239I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8217	0.8616	0.760184	0.8453	-0.811	0.040	0.508	-2.2	0.000	.	.	.	SLC29A3:uc001jrt.4:exon3:c.G97A:p.V33I,SLC29A3:uc010qjq.2:exon4:c.G277A:p.V93I,SLC29A3:uc001jrr.4:exon5:c.G715A:p.V239I,SLC29A3:uc001jrs.4:exon5:c.G715A:p.V239I	-0.980	AFR:0.8111,AMR:0.6850,EAS:0.6926,FIN:0.8490,NFE:0.8875,OTH:0.8520,ASJ:0.93	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.002	-0.28	0.000	1.37	10	MU14239707	unknown
10	73121913	73121913	A	G	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs2487068	ENSG00000198246:ENST00000373189:exon6:c.A976G:p.I326V	SLC29A3:NM_001363518:exon6:c.A742G:p.I248V,SLC29A3:NM_018344:exon6:c.A976G:p.I326V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8246	0.8923	0.792732	0.8745	-2.319	0.001	1.0	-9.0	0.003	.	.	.	SLC29A3:uc001jrt.4:exon4:c.A358G:p.I120V,SLC29A3:uc010qjq.2:exon5:c.A538G:p.I180V,SLC29A3:uc001jrr.4:exon6:c.A976G:p.I326V	-0.954	AFR:0.9235,AMR:0.6771,EAS:0.7228,FIN:0.8389,NFE:0.8824,OTH:0.8599,ASJ:0.8874	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.002	0.05	0.000	-0.515	10	MU14239795	hom
10	73121945	73121945	T	C	SLC29A3	exonic	synonymous SNV	ENSG00000198246	rs1084004	ENSG00000198246:ENST00000373189:exon6:c.T1008C:p.G336G	SLC29A3:NM_001363518:exon6:c.T774C:p.G258G,SLC29A3:NM_018344:exon6:c.T1008C:p.G336G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8302	0.8666	0.753794	0.8444	.	.	.	.	.	.	.	.	SLC29A3:uc001jrt.4:exon4:c.T390C:p.G130G,SLC29A3:uc010qjq.2:exon5:c.T570C:p.G190G,SLC29A3:uc001jrr.4:exon6:c.T1008C:p.G336G	.	AFR:0.7526,AMR:0.6758,EAS:0.7271,FIN:0.8288,NFE:0.9204,OTH:0.8643,ASJ:0.9338	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	.	.	.	.	10	MU14239860	hom
10	75865065	75865065	G	A	VCL	exonic	synonymous SNV	ENSG00000035403	rs767809	ENSG00000035403:ENST00000436396:exon9:c.G1404A:p.P468P,ENSG00000035403:ENST00000211998:exon16:c.G2388A:p.P796P,ENSG00000035403:ENST00000372755:exon16:c.G2388A:p.P796P	VCL:NM_003373:exon16:c.G2388A:p.P796P,VCL:NM_014000:exon16:c.G2388A:p.P796P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4761	0.4387	0.324681	3(lung)	.	.	.	.	.	.	.	.	VCL:uc010qky.1:exon15:c.G2109A:p.P703P,VCL:uc001jwd.3:exon16:c.G2388A:p.P796P,VCL:uc001jwe.3:exon16:c.G2388A:p.P796P,VCL:uc009xrr.3:exon18:c.G1635A:p.P545P	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU63916,EAS:0.4299,FIN:0.1369,NFE:0.4511,OTH:0.6967,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	193065	611407;613255;	154;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~	.	.	.	.	.	.	.	.	10	1(large_intestine)	0.2801
10	76781906	76781908	GAA	-	KAT6B	exonic	nonframeshift deletion	ENSG00000156650	rs71929101	ENSG00000156650:ENST00000372711:exon15:c.2740_2742del:p.914_914del,ENSG00000156650:ENST00000372714:exon15:c.2413_2415del:p.805_805del,ENSG00000156650:ENST00000372725:exon15:c.2413_2415del:p.805_805del,ENSG00000156650:ENST00000287239:exon16:c.3289_3291del:p.1097_1097del,ENSG00000156650:ENST00000372724:exon16:c.2413_2415del:p.805_805del	KAT6B:NM_001370135:exon8:c.946_948del:p.316_316del,KAT6B:NM_001370133:exon9:c.1600_1602del:p.534_534del,KAT6B:NM_001370134:exon10:c.1204_1206del:p.402_402del,KAT6B:NM_001370143:exon13:c.2224_2226del:p.742_742del,KAT6B:NM_001370144:exon14:c.2224_2226del:p.742_742del,KAT6B:NM_001370132:exon15:c.2251_2253del:p.751_751del,KAT6B:NM_001370141:exon15:c.2413_2415del:p.805_805del,KAT6B:NM_001370142:exon15:c.2413_2415del:p.805_805del,KAT6B:NM_001256468:exon16:c.2740_2742del:p.914_914del,KAT6B:NM_001256469:exon16:c.2413_2415del:p.805_805del,KAT6B:NM_001370136:exon16:c.3289_3291del:p.1097_1097del,KAT6B:NM_001370137:exon16:c.3289_3291del:p.1097_1097del,KAT6B:NM_001370138:exon16:c.2740_2742del:p.914_914del,KAT6B:NM_001370139:exon16:c.2413_2415del:p.805_805del,KAT6B:NM_001370140:exon16:c.2413_2415del:p.805_805del,KAT6B:NM_012330:exon16:c.3289_3291del:p.1097_1097del	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2507	.	0.458666	0.3003	.	.	.	.	.	.	.	.	KAT6B:uc001jwm.2:exon16:c.2413_2415del:p.805_805del,KAT6B:uc001jwn.2:exon16:c.3289_3291del:p.1097_1097del,KAT6B:uc031pvy.1:exon16:c.2740_2742del:p.914_914del	.	AFR:0.7455,AMR:0.2833,EAS:0.3266,FIN:0.0878,NFE:0.1064,OTH:0.1763,ASJ:0.1318	605880	603736;606170;	85201;3047;	85201|Absent patellae-scrotal hypoplasia-renal anomalies-facial dysmorphism-intellectual disability syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|606170 ~3047|Hypothyroidism-dysmorphism-postaxial polydactyly-intellectual disability syndrome<br>SBBYSS<br>Say-Barber-Biesecker-Young-Simpson syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|603736 ~	.	.	.	.	.	.	.	.	10	MU9689	het
10	88635779	88635779	C	A	BMPR1A	exonic	nonsynonymous SNV	ENSG00000107779	rs11528010	ENSG00000107779:ENST00000372037:exon3:c.C4A:p.P2T	BMPR1A:NM_004329:exon3:c.C4A:p.P2T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3558	0.3895	0.4998	COCA-CN|5|321|0.0155763	0.677	8.674	1.0	5.3	0.971	.	.	.	BMPR1A:uc001kdy.3:exon3:c.C4A:p.P2T	-0.953	AFR:0.4141,AMR:0.6605,EAS:0.3974,FIN:0.7150,NFE:0.3735,OTH:0.2552,ASJ:0.3792	601299	174900;610069;	157794;2929;329971;	157794|HMPS|-|Autosomal dominant|Childhood|601228 610069 ~2929|JIP<br>JPS<br>Juvenile gastrointestinal polyposis<br>Juvenile intestinal polyposis|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|174900 175050 612242 ~329971|-|Unknown|Autosomal dominant|All ages|174900 ~	.	.	.	.	0.0	-1.5	0.000	-0.805	10	1(large_intestine)	0.3340
10	88672011	88672011	G	A	BMPR1A	exonic	nonsynonymous SNV	ENSG00000107779	.	ENSG00000107779:ENST00000372037:exon8:c.G545A:p.S182N	BMPR1A:NM_004329:exon8:c.G545A:p.S182N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	2.435	19.05	0.47	5.21	0.998	.	.	.	BMPR1A:uc001kdy.3:exon8:c.G545A:p.S182N	-0.601	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601299	174900;610069;	157794;2929;329971;	157794|HMPS|-|Autosomal dominant|Childhood|601228 610069 ~2929|JIP<br>JPS<br>Juvenile gastrointestinal polyposis<br>Juvenile intestinal polyposis|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|174900 175050 612242 ~329971|-|Unknown|Autosomal dominant|All ages|174900 ~	.	.	.	.	0.0	-1.67	0.303	0.345	10	.	hom
10	88683122	88683122	T	C	BMPR1A	intronic	.	ENSG00000107779	rs7074064	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3538	0.3898	0.496605	0.4136	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.6629,AMR:0.3556,EAS:0.7134,FIN:0.3741,NFE:0.2547,OTH:0.3340,ASJ:0.3867	601299	174900;610069;	157794;2929;329971;	157794|HMPS|-|Autosomal dominant|Childhood|601228 610069 ~2929|JIP<br>JPS<br>Juvenile gastrointestinal polyposis<br>Juvenile intestinal polyposis|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|174900 175050 612242 ~329971|-|Unknown|Autosomal dominant|All ages|174900 ~	.	.	.	.	.	.	.	.	10	MU14485379	hom
10	88911711	88911711	A	G	SHLD2	exonic	synonymous SNV	ENSG00000122376	rs370891814	ENSG00000122376:ENST00000298784:exon3:c.A600G:p.P200P,ENSG00000122376:ENST00000298786:exon3:c.A600G:p.P200P	SHLD2:NM_001330112:exon3:c.A600G:p.P200P,SHLD2:NM_019054:exon3:c.A600G:p.P200P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0017	0.0024	0.00439297	0.0034	.	.	.	.	.	.	.	.	FAM35A:uc001kei.4:exon3:c.A600G:p.P200P	.	AFR:0.0112,AMR:0,EAS:0,FIN:0.0003,NFE:0,OTH:0.0051,ASJ:0	.	.	.	.	.	.	.	.	.	.	.	.	10	.	hom
10	89623755	89623755	G	A	PTEN	exonic	nonsynonymous SNV	ENSG00000171862	.	.	PTEN:NM_001304717:exon1:c.G49A:p.A17T	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 1, 0, 1, 0, 0, 1, 0, 1, 0, 1, 1] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601728	153480;155600;158350;176807;275355;276950;605309;607174;608089;613028;	182067;263662;210548;3412;67037;1331;201;2969;65285;404560;618;109;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~263662|-|Unknown|Autosomal dominant|All ages|607174 ~210548|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|605309 ~3412|Sujansky-Leonard syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|276950 314390 ~67037|HNSCC<br>Head and neck squamous cell carcinoma|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|275355 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~2969|Cohen-Hayden syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|158350 ~65285|Dysplastic gangliocytoma of the cerebellum<br>LDD|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|158350 ~404560|B-K mole syndrome<br>FAMM-PC syndrome<br>FAMMM syndrome<br>Familial Clark nevus syndrome<br>Familial atypical mole syndrome<br>Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome<br>Familial dysplastic nevus syndrome<br>Melanoma-pancreatic cancer syndrome|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|155600 606719 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~109|BRRS<br>Myhre-Riley-Smith syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|153480 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04212 Longevity regulating pathway - worm~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04931 Insulin resistance~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05222 Small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05230 Central carbon metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,9294,9268,9271,9293,9301,9303,9315,9307,9320,9322,9308,9267,9297,9329,9291,9290,9305,9316,9306,9298,9314,9269,9296,9327,9272,9324,9310,9325,9295,9330,9299,9328,9292,9326,9319,9300,9270,9304,9321,9274,9273,9309,9323,9311,9275,9313,9317,9302,9276	,9312	.	.	.	.	.	10	.	hom
10	95549836	95549836	-	T	LGI1	intronic	.	ENSG00000108231	rs371933363	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4209	.	0.395767	0.1251	.	.	.	.	.	.	.	.	.	.	AFR:0.2172,AMR:0.0644,EAS:0.0997,FIN:0.1581,NFE:0.0737,OTH:0.0943,ASJ:0.1379	604619	600512;	101046;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~	.	.	.	.	.	.	.	.	10	MU10198225	unknown
10	95552653	95552653	T	C	LGI1	exonic	synonymous SNV	ENSG00000108231	rs1111820	ENSG00000108231:ENST00000542308:exon4:c.T513C:p.F171F,ENSG00000108231:ENST00000371413:exon6:c.T657C:p.F219F,ENSG00000108231:ENST00000371418:exon6:c.T657C:p.F219F	LGI1:NM_001308276:exon4:c.T513C:p.F171F,LGI1:NM_001308275:exon6:c.T657C:p.F219F,LGI1:NM_005097:exon6:c.T657C:p.F219F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9928	0.9769	0.977436	0.9798	.	.	.	.	.	.	.	.	LGI1:uc010qnv.2:exon4:c.T513C:p.F171F,LGI1:uc001kjc.4:exon6:c.T657C:p.F219F,LGI1:uc021pwk.1:exon6:c.T657C:p.F219F	.	AFR:0.9302,AMR:0.9964,EAS:1,FIN:0.9997,NFE:0.9995,OTH:0.9959,ASJ:1	604619	600512;	101046;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~	.	.	.	.	.	.	.	.	10	MU81883389	hom
10	96541616	96541616	G	A	CYP2C19	exonic	synonymous SNV	ENSG00000165841	rs4244285	ENSG00000165841:ENST00000371321:exon5:c.G681A:p.P227P	CYP2C19:NM_000769:exon5:c.G681A:p.P227P	clinvar: drug_response 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1856	0.1541	0.221446	0.1673	.	.	.	.	.	.	.	.	CYP2C19:uc009xus.1:exon3:c.G276A:p.P92P,CYP2C19:uc010qnz.2:exon5:c.G681A:p.P227P,CYP2C19:uc010qny.2:exon10:c.G615A:p.P205P	.	AFR:0.1792,AMR:0.1220,EAS:0.3125,FIN:0.1816,NFE:0.1439,OTH:0.1728,ASJ:0.1556	124020	609535;	240935;	240935|-|-|-|-|609535 ~	~ko00590 Arachidonic acid metabolism~ko00591 Linoleic acid metabolism~ko00982 Drug metabolism - cytochrome P450~ko01100 Metabolic pathways~ko04726 Serotonergic synapse~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	10	MU749853	hom
10	96602622	96602622	C	T	CYP2C19	exonic	synonymous SNV	ENSG00000165841	rs3758580	ENSG00000165841:ENST00000371321:exon7:c.C990T:p.V330V	CYP2C19:NM_000769:exon7:c.C990T:p.V330V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1835	0.1542	0.221246	0.1664	.	.	.	.	.	.	.	.	CYP2C19:uc010qnz.2:exon7:c.C990T:p.V330V,CYP2C19:uc010qny.2:exon12:c.C924T:p.V308V	.	AFR:0.1794,AMR:0.1223,EAS:0.3137,FIN:0.1793,NFE:0.1421,OTH:0.1731,ASJ:0.1556	124020	609535;	240935;	240935|-|-|-|-|609535 ~	~ko00590 Arachidonic acid metabolism~ko00591 Linoleic acid metabolism~ko00982 Drug metabolism - cytochrome P450~ko01100 Metabolic pathways~ko04726 Serotonergic synapse~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	10	MU11785153	hom
10	96827119	96827119	-	A	CYP2C8	intronic	.	ENSG00000138115	rs11572078	ENSG00000138115:ENST00000539050:exon2:c.68dupT:p.L23fs	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2679	0.3041	0.34984	0.2909	.	.	.	.	.	.	.	.	CYP2C8:uc010qob.2:exon2:c.68dupT:p.L23fs,CYP2C8:uc010qod.1:exon2:c.68dupT:p.L23fs	.	AFR:0.4530,AMR:0.1882,EAS:0.3807,FIN:0.2096,NFE:0.2130,OTH:0.2556,ASJ:0.3179	601129	.	.	.	~ko00590 Arachidonic acid metabolism~ko00591 Linoleic acid metabolism~ko00830 Retinol metabolism~ko00982 Drug metabolism - cytochrome P450~ko01100 Metabolic pathways~ko04726 Serotonergic synapse~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	10	.	het
10	99219885	99219885	G	A	MMS19	exonic	synonymous SNV	ENSG00000155229	rs2152092	ENSG00000155229:ENST00000327238:exon24:c.C2280T:p.A760A,ENSG00000155229:ENST00000355839:exon25:c.C2445T:p.A815A,ENSG00000155229:ENST00000438925:exon26:c.C2574T:p.A858A,ENSG00000155229:ENST00000370782:exon27:c.C2574T:p.A858A	MMS19:NM_001330128:exon24:c.C2280T:p.A760A,MMS19:NM_001289403:exon25:c.C2445T:p.A815A,MMS19:NM_001289404:exon25:c.C2097T:p.A699A,MMS19:NM_001351357:exon25:c.C2100T:p.A700A,MMS19:NM_001351358:exon25:c.C1482T:p.A494A,MMS19:NM_001351359:exon26:c.C1482T:p.A494A,MMS19:NM_022362:exon26:c.C2574T:p.A858A,MMS19:NM_001289405:exon27:c.C2574T:p.A858A,MMS19:NM_001351356:exon27:c.C2691T:p.A897A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5370	0.5026	0.52516	1(lung)	.	.	.	.	.	.	.	.	MMS19:uc001knq.3:exon4:c.C363T:p.A121A,MMS19:uc009xvs.3:exon13:c.C1329T:p.A443A,MMS19:uc009xvt.3:exon23:c.C1806T:p.A602A,MMS19:uc001knr.3:exon25:c.C2097T:p.A699A,MMS19:uc010qox.3:exon25:c.C2445T:p.A815A,MMS19:uc001kns.4:exon26:c.C2574T:p.A858A,MMS19:uc001knt.3:exon27:c.C2574T:p.A858A	.	AFR:MU730327,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,EAS:0.4120,FIN:0.4940,NFE:0.5861,OTH:0.5810,ASJ:0.5159	614777	.	.	.	.	.	.	.	.	.	.	.	10	1(urinary_tract)	0.5547
10	99229489	99229489	G	A	MMS19	intronic	.	ENSG00000155229	rs11592973	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2197	0.2302	0.159744	0.2355	.	.	.	.	.	0.0003	0.054	.	.	.	AFR:0.1654,AMR:0.2069,EAS:0.0377,FIN:0.2920,NFE:0.2849,OTH:0.2694,ASJ:0.19	614777	.	.	.	.	.	.	.	.	.	.	.	10	MU85509719	het
10	99240048	99240048	C	T	MMS19	exonic	nonsynonymous SNV	ENSG00000155229	rs7897727	ENSG00000155229:ENST00000422685:exon4:c.G329A:p.R110Q	MMS19:NM_001351356:exon4:c.G329A:p.R110Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5807	.	0.507388	0.5076	0.685	8.726	0.028	0.046	0.001	.	.	Armadillo-like helical	.	-0.939	AFR:0.3955,AMR:0.4084,EAS:0.5564,FIN:0.5608,NFE:0.5547,OTH:0.5760,ASJ:0.59	614777	.	.	.	.	.	.	.	.	1.91	0.000	.	10	MU4558789	hom
10	99240758	99240758	G	C	MMS19	exonic	nonsynonymous SNV	ENSG00000155229	rs2275586	ENSG00000155229:ENST00000327238:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000355839:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000422685:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000437002:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000438925:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000439048:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000448660:exon3:c.C197G:p.A66G,ENSG00000155229:ENST00000370782:exon4:c.C203G:p.A68G	MMS19:NM_001289403:exon3:c.C203G:p.A68G,MMS19:NM_001330128:exon3:c.C203G:p.A68G,MMS19:NM_001351356:exon3:c.C203G:p.A68G,MMS19:NM_022362:exon3:c.C203G:p.A68G,MMS19:NM_001289405:exon4:c.C203G:p.A68G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9649	0.9468	0.9375	0.9507	1.135	11.40	1.0	6.08	0.993	.	.	Armadillo-like helical;Armadillo-like helical|Armadillo-type fold	MMS19:uc001kns.4:exon3:c.C203G:p.A68G,MMS19:uc010qox.3:exon3:c.C203G:p.A68G,MMS19:uc001knt.3:exon4:c.C203G:p.A68G	-0.955	AFR:0.8826,AMR:0.9821,EAS:0.9796,FIN:0.9614,NFE:0.9804,OTH:0.9827,ASJ:0.9669	614777	.	.	.	.	.	.	.	0.0	-0.57	0.000	-0.515	10	MU81883983	hom
10	101544447	101544447	A	T	ABCC2	exonic	nonsynonymous SNV	ENSG00000023839	rs927344	ENSG00000023839:ENST00000370434:exon2:c.A116T:p.Y39F,ENSG00000023839:ENST00000370449:exon2:c.A116T:p.Y39F	ABCC2:NM_000392:exon2:c.A116T:p.Y39F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9980	0.9935	0.994609	0.9944	1.609	13.90	1.0	5.58	0.991	.	.	.	ABCC2:uc001kqf.2:exon2:c.A116T:p.Y39F	-0.937	AFR:0.9802,AMR:1,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	601107	237500;	234;	234|Dubin-Sprinz disease<br>Hyperbilirubinemia type 2<br>Sprinz-Nelson syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|237500 ~	.	.	.	.	0.0	0.5	0.000	-1.375	10	MU81884479	hom
10	101563815	101563815	G	A	ABCC2	exonic	nonsynonymous SNV	ENSG00000023839	rs2273697	ENSG00000023839:ENST00000370449:exon10:c.G1249A:p.V417I	ABCC2:NM_000392:exon10:c.G1249A:p.V417I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1953	0.1921	0.186502	0.1759	-0.011	2.478	0.161	-10.3	0.657	.	.	ABC transporter type 1, transmembrane domain	ABCC2:uc001kqf.2:exon10:c.G1249A:p.V417I	-1.097	AFR:0.1791,AMR:0.1595,EAS:0.0962,FIN:0.1639,NFE:0.1857,OTH:0.1765,ASJ:0.2020	601107	237500;	234;	234|Dubin-Sprinz disease<br>Hyperbilirubinemia type 2<br>Sprinz-Nelson syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|237500 ~	.	.	.	.	0.008	-2.76	0.001	0.245	10	MU150011	het
10	103339482	103339482	G	A	POLL	exonic	nonsynonymous SNV	ENSG00000166169	rs751854163	ENSG00000166169:ENST00000370168:exon3:c.C475T:p.H159Y,ENSG00000166169:ENST00000339310:exon5:c.C625T:p.H209Y,ENSG00000166169:ENST00000370158:exon5:c.C631T:p.H211Y,ENSG00000166169:ENST00000429502:exon6:c.C625T:p.H209Y,ENSG00000166169:ENST00000456836:exon7:c.C667T:p.H223Y,ENSG00000166169:ENST00000370169:exon8:c.C1456T:p.H486Y,ENSG00000166169:ENST00000415897:exon8:c.C1201T:p.H401Y,ENSG00000166169:ENST00000299206:exon9:c.C1456T:p.H486Y,ENSG00000166169:ENST00000370162:exon9:c.C1456T:p.H486Y,ENSG00000166169:ENST00000370172:exon9:c.C1192T:p.H398Y	POLL:NM_001308382:exon6:c.C631T:p.H211Y,POLL:NM_001174084:exon9:c.C1456T:p.H486Y,POLL:NM_001174085:exon9:c.C1180T:p.H394Y,POLL:NM_013274:exon9:c.C1456T:p.H486Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0] 	8.286e-06	.	.	.	4.161	23.8	0.03	3.39	0.945	.	.	DNA polymerase beta, palm domain|DNA-directed DNA polymerase X	POLL:uc001ktd.1:exon3:c.C475T:p.H159Y,POLL:uc001kte.1:exon4:c.C532T:p.H178Y,POLL:uc001kth.1:exon5:c.C631T:p.H211Y,POLL:uc010qqa.2:exon7:c.C673T:p.H225Y,POLL:uc001ktg.1:exon8:c.C1456T:p.H486Y,POLL:uc010qqc.2:exon8:c.C532T:p.H178Y,POLL:uc001ktf.3:exon9:c.C1180T:p.H394Y,POLL:uc001kti.2:exon9:c.C1456T:p.H486Y,POLL:uc001ktj.2:exon9:c.C1456T:p.H486Y,POLL:uc001ktl.3:exon9:c.C1192T:p.H398Y,POLL:uc001ktm.3:exon9:c.C1456T:p.H486Y	-1.002	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606343	.	.	.	.	.	.	.	0.906	1.55	0.125	2.375	10	.	hom
10	103340144	103340144	A	G	POLL	exonic	synonymous SNV	ENSG00000166169	rs3730476	ENSG00000166169:ENST00000370168:exon2:c.T243C:p.S81S,ENSG00000166169:ENST00000339310:exon4:c.T393C:p.S131S,ENSG00000166169:ENST00000370158:exon4:c.T399C:p.S133S,ENSG00000166169:ENST00000429502:exon5:c.T393C:p.S131S,ENSG00000166169:ENST00000456836:exon6:c.T435C:p.S145S,ENSG00000166169:ENST00000370169:exon7:c.T1224C:p.S408S,ENSG00000166169:ENST00000415897:exon7:c.T948C:p.S316S,ENSG00000166169:ENST00000299206:exon8:c.T1224C:p.S408S,ENSG00000166169:ENST00000370162:exon8:c.T1224C:p.S408S,ENSG00000166169:ENST00000370172:exon8:c.T960C:p.S320S	POLL:NM_001308382:exon5:c.T399C:p.S133S,POLL:NM_001174084:exon8:c.T1224C:p.S408S,POLL:NM_001174085:exon8:c.T948C:p.S316S,POLL:NM_013274:exon8:c.T1224C:p.S408S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2306	0.2654	0.163139	MU11561798	.	.	.	.	.	.	.	.	POLL:uc001ktd.1:exon2:c.T243C:p.S81S,POLL:uc001kte.1:exon3:c.T300C:p.S100S,POLL:uc001kth.1:exon4:c.T399C:p.S133S,POLL:uc010qqa.2:exon6:c.T441C:p.S147S,POLL:uc001ktg.1:exon7:c.T1224C:p.S408S,POLL:uc010qqc.2:exon7:c.T300C:p.S100S,POLL:uc001ktf.3:exon8:c.T948C:p.S316S,POLL:uc001kti.2:exon8:c.T1224C:p.S408S,POLL:uc001ktj.2:exon8:c.T1224C:p.S408S,POLL:uc001ktl.3:exon8:c.T960C:p.S320S,POLL:uc001ktm.3:exon8:c.T1224C:p.S408S	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.2408,EAS:0.1802,FIN:0.2682,NFE:0.0340,OTH:0.2447,ASJ:0.1788	606343	.	.	.	.	.	.	.	.	.	.	.	10	1(stomach)	0.3005
10	103340179	103340179	A	G	POLL	intronic	.	ENSG00000166169;ENSG00000166171	rs3730475	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2320	0.2597	0.163339	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235	.	.	.	.	.	0	0.002	.	.	.	AFR:0.2412,AMR:0.1791,EAS:0.2682,FIN:0.0340,NFE:0.2447,OTH:0.3010,ASJ:0.1806	606343	.	.	.	.	.	.	.	.	.	.	.	10	1(haematopoietic_and_lymphoid_tissue)	0.2531
10	103344589	103344589	T	G	POLL	exonic	nonsynonymous SNV	ENSG00000166169	rs3730463	ENSG00000166169:ENST00000370169:exon4:c.A661C:p.T221P,ENSG00000166169:ENST00000299206:exon5:c.A661C:p.T221P,ENSG00000166169:ENST00000370162:exon5:c.A661C:p.T221P,ENSG00000166169:ENST00000370172:exon5:c.A397C:p.T133P,ENSG00000166169:ENST00000413344:exon5:c.A661C:p.T221P,ENSG00000166169:ENST00000426919:exon5:c.A694C:p.T232P	POLL:NM_001174084:exon5:c.A661C:p.T221P,POLL:NM_013274:exon5:c.A661C:p.T221P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0644	0.0812	0.0583067	.	-0.519	0.197	0.191	3.61	0.362	.	.	.	POLL:uc001ktg.1:exon4:c.A661C:p.T221P,POLL:uc001kti.2:exon5:c.A661C:p.T221P,POLL:uc001ktj.2:exon5:c.A661C:p.T221P,POLL:uc001ktl.3:exon5:c.A397C:p.T133P,POLL:uc001ktm.3:exon5:c.A661C:p.T221P	-1.107	AFR:0.0768,AMR:0.1020,EAS:0.0331,FIN:0.0031,NFE:0.0575,OTH:0.0775,ASJ:0.0489	606343	.	.	.	.	.	.	.	0.229	2.69	0.002	1.375	10	1(thyroid)	0.0697
10	104157727	104157727	C	T	NFKB2	intronic	.	ENSG00000077150	rs4919632	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9646	0.9222	0.922125	0.9335	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.8030,AMR:0.9678,EAS:1,FIN:0.9963,NFE:0.9820,OTH:0.9785,ASJ:0.9636	164012	615577;	1572;293978;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~293978|DAVID syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615577 ~	~ko04010 MAPK signaling pathway~ko04064 NF-kappa B signaling pathway~ko04380 Osteoclast differentiation~ko04625 C-type lectin receptor signaling pathway~ko05134 Legionellosis~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05224 Breast cancer ~	.	.	.	.	.	.	.	10	MU81884905	hom
10	104264107	104264107	C	T	SUFU	intronic	.	ENSG00000107882	rs2274351	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4857	0.4795	0.396166	0.4626	.	.	.	.	.	.	.	.	.	.	AFR:0.3195,AMR:0.3652,EAS:0.3451,FIN:0.5258,NFE:0.5417,OTH:0.5103,ASJ:0.6854	607035	109400;155255;607174;	263662;251858;251863;251867;616;377;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	10	MU26588926	hom
10	104389932	104389932	T	G	SUFU	UTR3	.	ENSG00000107882	rs4917980	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9994	0.9978	0.997404	0.9983	.	.	.	.	.	.	.	.	.	.	AFR:0.9940,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	607035	109400;155255;607174;	263662;251858;251863;251867;616;377;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	10	MU81885050	hom
10	104849468	104849468	G	A	NT5C2	exonic	synonymous SNV	ENSG00000076685	rs3740387	ENSG00000076685:ENST00000404739:exon17:c.C1647T:p.D549D,ENSG00000076685:ENST00000423468:exon17:c.C1560T:p.D520D,ENSG00000076685:ENST00000343289:exon18:c.C1647T:p.D549D	NT5C2:NM_001351181:exon16:c.C1074T:p.D358D,NT5C2:NM_001351174:exon17:c.C1560T:p.D520D,NT5C2:NM_001351183:exon17:c.C1074T:p.D358D,NT5C2:NM_001351191:exon17:c.C1074T:p.D358D,NT5C2:NM_001134373:exon18:c.C1647T:p.D549D,NT5C2:NM_001351176:exon18:c.C1074T:p.D358D,NT5C2:NM_001351180:exon18:c.C1074T:p.D358D,NT5C2:NM_001351192:exon18:c.C1074T:p.D358D,NT5C2:NM_001351194:exon18:c.C933T:p.D311D,NT5C2:NM_001351169:exon19:c.C1647T:p.D549D,NT5C2:NM_001351170:exon19:c.C1671T:p.D557D,NT5C2:NM_001351173:exon19:c.C1671T:p.D557D,NT5C2:NM_001351177:exon19:c.C1074T:p.D358D,NT5C2:NM_001351184:exon19:c.C1074T:p.D358D,NT5C2:NM_001351185:exon19:c.C1074T:p.D358D,NT5C2:NM_001351188:exon19:c.C1074T:p.D358D,NT5C2:NM_001351189:exon19:c.C1074T:p.D358D,NT5C2:NM_001351190:exon19:c.C1074T:p.D358D,NT5C2:NM_001351193:exon19:c.C1074T:p.D358D,NT5C2:NM_012229:exon19:c.C1647T:p.D549D,NT5C2:NM_001351171:exon20:c.C1671T:p.D557D,NT5C2:NM_001351172:exon20:c.C1671T:p.D557D,NT5C2:NM_001351175:exon20:c.C1554T:p.D518D,NT5C2:NM_001351179:exon20:c.C1074T:p.D358D,NT5C2:NM_001351182:exon20:c.C1074T:p.D358D,NT5C2:NM_001351195:exon20:c.C933T:p.D311D,NT5C2:NM_001351197:exon20:c.C1074T:p.D358D,NT5C2:NM_001351178:exon21:c.C1074T:p.D358D,NT5C2:NM_001351186:exon21:c.C1074T:p.D358D,NT5C2:NM_001351196:exon21:c.C933T:p.D311D,NT5C2:NM_001351187:exon22:c.C1074T:p.D358D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4171	0.3968	0.422125	1(stomach)	.	.	.	.	.	.	.	.	NT5C2:uc010qqp.2:exon17:c.C1560T:p.D520D,NT5C2:uc001kwq.3:exon18:c.C1647T:p.D549D,NT5C2:uc001kwo.3:exon19:c.C1647T:p.D549D,NT5C2:uc001kwp.3:exon19:c.C1188T:p.D396D	.	AFR:1(urinary_tract),AMR:MU23889750,EAS:0.4122,FIN:0.3846,NFE:0.4067,OTH:0.4735,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205	600417	613162;	320396;	320396|Autosomal recessive spastic paraplegia type 65<br>SPG45<br>SPG65|<1 / 1 000 000|-|Neonatal<br>Infancy|613162 ~	.	,8380	.	.	.	.	.	.	10	2(haematopoietic_and_lymphoid_tissue)	0.5211
10	114849142	114849142	T	A	TCF7L2	intronic	.	ENSG00000148737	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602228	125853;	.	.	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04916 Melanogenesis~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	10	.	hom
10	114925637	114925637	T	C	TCF7L2	exonic	nonsynonymous SNV	ENSG00000148737	rs540099279	ENSG00000148737:ENST00000369397:exon14:c.T1697C:p.I566T,ENSG00000148737:ENST00000536810:exon14:c.T1715C:p.I572T,ENSG00000148737:ENST00000543371:exon14:c.T1715C:p.I572T,ENSG00000148737:ENST00000355995:exon15:c.T1766C:p.I589T,ENSG00000148737:ENST00000542695:exon15:c.T914C:p.I305T,ENSG00000148737:ENST00000545257:exon15:c.T1766C:p.I589T	TCF7L2:NM_001146285:exon13:c.T1646C:p.I549T,TCF7L2:NM_001198526:exon13:c.T1646C:p.I549T,TCF7L2:NM_001146274:exon14:c.T1715C:p.I572T,TCF7L2:NM_030756:exon14:c.T1697C:p.I566T,TCF7L2:NM_001367943:exon15:c.T1766C:p.I589T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	8.672e-06	.	0.000199681	.	0.839	9.702	0.05	4.95	0.174	.	.	.	TCF7L2:uc001laf.4:exon13:c.T1646C:p.I549T,TCF7L2:uc010qrl.2:exon13:c.T1646C:p.I549T,TCF7L2:uc010qrs.2:exon13:c.T1379C:p.I460T,TCF7L2:uc010qrt.2:exon13:c.T1379C:p.I460T,TCF7L2:uc021pyk.1:exon13:c.T1661C:p.I554T,TCF7L2:uc001lac.4:exon14:c.T1697C:p.I566T,TCF7L2:uc001lae.4:exon14:c.T1715C:p.I572T,TCF7L2:uc010qrr.2:exon14:c.T1511C:p.I504T,TCF7L2:uc021pyn.1:exon14:c.T1730C:p.I577T,TCF7L2:uc021pyg.1:exon15:c.T914C:p.I305T,TCF7L2:uc021pyi.1:exon15:c.T1766C:p.I589T	0.225	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602228	125853;	.	.	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04916 Melanogenesis~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	0.011	-4.92	0.814	0.345	10	.	hom
10	123298158	123298158	T	C	FGFR2	exonic	synonymous SNV	ENSG00000066468	rs1047100	ENSG00000066468:ENST00000356226:exon4:c.A351G:p.V117V,ENSG00000066468:ENST00000369059:exon4:c.A351G:p.V117V,ENSG00000066468:ENST00000604236:exon4:c.A351G:p.V117V,ENSG00000066468:ENST00000336553:exon5:c.A429G:p.V143V,ENSG00000066468:ENST00000346997:exon5:c.A696G:p.V232V,ENSG00000066468:ENST00000357555:exon5:c.A429G:p.V143V,ENSG00000066468:ENST00000360144:exon5:c.A429G:p.V143V,ENSG00000066468:ENST00000369056:exon5:c.A696G:p.V232V,ENSG00000066468:ENST00000369061:exon5:c.A696G:p.V232V,ENSG00000066468:ENST00000351936:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000358487:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000359354:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000369058:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000369060:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000457416:exon6:c.A696G:p.V232V	FGFR2:NM_001144916:exon3:c.A351G:p.V117V,FGFR2:NM_001144918:exon4:c.A351G:p.V117V,FGFR2:NM_023029:exon4:c.A429G:p.V143V,FGFR2:NM_001144913:exon5:c.A696G:p.V232V,FGFR2:NM_001144914:exon5:c.A696G:p.V232V,FGFR2:NM_001144915:exon5:c.A429G:p.V143V,FGFR2:NM_001144919:exon5:c.A429G:p.V143V,FGFR2:NM_000141:exon6:c.A696G:p.V232V,FGFR2:NM_001144917:exon6:c.A696G:p.V232V,FGFR2:NM_001320658:exon6:c.A696G:p.V232V,FGFR2:NM_022970:exon6:c.A696G:p.V232V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7797	0.7667	0.795327	0.7635	.	.	.	.	.	.	.	.	FGFR2:uc010qto.2:exon3:c.A408G:p.V136V,FGFR2:uc021pzw.1:exon3:c.A351G:p.V117V,FGFR2:uc010qtm.2:exon4:c.A351G:p.V117V,FGFR2:uc031pxk.1:exon4:c.A429G:p.V143V,FGFR2:uc010qtn.2:exon5:c.A753G:p.V251V,FGFR2:uc010qtp.2:exon5:c.A753G:p.V251V,FGFR2:uc010qtq.2:exon5:c.A753G:p.V251V,FGFR2:uc021pzv.1:exon5:c.A696G:p.V232V,FGFR2:uc021pzx.1:exon5:c.A429G:p.V143V,FGFR2:uc021qaa.1:exon5:c.A696G:p.V232V,FGFR2:uc021qab.1:exon5:c.A429G:p.V143V,FGFR2:uc021qac.1:exon5:c.A486G:p.V162V,FGFR2:uc001lfo.1:exon6:c.A753G:p.V251V,FGFR2:uc010qtl.2:exon6:c.A696G:p.V232V,FGFR2:uc021pzy.1:exon6:c.A696G:p.V232V,FGFR2:uc021pzz.1:exon6:c.A696G:p.V232V	.	AFR:0.7530,AMR:0.8126,EAS:0.9030,FIN:0.7590,NFE:0.7519,OTH:0.7459,ASJ:0.8676	176943	101200;101400;101600;123150;123500;123790;149730;207410;609579;613659;614592;	313855;168624;83;2363;1555;207;1540;710;794;87;	313855|Perinatal lethal bent bone dysplasia|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614592 ~168624|Scaphocephaly-macrocephaly-maxillary retrusion-intellectual disability syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609579 ~83|-|<1 / 1 000 000|Autosomal recessive|Neonatal|207410 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~1555|Beare-Stevenson cutis gyrata syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|123790 ~207|Crouzon craniofacial dysostosis|1-9 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123500 ~1540|Craniosynostosis-midfacial hypoplasia-foot abnormalities syndrome<br>JWS|<1 / 1 000 000|Autosomal dominant|Neonatal|123150 ~710|ACS5<br>Acrocephalosyndactyly type 5|Unknown|Autosomal dominant|Antenatal<br>Neonatal|101600 ~794|ACS3<br>Acrocephalosyndactyly type 3<br>SCS|1-9 / 100 000|Autosomal dominant|Neonatal|101400 ~87|ACS1<br>Acrocephalosyndactyly type 1|1-9 / 100 000|Autosomal dominant|Antenatal<br>Neonatal|101200 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05215 Prostate cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,5287,5323,5294,5290,5292,5288,5280,5281,5282,5284,5283,5293,5289,5291,5219,5295,5285,5286	.	.	.	.	.	.	10	MU81887223	hom
10	124271589	124271589	G	A	HTRA1	intronic	.	ENSG00000166033	rs2672586	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9998	0.9994	0.999401	0.9996	.	.	.	.	.	0.0001	0.076	.	.	.	AFR:0.9986,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	602194	600142;610149;616779;	199354;	199354|Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy<br>Maeda syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|600142 ~	.	.	.	.	.	.	.	.	10	MU81887516	hom
11	2018344	2018344	G	A	H19	ncRNA_exonic	.	ENSG00000130600	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	.	hom
11	2466659	2466659	T	C	KCNQ1	exonic	nonsynonymous SNV	ENSG00000053918	.	ENSG00000053918:ENST00000155840:exon1:c.T331C:p.Y111H,ENSG00000053918:ENST00000496887:exon2:c.T70C:p.Y24H	KCNQ1:NM_000218:exon1:c.T331C:p.Y111H	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	4.919	25.0	0.053	3.04	1.000	.	.	.	KCNQ1:uc001lwn.3:exon1:c.T331C:p.Y111H,KCNQ1:uc009ydo.1:exon1:c.T331C:p.Y111H	0.927	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607542	192500;220400;607554;609621;	51083;334;768;90647;101016;768;	51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~90647|Long QT interval-deafness syndrome|1-9 / 1 000 000|Autosomal recessive|Childhood|220400 612347 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.995	-8.35	0.993	1.975	11	.	hom
11	2797237	2797237	G	A	KCNQ1	exonic	synonymous SNV	ENSG00000053918	rs1057128	ENSG00000053918:ENST00000155840:exon13:c.G1638A:p.S546S,ENSG00000053918:ENST00000335475:exon13:c.G1257A:p.S419S	KCNQ1:NM_000218:exon13:c.G1638A:p.S546S,KCNQ1:NM_181798:exon13:c.G1257A:p.S419S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2584	0.1435	0.180911	MU824185	.	.	.	.	.	.	.	.	KCNQ1:uc009ydp.2:exon11:c.G990A:p.S330S,KCNQ1:uc001lwn.3:exon13:c.G1638A:p.S546S,KCNQ1:uc001lwo.4:exon13:c.G1257A:p.S419S	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,LINC-JP|1|394|0.00253807,AMR:0.1654,EAS:0.3329,FIN:0.1490,NFE:0.2932,OTH:0.1970,ASJ:0.0459	607542	192500;220400;607554;609621;	51083;334;768;90647;101016;768;	51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~90647|Long QT interval-deafness syndrome|1-9 / 1 000 000|Autosomal recessive|Childhood|220400 612347 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	1(lung)	0.2029
11	6630029	6630029	C	-	TAF10	UTR3	.	ENSG00000166333	rs11314683	ENSG00000166333:ENST00000527327:exon5:c.457delC:p.P153fs,ENSG00000166333:ENST00000527394:exon5:c.457delC:p.P153fs	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600475	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	8251921	8251921	G	C	LMO1	exonic	synonymous SNV	ENSG00000166407	rs3750952	ENSG00000166407:ENST00000335790:exon2:c.C156G:p.A52A,ENSG00000166407:ENST00000428101:exon2:c.C153G:p.A51A,ENSG00000166407:ENST00000534484:exon2:c.C123G:p.A41A	LMO1:NM_001270428:exon2:c.C153G:p.A51A,LMO1:NM_002315:exon2:c.C156G:p.A52A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4466	0.3592	0.333866	1(stomach)	.	.	.	.	.	.	.	.	LMO1:uc001mgg.2:exon2:c.C156G:p.A52A,LMO1:uc001mgh.2:exon2:c.C153G:p.A51A	.	AFR:1(lung),AMR:MU728619,EAS:0.3704,FIN:0.1079,NFE:0.5096,OTH:0.4768,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	186921	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.3315
11	8256255	8256255	A	C	LMO1	intronic	.	ENSG00000166407	rs204924	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.995807	0.9964	.	.	.	.	.	.	.	.	.	.	AFR:0.9877,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	186921	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	8751640	8751640	G	C	ST5	exonic	nonsynonymous SNV	ENSG00000166444	rs3812762	ENSG00000166444:ENST00000313726:exon3:c.C1197G:p.D399E,ENSG00000166444:ENST00000357665:exon4:c.C1197G:p.D399E,ENSG00000166444:ENST00000534127:exon6:c.C1197G:p.D399E	ST5:NM_213618:exon3:c.C1197G:p.D399E,ST5:NM_005418:exon6:c.C1197G:p.D399E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3119	0.2586	0.265375	1(skin)	0.700	8.829	0.747	5.25	1.000	.	.	.	ST5:uc001mgt.3:exon3:c.C1197G:p.D399E,ST5:uc001mgv.3:exon6:c.C1197G:p.D399E,ST5:uc001mgw.1:exon7:c.C1197G:p.D399E	-0.921	AFR:MU4552266,AMR:LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.1477,FIN:0.3484,NFE:0.4040,OTH:0.2009,ASJ:0.2639	140750	.	.	.	.	.	.	.	0.02	3.61	0.000	1.59	11	1(thyroid)	0.3100
11	8788225	8788225	A	C	ST5	intronic	.	ENSG00000166444	rs10734637	ENSG00000166444:ENST00000527930:exon1:c.T24G:p.G8G,ENSG00000166444:ENST00000532734:exon1:c.T24G:p.G8G	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6366	.	0.616813	0.6461	.	.	.	.	.	.	.	.	.	.	AFR:0.5597,AMR:0.6280,EAS:0.6776,FIN:0.6955,NFE:0.6832,OTH:0.6459,ASJ:0.61	140750	.	.	.	.	.	.	.	.	.	.	.	11	MU4552287	het
11	10786142	10786142	C	T	CTR9	exonic	synonymous SNV	ENSG00000198730	rs3736326	ENSG00000198730:ENST00000361367:exon12:c.C1461T:p.H487H	CTR9:NM_001346279:exon12:c.C1461T:p.H487H,CTR9:NM_014633:exon12:c.C1461T:p.H487H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6377	0.5111	0.611621	0.5535	.	.	.	.	.	.	.	.	CTR9:uc001mja.3:exon12:c.C1461T:p.H487H	.	AFR:0.3711,AMR:0.7184,EAS:0.8395,FIN:0.6282,NFE:0.5961,OTH:0.6255,ASJ:0.6192	609366	.	.	.	.	.	.	.	.	.	.	.	11	MU4555501	hom
11	11986061	11986061	T	C	DKK3	exonic	nonsynonymous SNV	ENSG00000050165	rs3206824	ENSG00000050165:ENST00000450094:exon6:c.A919G:p.R307G,ENSG00000050165:ENST00000326932:exon8:c.A1003G:p.R335G,ENSG00000050165:ENST00000396505:exon8:c.A1003G:p.R335G,ENSG00000050165:ENST00000525493:exon8:c.A1045G:p.R349G	DKK3:NM_001018057:exon7:c.A1003G:p.R335G,DKK3:NM_001330220:exon8:c.A1045G:p.R349G,DKK3:NM_013253:exon8:c.A1003G:p.R335G,DKK3:NM_015881:exon8:c.A1003G:p.R335G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7781	0.7718	0.812101	1(liver)	-0.421	0.344	0.693	-2.65	0.008	.	.	.	DKK3:uc010rcf.2:exon6:c.A919G:p.R307G,DKK3:uc001mju.3:exon7:c.A1003G:p.R335G,DKK3:uc001mjv.3:exon8:c.A1003G:p.R335G,DKK3:uc001mjw.3:exon8:c.A1003G:p.R335G,DKK3:uc010rcg.1:exon8:c.A1045G:p.R349G	-1.001	AFR:1(thyroid),AMR:MU751806,EAS:0.7566,FIN:0.8232,NFE:0.8711,OTH:0.8676,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	605416	.	.	.	.	.	.	.	0.0	2.29	0.000	-2.08	11	1(urinary_tract)	0.8019
11	14303282	14303282	T	A	RRAS2	intronic	.	ENSG00000133818	rs2303972	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4165	0.3645	0.338458	SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.3537,AMR:0.1989,EAS:0.3907,FIN:0.3213,NFE:0.3285,OTH:0.4365,ASJ:0.5933	600098	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	1(haematopoietic_and_lymphoid_tissue)	0.3912
11	20628650	20628650	A	G	SLC6A5	exonic	synonymous SNV	ENSG00000165970	rs34505618	ENSG00000165970:ENST00000525748:exon4:c.A777G:p.P259P	SLC6A5:NM_001318369:exon3:c.A75G:p.P25P,SLC6A5:NM_004211:exon4:c.A777G:p.P259P	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0354	0.0278	0.0151757	0.0371	.	.	.	.	.	.	.	.	SLC6A5:uc009yic.3:exon3:c.A72G:p.P24P,SLC6A5:uc001mqd.3:exon4:c.A777G:p.P259P	.	AFR:0.0062,AMR:0.0155,EAS:0,FIN:0.0750,NFE:0.0505,OTH:0.0490,ASJ:0.0497	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	.	.	.	.	11	.	het
11	20639400	20639400	A	G	SLC6A5	exonic	synonymous SNV	ENSG00000165970	rs7925597	ENSG00000165970:ENST00000525748:exon7:c.A1230G:p.S410S	SLC6A5:NM_001318369:exon6:c.A528G:p.S176S,SLC6A5:NM_004211:exon7:c.A1230G:p.S410S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9989	0.9950	0.997404	0.9969	.	.	.	.	.	.	.	.	SLC6A5:uc009yic.3:exon6:c.A525G:p.S175S,SLC6A5:uc001mqd.3:exon7:c.A1230G:p.S410S	.	AFR:0.9891,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	.	.	.	.	11	MU81897460	hom
11	22647366	22647366	G	A	FANCF	UTR5	.	ENSG00000183161;ENSG00000229387	rs3740615	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1567	0.1466	0.113818	0.1679	.	.	.	.	.	.	.	.	.	.	AFR:0.0630,AMR:0.0682,EAS:0.2280,FIN:0.2980,NFE:0.1938,OTH:0.2077,ASJ:0.2417	613897	603467;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	11	MU807082	hom
11	31811461	31811461	T	-	PAX6	exonic	frameshift deletion	ENSG00000007372	rs780753075	.	PAX6:NM_001368929:exon9:c.731delA:p.K244fs,PAX6:NM_001368911:exon10:c.1184delA:p.K395fs,PAX6:NM_001368916:exon11:c.1139delA:p.K380fs,PAX6:NM_001368913:exon12:c.1181delA:p.K394fs,PAX6:NM_001368915:exon12:c.1139delA:p.K380fs,PAX6:NM_001368917:exon12:c.1139delA:p.K380fs,PAX6:NM_001368912:exon13:c.1181delA:p.K394fs,PAX6:NM_001368914:exon13:c.1181delA:p.K394fs,PAX6:NM_001368921:exon13:c.980delA:p.K327fs	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0009	.	.	0.1682	.	.	.	.	.	.	.	.	.	.	AFR:0.1336,AMR:0.1561,EAS:0.0359,FIN:0.0268,NFE:0.2075,OTH:0.1606,ASJ:0.2121	607108	106210;120200;120430;136520;148190;165550;604229;	708;137902;2334;2253;35737;194;98942;98944;250923;	708|Peters congenital glaucoma|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|604229 ~137902|-|-|Autosomal dominant|-|165550 ~2334|Hereditary keratitis|Unknown|Autosomal dominant|Childhood|148190 ~2253|O'Donnell-Pappas syndrome|<1 / 1 000 000|Autosomal dominant|Adult|136520 ~35737|Ectasic coloboma<br>Volubilis syndrome|Unknown|Autosomal dominant|Childhood|120430 ~194|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|120200 216820 ~98942|-|-|-|-|120200 ~98944|-|-|-|-|120200 ~250923|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|106210 617141 617142 ~	.	.	.	.	.	.	.	.	11	.	unknown
11	32417945	32417945	T	C	WT1	exonic	synonymous SNV	ENSG00000184937	rs16754	ENSG00000184937:ENST00000452863:exon6:c.A1056G:p.R352R,ENSG00000184937:ENST00000530998:exon6:c.A420G:p.R140R,ENSG00000184937:ENST00000332351:exon7:c.A1107G:p.R369R,ENSG00000184937:ENST00000379079:exon7:c.A471G:p.R157R,ENSG00000184937:ENST00000448076:exon7:c.A1107G:p.R369R,ENSG00000184937:ENST00000527775:exon7:c.A360G:p.R120R	WT1:NM_000378:exon6:c.A1071G:p.R357R,WT1:NM_001198552:exon6:c.A420G:p.R140R,WT1:NM_001198551:exon7:c.A471G:p.R157R,WT1:NM_024424:exon7:c.A1122G:p.R374R,WT1:NM_024426:exon7:c.A1122G:p.R374R	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2335	0.1303	0.33147	2(large_intestine)	.	.	.	.	.	.	.	.	WT1:uc001mtm.2:exon6:c.A420G:p.R140R,WT1:uc001mtq.2:exon6:c.A1056G:p.R352R,WT1:uc001mtl.2:exon7:c.A471G:p.R157R,WT1:uc001mtn.2:exon7:c.A1107G:p.R369R,WT1:uc001mto.2:exon7:c.A1107G:p.R369R	.	AFR:1(bone),AMR:MU117615,EAS:0.1757,FIN:0.1051,NFE:0.3270,OTH:0.1921,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|7|321|0.0218069	607102	136680;156240;194070;194080;256370;608978;	3097;656;220;654;50251;347;	3097|Meacham-Winn-Culler syndrome<br>Rhabdomyomatous dysplasia-cardiopathy-genital anomalies syndrome|<1 / 1 000 000|-|Infancy<br>Neonatal|608978 ~656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~220|Drash syndrome<br>Wilms tumor and pseudohermaphroditism|<1 / 1 000 000|-|Infancy<br>Neonatal|194080 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~50251|-|1-9 / 100 000|Not applicable|All ages|156240 ~347|-|<1 / 1 000 000|Autosomal dominant|Childhood|136680 ~	~ko05202 Transcriptional misregulation in cancer ~	,10422	.	.	.	.	.	.	11	94(prostate)	0.7135
11	43911365	43911365	T	C	ALKBH3	exonic	synonymous SNV	ENSG00000166199	rs2434478	ENSG00000166199:ENST00000529366:exon5:c.T354C:p.T118T,ENSG00000166199:ENST00000302708:exon6:c.T357C:p.T119T,ENSG00000166199:ENST00000378840:exon6:c.T354C:p.T118T,ENSG00000166199:ENST00000530803:exon6:c.T354C:p.T118T,ENSG00000166199:ENST00000532962:exon6:c.T357C:p.T119T	ALKBH3:NM_139178:exon6:c.T357C:p.T119T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9990	0.9968	0.997604	0.9968	.	.	.	.	.	.	.	.	ALKBH3:uc001mxs.2:exon6:c.T357C:p.T119T	.	AFR:0.9888,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	610603	.	.	.	.	.	.	.	.	.	.	.	11	MU81898914	hom
11	44219498	44219498	A	G	EXT2	exonic	synonymous SNV	ENSG00000151348	rs533065326	ENSG00000151348:ENST00000343631:exon9:c.A1425G:p.E475E,ENSG00000151348:ENST00000395673:exon9:c.A1524G:p.E508E,ENSG00000151348:ENST00000533608:exon9:c.A1425G:p.E475E,ENSG00000151348:ENST00000358681:exon10:c.A1455G:p.E485E	EXT2:NM_000401:exon9:c.A1524G:p.E508E,EXT2:NM_207122:exon9:c.A1425G:p.E475E,EXT2:NM_001178083:exon10:c.A1455G:p.E485E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0003	.	0.000599042	.	.	.	.	.	.	.	.	.	EXT2:uc001mxz.3:exon9:c.A1425G:p.E475E,EXT2:uc001mya.3:exon9:c.A1524G:p.E508E,EXT2:uc010rfo.2:exon9:c.A1509G:p.E503E,EXT2:uc009ykt.3:exon10:c.A1455G:p.E485E	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608210	133701;616682;	321;	321|Bessel-Hagen disease<br>EXT1/EXT2-CDG<br>Multiple cartilaginous exostoses|1-9 / 100 000|Autosomal dominant|Childhood|133700 133701 600209 ~	.	.	.	.	.	.	.	.	11	.	het
11	47238522	47238522	T	C	DDB2	exonic	synonymous SNV	ENSG00000134574	rs326212	ENSG00000134574:ENST00000256996:exon3:c.T378C:p.T126T,ENSG00000134574:ENST00000378600:exon3:c.T378C:p.T126T,ENSG00000134574:ENST00000378601:exon3:c.T378C:p.T126T	DDB2:NM_000107:exon3:c.T378C:p.T126T,DDB2:NM_001300734:exon3:c.T378C:p.T126T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9987	0.9953	0.994209	0.9963	.	.	.	.	.	.	.	.	DDB2:uc001nef.2:exon2:c.T336C:p.T112T,DDB2:uc001neb.2:exon3:c.T378C:p.T126T,DDB2:uc001nee.2:exon3:c.T378C:p.T126T	.	AFR:0.9869,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600811	278740;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	~ko03420 Nucleotide excision repair~ko04115 p53 signaling pathway~ko04120 Ubiquitin mediated proteolysis~ko05161 Hepatitis B~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	MU81899467	hom
11	48145247	48145247	T	C	PTPRJ	exonic	synonymous SNV	ENSG00000149177	rs2270992	ENSG00000149177:ENST00000527952:exon4:c.T435C:p.T145T,ENSG00000149177:ENST00000418331:exon5:c.T699C:p.T233T,ENSG00000149177:ENST00000440289:exon5:c.T699C:p.T233T	PTPRJ:NM_001098503:exon5:c.T699C:p.T233T,PTPRJ:NM_002843:exon5:c.T699C:p.T233T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5721	0.4686	0.452276	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	PTPRJ:uc001ngo.4:exon5:c.T699C:p.T233T,PTPRJ:uc001ngp.4:exon5:c.T699C:p.T233T	.	AFR:0.4967,AMR:0.1920,EAS:0.5795,FIN:0.5149,NFE:0.6582,OTH:0.6178,ASJ:0.6770	600925	114500;	.	.	.	.	.	.	.	.	.	.	11	1(lung)	0.5736
11	48166267	48166267	G	C	PTPRJ	exonic	nonsynonymous SNV	ENSG00000149177	rs4752904	ENSG00000149177:ENST00000418331:exon13:c.G2616C:p.E872D	PTPRJ:NM_002843:exon13:c.G2616C:p.E872D	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5153	0.4313	0.367212	0.4539	-2.152	0.001	0.645	-10.9	0.852	.	.	Fibronectin type III|Immunoglobulin-like fold	PTPRJ:uc001ngp.4:exon13:c.G2616C:p.E872D	-0.911	AFR:0.1318,AMR:0.6217,EAS:0.4023,FIN:0.6186,NFE:0.5899,OTH:0.5367,ASJ:0.6167	600925	114500;	.	.	.	.	.	.	0.007	2.57	0.000	0.55	11	MU742433	hom
11	57563192	57563192	A	G	CTNND1	exonic	synonymous SNV	ENSG00000198561	.	ENSG00000198561:ENST00000532245:exon2:c.A108G:p.T36T,ENSG00000198561:ENST00000534647:exon2:c.A177G:p.T59T,ENSG00000198561:ENST00000415361:exon3:c.A108G:p.T36T,ENSG00000198561:ENST00000426142:exon3:c.A108G:p.T36T,ENSG00000198561:ENST00000528232:exon3:c.A108G:p.T36T,ENSG00000198561:ENST00000529986:exon3:c.A108G:p.T36T,ENSG00000198561:ENST00000530094:exon3:c.A108G:p.T36T,ENSG00000198561:ENST00000532463:exon3:c.A108G:p.T36T,ENSG00000198561:ENST00000532787:exon3:c.A108G:p.T36T,ENSG00000198561:ENST00000428599:exon4:c.A411G:p.T137T,ENSG00000198561:ENST00000526357:exon4:c.A249G:p.T83T,ENSG00000198561:ENST00000526938:exon4:c.A411G:p.T137T,ENSG00000198561:ENST00000528621:exon4:c.A249G:p.T83T,ENSG00000198561:ENST00000529873:exon4:c.A249G:p.T83T,ENSG00000198561:ENST00000530068:exon4:c.A249G:p.T83T,ENSG00000198561:ENST00000530748:exon4:c.A249G:p.T83T,ENSG00000198561:ENST00000532844:exon4:c.A249G:p.T83T,ENSG00000198561:ENST00000358694:exon5:c.A411G:p.T137T,ENSG00000198561:ENST00000360682:exon5:c.A411G:p.T137T,ENSG00000198561:ENST00000361332:exon5:c.A411G:p.T137T,ENSG00000198561:ENST00000361391:exon5:c.A411G:p.T137T,ENSG00000198561:ENST00000361796:exon5:c.A411G:p.T137T,ENSG00000198561:ENST00000399039:exon5:c.A411G:p.T137T,ENSG00000198561:ENST00000399050:exon5:c.A411G:p.T137T,ENSG00000198561:ENST00000524630:exon5:c.A411G:p.T137T,ENSG00000198561:ENST00000529526:exon5:c.A249G:p.T83T,ENSG00000198561:ENST00000529919:exon5:c.A411G:p.T137T,ENSG00000198561:ENST00000532649:exon5:c.A249G:p.T83T,ENSG00000198561:ENST00000534579:exon5:c.A249G:p.T83T	CTNND1:NM_001085469:exon2:c.A108G:p.T36T,CTNND1:NM_001085463:exon3:c.A108G:p.T36T,CTNND1:NM_001085464:exon3:c.A108G:p.T36T,CTNND1:NM_001085465:exon3:c.A108G:p.T36T,CTNND1:NM_001085466:exon3:c.A108G:p.T36T,CTNND1:NM_001085467:exon3:c.A108G:p.T36T,CTNND1:NM_001085468:exon3:c.A108G:p.T36T,CTNND1:NM_001206890:exon3:c.A108G:p.T36T,CTNND1:NM_001085462:exon4:c.A411G:p.T137T,CTNND1:NM_001206883:exon4:c.A249G:p.T83T,CTNND1:NM_001206884:exon4:c.A249G:p.T83T,CTNND1:NM_001206886:exon4:c.A249G:p.T83T,CTNND1:NM_001206887:exon4:c.A249G:p.T83T,CTNND1:NM_001206888:exon4:c.A249G:p.T83T,CTNND1:NM_001085458:exon5:c.A411G:p.T137T,CTNND1:NM_001085459:exon5:c.A411G:p.T137T,CTNND1:NM_001085460:exon5:c.A411G:p.T137T,CTNND1:NM_001085461:exon5:c.A411G:p.T137T,CTNND1:NM_001206885:exon5:c.A411G:p.T137T,CTNND1:NM_001206889:exon5:c.A249G:p.T83T,CTNND1:NM_001206891:exon5:c.A249G:p.T83T,CTNND1:NM_001331:exon5:c.A411G:p.T137T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	CTNND1:uc001nlw.4:exon2:c.A108G:p.T36T,CTNND1:uc001nlo.4:exon3:c.A108G:p.T36T,CTNND1:uc001nlq.4:exon3:c.A108G:p.T36T,CTNND1:uc001nls.4:exon3:c.A108G:p.T36T,CTNND1:uc001nlt.4:exon3:c.A108G:p.T36T,CTNND1:uc001nlu.4:exon3:c.A108G:p.T36T,CTNND1:uc001nlv.4:exon3:c.A108G:p.T36T,CTNND1:uc001nmi.4:exon3:c.A108G:p.T36T,CTNND1:uc001nlj.4:exon4:c.A249G:p.T83T,CTNND1:uc001nlk.4:exon4:c.A249G:p.T83T,CTNND1:uc001nln.4:exon4:c.A411G:p.T137T,CTNND1:uc001nlp.4:exon4:c.A249G:p.T83T,CTNND1:uc001nlr.4:exon4:c.A249G:p.T83T,CTNND1:uc001nmd.4:exon4:c.A249G:p.T83T,TMX2-CTNND1:uc001nlh.1:exon5:c.A411G:p.T137T,CTNND1:uc001nli.4:exon5:c.A411G:p.T137T,CTNND1:uc001nll.4:exon5:c.A249G:p.T83T,CTNND1:uc001nlm.4:exon5:c.A411G:p.T137T,CTNND1:uc001nmc.4:exon5:c.A411G:p.T137T,CTNND1:uc001nme.4:exon5:c.A411G:p.T137T,CTNND1:uc001nmf.4:exon5:c.A411G:p.T137T,CTNND1:uc001nmg.4:exon5:c.A249G:p.T83T,CTNND1:uc001nmh.4:exon5:c.A411G:p.T137T,CTNND1:uc021qjk.1:exon5:c.A411G:p.T137T,TMX2-CTNND1:uc001nlf.2:exon6:c.A411G:p.T137T	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601045	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	57571232	57571232	C	T	CTNND1	exonic	synonymous SNV	ENSG00000198561	rs11229137	ENSG00000198561:ENST00000525902:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000526772:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000527467:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000531014:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000533667:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000532245:exon5:c.C1257T:p.H419H,ENSG00000198561:ENST00000415361:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000426142:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000528232:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000529986:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000530094:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000532463:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000532787:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000428599:exon7:c.C1560T:p.H520H,ENSG00000198561:ENST00000526357:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000526938:exon7:c.C1560T:p.H520H,ENSG00000198561:ENST00000528621:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000529873:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000530748:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000532844:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000358694:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000360682:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000361332:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000361391:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000361796:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000399039:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000399050:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000524630:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000529526:exon8:c.C1398T:p.H466H,ENSG00000198561:ENST00000529919:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000532649:exon8:c.C1398T:p.H466H,ENSG00000198561:ENST00000534579:exon8:c.C1398T:p.H466H	CTNND1:NM_001085469:exon5:c.C1257T:p.H419H,CTNND1:NM_001085463:exon6:c.C1257T:p.H419H,CTNND1:NM_001085464:exon6:c.C1257T:p.H419H,CTNND1:NM_001085465:exon6:c.C1257T:p.H419H,CTNND1:NM_001085466:exon6:c.C1257T:p.H419H,CTNND1:NM_001085467:exon6:c.C1257T:p.H419H,CTNND1:NM_001085468:exon6:c.C1257T:p.H419H,CTNND1:NM_001206890:exon6:c.C1257T:p.H419H,CTNND1:NM_001085462:exon7:c.C1560T:p.H520H,CTNND1:NM_001206883:exon7:c.C1398T:p.H466H,CTNND1:NM_001206884:exon7:c.C1398T:p.H466H,CTNND1:NM_001206886:exon7:c.C1398T:p.H466H,CTNND1:NM_001206887:exon7:c.C1398T:p.H466H,CTNND1:NM_001206888:exon7:c.C1398T:p.H466H,CTNND1:NM_001085458:exon8:c.C1560T:p.H520H,CTNND1:NM_001085459:exon8:c.C1560T:p.H520H,CTNND1:NM_001085460:exon8:c.C1560T:p.H520H,CTNND1:NM_001085461:exon8:c.C1560T:p.H520H,CTNND1:NM_001206885:exon8:c.C1560T:p.H520H,CTNND1:NM_001206889:exon8:c.C1398T:p.H466H,CTNND1:NM_001206891:exon8:c.C1398T:p.H466H,CTNND1:NM_001331:exon8:c.C1560T:p.H520H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9992	0.9979	0.996206	0.9972	.	.	.	.	.	.	.	.	CTNND1:uc001nlx.4:exon3:c.C591T:p.H197H,CTNND1:uc001nly.4:exon3:c.C591T:p.H197H,CTNND1:uc001nlz.4:exon3:c.C591T:p.H197H,CTNND1:uc001nma.4:exon3:c.C591T:p.H197H,CTNND1:uc001nmb.4:exon3:c.C591T:p.H197H,CTNND1:uc009ymn.3:exon3:c.C591T:p.H197H,CTNND1:uc001nlw.4:exon5:c.C1257T:p.H419H,CTNND1:uc001nlo.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlq.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nls.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlt.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlu.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlv.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nmi.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlj.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nlk.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nln.4:exon7:c.C1560T:p.H520H,CTNND1:uc001nlp.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nlr.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nmd.4:exon7:c.C1398T:p.H466H,TMX2-CTNND1:uc001nlh.1:exon8:c.C1560T:p.H520H,CTNND1:uc001nli.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nll.4:exon8:c.C1398T:p.H466H,CTNND1:uc001nlm.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nmc.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nme.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nmf.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nmg.4:exon8:c.C1398T:p.H466H,CTNND1:uc001nmh.4:exon8:c.C1560T:p.H520H,CTNND1:uc021qjk.1:exon8:c.C1560T:p.H520H,TMX2-CTNND1:uc001nlf.2:exon9:c.C1560T:p.H520H	.	AFR:0.9899,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	601045	.	.	.	.	.	.	.	.	.	.	.	11	MU81901822	hom
11	60665409	60665409	G	A	PRPF19	exonic	synonymous SNV	ENSG00000110107	.	ENSG00000110107:ENST00000535326:exon3:c.C171T:p.I57I,ENSG00000110107:ENST00000227524:exon15:c.C1326T:p.I442I	PRPF19:NM_014502:exon15:c.C1326T:p.I442I	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	PRPF19:uc001nqf.3:exon15:c.C1326T:p.I442I	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608330	.	.	.	.	.	.	.	.	.	.	.	11	MU129233144	hom
11	62290630	62290630	G	A	AHNAK	exonic	synonymous SNV	ENSG00000124942	rs371955022	ENSG00000124942:ENST00000378024:exon5:c.C11259T:p.N3753N	AHNAK:NM_001346445:exon5:c.C11259T:p.N3753N,AHNAK:NM_001346446:exon5:c.C11259T:p.N3753N,AHNAK:NM_001620:exon5:c.C11259T:p.N3753N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	5.766e-05	7.7e-05	0.000199681	3.238e-05	.	.	.	.	.	.	.	.	AHNAK:uc001ntl.3:exon5:c.C11259T:p.N3753N	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	103390	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	62292882	62292882	G	T	AHNAK	exonic	nonsynonymous SNV	ENSG00000124942	rs566144	ENSG00000124942:ENST00000378024:exon5:c.C9007A:p.Q3003K	AHNAK:NM_001346445:exon5:c.C9007A:p.Q3003K,AHNAK:NM_001346446:exon5:c.C9007A:p.Q3003K,AHNAK:NM_001620:exon5:c.C9007A:p.Q3003K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	1	.	1	0.9999	-0.671	0.084	1.0	3.97	0.067	.	.	.	AHNAK:uc001ntl.3:exon5:c.C9007A:p.Q3003K	-1.013	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	103390	.	.	.	.	.	.	.	0.0	2.88	0.000	-2.045	11	MU81903251	hom
11	62293948	62293948	G	A	AHNAK	exonic	synonymous SNV	ENSG00000124942	rs486903	ENSG00000124942:ENST00000378024:exon5:c.C7941T:p.S2647S	AHNAK:NM_001346445:exon5:c.C7941T:p.S2647S,AHNAK:NM_001346446:exon5:c.C7941T:p.S2647S,AHNAK:NM_001620:exon5:c.C7941T:p.S2647S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6638	0.5583	0.473043	1(large_intestine)	.	.	.	.	.	.	.	.	AHNAK:uc001ntl.3:exon5:c.C7941T:p.S2647S	.	AFR:MU150832,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.1716,FIN:0.6845,NFE:0.6093,OTH:0.2963,ASJ:0.5748	103390	.	.	.	.	.	.	.	.	.	.	.	11	1(lung)	0.8322
11	64572018	64572018	T	C	MEN1	exonic	nonsynonymous SNV	ENSG00000133895	rs2959656	ENSG00000133895:ENST00000377316:exon8:c.A1456G:p.T486A,ENSG00000133895:ENST00000377313:exon9:c.A1636G:p.T546A,ENSG00000133895:ENST00000377326:exon9:c.A1621G:p.T541A,ENSG00000133895:ENST00000312049:exon10:c.A1621G:p.T541A,ENSG00000133895:ENST00000315422:exon10:c.A1621G:p.T541A,ENSG00000133895:ENST00000337652:exon10:c.A1636G:p.T546A,ENSG00000133895:ENST00000377321:exon10:c.A1516G:p.T506A,ENSG00000133895:ENST00000394374:exon10:c.A1636G:p.T546A,ENSG00000133895:ENST00000443283:exon10:c.A1636G:p.T546A,ENSG00000133895:ENST00000394376:exon11:c.A1636G:p.T546A	MEN1:NM_000244:exon10:c.A1636G:p.T546A,MEN1:NM_001370259:exon10:c.A1621G:p.T541A,MEN1:NM_001370260:exon10:c.A1621G:p.T541A,MEN1:NM_001370261:exon10:c.A1621G:p.T541A,MEN1:NM_001370262:exon10:c.A1516G:p.T506A,MEN1:NM_001370263:exon10:c.A1516G:p.T506A,MEN1:NM_130799:exon10:c.A1621G:p.T541A,MEN1:NM_130800:exon10:c.A1636G:p.T546A,MEN1:NM_130801:exon10:c.A1636G:p.T546A,MEN1:NM_130802:exon10:c.A1636G:p.T546A,MEN1:NM_130803:exon10:c.A1636G:p.T546A,MEN1:NM_001370251:exon11:c.A1747G:p.T583A,MEN1:NM_130804:exon11:c.A1636G:p.T546A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9378	0.9084	0.834465	MU17436755	-0.869	0.030	0.866	3.35	0.004	.	.	.	MEN1:uc001obj.3:exon10:c.A1636G:p.T546A,MEN1:uc001obk.3:exon10:c.A1636G:p.T546A,MEN1:uc001obl.3:exon10:c.A1516G:p.T506A,MEN1:uc001obm.3:exon10:c.A1621G:p.T541A,MEN1:uc001obn.3:exon10:c.A1636G:p.T546A,MEN1:uc001obo.3:exon10:c.A1636G:p.T546A,MEN1:uc001obr.3:exon10:c.A1636G:p.T546A,MEN1:uc001obq.3:exon11:c.A1636G:p.T546A	-0.936	AFR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.8934,EAS:0.8986,FIN:0.9967,NFE:0.6936,OTH:0.9814,ASJ:0.7058	613733	131100;	652;	652|MEN1<br>Wermer syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|131100 ~	~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.0	-5.71	0.000	-0.69	11	22(soft_tissue)	0.9959
11	64572557	64572557	A	G	MEN1	exonic	synonymous SNV	ENSG00000133895	rs540012	ENSG00000133895:ENST00000377313:exon8:c.T1314C:p.H438H,ENSG00000133895:ENST00000377326:exon8:c.T1299C:p.H433H,ENSG00000133895:ENST00000312049:exon9:c.T1299C:p.H433H,ENSG00000133895:ENST00000315422:exon9:c.T1299C:p.H433H,ENSG00000133895:ENST00000337652:exon9:c.T1314C:p.H438H,ENSG00000133895:ENST00000377321:exon9:c.T1194C:p.H398H,ENSG00000133895:ENST00000394374:exon9:c.T1314C:p.H438H,ENSG00000133895:ENST00000443283:exon9:c.T1314C:p.H438H,ENSG00000133895:ENST00000394376:exon10:c.T1314C:p.H438H	MEN1:NM_000244:exon9:c.T1314C:p.H438H,MEN1:NM_001370259:exon9:c.T1299C:p.H433H,MEN1:NM_001370260:exon9:c.T1299C:p.H433H,MEN1:NM_001370261:exon9:c.T1299C:p.H433H,MEN1:NM_001370262:exon9:c.T1194C:p.H398H,MEN1:NM_001370263:exon9:c.T1194C:p.H398H,MEN1:NM_130799:exon9:c.T1299C:p.H433H,MEN1:NM_130800:exon9:c.T1314C:p.H438H,MEN1:NM_130801:exon9:c.T1314C:p.H438H,MEN1:NM_130802:exon9:c.T1314C:p.H438H,MEN1:NM_130803:exon9:c.T1314C:p.H438H,MEN1:NM_001370251:exon10:c.T1425C:p.H475H,MEN1:NM_130804:exon10:c.T1314C:p.H438H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9927	0.9761	0.976038	0.9768	.	.	.	.	.	.	.	.	MEN1:uc001obj.3:exon9:c.T1314C:p.H438H,MEN1:uc001obk.3:exon9:c.T1314C:p.H438H,MEN1:uc001obl.3:exon9:c.T1194C:p.H398H,MEN1:uc001obm.3:exon9:c.T1299C:p.H433H,MEN1:uc001obn.3:exon9:c.T1314C:p.H438H,MEN1:uc001obo.3:exon9:c.T1314C:p.H438H,MEN1:uc001obr.3:exon9:c.T1314C:p.H438H,MEN1:uc001obq.3:exon10:c.T1314C:p.H438H	.	AFR:0.9185,AMR:0.9976,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	613733	131100;	652;	652|MEN1<br>Wermer syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|131100 ~	~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	11	MU81904595	hom
11	64572602	64572602	G	A	MEN1	exonic	synonymous SNV	ENSG00000133895	rs2071313	ENSG00000133895:ENST00000377313:exon8:c.C1269T:p.D423D,ENSG00000133895:ENST00000377326:exon8:c.C1254T:p.D418D,ENSG00000133895:ENST00000312049:exon9:c.C1254T:p.D418D,ENSG00000133895:ENST00000315422:exon9:c.C1254T:p.D418D,ENSG00000133895:ENST00000337652:exon9:c.C1269T:p.D423D,ENSG00000133895:ENST00000377321:exon9:c.C1149T:p.D383D,ENSG00000133895:ENST00000394374:exon9:c.C1269T:p.D423D,ENSG00000133895:ENST00000443283:exon9:c.C1269T:p.D423D,ENSG00000133895:ENST00000394376:exon10:c.C1269T:p.D423D	MEN1:NM_000244:exon9:c.C1269T:p.D423D,MEN1:NM_001370259:exon9:c.C1254T:p.D418D,MEN1:NM_001370260:exon9:c.C1254T:p.D418D,MEN1:NM_001370261:exon9:c.C1254T:p.D418D,MEN1:NM_001370262:exon9:c.C1149T:p.D383D,MEN1:NM_001370263:exon9:c.C1149T:p.D383D,MEN1:NM_130799:exon9:c.C1254T:p.D418D,MEN1:NM_130800:exon9:c.C1269T:p.D423D,MEN1:NM_130801:exon9:c.C1269T:p.D423D,MEN1:NM_130802:exon9:c.C1269T:p.D423D,MEN1:NM_130803:exon9:c.C1269T:p.D423D,MEN1:NM_001370251:exon10:c.C1380T:p.D460D,MEN1:NM_130804:exon10:c.C1269T:p.D423D	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3934	0.3040	0.307907	1(liver)	.	.	.	.	.	.	.	.	MEN1:uc001obj.3:exon9:c.C1269T:p.D423D,MEN1:uc001obk.3:exon9:c.C1269T:p.D423D,MEN1:uc001obl.3:exon9:c.C1149T:p.D383D,MEN1:uc001obm.3:exon9:c.C1254T:p.D418D,MEN1:uc001obn.3:exon9:c.C1269T:p.D423D,MEN1:uc001obo.3:exon9:c.C1269T:p.D423D,MEN1:uc001obr.3:exon9:c.C1269T:p.D423D,MEN1:uc001obq.3:exon10:c.C1269T:p.D423D	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:1(breast),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,FIN:0.3262,NFE:0.0877,OTH:0.3285,ASJ:MU90806	613733	131100;	652;	652|MEN1<br>Wermer syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|131100 ~	~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	11	3(lung)	0.3576
11	65629932	65629932	T	C	MUS81	exonic	synonymous SNV	ENSG00000172732	rs659857	ENSG00000172732:ENST00000525768:exon5:c.T312C:p.A104A,ENSG00000172732:ENST00000308110:exon6:c.T537C:p.A179A,ENSG00000172732:ENST00000533035:exon6:c.T312C:p.A104A	MUS81:NM_001350283:exon6:c.T537C:p.A179A,MUS81:NM_025128:exon6:c.T537C:p.A179A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5752	0.5247	0.428115	COCA-CN|3|321|0.00934579,BLCA-CN|1|103|0.00970874	.	.	.	.	.	.	.	.	MUS81:uc001ofv.4:exon6:c.T537C:p.A179A	.	AFR:0.5305,AMR:0.2557,EAS:0.6722,FIN:0.3077,NFE:0.7027,OTH:0.6739,ASJ:0.4017	606591	.	.	.	.	.	.	.	.	.	.	.	11	1(thyroid)	0.6167
11	65629934	65629934	G	C	MUS81	exonic	nonsynonymous SNV	ENSG00000172732	rs545500	ENSG00000172732:ENST00000525768:exon5:c.G314C:p.R105P,ENSG00000172732:ENST00000308110:exon6:c.G539C:p.R180P,ENSG00000172732:ENST00000533035:exon6:c.G314C:p.R105P	MUS81:NM_001350283:exon6:c.G539C:p.R180P,MUS81:NM_025128:exon6:c.G539C:p.R180P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5752	0.5262	0.428115	MU115031	1.935	15.80	0.087	-1.98	0.337	.	.	Winged helix-turn-helix DNA-binding domain	MUS81:uc001ofv.4:exon6:c.G539C:p.R180P	-0.973	AFR:COCA-CN|3|321|0.00934579,BLCA-CN|1|103|0.00970874,AMR:0.5303,EAS:0.4017,FIN:0.6722,NFE:0.3077,OTH:0.7027,ASJ:0.2555	606591	.	.	.	.	.	.	.	0.678	2.47	0.000	1.79	11	1(large_intestine)	0.6738
11	65631973	65631973	G	A	MUS81	exonic	synonymous SNV	ENSG00000172732	rs630303	ENSG00000172732:ENST00000308110:exon11:c.G1065A:p.R355R,ENSG00000172732:ENST00000533035:exon11:c.G840A:p.R280R	MUS81:NM_001350283:exon11:c.G1068A:p.R356R,MUS81:NM_025128:exon11:c.G1065A:p.R355R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5793	0.5308	0.429912	1(breast)	.	.	.	.	.	.	.	.	MUS81:uc001ofv.4:exon11:c.G1065A:p.R355R	.	AFR:2(large_intestine),AMR:MU115052,EAS:0.5330,FIN:0.2591,NFE:0.4007,OTH:0.6722,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	606591	.	.	.	.	.	.	.	.	.	.	.	11	1(lung)	0.3088
11	65632262	65632262	G	T	MUS81	exonic	synonymous SNV	ENSG00000172732	rs558114	ENSG00000172732:ENST00000308110:exon12:c.G1248T:p.T416T,ENSG00000172732:ENST00000533035:exon12:c.G1023T:p.T341T	MUS81:NM_001350283:exon12:c.G1251T:p.T417T,MUS81:NM_025128:exon12:c.G1248T:p.T416T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5789	0.5299	0.428315	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	MUS81:uc001ofv.4:exon12:c.G1248T:p.T416T	.	AFR:0.5323,AMR:0.2571,EAS:0.6722,FIN:0.3093,NFE:0.7030,OTH:0.6762,ASJ:0.4017	606591	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.6111
11	65664346	65664346	T	C	FOSL1	exonic	synonymous SNV	ENSG00000175592	rs637571	ENSG00000175592:ENST00000312562:exon2:c.A231G:p.Q77Q,ENSG00000175592:ENST00000531493:exon2:c.A231G:p.Q77Q,ENSG00000175592:ENST00000532401:exon2:c.A231G:p.Q77Q	FOSL1:NM_001300844:exon2:c.A231G:p.Q77Q,FOSL1:NM_001300855:exon2:c.A231G:p.Q77Q,FOSL1:NM_005438:exon2:c.A231G:p.Q77Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5077	0.4840	0.56849	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FOSL1:uc001ogg.1:exon2:c.A231G:p.Q77Q	.	AFR:0.4865,AMR:0.5561,EAS:0.4570,FIN:0.7665,NFE:0.3964,OTH:0.4281,ASJ:0.6679	136515	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.4743
11	67257823	67257823	C	A	AIP	exonic	nonsynonymous SNV	ENSG00000110711	rs641081	ENSG00000110711:ENST00000525341:exon3:c.C334A:p.Q112K,ENSG00000110711:ENST00000528641:exon4:c.C493A:p.Q165K,ENSG00000110711:ENST00000279146:exon5:c.C682A:p.Q228K	AIP:NM_001302959:exon5:c.C505A:p.Q169K,AIP:NM_001302960:exon5:c.C682A:p.Q228K,AIP:NM_003977:exon5:c.C682A:p.Q228K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9550	0.8343	0.845447	0.8508	-1.180	0.007	1.0	1.08	0.068	.	.	Tetratricopeptide-like helical domain	AIP:uc001olv.3:exon5:c.C682A:p.Q228K	-0.952	AFR:0.4803,AMR:0.9582,EAS:0.9994,FIN:1,NFE:0.9977,OTH:0.9755,ASJ:1	605555	102200;219090;600634;	314777;96253;314777;96256;963;99725;	314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96253|Corticotroph pituitary adenoma<br>Pituitary corticotroph micro-adenoma<br>Pituitary-dependent Cushing syndrome|1-9 / 100 000|Not applicable|Adult|219090 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	.	.	.	.	0.0	-0.72	0.000	0.42	11	MU4550249	hom
11	67258391	67258391	A	G	AIP	exonic	nonsynonymous SNV	ENSG00000110711	rs4930199	ENSG00000110711:ENST00000279146:exon6:c.A920G:p.Q307R	AIP:NM_001302959:exon6:c.A743G:p.Q248R,AIP:NM_003977:exon6:c.A920G:p.Q307R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9999	0.9998	0.999401	0.9998	.	.	.	.	.	.	.	.	AIP:uc001olv.3:exon6:c.A920G:p.Q307R	.	AFR:0.9995,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	605555	102200;219090;600634;	314777;96253;314777;96256;963;99725;	314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96253|Corticotroph pituitary adenoma<br>Pituitary corticotroph micro-adenoma<br>Pituitary-dependent Cushing syndrome|1-9 / 100 000|Not applicable|Adult|219090 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	.	.	.	.	.	.	.	.	11	MU4550266	hom
11	67351585	67351585	C	G	GSTP1	intronic	.	ENSG00000084207	rs4147581	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4913	0.3879	0.424321	0.4018	.	.	.	.	.	.	.	.	.	.	AFR:0.1433,AMR:0.3816,EAS:0.7071,FIN:0.5032,NFE:0.4885,OTH:0.4815,ASJ:0.5933	134660	.	.	.	~ko00480 Glutathione metabolism~ko00980 Metabolism of xenobiotics by cytochrome P450~ko00982 Drug metabolism - cytochrome P450~ko00983 Drug metabolism - other enzymes~ko01100 Metabolic pathways~ko01524 Platinum drug resistance~ko04212 Longevity regulating pathway - worm~ko05200 Pathways in cancer~ko05204 Chemical carcinogenesis~ko05225 Hepatocellular carcinoma~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	11	MU796812	hom
11	68171013	68171013	T	C	LRP5	exonic	synonymous SNV	ENSG00000162337	rs545382	ENSG00000162337:ENST00000294304:exon8:c.T1647C:p.F549F	LRP5:NM_002335:exon8:c.T1647C:p.F549F	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9001	0.8154	0.841454	0.8459	.	.	.	.	.	.	.	.	LRP5:uc001ont.3:exon8:c.T1647C:p.F549F	.	AFR:0.6314,AMR:0.9320,EAS:0.9883,FIN:0.9645,NFE:0.9169,OTH:0.9153,ASJ:0.9073	603506	144750;166710;259770;601813;601884;607634;607636;	3416;2783;891;2788;2790;	3416|Van Buchem disease|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent|239100 607636 ~2783|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Childhood|607634 ~891|Criswick-Schepens syndrome<br>FEVR|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|133780 305390 601813 605750 613310 616468 ~2788|OPPG<br>Ocular form of osteogenesis imperfecta|<1 / 1 000 000|Autosomal recessive|Childhood|259770 ~2790|Endosteal hyperostosis, Worth type<br>Worth syndrome|-|Autosomal dominant|-|144750 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	MU4557319	hom
11	68192690	68192690	G	A	LRP5	exonic	synonymous SNV	ENSG00000162337	rs556442	ENSG00000162337:ENST00000294304:exon15:c.G3357A:p.V1119V	LRP5:NM_001291902:exon15:c.G1614A:p.V538V,LRP5:NM_002335:exon15:c.G3357A:p.V1119V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6755	0.5265	0.579273	2(large_intestine)	.	.	.	.	.	.	.	.	LRP5:uc001ont.3:exon15:c.G3357A:p.V1119V	.	AFR:MU64296,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EAS:0.2359,FIN:0.6675,NFE:0.6258,OTH:0.7689,ASJ:0.5925	603506	144750;166710;259770;601813;601884;607634;607636;	3416;2783;891;2788;2790;	3416|Van Buchem disease|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent|239100 607636 ~2783|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Childhood|607634 ~891|Criswick-Schepens syndrome<br>FEVR|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|133780 305390 601813 605750 613310 616468 ~2788|OPPG<br>Ocular form of osteogenesis imperfecta|<1 / 1 000 000|Autosomal recessive|Childhood|259770 ~2790|Endosteal hyperostosis, Worth type<br>Worth syndrome|-|Autosomal dominant|-|144750 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	1(skin)	0.8595
11	68201226	68201226	G	A	LRP5	exonic	nonsynonymous SNV	ENSG00000162337	rs760090713	ENSG00000162337:ENST00000294304:exon18:c.G3920A:p.R1307Q	LRP5:NM_001291902:exon18:c.G2177A:p.R726Q,LRP5:NM_002335:exon18:c.G3920A:p.R1307Q	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 2, 1, 1, 0] 	3.383e-05	.	.	0.0001	3.969	23.6	0.116	3.39	0.992	.	.	.	LRP5:uc001ont.3:exon18:c.G3920A:p.R1307Q	-0.213	AFR:0.0002,AMR:0,EAS:0,FIN:0,NFE:0.0001,OTH:0,ASJ:0	603506	144750;166710;259770;601813;601884;607634;607636;	3416;2783;891;2788;2790;	3416|Van Buchem disease|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent|239100 607636 ~2783|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Childhood|607634 ~891|Criswick-Schepens syndrome<br>FEVR|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|133780 305390 601813 605750 613310 616468 ~2788|OPPG<br>Ocular form of osteogenesis imperfecta|<1 / 1 000 000|Autosomal recessive|Childhood|259770 ~2790|Endosteal hyperostosis, Worth type<br>Worth syndrome|-|Autosomal dominant|-|144750 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	0.709	-2.27	0.375	0.49	11	MU131105410	hom
11	68822739	68822739	T	C	TPCN2	exonic	synonymous SNV	ENSG00000162341	rs1470892	ENSG00000162341:ENST00000294309:exon4:c.T348C:p.A116A,ENSG00000162341:ENST00000542467:exon4:c.T348C:p.A116A	TPCN2:NM_139075:exon4:c.T348C:p.A116A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9994	0.9975	0.998802	0.9977	.	.	.	.	.	.	.	.	TPCN2:uc001oos.2:exon4:c.T348C:p.A116A,TPCN2:uc010rqg.1:exon4:c.T348C:p.A116A	.	AFR:0.9921,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	MU81906316	hom
11	68825037	68825037	A	C	TPCN2	intronic	.	ENSG00000162341	rs3750973	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8786	0.9005	0.747804	0.8742	.	.	.	.	.	0.0001	0.028	.	.	.	AFR:0.7215,AMR:0.6026,EAS:0.5278,FIN:0.9797,NFE:0.9844,OTH:0.9399,ASJ:0.9768	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	MU726998	hom
11	68834968	68834968	T	C	TPCN2	intronic	.	ENSG00000162341	rs6591368	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9577	0.9435	0.898363	0.9415	.	.	.	.	.	0.0001	0.02	.	.	.	AFR:0.8347,AMR:0.9296,EAS:0.8609,FIN:0.9926,NFE:0.9974,OTH:0.9827,ASJ:0.9901	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	MU23558361	hom
11	68840160	68840160	A	G	TPCN2	exonic	nonsynonymous SNV	ENSG00000162341	rs3750965	ENSG00000162341:ENST00000294309:exon12:c.A1127G:p.K376R,ENSG00000162341:ENST00000542467:exon12:c.A1127G:p.K376R	TPCN2:NM_139075:exon12:c.A1127G:p.K376R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.2934	0.2917	0.290735	MU23558422	-0.014	2.458	0.5	2.61	0.618	.	.	.	TPCN2:uc001oor.2:exon10:c.A872G:p.K291R,TPCN2:uc001oos.2:exon12:c.A1127G:p.K376R,TPCN2:uc010rqg.1:exon12:c.A1127G:p.K376R	-1.154	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.2626,EAS:0.1719,FIN:0.2833,NFE:0.2160,OTH:0.2224,ASJ:0.2376	612163	612267;	.	.	.	.	.	.	0.287	-4.16	0.000	1.95	11	1(upper_aerodigestive_tract)	0.2962
11	68845992	68845992	G	A	TPCN2	exonic	nonsynonymous SNV	ENSG00000162341	rs377275836	ENSG00000162341:ENST00000294309:exon14:c.G1273A:p.A425T,ENSG00000162341:ENST00000542467:exon14:c.G1273A:p.A425T	TPCN2:NM_139075:exon14:c.G1273A:p.A425T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	2.485e-05	7.7e-05	.	6.465e-05	2.762	21.2	0.092	3.81	0.944	.	.	.	TPCN2:uc001oor.2:exon12:c.G1018A:p.A340T,TPCN2:uc001oos.2:exon14:c.G1273A:p.A425T,TPCN2:uc010rqg.1:exon14:c.G1273A:p.A425T	0.136	AFR:0.0001,AMR:0.0012,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	612163	612267;	.	.	.	.	.	.	0.148	-4.28	0.771	1.91	11	.	het
11	68847304	68847304	T	C	TPCN2	exonic	synonymous SNV	ENSG00000162341	.	ENSG00000162341:ENST00000294309:exon17:c.T1542C:p.V514V	TPCN2:NM_139075:exon17:c.T1542C:p.V514V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	TPCN2:uc001oos.2:exon17:c.T1542C:p.V514V	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	68851414	68851414	T	C	TPCN2	exonic	nonsynonymous SNV	ENSG00000162341	rs2376558	ENSG00000162341:ENST00000294309:exon19:c.T1691C:p.L564P	TPCN2:NM_139075:exon19:c.T1691C:p.L564P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8797	0.9113	0.752995	LICA-CN|3|402|0.00746269,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763	1.001	10.67	0.245	2.65	0.031	0.0001	0.01	Ion transport domain	TPCN2:uc001oos.2:exon19:c.T1691C:p.L564P	-0.952	AFR:0.8821,AMR:0.7519,EAS:0.9768,FIN:0.5155,NFE:0.9797,OTH:0.9843,ASJ:0.6014	612163	612267;	.	.	.	.	.	.	0.001	-4.93	0.000	.	11	1(haematopoietic_and_lymphoid_tissue)	0.9409
11	69462910	69462910	G	A	CCND1	exonic	synonymous SNV	ENSG00000110092	rs9344	ENSG00000110092:ENST00000227507:exon4:c.G723A:p.P241P	CCND1:NM_053056:exon4:c.G723A:p.P241P	clinvar: risk_factor 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4551	0.3867	0.413538	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	0.4188	0.388	.	CCND1:uc001opa.3:exon4:c.G723A:p.P241P	.	AFR:12(meninges),AMR:1(thyroid),EAS:MU4550663,FIN:LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611,NFE:0.3966,OTH:0.2158,ASJ:1(salivary_gland)	168461	114500;193300;254500;	29073;314701;85443;892;	29073|Kahler's disease<br>Medullary plasmacytoma<br>Myelomatosis<br>Plasma cell myeloma|1-5 / 10 000|-|Adult|254500 ~314701|Systemic AL amyloidosis|-|Not applicable|-|254500 ~85443|Light-chain amyloidosis<br>Primary amyloidosis|1-5 / 10 000|Not applicable|Adult|254500 ~892|Familial cerebelloretinal angiomatosis<br>Lindau disease<br>VHL<br>Von Hippel-Lindau syndrome|1-9 / 100 000|Autosomal dominant|Adult|193300 ~	~ko01522 Endocrine resistance~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04218 Cellular senescence~ko04310 Wnt signaling pathway~ko04340 Hedgehog signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04510 Focal adhesion~ko04530 Tight junction~ko04630 JAK-STAT signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	11	1(prostate)	0.4125
11	74329615	74329615	T	C	POLD3	exonic	synonymous SNV	ENSG00000077514	rs4944052	ENSG00000077514:ENST00000531615:exon4:c.T309C:p.P103P,ENSG00000077514:ENST00000532497:exon5:c.T108C:p.P36P,ENSG00000077514:ENST00000263681:exon6:c.T426C:p.P142P,ENSG00000077514:ENST00000527458:exon6:c.T309C:p.P103P,ENSG00000077514:ENST00000528481:exon6:c.T309C:p.P103P,ENSG00000077514:ENST00000530511:exon6:c.T309C:p.P103P	POLD3:NM_001363597:exon6:c.T309C:p.P103P,POLD3:NM_006591:exon6:c.T426C:p.P142P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3710	0.4061	0.449081	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	POLD3:uc009yua.2:exon5:c.T108C:p.P36P,POLD3:uc001ovf.2:exon6:c.T426C:p.P142P,POLD3:uc031qcr.1:exon6:c.T309C:p.P103P	.	AFR:MU132016,AMR:SKCA-BR|1|100|0.01,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,EAS:0.5660,FIN:0.4200,NFE:0.2616,OTH:0.3259,ASJ:0.3766	611415	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.2702
11	76164348	76164348	T	C	EMSY	intronic	.	ENSG00000158636	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.4730	0.536	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608574	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	76257215	76257215	T	C	EMSY	exonic	synonymous SNV	ENSG00000158636	rs3753051	ENSG00000158636:ENST00000533248:exon17:c.T3375C:p.T1125T,ENSG00000158636:ENST00000524490:exon18:c.T3354C:p.T1118T,ENSG00000158636:ENST00000525038:exon19:c.T3651C:p.T1217T,ENSG00000158636:ENST00000525919:exon19:c.T3651C:p.T1217T,ENSG00000158636:ENST00000529032:exon19:c.T3648C:p.T1216T,ENSG00000158636:ENST00000334736:exon20:c.T3648C:p.T1216T,ENSG00000158636:ENST00000524767:exon20:c.T3693C:p.T1231T	EMSY:NM_001300943:exon20:c.T3651C:p.T1217T,EMSY:NM_001300944:exon20:c.T3651C:p.T1217T,EMSY:NM_020193:exon20:c.T3648C:p.T1216T,EMSY:NM_001300942:exon21:c.T3693C:p.T1231T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2695	0.2863	0.206869	LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	C11orf30:uc010rse.2:exon5:c.T1389C:p.T463T,C11orf30:uc010rsd.2:exon17:c.T3375C:p.T1125T,C11orf30:uc001oxm.3:exon18:c.T3354C:p.T1118T,C11orf30:uc001oxn.3:exon19:c.T3651C:p.T1217T,C11orf30:uc010rsc.2:exon19:c.T3651C:p.T1217T,C11orf30:uc001oxl.3:exon20:c.T3648C:p.T1216T,C11orf30:uc010rsb.2:exon20:c.T3693C:p.T1231T	.	AFR:0.2702,AMR:0.2045,EAS:0.3933,FIN:0.1142,NFE:0.3365,OTH:0.3135,ASJ:0.1742	608574	.	.	.	.	.	.	.	.	.	.	.	11	1(haematopoietic_and_lymphoid_tissue)	0.2612
11	92088177	92088177	C	T	FAT3	exonic	synonymous SNV	ENSG00000165323	rs7479732	ENSG00000165323:ENST00000298047:exon1:c.C2899T:p.L967L,ENSG00000165323:ENST00000409404:exon1:c.C2899T:p.L967L,ENSG00000165323:ENST00000525166:exon1:c.C2449T:p.L817L,ENSG00000165323:ENST00000541502:exon1:c.C2899T:p.L967L	FAT3:NM_001008781:exon1:c.C2899T:p.L967L,FAT3:NM_001367949:exon2:c.C2899T:p.L967L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2449	0.3579	0.351038	ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	FAT3:uc001pdj.4:exon1:c.C2899T:p.L967L	.	AFR:0.3433,AMR:0.7015,EAS:0.3411,FIN:0.1590,NFE:0.1631,OTH:0.2106,ASJ:0.2022	612483	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.2536
11	92088488	92088488	A	G	FAT3	exonic	synonymous SNV	ENSG00000165323	rs778473915	ENSG00000165323:ENST00000298047:exon1:c.A3210G:p.E1070E,ENSG00000165323:ENST00000409404:exon1:c.A3210G:p.E1070E,ENSG00000165323:ENST00000525166:exon1:c.A2760G:p.E920E,ENSG00000165323:ENST00000541502:exon1:c.A3210G:p.E1070E	FAT3:NM_001008781:exon1:c.A3210G:p.E1070E,FAT3:NM_001367949:exon2:c.A3210G:p.E1070E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	1.663e-05	.	.	.	.	.	.	.	.	.	.	.	FAT3:uc001pdj.4:exon1:c.A3210G:p.E1070E	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	612483	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	92088521	92088521	C	T	FAT3	exonic	synonymous SNV	ENSG00000165323	.	ENSG00000165323:ENST00000298047:exon1:c.C3243T:p.S1081S,ENSG00000165323:ENST00000409404:exon1:c.C3243T:p.S1081S,ENSG00000165323:ENST00000525166:exon1:c.C2793T:p.S931S,ENSG00000165323:ENST00000541502:exon1:c.C3243T:p.S1081S	FAT3:NM_001008781:exon1:c.C3243T:p.S1081S,FAT3:NM_001367949:exon2:c.C3243T:p.S1081S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	FAT3:uc001pdj.4:exon1:c.C3243T:p.S1081S	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	612483	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	92227198	92227200	TTT	-	FAT3	intronic	.	ENSG00000165323	rs201710620	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.4738	.	.	.	.	.	.	.	.	.	.	AFR:0.4523,AMR:0.5763,EAS:0.5728,FIN:0.4808,NFE:0.4673,OTH:0.4742,ASJ:0.5752	612483	.	.	.	.	.	.	.	.	.	.	.	11	.	het
11	92531356	92531356	A	G	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs7949157	ENSG00000165323:ENST00000298047:exon9:c.A5177G:p.Q1726R,ENSG00000165323:ENST00000409404:exon9:c.A5177G:p.Q1726R,ENSG00000165323:ENST00000525166:exon9:c.A4727G:p.Q1576R	FAT3:NM_001008781:exon9:c.A5177G:p.Q1726R,FAT3:NM_001367949:exon10:c.A5177G:p.Q1726R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8230	0.7982	0.769768	0.8011	-0.294	0.685	0.348	0.257	0.132	.	.	Cadherin|Cadherin-like	FAT3:uc001pdj.4:exon9:c.A5177G:p.Q1726R	-1.004	AFR:0.6949,AMR:0.8589,EAS:0.7438,FIN:0.8701,NFE:0.8467,OTH:0.8371,ASJ:0.8212	612483	.	.	.	.	.	.	.	0.0	0.75	0.000	0.215	11	MU17485846	hom
11	92532677	92532677	T	C	FAT3	exonic	synonymous SNV	ENSG00000165323	rs12362722	ENSG00000165323:ENST00000298047:exon9:c.T6498C:p.P2166P,ENSG00000165323:ENST00000409404:exon9:c.T6498C:p.P2166P,ENSG00000165323:ENST00000525166:exon9:c.T6048C:p.P2016P	FAT3:NM_001008781:exon9:c.T6498C:p.P2166P,FAT3:NM_001367949:exon10:c.T6498C:p.P2166P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8272	0.8269	0.799321	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FAT3:uc001pdj.4:exon9:c.T6498C:p.P2166P	.	AFR:0.8210,AMR:0.7962,EAS:0.8179,FIN:0.7469,NFE:0.8353,OTH:0.8374,ASJ:0.8652	612483	.	.	.	.	.	.	.	.	.	.	.	11	1(upper_aerodigestive_tract)	0.8238
11	92534442	92534442	A	G	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs3847531	ENSG00000165323:ENST00000298047:exon9:c.A8263G:p.I2755V,ENSG00000165323:ENST00000409404:exon9:c.A8263G:p.I2755V,ENSG00000165323:ENST00000525166:exon9:c.A7813G:p.I2605V	FAT3:NM_001008781:exon9:c.A8263G:p.I2755V,FAT3:NM_001367949:exon10:c.A8263G:p.I2755V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8637	0.8229	0.85643	0.8408	-0.756	0.054	1.0	4.8	0.559	.	.	Cadherin|Cadherin-like	FAT3:uc001pdj.4:exon9:c.A8263G:p.I2755V	-0.957	AFR:0.7577,AMR:0.8699,EAS:0.9543,FIN:0.9124,NFE:0.8554,OTH:0.8735,ASJ:0.8907	612483	.	.	.	.	.	.	.	0.0	0.18	0.000	-0.49	11	MU23948427	hom
11	92590448	92590448	A	G	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs4753069	ENSG00000165323:ENST00000533797:exon2:c.A439G:p.S147G,ENSG00000165323:ENST00000298047:exon19:c.A11434G:p.S3812G,ENSG00000165323:ENST00000409404:exon19:c.A11434G:p.S3812G,ENSG00000165323:ENST00000525166:exon19:c.A10984G:p.S3662G	FAT3:NM_001008781:exon19:c.A11434G:p.S3812G,FAT3:NM_001367949:exon20:c.A11434G:p.S3812G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8175	0.8418	0.828474	0.8266	1.015	10.75	0.872	4.1	0.893	.	.	EGF-like domain	FAT3:uc001pdi.4:exon3:c.A754G:p.S252G,FAT3:uc001pdj.4:exon19:c.A11434G:p.S3812G	-1.008	AFR:0.9099,AMR:0.8278,EAS:0.6755,FIN:0.7872,NFE:0.8031,OTH:0.8200,ASJ:0.8676	612483	.	.	.	.	.	.	.	0.0	1.64	0.000	-1.04	11	MU737516	het
11	93527219	93527219	T	C	MED17	intronic	.	ENSG00000042429	rs657177	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9826	0.9399	0.933107	0.9455	.	.	.	.	.	.	.	.	.	.	AFR:0.8101,AMR:0.9856,EAS:1,FIN:0.9994,NFE:0.9992,OTH:0.9949,ASJ:1	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	.	.	.	.	11	MU81909259	hom
11	94197260	94197260	A	G	MRE11	intronic	.	ENSG00000020922	rs641936	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3783	0.3521	0.388778	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:1(large_intestine),AMR:MU14901128,EAS:0.3562,FIN:0.3732,NFE:0.4366,OTH:0.3874,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611	600814	604391;	251347;	251347|ATLD|Unknown|Autosomal recessive|Infancy<br>Neonatal|604391 ~	.	.	.	.	.	.	.	.	11	1(upper_aerodigestive_tract)	0.3964
11	108183167	108183167	A	G	ATM	exonic	nonsynonymous SNV	ENSG00000149311	rs659243	ENSG00000149311:ENST00000278616:exon40:c.A5948G:p.N1983S,ENSG00000149311:ENST00000452508:exon41:c.A5948G:p.N1983S	ATM:NM_000051:exon40:c.A5948G:p.N1983S,ATM:NM_001351834:exon41:c.A5948G:p.N1983S	clinvar: Benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	1	.	1	MU81910525	.	.	.	.	.	.	.	.	ATM:uc009yxt.1:exon3:c.A290G:p.N97S,ATM:uc001pkg.1:exon8:c.A1019G:p.N340S,ATM:uc001pke.2:exon14:c.A1904G:p.N635S,ATM:uc001pkb.1:exon40:c.A5948G:p.N1983S,ATM:uc009yxr.1:exon41:c.A5948G:p.N1983S	.	AFR:COCA-CN|5|321|0.0155763,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko03440 Homologous recombination~ko04064 NF-kappa B signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	912,,898,907,906,911,902,904,877,908,903,899,909,893,895,901,894,910,900	.	,896,897	.	.	.	.	11	85(lung)	1
11	111248514	111248514	C	G	POU2AF1	intronic	.	ENSG00000110777	rs4622303	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.561102	0.6695	.	.	.	.	.	.	.	.	.	.	AFR:0.5779,AMR:0.8177,EAS:0.3790,FIN:0.6764,NFE:0.7414,OTH:0.6893,ASJ:0.7433	601206	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	118651841	118651841	T	C	DDX6	exonic	nonsynonymous SNV	ENSG00000110367	.	ENSG00000110367:ENST00000264018:exon3:c.A253G:p.I85V,ENSG00000110367:ENST00000526070:exon3:c.A253G:p.I85V,ENSG00000110367:ENST00000534980:exon3:c.A253G:p.I85V	DDX6:NM_001257191:exon3:c.A253G:p.I85V,DDX6:NM_004397:exon3:c.A253G:p.I85V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	1.329	12.42	0.793	5.81	1.000	.	.	P-loop containing nucleoside triphosphate hydrolase	DDX6:uc001pub.2:exon3:c.A253G:p.I85V,DDX6:uc001puc.2:exon3:c.A253G:p.I85V	-1.050	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600326	.	.	.	.	.	.	.	0.0	1.62	0.038	0.205	11	.	hom
11	119156169	119156169	A	G	CBL	exonic	nonsynonymous SNV	ENSG00000110395	rs764845853	ENSG00000110395:ENST00000264033:exon11:c.A1834G:p.R612G	CBL:NM_005188:exon11:c.A1834G:p.R612G	clinvar: UNK 	 CancerVar: 8#Tier_II_potential EVS=[1, 0, 1, 1, 0, 0, 1, 0, 1, 1, 1, 1] 	8.244e-06	.	.	.	2.025	16.37	0.0	1.73	0.960	.	.	.	CBL:uc001pwe.4:exon11:c.A1834G:p.R612G	-0.596	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	165360	607785;613563;	363972;86834;	363972|CBL syndrome<br>Noonan syndrome-like disorder with JMML|-|Autosomal dominant|-|613563 ~86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	~ko04012 ErbB signaling pathway~ko04120 Ubiquitin mediated proteolysis~ko04144 Endocytosis~ko04910 Insulin signaling pathway~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05220 Chronic myeloid leukemia ~	,1881,1884	.	,1885	0.524	-1.31	0.352	2.215	11	.	hom
11	120292570	120292570	T	A	ARHGEF12	intronic	.	ENSG00000196914	rs532006	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9964	0.9865	0.985024	0.9891	.	.	.	.	.	.	.	.	.	.	AFR:0.9618,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	MU81913066	hom
11	125525195	125525195	A	G	CHEK1	exonic	nonsynonymous SNV	ENSG00000149554	rs506504	ENSG00000149554:ENST00000278916:exon11:c.A1279G:p.I427V,ENSG00000149554:ENST00000427383:exon12:c.A1459G:p.I487V,ENSG00000149554:ENST00000524737:exon12:c.A1411G:p.I471V,ENSG00000149554:ENST00000544373:exon12:c.A1309G:p.I437V,ENSG00000149554:ENST00000428830:exon13:c.A1411G:p.I471V,ENSG00000149554:ENST00000438015:exon13:c.A1411G:p.I471V,ENSG00000149554:ENST00000534070:exon13:c.A1411G:p.I471V	CHEK1:NM_001244846:exon12:c.A1309G:p.I437V,CHEK1:NM_001330427:exon12:c.A1459G:p.I487V,CHEK1:NM_001330428:exon12:c.A1129G:p.I377V,CHEK1:NM_001114121:exon13:c.A1411G:p.I471V,CHEK1:NM_001114122:exon13:c.A1411G:p.I471V,CHEK1:NM_001274:exon13:c.A1411G:p.I471V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9726	0.9738	0.985823	0.9774	-0.257	0.830	1.0	1.8	0.993	.	.	.	CHEK1:uc010sbh.2:exon12:c.A1459G:p.I487V,CHEK1:uc010sbi.2:exon12:c.A1309G:p.I437V,CHEK1:uc001qcf.4:exon13:c.A1411G:p.I471V,CHEK1:uc001qcg.4:exon13:c.A1411G:p.I471V,CHEK1:uc009zbo.3:exon13:c.A1411G:p.I471V,CHEK1:uc009zbp.3:exon13:c.A1411G:p.I471V	-0.951	AFR:0.9928,AMR:0.9761,EAS:1,FIN:0.9694,NFE:0.9683,OTH:0.9776,ASJ:0.9603	603078	.	.	.	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04115 p53 signaling pathway~ko04218 Cellular senescence~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	0.0	-0.5	0.000	-1.155	11	MU81914120	hom
11	125880451	125880451	G	A	CDON	exonic	nonsynonymous SNV	ENSG00000064309	.	ENSG00000064309:ENST00000263577:exon8:c.C1337T:p.T446I,ENSG00000064309:ENST00000392693:exon8:c.C1337T:p.T446I	CDON:NM_001243597:exon8:c.C1337T:p.T446I,CDON:NM_016952:exon8:c.C1337T:p.T446I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	1.554	13.60	0.077	4.4	0.999	.	.	Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	CDON:uc001qdc.4:exon8:c.C1337T:p.T446I,CDON:uc009zbw.3:exon8:c.C1337T:p.T446I	-0.836	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	0.88	-0.3	0.142	0.675	11	.	hom
11	128333503	128333503	T	C	ETS1	exonic	synonymous SNV	ENSG00000134954	rs2230004	ENSG00000134954:ENST00000535549:exon3:c.A363G:p.L121L,ENSG00000134954:ENST00000345075:exon6:c.A750G:p.L250L,ENSG00000134954:ENST00000526145:exon6:c.A750G:p.L250L,ENSG00000134954:ENST00000319397:exon7:c.A1011G:p.L337L,ENSG00000134954:ENST00000392668:exon9:c.A1143G:p.L381L	ETS1:NM_001162422:exon3:c.A363G:p.L121L,ETS1:NM_001330451:exon6:c.A750G:p.L250L,ETS1:NM_005238:exon7:c.A1011G:p.L337L,ETS1:NM_001143820:exon9:c.A1143G:p.L381L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4668	0.4712	0.479633	0.4959	.	.	.	.	.	.	.	.	ETS1:uc009zch.2:exon3:c.A363G:p.L121L,ETS1:uc010sbs.1:exon7:c.A1011G:p.L337L,ETS1:uc001qej.2:exon9:c.A1143G:p.L381L	.	AFR:0.4745,AMR:0.3385,EAS:0.5700,FIN:0.5507,NFE:0.4991,OTH:0.4898,ASJ:0.38	164720	.	.	.	~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04218 Cellular senescence~ko04320 Dorso-ventral axis formation~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	11	MU20946672	hom
11	128781339	128781339	T	C	KCNJ5	exonic	synonymous SNV	ENSG00000120457	rs6590357	ENSG00000120457:ENST00000533599:exon1:c.T171C:p.S57S,ENSG00000120457:ENST00000529694:exon2:c.T171C:p.S57S,ENSG00000120457:ENST00000338350:exon3:c.T171C:p.S57S	KCNJ5:NM_000890:exon2:c.T171C:p.S57S,KCNJ5:NM_001354169:exon3:c.T171C:p.S57S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8436	0.8483	0.869808	0.8476	.	.	.	.	.	.	.	.	KCNJ5:uc001qew.3:exon1:c.T171C:p.S57S,KCNJ5:uc001qet.3:exon2:c.T171C:p.S57S,KCNJ5:uc009zck.3:exon3:c.T171C:p.S57S	.	AFR:0.9048,AMR:0.8162,EAS:0.8915,FIN:0.7991,NFE:0.8249,OTH:0.8218,ASJ:0.8179	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU19381753	hom
11	128782002	128782002	T	C	KCNJ5	exonic	synonymous SNV	ENSG00000120457	rs7118833	ENSG00000120457:ENST00000533599:exon1:c.T834C:p.H278H,ENSG00000120457:ENST00000529694:exon2:c.T834C:p.H278H,ENSG00000120457:ENST00000338350:exon3:c.T834C:p.H278H	KCNJ5:NM_000890:exon2:c.T834C:p.H278H,KCNJ5:NM_001354169:exon3:c.T834C:p.H278H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8416	0.8440	0.867013	0.8435	.	.	.	.	.	.	.	.	KCNJ5:uc001qew.3:exon1:c.T834C:p.H278H,KCNJ5:uc001qet.3:exon2:c.T834C:p.H278H,KCNJ5:uc009zck.3:exon3:c.T834C:p.H278H	.	AFR:0.8970,AMR:0.8182,EAS:0.8912,FIN:0.7991,NFE:0.8211,OTH:0.8193,ASJ:0.8167	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU16066762	hom
11	128782012	128782012	C	G	KCNJ5	exonic	nonsynonymous SNV	ENSG00000120457	rs7102584	ENSG00000120457:ENST00000533599:exon1:c.C844G:p.Q282E,ENSG00000120457:ENST00000529694:exon2:c.C844G:p.Q282E,ENSG00000120457:ENST00000338350:exon3:c.C844G:p.Q282E	KCNJ5:NM_000890:exon2:c.C844G:p.Q282E,KCNJ5:NM_001354169:exon3:c.C844G:p.Q282E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9865	0.9871	0.995008	0.9849	0.157	4.219	1.0	5.46	0.990	.	.	Immunoglobulin E-set|Potassium channel, inwardly rectifying, Kir, cytoplasmic	KCNJ5:uc001qew.3:exon1:c.C844G:p.Q282E,KCNJ5:uc001qet.3:exon2:c.C844G:p.Q282E,KCNJ5:uc009zck.3:exon3:c.C844G:p.Q282E	-0.907	AFR:0.9984,AMR:0.9940,EAS:1,FIN:0.9728,NFE:0.9776,OTH:0.9805,ASJ:1	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.0	-2.58	0.000	-1.455	11	MU194151	hom
11	128786294	128786294	G	A	KCNJ5	intronic	.	ENSG00000120457	rs4937391	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7346	0.7478	0.735823	0.7394	.	.	.	.	.	0	0.002	.	.	.	AFR:0.7966,AMR:0.7022,EAS:0.6720,FIN:0.6878,NFE:0.7287,OTH:0.7274,ASJ:0.7219	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU17126561	hom
12	862989	862989	T	C	WNK1	exonic	synonymous SNV	ENSG00000060237	rs3168640	ENSG00000060237:ENST00000315939:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000447667:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000530271:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000535572:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000537687:exon1:c.T258C:p.C86C	WNK1:NM_001184985:exon1:c.T258C:p.C86C,WNK1:NM_014823:exon1:c.T258C:p.C86C,WNK1:NM_018979:exon1:c.T258C:p.C86C,WNK1:NM_213655:exon1:c.T258C:p.C86C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9924	0.9724	0.975639	0.9784	.	.	.	.	.	.	.	.	WNK1:uc001qin.3:exon1:c.T258C:p.C86C,WNK1:uc001qio.4:exon1:c.T258C:p.C86C,WNK1:uc001qip.4:exon1:c.T258C:p.C86C,WNK1:uc021qss.1:exon1:c.T258C:p.C86C,WNK1:uc021qst.1:exon1:c.T258C:p.C86C,WNK1:uc031qfk.1:exon1:c.T258C:p.C86C	.	AFR:0.9240,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9949,ASJ:1	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	MU81915326	hom
12	939302	939302	A	G	WNK1	exonic	synonymous SNV	ENSG00000060237	rs10774466	ENSG00000060237:ENST00000315939:exon4:c.A1287G:p.A429A,ENSG00000060237:ENST00000530271:exon4:c.A1287G:p.A429A,ENSG00000060237:ENST00000535572:exon4:c.A1287G:p.A429A,ENSG00000060237:ENST00000537687:exon4:c.A1287G:p.A429A	WNK1:NM_001184985:exon4:c.A1287G:p.A429A,WNK1:NM_014823:exon4:c.A1287G:p.A429A,WNK1:NM_018979:exon4:c.A1287G:p.A429A,WNK1:NM_213655:exon4:c.A1287G:p.A429A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7451	0.6855	0.69349	0.7201	.	.	.	.	.	.	.	.	WNK1:uc001qio.4:exon4:c.A1287G:p.A429A,WNK1:uc001qip.4:exon4:c.A1287G:p.A429A,WNK1:uc021qss.1:exon4:c.A1287G:p.A429A,WNK1:uc021qst.1:exon4:c.A1287G:p.A429A,WNK1:uc031qfk.1:exon4:c.A1287G:p.A429A	.	AFR:0.5713,AMR:0.7757,EAS:0.8843,FIN:0.8041,NFE:0.7632,OTH:0.7796,ASJ:0.6689	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	MU147437	het
12	974326	974326	G	C	WNK1	exonic	nonsynonymous SNV	ENSG00000060237	rs11611231	ENSG00000060237:ENST00000530271:exon9:c.G2190C:p.L730F	WNK1:NM_213655:exon9:c.G2190C:p.L730F	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0937	.	0.140974	1(lung)	1.906	15.63	0.004	3.75	0.326	.	.	.	WNK1:uc021qst.1:exon9:c.G2190C:p.L730F	-0.957	AFR:1(stomach),AMR:MU12234442,EAS:0.1226,FIN:0.1333,NFE:0.1172,OTH:0.1333,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	0.92	0.000	.	12	1(haematopoietic_and_lymphoid_tissue)	0.2164
12	974355	974355	-	C	WNK1	exonic	frameshift insertion	ENSG00000060237	rs11441897	ENSG00000060237:ENST00000530271:exon9:c.2220dupC:p.L740fs	WNK1:NM_213655:exon9:c.2220dupC:p.L740fs	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0] 	0.5445	.	0.518371	0.5581	.	.	.	.	.	.	.	.	WNK1:uc021qst.1:exon9:c.2220dupC:p.L740fs	.	AFR:0.4628,AMR:0.4189,EAS:0.5392,FIN:0.6465,NFE:0.6012,OTH:0.5969,ASJ:0.5133	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	.	het
12	974404	974404	T	C	WNK1	exonic	synonymous SNV	ENSG00000060237	rs7300829	ENSG00000060237:ENST00000530271:exon9:c.T2268C:p.P756P	WNK1:NM_213655:exon9:c.T2268C:p.P756P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6031	.	0.653954	LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	WNK1:uc021qst.1:exon9:c.T2268C:p.P756P	.	AFR:0.6457,AMR:0.7034,EAS:0.5596,FIN:0.5876,NFE:0.6814,OTH:0.6158,ASJ:0.5871	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	3(haematopoietic_and_lymphoid_tissue)	0.6350
12	990912	990912	A	C	WNK1	exonic	nonsynonymous SNV	ENSG00000060237	rs956868	ENSG00000060237:ENST00000340908:exon10:c.A1945C:p.T649P,ENSG00000060237:ENST00000535572:exon11:c.A2425C:p.T809P,ENSG00000060237:ENST00000315939:exon13:c.A3166C:p.T1056P,ENSG00000060237:ENST00000537687:exon13:c.A3946C:p.T1316P,ENSG00000060237:ENST00000530271:exon15:c.A4660C:p.T1554P	WNK1:NM_014823:exon11:c.A2425C:p.T809P,WNK1:NM_001184985:exon13:c.A3946C:p.T1316P,WNK1:NM_018979:exon13:c.A3166C:p.T1056P,WNK1:NM_213655:exon13:c.A3922C:p.T1308P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8314	0.8526	0.852835	0.8317	-0.728	0.062	1.0	0.635	0.064	.	.	.	WNK1:uc001qir.4:exon4:c.A685C:p.T229P,WNK1:uc001qip.4:exon11:c.A2425C:p.T809P,WNK1:uc001qio.4:exon13:c.A3166C:p.T1056P,WNK1:uc021qss.1:exon13:c.A3946C:p.T1316P,WNK1:uc021qst.1:exon13:c.A3922C:p.T1308P,WNK1:uc031qfk.1:exon14:c.A4405C:p.T1469P	-1.004	AFR:0.8503,AMR:0.8783,EAS:0.8021,FIN:0.7460,NFE:0.8424,OTH:0.8194,ASJ:0.8212	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	0.0	2.86	0.000	-1.445	12	MU777778	hom
12	994487	994487	G	C	WNK1	exonic	nonsynonymous SNV	ENSG00000060237	rs7955371	ENSG00000060237:ENST00000340908:exon16:c.G3296C:p.C1099S,ENSG00000060237:ENST00000535572:exon17:c.G3776C:p.C1259S,ENSG00000060237:ENST00000315939:exon19:c.G4517C:p.C1506S,ENSG00000060237:ENST00000537687:exon19:c.G5297C:p.C1766S,ENSG00000060237:ENST00000530271:exon21:c.G6011C:p.C2004S	WNK1:NM_014823:exon17:c.G3776C:p.C1259S,WNK1:NM_001184985:exon19:c.G5297C:p.C1766S,WNK1:NM_018979:exon19:c.G4517C:p.C1506S,WNK1:NM_213655:exon19:c.G5273C:p.C1758S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9963	0.9861	0.986821	0.9877	-1.695	0.002	1.0	5.3	0.235	.	.	.	WNK1:uc001qir.4:exon10:c.G2036C:p.C679S,WNK1:uc001qip.4:exon17:c.G3776C:p.C1259S,WNK1:uc001qio.4:exon19:c.G4517C:p.C1506S,WNK1:uc021qss.1:exon19:c.G5297C:p.C1766S,WNK1:uc021qst.1:exon19:c.G5273C:p.C1758S,WNK1:uc031qfk.1:exon20:c.G5756C:p.C1919S	-0.954	AFR:0.9570,AMR:0.9964,EAS:1,FIN:1,NFE:0.9998,OTH:0.9990,ASJ:1	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	0.0	-0.2	0.000	-1.79	12	MU81915388	hom
12	1017197	1017197	C	T	WNK1	exonic	synonymous SNV	ENSG00000060237	rs4766334	ENSG00000060237:ENST00000340908:exon24:c.C5607T:p.Y1869Y,ENSG00000060237:ENST00000535572:exon25:c.C6084T:p.Y2028Y,ENSG00000060237:ENST00000315939:exon27:c.C6828T:p.Y2276Y,ENSG00000060237:ENST00000537687:exon27:c.C7608T:p.Y2536Y,ENSG00000060237:ENST00000530271:exon29:c.C8322T:p.Y2774Y	WNK1:NM_014823:exon25:c.C6084T:p.Y2028Y,WNK1:NM_001184985:exon27:c.C7608T:p.Y2536Y,WNK1:NM_018979:exon27:c.C6828T:p.Y2276Y,WNK1:NM_213655:exon27:c.C7584T:p.Y2528Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9964	0.9862	0.987021	0.9884	.	.	.	.	.	.	.	.	WNK1:uc001qir.4:exon18:c.C4347T:p.Y1449Y,WNK1:uc001qip.4:exon25:c.C6084T:p.Y2028Y,WNK1:uc001qio.4:exon27:c.C6828T:p.Y2276Y,WNK1:uc021qss.1:exon27:c.C7608T:p.Y2536Y,WNK1:uc021qst.1:exon27:c.C7584T:p.Y2528Y,WNK1:uc031qfk.1:exon30:c.C8181T:p.Y2727Y	.	AFR:0.9597,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9990,ASJ:1	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	MU4552882	hom
12	1035947	1035947	C	A	RAD52	intronic	.	ENSG00000002016	rs6489763	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9969	0.9937	0.992812	0.9935	.	.	.	.	.	.	.	.	.	.	AFR:0.9773,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	600392	.	.	.	.	.	.	.	.	.	.	.	12	MU81915469	hom
12	1040373	1040373	T	C	RAD52	intronic	.	ENSG00000002016	rs7303748	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5490	0.5512	0.544928	LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.5323,AMR:0.5221,EAS:0.6126,FIN:0.4588,NFE:0.5437,OTH:0.5467,ASJ:0.4185	600392	.	.	.	.	.	.	.	.	.	.	.	12	1(haematopoietic_and_lymphoid_tissue)	0.5575
12	4387909	4387909	C	T	CCND2	intronic	.	ENSG00000118971	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	123833	615938;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04310 Wnt signaling pathway~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko04510 Focal adhesion~ko04630 JAK-STAT signaling pathway~ko04917 Prolactin signaling pathway~ko05162 Measles~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	12	.	hom
12	4553332	4553332	A	G	FGF6	exonic	synonymous SNV	ENSG00000111241	rs2241280	ENSG00000111241:ENST00000543077:exon1:c.T54C:p.V18V,ENSG00000111241:ENST00000228837:exon2:c.T417C:p.V139V	FGF6:NM_020996:exon2:c.T417C:p.V139V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4245	0.4533	0.472244	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	FGF6:uc001qmr.1:exon2:c.T417C:p.V139V	.	AFR:0.4362,AMR:0.5645,EAS:0.2967,FIN:0.4356,NFE:0.4028,OTH:0.3793,ASJ:0.3489	134921	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	2(haematopoietic_and_lymphoid_tissue)	0.4012
12	4553383	4553383	A	G	FGF6	exonic	synonymous SNV	ENSG00000111241	rs2241279	ENSG00000111241:ENST00000543077:exon1:c.T3C:p.T1T,ENSG00000111241:ENST00000228837:exon2:c.T366C:p.T122T	FGF6:NM_020996:exon2:c.T366C:p.T122T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4265	0.4612	0.479633	1(lung)	.	.	.	.	.	.	.	.	FGF6:uc001qmr.1:exon2:c.T366C:p.T122T	.	AFR:MU153822,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,EAS:0.5890,FIN:0.3505,NFE:0.3013,OTH:0.4338,ASJ:0.4430	134921	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	1(large_intestine)	0.4028
12	4554548	4554548	G	C	FGF6	exonic	synonymous SNV	ENSG00000111241	rs7358740	ENSG00000111241:ENST00000228837:exon1:c.C189G:p.A63A	FGF6:NM_020996:exon1:c.C189G:p.A63A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9721	0.9056	0.903155	0.9177	.	.	.	.	.	.	.	.	FGF6:uc001qmr.1:exon1:c.C189G:p.A63A	.	AFR:0.7134,AMR:0.9821,EAS:1,FIN:1,NFE:0.9993,OTH:0.9764,ASJ:0.9967	134921	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	MU4555769	hom
12	6691452	6691452	G	A	CHD4	intronic	.	ENSG00000247853	rs7316626	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1662	0.2540	0.207668	0.2270	.	.	.	.	.	0.0001	0.022	.	.	.	AFR:0.4298,AMR:0.0909,EAS:0.0185,FIN:0.1555,NFE:0.1637,OTH:0.1509,ASJ:0.1133	603277	.	.	.	~ko05165 Human papillomavirus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	12	MU80635384	het
12	6711145	6711147	TCC	-	CHD4	exonic	nonframeshift deletion	ENSG00000111642	rs71584865	ENSG00000111642:ENST00000309577:exon4:c.417_419del:p.139_140del,ENSG00000111642:ENST00000357008:exon4:c.417_419del:p.139_140del,ENSG00000111642:ENST00000544040:exon4:c.396_398del:p.132_133del,ENSG00000111642:ENST00000544484:exon4:c.408_410del:p.136_137del,ENSG00000111642:ENST00000545942:exon4:c.417_419del:p.139_140del	CHD4:NM_001297553:exon3:c.396_398del:p.132_133del,CHD4:NM_001273:exon4:c.417_419del:p.139_140del,CHD4:NM_001363606:exon4:c.417_419del:p.139_140del	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0135	.	.	0.0002	.	.	.	.	.	.	.	.	CHD4:uc001qpn.3:exon3:c.396_398del:p.132_133del,CHD4:uc001qpo.3:exon4:c.417_419del:p.139_140del,CHD4:uc001qpp.3:exon4:c.408_410del:p.136_137del	.	AFR:0.0001,AMR:0,EAS:0.0006,FIN:0,NFE:0.0002,OTH:0,ASJ:0	603277	.	.	.	~ko05165 Human papillomavirus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	12	MU627344	het
12	7065576	7065576	G	A	PTPN6	intronic	.	ENSG00000111679	rs2110071	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9141	0.7978	0.816094	0.8137	.	.	.	.	.	0	0.042	.	.	.	AFR:0.4921,AMR:0.9296,EAS:0.9994,FIN:0.9304,NFE:0.9366,OTH:0.9184,ASJ:0.9735	176883	.	.	.	~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05140 Leishmaniasis~ko05205 Proteoglycans in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	12	MU81917016	hom
12	7065635	7065635	T	C	PTPN6	exonic	synonymous SNV	ENSG00000111679	rs2110072	ENSG00000111679:ENST00000447931:exon8:c.T861C:p.G287G,ENSG00000111679:ENST00000318974:exon9:c.T978C:p.G326G,ENSG00000111679:ENST00000399448:exon9:c.T984C:p.G328G,ENSG00000111679:ENST00000456013:exon9:c.T978C:p.G326G	PTPN6:NM_002831:exon9:c.T978C:p.G326G,PTPN6:NM_080548:exon9:c.T984C:p.G328G,PTPN6:NM_080549:exon9:c.T978C:p.G326G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9499	0.9216	0.948682	0.9221	.	.	.	.	.	.	.	.	PTPN6:uc010sfr.1:exon8:c.T861C:p.G287G,PTPN6:uc010sfs.1:exon8:c.T942C:p.G314G,PTPN6:uc001qsa.1:exon9:c.T984C:p.G328G,PTPN6:uc001qsb.2:exon9:c.T978C:p.G326G,PTPN6:uc009zfl.1:exon9:c.T978C:p.G326G	.	AFR:0.8686,AMR:0.9606,EAS:1,FIN:0.9306,NFE:0.9383,OTH:0.9409,ASJ:0.9768	176883	.	.	.	~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05140 Leishmaniasis~ko05205 Proteoglycans in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	12	MU81917038	hom
12	7069873	7069873	G	A	PTPN6	exonic	nonsynonymous SNV	ENSG00000111679	rs781863006	ENSG00000111679:ENST00000456013:exon15:c.G1721A:p.R574Q	PTPN6:NM_080549:exon15:c.G1721A:p.R574Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	0.0065	.	0.00499201	9.706e-05	1.494	13.28	0.144	-1.24	0.001	.	.	.	PTPN6:uc009zfl.1:exon15:c.G1721A:p.R574Q	-0.928	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0031,ASJ:0	176883	.	.	.	~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05140 Leishmaniasis~ko05205 Proteoglycans in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	0.109	2.6	0.014	.	12	.	het
12	12291479	12291479	G	C	LRP6	intronic	.	ENSG00000070018;ENSG00000121380	rs2075241	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1742	0.1975	0.174321	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647	.	.	.	.	.	0.0157	0.212	.	.	.	AFR:0.1818,AMR:0.2394,EAS:0.2748,FIN:0.0948,NFE:0.1072,OTH:0.1727,ASJ:0.2033	603507	610947;616724;	99798;	99798|Selective tooth agenesis|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|106600 150400 313500 604625 610926 616724 617073 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	1(lung)	0.1694
12	12301898	12301898	C	T	LRP6	exonic	nonsynonymous SNV	ENSG00000070018	rs2302685	ENSG00000070018:ENST00000261349:exon14:c.G3184A:p.V1062I,ENSG00000070018:ENST00000543091:exon14:c.G3184A:p.V1062I	LRP6:NM_002336:exon14:c.G3184A:p.V1062I	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8474	0.8400	0.885583	0.8348	2.258	17.89	1.0	5.45	1.000	.	.	Six-bladed beta-propeller, TolB-like	LRP6:uc001rah.4:exon14:c.G3184A:p.V1062I,LRP6:uc010shl.1:exon14:c.G3184A:p.V1062I	-0.936	AFR:0.8707,AMR:0.9113,EAS:0.9376,FIN:0.8148,NFE:0.8037,OTH:0.8227,ASJ:0.85	603507	610947;616724;	99798;	99798|Selective tooth agenesis|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|106600 150400 313500 604625 610926 616724 617073 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	0.0	-2.67	0.000	-2.195	12	MU25428801	hom
12	18473928	18473928	T	C	PIK3C2G	exonic	synonymous SNV	ENSG00000139144	rs12309666	ENSG00000139144:ENST00000266497:exon6:c.T1170C:p.N390N,ENSG00000139144:ENST00000538779:exon6:c.T1170C:p.N390N,ENSG00000139144:ENST00000433979:exon7:c.T1170C:p.N390N,ENSG00000139144:ENST00000535651:exon7:c.T1170C:p.N390N	PIK3C2G:NM_001288772:exon7:c.T1170C:p.N390N,PIK3C2G:NM_001288774:exon7:c.T504C:p.N168N,PIK3C2G:NM_004570:exon7:c.T1170C:p.N390N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1833	0.1842	0.223842	MU582594	.	.	.	.	.	.	.	.	PIK3C2G:uc010sib.2:exon6:c.T1170C:p.N390N,PIK3C2G:uc010sic.2:exon6:c.T504C:p.N168N,PIK3C2G:uc001rdt.3:exon7:c.T1170C:p.N390N	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,AMR:0.1953,EAS:0.2284,FIN:0.0993,NFE:0.2143,OTH:0.1580,ASJ:0.4049	609001	.	.	.	.	.	.	.	.	.	.	.	12	1(haematopoietic_and_lymphoid_tissue)	0.0850
12	18499636	18499636	C	T	PIK3C2G	exonic	synonymous SNV	ENSG00000139144	rs17847788	ENSG00000139144:ENST00000266497:exon10:c.C1491T:p.Y497Y,ENSG00000139144:ENST00000538779:exon10:c.C1491T:p.Y497Y,ENSG00000139144:ENST00000433979:exon11:c.C1491T:p.Y497Y,ENSG00000139144:ENST00000535651:exon11:c.C1491T:p.Y497Y	PIK3C2G:NM_001288772:exon11:c.C1491T:p.Y497Y,PIK3C2G:NM_001288774:exon11:c.C825T:p.Y275Y,PIK3C2G:NM_004570:exon11:c.C1491T:p.Y497Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1075	0.0977	0.139776	MU582595	.	.	.	.	.	.	.	.	PIK3C2G:uc010sib.2:exon10:c.C1491T:p.Y497Y,PIK3C2G:uc010sic.2:exon10:c.C825T:p.Y275Y,PIK3C2G:uc001rdt.3:exon11:c.C1491T:p.Y497Y	.	AFR:LICA-CN|1|402|0.00248756,AMR:0.1202,EAS:0.2601,FIN:0.0960,NFE:0.1677,OTH:0.1561,ASJ:0.1739	609001	.	.	.	.	.	.	.	.	.	.	.	12	1(central_nervous_system)	0.0695
12	18499777	18499777	C	G	PIK3C2G	intronic	.	ENSG00000139144	rs10770357	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	0.0002	0.032	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	609001	.	.	.	.	.	.	.	.	.	.	.	12	MU81920074	hom
12	18762450	18762450	A	C	PIK3C2G	intronic	.	ENSG00000139144	rs2277328	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2151	0.1511	0.165535	4(meninges)	.	.	.	.	.	.	.	.	.	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:1(breast),EAS:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,FIN:0.1598,NFE:0.1867,OTH:0.1499,ASJ:MU12097381	609001	.	.	.	.	.	.	.	.	.	.	.	12	2(upper_aerodigestive_tract)	0.0927
12	21011480	21011480	T	G	SLCO1B3;SLCO1B3-SLCO1B7	exonic	nonsynonymous SNV	ENSG00000111700;ENSG00000205754;ENSG00000257046	rs4149117	ENSG00000257046:ENST00000381541:exon3:c.T334G:p.S112A,ENSG00000257046:ENST00000540229:exon3:c.T334G:p.S112A,ENSG00000111700:ENST00000553473:exon3:c.T334G:p.S112A,ENSG00000205754:ENST00000554957:exon3:c.T334G:p.S112A,ENSG00000111700:ENST00000261196:exon4:c.T334G:p.S112A,ENSG00000111700:ENST00000540853:exon4:c.T334G:p.S112A,ENSG00000111700:ENST00000381545:exon5:c.T334G:p.S112A	SLCO1B3:NM_001349920:exon3:c.T250G:p.S84A,SLCO1B3-SLCO1B7:NM_001371097:exon3:c.T334G:p.S112A,SLCO1B3:NM_019844:exon5:c.T334G:p.S112A	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8045	0.7229	0.702476	COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	0.800	9.463	1.0	3.99	0.885	.	.	Major facilitator superfamily domain	SLCO1B3:uc010sil.2:exon3:c.T334G:p.S112A,SLCO1B7:uc010sim.2:exon3:c.T334G:p.S112A,SLCO1B3:uc031qgp.1:exon4:c.T334G:p.S112A,SLCO1B3:uc001rel.4:exon5:c.T334G:p.S112A	-0.938	AFR:0.7021,AMR:0.4330,EAS:0.8841,FIN:0.7351,NFE:0.7477,OTH:0.8294,ASJ:0.8007	.	.	.	.	.	.	.	.	0.0	0.68	0.000	-1.73	12	1(haematopoietic_and_lymphoid_tissue)	0.7924
12	21013948	21013948	C	T	SLCO1B3;SLCO1B3-SLCO1B7	intronic	.	ENSG00000111700;ENSG00000205754;ENSG00000257046	rs3764009	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8066	0.7222	0.702276	0.7025	.	.	.	.	.	0.0003	0.02	.	.	.	AFR:0.4334,AMR:0.7998,EAS:0.7364,FIN:0.7469,NFE:0.8296,OTH:0.7929,ASJ:0.8841	.	.	.	.	.	.	.	.	.	.	.	.	12	MU12102388	hom
12	21015760	21015760	G	A	SLCO1B3;SLCO1B3-SLCO1B7	exonic	nonsynonymous SNV	ENSG00000111700;ENSG00000257046	rs7311358	ENSG00000111700:ENST00000544370:exon2:c.G171A:p.M57I,ENSG00000257046:ENST00000540229:exon6:c.G699A:p.M233I,ENSG00000111700:ENST00000553473:exon6:c.G699A:p.M233I,ENSG00000111700:ENST00000261196:exon7:c.G699A:p.M233I,ENSG00000111700:ENST00000540853:exon7:c.G699A:p.M233I,ENSG00000111700:ENST00000381545:exon8:c.G699A:p.M233I	SLCO1B3:NM_001349920:exon6:c.G615A:p.M205I,SLCO1B3-SLCO1B7:NM_001371097:exon6:c.G699A:p.M233I,SLCO1B3:NM_019844:exon8:c.G699A:p.M233I	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8044	0.7228	0.702476	COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	0.775	9.308	0.447	-2.0	0.910	.	.	Major facilitator superfamily domain	SLCO1B3:uc010sil.2:exon6:c.G699A:p.M233I,SLCO1B3:uc031qgp.1:exon7:c.G699A:p.M233I,SLCO1B3:uc001rel.4:exon8:c.G699A:p.M233I	-1.046	AFR:0.7024,AMR:0.4328,EAS:0.8833,FIN:0.7379,NFE:0.7470,OTH:0.8296,ASJ:0.8002	.	.	.	.	.	.	.	.	0.092	1.31	0.000	0.33	12	1(haematopoietic_and_lymphoid_tissue)	0.7933
12	21036411	21036411	A	G	SLCO1B3;SLCO1B3-SLCO1B7	exonic	synonymous SNV	ENSG00000111700;ENSG00000257046	rs2053098	ENSG00000111700:ENST00000544370:exon7:c.A1029G:p.A343A,ENSG00000257046:ENST00000540229:exon11:c.A1557G:p.A519A,ENSG00000111700:ENST00000553473:exon11:c.A1557G:p.A519A,ENSG00000111700:ENST00000261196:exon12:c.A1557G:p.A519A,ENSG00000111700:ENST00000381545:exon13:c.A1557G:p.A519A	SLCO1B3:NM_001349920:exon11:c.A1473G:p.A491A,SLCO1B3-SLCO1B7:NM_001371097:exon11:c.A1557G:p.A519A,SLCO1B3:NM_019844:exon13:c.A1557G:p.A519A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8047	0.7231	0.702875	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SLCO1B3:uc010sil.2:exon11:c.A1557G:p.A519A,SLCO1B3:uc001rel.4:exon13:c.A1557G:p.A519A	.	AFR:0.7023,AMR:0.4326,EAS:0.8841,FIN:0.7348,NFE:0.7468,OTH:0.8298,ASJ:0.8002	.	.	.	.	.	.	.	.	.	.	.	.	12	1(lung)	0.7904
12	21331599	21331599	T	C	SLCO1B1	exonic	synonymous SNV	ENSG00000134538	rs4149057	ENSG00000134538:ENST00000256958:exon6:c.T571C:p.L191L	SLCO1B1:NM_006446:exon6:c.T571C:p.L191L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5260	0.4881	0.367412	0.4538	.	.	.	.	.	.	.	.	SLCO1B1:uc001req.4:exon6:c.T571C:p.L191L	.	AFR:0.2051,AMR:0.5287,EAS:0.2478,FIN:0.5014,NFE:0.5976,OTH:0.5194,ASJ:0.6424	604843	237450;	3111;	3111|Hyperbilirubinemia, Rotor type|<1 / 1 000 000|Autosomal recessive|All ages|237450 ~	.	.	.	.	.	.	.	.	12	MU139556	het
12	21358922	21358922	C	T	SLCO1B1	exonic	synonymous SNV	ENSG00000134538	rs74064211	ENSG00000134538:ENST00000256958:exon11:c.C1452T:p.P484P	SLCO1B1:NM_006446:exon11:c.C1452T:p.P484P	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0082	0.0133	0.0159744	0.0091	.	.	.	.	.	.	.	.	SLCO1B1:uc001req.4:exon11:c.C1452T:p.P484P	.	AFR:0.0317,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0041,ASJ:0	604843	237450;	3111;	3111|Hyperbilirubinemia, Rotor type|<1 / 1 000 000|Autosomal recessive|All ages|237450 ~	.	.	.	.	.	.	.	.	12	.	het
12	21391976	21391976	A	C	SLCO1B1	exonic	nonsynonymous SNV	ENSG00000134538	rs34671512	ENSG00000134538:ENST00000256958:exon15:c.A1929C:p.L643F	SLCO1B1:NM_006446:exon15:c.A1929C:p.L643F	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0463	0.0584	0.0443291	0.0494	0.082	3.415	0.633	-2.63	0.770	.	.	Major facilitator superfamily domain	SLCO1B1:uc001req.4:exon15:c.A1929C:p.L643F	-1.082	AFR:0.0670,AMR:0.0385,EAS:0.0006,FIN:0.0346,NFE:0.0481,OTH:0.0463,ASJ:0.0728	604843	237450;	3111;	3111|Hyperbilirubinemia, Rotor type|<1 / 1 000 000|Autosomal recessive|All ages|237450 ~	.	.	.	.	0.002	0.24	0.008	0.09	12	.	hom
12	25368462	25368462	C	T	KRAS	exonic	synonymous SNV	ENSG00000133703	rs4362222	ENSG00000133703:ENST00000256078:exon5:c.G483A:p.R161R	KRAS:NM_001369786:exon5:c.G483A:p.R161R,KRAS:NM_033360:exon5:c.G483A:p.R161R	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9995	0.9985	0.997604	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	KRAS:uc001rgp.1:exon5:c.G483A:p.R161R	.	AFR:0.9985,AMR:0.9948,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04137 Mitophagy - animal~ko04138 Autophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko04320 Dorso-ventral axis formation~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7009,7038,7052,7005,6844,7018,7016,7044,7001,7051,7036,6838,7062,7061,7056,7028,6998,7007,7064,7030,7050,6845,7010,6997,7035,7055,7015,7060,7019,7037,7000,7040,7006,7053,7057,7029,7033,7054,7013,7043,6842,7049,7058,7027,7042,7024,6837,7008,7045,6841,7002,7031,7014,7063,7025,7012,7022,7059,6999,7041,7048,7004,6835,7032,7021,6843,6836,7046,7047,7023,6839,7017,6840,7039,7034,7003	.	,7020,7011,7026	.	.	.	.	12	4(meninges)	1
12	40619082	40619082	G	A	LRRK2	exonic	nonsynonymous SNV	ENSG00000188906	rs2256408	ENSG00000188906:ENST00000298910:exon1:c.G149A:p.R50H,ENSG00000188906:ENST00000343742:exon1:c.G149A:p.R50H	LRRK2:NM_198578:exon1:c.G149A:p.R50H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9911	0.9655	0.969249	0.9708	1.601	13.86	1.0	-1.31	0.559	0	0	Armadillo-like helical|Armadillo-type fold;Armadillo-type fold	LRRK2:uc001rmg.4:exon1:c.G149A:p.R50H	-0.974	AFR:0.8981,AMR:0.9916,EAS:1,FIN:1,NFE:0.9999,OTH:0.9939,ASJ:1	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	0.0	0.7	0.000	-0.255	12	MU81922046	hom
12	40671989	40671989	A	G	LRRK2	exonic	nonsynonymous SNV	ENSG00000188906	rs10878307	ENSG00000188906:ENST00000416796:exon14:c.A1411G:p.I471V,ENSG00000188906:ENST00000298910:exon18:c.A2167G:p.I723V,ENSG00000188906:ENST00000343742:exon18:c.A2167G:p.I723V	LRRK2:NM_198578:exon18:c.A2167G:p.I723V	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0592	0.0518	0.0403355	0.0414	0.279	5.489	0.68	-0.905	0.999	.	.	Ankyrin repeat-containing domain	LRRK2:uc001rmh.1:exon9:c.A1033G:p.I345V,LRRK2:uc001rmg.4:exon18:c.A2167G:p.I723V	-1.025	AFR:0.0111,AMR:0.0383,EAS:0.0031,FIN:0.0272,NFE:0.0632,OTH:0.0480,ASJ:0.1887	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	0.001	0.6	0.004	0.49	12	.	het
12	42854205	42854205	A	G	PRICKLE1	exonic	synonymous SNV	ENSG00000139174	rs3747562	ENSG00000139174:ENST00000345127:exon8:c.T1902C:p.S634S,ENSG00000139174:ENST00000445766:exon8:c.T1902C:p.S634S,ENSG00000139174:ENST00000455697:exon8:c.T1902C:p.S634S,ENSG00000139174:ENST00000548696:exon8:c.T1902C:p.S634S,ENSG00000139174:ENST00000552240:exon8:c.T1902C:p.S634S	PRICKLE1:NM_001144881:exon8:c.T1902C:p.S634S,PRICKLE1:NM_001144882:exon8:c.T1902C:p.S634S,PRICKLE1:NM_001144883:exon8:c.T1902C:p.S634S,PRICKLE1:NM_153026:exon8:c.T1902C:p.S634S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4385	0.4353	0.429313	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PRICKLE1:uc001rnl.3:exon8:c.T1902C:p.S634S,PRICKLE1:uc001rnm.3:exon8:c.T1902C:p.S634S,PRICKLE1:uc010skv.2:exon8:c.T1902C:p.S634S,PRICKLE1:uc010skw.2:exon8:c.T1902C:p.S634S	.	AFR:0.4552,AMR:0.4609,EAS:0.4073,FIN:0.4338,NFE:0.4291,OTH:0.4633,ASJ:0.4689	608500	612437;	308;	308|PME type 1<br>Progressive myoclonic epilepsy type 1<br>Progressive myoclonus epilepsy type 1<br>ULD|1-9 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent|254800 310370 612437 ~	.	.	.	.	.	.	.	.	12	1(lung)	0.4110
12	42854208	42854208	A	G	PRICKLE1	exonic	synonymous SNV	ENSG00000139174	rs3747563	ENSG00000139174:ENST00000345127:exon8:c.T1899C:p.F633F,ENSG00000139174:ENST00000445766:exon8:c.T1899C:p.F633F,ENSG00000139174:ENST00000455697:exon8:c.T1899C:p.F633F,ENSG00000139174:ENST00000548696:exon8:c.T1899C:p.F633F,ENSG00000139174:ENST00000552240:exon8:c.T1899C:p.F633F	PRICKLE1:NM_001144881:exon8:c.T1899C:p.F633F,PRICKLE1:NM_001144882:exon8:c.T1899C:p.F633F,PRICKLE1:NM_001144883:exon8:c.T1899C:p.F633F,PRICKLE1:NM_153026:exon8:c.T1899C:p.F633F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3459	0.2999	0.270567	5(lung)	.	.	.	.	.	.	.	.	PRICKLE1:uc001rnl.3:exon8:c.T1899C:p.F633F,PRICKLE1:uc001rnm.3:exon8:c.T1899C:p.F633F,PRICKLE1:uc010skv.2:exon8:c.T1899C:p.F633F,PRICKLE1:uc010skw.2:exon8:c.T1899C:p.F633F	.	AFR:MU12145019,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|6|170|0.0352941,COCA-CN|3|321|0.00934579,EAS:0.2048,FIN:0.3720,NFE:0.3113,OTH:0.2640,ASJ:0.3308	608500	612437;	308;	308|PME type 1<br>Progressive myoclonic epilepsy type 1<br>Progressive myoclonus epilepsy type 1<br>ULD|1-9 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent|254800 310370 612437 ~	.	.	.	.	.	.	.	.	12	1(breast)	0.3948
12	46287327	46287327	G	A	ARID2	splicing	.	ENSG00000189079	.	.	.	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	5.054	25.2	.	5.23	0.988	1.0000	0.916	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	609539	.	.	.	.	.	.	.	.	.	.	.	12	.	hom
12	48370606	48370606	G	A	COL2A1	exonic	nonsynonymous SNV	ENSG00000139219	rs1055360917	ENSG00000139219:ENST00000337299:exon47:c.C3217T:p.P1073S,ENSG00000139219:ENST00000380518:exon48:c.C3424T:p.P1142S	COL2A1:NM_033150:exon47:c.C3217T:p.P1073S,COL2A1:NM_001844:exon48:c.C3424T:p.P1142S	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 2, 1, 0] 	.	.	.	.	4.793	24.7	0.001	5.43	0.963	.	.	.	COL2A1:uc001rqv.3:exon47:c.C3217T:p.P1073S,COL2A1:uc001rqu.3:exon48:c.C3424T:p.P1142S	1.097	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	0.999	-4.06	0.952	3.515	12	.	hom
12	48389023	48389023	C	T	COL2A1	intronic	.	ENSG00000139219	rs10875716	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2935	0.2676	0.160743	0.2519	.	.	.	.	.	.	.	.	.	.	AFR:0.0677,AMR:0.2596,EAS:0.0074,FIN:0.3253,NFE:0.3610,OTH:0.3286,ASJ:0.3609	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	MU113684275	het
12	48399403	48399403	T	C	COL2A1;SENP1	intergenic	.	ENSG00000258203	rs1859444	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.702077	0.7673	.	.	.	.	.	.	.	.	.	.	AFR:0.7114,AMR:0.6196,EAS:0.6157,FIN:0.7464,NFE:0.8272,OTH:0.7883,ASJ:0.8	.	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	49431180	49431180	G	A	KMT2D	exonic	nonsynonymous SNV	ENSG00000167548	rs886049478	ENSG00000167548:ENST00000301067:exon34:c.C9959T:p.A3320V	KMT2D:NM_003482:exon34:c.C9959T:p.A3320V	clinvar: Uncertain_significance 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	2.266	17.95	0.003	5.61	0.446	.	.	.	KMT2D:uc001rta.4:exon34:c.C9959T:p.A3320V	-0.700	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	0.1	-1.27	0.256	0.345	12	.	hom
12	56079084	56079084	C	G	ITGA7	intronic	.	ENSG00000135424	rs3852533	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5841	0.4394	0.594649	0.5018	.	.	.	.	.	0.0001	0.038	.	.	.	AFR:0.2954,AMR:0.6400,EAS:0.9442,FIN:0.6297,NFE:0.5333,OTH:0.5684,ASJ:0.4536	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU81926243	hom
12	56088773	56088773	C	T	ITGA7	intronic	.	ENSG00000135424	rs2293410	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5900	0.4380	0.589257	0.5015	.	.	.	.	.	.	.	.	.	.	AFR:0.2915,AMR:0.6379,EAS:0.9442,FIN:0.6311,NFE:0.5346,OTH:0.5647,ASJ:0.4463	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU81926272	hom
12	56089357	56089357	C	T	ITGA7	exonic	nonsynonymous SNV	ENSG00000135424	rs1800974	ENSG00000135424:ENST00000257879:exon14:c.G1952A:p.R651H,ENSG00000135424:ENST00000347027:exon14:c.G1934A:p.R645H,ENSG00000135424:ENST00000394229:exon14:c.G1952A:p.R651H,ENSG00000135424:ENST00000394230:exon14:c.G1964A:p.R655H,ENSG00000135424:ENST00000452168:exon14:c.G1673A:p.R558H,ENSG00000135424:ENST00000553804:exon14:c.G1964A:p.R655H,ENSG00000135424:ENST00000257880:exon15:c.G2084A:p.R695H,ENSG00000135424:ENST00000555728:exon15:c.G2084A:p.R695H	ITGA7:NM_001367994:exon13:c.G608A:p.R203H,ITGA7:NM_001144996:exon14:c.G1964A:p.R655H,ITGA7:NM_001144997:exon14:c.G1673A:p.R558H,ITGA7:NM_002206:exon14:c.G1952A:p.R651H,ITGA7:NM_001367993:exon15:c.G1625A:p.R542H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5854	0.4513	0.599441	0.5134	2.355	18.52	0.281	-0.706	0.124	.	.	Integrin alpha-2|Integrin domain	ITGA7:uc009znx.3:exon12:c.G1595A:p.R532H,ITGA7:uc001shg.3:exon14:c.G1952A:p.R651H,ITGA7:uc001shh.3:exon14:c.G1964A:p.R655H,ITGA7:uc010sps.2:exon14:c.G1673A:p.R558H	-1.002	AFR:0.3328,AMR:0.6423,EAS:0.9455,FIN:0.6320,NFE:0.5344,OTH:0.5661,ASJ:0.45	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	0.0	0.84	0.000	0.345	12	MU4556768	het
12	56091617	56091617	A	G	ITGA7	intronic	.	ENSG00000135424	rs2293412	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6206	0.5648	0.702676	0.6065	.	.	.	.	.	0.0041	0	.	.	.	AFR:0.6506,AMR:0.6790,EAS:0.9524,FIN:0.6341,NFE:0.5370,OTH:0.5792,ASJ:0.4765	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU4326330	het
12	56477694	56477694	A	T	ERBB3	intronic	.	ENSG00000065361	rs2271194	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6173	0.4955	0.592252	0.5370	.	.	.	.	.	0	0	.	.	.	AFR:0.3344,AMR:0.7279,EAS:0.7841,FIN:0.5922,NFE:0.6002,OTH:0.6074,ASJ:0.5199	190151	607598;	137776;	137776|LCCS2<br>Multiple contracture syndrome, Israeli-Bedouin type|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|607598 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04151 PI3K-Akt signaling pathway~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	12	MU28644046	hom
12	57859431	57859431	G	A	GLI1	exonic	synonymous SNV	ENSG00000111087	rs2228225	ENSG00000111087:ENST00000528467:exon4:c.G453A:p.E151E,ENSG00000111087:ENST00000532291:exon4:c.G192A:p.E64E,ENSG00000111087:ENST00000543426:exon4:c.G192A:p.E64E,ENSG00000111087:ENST00000546141:exon5:c.G453A:p.E151E,ENSG00000111087:ENST00000228682:exon6:c.G576A:p.E192E	GLI1:NM_001160045:exon4:c.G192A:p.E64E,GLI1:NM_001167609:exon5:c.G453A:p.E151E,GLI1:NM_005269:exon6:c.G576A:p.E192E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4999	0.4976	0.363019	1(breast)	.	.	.	.	.	.	.	.	GLI1:uc009zpq.3:exon4:c.G192A:p.E64E,GLI1:uc021qzi.1:exon5:c.G453A:p.E151E,GLI1:uc001snx.3:exon6:c.G576A:p.E192E	.	AFR:MU12167256,AMR:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,EAS:0.2446,FIN:0.4041,NFE:0.5695,OTH:0.2787,ASJ:0.4690	165220	.	.	.	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	12	3(haematopoietic_and_lymphoid_tissue)	0.5198
12	57865821	57865821	G	C	GLI1	exonic	nonsynonymous SNV	ENSG00000111087	rs2228226	ENSG00000111087:ENST00000528467:exon10:c.G3175C:p.E1059Q,ENSG00000111087:ENST00000543426:exon10:c.G2914C:p.E972Q,ENSG00000111087:ENST00000546141:exon11:c.G3175C:p.E1059Q,ENSG00000111087:ENST00000228682:exon12:c.G3298C:p.E1100Q	GLI1:NM_001160045:exon10:c.G2914C:p.E972Q,GLI1:NM_001167609:exon11:c.G3175C:p.E1059Q,GLI1:NM_005269:exon12:c.G3298C:p.E1100Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6061	0.7118	0.586262	0.6558	0.353	6.190	1.0	4.69	1.000	.	.	.	GLI1:uc009zpq.3:exon10:c.G2914C:p.E972Q,GLI1:uc021qzi.1:exon11:c.G3175C:p.E1059Q,GLI1:uc001snx.3:exon12:c.G3298C:p.E1100Q	-1.052	AFR:0.7710,AMR:0.4737,EAS:0.3429,FIN:0.5720,NFE:0.6562,OTH:0.5871,ASJ:0.6788	165220	.	.	.	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.0	2.99	0.000	-1.245	12	MU723291	hom
12	65514266	65514266	T	C	WIF1	exonic	synonymous SNV	ENSG00000156076	rs7301320	ENSG00000156076:ENST00000546001:exon1:c.A33G:p.A11A,ENSG00000156076:ENST00000286574:exon2:c.A219G:p.A73A	WIF1:NM_007191:exon2:c.A219G:p.A73A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7765	0.7476	0.824081	0.7638	.	.	.	.	.	.	.	.	WIF1:uc001ssk.3:exon2:c.A219G:p.A73A	.	AFR:0.7632,AMR:0.7005,EAS:0.9981,FIN:0.7507,NFE:0.7451,OTH:0.7612,ASJ:0.7881	605186	.	.	.	.	.	.	.	.	.	.	.	12	MU81927819	hom
12	88454594	88454594	-	A	CEP290	intronic	.	ENSG00000198707	rs11405846	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.8612	0.7616	0.761581	0.7892	.	.	.	.	.	.	.	.	.	.	AFR:0.4244,AMR:0.9159,EAS:0.9685,FIN:0.9578,NFE:0.9262,OTH:0.9165,ASJ:0.8885	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	.	het
12	88505633	88505633	A	G	CEP290	exonic	synonymous SNV	ENSG00000198707	rs45465996	ENSG00000198707:ENST00000547926:exon18:c.T1810C:p.Y604H	CEP290:NM_025114:exon21:c.T2055C:p.A685A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1703	0.1384	0.0688898	0.1097	.	.	.	.	.	.	.	.	CEP290:uc001tat.3:exon13:c.T1434C:p.A478A,CEP290:uc001tar.3:exon21:c.T2055C:p.A685A	.	AFR:0.0441,AMR:0.0986,EAS:0.0012,FIN:0.1151,NFE:0.1561,OTH:0.1309,ASJ:0.1867	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	MU113403532	hom
12	89743223	89743223	G	A	DUSP6	exonic	synonymous SNV	ENSG00000139318	rs704075	ENSG00000139318:ENST00000308385:exon2:c.C516T:p.D172D,ENSG00000139318:ENST00000547291:exon2:c.C579T:p.D193D,ENSG00000139318:ENST00000279488:exon3:c.C954T:p.D318D	DUSP6:NM_022652:exon2:c.C516T:p.D172D,DUSP6:NM_001946:exon3:c.C954T:p.D318D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9965	0.9882	0.985024	0.9884	.	.	.	.	.	.	.	.	DUSP6:uc001taz.3:exon2:c.C516T:p.D172D,DUSP6:uc001tay.3:exon3:c.C954T:p.D318D	.	AFR:0.9594,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:1	602748	615269;	432;478;	432|Gonadotropic deficiency<br>Isolated congenital gonadotropin deficiency<br>Normosmic idiopathic hypogonadotropic hypogonadism<br>nIHH|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|146110 147950 244200 308700 610628 612370 612702 614837 614838 614839 614840 614841 614842 614858 614880 615266 615269 615270 ~478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	~ko04010 MAPK signaling pathway~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	.	.	.	.	12	MU81929270	hom
12	102517804	102517804	G	A	PARPBP	exonic	synonymous SNV	ENSG00000185480	rs2036771	ENSG00000185480:ENST00000412715:exon1:c.G39A:p.A13A,ENSG00000185480:ENST00000417507:exon1:c.G39A:p.A13A,ENSG00000185480:ENST00000457614:exon1:c.G39A:p.A13A,ENSG00000185480:ENST00000358383:exon2:c.G138A:p.A46A,ENSG00000185480:ENST00000378128:exon2:c.G138A:p.A46A,ENSG00000185480:ENST00000392909:exon2:c.G138A:p.A46A,ENSG00000185480:ENST00000537257:exon2:c.G138A:p.A46A,ENSG00000185480:ENST00000541394:exon2:c.G138A:p.A46A,ENSG00000185480:ENST00000543784:exon2:c.G138A:p.A46A	PARPBP:NM_001319988:exon2:c.G138A:p.A46A,PARPBP:NM_001319996:exon2:c.G138A:p.A46A,PARPBP:NM_017915:exon2:c.G138A:p.A46A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2180	.	0.286342	MU18893791	.	.	.	.	.	.	.	.	PARPBP:uc009zuc.3:exon1:c.G46A:p.G16R	.	AFR:ESAD-UK|1|409|0.00244499,SKCA-BR|1|100|0.01,LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,AMR:0.2709,EAS:0.2506,FIN:0.1722,NFE:0.4032,OTH:0.3112,ASJ:0.3006	613687	.	.	.	.	.	.	.	.	.	.	.	12	10(upper_aerodigestive_tract)	0.2325
12	102545563	102545563	A	G	PARPBP	exonic	synonymous SNV	ENSG00000185480	rs55772007	ENSG00000185480:ENST00000541394:exon4:c.A603G:p.A201A	PARPBP:NM_001319988:exon4:c.A603G:p.A201A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2114	.	0.288738	0.2718	.	.	.	.	.	.	.	.	PARPBP:uc010swa.2:exon4:c.A603G:p.A201A	.	AFR:0.3049,AMR:0.2542,EAS:0.4026,FIN:0.3106,NFE:0.2319,OTH:0.2823,ASJ:0.1722	613687	.	.	.	.	.	.	.	.	.	.	.	12	MU4557190	het
12	102571707	102571707	A	G	PARPBP	intronic	.	ENSG00000185480	rs7308354	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.147764	0.1939	.	.	.	.	.	.	.	.	.	.	AFR:0.1766,AMR:0.1110,EAS:0.1199,FIN:0.2247,NFE:0.2094,OTH:0.2016,ASJ:0.1689	613687	.	.	.	.	.	.	.	.	.	.	.	12	MU88123702	het
12	102875569	102875569	A	G	IGF1;LINC00485	intergenic	.	ENSG00000017427;ENSG00000257254	rs35767	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.696286	0.7437	.	.	.	.	.	.	.	.	.	.	AFR:0.5698,AMR:0.7513,EAS:0.6484,FIN:0.8014,NFE:0.8411,OTH:0.7927,ASJ:0.7886	.	.	.	.	.	.	.	.	.	.	.	.	12	MU19938323	hom
12	104376608	104376608	G	A	TDG	exonic	synonymous SNV	ENSG00000139372	rs61937629	ENSG00000139372:ENST00000544861:exon4:c.G81A:p.E27E,ENSG00000139372:ENST00000392872:exon5:c.G510A:p.E170E,ENSG00000139372:ENST00000537100:exon5:c.G489A:p.E163E,ENSG00000139372:ENST00000266775:exon6:c.G498A:p.E166E	TDG:NM_001363612:exon4:c.G81A:p.E27E,TDG:NM_003211:exon5:c.G510A:p.E170E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1110	.	.	4(liver)	.	.	.	.	.	.	.	.	TDG:uc010swi.2:exon4:c.G81A:p.E27E,TDG:uc001tkg.3:exon5:c.G510A:p.E170E,TDG:uc009zuk.3:exon6:c.G498A:p.E166E	.	AFR:2(thyroid),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:1(stomach),FIN:1(urinary_tract),NFE:2(central_nervous_system),OTH:MU579098,ASJ:3(lung)	601423	.	.	.	.	.	.	.	.	.	.	.	12	1(biliary_tract)	MELA-AU|1|183|0.00546448,LICA-CN|5|402|0.0124378,LAML-KR|1|205|0.00487805
12	109540752	109540752	-	TT	UNG	intronic	.	ENSG00000076248	rs386377711	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0198	.	.	0.1499	.	.	.	.	.	.	.	.	.	.	AFR:0.1439,AMR:0.125,EAS:0.3089,FIN:0.0556,NFE:0.1426,OTH:0.1536,ASJ:0.1968	191525	608106;	101092;183666;	101092|HIGM5<br>Hyper-IgM syndrome due to UNG deficiency<br>Hyper-IgM syndrome due to uracil N-glycosylase|-|-|-|608106 ~183666|HIGM without susceptibility to opportunistic infections|-|-|-|605258 608106 608184 ~	.	.	.	.	.	.	.	.	12	.	het
12	109605730	109605730	C	T	ACACB	exonic	synonymous SNV	ENSG00000076555	rs4766516	ENSG00000076555:ENST00000377848:exon3:c.C816T:p.A272A,ENSG00000076555:ENST00000377854:exon3:c.C816T:p.A272A,ENSG00000076555:ENST00000544726:exon3:c.C210T:p.A70A,ENSG00000076555:ENST00000338432:exon4:c.C816T:p.A272A	ACACB:NM_001093:exon4:c.C816T:p.A272A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2280	0.1571	0.231629	MU668362	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon3:c.C816T:p.A272A,ACACB:uc001tob.3:exon4:c.C816T:p.A272A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.1855,EAS:0.2506,FIN:0.2550,NFE:0.5685,OTH:0.2227,ASJ:0.0723	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.1947
12	109617793	109617793	T	C	ACACB	exonic	synonymous SNV	ENSG00000076555	rs151000936	ENSG00000076555:ENST00000377848:exon10:c.T1719C:p.D573D,ENSG00000076555:ENST00000377854:exon10:c.T1719C:p.D573D,ENSG00000076555:ENST00000338432:exon11:c.T1719C:p.D573D	ACACB:NM_001093:exon11:c.T1719C:p.D573D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	1.648e-05	7.7e-05	0.000199681	6.457e-05	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon10:c.T1719C:p.D573D,ACACB:uc001tob.3:exon11:c.T1719C:p.D573D	.	AFR:0.0001,AMR:0.0012,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	601557	.	.	.	.	.	.	.	.	.	.	.	12	.	hom
12	109617865	109617865	T	C	ACACB	exonic	synonymous SNV	ENSG00000076555	rs11065772	ENSG00000076555:ENST00000377848:exon10:c.T1791C:p.D597D,ENSG00000076555:ENST00000377854:exon10:c.T1791C:p.D597D,ENSG00000076555:ENST00000338432:exon11:c.T1791C:p.D597D	ACACB:NM_001093:exon11:c.T1791C:p.D597D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7715	0.7400	0.677316	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon10:c.T1791C:p.D597D,ACACB:uc001tob.3:exon11:c.T1791C:p.D597D	.	AFR:0.7444,AMR:0.5579,EAS:0.9067,FIN:0.7333,NFE:0.8340,OTH:0.8309,ASJ:0.6587	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(thyroid)	0.7996
12	109625977	109625984	TCCTTCCT	-	ACACB	intronic	.	ENSG00000076555	rs1060499836	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0364	.	0.294529	0.3129	.	.	.	.	.	.	.	.	.	.	AFR:0.1771,AMR:0.2373,EAS:0.3029,FIN:0.3975,NFE:0.3699,OTH:0.3552,ASJ:0.2816	601557	.	.	.	.	.	.	.	.	.	.	.	12	MU74317174	het
12	109629457	109629457	C	T	ACACB	exonic	synonymous SNV	ENSG00000076555	rs7135947	ENSG00000076555:ENST00000377848:exon13:c.C2184T:p.G728G,ENSG00000076555:ENST00000377854:exon13:c.C2184T:p.G728G,ENSG00000076555:ENST00000338432:exon14:c.C2184T:p.G728G	ACACB:NM_001093:exon14:c.C2184T:p.G728G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4891	0.4450	0.38139	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon13:c.C2184T:p.G728G,ACACB:uc001tob.3:exon14:c.C2184T:p.G728G	.	AFR:MU4553399,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.2543,FIN:0.5361,NFE:0.5397,OTH:0.2611,ASJ:0.4447	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(thyroid)	0.5198
12	109637188	109637188	G	C	ACACB	intronic	.	ENSG00000076555	rs7299171	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5686	0.6176	0.571086	0.5994	.	.	.	.	.	.	.	.	.	.	AFR:0.7023,AMR:0.5863,EAS:0.2957,FIN:0.5544,NFE:0.5851,OTH:0.5767,ASJ:0.5927	601557	.	.	.	.	.	.	.	.	.	.	.	12	MU12049097	het
12	109696838	109696838	G	A	ACACB	exonic	nonsynonymous SNV	ENSG00000076555	rs2075260	ENSG00000076555:ENST00000543201:exon19:c.G2419A:p.V807I,ENSG00000076555:ENST00000377854:exon45:c.G6211A:p.V2071I,ENSG00000076555:ENST00000377848:exon46:c.G6421A:p.V2141I,ENSG00000076555:ENST00000338432:exon47:c.G6421A:p.V2141I	ACACB:NM_001093:exon47:c.G6421A:p.V2141I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7891	0.7810	0.738818	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	2.067	16.64	1.0	5.07	0.992	.	.	Acetyl-CoA carboxylase|Acetyl-coenzyme A carboxyltransferase, C-terminal|ClpP/crotonase-like domain	ACACB:uc010sxm.2:exon20:c.G2419A:p.V807I,ACACB:uc001toc.3:exon46:c.G6421A:p.V2141I,ACACB:uc001tob.3:exon47:c.G6421A:p.V2141I	-0.903	AFR:0.7894,AMR:0.7096,EAS:0.8642,FIN:0.7373,NFE:0.8456,OTH:0.8210,ASJ:0.8711	601557	.	.	.	.	.	.	.	0.002	-4.36	0.000	-3.51	12	1(lung)	0.8084
12	109703086	109703086	G	A	ACACB	splicing	.	ENSG00000076555	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	5.240	25.6	.	4.3	0.993	1.0000	0.946	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601557	.	.	.	.	.	.	.	.	.	.	.	12	.	hom
12	111353556	111353556	A	G	MYL2	exonic	synonymous SNV	ENSG00000111245	rs2301610	ENSG00000111245:ENST00000228841:exon3:c.T132C:p.I44I	MYL2:NM_000432:exon3:c.T132C:p.I44I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1025	0.0764	0.115216	0.0931	.	.	.	.	.	.	.	.	MYL2:uc001trx.4:exon2:c.T75C:p.I25I,MYL2:uc001try.4:exon3:c.T132C:p.I44I	.	AFR:0.0700,AMR:0.0513,EAS:0.2432,FIN:0.1064,NFE:0.0908,OTH:0.0898,ASJ:0.0464	160781	608758;	.	.	.	.	.	.	.	.	.	.	12	MU121128	hom
12	112036797	112036797	C	T	ATXN2	exonic	synonymous SNV	ENSG00000204842	rs4098854	ENSG00000204842:ENST00000377617:exon1:c.G522A:p.Q174Q,ENSG00000204842:ENST00000550104:exon1:c.G522A:p.Q174Q,ENSG00000204842:ENST00000608853:exon1:c.G42A:p.Q14Q	ATXN2:NM_002973:exon1:c.G42A:p.Q14Q	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6209	.	0.656749	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	ATXN2:uc001tsj.3:exon1:c.G522A:p.Q174Q	.	AFR:0.7523,AMR:0.7127,EAS:0.8596,FIN:0.6469,NFE:0.7924,OTH:0.7792,ASJ:0.7054	601517	168600;183090;	98756;	98756|SCA2|1-9 / 100 000|Autosomal dominant|All ages|183090 ~	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.7306
12	115112539	115112539	C	T	TBX3	exonic	nonsynonymous SNV	ENSG00000135111	.	ENSG00000135111:ENST00000349155:exon6:c.G1141A:p.E381K,ENSG00000135111:ENST00000257566:exon7:c.G1201A:p.E401K	TBX3:NM_005996:exon6:c.G1141A:p.E381K,TBX3:NM_016569:exon7:c.G1201A:p.E401K	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 0] 	.	.	.	.	4.134	23.8	0.008	4.99	0.724	.	.	Transcription factor, T-box, region of unknown function	TBX3:uc001tvu.1:exon6:c.G1141A:p.E381K,TBX3:uc001tvt.1:exon7:c.G1201A:p.E401K	-0.444	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601621	181450;	3138;	3138|Pallister ulnar-mammary syndrome<br>Schinzel syndrome<br>UMS|Unknown|Autosomal dominant|Infancy<br>Neonatal|181450 ~	.	.	.	.	0.009	-2.26	0.605	1.59	12	.	hom
12	121437221	121437221	T	C	HNF1A	intronic	.	ENSG00000135100	rs1169304	ENSG00000135100:ENST00000541395:exon8:c.T1652C:p.L551S	.	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8145	0.7439	0.776957	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	-0.395	0.398	0.046	-10.8	0.000	.	.	.	HNF1A:uc021rfa.1:exon8:c.T1652C:p.L551S	-0.976	AFR:0.7423,AMR:0.5893,EAS:0.8808,FIN:0.8666,NFE:0.8200,OTH:0.7835,ASJ:0.8986	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	.	-5.3	0.000	.	12	18(meninges)	0.8170
12	122807369	122807369	A	C	CLIP1	intronic	.	ENSG00000256304	rs868181	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.436901	0.5076	.	.	.	.	.	.	.	.	.	.	AFR:0.1974,AMR:0.5286,EAS:0.3930,FIN:0.7046,NFE:0.6419,OTH:0.6367,ASJ:0.6490	179838	.	.	.	.	.	.	.	.	.	.	.	12	.	hom
12	122807572	122807572	C	T	CLIP1	intronic	.	ENSG00000256304	rs11057522	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.436502	0.5075	.	.	.	.	.	.	.	.	.	.	AFR:0.1971,AMR:0.5288,EAS:0.3904,FIN:0.7040,NFE:0.6422,OTH:0.6378,ASJ:0.6490	179838	.	.	.	.	.	.	.	.	.	.	.	12	MU27354982	hom
12	122812503	122812503	G	C	CLIP1	exonic	nonsynonymous SNV	ENSG00000130779	rs1129167	ENSG00000130779:ENST00000545889:exon12:c.C1965G:p.D655E,ENSG00000130779:ENST00000302528:exon15:c.C3207G:p.D1069E,ENSG00000130779:ENST00000361654:exon15:c.C2874G:p.D958E,ENSG00000130779:ENST00000537178:exon15:c.C3102G:p.D1034E,ENSG00000130779:ENST00000358808:exon16:c.C3207G:p.D1069E,ENSG00000130779:ENST00000540338:exon16:c.C3240G:p.D1080E	CLIP1:NM_198240:exon15:c.C3102G:p.D1034E,CLIP1:NM_002956:exon16:c.C3207G:p.D1069E,CLIP1:NM_001247997:exon17:c.C3240G:p.D1080E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5625	0.4683	0.40655	MU12068476	-0.563	0.154	0.428	0.728	0.376	.	.	.	CLIP1:uc001ucj.1:exon12:c.C1965G:p.D655E,CLIP1:uc001uci.1:exon15:c.C3102G:p.D1034E,CLIP1:uc001uch.1:exon16:c.C3207G:p.D1069E,CLIP1:uc001ucg.2:exon17:c.C3240G:p.D1080E	-0.930	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611,AMR:0.4857,EAS:0.5191,FIN:0.6324,NFE:0.3775,OTH:0.7017,ASJ:0.1444	179838	.	.	.	.	.	.	.	0.0	1.26	0.000	0.145	12	4(lung)	0.6316
12	133208979	133208979	T	C	POLE	exonic	synonymous SNV	ENSG00000177084	rs5745022	ENSG00000177084:ENST00000535270:exon44:c.A6171G:p.S2057S,ENSG00000177084:ENST00000320574:exon45:c.A6252G:p.S2084S	POLE:NM_006231:exon45:c.A6252G:p.S2084S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6381	0.6427	0.699081	0.6546	.	.	.	.	.	.	.	.	POLE:uc001ukq.1:exon7:c.A882G:p.S294S,POLE:uc001ukr.1:exon19:c.A2664G:p.S888S,POLE:uc001uks.1:exon45:c.A6252G:p.S2084S	.	AFR:0.7676,AMR:0.7685,EAS:0.8075,FIN:0.5790,NFE:0.5901,OTH:0.5992,ASJ:0.5099	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	9089,9090,9091,	.	.	.	.	.	.	12	MU20983838	het
12	133219831	133219831	T	C	POLE	exonic	synonymous SNV	ENSG00000177084	rs5744944	ENSG00000177084:ENST00000535270:exon34:c.A4449G:p.A1483A,ENSG00000177084:ENST00000320574:exon35:c.A4530G:p.A1510A	POLE:NM_006231:exon35:c.A4530G:p.A1510A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5032	0.5224	0.605232	0.5291	.	.	.	.	.	.	.	.	POLE:uc001ukr.1:exon9:c.A942G:p.A314A,POLE:uc009zyu.1:exon34:c.A4449G:p.A1483A,POLE:uc001uks.1:exon35:c.A4530G:p.A1510A	.	AFR:0.7113,AMR:0.5897,EAS:0.7043,FIN:0.4335,NFE:0.4301,OTH:0.4684,ASJ:0.3733	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	9089,9090,9091,	.	.	.	.	.	.	12	MU4555145	het
13	20763341	20763341	C	T	GJB2	exonic	nonsynonymous SNV	ENSG00000165474	rs111033196	ENSG00000165474:ENST00000382844:exon1:c.G380A:p.R127H,ENSG00000165474:ENST00000382848:exon2:c.G380A:p.R127H	GJB2:NM_004004:exon2:c.G380A:p.R127H	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 1, 1, -1, 0, 0] 	0.0154	0.0023	0.0269569	0.0015	3.543	23.1	0.207	5.47	0.997	.	.	Connexin, N-terminal	GJB2:uc021rha.1:exon1:c.G380A:p.R127H,GJB2:uc001umy.3:exon2:c.G380A:p.R127H	0.322	AFR:0.0005,AMR:0.0012,EAS:0.0006,FIN:0,NFE:0.0021,OTH:0.0092,ASJ:0	121011	124500;148210;148350;149200;220290;601544;602540;	477;90635;90636;2698;2202;477;494;	477|KID/HID syndrome<br>Keratitis-ichthyosis-deafness/Hystrix-like ichthyosis-deafness syndrome<br>Senter syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|148210 242150 602540 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~2698|Bart-Pumphrey syndrome<br>Knuckle pads-leukonychia-sensorineural deafness-palmoplantar keratoderma syndrome|<1 / 1 000 000|-|Childhood|149200 ~2202|PPK-deafness syndrome<br>Palmoplantar hyperkeratosis-deafness syndrome<br>Palmoplantar hyperkeratosis-hearing loss syndrome<br>Palmoplantar keratoderma-hearing loss syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Mitochondrial inheritance|Childhood|148350 ~477|KID/HID syndrome<br>Keratitis-ichthyosis-deafness/Hystrix-like ichthyosis-deafness syndrome<br>Senter syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|148210 242150 602540 ~494|Mutilating keratoderma of Vohwinkel<br>Mutilating keratoderma plus deafness<br>PPK mutilans and deafness<br>Vohwinkel syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|124500 ~	.	.	.	.	0.001	-4.51	0.757	1.325	13	.	het
13	21562241	21562241	T	C	LATS2	exonic	nonsynonymous SNV	ENSG00000150457	.	ENSG00000150457:ENST00000382592:exon4:c.A1678G:p.S560G,ENSG00000150457:ENST00000542899:exon4:c.A1678G:p.S560G	LATS2:NM_014572:exon4:c.A1678G:p.S560G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	-0.726	0.063	0.282	-5.54	0.261	.	.	.	LATS2:uc001unr.4:exon4:c.A1678G:p.S560G,LATS2:uc009zzs.3:exon4:c.A1678G:p.S560G	-1.002	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604861	.	.	.	.	.	.	.	0.0	0.33	0.100	-0.55	13	.	hom
13	21620085	21620085	T	C	LATS2	exonic	synonymous SNV	ENSG00000150457	rs7317471	ENSG00000150457:ENST00000382592:exon2:c.A81G:p.K27K,ENSG00000150457:ENST00000542899:exon2:c.A81G:p.K27K	LATS2:NM_014572:exon2:c.A81G:p.K27K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8496	0.7806	0.807508	0.8142	.	.	.	.	.	.	.	.	LATS2:uc001unr.4:exon2:c.A81G:p.K27K,LATS2:uc009zzs.3:exon2:c.A81G:p.K27K	.	AFR:0.6717,AMR:0.8969,EAS:0.9047,FIN:0.8845,NFE:0.8646,OTH:0.8661,ASJ:0.7185	604861	.	.	.	.	.	.	.	.	.	.	.	13	MU114292	hom
13	22249144	22249144	C	G	FGF9	intronic	.	ENSG00000102678	rs12430456	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.834864	0.8289	.	.	.	.	.	.	.	.	.	.	AFR:0.7127,AMR:0.8990,EAS:1,FIN:0.8364,NFE:0.8634,OTH:0.8610,ASJ:0.8214	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	.	hom
13	22255167	22255167	C	T	FGF9	intronic	.	ENSG00000102678	rs3818460	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3215	0.2470	0.253395	LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.2789,AMR:0.0628,EAS:0.3245,FIN:0.4146,NFE:0.3756,OTH:0.3576,ASJ:0.3744	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	1(haematopoietic_and_lymphoid_tissue)	0.3354
13	22275394	22275394	A	G	FGF9	exonic	synonymous SNV	ENSG00000102678	rs9509841	ENSG00000102678:ENST00000382353:exon3:c.A447G:p.S149S	FGF9:NM_002010:exon3:c.A447G:p.S149S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8398	0.7740	0.832468	0.7863	.	.	.	.	.	.	.	.	FGF9:uc001uog.2:exon3:c.A447G:p.S149S	.	AFR:0.6565,AMR:0.9067,EAS:0.9561,FIN:0.7947,NFE:0.8312,OTH:0.8259,ASJ:0.8278	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	MU28813827	hom
13	26107422	26107422	G	C	ATP8A2	exonic	nonsynonymous SNV	ENSG00000132932	rs779268827	ENSG00000132932:ENST00000255283:exon5:c.G358C:p.G120R,ENSG00000132932:ENST00000381655:exon6:c.G478C:p.G160R	ATP8A2:NM_001313741:exon6:c.G358C:p.G120R,ATP8A2:NM_016529:exon6:c.G478C:p.G160R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0] 	0.0001	.	.	.	6.420	29.7	0.038	5.94	1.000	.	.	P-type ATPase, A  domain	ATP8A2:uc001uql.1:exon5:c.G358C:p.G120R,ATP8A2:uc001uqk.3:exon6:c.G478C:p.G160R,ATP8A2:uc010tdi.2:exon6:c.G358C:p.G120R	0.844	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	0.988	-2.78	0.862	2.55	13	.	hom
13	26155953	26155953	G	C	ATP8A2	intronic	.	ENSG00000132932	rs7335339	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5764	0.6578	0.43111	LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	0	0	.	.	.	AFR:0.6009,AMR:0.5279,EAS:0.6733,FIN:0.0105,NFE:0.6420,OTH:0.7033,ASJ:0.4450	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	1(large_intestine)	0.6260
13	26273385	26273385	G	C	ATP8A2	exonic	synonymous SNV	ENSG00000132932	rs6491088	ENSG00000132932:ENST00000255283:exon24:c.G2166C:p.L722L,ENSG00000132932:ENST00000281620:exon24:c.G1806C:p.L602L,ENSG00000132932:ENST00000381655:exon25:c.G2286C:p.L762L	ATP8A2:NM_001313741:exon25:c.G2166C:p.L722L,ATP8A2:NM_016529:exon25:c.G2286C:p.L762L	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9973	0.9898	0.98742	0.9919	.	.	.	.	.	.	.	.	ATP8A2:uc010aaj.1:exon11:c.G936C:p.L312L,ATP8A2:uc001uqk.3:exon25:c.G2286C:p.L762L,ATP8A2:uc010tdi.2:exon25:c.G2166C:p.L722L	.	AFR:0.9715,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:0.9990,ASJ:1	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU81937382	hom
13	26436641	26436641	C	T	ATP8A2	intronic	.	ENSG00000132932	rs2249800	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.503195	0.5360	.	.	.	.	.	.	.	.	.	.	AFR:0.4786,AMR:0.3864,EAS:0.6225,FIN:0.6073,NFE:0.5490,OTH:0.5898,ASJ:0.5	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU12280346	het
13	26586775	26586775	C	T	ATP8A2	intronic	.	ENSG00000132932	rs2274135	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4948	0.4447	0.534545	0.5218	.	.	.	.	.	.	.	.	.	.	AFR:0.4039,AMR:0.6131,EAS:0.7478,FIN:0.6004,NFE:0.5386,OTH:0.5867,ASJ:0.4422	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU18447171	hom
13	28610183	28610183	A	G	FLT3	intronic	.	ENSG00000122025	rs2491231	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6993	0.6164	0.563299	1(bone)	.	.	.	.	.	0	0.01	.	.	.	AFR:1(soft_tissue),AMR:MU12284971,EAS:0.6236,FIN:0.261,NFE:0.7117,OTH:0.7450,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	13	1(breast)	0.7584
13	28636084	28636084	G	A	FLT3	exonic	synonymous SNV	ENSG00000122025	rs7338903	ENSG00000122025:ENST00000241453:exon3:c.C288T:p.D96D,ENSG00000122025:ENST00000380982:exon3:c.C288T:p.D96D,ENSG00000122025:ENST00000380987:exon3:c.C288T:p.D96D,ENSG00000122025:ENST00000537084:exon3:c.C288T:p.D96D	FLT3:NM_004119:exon3:c.C288T:p.D96D	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9827	0.9599	0.958067	0.9662	.	.	.	.	.	.	.	.	FLT3:uc001urw.3:exon3:c.C288T:p.D96D,FLT3:uc010tdn.2:exon3:c.C288T:p.D96D	.	AFR:0.9027,AMR:0.9869,EAS:0.9994,FIN:0.9957,NFE:0.9893,OTH:0.9898,ASJ:0.9967	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05230 Central carbon metabolism in cancer ~	5790,,5784,5786,5795,5780,5785,5789,5782,5787,5791,5779,5783,5781,5788	.	.	.	.	.	.	13	MU81937601	hom
13	28883061	28883061	G	A	FLT1	exonic	synonymous SNV	ENSG00000102755	rs7993418	ENSG00000102755:ENST00000543394:exon8:c.C708T:p.Y236Y,ENSG00000102755:ENST00000540678:exon15:c.C1293T:p.Y431Y,ENSG00000102755:ENST00000282397:exon28:c.C3639T:p.Y1213Y	FLT1:NM_002019:exon28:c.C3639T:p.Y1213Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7921	0.6465	0.730831	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FLT1:uc010aap.2:exon7:c.C654T:p.Y218Y,FLT1:uc010aaq.2:exon10:c.C1014T:p.Y338Y,FLT1:uc001usa.3:exon15:c.C1293T:p.Y431Y,FLT1:uc001usb.3:exon28:c.C3639T:p.Y1213Y	.	AFR:0.6798,AMR:0.3548,EAS:0.8477,FIN:0.9969,NFE:0.7871,OTH:0.7888,ASJ:0.8433	165070	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05202 Transcriptional misregulation in cancer~ko05323 Rheumatoid arthritis ~	.	.	.	.	.	.	.	13	1(lung)	0.7990
13	32911888	32911888	A	G	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs1801406	ENSG00000139618:ENST00000380152:exon11:c.A3396G:p.K1132K,ENSG00000139618:ENST00000544455:exon11:c.A3396G:p.K1132K	BRCA2:NM_000059:exon11:c.A3396G:p.K1132K	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2945	0.2798	0.266773	0.2984	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon11:c.A3396G:p.K1132K	.	AFR:0.2348,AMR:0.2100,EAS:0.3863,FIN:0.3113,NFE:0.3267,OTH:0.3108,ASJ:0.3212	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1824,1835,1842,1829,1833,1827,1836,1841,1840,1845,1825,1843,1820,1838,1823,1831,1837,1832,1828,1830,1819,1839,1834,1844,1826	.	,1822,1821	.	.	.	.	13	MU12290327	hom
13	32913055	32913055	A	G	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs206075	ENSG00000139618:ENST00000380152:exon11:c.A4563G:p.L1521L,ENSG00000139618:ENST00000544455:exon11:c.A4563G:p.L1521L	BRCA2:NM_000059:exon11:c.A4563G:p.L1521L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9931	0.9758	0.974042	0.9799	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon11:c.A4563G:p.L1521L	.	AFR:0.9301,AMR:0.9976,EAS:0.9994,FIN:1,NFE:0.9997,OTH:0.9959,ASJ:1	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1824,1835,1842,1829,1833,1827,1836,1841,1840,1845,1825,1843,1820,1838,1823,1831,1837,1832,1828,1830,1819,1839,1834,1844,1826	.	,1822,1821	.	.	.	.	13	MU81938056	hom
13	32915005	32915005	G	C	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs206076	ENSG00000139618:ENST00000380152:exon11:c.G6513C:p.V2171V,ENSG00000139618:ENST00000544455:exon11:c.G6513C:p.V2171V	BRCA2:NM_000059:exon11:c.G6513C:p.V2171V	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9930	0.9755	0.973642	0.9798	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon11:c.G6513C:p.V2171V	.	AFR:0.9299,AMR:0.9976,EAS:0.9994,FIN:1,NFE:0.9997,OTH:0.9959,ASJ:1	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1824,1835,1842,1829,1833,1827,1836,1841,1840,1845,1825,1843,1820,1838,1823,1831,1837,1832,1828,1830,1819,1839,1834,1844,1826	.	,1822,1821	.	.	.	.	13	MU4551142	hom
13	32929387	32929387	T	C	BRCA2	exonic	nonsynonymous SNV	ENSG00000139618	rs169547	ENSG00000139618:ENST00000380152:exon14:c.T7397C:p.V2466A,ENSG00000139618:ENST00000544455:exon14:c.T7397C:p.V2466A	BRCA2:NM_000059:exon14:c.T7397C:p.V2466A	clinvar: Benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9937	0.9777	0.975839	0.9819	-0.407	0.372	1.0	5.07	0.005	.	.	.	BRCA2:uc031qky.1:exon1:c.T221C:p.V74A,BRCA2:uc001uub.1:exon14:c.T7397C:p.V2466A	-0.930	AFR:0.9369,AMR:0.9976,EAS:0.9994,FIN:1,NFE:0.9997,OTH:0.9980,ASJ:1	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1824,1835,1842,1829,1833,1827,1836,1841,1840,1845,1825,1843,1820,1838,1823,1831,1837,1832,1828,1830,1819,1839,1834,1844,1826	.	,1822,1821	.	5.95	0.000	.	13	MU81938081	hom
13	32936646	32936646	T	C	BRCA2	intronic	.	ENSG00000139618	rs9534262	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5208	0.5202	0.53155	0.5470	.	.	.	.	.	.	.	.	.	.	AFR:0.5768,AMR:0.5167,EAS:0.5527,FIN:0.5659,NFE:0.5281,OTH:0.5468,ASJ:0.4633	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	13	MU734294	het
13	32972727	32972727	A	G	BRCA2	exonic	synonymous SNV	ENSG00000139618	.	ENSG00000139618:ENST00000380152:exon27:c.A10077G:p.E3359E,ENSG00000139618:ENST00000544455:exon27:c.A10077G:p.E3359E	BRCA2:NM_000059:exon27:c.A10077G:p.E3359E	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 1, 0, 1, 0, 1, 1] 	.	.	.	.	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon27:c.A10077G:p.E3359E	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	,1824,1835,1842,1829,1833,1827,1836,1841,1840,1845,1825,1843,1820,1838,1823,1831,1837,1832,1828,1830,1819,1839,1834,1844,1826	.	,1822,1821	.	.	.	.	13	.	hom
13	33590851	33590851	T	C	KL	exonic	synonymous SNV	ENSG00000133116	rs2772364	ENSG00000133116:ENST00000380099:exon1:c.T273C:p.D91D	KL:NM_004795:exon1:c.T273C:p.D91D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9865	0.9475	0.944089	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	KL:uc001uus.3:exon1:c.T273C:p.D91D	.	AFR:0.9500,AMR:0.8254,EAS:1,FIN:1,NFE:1,OTH:0.9993,ASJ:0.9892	604824	211900;	306661;53715;	306661|Hypercalcemic tumoral calcinosis|-|Autosomal recessive|-|211900 ~53715|-|Unknown|Autosomal recessive|Childhood|211900 610455 ~	.	.	.	.	.	.	.	.	13	2(thyroid)	0.9927
13	33635835	33635835	T	C	KL	exonic	synonymous SNV	ENSG00000133116	rs649964	ENSG00000133116:ENST00000380099:exon4:c.T2619C:p.N873N	KL:NM_004795:exon4:c.T2619C:p.N873N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9919	0.9683	0.976238	0.9760	.	.	.	.	.	.	.	.	KL:uc001uus.3:exon4:c.T2619C:p.N873N	.	AFR:0.9164,AMR:0.9893,EAS:0.9994,FIN:1,NFE:0.9997,OTH:1,ASJ:1	604824	211900;	306661;53715;	306661|Hypercalcemic tumoral calcinosis|-|Autosomal recessive|-|211900 ~53715|-|Unknown|Autosomal recessive|Childhood|211900 610455 ~	.	.	.	.	.	.	.	.	13	MU81938143	hom
13	35644252	35644252	T	C	NBEA	intronic	.	ENSG00000172915	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604889	.	.	.	.	.	.	.	.	.	.	.	13	.	hom
13	35644257	35644257	G	A	NBEA	intronic	.	ENSG00000172915	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604889	.	.	.	.	.	.	.	.	.	.	.	13	.	hom
13	41188292	41188292	A	G	FOXO1	intronic	.	ENSG00000150907	rs3900833	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.492013	0.3903	.	.	.	.	.	.	.	.	.	.	AFR:0.4657,AMR:0.4605,EAS:0.7395,FIN:0.3845,NFE:0.3100,OTH:0.3676,ASJ:0.2815	136533	268220;	780;99756;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~	~ko04068 FoxO signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko04931 Insulin resistance~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	13	.	hom
13	52511606	52511606	G	A	ATP7B	intronic	.	ENSG00000123191	rs2282057	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5374	0.5491	0.501797	LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	.	.	.	.	.	0	0	.	.	.	AFR:0.5452,AMR:0.4886,EAS:0.5762,FIN:0.3923,NFE:0.6126,OTH:0.5789,ASJ:0.4976	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	.	.	.	.	13	3(lung)	0.5757
13	52520435	52520435	C	T	ATP7B	exonic	synonymous SNV	ENSG00000123191	rs1801248	ENSG00000123191:ENST00000400370:exon5:c.G1755A:p.L585L,ENSG00000123191:ENST00000417240:exon7:c.G861A:p.L287L,ENSG00000123191:ENST00000344297:exon9:c.G2424A:p.L808L,ENSG00000123191:ENST00000448424:exon12:c.G2811A:p.L937L,ENSG00000123191:ENST00000242839:exon13:c.G3045A:p.L1015L,ENSG00000123191:ENST00000400366:exon14:c.G2712A:p.L904L	ATP7B:NM_001005918:exon9:c.G2424A:p.L808L,ATP7B:NM_001330579:exon11:c.G2793A:p.L931L,ATP7B:NM_001330578:exon12:c.G2811A:p.L937L,ATP7B:NM_000053:exon13:c.G3045A:p.L1015L,ATP7B:NM_001243182:exon14:c.G2712A:p.L904L	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0549	0.0295	0.0123802	0.0252	.	.	.	.	.	.	.	.	ATP7B:uc010adv.2:exon5:c.G1755A:p.L585L,ATP7B:uc001vfv.2:exon6:c.G861A:p.L287L,ATP7B:uc010tgs.1:exon7:c.G861A:p.L287L,ATP7B:uc001vfx.2:exon9:c.G2424A:p.L808L,ATP7B:uc010tgv.1:exon12:c.G2811A:p.L937L,ATP7B:uc001vfw.2:exon13:c.G3045A:p.L1015L,ATP7B:uc010tgu.1:exon13:c.G2901A:p.L967L,ATP7B:uc001vfy.2:exon14:c.G2712A:p.L904L	.	AFR:0.0080,AMR:0.0155,EAS:0,FIN:0.0246,NFE:0.0379,OTH:0.0346,ASJ:0.0265	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	.	.	.	.	13	.	hom
13	52524488	52524488	T	C	ATP7B	exonic	nonsynonymous SNV	ENSG00000123191	rs1061472	ENSG00000123191:ENST00000417240:exon4:c.A311G:p.K104R,ENSG00000123191:ENST00000344297:exon7:c.A2009G:p.K670R,ENSG00000123191:ENST00000448424:exon9:c.A2261G:p.K754R,ENSG00000123191:ENST00000242839:exon10:c.A2495G:p.K832R,ENSG00000123191:ENST00000418097:exon10:c.A2495G:p.K832R,ENSG00000123191:ENST00000400366:exon11:c.A2162G:p.K721R	ATP7B:NM_001005918:exon7:c.A2009G:p.K670R,ATP7B:NM_001330579:exon8:c.A2243G:p.K748R,ATP7B:NM_001330578:exon9:c.A2261G:p.K754R,ATP7B:NM_000053:exon10:c.A2495G:p.K832R,ATP7B:NM_001243182:exon11:c.A2162G:p.K721R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5384	0.5522	0.502396	MU155019	2.981	22.2	0.087	5.54	1.000	.	.	P-type ATPase, A  domain	ATP7B:uc001vfv.2:exon3:c.A311G:p.K104R,ATP7B:uc010tgs.1:exon4:c.A311G:p.K104R,ATP7B:uc001vfx.2:exon7:c.A2009G:p.K670R,ATP7B:uc010tgv.1:exon9:c.A2261G:p.K754R,ATP7B:uc001vfw.2:exon10:c.A2495G:p.K832R,ATP7B:uc010tgt.1:exon10:c.A2495G:p.K832R,ATP7B:uc010tgu.1:exon10:c.A2351G:p.K784R,ATP7B:uc001vfy.2:exon11:c.A2162G:p.K721R	-0.931	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.5472,EAS:0.4988,FIN:0.5795,NFE:0.3883,OTH:0.6105,ASJ:0.4975	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	0.111	-2.64	0.000	0.41	13	3(large_intestine)	0.5787
13	52548140	52548140	A	C	ATP7B	exonic	nonsynonymous SNV	ENSG00000123191	rs1801243	ENSG00000123191:ENST00000542656:exon1:c.T1120G:p.S374A,ENSG00000123191:ENST00000242839:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000344297:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000400370:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000418097:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000448424:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000400366:exon3:c.T883G:p.S295A	ATP7B:NM_000053:exon2:c.T1216G:p.S406A,ATP7B:NM_001005918:exon2:c.T1216G:p.S406A,ATP7B:NM_001330578:exon2:c.T1216G:p.S406A,ATP7B:NM_001330579:exon2:c.T1216G:p.S406A,ATP7B:NM_001243182:exon3:c.T883G:p.S295A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4388	0.4012	0.376198	0.4155	-0.551	0.164	0.753	-0.027	0.946	.	.	Heavy metal-associated domain, HMA|Heavy metal-associated domain, copper ion-binding	ATP7B:uc001vfw.2:exon2:c.T1216G:p.S406A,ATP7B:uc001vfx.2:exon2:c.T1216G:p.S406A,ATP7B:uc010adv.2:exon2:c.T1216G:p.S406A,ATP7B:uc010tgt.1:exon2:c.T1216G:p.S406A,ATP7B:uc010tgu.1:exon2:c.T1216G:p.S406A,ATP7B:uc010tgv.1:exon2:c.T1216G:p.S406A,ATP7B:uc010tgw.1:exon2:c.T1120G:p.S374A,ATP7B:uc001vfy.2:exon3:c.T883G:p.S295A	-0.999	AFR:0.1954,AMR:0.4069,EAS:0.5285,FIN:0.5421,NFE:0.4971,OTH:0.4744,ASJ:0.4901	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	0.003	-2.09	0.000	0.695	13	MU155008	het
13	73343039	73343039	C	T	DIS3	exonic	synonymous SNV	ENSG00000083520	rs2196979	ENSG00000083520:ENST00000377767:exon14:c.G1767A:p.T589T,ENSG00000083520:ENST00000377780:exon14:c.G1677A:p.T559T,ENSG00000083520:ENST00000545453:exon15:c.G1281A:p.T427T	DIS3:NM_001322348:exon13:c.G1398A:p.T466T,DIS3:NM_001128226:exon14:c.G1677A:p.T559T,DIS3:NM_014953:exon14:c.G1767A:p.T589T,DIS3:NM_001322349:exon15:c.G1281A:p.T427T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7373	0.7476	0.770168	0.7393	.	.	.	.	.	.	.	.	DIS3:uc001vix.4:exon14:c.G1767A:p.T589T,DIS3:uc001viy.4:exon14:c.G1677A:p.T559T	.	AFR:0.8187,AMR:0.8098,EAS:0.7503,FIN:0.6790,NFE:0.7044,OTH:0.7026,ASJ:0.7384	607533	.	.	.	.	.	.	.	.	.	.	.	13	MU20994899	hom
13	73351543	73351544	AA	-	DIS3	intronic	.	ENSG00000083520	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607533	.	.	.	.	.	.	.	.	.	.	.	13	.	het
13	101720300	101720300	T	G	NALCN	exonic	synonymous SNV	ENSG00000102452	rs1289556	ENSG00000102452:ENST00000251127:exon39:c.A4416C:p.I1472I	NALCN:NM_001350750:exon38:c.A4329C:p.I1443I,NALCN:NM_001350751:exon38:c.A4329C:p.I1443I,NALCN:NM_001350749:exon39:c.A4416C:p.I1472I,NALCN:NM_052867:exon39:c.A4416C:p.I1472I,NALCN:NM_001350748:exon40:c.A4503C:p.I1501I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3529	0.4826	0.402955	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	NALCN:uc001vox.1:exon39:c.A4416C:p.I1472I	.	AFR:MU4557800,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841,EAS:0.7140,FIN:0.2446,NFE:0.4272,OTH:0.1326,ASJ:0.4464	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	1(biliary_tract)	0.3573
13	101721029	101721029	T	C	NALCN	intronic	.	ENSG00000102452	rs11616341	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2425	0.3079	0.221246	0.2774	.	.	.	.	.	.	.	.	.	.	AFR:0.3539,AMR:0.1651,EAS:0.0062,FIN:0.2423,NFE:0.2771,OTH:0.2602,ASJ:0.3113	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	.	hom
13	101736075	101736075	A	G	NALCN	exonic	synonymous SNV	ENSG00000102452	rs686141	ENSG00000102452:ENST00000251127:exon31:c.T3570C:p.L1190L	NALCN:NM_001350750:exon30:c.T3483C:p.L1161L,NALCN:NM_001350751:exon30:c.T3483C:p.L1161L,NALCN:NM_001350749:exon31:c.T3570C:p.L1190L,NALCN:NM_052867:exon31:c.T3570C:p.L1190L,NALCN:NM_001350748:exon32:c.T3657C:p.L1219L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6992	0.7610	0.724641	1(thyroid)	.	.	.	.	.	.	.	.	NALCN:uc001vox.1:exon31:c.T3570C:p.L1190L	.	AFR:MU117493,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,THCA-SA|1|243|0.00411523,EAS:0.8418,FIN:0.5,NFE:0.7682,OTH:0.6006,ASJ:0.7478	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	2(haematopoietic_and_lymphoid_tissue)	0.7252
13	101999939	101999939	A	G	NALCN	intronic	.	ENSG00000102452	rs9582475	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.388778	0.3415	.	.	.	.	.	.	.	.	.	.	AFR:0.3471,AMR:0.4820,EAS:0.3717,FIN:0.2897,NFE:0.3368,OTH:0.3569,ASJ:0.4172	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	.	hom
13	108863230	108863230	T	A	LIG4	exonic	synonymous SNV	ENSG00000174405	.	ENSG00000174405:ENST00000356922:exon2:c.A387T:p.A129A,ENSG00000174405:ENST00000405925:exon2:c.A387T:p.A129A,ENSG00000174405:ENST00000442234:exon2:c.A387T:p.A129A	LIG4:NM_001098268:exon2:c.A387T:p.A129A,LIG4:NM_002312:exon2:c.A387T:p.A129A,LIG4:NM_001330595:exon3:c.A186T:p.A62A,LIG4:NM_001352601:exon3:c.A387T:p.A129A,LIG4:NM_001352602:exon3:c.A387T:p.A129A,LIG4:NM_001352603:exon3:c.A387T:p.A129A,LIG4:NM_001352604:exon3:c.A423T:p.A141A,LIG4:NM_206937:exon3:c.A387T:p.A129A,LIG4:NM_001352598:exon4:c.A387T:p.A129A,LIG4:NM_001352599:exon4:c.A387T:p.A129A,LIG4:NM_001352600:exon4:c.A387T:p.A129A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	LIG4:uc021rmk.1:exon1:c.A387T:p.A129A,LIG4:uc001vqn.3:exon2:c.A387T:p.A129A,LIG4:uc001vqp.3:exon2:c.A387T:p.A129A,LIG4:uc001vqo.3:exon3:c.A387T:p.A129A,LIG4:uc010agf.3:exon3:c.A387T:p.A129A,LIG4:uc010agg.1:exon3:c.A186T:p.A62A	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601837	254500;606593;	99812;29073;314701;85443;	99812|DNA ligase IV deficiency<br>Ligase 4 syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|606593 ~29073|Kahler's disease<br>Medullary plasmacytoma<br>Myelomatosis<br>Plasma cell myeloma|1-5 / 10 000|-|Adult|254500 ~314701|Systemic AL amyloidosis|-|Not applicable|-|254500 ~85443|Light-chain amyloidosis<br>Primary amyloidosis|1-5 / 10 000|Not applicable|Adult|254500 ~	.	.	.	.	.	.	.	.	13	.	hom
13	110435953	110435953	A	G	IRS2	exonic	synonymous SNV	ENSG00000185950	rs4773092	ENSG00000185950:ENST00000375856:exon1:c.T2448C:p.C816C	IRS2:NM_003749:exon1:c.T2448C:p.C816C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5871	0.6018	0.563898	0.6108	.	.	.	.	.	.	.	.	IRS2:uc001vqv.3:exon1:c.T2448C:p.C816C	.	AFR:0.6150,AMR:0.6885,EAS:0.4623,FIN:0.6269,NFE:0.6172,OTH:0.6031,ASJ:0.5960	600797	125853;	.	.	.	.	.	.	.	.	.	.	13	MU119589	hom
13	113888201	113888201	T	C	CUL4A	intronic	.	ENSG00000139842	rs2146408	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9753	0.9108	0.911941	0.9240	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.7357,AMR:0.9809,EAS:1,FIN:1,NFE:0.9987,OTH:0.9878,ASJ:0.9901	603137	.	.	.	.	.	.	.	.	.	.	.	13	MU81942591	hom
13	113889474	113889474	C	T	CUL4A	intronic	.	ENSG00000139842	rs2287250	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6738	0.7040	0.573283	MU732829	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.6723,EAS:0.5767,FIN:0.8344,NFE:0.4093,OTH:0.7117,ASJ:0.5802	603137	.	.	.	.	.	.	.	.	.	.	.	13	1(haematopoietic_and_lymphoid_tissue)	0.7467
13	113965176	113965176	C	A	LAMP1	exonic	synonymous SNV	ENSG00000185896	rs9577503	ENSG00000185896:ENST00000332556:exon4:c.C556A:p.R186R	LAMP1:NM_005561:exon4:c.C556A:p.R186R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9916	0.9809	0.979233	0.9753	.	.	.	.	.	.	.	.	LAMP1:uc001vtm.1:exon4:c.C556A:p.R186R	.	AFR:0.9157,AMR:0.9905,EAS:1,FIN:1,NFE:0.9989,OTH:0.9928,ASJ:1	153330	.	.	.	.	.	.	.	.	.	.	.	13	MU81942635	hom
14	20916249	20916249	T	C	OSGEP	intronic	.	ENSG00000092094	rs2275008	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2581	0.3075	0.244808	MU652858	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,RECA-EU|1|422|0.00236967,BRCA-KR|1|50|0.02,AMR:0.2995,EAS:0.2745,FIN:0.2384,NFE:0.0723,OTH:0.3184,ASJ:0.3443	610107	.	.	.	.	.	.	.	.	.	.	.	14	1(breast)	0.2970
14	20916958	20916958	T	C	OSGEP	exonic	synonymous SNV	ENSG00000092094	rs938883	ENSG00000092094:ENST00000554249:exon2:c.A24G:p.L8L,ENSG00000092094:ENST00000555223:exon5:c.A24G:p.L8L,ENSG00000092094:ENST00000206542:exon6:c.A570G:p.L190L	OSGEP:NM_017807:exon6:c.A570G:p.L190L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5355	0.5574	0.495607	2(stomach)	.	.	.	.	.	.	.	.	OSGEP:uc001vxf.3:exon6:c.A570G:p.L190L	.	AFR:1(lung),AMR:1(upper_aerodigestive_tract),EAS:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205,FIN:0.5455,NFE:0.5360,OTH:0.4187,ASJ:MU583115	610107	.	.	.	.	.	.	.	.	.	.	.	14	1(oesophagus)	0.6291
14	20916987	20916987	G	A	OSGEP	intronic	.	ENSG00000092094	rs938882	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5073	0.5279	0.433506	MU12429740	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.5067,EAS:0.4091,FIN:0.6126,NFE:0.2327,OTH:0.5893,ASJ:0.4647	610107	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.5415
14	20920250	20920250	T	C	OSGEP	exonic	synonymous SNV	ENSG00000092094	rs2275007	ENSG00000092094:ENST00000206542:exon3:c.A294G:p.Q98Q,ENSG00000092094:ENST00000488532:exon3:c.A294G:p.Q98Q,ENSG00000092094:ENST00000553640:exon3:c.A294G:p.Q98Q	OSGEP:NM_017807:exon3:c.A294G:p.Q98Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5802	0.6050	0.553115	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	OSGEP:uc001vxf.3:exon3:c.A294G:p.Q98Q	.	AFR:0.5896,AMR:0.6022,EAS:0.6867,FIN:0.3973,NFE:0.6661,OTH:0.5878,ASJ:0.4689	610107	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.6207
14	20925154	20925154	T	G	APEX1	exonic	nonsynonymous SNV	ENSG00000100823	rs1130409	ENSG00000100823:ENST00000216714:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000398030:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000553681:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000555414:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000556054:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000557150:exon5:c.T393G:p.D131E,ENSG00000100823:ENST00000557592:exon5:c.T393G:p.D131E	APEX1:NM_001244249:exon5:c.T444G:p.D148E,APEX1:NM_001641:exon5:c.T444G:p.D148E,APEX1:NM_080648:exon5:c.T444G:p.D148E,APEX1:NM_080649:exon5:c.T444G:p.D148E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4280	0.4356	0.375599	COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	-1.666	0.002	1.0	-2.6	0.267	.	.	Endonuclease/exonuclease/phosphatase	APEX1:uc001vxg.3:exon5:c.T444G:p.D148E,APEX1:uc001vxh.3:exon5:c.T444G:p.D148E,APEX1:uc001vxi.3:exon5:c.T444G:p.D148E,APEX1:uc021rnr.1:exon5:c.T444G:p.D148E	-1.027	AFR:0.4400,AMR:0.3563,EAS:0.3675,FIN:0.3941,NFE:0.5232,OTH:0.4764,ASJ:0.4141	107748	.	.	.	.	.	.	.	0.0	-1.31	0.000	0.625	14	1(large_intestine)	0.4508
14	23777374	23777374	A	G	BCL2L2;BCL2L2-PABPN1	exonic	nonsynonymous SNV	ENSG00000129473;ENSG00000258643	rs910332	ENSG00000258643:ENST00000557008:exon2:c.A398G:p.Q133R,ENSG00000129473:ENST00000250405:exon3:c.A398G:p.Q133R,ENSG00000258643:ENST00000553781:exon3:c.A398G:p.Q133R,ENSG00000258643:ENST00000556100:exon3:c.A398G:p.Q133R,ENSG00000129473:ENST00000557236:exon3:c.A398G:p.Q133R,ENSG00000129473:ENST00000557579:exon3:c.A398G:p.Q133R	BCL2L2:NM_001199839:exon3:c.A398G:p.Q133R,BCL2L2-PABPN1:NM_001199864:exon3:c.A398G:p.Q133R,BCL2L2:NM_004050:exon3:c.A398G:p.Q133R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9979	0.9977	0.999401	0.9983	-0.797	0.043	0.187	1.43	0.992	.	.	.	BCL2L2:uc001wji.4:exon2:c.A398G:p.Q133R,BCL2L2:uc001wjg.4:exon3:c.A398G:p.Q133R,BCL2L2-PABPN1:uc001wjh.4:exon3:c.A398G:p.Q133R,BCL2L2:uc021rqx.1:exon3:c.A398G:p.Q133R	-1.011	AFR:0.9993,AMR:0.9988,EAS:1,FIN:1,NFE:0.9970,OTH:0.9990,ASJ:1	.	.	.	.	.	.	.	.	0.0	1.1	0.000	0.11	14	MU4559093	hom
14	30066929	30066929	A	G	PRKD1	exonic	synonymous SNV	ENSG00000184304	rs2230505	ENSG00000184304:ENST00000331968:exon16:c.T2202C:p.I734I,ENSG00000184304:ENST00000415220:exon17:c.T2226C:p.I742I	PRKD1:NM_002742:exon16:c.T2202C:p.I734I,PRKD1:NM_001330069:exon17:c.T2226C:p.I742I,PRKD1:NM_001348390:exon17:c.T1938C:p.I646I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4350	0.5095	0.511781	MU133037	.	.	.	.	.	.	.	.	PRKD1:uc001wqh.3:exon16:c.T2202C:p.I734I	.	AFR:LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,AMR:0.4944,EAS:0.4590,FIN:0.3311,NFE:0.2010,OTH:0.4068,ASJ:0.7796	605435	.	.	.	.	.	.	.	.	.	.	.	14	3(haematopoietic_and_lymphoid_tissue)	0.3912
14	30066976	30066976	A	T	PRKD1	intronic	.	ENSG00000184304	rs3783299	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4170	0.4305	0.430711	0.4260	.	.	.	.	.	0.2090	0.472	.	.	.	AFR:0.5418,AMR:0.4356,EAS:0.2017,FIN:0.4064,NFE:0.3902,OTH:0.4031,ASJ:0.3333	605435	.	.	.	.	.	.	.	.	.	.	.	14	MU12450159	het
14	30194899	30194899	T	C	PRKD1	intronic	.	ENSG00000184304	rs11626603	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1972	0.1821	0.164537	0.1821	.	.	.	.	.	.	.	.	.	.	AFR:0.1315,AMR:0.2584,EAS:0.0438,FIN:0.1874,NFE:0.2180,OTH:0.2138,ASJ:0.2285	605435	.	.	.	.	.	.	.	.	.	.	.	14	MU82277372	hom
14	35873770	35873770	G	A	NFKBIA	exonic	synonymous SNV	ENSG00000100906	rs1957106	ENSG00000100906:ENST00000216797:exon1:c.C81T:p.D27D,ENSG00000100906:ENST00000553342:exon1:c.C81T:p.D27D,ENSG00000100906:ENST00000554001:exon1:c.C81T:p.D27D,ENSG00000100906:ENST00000557140:exon1:c.C81T:p.D27D	NFKBIA:NM_020529:exon1:c.C81T:p.D27D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3431	0.2287	0.244409	12(soft_tissue)	.	.	.	.	.	.	.	.	NFKBIA:uc001wtf.4:exon1:c.C81T:p.D27D	.	AFR:1(stomach),AMR:MU122904,EAS:0.2779,FIN:0.1469,NFE:0.2062,OTH:0.2033,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	164008	612132;	238468;98813;	238468|Anhidrotic ectodermal dysplasia<br>HED|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|129490 224900 300291 305100 612132 614940 614941 ~98813|Anhidrotic ectodermal dysplasia with immunodeficiency<br>EDA-ID<br>HED-ID|Unknown|Autosomal dominant<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300291 612132 ~	~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04210 Apoptosis~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04623 Cytosolic DNA-sensing pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04926 Relaxin signaling pathway~ko04931 Insulin resistance~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	14	1(large_intestine)	0.2491
14	50140931	50140931	C	T	POLE2	exonic	synonymous SNV	ENSG00000100479	.	ENSG00000100479:ENST00000539565:exon4:c.G249A:p.L83L,ENSG00000100479:ENST00000216367:exon5:c.G327A:p.L109L,ENSG00000100479:ENST00000554396:exon5:c.G327A:p.L109L	POLE2:NM_001197330:exon4:c.G249A:p.L83L,POLE2:NM_001197331:exon5:c.G327A:p.L109L,POLE2:NM_001348384:exon5:c.G327A:p.L109L,POLE2:NM_001348385:exon5:c.G96A:p.L32L,POLE2:NM_002692:exon5:c.G327A:p.L109L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	POLE2:uc021rsr.1:exon4:c.G249A:p.L83L,POLE2:uc001wwu.3:exon5:c.G327A:p.L109L,POLE2:uc010ano.3:exon5:c.G327A:p.L109L	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602670	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	51206021	51206021	A	G	NIN	intronic	.	ENSG00000100503	rs3015485	.	.	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9976	0.9913	0.992612	0.9927	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.9748,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:1	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU81947943	hom
14	51223789	51223789	C	T	NIN	exonic	nonsynonymous SNV	ENSG00000100503	rs2073347	ENSG00000100503:ENST00000530997:exon16:c.G3959A:p.G1320E,ENSG00000100503:ENST00000245441:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000324330:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000382041:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000453196:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000476352:exon18:c.G3959A:p.G1320E	NIN:NM_020921:exon18:c.G3959A:p.G1320E,NIN:NM_182944:exon18:c.G3959A:p.G1320E,NIN:NM_182946:exon18:c.G3959A:p.G1320E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7454	0.7922	0.764377	MU28671496	1.353	12.54	1.0	6.06	0.945	.	.	.	NIN:uc001wyi.3:exon18:c.G3959A:p.G1320E,NIN:uc001wym.2:exon18:c.G3959A:p.G1320E,NIN:uc001wyo.3:exon18:c.G3959A:p.G1320E	-0.997	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,AMR:0.7599,EAS:0.8353,FIN:0.8245,NFE:0.6617,OTH:0.6770,ASJ:0.8613	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	0.0	3.8	0.000	-2.085	14	2(lung)	0.7277
14	51224658	51224658	T	A	NIN	exonic	synonymous SNV	ENSG00000100503	rs2073348	ENSG00000100503:ENST00000530997:exon16:c.A3090T:p.S1030S,ENSG00000100503:ENST00000245441:exon18:c.A3090T:p.S1030S,ENSG00000100503:ENST00000324330:exon18:c.A3090T:p.S1030S,ENSG00000100503:ENST00000382041:exon18:c.A3090T:p.S1030S,ENSG00000100503:ENST00000453196:exon18:c.A3090T:p.S1030S,ENSG00000100503:ENST00000476352:exon18:c.A3090T:p.S1030S	NIN:NM_020921:exon18:c.A3090T:p.S1030S,NIN:NM_182944:exon18:c.A3090T:p.S1030S,NIN:NM_182946:exon18:c.A3090T:p.S1030S	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3248	0.2751	0.320887	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon18:c.A3090T:p.S1030S,NIN:uc001wym.2:exon18:c.A3090T:p.S1030S,NIN:uc001wyo.3:exon18:c.A3090T:p.S1030S	.	AFR:MU12492660,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,EAS:0.1963,FIN:0.4511,NFE:0.3245,OTH:0.5180,ASJ:0.2960	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	1(liver)	0.3312
14	51225132	51225132	G	T	NIN	exonic	synonymous SNV	ENSG00000100503	rs2073349	ENSG00000100503:ENST00000530997:exon16:c.C2616A:p.A872A,ENSG00000100503:ENST00000245441:exon18:c.C2616A:p.A872A,ENSG00000100503:ENST00000324330:exon18:c.C2616A:p.A872A,ENSG00000100503:ENST00000382041:exon18:c.C2616A:p.A872A,ENSG00000100503:ENST00000453196:exon18:c.C2616A:p.A872A,ENSG00000100503:ENST00000476352:exon18:c.C2616A:p.A872A	NIN:NM_020921:exon18:c.C2616A:p.A872A,NIN:NM_182944:exon18:c.C2616A:p.A872A,NIN:NM_182946:exon18:c.C2616A:p.A872A	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3775	0.3411	0.38758	MU718965	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon18:c.C2616A:p.A872A,NIN:uc001wym.2:exon18:c.C2616A:p.A872A,NIN:uc001wyo.3:exon18:c.C2616A:p.A872A	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.3583,EAS:0.4964,FIN:0.3974,NFE:0.5248,OTH:0.3697,ASJ:0.2917	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	1(lung)	0.3667
14	51237701	51237701	A	G	NIN	exonic	synonymous SNV	ENSG00000100503	rs17793018	ENSG00000100503:ENST00000530997:exon9:c.T1128C:p.V376V,ENSG00000100503:ENST00000382043:exon10:c.T1128C:p.V376V,ENSG00000100503:ENST00000245441:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000324330:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000382041:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000389868:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000453196:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000453401:exon11:c.T1014C:p.V338V,ENSG00000100503:ENST00000476352:exon11:c.T1128C:p.V376V	NIN:NM_016350:exon11:c.T1128C:p.V376V,NIN:NM_020921:exon11:c.T1128C:p.V376V,NIN:NM_182944:exon11:c.T1128C:p.V376V,NIN:NM_182946:exon11:c.T1128C:p.V376V	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6207	0.5033	0.577276	0.5651	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon11:c.T1128C:p.V376V,NIN:uc001wyk.3:exon11:c.T1128C:p.V376V,NIN:uc001wym.2:exon11:c.T1128C:p.V376V,NIN:uc001wyo.3:exon11:c.T1128C:p.V376V,NIN:uc001wyp.1:exon11:c.T1014C:p.V338V	.	AFR:0.2872,AMR:0.6611,EAS:0.8744,FIN:0.6938,NFE:0.6522,OTH:0.6663,ASJ:0.5232	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU123123	het
14	51239067	51239067	C	G	NIN	exonic	synonymous SNV	ENSG00000100503	rs8020503	ENSG00000100503:ENST00000530997:exon7:c.G933C:p.L311L,ENSG00000100503:ENST00000382043:exon8:c.G933C:p.L311L,ENSG00000100503:ENST00000245441:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000324330:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000382041:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000389868:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000453196:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000453401:exon9:c.G819C:p.L273L,ENSG00000100503:ENST00000476352:exon9:c.G933C:p.L311L	NIN:NM_016350:exon9:c.G933C:p.L311L,NIN:NM_020921:exon9:c.G933C:p.L311L,NIN:NM_182944:exon9:c.G933C:p.L311L,NIN:NM_182946:exon9:c.G933C:p.L311L	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9973	0.9907	0.992412	0.9924	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon9:c.G933C:p.L311L,NIN:uc001wyk.3:exon9:c.G933C:p.L311L,NIN:uc001wym.2:exon9:c.G933C:p.L311L,NIN:uc001wyo.3:exon9:c.G933C:p.L311L,NIN:uc001wyp.1:exon9:c.G819C:p.L273L	.	AFR:0.9735,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU81947976	hom
14	51378591	51378591	T	-	PYGL	splicing	.	ENSG00000100504	rs11356035	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4379	0.4435	0.551917	0.4559	.	.	.	.	.	.	.	.	.	.	AFR:0.6589,AMR:0.6253,EAS:0.6043,FIN:0.3460,NFE:0.3433,OTH:0.4031,ASJ:0.3576	613741	232700;	369;	369|GSD due to liver glycogen phosphorylase deficiency<br>GSD type 6<br>GSD type VI<br>Glycogen storage disease type 6<br>Glycogen storage disease type VI<br>Glycogenosis due to liver glycogen phosphorylase deficiency<br>Glycogenosis type 6<br>Glycogenosis type VI<br>Hepatic glycogen phosphorylase deficiency<br>Hepatic phosphorylase deficiency<br>Hers disease<br>Liver glycogen phosphorylase deficiency|Unknown|Autosomal recessive|Childhood|232700 ~	.	.	.	.	.	.	.	.	14	MU149537	het
14	58838668	58838668	A	G	ARID4A	exonic	synonymous SNV	ENSG00000032219	rs1051860	ENSG00000032219:ENST00000431317:exon22:c.A3528G:p.S1176S,ENSG00000032219:ENST00000348476:exon23:c.A3528G:p.S1176S,ENSG00000032219:ENST00000355431:exon24:c.A3735G:p.S1245S,ENSG00000032219:ENST00000395168:exon24:c.A3573G:p.S1191S	ARID4A:NM_023001:exon23:c.A3528G:p.S1176S,ARID4A:NM_002892:exon24:c.A3735G:p.S1245S,ARID4A:NM_023000:exon24:c.A3573G:p.S1191S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5777	0.5303	0.539137	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ARID4A:uc001xdq.3:exon23:c.A3528G:p.S1176S,ARID4A:uc001xdo.3:exon24:c.A3573G:p.S1191S,ARID4A:uc001xdp.3:exon24:c.A3735G:p.S1245S	.	AFR:1(oesophagus),AMR:MU791666,EAS:0.5370,FIN:0.4099,NFE:0.6571,OTH:0.5767,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02	180201	.	.	.	.	.	.	.	.	.	.	.	14	1(lung)	0.5118
14	58838701	58838701	C	T	ARID4A	exonic	synonymous SNV	ENSG00000032219	rs1051861	ENSG00000032219:ENST00000431317:exon22:c.C3561T:p.C1187C,ENSG00000032219:ENST00000348476:exon23:c.C3561T:p.C1187C,ENSG00000032219:ENST00000355431:exon24:c.C3768T:p.C1256C,ENSG00000032219:ENST00000395168:exon24:c.C3606T:p.C1202C	ARID4A:NM_023001:exon23:c.C3561T:p.C1187C,ARID4A:NM_002892:exon24:c.C3768T:p.C1256C,ARID4A:NM_023000:exon24:c.C3606T:p.C1202C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5737	0.5220	0.531949	1(breast)	.	.	.	.	.	.	.	.	ARID4A:uc001xdq.3:exon23:c.C3561T:p.C1187C,ARID4A:uc001xdo.3:exon24:c.C3606T:p.C1202C,ARID4A:uc001xdp.3:exon24:c.C3768T:p.C1256C	.	AFR:1(oesophagus),AMR:MU791663,EAS:0.5304,FIN:0.3867,NFE:0.6567,OTH:0.5767,ASJ:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02	180201	.	.	.	.	.	.	.	.	.	.	.	14	1(stomach)	0.5137
14	61445967	61445967	A	G	TRMT5	exonic	nonsynonymous SNV	ENSG00000126814	rs7142228	ENSG00000126814:ENST00000261249:exon2:c.T649C:p.S217P	TRMT5:NM_001350253:exon2:c.T733C:p.S245P,TRMT5:NM_001350254:exon2:c.T730C:p.S244P,TRMT5:NM_020810:exon2:c.T649C:p.S217P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	TRMT5:uc001xff.4:exon2:c.T649C:p.S217P	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	611023	616539;	.	.	.	.	.	.	.	.	.	.	14	MU81949241	hom
14	64700045	64700045	T	C	ESR2	intronic	.	ENSG00000140009	rs944050	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0916	0.0603	0.161542	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	0	0.03	.	.	.	AFR:MU645524,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.1139,FIN:0.1639,NFE:0.0099,OTH:0.4671,ASJ:0.0964	601663	.	.	.	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04929 GnRH secretion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	14	1(soft_tissue)	0.0882
14	65544367	65544367	C	A	MAX	intronic	.	ENSG00000125952	rs762810	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3400	.	0.20627	0.2819	.	.	.	.	.	0.0001	0.038	.	.	.	AFR:0.1605,AMR:0.1998,EAS:0.1184,FIN:0.4232,NFE:0.3408,OTH:0.3279,ASJ:0.1867	154950	171300;	29072;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~	~ko04010 MAPK signaling pathway~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	14	MU81949947	het
14	69006916	69006916	G	A	RAD51B	splicing	.	ENSG00000182185	rs55670604	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.0261581	0.0488	.	.	.	.	.	.	.	.	.	.	AFR:0.0123,AMR:0.0417,EAS:0,FIN:0.0686,NFE:0.0744,OTH:0.0460,ASJ:0.1087	602948	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	75513883	75513883	T	C	MLH3	exonic	nonsynonymous SNV	ENSG00000119684	rs175081	ENSG00000119684:ENST00000556740:exon1:c.A2476G:p.N826D,ENSG00000119684:ENST00000238662:exon2:c.A2476G:p.N826D,ENSG00000119684:ENST00000355774:exon2:c.A2476G:p.N826D,ENSG00000119684:ENST00000556257:exon2:c.A2476G:p.N826D	MLH3:NM_001040108:exon2:c.A2476G:p.N826D,MLH3:NM_014381:exon2:c.A2476G:p.N826D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9968	0.9888	0.990415	0.9902	-0.981	0.017	0.848	1.33	0.019	.	.	.	MLH3:uc001xrd.1:exon2:c.A2476G:p.N826D,MLH3:uc001xre.1:exon2:c.A2476G:p.N826D	-0.969	AFR:0.9660,AMR:0.9988,EAS:0.9994,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:1	604395	114500;608089;614385;	144;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	.	.	.	.	0.001	-1.3	0.000	0	14	MU81951479	hom
14	75515221	75515221	T	C	MLH3	exonic	nonsynonymous SNV	ENSG00000119684	.	ENSG00000119684:ENST00000556740:exon1:c.A1138G:p.K380E,ENSG00000119684:ENST00000238662:exon2:c.A1138G:p.K380E,ENSG00000119684:ENST00000355774:exon2:c.A1138G:p.K380E,ENSG00000119684:ENST00000556257:exon2:c.A1138G:p.K380E	MLH3:NM_001040108:exon2:c.A1138G:p.K380E,MLH3:NM_014381:exon2:c.A1138G:p.K380E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	0.345	6.125	0.124	3.78	0.873	.	.	.	MLH3:uc001xrd.1:exon2:c.A1138G:p.K380E,MLH3:uc001xre.1:exon2:c.A1138G:p.K380E	-0.541	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604395	114500;608089;614385;	144;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	.	.	.	.	0.763	-1.43	0.350	1.545	14	.	hom
14	81574959	81574959	A	G	TSHR	exonic	synonymous SNV	ENSG00000165409	rs3783942	ENSG00000165409:ENST00000342443:exon9:c.A696G:p.L232L,ENSG00000165409:ENST00000554435:exon9:c.A759G:p.L253L	TSHR:NM_001018036:exon9:c.A696G:p.L232L,TSHR:NM_001142626:exon9:c.A759G:p.L253L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6468	0.6438	0.611222	0.6259	.	.	.	.	.	.	.	.	TSHR:uc001xvc.3:exon9:c.A696G:p.L232L,TSHR:uc010tvs.2:exon9:c.A759G:p.L253L	.	AFR:0.6285,AMR:0.6635,EAS:0.3247,FIN:0.6673,NFE:0.6404,OTH:0.6612,ASJ:0.7583	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	.	.	.	.	14	MU16499962	hom
14	81575005	81575005	C	A	TSHR	exonic	nonsynonymous SNV	ENSG00000165409	rs3783941	ENSG00000165409:ENST00000342443:exon9:c.C742A:p.R248S,ENSG00000165409:ENST00000554435:exon9:c.C805A:p.R269S	TSHR:NM_001018036:exon9:c.C742A:p.R248S,TSHR:NM_001142626:exon9:c.C805A:p.R269S	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6465	0.6425	0.610224	0.6233	0.085	3.453	1.0	-8.59	0.000	.	.	Leucine-rich repeat domain, L domain-like	TSHR:uc001xvc.3:exon9:c.C742A:p.R248S,TSHR:uc010tvs.2:exon9:c.C805A:p.R269S	-1.021	AFR:0.6213,AMR:0.6623,EAS:0.3224,FIN:0.6665,NFE:0.6397,OTH:0.6608,ASJ:0.7583	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	0.0	-1.17	0.000	.	14	MU16500020	hom
14	81609779	81609779	G	A	TSHR	exonic	synonymous SNV	ENSG00000165409	rs113951800	ENSG00000165409:ENST00000298171:exon10:c.G1377A:p.A459A,ENSG00000165409:ENST00000541158:exon11:c.G1377A:p.A459A	TSHR:NM_000369:exon10:c.G1377A:p.A459A	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0182	0.0172	0.0157748	0.0134	.	.	.	.	.	.	.	.	TSHR:uc001xvd.1:exon10:c.G1377A:p.A459A	.	AFR:0.0047,AMR:0.0131,EAS:0.0006,FIN:0.0126,NFE:0.0198,OTH:0.0132,ASJ:0.0298	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	.	.	.	.	14	MU67331248	het
14	81610583	81610583	G	C	TSHR	exonic	nonsynonymous SNV	ENSG00000165409	rs1991517	ENSG00000165409:ENST00000298171:exon10:c.G2181C:p.E727D,ENSG00000165409:ENST00000541158:exon11:c.G2181C:p.E727D	TSHR:NM_000369:exon10:c.G2181C:p.E727D	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9004	0.9233	0.896765	0.8977	-1.490	0.003	1.0	2.08	0.751	.	.	.	TSHR:uc001xvd.1:exon10:c.G2181C:p.E727D	-0.975	AFR:0.9392,AMR:0.8675,EAS:0.8100,FIN:0.8495,NFE:0.8968,OTH:0.8798,ASJ:0.9106	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	0.0	-0.92	0.000	.	14	MU19600230	hom
14	93276654	93276654	T	C	GOLGA5	exonic	nonsynonymous SNV	ENSG00000066455	rs1040835	ENSG00000066455:ENST00000163416:exon5:c.T1048C:p.F350L,ENSG00000066455:ENST00000355976:exon5:c.T1048C:p.F350L	GOLGA5:NM_005113:exon5:c.T1048C:p.F350L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7999	0.7962	0.859625	MU103194	1.303	12.28	1.0	4.75	0.990	.	.	.	GOLGA5:uc001yaz.1:exon5:c.T1048C:p.F350L	-0.989	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.8175,EAS:0.8484,FIN:0.7252,NFE:0.8802,OTH:0.8143,ASJ:0.9357	606918	.	.	.	.	.	.	.	0.0	2.73	0.000	-1.975	14	1(thyroid)	0.7439
14	94844843	94844843	T	G	SERPINA1	exonic	nonsynonymous SNV	ENSG00000197249	rs1303	ENSG00000197249:ENST00000355814:exon5:c.A1200C:p.E400D,ENSG00000197249:ENST00000393087:exon5:c.A1200C:p.E400D,ENSG00000197249:ENST00000440909:exon5:c.A1200C:p.E400D,ENSG00000197249:ENST00000404814:exon6:c.A1200C:p.E400D,ENSG00000197249:ENST00000437397:exon6:c.A1200C:p.E400D,ENSG00000197249:ENST00000449399:exon6:c.A1200C:p.E400D,ENSG00000197249:ENST00000393088:exon7:c.A1200C:p.E400D,ENSG00000197249:ENST00000448921:exon7:c.A1200C:p.E400D	SERPINA1:NM_000295:exon5:c.A1200C:p.E400D,SERPINA1:NM_001002235:exon5:c.A1200C:p.E400D,SERPINA1:NM_001127700:exon5:c.A1200C:p.E400D,SERPINA1:NM_001127702:exon6:c.A1200C:p.E400D,SERPINA1:NM_001127706:exon6:c.A1200C:p.E400D,SERPINA1:NM_001127707:exon6:c.A1200C:p.E400D,SERPINA1:NM_001002236:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127701:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127703:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127704:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127705:exon7:c.A1200C:p.E400D	clinvar: Benign/Likely_benign,_other 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2747	0.2071	0.280351	3(stomach)	-2.890	0.001	1.0	-9.02	0.000	.	.	Serpin domain	SERPINA1:uc001ycx.4:exon5:c.A1200C:p.E400D,SERPINA1:uc001ycz.4:exon5:c.A1200C:p.E400D,SERPINA1:uc010aux.3:exon5:c.A1200C:p.E400D,SERPINA1:uc001ydc.4:exon6:c.A1200C:p.E400D,SERPINA1:uc010auz.3:exon6:c.A1200C:p.E400D,SERPINA1:uc010avb.3:exon6:c.A1200C:p.E400D,SERPINA1:uc001ycy.4:exon7:c.A1200C:p.E400D,SERPINA1:uc001ydb.4:exon7:c.A1200C:p.E400D,SERPINA1:uc010auw.3:exon7:c.A1200C:p.E400D,SERPINA1:uc010auy.3:exon7:c.A1200C:p.E400D,SERPINA1:uc010ava.3:exon7:c.A1200C:p.E400D	-0.918	AFR:4(haematopoietic_and_lymphoid_tissue),AMR:1(large_intestine),EAS:MU158468,FIN:LAML-KR|2|205|0.0097561,GACA-CN|1|123|0.00813008,COCA-CN|3|321|0.00934579,NFE:0.2132,OTH:0.1141,ASJ:1(biliary_tract)	107400	606963;613490;	60;	60|Deficiency in Alpa-1-proteinase inhibitor|1-5 / 10 000|Autosomal recessive|All ages|613490 ~	.	.	.	.	0.0	-2.13	0.000	-0.585	14	1(prostate)	0.3441
14	95566108	95566108	C	A	DICER1	intronic	.	ENSG00000100697	rs1778057	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0394	.	0.870008	0.0661	.	.	.	.	.	.	.	.	.	.	AFR:0.0718,AMR:0.0485,EAS:0.0163,FIN:0.0758,NFE:0.0658,OTH:0.0654,ASJ:0.1353	606241	138800;180295;601200;	284343;64742;276399;	284343|DICER1 syndrome<br>PPB familial tumor susceptibility syndrome<br>PPBFTDS<br>Pleuro-pulmonary blastoma familial tumor susceptibility syndrome|-|Autosomal dominant|Adolescent<br>Childhood<br>Adult|601200 ~64742|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|601200 ~276399|FMNG<br>Familial MNG|Unknown|Autosomal dominant|Adolescent|138800 ~	.	.	.	.	.	.	.	.	14	MU28866641	hom
14	96178149	96178150	AG	-	TCL1A	intronic	.	ENSG00000257275	rs142205645	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1807	.	.	0.0003	.	.	.	.	.	.	.	.	.	.	AFR:0.0003,AMR:0,EAS:0,FIN:0.0007,NFE:0.0002,OTH:0,ASJ:0	186960	.	.	.	.	.	.	.	.	.	.	.	14	MU40991110	unknown
14	97299853	97299853	A	G	VRK1	exonic	synonymous SNV	ENSG00000100749	rs2145635	ENSG00000100749:ENST00000216639:exon2:c.A45G:p.A15A	VRK1:NM_003384:exon2:c.A45G:p.A15A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3565	0.3309	0.289537	MU130355	.	.	.	.	.	.	.	.	VRK1:uc001yft.3:exon2:c.A45G:p.A15A	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.3264,EAS:0.3520,FIN:0.2933,NFE:0.1040,OTH:0.3974,ASJ:0.2168	602168	607596;	2254;	2254|Norman disease<br>PCH1|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607596 614678 616081 ~	.	.	.	.	.	.	.	.	14	1(lung)	0.3943
14	101295830	101295830	G	C	MEG3	ncRNA_exonic	.	ENSG00000214548	rs941575	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.955671	0.9330	.	.	.	.	.	.	.	.	.	.	AFR:0.9362,AMR:0.9594,EAS:0.9790,FIN:0.9390,NFE:0.9228,OTH:0.9338,ASJ:0.9570	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	101301038	101301038	C	G	MEG3	ncRNA_exonic	.	ENSG00000214548	rs3194464	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1367	.	0.105831	0.1136	.	.	.	.	.	.	.	.	.	.	AFR:0.0540,AMR:0.2105,EAS:0.0771,FIN:0.1245,NFE:0.1431,OTH:0.1337,ASJ:0.1126	605636	.	.	.	.	.	.	.	.	.	.	.	14	MU22871718	het
14	101302211	101302211	G	T	MEG3	ncRNA_exonic	.	ENSG00000214548	rs11859	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.351038	0.2551	.	.	.	.	.	.	.	.	.	.	AFR:0.3916,AMR:0.1770,EAS:0.4522,FIN:0.1464,NFE:0.1890,OTH:0.1861,ASJ:0.2367	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	101314823	101314823	G	T	MEG3	ncRNA_exonic	.	ENSG00000214548	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	3.227e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.66e-05,OTH:0,ASJ:0	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101316518	101316518	G	A	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs12431495	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.232029	0.2656	.	.	.	.	.	.	.	.	.	.	AFR:0.1031,AMR:0.3294,EAS:0.2550,FIN:0.3220,NFE:0.3402,OTH:0.3224,ASJ:0.3046	605636	.	.	.	.	.	.	.	.	.	.	.	14	MU113782055	hom
14	101318311	101318311	C	G	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs2295389	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.274161	0.2980	.	.	.	.	.	.	.	.	.	.	AFR:0.1104,AMR:0.3389,EAS:0.3288,FIN:0.4107,NFE:0.3694,OTH:0.3865,ASJ:0.3079	605636	.	.	.	.	.	.	.	.	.	.	.	14	MU113782627	het
14	101319424	101319424	A	G	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs7158663	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.515375	0.4184	.	.	.	.	.	.	.	.	.	.	AFR:0.2245,AMR:0.5668,EAS:0.7553,FIN:0.4255,NFE:0.4807,OTH:0.4796,ASJ:0.4338	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101320034	101320034	A	G	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs1998053	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.936901	0.9265	.	.	.	.	.	.	.	.	.	.	AFR:0.9848,AMR:0.9582,EAS:0.8832,FIN:0.8650,NFE:0.9116,OTH:0.8921,ASJ:0.9536	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	104165753	104165753	G	A	XRCC3	exonic	nonsynonymous SNV	ENSG00000126215	rs861539	ENSG00000126215:ENST00000554974:exon2:c.C107T:p.T36M,ENSG00000126215:ENST00000553264:exon6:c.C722T:p.T241M,ENSG00000126215:ENST00000352127:exon7:c.C722T:p.T241M,ENSG00000126215:ENST00000445556:exon7:c.C722T:p.T241M,ENSG00000126215:ENST00000554913:exon8:c.C722T:p.T241M,ENSG00000126215:ENST00000555055:exon8:c.C722T:p.T241M	XRCC3:NM_001100118:exon7:c.C722T:p.T241M,XRCC3:NM_001100119:exon8:c.C722T:p.T241M,XRCC3:NM_001371229:exon8:c.C722T:p.T241M,XRCC3:NM_001371231:exon8:c.C722T:p.T241M,XRCC3:NM_001371232:exon8:c.C722T:p.T241M,XRCC3:NM_005432:exon8:c.C722T:p.T241M	clinvar: risk_factor 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3075	0.3232	0.216853	1(prostate)	0.979	10.54	0.137	1.35	0.001	.	.	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|P-loop containing nucleoside triphosphate hydrolase;DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|P-loop containing nucleoside triphosphate hydrolase|Rad51/DMC1/RadA	XRCC3:uc001ynz.4:exon7:c.C722T:p.T241M,XRCC3:uc001ynx.4:exon8:c.C722T:p.T241M,XRCC3:uc001yny.4:exon8:c.C722T:p.T241M,XRCC3:uc001yoa.4:exon8:c.C722T:p.T241M	-0.912	AFR:MU4558524,AMR:LAML-KR|1|205|0.00487805,EAS:0.2072,FIN:0.2309,NFE:0.4205,OTH:0.0514,ASJ:0.2910	600675	114480;613972;	618;227535;	618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.541	1.05	0.000	1.175	14	1(large_intestine)	0.2910
14	105243011	105243011	T	C	AKT1	exonic	nonsynonymous SNV	ENSG00000142208	.	ENSG00000142208:ENST00000544168:exon2:c.A86G:p.E29G,ENSG00000142208:ENST00000554581:exon3:c.A272G:p.E91G,ENSG00000142208:ENST00000555380:exon3:c.A86G:p.E29G,ENSG00000142208:ENST00000402615:exon4:c.A272G:p.E91G,ENSG00000142208:ENST00000407796:exon4:c.A272G:p.E91G,ENSG00000142208:ENST00000554848:exon4:c.A272G:p.E91G,ENSG00000142208:ENST00000555528:exon4:c.A272G:p.E91G,ENSG00000142208:ENST00000349310:exon5:c.A272G:p.E91G,ENSG00000142208:ENST00000555926:exon5:c.A272G:p.E91G	AKT1:NM_001014431:exon4:c.A272G:p.E91G,AKT1:NM_005163:exon4:c.A272G:p.E91G,AKT1:NM_001014432:exon5:c.A272G:p.E91G	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 1] 	.	.	.	.	4.451	24.2	0.011	4.48	0.881	.	.	PH domain-like|Pleckstrin homology domain	AKT1:uc010tyk.2:exon2:c.A86G:p.E29G,AKT1:uc001ypl.3:exon3:c.A272G:p.E91G,AKT1:uc001ypk.3:exon4:c.A272G:p.E91G,AKT1:uc001ypn.3:exon4:c.A272G:p.E91G,AKT1:uc010axa.3:exon4:c.A272G:p.E91G,AKT1:uc001ypm.3:exon5:c.A272G:p.E91G	0.086	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	164730	114480;114500;167000;176920;181500;615109;	201;744;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~744|Partial gigantism-nevi-hemihypertrophy-macrocephaly syndrome|<1 / 1 000 000|Not applicable|Infancy|176920 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04261 Adrenergic signaling in cardiomyocytes~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04973 Carbohydrate digestion and absorption~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,391,396,395,390,394,392,393	.	.	0.184	-1.22	0.540	2.475	14	.	hom
14	105722726	105722726	T	C	BRF1	exonic	synonymous SNV	ENSG00000185024	rs1008628	ENSG00000185024:ENST00000548421:exon4:c.A600G:p.P200P	BRF1:NM_001242790:exon4:c.A600G:p.P200P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3709	.	0.222644	MU4558705	.	.	.	.	.	.	.	.	BRF1:uc001yqr.3:exon4:c.A600G:p.P200P	.	AFR:LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,AMR:0.2567,EAS:0.2285,FIN:0.2119,NFE:0.1269,OTH:0.3364,ASJ:0.2338	604902	616202;	444072;	444072|Cerebellofaciodental syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal<br>Neonatal|616202 ~	.	.	.	.	.	.	.	.	14	2(lung)	0.2663
15	28446663	28446663	T	C	HERC2	exonic	nonsynonymous SNV	ENSG00000128731	rs745742003	ENSG00000128731:ENST00000261609:exon48:c.A7655G:p.K2552R	HERC2:NM_004667:exon48:c.A7655G:p.K2552R	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	8.237e-06	.	.	.	4.351	24.1	0.27	5.18	0.994	.	.	Ribosomal protein L2 domain 2	HERC2:uc001zbk.1:exon3:c.A260G:p.K87R,HERC2:uc001zbj.4:exon48:c.A7655G:p.K2552R	-0.761	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	0.997	1.03	0.230	2.38	15	.	hom
15	28502279	28502279	A	G	HERC2	exonic	synonymous SNV	ENSG00000128731	rs11631797	ENSG00000128731:ENST00000261609:exon17:c.T2445C:p.G815G	HERC2:NM_004667:exon17:c.T2445C:p.G815G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6876	0.6671	0.442492	0.6865	.	.	.	.	.	.	.	.	HERC2:uc001zbj.4:exon17:c.T2445C:p.G815G,HERC2:uc001zbl.2:exon18:c.T1530C:p.G510G	.	AFR:0.2970,AMR:0.6127,EAS:0.2889,FIN:0.9628,NFE:0.8841,OTH:0.8218,ASJ:0.7781	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU15035966	het
15	31197564	31197564	G	A	FAN1	exonic	nonsynonymous SNV	ENSG00000198690	rs4779794	ENSG00000198690:ENST00000362065:exon2:c.G698A:p.G233E,ENSG00000198690:ENST00000561594:exon2:c.G698A:p.G233E,ENSG00000198690:ENST00000561607:exon2:c.G698A:p.G233E,ENSG00000198690:ENST00000565280:exon2:c.G698A:p.G233E,ENSG00000198690:ENST00000565466:exon2:c.G698A:p.G233E	FAN1:NM_001146094:exon2:c.G698A:p.G233E,FAN1:NM_001146095:exon2:c.G698A:p.G233E,FAN1:NM_001146096:exon2:c.G698A:p.G233E,FAN1:NM_014967:exon2:c.G698A:p.G233E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4594	0.3195	0.422524	MU4560159	-1.462	0.003	0.791	-2.16	0.002	.	.	.	FAN1:uc001zfc.3:exon2:c.G698A:p.G233E,FAN1:uc001zfd.3:exon2:c.G698A:p.G233E,FAN1:uc001zff.3:exon2:c.G698A:p.G233E,FAN1:uc010azw.2:exon2:c.G698A:p.G233E	-0.903	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,THCA-SA|1|243|0.00411523,AMR:0.3667,EAS:0.5456,FIN:0.54,NFE:0.8103,OTH:0.4811,ASJ:0.1055	613534	614817;	401996;	401996|KIN<br>Systemic karyomegaly|<1 / 1 000 000|Autosomal recessive|Adult|614817 ~	.	.	.	.	0.146	1.01	0.000	2.045	15	2(pancreas)	0.4257
15	31229420	31229420	T	C	FAN1	exonic	synonymous SNV	ENSG00000198690	rs2955795	ENSG00000198690:ENST00000362065:exon14:c.T3015C:p.H1005H	FAN1:NM_014967:exon14:c.T3015C:p.H1005H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4755	0.3482	0.457069	MU20615899	.	.	.	.	.	.	.	.	FAN1:uc001zff.3:exon14:c.T3015C:p.H1005H,FAN1:uc001zfe.3:exon15:c.T1830C:p.H610H	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.3958,EAS:0.5585,FIN:0.5563,NFE:0.8583,OTH:0.4911,ASJ:0.1658	613534	614817;	401996;	401996|KIN<br>Systemic karyomegaly|<1 / 1 000 000|Autosomal recessive|Adult|614817 ~	.	.	.	.	.	.	.	.	15	1(urinary_tract)	0.4408
15	38614525	38614525	G	A	SPRED1	exonic	synonymous SNV	ENSG00000166068	rs7182445	ENSG00000166068:ENST00000299084:exon3:c.G291A:p.K97K,ENSG00000166068:ENST00000561317:exon4:c.G228A:p.K76K	SPRED1:NM_152594:exon3:c.G291A:p.K97K	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8637	0.8258	0.80012	LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SPRED1:uc001zka.4:exon3:c.G291A:p.K97K	.	AFR:0.8318,AMR:0.6692,EAS:0.8709,FIN:0.7922,NFE:0.9345,OTH:0.9005,ASJ:0.8517	609291	611431;	137605;	137605|NF1-like syndrome<br>Neurofibromatosis 1-like syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|611431 ~	.	.	.	.	.	.	.	.	15	1(thyroid)	0.8939
15	38631930	38631930	C	A	SPRED1	intronic	.	ENSG00000166068	rs7180446	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8637	0.8255	0.799321	0.8318	.	.	.	.	.	0.0051	0.082	.	.	.	AFR:0.6692,AMR:0.8520,EAS:0.7932,FIN:0.9352,NFE:0.9005,OTH:0.8939,ASJ:0.8709	609291	611431;	137605;	137605|NF1-like syndrome<br>Neurofibromatosis 1-like syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|611431 ~	.	.	.	.	.	.	.	.	15	MU666813	hom
15	38643574	38643574	T	C	SPRED1	exonic	synonymous SNV	ENSG00000166068	rs3751526	ENSG00000166068:ENST00000299084:exon7:c.T1044C:p.V348V	SPRED1:NM_152594:exon7:c.T1044C:p.V348V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8637	0.8254	0.799521	LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SPRED1:uc001zka.4:exon7:c.T1044C:p.V348V	.	AFR:0.8315,AMR:0.6681,EAS:0.8709,FIN:0.7924,NFE:0.9345,OTH:0.9005,ASJ:0.8508	609291	611431;	137605;	137605|NF1-like syndrome<br>Neurofibromatosis 1-like syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|611431 ~	.	.	.	.	.	.	.	.	15	4(haematopoietic_and_lymphoid_tissue)	0.8941
15	39880358	39880358	C	T	THBS1	exonic	synonymous SNV	ENSG00000137801	rs2228261	ENSG00000137801:ENST00000260356:exon9:c.C1410T:p.N470N	THBS1:NM_003246:exon9:c.C1410T:p.N470N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1635	0.2179	0.266773	0.2058	.	.	.	.	.	.	.	.	THBS1:uc001zkh.3:exon9:c.C1410T:p.N470N	.	AFR:0.4011,AMR:0.1100,EAS:0.3156,FIN:0.1013,NFE:0.1162,OTH:0.1357,ASJ:0.1391	188060	.	.	.	~ko04015 Rap1 signaling pathway~ko04115 p53 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04350 TGF-beta signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05144 Malaria~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	15	MU583513	hom
15	39880822	39880822	A	G	THBS1	exonic	nonsynonymous SNV	ENSG00000137801	rs2292305	ENSG00000137801:ENST00000260356:exon10:c.A1567G:p.T523A	THBS1:NM_003246:exon10:c.A1567G:p.T523A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.1689	0.2246	0.274561	0.2105	-0.418	0.350	0.76	-2.47	0.997	.	.	.	THBS1:uc001zkh.3:exon10:c.A1567G:p.T523A	-0.991	AFR:0.4140,AMR:0.1091,EAS:0.3306,FIN:0.1013,NFE:0.1167,OTH:0.1385,ASJ:0.1457	188060	.	.	.	~ko04015 Rap1 signaling pathway~ko04115 p53 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04350 TGF-beta signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05144 Malaria~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05219 Bladder cancer ~	.	.	.	0.0	0.22	0.000	-0.785	15	MU96876	hom
15	40477831	40477831	G	A	BUB1B	exonic	nonsynonymous SNV	ENSG00000156970	rs1801376	ENSG00000156970:ENST00000287598:exon8:c.G1046A:p.R349Q,ENSG00000156970:ENST00000412359:exon8:c.G1088A:p.R363Q	BUB1B:NM_001211:exon8:c.G1046A:p.R349Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6566	0.7360	0.628195	72(lung)	2.297	18.15	1.0	4.72	0.977	.	.	.	BUB1B:uc010ucl.1:exon4:c.G635A:p.R212Q,BUB1B:uc001zkx.4:exon8:c.G1046A:p.R349Q	-0.980	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU20627954,EAS:0.7235,FIN:0.8293,NFE:0.6325,OTH:0.6159,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	602860	114500;176430;257300;	1052;	1052|Warburton-Anyane-Yeboa syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|257300 614114 ~	.	.	.	.	0.0	2.74	0.000	-2.255	15	1(large_intestine)	0.3188
15	40898643	40898643	G	C	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs7177192	ENSG00000137812:ENST00000346991:exon4:c.G128C:p.R43T,ENSG00000137812:ENST00000399668:exon4:c.G128C:p.R43T,ENSG00000137812:ENST00000527044:exon4:c.G128C:p.R43T	KNL1:NM_144508:exon4:c.G128C:p.R43T,KNL1:NM_170589:exon4:c.G128C:p.R43T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7456	0.8222	0.653754	1(haematopoietic_and_lymphoid_tissue)	-1.469	0.003	0.53	-4.84	0.891	.	.	.	CASC5:uc001zme.3:exon4:c.G128C:p.R43T,CASC5:uc010bbs.1:exon4:c.G128C:p.R43T,CASC5:uc010bbt.1:exon4:c.G128C:p.R43T	-0.968	AFR:1(large_intestine),AMR:MU583520,EAS:0.7939,FIN:0.7709,NFE:0.5634,OTH:0.8046,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.0	1.93	0.000	-1.61	15	2(prostate)	0.2983
15	40915190	40915190	A	G	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs8040502	ENSG00000137812:ENST00000399668:exon10:c.A2728G:p.R910G,ENSG00000137812:ENST00000346991:exon11:c.A2806G:p.R936G	KNL1:NM_144508:exon10:c.A2728G:p.R910G,KNL1:NM_170589:exon11:c.A2806G:p.R936G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7589	0.8695	0.705671	1(prostate)	0.453	7.062	1.0	3.03	0.884	.	.	.	CASC5:uc010ucq.1:exon9:c.A2278G:p.R760G,CASC5:uc001zme.3:exon10:c.A2728G:p.R910G,CASC5:uc010bbt.1:exon10:c.A2728G:p.R910G,CASC5:uc010bbs.1:exon11:c.A2806G:p.R936G	-1.015	AFR:1(stomach),AMR:2(haematopoietic_and_lymphoid_tissue),EAS:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,FIN:0.8352,NFE:0.9146,OTH:0.5680,ASJ:MU583521	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.0	2.57	0.000	-1.59	15	1(lung)	0.8046
15	41796825	41796825	G	A	LTK	exonic	synonymous SNV	ENSG00000062524	.	ENSG00000062524:ENST00000561619:exon12:c.C1228T:p.L410L,ENSG00000062524:ENST00000453182:exon16:c.C1744T:p.L582L,ENSG00000062524:ENST00000355166:exon17:c.C1951T:p.L651L,ENSG00000062524:ENST00000263800:exon18:c.C2134T:p.L712L	LTK:NM_001135685:exon16:c.C1744T:p.L582L,LTK:NM_206961:exon17:c.C1951T:p.L651L,LTK:NM_002344:exon18:c.C2134T:p.L712L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	LTK:uc010bcg.2:exon12:c.C1228T:p.L410L,LTK:uc010ucx.1:exon16:c.C1744T:p.L582L,LTK:uc001zob.3:exon17:c.C1951T:p.L651L,LTK:uc001zoa.3:exon18:c.C2134T:p.L712L	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	151520	.	.	.	.	.	.	.	.	.	.	.	15	.	hom
15	41865488	41865488	C	T	TYRO3	intronic	.	ENSG00000092445	rs2246444	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4163	0.3897	0.446685	0.4406	.	.	.	.	.	.	.	.	.	.	AFR:0.4291,AMR:0.4339,EAS:0.7968,FIN:0.3794,NFE:0.4245,OTH:0.4156,ASJ:0.3442	600341	.	.	.	.	.	.	.	.	.	.	.	15	MU4328220	hom
15	48797307	48797307	A	G	FBN1	exonic	synonymous SNV	ENSG00000166147	rs25458	ENSG00000166147:ENST00000316623:exon16:c.T1875C:p.N625N	FBN1:NM_000138:exon16:c.T1875C:p.N625N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2006	0.2444	0.296925	1(breast)	.	.	.	.	.	.	.	.	FBN1:uc001zwx.2:exon16:c.T1875C:p.N625N	.	AFR:MU4560566,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.4571,FIN:0.1787,NFE:0.0662,OTH:0.3323,ASJ:0.2590	134797	102370;129600;154700;184900;604308;608328;614185;616914;	300382;2623;2084;3449;2833;284963;558;1885;969;	300382|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616914 ~2623|Geleophysic dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|231050 614185 ~2084|GEMSS syndrome|<1 / 1 000 000|Autosomal dominant|All ages|608328 ~3449|Spherophakia-brachymorphia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|277600 608328 614819 ~2833|-|-|-|-|184900 228020 ~284963|MFS1|-|Autosomal dominant|All ages|154700 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~1885|Ectopia lentis syndrome<br>Familial ectopia lentis|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|129600 225100 225200 ~969|-|<1 / 1 000 000|Autosomal dominant|Neonatal|102370 ~	.	.	.	.	.	.	.	.	15	1(skin)	0.2102
15	48807637	48807637	C	T	FBN1	exonic	nonsynonymous SNV	ENSG00000166147	rs4775765	ENSG00000166147:ENST00000316623:exon12:c.G1415A:p.C472Y	FBN1:NM_000138:exon12:c.G1415A:p.C472Y	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	1	.	1	1	.	.	.	.	.	.	.	.	FBN1:uc001zwx.2:exon12:c.G1415A:p.C472Y	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	134797	102370;129600;154700;184900;604308;608328;614185;616914;	300382;2623;2084;3449;2833;284963;558;1885;969;	300382|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616914 ~2623|Geleophysic dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|231050 614185 ~2084|GEMSS syndrome|<1 / 1 000 000|Autosomal dominant|All ages|608328 ~3449|Spherophakia-brachymorphia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|277600 608328 614819 ~2833|-|-|-|-|184900 228020 ~284963|MFS1|-|Autosomal dominant|All ages|154700 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~1885|Ectopia lentis syndrome<br>Familial ectopia lentis|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|129600 225100 225200 ~969|-|<1 / 1 000 000|Autosomal dominant|Neonatal|102370 ~	.	.	.	.	.	.	.	.	15	MU81961571	hom
15	48807719	48807719	G	A	FBN1	exonic	synonymous SNV	ENSG00000166147	.	ENSG00000166147:ENST00000316623:exon12:c.C1333T:p.L445L	FBN1:NM_000138:exon12:c.C1333T:p.L445L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	FBN1:uc001zwx.2:exon12:c.C1333T:p.L445L	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	134797	102370;129600;154700;184900;604308;608328;614185;616914;	300382;2623;2084;3449;2833;284963;558;1885;969;	300382|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616914 ~2623|Geleophysic dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|231050 614185 ~2084|GEMSS syndrome|<1 / 1 000 000|Autosomal dominant|All ages|608328 ~3449|Spherophakia-brachymorphia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|277600 608328 614819 ~2833|-|-|-|-|184900 228020 ~284963|MFS1|-|Autosomal dominant|All ages|154700 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~1885|Ectopia lentis syndrome<br>Familial ectopia lentis|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|129600 225100 225200 ~969|-|<1 / 1 000 000|Autosomal dominant|Neonatal|102370 ~	.	.	.	.	.	.	.	.	15	.	hom
15	51502986	51502986	G	A	MIR4713HG	ncRNA_intronic	.	ENSG00000259240	rs10046	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4492	0.4329	0.362819	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4477,AMR:0.2428,EAS:0.5331,FIN:0.5267,NFE:0.5272,OTH:0.5416,ASJ:0.3305	.	.	.	.	.	.	.	.	.	.	.	.	15	1(haematopoietic_and_lymphoid_tissue)	0.4949
15	57489962	57489962	C	T	TCF12	intronic	.	ENSG00000140262	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	0	0.036	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600480	615314;	35098;35099;	35098|Non-syndromic unicoronal synostosis<br>Synostotic plagiocephaly|-|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|123100 615314 616602 ~35099|Non-syndromic bicoronal synostosis|-|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|123100 615314 616602 ~	.	.	.	.	.	.	.	.	15	.	hom
15	67457335	67457335	A	G	SMAD3	exonic	synonymous SNV	ENSG00000166949	rs1065080	ENSG00000166949:ENST00000559092:exon2:c.A254G:p.Y85C	SMAD3:NM_001145103:exon2:c.A177G:p.L59L,SMAD3:NM_005902:exon2:c.A309G:p.L103L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8635	0.88	0.834065	0.8640	0.949	10.37	.	2.36	0.993	.	.	.	SMAD3:uc002aqj.3:exon2:c.A309G:p.L103L,SMAD3:uc010ujs.2:exon2:c.A177G:p.L59L	.	AFR:0.8614,AMR:0.9177,EAS:0.7472,FIN:0.8660,NFE:0.8754,OTH:0.8582,ASJ:0.8477	603109	613795;	284984;	284984|-|<1 / 1 000 000|Autosomal dominant|All ages|613795 ~	~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04659 Th17 cell differentiation~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	15	MU675295	hom
15	75664570	75664570	A	T	SIN3A	intronic	.	ENSG00000169375	rs4886696	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6939	0.4284	0.58726	0.6572	.	.	.	.	.	.	.	.	.	.	AFR:0.4607,AMR:0.7392,EAS:0.5546,FIN:0.7828,NFE:0.7481,OTH:0.6780,ASJ:0.6093	607776	613406;	94065;	94065|Del(15)(q24)<br>Monosomy 15q24|<1 / 1 000 000|Not applicable<br>or&nbsp;Unknown|Childhood|613406 ~	~ko04139 Mitophagy - yeast~ko04919 Thyroid hormone signaling pathway~ko05016 Huntington disease~ko05169 Epstein-Barr virus infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	15	MU677604	unknown
15	80450389	80450389	G	A	FAH	intronic	.	ENSG00000103876	rs1370275	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5141	0.4463	0.506789	0.4629	.	.	.	.	.	.	.	.	.	.	AFR:0.3137,AMR:0.4233,EAS:0.7553,FIN:0.4593,NFE:0.5188,OTH:0.4794,ASJ:0.5265	613871	276700;	882;	882|FAH deficiency<br>Fumarylacetoacetase deficiency<br>Fumarylacetoacetate hydrolase deficiency<br>Hepatorenal tyrosinemia<br>Tyrosinemia type I|Unknown|Autosomal recessive|All ages|276700 ~	.	.	.	.	.	.	.	.	15	MU20682033	hom
15	85186837	85186837	T	C	WDR73	exonic	nonsynonymous SNV	ENSG00000177082	rs72750868	ENSG00000177082:ENST00000434634:exon8:c.A1001G:p.D334G	WDR73:NM_032856:exon8:c.A1001G:p.D334G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0755	0.0645	0.0443291	0.0707	-0.032	2.292	0.531	2.11	0.470	.	.	Six-bladed beta-propeller, TolB-like|WD40-repeat-containing domain	WDR73:uc002bkw.2:exon8:c.A1001G:p.D334G	-1.084	AFR:0.0393,AMR:0.0513,EAS:0.0056,FIN:0.1094,NFE:0.0874,OTH:0.0736,ASJ:0.0993	616144	251300;	2065;	2065|Galloway syndrome<br>Microcephaly-hiatus hernia-nephrotic syndrome<br>Nephrosis-neuronal dysmigration syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|251300 ~	.	.	.	.	0.005	0.85	0.002	1.08	15	.	het
15	85186877	85186894	CTTGGCTCCGTGTTCCAT	-	WDR73	exonic	nonframeshift deletion	ENSG00000177082	rs11267906	ENSG00000177082:ENST00000434634:exon8:c.944_961del:p.315_321del	WDR73:NM_032856:exon8:c.944_961del:p.315_321del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1852	0.1324	0.158546	0.1668	.	.	.	.	.	.	.	.	WDR73:uc002bkw.2:exon8:c.944_961del:p.315_321del	.	AFR:0.1276,AMR:0.1038,EAS:0.1101,FIN:0.2208,NFE:0.1850,OTH:0.1906,ASJ:0.1689	616144	251300;	2065;	2065|Galloway syndrome<br>Microcephaly-hiatus hernia-nephrotic syndrome<br>Nephrosis-neuronal dysmigration syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|251300 ~	.	.	.	.	.	.	.	.	15	MU47803	het
15	85188994	85188994	T	C	WDR73	exonic	synonymous SNV	ENSG00000177082	rs2271432	ENSG00000177082:ENST00000434634:exon7:c.A591G:p.S197S	WDR73:NM_032856:exon7:c.A591G:p.S197S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8550	0.8788	0.895367	0.8747	.	.	.	.	.	.	.	.	AL357213:uc002bky.1:exon1:c.T486C:p.P162P,WDR73:uc002bkw.2:exon7:c.A591G:p.S197S	.	AFR:0.9672,AMR:0.9117,EAS:0.9407,FIN:0.7903,NFE:0.8342,OTH:0.8259,ASJ:0.8874	616144	251300;	2065;	2065|Galloway syndrome<br>Microcephaly-hiatus hernia-nephrotic syndrome<br>Nephrosis-neuronal dysmigration syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|251300 ~	.	.	.	.	.	.	.	.	15	MU4561231	hom
15	88679785	88679785	G	A	NTRK3	exonic	synonymous SNV	ENSG00000140538	rs1863480	ENSG00000140538:ENST00000540489:exon6:c.C678T:p.N226N,ENSG00000140538:ENST00000542733:exon6:c.C384T:p.N128N,ENSG00000140538:ENST00000557856:exon6:c.C678T:p.N226N,ENSG00000140538:ENST00000558676:exon6:c.C678T:p.N226N,ENSG00000140538:ENST00000317501:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000355254:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000357724:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000360948:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000394480:exon8:c.C678T:p.N226N	NTRK3:NM_001320134:exon6:c.C678T:p.N226N,NTRK3:NM_001320135:exon6:c.C384T:p.N128N,NTRK3:NM_001007156:exon8:c.C678T:p.N226N,NTRK3:NM_001012338:exon8:c.C678T:p.N226N,NTRK3:NM_001243101:exon8:c.C678T:p.N226N,NTRK3:NM_002530:exon8:c.C678T:p.N226N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9967	0.9958	0.998203	0.9971	.	.	.	.	.	.	.	.	NTRK3:uc002bmh.2:exon6:c.C678T:p.N226N,NTRK3:uc010bnh.1:exon6:c.C678T:p.N226N,NTRK3:uc010upl.1:exon6:c.C384T:p.N128N,NTRK3:uc002bme.2:exon8:c.C678T:p.N226N,NTRK3:uc002bmf.2:exon8:c.C678T:p.N226N,NTRK3:uc002bmg.3:exon8:c.C678T:p.N226N,NTRK3:uc021sua.1:exon8:c.C678T:p.N226N	.	AFR:0.9995,AMR:0.9988,EAS:1,FIN:0.9977,NFE:0.9951,OTH:0.9969,ASJ:0.9967	191316	.	.	.	~ko04722 Neurotrophin signaling pathway~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	15	MU4561260	hom
15	89804043	89804043	C	T	FANCI	exonic	nonsynonymous SNV	ENSG00000140525	rs17803620	ENSG00000140525:ENST00000300027:exon4:c.C257T:p.A86V,ENSG00000140525:ENST00000310775:exon4:c.C257T:p.A86V,ENSG00000140525:ENST00000447611:exon4:c.C257T:p.A86V,ENSG00000140525:ENST00000563250:exon4:c.C257T:p.A86V,ENSG00000140525:ENST00000565255:exon4:c.C257T:p.A86V,ENSG00000140525:ENST00000567891:exon4:c.C257T:p.A86V,ENSG00000140525:ENST00000564920:exon5:c.C257T:p.A86V,ENSG00000140525:ENST00000567996:exon6:c.C257T:p.A86V	FANCI:NM_001113378:exon4:c.C257T:p.A86V,FANCI:NM_018193:exon4:c.C257T:p.A86V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3569	0.2863	0.259784	1(large_intestine)	3.818	23.4	0.339	4.45	0.984	.	.	FANCI solenoid 1 domain	FANCI:uc002bnm.1:exon4:c.C257T:p.A86V,FANCI:uc010bnp.1:exon4:c.C257T:p.A86V,FANCI:uc002bno.3:exon6:c.C257T:p.A86V	-0.962	AFR:1(thyroid),AMR:MU152349,EAS:0.3184,FIN:0.0916,NFE:0.3365,OTH:0.3907,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.191	0.95	0.000	2.215	15	1(lung)	0.3213
15	89806710	89806710	C	T	FANCI	intronic	.	ENSG00000140525	rs1981623	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3820	0.3481	0.338858	1(breast)	.	.	.	.	.	.	.	.	.	.	AFR:MU731492,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.3333,FIN:0.3556,NFE:0.3940,OTH:0.3221,ASJ:0.3888	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	15	14(soft_tissue)	0.4573
15	89826496	89826496	C	T	FANCI	intronic	.	ENSG00000140525	rs9806604	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4173	0.4680	0.439297	MU731523	.	.	.	.	.	.	.	.	.	.	AFR:SKCA-BR|1|100|0.01,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.4804,EAS:0.3854,FIN:0.3742,NFE:0.3445,OTH:0.4857,ASJ:0.6261	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	15	1(haematopoietic_and_lymphoid_tissue)	0.4195
15	89836228	89836228	G	C	FANCI	exonic	nonsynonymous SNV	ENSG00000140525	rs2283432	ENSG00000140525:ENST00000300027:exon22:c.G2225C:p.C742S,ENSG00000140525:ENST00000310775:exon22:c.G2225C:p.C742S,ENSG00000140525:ENST00000447611:exon22:c.G2225C:p.C742S	FANCI:NM_001113378:exon22:c.G2225C:p.C742S,FANCI:NM_018193:exon22:c.G2225C:p.C742S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3623	0.2899	0.264976	14(soft_tissue)	1.945	15.87	0.498	4.89	0.995	.	.	FANCI helical domain 2	FANCI:uc002bnq.1:exon8:c.G464C:p.C155S,FANCI:uc002bnp.1:exon16:c.G1688C:p.C563S,FANCI:uc002bnm.1:exon22:c.G2225C:p.C742S,FANCI:uc010bnp.1:exon22:c.G2225C:p.C742S	-0.901	AFR:1(liver),AMR:1(breast),EAS:1(large_intestine),FIN:MU152359,NFE:LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,OTH:0.3209,ASJ:1(thyroid)	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.007	1.63	0.000	1.95	15	1(lung)	0.0924
15	89838236	89838236	G	A	FANCI	exonic	synonymous SNV	ENSG00000140525	rs7183618	ENSG00000140525:ENST00000310775:exon24:c.G2547A:p.K849K	FANCI:NM_001113378:exon24:c.G2547A:p.K849K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9593	0.9601	0.980831	0.9538	.	.	.	.	.	.	.	.	FANCI:uc002bnq.1:exon10:c.G786A:p.K262K,FANCI:uc010bnp.1:exon24:c.G2547A:p.K849K	.	AFR:0.9905,AMR:0.9821,EAS:1,FIN:0.8758,NFE:0.9457,OTH:0.9274,ASJ:0.9636	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	15	MU81967158	hom
15	89844688	89844688	A	C	FANCI	intronic	.	ENSG00000140525	rs2159081	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3944	0.3672	0.36262	1(liver)	.	.	.	.	.	.	.	.	.	.	AFR:1(breast),AMR:MU12715937,EAS:0.3999,FIN:0.3389,NFE:0.3612,OTH:0.3940,ASJ:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	15	1(lung)	0.3837
15	89858602	89858602	T	C	FANCI	exonic	synonymous SNV	ENSG00000140525	rs1138465	ENSG00000140525:ENST00000300027:exon36:c.T3726C:p.G1242G,ENSG00000140525:ENST00000310775:exon37:c.T3906C:p.G1302G	FANCI:NM_018193:exon36:c.T3726C:p.G1242G,FANCI:NM_001113378:exon37:c.T3906C:p.G1302G	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4123	0.4096	0.41234	MU152374	.	.	.	.	.	.	.	.	FANCI:uc002bnq.1:exon23:c.T2145C:p.G715G,FANCI:uc002bnp.1:exon30:c.T3186C:p.G1062G,FANCI:uc002bnm.1:exon36:c.T3726C:p.G1242G,FANCI:uc010bnp.1:exon37:c.T3906C:p.G1302G	.	AFR:COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.4372,EAS:0.3768,FIN:0.3933,NFE:0.4398,OTH:0.5040,ASJ:0.4436	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	15	1(large_intestine)	0.4220
15	89862341	89862341	A	G	POLG	intronic	.	ENSG00000140521	rs2302084	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3747	.	0.298123	COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	0.0001	0.136	.	.	.	AFR:0.3518,AMR:0.1837,EAS:0.3907,FIN:0.3249,NFE:0.4745,OTH:0.4197,ASJ:0.3477	174763	157640;203700;258450;607459;613662;	298;254881;70595;254886;726;254892;	298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~254881|MSCAE<br>Mitochondrial spinocerebellar ataxia with epilepsy<br>SCAE|-|Autosomal recessive|Adolescent<br>Childhood|607459 ~70595|SANDO|Unknown|Autosomal recessive|Adult|607459 ~254886|arPEO|-|Autosomal recessive|All ages|258450 617069 ~726|Alpers progressive sclerosing poliodystrophy<br>Alpers syndrome<br>Progressive neuronal degeneration of childhood with liver disease|<1 / 1 000 000|Autosomal recessive|Infancy<br>Childhood<br>Adolescent<br>Adult|203700 ~254892|adPEO|-|-|-|157640 609283 609286 610131 613077 ~	.	.	.	.	.	.	.	.	15	1(haematopoietic_and_lymphoid_tissue)	0.4092
15	91312388	91312388	C	A	BLM	exonic	nonsynonymous SNV	ENSG00000197299	.	ENSG00000197299:ENST00000355112:exon11:c.C2333A:p.S778Y,ENSG00000197299:ENST00000560509:exon11:c.C2333A:p.S778Y	BLM:NM_000057:exon11:c.C2333A:p.S778Y,BLM:NM_001287247:exon11:c.C2333A:p.S778Y,BLM:NM_001287248:exon11:c.C1208A:p.S403Y,BLM:NM_001287246:exon12:c.C2333A:p.S778Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	6.018	27.9	0.005	5.3	0.972	.	.	DEAD/DEAH box helicase domain|Helicase superfamily 1/2, ATP-binding domain|P-loop containing nucleoside triphosphate hydrolase	BLM:uc002bpr.3:exon11:c.C2333A:p.S778Y,BLM:uc010bnx.3:exon11:c.C2333A:p.S778Y,BLM:uc010uqi.2:exon11:c.C1208A:p.S403Y,BLM:uc010uqh.2:exon12:c.C2333A:p.S778Y	0.210	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604610	210900;	125;	125|BSyn|Unknown|Autosomal recessive|Neonatal<br>Antenatal|210900 ~	.	.	.	.	0.363	-1.13	0.584	1.585	15	.	hom
15	91428290	91428290	C	T	FES	exonic	synonymous SNV	ENSG00000182511	rs11539637	ENSG00000182511:ENST00000394300:exon1:c.C15T:p.S5S,ENSG00000182511:ENST00000444422:exon1:c.C15T:p.S5S,ENSG00000182511:ENST00000450438:exon1:c.C15T:p.S5S,ENSG00000182511:ENST00000328850:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000394302:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000414248:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000416779:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000443697:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000452243:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000464684:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000470152:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000559355:exon2:c.C15T:p.S5S	FES:NM_001143783:exon1:c.C15T:p.S5S,FES:NM_001143784:exon1:c.C15T:p.S5S,FES:NM_001143785:exon2:c.C15T:p.S5S,FES:NM_002005:exon2:c.C15T:p.S5S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5849	0.4937	0.58746	1(cervix)	.	.	.	.	.	.	.	.	FES:uc002bpx.3:exon1:c.C15T:p.S5S,FES:uc002bpy.3:exon1:c.C15T:p.S5S,FES:uc010bny.3:exon1:c.C15T:p.S5S,FES:uc002bpv.3:exon2:c.C15T:p.S5S,FES:uc010uqj.2:exon2:c.C15T:p.S5S,FES:uc010uqk.2:exon2:c.C15T:p.S5S	.	AFR:MU4326664,AMR:COCA-CN|5|321|0.0155763,EAS:0.4141,FIN:0.7416,NFE:0.5033,OTH:0.8063,ASJ:0.5301	190030	.	.	.	.	.	.	.	.	.	.	.	15	1(urinary_tract)	0.6337
15	91430436	91430436	T	C	FES	exonic	synonymous SNV	ENSG00000182511	rs2071383	ENSG00000182511:ENST00000394300:exon3:c.T330C:p.A110A,ENSG00000182511:ENST00000450438:exon3:c.T330C:p.A110A,ENSG00000182511:ENST00000394302:exon4:c.T330C:p.A110A,ENSG00000182511:ENST00000414248:exon4:c.T330C:p.A110A,ENSG00000182511:ENST00000444422:exon4:c.T504C:p.A168A,ENSG00000182511:ENST00000328850:exon5:c.T504C:p.A168A,ENSG00000182511:ENST00000464684:exon5:c.T504C:p.A168A,ENSG00000182511:ENST00000559355:exon5:c.T504C:p.A168A	FES:NM_001143783:exon3:c.T330C:p.A110A,FES:NM_001143784:exon4:c.T504C:p.A168A,FES:NM_001143785:exon4:c.T330C:p.A110A,FES:NM_002005:exon5:c.T504C:p.A168A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9608	0.9552	0.9377	0.9534	.	.	.	.	.	.	.	.	FES:uc002bpy.3:exon3:c.T330C:p.A110A,FES:uc010bny.3:exon3:c.T330C:p.A110A,FES:uc002bpx.3:exon4:c.T504C:p.A168A,FES:uc010uqj.2:exon4:c.T330C:p.A110A,FES:uc002bpv.3:exon5:c.T504C:p.A168A,FES:uc010uqk.2:exon5:c.T450C:p.A150A	.	AFR:0.9307,AMR:0.9821,EAS:0.8909,FIN:0.9533,NFE:0.9708,OTH:0.9664,ASJ:0.9603	190030	.	.	.	.	.	.	.	.	.	.	.	15	MU82136926	hom
15	93510603	93510603	A	G	CHD2	exonic	synonymous SNV	ENSG00000173575	rs4777755	ENSG00000173575:ENST00000394196:exon17:c.A2049G:p.E683E,ENSG00000173575:ENST00000557381:exon17:c.A2049G:p.E683E	CHD2:NM_001271:exon17:c.A2049G:p.E683E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8419	0.7656	0.826478	0.7708	.	.	.	.	.	.	.	.	CHD2:uc002bso.1:exon17:c.A2049G:p.E683E,CHD2:uc002bsp.3:exon17:c.A2049G:p.E683E	.	AFR:0.6178,AMR:0.9105,EAS:0.9981,FIN:0.7596,NFE:0.8233,OTH:0.8219,ASJ:0.9305	602119	615369;	1942;2382;	1942|Doose syndrome<br>EMAS<br>Epilepsy with myoclonic-astatic seizures<br>Epilepsy with myoclonic-atonic seizures<br>MAE<br>Myoclonic atonic epilepsy<br>Myoclonic-astatic epilepsy in early childhood|Unknown|Unknown|Childhood|615369 616421 ~2382|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Childhood|615369 616346 617113 ~	.	.	.	.	.	.	.	.	15	MU81967798	hom
15	93521604	93521604	A	G	CHD2	exonic	synonymous SNV	ENSG00000173575	rs11074121	ENSG00000173575:ENST00000557116:exon3:c.A258G:p.Q86Q,ENSG00000173575:ENST00000394196:exon21:c.A2718G:p.Q906Q,ENSG00000173575:ENST00000557381:exon21:c.A2718G:p.Q906Q	CHD2:NM_001271:exon21:c.A2718G:p.Q906Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8353	0.7477	0.809105	0.7534	.	.	.	.	.	.	.	.	CHD2:uc010bog.1:exon4:c.A539G:p.K180R	.	AFR:0.5632,AMR:0.9069,EAS:0.9981,FIN:0.7585,NFE:0.8202,OTH:0.8112,ASJ:0.9272	602119	615369;	1942;2382;	1942|Doose syndrome<br>EMAS<br>Epilepsy with myoclonic-astatic seizures<br>Epilepsy with myoclonic-atonic seizures<br>MAE<br>Myoclonic atonic epilepsy<br>Myoclonic-astatic epilepsy in early childhood|Unknown|Unknown|Childhood|615369 616421 ~2382|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Childhood|615369 616346 617113 ~	.	.	.	.	.	.	.	.	15	MU81967815	hom
15	93540328	93540328	G	A	CHD2	intronic	.	ENSG00000173575	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.0002	0.002	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602119	615369;	1942;2382;	1942|Doose syndrome<br>EMAS<br>Epilepsy with myoclonic-astatic seizures<br>Epilepsy with myoclonic-atonic seizures<br>MAE<br>Myoclonic atonic epilepsy<br>Myoclonic-astatic epilepsy in early childhood|Unknown|Unknown|Childhood|615369 616421 ~2382|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Childhood|615369 616346 617113 ~	.	.	.	.	.	.	.	.	15	.	hom
15	93567864	93567864	A	C	CHD2	exonic	synonymous SNV	ENSG00000173575	rs12906163	ENSG00000173575:ENST00000394196:exon39:c.A5416C:p.R1806R	CHD2:NM_001271:exon39:c.A5416C:p.R1806R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2946	0.3147	0.186502	0.2671	.	.	.	.	.	.	.	.	CHD2:uc002bsp.3:exon39:c.A5416C:p.R1806R	.	AFR:0.1384,AMR:0.2189,EAS:0.0784,FIN:0.2251,NFE:0.3686,OTH:0.3101,ASJ:0.4371	602119	615369;	1942;2382;	1942|Doose syndrome<br>EMAS<br>Epilepsy with myoclonic-astatic seizures<br>Epilepsy with myoclonic-atonic seizures<br>MAE<br>Myoclonic atonic epilepsy<br>Myoclonic-astatic epilepsy in early childhood|Unknown|Unknown|Childhood|615369 616421 ~2382|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Childhood|615369 616346 617113 ~	.	.	.	.	.	.	.	.	15	MU12726620	hom
15	99251356	99251356	C	T	IGF1R	intronic	.	ENSG00000140443	rs7174918	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2907	0.2642	0.233427	COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.2568,AMR:0.1319,EAS:0.3974,FIN:0.2311,NFE:0.2657,OTH:0.3260,ASJ:0.2356	147370	270450;	73273;	73273|Resistance to IGF-1|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|270450 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04510 Focal adhesion~ko04520 Adherens junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04730 Long-term depression~ko04913 Ovarian steroidogenesis~ko04914 Progesterone-mediated oocyte maturation~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma ~	.	.	.	.	.	.	.	15	9(soft_tissue)	0.2957
15	100218867	100218867	A	G	MEF2A	exonic	nonsynonymous SNV	ENSG00000068305	rs2581470	.	MEF2A:NM_001365210:exon8:c.A691G:p.K231E,MEF2A:NM_001365211:exon8:c.A685G:p.K229E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.630791	0.6681	.	.	.	.	.	.	.	.	.	.	AFR:0.3552,AMR:0.7045,EAS:0.7109,FIN:0.8311,NFE:0.7923,OTH:0.8143,ASJ:0.8510	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	MU12577973	hom
15	100246936	100246936	T	C	MEF2A	exonic	synonymous SNV	ENSG00000068305	rs325408	ENSG00000068305:ENST00000449277:exon7:c.T657C:p.N219N,ENSG00000068305:ENST00000453228:exon8:c.T861C:p.N287N,ENSG00000068305:ENST00000558812:exon8:c.T681C:p.N227N,ENSG00000068305:ENST00000354410:exon9:c.T867C:p.N289N,ENSG00000068305:ENST00000557785:exon9:c.T861C:p.N287N,ENSG00000068305:ENST00000338042:exon10:c.T888C:p.N296N,ENSG00000068305:ENST00000557942:exon10:c.T885C:p.N295N	MEF2A:NM_001130928:exon6:c.T657C:p.N219N,MEF2A:NM_001130926:exon8:c.T861C:p.N287N,MEF2A:NM_001130927:exon8:c.T681C:p.N227N,MEF2A:NM_001365206:exon8:c.T879C:p.N293N,MEF2A:NM_001365207:exon8:c.T867C:p.N289N,MEF2A:NM_001352616:exon9:c.T885C:p.N295N,MEF2A:NM_001352617:exon9:c.T867C:p.N289N,MEF2A:NM_001352618:exon9:c.T879C:p.N293N,MEF2A:NM_001365202:exon9:c.T903C:p.N301N,MEF2A:NM_001365204:exon9:c.T891C:p.N297N,MEF2A:NM_001365205:exon9:c.T885C:p.N295N,MEF2A:NM_001365208:exon9:c.T861C:p.N287N,MEF2A:NM_001365209:exon9:c.T681C:p.N227N,MEF2A:NM_005587:exon9:c.T867C:p.N289N,MEF2A:NM_001171894:exon10:c.T861C:p.N287N,MEF2A:NM_001319206:exon10:c.T885C:p.N295N,MEF2A:NM_001352614:exon10:c.T861C:p.N287N,MEF2A:NM_001365201:exon10:c.T903C:p.N301N,MEF2A:NM_001365203:exon10:c.T891C:p.N297N,MEF2A:NM_001352615:exon11:c.T861C:p.N287N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7471	0.6406	0.61242	0.6476	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon6:c.T657C:p.N219N,MEF2A:uc002bvi.3:exon8:c.T861C:p.N287N,MEF2A:uc010bos.3:exon8:c.T861C:p.N287N,MEF2A:uc010urv.2:exon8:c.T681C:p.N227N,MEF2A:uc002bvf.3:exon9:c.T867C:p.N289N,MEF2A:uc010urw.2:exon9:c.T891C:p.N297N,MEF2A:uc002bve.3:exon10:c.T885C:p.N295N,MEF2A:uc002bvg.3:exon10:c.T861C:p.N287N	.	AFR:0.2872,AMR:0.6974,EAS:0.7153,FIN:0.8232,NFE:0.7910,OTH:0.8086,ASJ:0.8477	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	MU700988	unknown
15	100246942	100246942	G	A	MEF2A	exonic	synonymous SNV	ENSG00000068305	rs325407	ENSG00000068305:ENST00000449277:exon7:c.G663A:p.Q221Q,ENSG00000068305:ENST00000453228:exon8:c.G867A:p.Q289Q,ENSG00000068305:ENST00000558812:exon8:c.G687A:p.Q229Q,ENSG00000068305:ENST00000354410:exon9:c.G873A:p.Q291Q,ENSG00000068305:ENST00000557785:exon9:c.G867A:p.Q289Q,ENSG00000068305:ENST00000338042:exon10:c.G894A:p.Q298Q,ENSG00000068305:ENST00000557942:exon10:c.G891A:p.Q297Q	MEF2A:NM_001130928:exon6:c.G663A:p.Q221Q,MEF2A:NM_001130926:exon8:c.G867A:p.Q289Q,MEF2A:NM_001130927:exon8:c.G687A:p.Q229Q,MEF2A:NM_001365206:exon8:c.G885A:p.Q295Q,MEF2A:NM_001365207:exon8:c.G873A:p.Q291Q,MEF2A:NM_001352616:exon9:c.G891A:p.Q297Q,MEF2A:NM_001352617:exon9:c.G873A:p.Q291Q,MEF2A:NM_001352618:exon9:c.G885A:p.Q295Q,MEF2A:NM_001365202:exon9:c.G909A:p.Q303Q,MEF2A:NM_001365204:exon9:c.G897A:p.Q299Q,MEF2A:NM_001365205:exon9:c.G891A:p.Q297Q,MEF2A:NM_001365208:exon9:c.G867A:p.Q289Q,MEF2A:NM_001365209:exon9:c.G687A:p.Q229Q,MEF2A:NM_005587:exon9:c.G873A:p.Q291Q,MEF2A:NM_001171894:exon10:c.G867A:p.Q289Q,MEF2A:NM_001319206:exon10:c.G891A:p.Q297Q,MEF2A:NM_001352614:exon10:c.G867A:p.Q289Q,MEF2A:NM_001365201:exon10:c.G909A:p.Q303Q,MEF2A:NM_001365203:exon10:c.G897A:p.Q299Q,MEF2A:NM_001352615:exon11:c.G867A:p.Q289Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9669	0.8850	0.886781	0.8929	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon6:c.G663A:p.Q221Q,MEF2A:uc002bvi.3:exon8:c.G867A:p.Q289Q,MEF2A:uc010bos.3:exon8:c.G867A:p.Q289Q,MEF2A:uc010urv.2:exon8:c.G687A:p.Q229Q,MEF2A:uc002bvf.3:exon9:c.G873A:p.Q291Q,MEF2A:uc010urw.2:exon9:c.G897A:p.Q299Q,MEF2A:uc002bve.3:exon10:c.G891A:p.Q297Q,MEF2A:uc002bvg.3:exon10:c.G867A:p.Q289Q	.	AFR:0.6237,AMR:0.9821,EAS:1,FIN:1,NFE:0.9985,OTH:0.9868,ASJ:1	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	MU81968211	unknown
15	100252710	100252715	CAGCAG	-	MEF2A	exonic	nonframeshift deletion	ENSG00000068305	rs3138597	ENSG00000068305:ENST00000449277:exon9:c.1024_1029del:p.342_343del,ENSG00000068305:ENST00000453228:exon10:c.1228_1233del:p.410_411del,ENSG00000068305:ENST00000558812:exon10:c.1048_1053del:p.350_351del,ENSG00000068305:ENST00000354410:exon11:c.1234_1239del:p.412_413del,ENSG00000068305:ENST00000557785:exon11:c.1228_1233del:p.410_411del,ENSG00000068305:ENST00000338042:exon12:c.1255_1260del:p.419_420del,ENSG00000068305:ENST00000557942:exon12:c.1252_1257del:p.418_419del	MEF2A:NM_001130928:exon8:c.1024_1029del:p.342_343del,MEF2A:NM_001130926:exon10:c.1228_1233del:p.410_411del,MEF2A:NM_001130927:exon10:c.1048_1053del:p.350_351del,MEF2A:NM_001365206:exon10:c.1246_1251del:p.416_417del,MEF2A:NM_001365207:exon10:c.1234_1239del:p.412_413del,MEF2A:NM_001352616:exon11:c.1252_1257del:p.418_419del,MEF2A:NM_001352617:exon11:c.1234_1239del:p.412_413del,MEF2A:NM_001352618:exon11:c.1246_1251del:p.416_417del,MEF2A:NM_001365202:exon11:c.1270_1275del:p.424_425del,MEF2A:NM_001365204:exon11:c.1258_1263del:p.420_421del,MEF2A:NM_001365205:exon11:c.1252_1257del:p.418_419del,MEF2A:NM_001365208:exon11:c.1228_1233del:p.410_411del,MEF2A:NM_001365209:exon11:c.1048_1053del:p.350_351del,MEF2A:NM_005587:exon11:c.1234_1239del:p.412_413del,MEF2A:NM_001171894:exon12:c.1228_1233del:p.410_411del,MEF2A:NM_001319206:exon12:c.1252_1257del:p.418_419del,MEF2A:NM_001352614:exon12:c.1228_1233del:p.410_411del,MEF2A:NM_001365201:exon12:c.1270_1275del:p.424_425del,MEF2A:NM_001365203:exon12:c.1258_1263del:p.420_421del,MEF2A:NM_001352615:exon13:c.1228_1233del:p.410_411del	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.2791	0.1623	.	0.2751	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon8:c.1024_1029del:p.342_343del,MEF2A:uc002bvi.3:exon10:c.1228_1233del:p.410_411del,MEF2A:uc010bos.3:exon10:c.1228_1233del:p.410_411del,MEF2A:uc010urv.2:exon10:c.1048_1053del:p.350_351del,MEF2A:uc002bvf.3:exon11:c.1234_1239del:p.412_413del,MEF2A:uc010urw.2:exon11:c.1258_1263del:p.420_421del,MEF2A:uc002bve.3:exon12:c.1252_1257del:p.418_419del,MEF2A:uc002bvg.3:exon12:c.1228_1233del:p.410_411del	.	AFR:0.0642,AMR:0.2845,EAS:0.3553,FIN:0.3896,NFE:0.3560,OTH:0.3650,ASJ:0.3221	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	.	hom
15	100252805	100252805	G	T	MEF2A	exonic	synonymous SNV	ENSG00000068305	rs325400	ENSG00000068305:ENST00000449277:exon9:c.G1119T:p.G373G,ENSG00000068305:ENST00000453228:exon10:c.G1323T:p.G441G,ENSG00000068305:ENST00000558812:exon10:c.G1143T:p.G381G,ENSG00000068305:ENST00000354410:exon11:c.G1329T:p.G443G,ENSG00000068305:ENST00000557785:exon11:c.G1323T:p.G441G,ENSG00000068305:ENST00000338042:exon12:c.G1350T:p.G450G,ENSG00000068305:ENST00000557942:exon12:c.G1347T:p.G449G	MEF2A:NM_001130928:exon8:c.G1119T:p.G373G,MEF2A:NM_001130926:exon10:c.G1323T:p.G441G,MEF2A:NM_001130927:exon10:c.G1143T:p.G381G,MEF2A:NM_001365206:exon10:c.G1341T:p.G447G,MEF2A:NM_001365207:exon10:c.G1329T:p.G443G,MEF2A:NM_001352616:exon11:c.G1347T:p.G449G,MEF2A:NM_001352617:exon11:c.G1329T:p.G443G,MEF2A:NM_001352618:exon11:c.G1341T:p.G447G,MEF2A:NM_001365202:exon11:c.G1365T:p.G455G,MEF2A:NM_001365204:exon11:c.G1353T:p.G451G,MEF2A:NM_001365205:exon11:c.G1347T:p.G449G,MEF2A:NM_001365208:exon11:c.G1323T:p.G441G,MEF2A:NM_001365209:exon11:c.G1143T:p.G381G,MEF2A:NM_005587:exon11:c.G1329T:p.G443G,MEF2A:NM_001171894:exon12:c.G1323T:p.G441G,MEF2A:NM_001319206:exon12:c.G1347T:p.G449G,MEF2A:NM_001352614:exon12:c.G1323T:p.G441G,MEF2A:NM_001365201:exon12:c.G1365T:p.G455G,MEF2A:NM_001365203:exon12:c.G1353T:p.G451G,MEF2A:NM_001352615:exon13:c.G1323T:p.G441G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4953	0.3889	0.349241	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon8:c.G1119T:p.G373G,MEF2A:uc002bvi.3:exon10:c.G1323T:p.G441G,MEF2A:uc010bos.3:exon10:c.G1323T:p.G441G,MEF2A:uc010urv.2:exon10:c.G1143T:p.G381G,MEF2A:uc002bvf.3:exon11:c.G1329T:p.G443G,MEF2A:uc010urw.2:exon11:c.G1353T:p.G451G,MEF2A:uc002bve.3:exon12:c.G1347T:p.G449G,MEF2A:uc002bvg.3:exon12:c.G1323T:p.G441G	.	AFR:0.4154,AMR:0.1778,EAS:0.5403,FIN:0.3194,NFE:0.5307,OTH:0.5236,ASJ:0.4916	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	1(lung)	0.5144
16	129277	129277	A	G	MPG	UTR5	.	ENSG00000103152	rs710080	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1977	0.2142	0.291134	0.2077	.	.	.	.	.	.	.	.	.	.	AFR:0.6642,AMR:0.1400,EAS:0.0927,FIN:0.0398,NFE:0.0107,OTH:0.0733,ASJ:0.0099	156565	.	.	.	.	.	.	.	.	.	.	.	16	MU80650107	hom
16	129654	129654	C	T	MPG	exonic	synonymous SNV	ENSG00000103152	rs710081	ENSG00000103152:ENST00000356432:exon2:c.C255T:p.F85F,ENSG00000103152:ENST00000397817:exon2:c.C219T:p.F73F,ENSG00000103152:ENST00000436333:exon2:c.C219T:p.F73F,ENSG00000103152:ENST00000219431:exon3:c.C270T:p.F90F	MPG:NM_001015052:exon2:c.C255T:p.F85F,MPG:NM_001015054:exon2:c.C219T:p.F73F,MPG:NM_002434:exon3:c.C270T:p.F90F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1658	0.1696	0.249401	MU583735	.	.	.	.	.	.	.	.	MPG:uc002cfm.4:exon2:c.C219T:p.F73F,MPG:uc002cfo.4:exon2:c.C255T:p.F85F,MPG:uc010bqp.3:exon2:c.C219T:p.F73F,MPG:uc002cfn.4:exon3:c.C270T:p.F90F	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.1708,EAS:0.1301,FIN:0.0033,NFE:0.0878,OTH:0.0323,ASJ:0.5416	156565	.	.	.	.	.	.	.	.	.	.	.	16	1(lung)	0.0095
16	348128	348128	G	A	AXIN1	exonic	nonsynonymous SNV	ENSG00000103126	rs748975424	ENSG00000103126:ENST00000262320:exon6:c.C1378T:p.R460W,ENSG00000103126:ENST00000354866:exon6:c.C1378T:p.R460W	AXIN1:NM_003502:exon6:c.C1378T:p.R460W,AXIN1:NM_181050:exon6:c.C1378T:p.R460W	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 1, 0] 	5.762e-05	.	.	6.469e-05	5.947	27.6	0.002	4.48	0.102	.	.	.	AXIN1:uc002cgp.2:exon6:c.C1378T:p.R460W,AXIN1:uc002cgq.2:exon6:c.C1378T:p.R460W	-0.493	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:6.679e-05,OTH:0,ASJ:0	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	1.0	0.1	0.261	2.215	16	.	hom
16	359953	359953	A	G	AXIN1	intronic	.	ENSG00000103126	rs2301522	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6387	0.7276	0.649161	0.6909	.	.	.	.	.	.	.	.	.	.	AFR:0.8845,AMR:0.5647,EAS:0.3653,FIN:0.6372,NFE:0.6400,OTH:0.6235,ASJ:0.5430	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU27447663	hom
16	396264	396264	A	G	AXIN1	exonic	synonymous SNV	ENSG00000103126	rs1805105	ENSG00000103126:ENST00000262320:exon2:c.T762C:p.D254D,ENSG00000103126:ENST00000354866:exon2:c.T762C:p.D254D	AXIN1:NM_003502:exon2:c.T762C:p.D254D,AXIN1:NM_181050:exon2:c.T762C:p.D254D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6218	0.7141	0.638978	0.6766	.	.	.	.	.	.	.	.	AXIN1:uc002cgp.2:exon2:c.T762C:p.D254D,AXIN1:uc002cgq.2:exon2:c.T762C:p.D254D	.	AFR:0.8682,AMR:0.4940,EAS:0.3050,FIN:0.6045,NFE:0.6388,OTH:0.6109,ASJ:0.5497	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU152642	het
16	2115518	2115518	A	C	TSC2	splicing	.	ENSG00000103197	.	.	.	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	3.060	22.4	.	5.56	0.130	1.0000	0.804	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	191092	606690;613254;	805;538;	805|Bourneville syndrome<br>Tuberous sclerosis|1-5 / 10 000|Autosomal dominant|All ages|191100 613254 ~538|LAM|1-9 / 1 000 000|Not applicable|Adult|606690 ~	~ko04072 Phospholipase D signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	16	.	hom
16	2162486	2162486	G	A	PKD1	intronic	.	ENSG00000261240	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.0001	0	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601313	173900;	.	.	.	.	.	.	.	.	.	.	16	.	hom
16	2164387	2164387	-	GCCACCAGGGCAGGGCAGACATTCTCAAAGCGGGCGCTGACACT	PKD1	exonic	frameshift insertion	ENSG00000008710	.	ENSG00000008710:ENST00000262304:exon11:c.2636_2637insAGTGTCAGCGCCCGCTTTGAGAATGTCTGCCCTGCCCTGGTGGC:p.A879fs,ENSG00000008710:ENST00000423118:exon11:c.2636_2637insAGTGTCAGCGCCCGCTTTGAGAATGTCTGCCCTGCCCTGGTGGC:p.A879fs	PKD1:NM_000296:exon11:c.2636_2637insAGTGTCAGCGCCCGCTTTGAGAATGTCTGCCCTGCCCTGGTGGC:p.A879fs,PKD1:NM_001009944:exon11:c.2636_2637insAGTGTCAGCGCCCGCTTTGAGAATGTCTGCCCTGCCCTGGTGGC:p.A879fs	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	PKD1:uc002cos.1:exon11:c.2636_2637insAGTGTCAGCGCCCGCTTTGAGAATGTCTGCCCTGCCCTGGTGGC:p.A879fs,PKD1:uc002cot.1:exon11:c.2636_2637insAGTGTCAGCGCCCGCTTTGAGAATGTCTGCCCTGCCCTGGTGGC:p.A879fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601313	173900;	.	.	.	.	.	.	.	.	.	.	16	.	hom
16	2167874	2167874	G	A	PKD1	exonic	synonymous SNV	ENSG00000008710	rs35842	ENSG00000008710:ENST00000568591:exon1:c.C87T:p.L29L,ENSG00000008710:ENST00000262304:exon5:c.C1119T:p.L373L,ENSG00000008710:ENST00000423118:exon5:c.C1119T:p.L373L	PKD1:NM_000296:exon5:c.C1119T:p.L373L,PKD1:NM_001009944:exon5:c.C1119T:p.L373L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9051	.	0.944289	.	.	.	.	.	.	.	.	.	PKD1:uc002cos.1:exon5:c.C1119T:p.L373L,PKD1:uc002cot.1:exon5:c.C1119T:p.L373L	.	AFR:0.8356,AMR:0.9129,EAS:0.7743,FIN:0.9515,NFE:0.8171,OTH:0.7820,ASJ:0.8883	601313	173900;	.	.	.	.	.	.	.	.	.	.	16	1(upper_aerodigestive_tract)	0.8191
16	3900637	3900637	C	T	CREBBP	exonic	synonymous SNV	ENSG00000005339	rs56388626	ENSG00000005339:ENST00000262367:exon2:c.G459A:p.P153P,ENSG00000005339:ENST00000382070:exon2:c.G459A:p.P153P	CREBBP:NM_001079846:exon2:c.G459A:p.P153P,CREBBP:NM_004380:exon2:c.G459A:p.P153P	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.0104	0.0065	0.00379393	0.0135	.	.	.	.	.	.	.	.	CREBBP:uc002cvv.3:exon2:c.G459A:p.P153P,CREBBP:uc002cvw.3:exon2:c.G459A:p.P153P	.	AFR:0.0023,AMR:0,EAS:0,FIN:0.0473,NFE:0.0138,OTH:0.0276,ASJ:0	600140	180849;	353277;783;	353277|-|-|-|-|180849 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	,2062	.	.	.	.	.	.	16	.	het
16	5122072	5122072	-	GTCT	ALG1	intronic	.	ENSG00000033011	rs112683515	ENSG00000033011:ENST00000591822:exon1:c.222_223insGTCT:p.R74fs	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.6041	0.5126	0.583466	0.5624	.	.	.	.	.	.	.	.	.	.	AFR:0.5416,AMR:0.4556,EAS:0.6941,FIN:0.5931,NFE:0.5623,OTH:0.5484,ASJ:0.4536	605907	608540;	79327;	79327|CDG syndrome type Ik<br>CDG-Ik<br>CDG1K<br>Carbohydrate deficient glycoprotein syndrome type Ik<br>Congenital disorder of glycosylation type 1k<br>Congenital disorder of glycosylation type Ik<br>Mannosyltransferase 1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|608540 ~	.	.	.	.	.	.	.	.	16	.	het
16	5132636	5132636	C	T	ALG1	exonic	synonymous SNV	ENSG00000033011	rs1047732	ENSG00000033011:ENST00000262374:exon11:c.C1149T:p.F383F,ENSG00000033011:ENST00000544428:exon11:c.C816T:p.F272F,ENSG00000033011:ENST00000588623:exon12:c.C816T:p.F272F	ALG1:NM_001330504:exon11:c.C816T:p.F272F,ALG1:NM_019109:exon11:c.C1149T:p.F383F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5243	0.4694	0.519768	0.5046	.	.	.	.	.	.	.	.	ALG1:uc002cym.3:exon11:c.C1149T:p.F383F,ALG1:uc010bue.3:exon11:c.C816T:p.F272F,ALG1:uc002cyj.3:exon12:c.C816T:p.F272F	.	AFR:0.4030,AMR:0.4400,EAS:0.6658,FIN:0.5702,NFE:0.5350,OTH:0.5204,ASJ:0.4404	605907	608540;	79327;	79327|CDG syndrome type Ik<br>CDG-Ik<br>CDG1K<br>Carbohydrate deficient glycoprotein syndrome type Ik<br>Congenital disorder of glycosylation type 1k<br>Congenital disorder of glycosylation type Ik<br>Mannosyltransferase 1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|608540 ~	.	.	.	.	.	.	.	.	16	MU62996	hom
16	10989374	10989374	C	T	CIITA	intronic	.	ENSG00000179583	rs11074937	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.949681	0.9548	.	.	.	.	.	.	.	.	.	.	AFR:0.8423,AMR:0.9893,EAS:0.9994,FIN:1,NFE:0.9994,OTH:0.9980,ASJ:0.9901	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	.	hom
16	11002904	11002904	G	A	CIITA	exonic	synonymous SNV	ENSG00000179583	rs2228238	ENSG00000179583:ENST00000381835:exon10:c.G924A:p.T308T,ENSG00000179583:ENST00000324288:exon12:c.G2676A:p.T892T	CIITA:NM_001286403:exon10:c.G924A:p.T308T,CIITA:NM_000246:exon12:c.G2676A:p.T892T,CIITA:NM_001286402:exon12:c.G2679A:p.T893T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6840	0.6347	0.663139	0.6606	.	.	.	.	.	.	.	.	CIITA:uc002dak.4:exon10:c.G924A:p.T308T,CIITA:uc002dai.4:exon12:c.G2676A:p.T892T,CIITA:uc002daj.4:exon12:c.G2679A:p.T893T	.	AFR:0.5082,AMR:0.5490,EAS:0.8681,FIN:0.7666,NFE:0.7023,OTH:0.7336,ASJ:0.7267	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	MU27455469	hom
16	11002927	11002927	A	G	CIITA	exonic	nonsynonymous SNV	ENSG00000179583	rs7197779	ENSG00000179583:ENST00000381835:exon10:c.A947G:p.Q316R,ENSG00000179583:ENST00000324288:exon12:c.A2699G:p.Q900R	CIITA:NM_001286403:exon10:c.A947G:p.Q316R,CIITA:NM_000246:exon12:c.A2699G:p.Q900R,CIITA:NM_001286402:exon12:c.A2702G:p.Q901R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9787	0.9199	0.928714	0.9325	-0.355	0.495	0.518	-0.248	0.010	.	.	.	CIITA:uc002dak.4:exon10:c.A947G:p.Q316R,CIITA:uc002dai.4:exon12:c.A2699G:p.Q900R,CIITA:uc002daj.4:exon12:c.A2702G:p.Q901R	-0.980	AFR:0.7626,AMR:0.9928,EAS:1,FIN:1,NFE:0.9994,OTH:0.9949,ASJ:1	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	0.001	-0.68	0.000	1.3	16	MU81973165	hom
16	11012695	11012695	C	T	CIITA	intronic	.	ENSG00000179583	rs8057835	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.375799	0.4303	.	.	.	.	.	.	.	.	.	.	AFR:0.5121,AMR:0.3103,EAS:0.2153,FIN:0.4694,NFE:0.4084,OTH:0.4112,ASJ:0.2483	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	MU26440559	hom
16	11012734	11012734	T	C	CIITA	intronic	.	ENSG00000179583	rs8062961	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.978435	0.9790	.	.	.	.	.	.	.	.	.	.	AFR:0.9259,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	.	hom
16	12060163	12060163	A	G	TNFRSF17	exonic	nonsynonymous SNV	ENSG00000048462	rs373496	ENSG00000048462:ENST00000053243:exon2:c.A242G:p.N81S	TNFRSF17:NM_001192:exon2:c.A242G:p.N81S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9792	0.9581	0.961262	0.9635	-2.420	0.001	1.0	-3.14	0.038	.	.	.	TNFRSF17:uc002dbv.3:exon2:c.A242G:p.N81S,TNFRSF17:uc010buy.3:exon2:c.A242G:p.N81S	-0.975	AFR:0.9007,AMR:0.9881,EAS:1,FIN:0.9917,NFE:0.9861,OTH:0.9868,ASJ:0.9901	109545	.	.	.	.	.	.	.	0.0	2.97	0.000	-0.345	16	MU81973453	hom
16	14041958	14041958	T	C	ERCC4	exonic	synonymous SNV	ENSG00000175595	rs1799801	ENSG00000175595:ENST00000311895:exon11:c.T2505C:p.S835S	ERCC4:NM_005236:exon11:c.T2505C:p.S835S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2723	0.2532	0.241214	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	ERCC4:uc010uyz.1:exon6:c.T1155C:p.S385S,ERCC4:uc002dce.2:exon11:c.T2505C:p.S835S	.	AFR:0.2433,AMR:0.1744,EAS:0.3245,FIN:0.2429,NFE:0.2291,OTH:0.2802,ASJ:0.2661	133520	278760;610965;615272;	84;220295;910;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	,4780	.	.	.	.	.	.	16	1(haematopoietic_and_lymphoid_tissue)	0.2984
16	15818141	15818141	A	C	MYH11	exonic	synonymous SNV	ENSG00000133392	rs2075511	ENSG00000133392:ENST00000300036:exon31:c.T4242G:p.A1414A,ENSG00000133392:ENST00000576790:exon31:c.T4242G:p.A1414A,ENSG00000133392:ENST00000396324:exon32:c.T4263G:p.A1421A,ENSG00000133392:ENST00000452625:exon32:c.T4263G:p.A1421A	MYH11:NM_002474:exon31:c.T4242G:p.A1414A,MYH11:NM_022844:exon31:c.T4242G:p.A1414A,MYH11:NM_001040113:exon32:c.T4263G:p.A1421A,MYH11:NM_001040114:exon32:c.T4263G:p.A1421A	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5009	0.4590	0.410144	MU15806372	.	.	.	.	.	.	.	.	MYH11:uc010bvh.3:exon3:c.T360G:p.A120A,MYH11:uc002ddw.3:exon31:c.T4242G:p.A1414A,MYH11:uc002ddy.3:exon31:c.T4242G:p.A1414A,MYH11:uc002ddv.3:exon32:c.T4263G:p.A1421A,MYH11:uc002ddx.3:exon32:c.T4263G:p.A1421A,MYH11:uc010bvg.3:exon32:c.T3738G:p.A1246A	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,AMR:0.4487,EAS:0.5800,FIN:0.6358,NFE:0.2938,OTH:0.5189,ASJ:0.3073	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	16	1(oesophagus)	0.5164
16	15865472	15865472	G	A	MYH11	exonic	synonymous SNV	ENSG00000133392	rs4781689	ENSG00000133392:ENST00000300036:exon9:c.C987T:p.T329T,ENSG00000133392:ENST00000576790:exon9:c.C987T:p.T329T,ENSG00000133392:ENST00000396324:exon10:c.C1008T:p.T336T,ENSG00000133392:ENST00000452625:exon10:c.C1008T:p.T336T	MYH11:NM_002474:exon9:c.C987T:p.T329T,MYH11:NM_022844:exon9:c.C987T:p.T329T,MYH11:NM_001040113:exon10:c.C1008T:p.T336T,MYH11:NM_001040114:exon10:c.C1008T:p.T336T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1026	0.0736	0.0573083	0.0868	.	.	.	.	.	.	.	.	MYH11:uc002dea.1:exon4:c.C105T:p.T35T,MYH11:uc002ddw.3:exon9:c.C987T:p.T329T,MYH11:uc002ddy.3:exon9:c.C987T:p.T329T,MYH11:uc002ddv.3:exon10:c.C1008T:p.T336T,MYH11:uc002ddx.3:exon10:c.C1008T:p.T336T,MYH11:uc010bvg.3:exon10:c.C483T:p.T161T	.	AFR:0.0190,AMR:0.1921,EAS:0.0019,FIN:0.1707,NFE:0.1099,OTH:0.0986,ASJ:0.0563	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	16	.	het
16	23646191	23646191	T	C	PALB2	exonic	nonsynonymous SNV	ENSG00000083093	rs152451	ENSG00000083093:ENST00000261584:exon4:c.A1676G:p.Q559R	PALB2:NM_024675:exon4:c.A1676G:p.Q559R	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.1176	0.1348	0.150759	0.1302	-2.181	0.001	1.0	-2.73	0.000	.	.	.	PALB2:uc002dlx.1:exon4:c.A1676G:p.Q559R	-0.980	AFR:0.2125,AMR:0.0885,EAS:0.1605,FIN:0.0960,NFE:0.0929,OTH:0.0978,ASJ:0.0662	610355	114480;610832;613348;	1333;84;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	8442,,8444,8443,8445	.	.	0.0	2.49	0.000	-0.41	16	MU24101773	hom
16	28621311	28621311	T	C	SULT1A1	UTR5	.	ENSG00000196502;ENSG00000196502	rs2077412	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6819	.	0.676518	MU25371586	.	.	.	.	.	.	.	.	SULT1A1:uc002dqn.3:exon3:c.A137G:p.N46S	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.7180,EAS:0.7653,FIN:0.7682,NFE:0.5227,OTH:0.7194,ASJ:0.7639	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	22(upper_aerodigestive_tract)	0.7106
16	31146780	31146780	C	T	PRSS8	exonic	nonsynonymous SNV	ENSG00000052344	.	ENSG00000052344:ENST00000317508:exon1:c.G40A:p.A14T,ENSG00000052344:ENST00000567531:exon1:c.G40A:p.A14T,ENSG00000052344:ENST00000567797:exon1:c.G40A:p.A14T,ENSG00000052344:ENST00000568261:exon1:c.G40A:p.A14T	PRSS8:NM_002773:exon1:c.G40A:p.A14T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	3.098	22.5	0.06	3.24	0.501	.	.	.	PRSS8:uc002ebc.4:exon1:c.G40A:p.A14T,PRSS8:uc010vfe.2:exon1:c.G40A:p.A14T,PRSS8:uc031qvu.1:exon1:c.G40A:p.A14T	-0.108	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600823	.	.	.	.	.	.	.	0.993	-2.36	0.738	1.845	16	.	hom
16	55523705	55523705	T	C	MMP2	exonic	synonymous SNV	ENSG00000087245	rs243849	ENSG00000087245:ENST00000219070:exon7:c.T1149C:p.D383D,ENSG00000087245:ENST00000437642:exon7:c.T999C:p.D333D,ENSG00000087245:ENST00000543485:exon7:c.T921C:p.D307D,ENSG00000087245:ENST00000570308:exon8:c.T921C:p.D307D	MMP2:NM_001127891:exon7:c.T999C:p.D333D,MMP2:NM_001302508:exon7:c.T921C:p.D307D,MMP2:NM_001302509:exon7:c.T921C:p.D307D,MMP2:NM_001302510:exon7:c.T921C:p.D307D,MMP2:NM_004530:exon7:c.T1149C:p.D383D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8378	0.7993	0.79992	0.8073	.	.	.	.	.	.	.	.	MMP2:uc002ehz.4:exon7:c.T1149C:p.D383D,MMP2:uc010ccc.3:exon7:c.T999C:p.D333D,MMP2:uc010vhd.2:exon7:c.T921C:p.D307D	.	AFR:0.7081,AMR:0.7955,EAS:0.7652,FIN:0.8688,NFE:0.8527,OTH:0.8476,ASJ:0.8278	120360	259600;	3460;371428;85196;	3460|Winchester syndrome|<1 / 1 000 000|-|Childhood|259600 277950 ~371428|MONA spectrum|Unknown|Autosomal recessive|Infancy<br>Childhood|259600 277950 ~85196|Multicentric osteolysis-nodulosis-arthropathy syndrome<br>NAO syndrome|-|-|-|259600 277950 ~	~ko01522 Endocrine resistance~ko04670 Leukocyte transendothelial migration~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	16	MU4562717	hom
16	55527113	55527113	G	A	MMP2	exonic	synonymous SNV	ENSG00000087245	rs2287074	ENSG00000087245:ENST00000570283:exon3:c.G255A:p.T85T,ENSG00000087245:ENST00000219070:exon9:c.G1380A:p.T460T,ENSG00000087245:ENST00000437642:exon9:c.G1230A:p.T410T,ENSG00000087245:ENST00000543485:exon9:c.G1152A:p.T384T,ENSG00000087245:ENST00000570308:exon10:c.G1152A:p.T384T	MMP2:NM_001127891:exon9:c.G1230A:p.T410T,MMP2:NM_001302508:exon9:c.G1152A:p.T384T,MMP2:NM_001302509:exon9:c.G1152A:p.T384T,MMP2:NM_001302510:exon9:c.G1152A:p.T384T,MMP2:NM_004530:exon9:c.G1380A:p.T460T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3927	0.3592	0.32488	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	MMP2:uc002ehz.4:exon9:c.G1380A:p.T460T,MMP2:uc010ccc.3:exon9:c.G1230A:p.T410T,MMP2:uc010vhd.2:exon9:c.G1152A:p.T384T	.	AFR:0.3610,AMR:0.2135,EAS:0.3411,FIN:0.2732,NFE:0.3788,OTH:0.4464,ASJ:0.4149	120360	259600;	3460;371428;85196;	3460|Winchester syndrome|<1 / 1 000 000|-|Childhood|259600 277950 ~371428|MONA spectrum|Unknown|Autosomal recessive|Infancy<br>Childhood|259600 277950 ~85196|Multicentric osteolysis-nodulosis-arthropathy syndrome<br>NAO syndrome|-|-|-|259600 277950 ~	~ko01522 Endocrine resistance~ko04670 Leukocyte transendothelial migration~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	16	1(large_intestine)	0.4115
16	55536687	55536687	A	G	MMP2	intronic	.	ENSG00000087245	rs243834	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4841	0.4432	0.48762	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:0.4569,AMR:0.3905,EAS:0.44,FIN:0.6386,NFE:0.5221,OTH:0.4596,ASJ:0.4519	120360	259600;	3460;371428;85196;	3460|Winchester syndrome|<1 / 1 000 000|-|Childhood|259600 277950 ~371428|MONA spectrum|Unknown|Autosomal recessive|Infancy<br>Childhood|259600 277950 ~85196|Multicentric osteolysis-nodulosis-arthropathy syndrome<br>NAO syndrome|-|-|-|259600 277950 ~	~ko01522 Endocrine resistance~ko04670 Leukocyte transendothelial migration~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	16	1(lung)	0.4836
16	56855496	56855496	C	G	NUP93	exonic	synonymous SNV	ENSG00000102900	rs2118017	ENSG00000102900:ENST00000563858:exon3:c.C24G:p.L8L,ENSG00000102900:ENST00000542526:exon5:c.C276G:p.L92L,ENSG00000102900:ENST00000564887:exon5:c.C276G:p.L92L,ENSG00000102900:ENST00000567641:exon5:c.C276G:p.L92L,ENSG00000102900:ENST00000569863:exon6:c.C276G:p.L92L,ENSG00000102900:ENST00000308159:exon7:c.C645G:p.L215L,ENSG00000102900:ENST00000569842:exon7:c.C645G:p.L215L	NUP93:NM_001242795:exon5:c.C276G:p.L92L,NUP93:NM_001242796:exon5:c.C276G:p.L92L,NUP93:NM_014669:exon7:c.C645G:p.L215L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8299	0.8329	0.875799	0.8261	.	.	.	.	.	.	.	.	NUP93:uc002ekb.3:exon5:c.C276G:p.L92L,NUP93:uc010vhi.2:exon5:c.C276G:p.L92L,NUP93:uc002eka.3:exon7:c.C645G:p.L215L	.	AFR:0.8848,AMR:0.8568,EAS:0.9137,FIN:0.7923,NFE:0.7896,OTH:0.8035,ASJ:0.8467	614351	616892;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	16	MU116544	hom
16	65016087	65016087	A	C	CDH11	exonic	nonsynonymous SNV	ENSG00000140937	rs35213	ENSG00000140937:ENST00000566827:exon7:c.T739G:p.S247A,ENSG00000140937:ENST00000268603:exon8:c.T1117G:p.S373A,ENSG00000140937:ENST00000394156:exon8:c.T1117G:p.S373A	CDH11:NM_001330576:exon7:c.T739G:p.S247A,CDH11:NM_001308392:exon8:c.T1117G:p.S373A,CDH11:NM_001797:exon8:c.T1117G:p.S373A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8043	0.6928	0.745407	0.7215	-0.605	0.122	0.716	1.34	0.089	.	.	Cadherin|Cadherin-like	CDH11:uc010vin.2:exon7:c.T739G:p.S247A,CDH11:uc002eoi.3:exon8:c.T1117G:p.S373A,CDH11:uc002eoj.3:exon8:c.T1117G:p.S373A	-0.969	AFR:0.4484,AMR:0.8213,EAS:0.9981,FIN:0.7975,NFE:0.8188,OTH:0.8184,ASJ:0.8046	600023	.	.	.	.	.	.	.	0.001	4.7	0.000	1.52	16	MU81978235	hom
16	65025658	65025658	T	C	CDH11	intronic	.	ENSG00000140937	rs35196	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9150	0.9021	0.926917	0.9068	.	.	.	.	.	.	.	.	.	.	AFR:0.8999,AMR:0.8998,EAS:1,FIN:0.8955,NFE:0.9033,OTH:0.9124,ASJ:0.9106	600023	.	.	.	.	.	.	.	.	.	.	.	16	MU81978243	hom
16	65025718	65025718	G	A	CDH11	exonic	nonsynonymous SNV	ENSG00000140937	rs35195	ENSG00000140937:ENST00000566827:exon5:c.C386T:p.T129M,ENSG00000140937:ENST00000268603:exon6:c.C764T:p.T255M,ENSG00000140937:ENST00000394156:exon6:c.C764T:p.T255M	CDH11:NM_001330576:exon5:c.C386T:p.T129M,CDH11:NM_001308392:exon6:c.C764T:p.T255M,CDH11:NM_001797:exon6:c.C764T:p.T255M	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0] 	0.2728	0.2601	0.18151	MU4562873	6.096	28.2	0.016	4.59	0.996	.	.	Cadherin|Cadherin-like	CDH11:uc010vin.2:exon5:c.C386T:p.T129M,CDH11:uc002eoi.3:exon6:c.C764T:p.T255M,CDH11:uc002eoj.3:exon6:c.C764T:p.T255M	-0.899	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.2473,EAS:0.2076,FIN:0.3742,NFE:0.2060,OTH:0.2440,ASJ:0.0691	600023	.	.	.	.	.	.	.	0.986	3.92	0.000	2.295	16	1(lung)	0.3518
16	65025849	65025849	A	G	CDH11	intronic	.	ENSG00000140937	rs35194	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9144	0.8999	0.925919	0.9052	.	.	.	.	.	0.0008	0.006	.	.	.	AFR:0.8951,AMR:0.8995,EAS:1,FIN:0.8955,NFE:0.9029,OTH:0.9121,ASJ:0.9106	600023	.	.	.	.	.	.	.	.	.	.	.	16	MU81978256	hom
16	68842480	68842480	G	C	CDH1	intronic	.	ENSG00000039068	rs33963999	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0383	0.0386	0.0179712	MU116719019	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,AMR:0.0406,EAS:0.0179,FIN:0.0464,NFE:0,OTH:0.0550,ASJ:0.0105	192090	114480;137215;167000;176807;608089;	1331;26106;227535;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko04015 Rap1 signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04514 Cell adhesion molecules (CAMs)~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05213 Endometrial cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	35(prostate)	0.0604
16	70287177	70287177	A	G	AARS	exonic	synonymous SNV	ENSG00000090861	rs4081753	ENSG00000090861:ENST00000261772:exon20:c.T2715C:p.V905V	AARS:NM_001605:exon20:c.T2715C:p.V905V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8241	0.8492	0.88119	0.8640	.	.	.	.	.	.	.	.	AARS:uc010vlu.1:exon16:c.T2253C:p.V751V,AARS:uc002eyn.1:exon20:c.T2715C:p.V905V	.	AFR:0.9664,AMR:0.8549,EAS:0.9697,FIN:0.8542,NFE:0.8008,OTH:0.8153,ASJ:0.7616	601065	613287;616339;	442835;228174;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~228174|CMT2N|<1 / 1 000 000|Autosomal dominant|All ages|613287 ~	.	.	.	.	.	.	.	.	16	MU4563135	hom
16	70303580	70303580	G	A	AARS	exonic	synonymous SNV	ENSG00000090861	rs2070203	ENSG00000090861:ENST00000261772:exon7:c.C903T:p.H301H	AARS:NM_001605:exon7:c.C903T:p.H301H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4659	0.4908	0.425319	MU29609616	.	.	.	.	.	.	.	.	AARS:uc010vlu.1:exon3:c.C393T:p.H131H,AARS:uc002eyn.1:exon7:c.C903T:p.H301H	.	AFR:LICA-CN|3|402|0.00746269,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.5054,EAS:0.4308,FIN:0.5563,NFE:0.4080,OTH:0.6069,ASJ:0.4641	601065	613287;616339;	442835;228174;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~228174|CMT2N|<1 / 1 000 000|Autosomal dominant|All ages|613287 ~	.	.	.	.	.	.	.	.	16	1(urinary_tract)	0.5190
16	72830539	72830539	C	G	ZFHX3	exonic	nonsynonymous SNV	ENSG00000140836	rs62051555	ENSG00000140836:ENST00000397992:exon8:c.G3300C:p.Q1100H,ENSG00000140836:ENST00000268489:exon9:c.G6042C:p.Q2014H	ZFHX3:NM_001164766:exon8:c.G3300C:p.Q1100H,ZFHX3:NM_006885:exon9:c.G6042C:p.Q2014H	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 1, 1, 0] 	0.0260	0.0288	0.014377	0.0347	2.360	18.56	0.041	4.79	0.932	.	.	Matrin/U1-C-like, C2H2-type zinc finger|Zinc finger C2H2-type	ZFHX3:uc002fcl.3:exon8:c.G3300C:p.Q1100H,ZFHX3:uc002fck.3:exon9:c.G6042C:p.Q2014H	-0.780	AFR:0.0072,AMR:0.0155,EAS:0,FIN:0.0717,NFE:0.0469,OTH:0.0428,ASJ:0.0033	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	0.947	-0.76	0.073	1.78	16	.	het
16	72831358	72831360	TTG	-	ZFHX3	exonic	nonframeshift deletion	ENSG00000140836	rs372909378	ENSG00000140836:ENST00000397992:exon8:c.2479_2481del:p.827_827del,ENSG00000140836:ENST00000268489:exon9:c.5221_5223del:p.1741_1741del	ZFHX3:NM_001164766:exon8:c.2479_2481del:p.827_827del,ZFHX3:NM_006885:exon9:c.5221_5223del:p.1741_1741del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0609	.	.	0.0013	.	.	.	.	.	.	.	.	ZFHX3:uc002fcl.3:exon8:c.2479_2481del:p.827_827del,ZFHX3:uc002fck.3:exon9:c.5221_5223del:p.1741_1741del	.	AFR:0.0030,AMR:0.0037,EAS:0.0019,FIN:0,NFE:0.0003,OTH:0.0031,ASJ:0	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	.	het
16	72832135	72832135	T	A	ZFHX3	exonic	synonymous SNV	ENSG00000140836	rs740178	ENSG00000140836:ENST00000397992:exon8:c.A1704T:p.A568A,ENSG00000140836:ENST00000268489:exon9:c.A4446T:p.A1482A	ZFHX3:NM_001164766:exon8:c.A1704T:p.A568A,ZFHX3:NM_006885:exon9:c.A4446T:p.A1482A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8362	0.8548	0.886182	0.8673	.	.	.	.	.	.	.	.	ZFHX3:uc002fcl.3:exon8:c.A1704T:p.A568A,ZFHX3:uc002fck.3:exon9:c.A4446T:p.A1482A	.	AFR:0.9647,AMR:0.8373,EAS:0.9710,FIN:0.8709,NFE:0.8043,OTH:0.8350,ASJ:0.7649	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	MU81979273	het
16	72832537	72832537	-	GGGGATGGTTTCAAATCTCCGCTTTGCTCTGTGCTTGC	ZFHX3	exonic	stopgain	ENSG00000140836	.	ENSG00000140836:ENST00000397992:exon8:c.1301_1302insGCAAGCACAGAGCAAAGCGGAGATTTGAAACCATCCCC:p.P434_A435delinsPQAQSKAEIX,ENSG00000140836:ENST00000268489:exon9:c.4043_4044insGCAAGCACAGAGCAAAGCGGAGATTTGAAACCATCCCC:p.P1348_A1349delinsPQAQSKAEIX	ZFHX3:NM_001164766:exon8:c.1301_1302insGCAAGCACAGAGCAAAGCGGAGATTTGAAACCATCCCC:p.P434_A435delinsPQAQSKAEIX,ZFHX3:NM_006885:exon9:c.4043_4044insGCAAGCACAGAGCAAAGCGGAGATTTGAAACCATCCCC:p.P1348_A1349delinsPQAQSKAEIX	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	ZFHX3:uc002fcl.3:exon8:c.1301_1302insGCAAGCACAGAGCAAAGCGGAGATTTGAAACCATCCCC:p.P434_A435delinsPQAQSKAEIX,ZFHX3:uc002fck.3:exon9:c.4043_4044insGCAAGCACAGAGCAAAGCGGAGATTTGAAACCATCCCC:p.P1348_A1349delinsPQAQSKAEIX	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	.	het
16	72992615	72992617	TCC	-	ZFHX3	exonic	nonframeshift deletion	ENSG00000140836	rs764428419	ENSG00000140836:ENST00000268489:exon2:c.1428_1430del:p.476_477del	ZFHX3:NM_006885:exon2:c.1428_1430del:p.476_477del	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	0.0002	.	.	9.714e-05	.	.	.	.	.	.	.	.	ZFHX3:uc002fck.3:exon2:c.1428_1430del:p.476_477del	.	AFR:0.0003,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	.	het
16	72993831	72993831	A	C	ZFHX3	exonic	nonsynonymous SNV	ENSG00000140836	rs7193297	ENSG00000140836:ENST00000268489:exon2:c.T214G:p.S72A	ZFHX3:NM_006885:exon2:c.T214G:p.S72A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4014	0.4739	0.470447	1(lung)	0.001	2.598	1.0	5.11	0.788	.	.	.	ZFHX3:uc002fck.3:exon2:c.T214G:p.S72A	-0.963	AFR:MU71249,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,EAS:0.7036,FIN:0.2542,NFE:0.4503,OTH:0.2667,ASJ:0.4903	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	0.006	-0.66	0.000	0.345	16	1(thyroid)	0.4885
16	78420775	78420775	G	A	WWOX	exonic	nonsynonymous SNV	ENSG00000186153	rs11545029	ENSG00000186153:ENST00000408984:exon6:c.G535A:p.A179T,ENSG00000186153:ENST00000566780:exon6:c.G535A:p.A179T	WWOX:NM_001291997:exon5:c.G196A:p.A66T,WWOX:NM_016373:exon6:c.G535A:p.A179T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4507	0.4593	0.263379	LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647	3.034	22.3	0.534	5.52	1.000	.	.	NAD(P)-binding domain	WWOX:uc010vnk.2:exon5:c.G196A:p.A66T,WWOX:uc002ffk.3:exon6:c.G535A:p.A179T	-0.928	AFR:0.4448,AMR:0.1962,EAS:0.5132,FIN:0.0525,NFE:0.5757,OTH:0.5974,ASJ:0.4117	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	0.098	-2.28	0.000	0.56	16	1(cervix)	0.5143
16	81819768	81819768	T	C	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1143685	ENSG00000197943:ENST00000359376:exon2:c.T174C:p.A58A,ENSG00000197943:ENST00000565054:exon3:c.T174C:p.A58A	PLCG2:NM_002661:exon2:c.T174C:p.A58A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7248	0.6680	0.733227	0.6846	.	.	.	.	.	.	.	.	PLCG2:uc010chg.1:exon1:c.T174C:p.A58A,PLCG2:uc002fgt.3:exon2:c.T174C:p.A58A	.	AFR:0.6496,AMR:0.7566,EAS:0.8813,FIN:0.7388,NFE:0.6671,OTH:0.6898,ASJ:0.6589	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU21476980	hom
16	81892708	81892708	T	A	PLCG2	intronic	.	ENSG00000197943	rs4888183	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5509	0.5570	0.541134	0.5554	.	.	.	.	.	.	.	.	.	.	AFR:0.5220,AMR:0.5490,EAS:0.6235,FIN:0.6192,NFE:0.5506,OTH:0.5703,ASJ:0.6258	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	16	MU19853130	hom
16	81953081	81953081	T	C	PLCG2	intronic	.	ENSG00000197943	rs12448130	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9969	0.9884	0.988618	0.9912	.	.	.	.	.	0	0	.	.	.	AFR:0.9698,AMR:0.9952,EAS:1,FIN:1,NFE:0.9997,OTH:1,ASJ:1	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	16	MU17469065	hom
16	81971403	81971403	T	C	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1071644	ENSG00000197943:ENST00000359376:exon28:c.T3093C:p.N1031N	PLCG2:NM_002661:exon28:c.T3093C:p.N1031N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4487	0.4056	0.313898	0.4023	.	.	.	.	.	.	.	.	PLCG2:uc002fgt.3:exon28:c.T3093C:p.N1031N	.	AFR:0.1394,AMR:0.3002,EAS:0.3775,FIN:0.5126,NFE:0.5296,OTH:0.4867,ASJ:0.5497	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU760686	hom
16	85948098	85948098	G	A	IRF8	exonic	synonymous SNV	ENSG00000140968	rs17444416	ENSG00000140968:ENST00000268638:exon6:c.G573A:p.G191G,ENSG00000140968:ENST00000564803:exon6:c.G573A:p.G191G	IRF8:NM_001363907:exon6:c.G603A:p.G201G,IRF8:NM_002163:exon6:c.G573A:p.G191G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0549	0.0442	0.0465256	0.0389	.	.	.	.	.	.	.	.	IRF8:uc002fjh.3:exon6:c.G573A:p.G191G	.	AFR:0.0107,AMR:0.0656,EAS:0.0635,FIN:0.0304,NFE:0.0526,OTH:0.0397,ASJ:0.0695	601565	614893;614894;	319600;	319600|MSMD due to partial IRF8 deficiency<br>MSMD due to partial interferon regulatory factor 8 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to partial interferon regulatory factor 8 deficiency|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614893 ~	.	.	.	.	.	.	.	.	16	MU772458	hom
16	88871908	88871908	A	G	CDT1	exonic	synonymous SNV	ENSG00000167513	rs1834065	ENSG00000167513:ENST00000301019:exon4:c.A549G:p.G183G	CDT1:NM_030928:exon4:c.A549G:p.G183G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0906	0.1527	0.136382	0.1215	.	.	.	.	.	.	.	.	CDT1:uc002flu.3:exon4:c.A549G:p.G183G	.	AFR:0.3051,AMR:0.0682,EAS:0.0025,FIN:0.0218,NFE:0.0572,OTH:0.0541,ASJ:0.1623	605525	613804;	2554;	2554|Meier-Gorlin syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Antenatal<br>Neonatal|224690 613800 613803 613804 613805 616835 617063 ~	.	.	.	.	.	.	.	.	16	MU113423981	hom
16	88945766	88945766	G	A	CBFA2T3	exonic	nonsynonymous SNV	ENSG00000129993	.	ENSG00000129993:ENST00000448839:exon9:c.C1346T:p.A449V,ENSG00000129993:ENST00000327483:exon10:c.C1316T:p.A439V,ENSG00000129993:ENST00000360302:exon10:c.C1316T:p.A439V,ENSG00000129993:ENST00000268679:exon11:c.C1574T:p.A525V,ENSG00000129993:ENST00000436887:exon11:c.C1460T:p.A487V	CBFA2T3:NM_175931:exon10:c.C1316T:p.A439V,CBFA2T3:NM_005187:exon11:c.C1574T:p.A525V	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 1, 0] 	.	.	.	.	3.909	23.5	0.018	4.7	0.961	.	.	NHR2-like	CBFA2T3:uc002fmk.2:exon2:c.C71T:p.A24V,CBFA2T3:uc002fml.2:exon10:c.C1316T:p.A439V,CBFA2T3:uc002fmm.2:exon11:c.C1574T:p.A525V	-0.447	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603870	.	.	.	.	.	.	.	0.977	0.96	0.264	2.36	16	.	hom
16	88945860	88945860	C	T	CBFA2T3	exonic	nonsynonymous SNV	ENSG00000129993	rs138801764	ENSG00000129993:ENST00000448839:exon9:c.G1252A:p.V418M,ENSG00000129993:ENST00000327483:exon10:c.G1222A:p.V408M,ENSG00000129993:ENST00000360302:exon10:c.G1222A:p.V408M,ENSG00000129993:ENST00000268679:exon11:c.G1480A:p.V494M,ENSG00000129993:ENST00000436887:exon11:c.G1366A:p.V456M	CBFA2T3:NM_175931:exon10:c.G1222A:p.V408M,CBFA2T3:NM_005187:exon11:c.G1480A:p.V494M	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 1, 1, 0] 	0.0002	7.7e-05	0.000599042	0.0004	5.918	27.5	0.021	3.75	0.947	.	.	NHR2-like	CBFA2T3:uc002fml.2:exon10:c.G1222A:p.V408M,CBFA2T3:uc002fmm.2:exon11:c.G1480A:p.V494M	-0.590	AFR:0,AMR:0,EAS:0,FIN:0.0026,NFE:0,OTH:0.0020,ASJ:0	603870	.	.	.	.	.	.	.	0.97	0.99	0.238	2.54	16	MU75289333	hom
16	89805977	89805977	G	A	ZNF276	UTR3	.	ENSG00000158805	rs1061646	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4098	0.3475	0.538139	0.4091	.	.	.	.	.	.	.	.	.	.	AFR:0.5340,AMR:0.5680,EAS:0.7338,FIN:0.3808,NFE:0.3033,OTH:0.4002,ASJ:0.2367	608460	.	.	.	.	.	.	.	.	.	.	.	16	MU67342665	hom
16	89836323	89836323	C	T	FANCA	exonic	nonsynonymous SNV	ENSG00000187741	rs7195066	ENSG00000187741:ENST00000567205:exon1:c.G110A:p.G37D,ENSG00000187741:ENST00000389301:exon26:c.G2426A:p.G809D,ENSG00000187741:ENST00000568369:exon26:c.G2426A:p.G809D	FANCA:NM_000135:exon26:c.G2426A:p.G809D,FANCA:NM_001286167:exon26:c.G2426A:p.G809D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.4690	0.4307	0.666733	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	0.068	3.273	0.528	-0.167	0.000	.	.	.	FANCA:uc002fou.1:exon26:c.G2426A:p.G809D,FANCA:uc010vpn.1:exon26:c.G2426A:p.G809D	-1.008	AFR:0.4758,AMR:0.6626,EAS:0.2583,FIN:0.9796,NFE:0.3961,OTH:0.3317,ASJ:0.5800	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	,4918	.	.	0.0	-1.85	0.000	-0.345	16	10(soft_tissue)	0.4488
16	89838078	89838078	A	G	FANCA	intronic	.	ENSG00000187741	rs1800340	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4315	0.3743	0.559904	0.4106	.	.	.	.	.	0	0	.	.	.	AFR:0.5094,AMR:0.5692,EAS:0.7345,FIN:0.3960,NFE:0.3151,OTH:0.4264,ASJ:0.2567	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU80655261	hom
16	89842143	89842143	A	T	FANCA	intronic	.	ENSG00000187741	rs377401016	.	.	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 1, 0] 	0.0002	7.7e-05	.	6.46e-05	.	.	.	.	.	0	0.004	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0001,OTH:0,ASJ:0	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	.	hom
16	89845194	89845194	A	G	FANCA	intronic	.	ENSG00000187741	rs1800337	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5115	0.4882	0.682508	0.5225	.	.	.	.	.	.	.	.	.	.	AFR:0.6752,AMR:0.6005,EAS:0.9790,FIN:0.4579,NFE:0.4010,OTH:0.4959,ASJ:0.3079	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU81983268	hom
16	89866043	89866043	T	C	FANCA	exonic	nonsynonymous SNV	ENSG00000187741	rs7190823	ENSG00000187741:ENST00000565582:exon7:c.A626G:p.H209R,ENSG00000187741:ENST00000543736:exon8:c.A700G:p.T234A,ENSG00000187741:ENST00000389301:exon9:c.A796G:p.T266A,ENSG00000187741:ENST00000389302:exon9:c.A796G:p.T266A,ENSG00000187741:ENST00000534992:exon9:c.A796G:p.T266A,ENSG00000187741:ENST00000563673:exon9:c.A796G:p.T266A,ENSG00000187741:ENST00000568369:exon9:c.A796G:p.T266A	FANCA:NM_001351830:exon8:c.A700G:p.T234A,FANCA:NM_000135:exon9:c.A796G:p.T266A,FANCA:NM_001018112:exon9:c.A796G:p.T266A,FANCA:NM_001286167:exon9:c.A796G:p.T266A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.5166	0.5060	0.690495	0.5344	-1.498	0.003	1.0	1.85	0.024	.	.	Fanconi anaemia group A protein, N-terminal domain	FANCA:uc010ciu.1:exon8:c.A700G:p.T234A,FANCA:uc002fou.1:exon9:c.A796G:p.T266A,FANCA:uc002fow.1:exon9:c.A796G:p.T266A,FANCA:uc002fox.1:exon9:c.A796G:p.T266A,FANCA:uc010vpn.1:exon9:c.A796G:p.T266A	-1.001	AFR:0.7087,AMR:0.6062,EAS:0.9802,FIN:0.4539,NFE:0.4064,OTH:0.5020,ASJ:0.3079	607139	227650;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	,4918	.	.	0.0	1.19	0.000	-2.125	16	MU81983326	hom
17	440316	440316	A	T	VPS53	exonic	nonsynonymous SNV	ENSG00000141252	.	ENSG00000141252:ENST00000401468:exon11:c.T1136A:p.L379Q,ENSG00000141252:ENST00000291074:exon17:c.T1880A:p.L627Q,ENSG00000141252:ENST00000437048:exon18:c.T1967A:p.L656Q,ENSG00000141252:ENST00000571805:exon18:c.T1967A:p.L656Q,ENSG00000141252:ENST00000446250:exon19:c.T1373A:p.L458Q	VPS53:NM_018289:exon17:c.T1880A:p.L627Q,VPS53:NM_001128159:exon18:c.T1967A:p.L656Q,VPS53:NM_001366253:exon18:c.T1967A:p.L656Q,VPS53:NM_001366254:exon19:c.T1373A:p.L458Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	6.131	28.4	0.001	5.75	0.998	.	.	.	VPS53:uc010cjp.1:exon11:c.T1136A:p.L379Q,VPS53:uc002frk.3:exon13:c.T524A:p.L175Q,VPS53:uc002frm.2:exon17:c.T1880A:p.L627Q,VPS53:uc002frn.2:exon18:c.T1967A:p.L656Q,VPS53:uc010cjo.2:exon18:c.T1967A:p.L656Q,VPS53:uc002fro.2:exon19:c.T1373A:p.L458Q	-0.010	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	615850	615851;	247198;	247198|PCCA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615851 ~	.	.	.	.	0.999	0.85	0.440	3.035	17	.	hom
17	465775	465775	G	A	VPS53	exonic	synonymous SNV	ENSG00000141252	rs2075443	ENSG00000141252:ENST00000401468:exon7:c.C693T:p.Y231Y,ENSG00000141252:ENST00000291074:exon13:c.C1437T:p.Y479Y,ENSG00000141252:ENST00000389040:exon13:c.C1380T:p.Y460Y,ENSG00000141252:ENST00000437048:exon14:c.C1524T:p.Y508Y,ENSG00000141252:ENST00000571805:exon14:c.C1524T:p.Y508Y,ENSG00000141252:ENST00000446250:exon15:c.C930T:p.Y310Y	VPS53:NM_018289:exon13:c.C1437T:p.Y479Y,VPS53:NM_001128159:exon14:c.C1524T:p.Y508Y,VPS53:NM_001366253:exon14:c.C1524T:p.Y508Y,VPS53:NM_001366254:exon15:c.C930T:p.Y310Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2784	0.3342	0.348642	LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	VPS53:uc010cjp.1:exon7:c.C693T:p.Y231Y,VPS53:uc002frk.3:exon9:c.C81T:p.Y27Y,VPS53:uc002frm.2:exon13:c.C1437T:p.Y479Y,VPS53:uc002frn.2:exon14:c.C1524T:p.Y508Y,VPS53:uc010cjo.2:exon14:c.C1524T:p.Y508Y,VPS53:uc002fro.2:exon15:c.C930T:p.Y310Y	.	AFR:0.3181,AMR:0.5503,EAS:0.1854,FIN:0.1925,NFE:0.1881,OTH:0.2281,ASJ:0.3947	615850	615851;	247198;	247198|PCCA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615851 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.2741
17	600735	600735	A	G	VPS53	intronic	.	ENSG00000141252	rs4968100	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1863	0.1881	0.221046	0.1878	.	.	.	.	.	0.0540	0.334	.	.	.	AFR:0.2585,AMR:0.2410,EAS:0.1897,FIN:0.1490,NFE:0.1537,OTH:0.1914,ASJ:0.1159	615850	615851;	247198;	247198|PCCA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615851 ~	.	.	.	.	.	.	.	.	17	MU22359478	hom
17	1733399	1733399	A	G	RPA1	exonic	synonymous SNV	ENSG00000132383	rs5030749	ENSG00000132383:ENST00000254719:exon1:c.A12G:p.Q4Q	RPA1:NM_001355121:exon1:c.A12G:p.Q4Q,RPA1:NM_002945:exon1:c.A12G:p.Q4Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7023	0.7446	0.544129	0.6919	.	.	.	.	.	.	.	.	RPA1:uc002fto.2:exon1:c.A12G:p.Q4Q	.	AFR:0.6418,AMR:0.4388,EAS:0.3939,FIN:0.6881,NFE:0.7698,OTH:0.6660,ASJ:0.6887	179835	.	.	.	.	.	.	.	.	.	.	.	17	MU153162	hom
17	2516934	2516934	T	C	PAFAH1B1	intronic	.	ENSG00000262480	rs9899704	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.259585	0.3114	.	.	.	.	.	.	.	.	.	.	AFR:0.3588,AMR:0.2399,EAS:0.1092,FIN:0.2709,NFE:0.3217,OTH:0.2719,ASJ:0.3079	601545	607432;	95232;99796;	95232|PAFAH1B1-related lissencephaly|-|-|-|607432 ~99796|Subcortical laminar heterotopia|-|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Unknown|-|300067 600348 607432 ~	.	.	.	.	.	.	.	.	17	MU30131808	hom
17	2517122	2517122	G	T	PAFAH1B1	intronic	.	ENSG00000262480	rs9897253	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.232428	0.2862	.	.	.	.	.	.	.	.	.	.	AFR:0.2715,AMR:0.2392,EAS:0.1092,FIN:0.2708,NFE:0.3210,OTH:0.2656,ASJ:0.3067	601545	607432;	95232;99796;	95232|PAFAH1B1-related lissencephaly|-|-|-|607432 ~99796|Subcortical laminar heterotopia|-|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Unknown|-|300067 600348 607432 ~	.	.	.	.	.	.	.	.	17	MU30131836	hom
17	4455500	4455500	T	C	MYBBP1A	exonic	synonymous SNV	ENSG00000132382	rs7206974	ENSG00000132382:ENST00000254718:exon7:c.A825G:p.A275A,ENSG00000132382:ENST00000381556:exon7:c.A825G:p.A275A	MYBBP1A:NM_001105538:exon7:c.A825G:p.A275A,MYBBP1A:NM_014520:exon7:c.A825G:p.A275A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9977	0.9906	0.992812	0.9914	.	.	.	.	.	.	.	.	MYBBP1A:uc002fxz.4:exon7:c.A825G:p.A275A,MYBBP1A:uc002fyb.4:exon7:c.A825G:p.A275A	.	AFR:0.9704,AMR:1,EAS:1,FIN:1,NFE:0.9997,OTH:0.9969,ASJ:1	604885	.	.	.	.	.	.	.	.	.	.	.	17	MU4564618	hom
17	5042894	5042894	T	C	USP6	exonic	nonsynonymous SNV	ENSG00000129204	rs8073787	ENSG00000129204:ENST00000250066:exon14:c.T1423C:p.W475R,ENSG00000129204:ENST00000572949:exon14:c.T1423C:p.W475R,ENSG00000129204:ENST00000304328:exon15:c.T472C:p.W158R,ENSG00000129204:ENST00000332776:exon22:c.T1423C:p.W475R,ENSG00000129204:ENST00000574788:exon22:c.T1423C:p.W475R	USP6:NM_004505:exon14:c.T1423C:p.W475R,USP6:NM_001304284:exon22:c.T1423C:p.W475R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6492	0.6377	0.77496	MU9249277	-0.312	0.625	0.067	-0.532	0.000	.	.	.	USP6:uc002gav.1:exon14:c.T1423C:p.W475R,USP6:uc010ckz.1:exon15:c.T472C:p.W158R,USP6:uc002gau.1:exon22:c.T1423C:p.W475R	-1.065	AFR:COCA-CN|5|321|0.0155763,AMR:0.6723,EAS:0.5791,FIN:0.5662,NFE:0.8974,OTH:0.6812,ASJ:0.8215	604334	.	.	.	.	.	.	.	0.003	3.11	0.000	0.69	17	1(salivary_gland)	0.5679
17	5058808	5058808	G	A	USP6	exonic	nonsynonymous SNV	ENSG00000129204	rs9899177	ENSG00000129204:ENST00000250066:exon23:c.G2735A:p.R912Q,ENSG00000129204:ENST00000304328:exon24:c.G1784A:p.R595Q,ENSG00000129204:ENST00000574788:exon31:c.G2735A:p.R912Q	USP6:NM_004505:exon23:c.G2735A:p.R912Q,USP6:NM_001304284:exon31:c.G2735A:p.R912Q	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 1, 0] 	0.5087	0.5202	0.337061	1(haematopoietic_and_lymphoid_tissue)	5.278	25.7	0.243	2.91	0.995	.	.	Peptidase C19, ubiquitin carboxyl-terminal hydrolase|Ubiquitin specific protease domain	USP6:uc002gav.1:exon23:c.G2735A:p.R912Q,USP6:uc010ckz.1:exon24:c.G1784A:p.R595Q,USP6:uc002gau.1:exon31:c.G2735A:p.R912Q	-1.109	AFR:MU81985839,AMR:LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.2714,FIN:0.5682,NFE:0.6033,OTH:0.1753,ASJ:0.4821	604334	.	.	.	.	.	.	.	0.996	2.99	0.000	2.01	17	1(bone)	0.4739
17	5066305	5066305	A	T	USP6	intronic	.	ENSG00000129204	rs2307138	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6994	0.7710	0.577276	MU4151119	.	.	.	.	.	0	0	.	.	.	AFR:LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,AMR:0.7478,EAS:0.6770,FIN:0.7947,NFE:0.3896,OTH:0.7708,ASJ:0.6973	604334	.	.	.	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.8131
17	7154534	7154534	G	A	CTDNEP1	exonic	synonymous SNV	ENSG00000175826	rs414206	ENSG00000175826:ENST00000570380:exon1:c.C82T:p.L28L,ENSG00000175826:ENST00000574205:exon1:c.C82T:p.L28L,ENSG00000175826:ENST00000574322:exon1:c.C82T:p.L28L,ENSG00000175826:ENST00000318988:exon2:c.C82T:p.L28L,ENSG00000175826:ENST00000571409:exon2:c.C82T:p.L28L,ENSG00000175826:ENST00000573600:exon2:c.C82T:p.L28L,ENSG00000175826:ENST00000575783:exon2:c.C82T:p.L28L	CTDNEP1:NM_001143775:exon1:c.C82T:p.L28L,CTDNEP1:NM_015343:exon2:c.C82T:p.L28L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6607	0.6938	0.701078	0.6985	.	.	.	.	.	.	.	.	CTDNEP1:uc002gfd.2:exon1:c.C82T:p.L28L,CTDNEP1:uc002gfe.2:exon2:c.C82T:p.L28L	.	AFR:0.8422,AMR:0.6017,EAS:0.6611,FIN:0.6675,NFE:0.6355,OTH:0.6478,ASJ:0.6589	610684	.	.	.	.	.	.	.	.	.	.	.	17	MU18201074	hom
17	7579472	7579472	G	C	TP53	exonic	nonsynonymous SNV	ENSG00000141510	rs1042522	ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R	TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R	clinvar: drug_response 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.6600	0.6300	0.542931	2(thyroid)	-0.415	0.355	0.262	1.87	0.001	.	.	.	TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R	-0.929	AFR:38(large_intestine),AMR:5(penis),EAS:15(bone),FIN:1(small_intestine),NFE:18(meninges),OTH:10(skin),ASJ:3(pancreas)	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04071 Sphingolipid signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04137 Mitophagy - animal~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04216 Ferroptosis~ko04218 Cellular senescence~ko04310 Wnt signaling pathway~ko04722 Neurotrophin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05016 Huntington disease~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05418 Fluid shear stress and atherosclerosis ~	,10109,10039,10169,10103,10166,10097,10115,10107,10191,10101,10127,10144,10139,10126,10089,10035,10114,10138,10043,10116,10112,10162,10098,10044,10136,10091,10134,10110,10036,10094,10099,10120,10172,10142,10121,10148,10189,10183,10178,10193,10130,10176,10088,10095,10174,10117,10188,10100,10149,10177,10124,10145,10141,10092,10041,10132,10105,10128,10135,10104,10108,10140,10194,10122,10125,10192,10131,10032,10182,10154,10118,10096,10190,10119,10042,10173,10133,10143,10040,10150,10037,10164,10137,10151,10113,10152,10123,10175,10180,10087,10093,10179,10181,10153,10106,10038,10102	.	,10161,10090,10160,10170,10168,10163,10159,10167,10111,10129,10147,10158,10171,10155,10156,10146,10157,10033,10165	0.0	-5.23	0.000	1.355	17	1(pleura)	1(endometrium)
17	7802454	7802454	A	C	CHD3	exonic	synonymous SNV	ENSG00000170004	rs11651304	ENSG00000170004:ENST00000330494:exon14:c.A2277C:p.L759L,ENSG00000170004:ENST00000358181:exon14:c.A2277C:p.L759L,ENSG00000170004:ENST00000380358:exon14:c.A2454C:p.L818L	CHD3:NM_001005271:exon14:c.A2454C:p.L818L,CHD3:NM_001005273:exon14:c.A2277C:p.L759L,CHD3:NM_005852:exon14:c.A2277C:p.L759L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0472	0.0314	0.0499201	0.0377	.	.	.	.	.	.	.	.	CHD3:uc002gjd.2:exon14:c.A2454C:p.L818L,CHD3:uc002gje.2:exon14:c.A2277C:p.L759L,CHD3:uc002gjf.2:exon14:c.A2277C:p.L759L	.	AFR:0.0089,AMR:0.1065,EAS:0.0457,FIN:0.0674,NFE:0.0415,OTH:0.0593,ASJ:0.0364	602120	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	7806333	7806333	C	G	CHD3	exonic	nonsynonymous SNV	ENSG00000170004	.	ENSG00000170004:ENST00000330494:exon22:c.C3449G:p.T1150S,ENSG00000170004:ENST00000358181:exon22:c.C3449G:p.T1150S,ENSG00000170004:ENST00000380358:exon22:c.C3626G:p.T1209S	CHD3:NM_001005271:exon22:c.C3626G:p.T1209S,CHD3:NM_001005273:exon22:c.C3449G:p.T1150S,CHD3:NM_005852:exon22:c.C3449G:p.T1150S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 2, 0, 0] 	.	.	.	.	6.053	28.0	0.001	4.57	0.999	.	.	Helicase, C-terminal|P-loop containing nucleoside triphosphate hydrolase	CHD3:uc002gjd.2:exon22:c.C3626G:p.T1209S,CHD3:uc002gje.2:exon22:c.C3449G:p.T1150S,CHD3:uc002gjf.2:exon22:c.C3449G:p.T1150S	1.000	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602120	.	.	.	.	.	.	.	0.996	-2.75	0.883	3.085	17	.	unknown
17	7806339	7806339	T	G	CHD3	exonic	nonsynonymous SNV	ENSG00000170004	rs75299897	ENSG00000170004:ENST00000330494:exon22:c.T3455G:p.I1152S,ENSG00000170004:ENST00000358181:exon22:c.T3455G:p.I1152S,ENSG00000170004:ENST00000380358:exon22:c.T3632G:p.I1211S	CHD3:NM_001005271:exon22:c.T3632G:p.I1211S,CHD3:NM_001005273:exon22:c.T3455G:p.I1152S,CHD3:NM_005852:exon22:c.T3455G:p.I1152S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 2, 0, 0] 	.	.	.	.	6.426	29.7	0.0	4.57	1.000	.	.	Helicase, C-terminal|P-loop containing nucleoside triphosphate hydrolase	CHD3:uc002gjd.2:exon22:c.T3632G:p.I1211S,CHD3:uc002gje.2:exon22:c.T3455G:p.I1152S,CHD3:uc002gjf.2:exon22:c.T3455G:p.I1152S	0.906	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602120	.	.	.	.	.	.	.	0.95	-1.63	0.802	4.605	17	.	unknown
17	7811998	7811998	T	C	CHD3	intronic	.	ENSG00000170004	rs4239111	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8852	0.8802	0.944888	0.9012	.	.	.	.	.	.	.	.	.	.	AFR:0.9727,AMR:0.9105,EAS:0.9988,FIN:0.8931,NFE:0.8527,OTH:0.8918,ASJ:0.8212	602120	.	.	.	.	.	.	.	.	.	.	.	17	MU81987243	hom
17	7982728	7982728	G	A	ALOX12B	exonic	nonsynonymous SNV	ENSG00000179477	.	ENSG00000179477:ENST00000319144:exon8:c.C1057T:p.P353S	ALOX12B:NM_001139:exon8:c.C1057T:p.P353S	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 2, 2, 0, 0] 	.	.	.	.	6.709	32	0.0	4.69	0.991	.	.	Lipoxygenase, C-terminal	ALOX12B:uc002gjy.1:exon8:c.C1057T:p.P353S	1.095	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603741	242100;	281122;79394;	281122|SHCB|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|242100 242300 606545 ~79394|CIE<br>Erythrodermic ichthyosis<br>Non-bullous congenital ichthyosiform erythroderma|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|242100 606545 612281 615022 615023 615024 ~	.	.	.	.	0.998	-4.51	0.967	3.46	17	MU30002381	hom
17	8046772	8046772	C	G	PER1	exonic	nonsynonymous SNV	ENSG00000179094	rs2585405	ENSG00000179094:ENST00000581082:exon18:c.G2815C:p.A939P,ENSG00000179094:ENST00000317276:exon19:c.G2884C:p.A962P	PER1:NM_002616:exon19:c.G2884C:p.A962P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8544	0.8592	0.771765	MU650358	0.259	5.289	0.581	3.22	0.001	.	.	.	PER1:uc002gkd.3:exon19:c.G2884C:p.A962P	-1.042	AFR:COCA-CN|4|321|0.0124611,AMR:0.8581,EAS:0.8091,FIN:0.7848,NFE:0.5131,OTH:0.9364,ASJ:0.8049	602260	.	.	.	.	.	.	.	0.0	2.59	0.000	-1.665	17	1(bone)	0.9092
17	8048283	8048283	G	A	PER1	exonic	synonymous SNV	ENSG00000179094	rs2735611	ENSG00000179094:ENST00000583559:exon2:c.C96T:p.G32G,ENSG00000179094:ENST00000581082:exon17:c.C2187T:p.G729G,ENSG00000179094:ENST00000317276:exon18:c.C2247T:p.G749G,ENSG00000179094:ENST00000354903:exon18:c.C2199T:p.G733G,ENSG00000179094:ENST00000582719:exon18:c.C2247T:p.G749G	PER1:NM_002616:exon18:c.C2247T:p.G749G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7253	0.7423	0.570487	MU657495	.	.	.	.	.	.	.	.	PER1:uc002gkd.3:exon18:c.C2247T:p.G749G,PER1:uc010vur.1:exon18:c.C2199T:p.G733G	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,AMR:0.7275,EAS:0.4582,FIN:0.6467,NFE:0.2966,OTH:0.8698,ASJ:0.5619	602260	.	.	.	.	.	.	.	.	.	.	.	17	2(thyroid)	0.8477
17	8051998	8051998	G	T	PER1	exonic	nonsynonymous SNV	ENSG00000179094	.	ENSG00000179094:ENST00000581082:exon7:c.C952A:p.L318M,ENSG00000179094:ENST00000317276:exon8:c.C1012A:p.L338M,ENSG00000179094:ENST00000354903:exon8:c.C964A:p.L322M,ENSG00000179094:ENST00000581395:exon8:c.C1012A:p.L338M,ENSG00000179094:ENST00000582719:exon8:c.C1012A:p.L338M	PER1:NM_002616:exon8:c.C1012A:p.L338M	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 1, 0] 	.	.	.	.	5.254	25.6	0.005	4.53	1.000	.	.	.	PER1:uc002gkd.3:exon8:c.C1012A:p.L338M,PER1:uc010vur.1:exon8:c.C964A:p.L322M	-0.296	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602260	.	.	.	.	.	.	.	1.0	1.69	0.338	2.545	17	.	hom
17	8053900	8053900	G	A	PER1	exonic	nonsynonymous SNV	ENSG00000179094	rs62063075	ENSG00000179094:ENST00000581082:exon1:c.C125T:p.A42V,ENSG00000179094:ENST00000317276:exon2:c.C125T:p.A42V,ENSG00000179094:ENST00000354903:exon2:c.C77T:p.A26V,ENSG00000179094:ENST00000577253:exon2:c.C125T:p.A42V,ENSG00000179094:ENST00000581395:exon2:c.C125T:p.A42V,ENSG00000179094:ENST00000581703:exon2:c.C125T:p.A42V,ENSG00000179094:ENST00000582719:exon2:c.C125T:p.A42V,ENSG00000179094:ENST00000584202:exon3:c.C125T:p.A42V	PER1:NM_002616:exon2:c.C125T:p.A42V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	1.309	12.32	0.174	4.86	0.911	.	.	.	PER1:uc010vus.1:exon1:c.C125T:p.A42V,PER1:uc002gkd.3:exon2:c.C125T:p.A42V,PER1:uc010vur.1:exon2:c.C77T:p.A26V	-0.863	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602260	.	.	.	.	.	.	.	0.95	2.61	0.128	0.41	17	.	hom
17	8053916	8053916	G	A	PER1	exonic	nonsynonymous SNV	ENSG00000179094	rs72845601	ENSG00000179094:ENST00000581082:exon1:c.C109T:p.P37S,ENSG00000179094:ENST00000317276:exon2:c.C109T:p.P37S,ENSG00000179094:ENST00000354903:exon2:c.C61T:p.P21S,ENSG00000179094:ENST00000577253:exon2:c.C109T:p.P37S,ENSG00000179094:ENST00000581395:exon2:c.C109T:p.P37S,ENSG00000179094:ENST00000581703:exon2:c.C109T:p.P37S,ENSG00000179094:ENST00000582719:exon2:c.C109T:p.P37S,ENSG00000179094:ENST00000584202:exon3:c.C109T:p.P37S	PER1:NM_002616:exon2:c.C109T:p.P37S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0] 	0.0110	0.0135	0.00539137	0.0092	1.954	15.92	0.005	4.33	0.986	.	.	.	PER1:uc010vus.1:exon1:c.C109T:p.P37S,PER1:uc002gkd.3:exon2:c.C109T:p.P37S,PER1:uc010vur.1:exon2:c.C61T:p.P21S	-0.934	AFR:0.0037,AMR:0.0072,EAS:0,FIN:0.0037,NFE:0.0147,OTH:0.0102,ASJ:0.0066	602260	.	.	.	.	.	.	.	0.999	2.61	0.053	0.55	17	.	hom
17	8108331	8108331	A	G	AURKB	exonic	nonsynonymous SNV	ENSG00000178999	rs1059476	ENSG00000178999:ENST00000534871:exon8:c.T770C:p.M257T,ENSG00000178999:ENST00000578549:exon8:c.T797C:p.M266T,ENSG00000178999:ENST00000316199:exon9:c.T896C:p.M299T,ENSG00000178999:ENST00000585124:exon9:c.T893C:p.M298T	AURKB:NM_001313955:exon7:c.T389C:p.M130T,AURKB:NM_001256834:exon8:c.T770C:p.M257T,AURKB:NM_001313952:exon8:c.T773C:p.M258T,AURKB:NM_001284526:exon9:c.T896C:p.M299T,AURKB:NM_001313950:exon9:c.T893C:p.M298T,AURKB:NM_001313951:exon9:c.T770C:p.M257T,AURKB:NM_001313953:exon9:c.T797C:p.M266T,AURKB:NM_001313954:exon9:c.T437C:p.M146T,AURKB:NM_004217:exon9:c.T893C:p.M298T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8306	0.8219	0.736022	MU656579	-1.014	0.015	0.39	-1.93	0.312	.	.	Protein kinase domain|Protein kinase-like domain	AURKB:uc010cnu.3:exon7:c.T353C:p.M118T,AURKB:uc010vuu.3:exon8:c.T770C:p.M257T,AURKB:uc021tpy.1:exon8:c.T797C:p.M266T,AURKB:uc002gkm.4:exon9:c.T893C:p.M298T,AURKB:uc002gkn.4:exon9:c.T896C:p.M299T	-0.992	AFR:LAML-KR|4|205|0.0195122,COCA-CN|4|321|0.0124611,AMR:0.8160,EAS:0.7728,FIN:0.76,NFE:0.5252,OTH:0.9068,ASJ:0.6942	604970	.	.	.	.	.	.	.	0.0	-0.07	0.000	-0.44	17	33(lung)	0.8955
17	8108339	8108339	G	A	AURKB	exonic	synonymous SNV	ENSG00000178999	rs2241909	ENSG00000178999:ENST00000534871:exon8:c.C762T:p.S254S,ENSG00000178999:ENST00000578549:exon8:c.C789T:p.S263S,ENSG00000178999:ENST00000316199:exon9:c.C888T:p.S296S,ENSG00000178999:ENST00000585124:exon9:c.C885T:p.S295S	AURKB:NM_001313955:exon7:c.C381T:p.S127S,AURKB:NM_001256834:exon8:c.C762T:p.S254S,AURKB:NM_001313952:exon8:c.C765T:p.S255S,AURKB:NM_001284526:exon9:c.C888T:p.S296S,AURKB:NM_001313950:exon9:c.C885T:p.S295S,AURKB:NM_001313951:exon9:c.C762T:p.S254S,AURKB:NM_001313953:exon9:c.C789T:p.S263S,AURKB:NM_001313954:exon9:c.C429T:p.S143S,AURKB:NM_004217:exon9:c.C885T:p.S295S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6547	0.6183	0.620807	2(thyroid)	.	.	.	.	.	.	.	.	AURKB:uc010cnu.3:exon7:c.C345T:p.S115S,AURKB:uc010vuu.3:exon8:c.C762T:p.S254S,AURKB:uc021tpy.1:exon8:c.C789T:p.S263S,AURKB:uc002gkm.4:exon9:c.C885T:p.S295S,AURKB:uc002gkn.4:exon9:c.C888T:p.S296S	.	AFR:MU773382,AMR:LAML-KR|4|205|0.0195122,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.5578,FIN:0.6719,NFE:0.5403,OTH:0.4729,ASJ:0.6398	604970	.	.	.	.	.	.	.	.	.	.	.	17	1(breast)	0.7446
17	8416901	8416901	C	T	MYH10	exonic	synonymous SNV	ENSG00000133026	rs11374	ENSG00000133026:ENST00000269243:exon21:c.G2607A:p.T869T,ENSG00000133026:ENST00000379980:exon22:c.G2655A:p.T885T,ENSG00000133026:ENST00000396239:exon22:c.G2670A:p.T890T,ENSG00000133026:ENST00000360416:exon23:c.G2700A:p.T900T	MYH10:NM_005964:exon21:c.G2607A:p.T869T,MYH10:NM_001256095:exon22:c.G2634A:p.T878T,MYH10:NM_001256012:exon23:c.G2700A:p.T900T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4031	0.3832	0.423323	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	MYH10:uc002gll.4:exon21:c.G2607A:p.T869T,MYH10:uc010cnx.4:exon22:c.G2634A:p.T878T,MYH10:uc002glm.4:exon23:c.G2700A:p.T900T	.	AFR:MU12983113,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.3787,FIN:0.3612,NFE:0.2933,OTH:0.4969,ASJ:0.4027	160776	.	.	.	.	.	.	.	.	.	.	.	17	1(prostate)	0.4441
17	8424270	8424270	G	A	MYH10	exonic	synonymous SNV	ENSG00000133026	rs8067456	ENSG00000133026:ENST00000269243:exon17:c.C2106T:p.N702N,ENSG00000133026:ENST00000379980:exon18:c.C2154T:p.N718N,ENSG00000133026:ENST00000396239:exon18:c.C2169T:p.N723N,ENSG00000133026:ENST00000360416:exon19:c.C2199T:p.N733N	MYH10:NM_005964:exon17:c.C2106T:p.N702N,MYH10:NM_001256095:exon18:c.C2133T:p.N711N,MYH10:NM_001256012:exon19:c.C2199T:p.N733N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9923	0.9700	0.979433	0.9765	.	.	.	.	.	.	.	.	MYH10:uc002gll.4:exon17:c.C2106T:p.N702N,MYH10:uc010cnx.4:exon18:c.C2133T:p.N711N,MYH10:uc002glm.4:exon19:c.C2199T:p.N733N	.	AFR:0.9179,AMR:0.9964,EAS:1,FIN:1,NFE:0.9997,OTH:0.9969,ASJ:1	160776	.	.	.	.	.	.	.	.	.	.	.	17	MU81987554	hom
17	9846521	9846521	G	C	GAS7	exonic	synonymous SNV	ENSG00000007237	rs17339499	ENSG00000007237:ENST00000580865:exon3:c.C228G:p.T76T,ENSG00000007237:ENST00000579158:exon6:c.C456G:p.T152T,ENSG00000007237:ENST00000432992:exon7:c.C648G:p.T216T,ENSG00000007237:ENST00000437099:exon7:c.C456G:p.T152T,ENSG00000007237:ENST00000542249:exon7:c.C456G:p.T152T,ENSG00000007237:ENST00000585266:exon7:c.C468G:p.T156T,ENSG00000007237:ENST00000323816:exon8:c.C468G:p.T156T,ENSG00000007237:ENST00000584146:exon8:c.C456G:p.T152T	GAS7:NM_003644:exon3:c.C228G:p.T76T,GAS7:NM_001130831:exon7:c.C456G:p.T152T,GAS7:NM_201432:exon7:c.C468G:p.T156T,GAS7:NM_201433:exon7:c.C648G:p.T216T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1955	0.2059	0.138179	.	.	.	.	.	.	.	.	.	GAS7:uc002gmh.1:exon3:c.C228G:p.T76T,GAS7:uc010vvc.1:exon3:c.C90G:p.T30T,GAS7:uc010vvd.1:exon6:c.C504G:p.T168T,GAS7:uc002gmg.1:exon7:c.C648G:p.T216T,GAS7:uc002gmi.2:exon7:c.C456G:p.T152T,GAS7:uc002gmj.1:exon7:c.C468G:p.T156T,GAS7:uc010coh.1:exon8:c.C468G:p.T156T	.	AFR:0.1972,AMR:0.1577,EAS:0.1755,FIN:0.0037,NFE:0.2378,OTH:0.2310,ASJ:0.1969	603127	.	.	.	.	.	.	.	.	.	.	.	17	1(bone)	0.2153
17	10415840	10415840	A	G	MYH1	exonic	synonymous SNV	ENSG00000109061	rs2007027	ENSG00000109061:ENST00000226207:exon12:c.T1032C:p.F344F	MYH1:NM_005963:exon12:c.T1032C:p.F344F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9288	0.8759	0.88139	0.8945	.	.	.	.	.	.	.	.	MYH1:uc002gmo.3:exon12:c.T1032C:p.F344F	.	AFR:0.7410,AMR:0.9436,EAS:0.9988,FIN:0.9805,NFE:0.9471,OTH:0.9318,ASJ:0.9040	160730	.	.	.	.	.	.	.	.	.	.	.	17	MU81988040	het
17	17948475	17948475	G	A	GID4	exonic	synonymous SNV	ENSG00000141034	rs2955355	ENSG00000141034:ENST00000268719:exon2:c.G453A:p.G151G,ENSG00000141034:ENST00000376345:exon2:c.G453A:p.G151G	GID4:NM_024052:exon2:c.G453A:p.G151G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5233	0.5973	0.366014	1(thyroid)	.	.	.	.	.	.	.	.	GID4:uc002gsg.1:exon2:c.G453A:p.G151G	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:1(lung),EAS:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,FIN:0.5574,NFE:0.4664,OTH:0.4199,ASJ:MU4563810	.	.	.	.	.	.	.	.	.	.	.	.	17	1(salivary_gland)	0.5728
17	17960011	17960011	C	T	GID4	intronic	.	ENSG00000141034	rs16960835	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2409	.	0.142173	0.0923	.	.	.	.	.	0.0013	0.066	.	.	.	AFR:0.0215,AMR:0.0764,EAS:0.0933,FIN:0.1265,NFE:0.1243,OTH:0.1191,ASJ:0.1060	.	.	.	.	.	.	.	.	.	.	.	.	17	MU19061387	hom
17	20107773	20107773	T	C	SPECC1	exonic	synonymous SNV	ENSG00000128487	rs2703805	ENSG00000128487:ENST00000395522:exon2:c.T168C:p.S56S,ENSG00000128487:ENST00000395525:exon2:c.T168C:p.S56S,ENSG00000128487:ENST00000395530:exon2:c.T168C:p.S56S,ENSG00000128487:ENST00000261503:exon4:c.T411C:p.S137S,ENSG00000128487:ENST00000395527:exon4:c.T411C:p.S137S,ENSG00000128487:ENST00000395529:exon4:c.T411C:p.S137S	SPECC1:NM_001033554:exon2:c.T168C:p.S56S,SPECC1:NM_001033555:exon2:c.T168C:p.S56S,SPECC1:NM_001243438:exon2:c.T168C:p.S56S,SPECC1:NM_001033553:exon4:c.T411C:p.S137S,SPECC1:NM_001243439:exon4:c.T411C:p.S137S,SPECC1:NM_152904:exon4:c.T411C:p.S137S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4782	0.3982	0.539936	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SPECC1:uc002gwt.3:exon2:c.T168C:p.S56S,SPECC1:uc002gwu.3:exon2:c.T168C:p.S56S,SPECC1:uc002gwv.3:exon2:c.T168C:p.S56S,SPECC1:uc002gwq.3:exon4:c.T411C:p.S137S,SPECC1:uc002gwr.3:exon4:c.T411C:p.S137S,SPECC1:uc002gws.3:exon4:c.T411C:p.S137S,SPECC1:uc010cqx.3:exon4:c.T411C:p.S137S	.	AFR:0.4545,AMR:0.4073,EAS:0.4305,FIN:0.8220,NFE:0.5049,OTH:0.4264,ASJ:0.4964	608793	.	.	.	.	.	.	.	.	.	.	.	17	2(urinary_tract)	0.4867
17	20109189	20109189	C	T	SPECC1	exonic	synonymous SNV	ENSG00000128487	rs2703807	ENSG00000128487:ENST00000584527:exon1:c.C81T:p.N27N,ENSG00000128487:ENST00000395522:exon2:c.C1584T:p.N528N,ENSG00000128487:ENST00000395525:exon2:c.C1584T:p.N528N,ENSG00000128487:ENST00000395530:exon2:c.C1584T:p.N528N,ENSG00000128487:ENST00000261503:exon4:c.C1827T:p.N609N,ENSG00000128487:ENST00000395527:exon4:c.C1827T:p.N609N,ENSG00000128487:ENST00000395529:exon4:c.C1827T:p.N609N	SPECC1:NM_001033554:exon2:c.C1584T:p.N528N,SPECC1:NM_001033555:exon2:c.C1584T:p.N528N,SPECC1:NM_001243438:exon2:c.C1584T:p.N528N,SPECC1:NM_001033553:exon4:c.C1827T:p.N609N,SPECC1:NM_001243439:exon4:c.C1827T:p.N609N,SPECC1:NM_152904:exon4:c.C1827T:p.N609N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4747	0.3805	0.522764	PACA-CA|1|268|0.00373134,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SPECC1:uc002gwt.3:exon2:c.C1584T:p.N528N,SPECC1:uc002gwu.3:exon2:c.C1584T:p.N528N,SPECC1:uc002gwv.3:exon2:c.C1584T:p.N528N,SPECC1:uc002gwq.3:exon4:c.C1827T:p.N609N,SPECC1:uc002gwr.3:exon4:c.C1827T:p.N609N,SPECC1:uc002gws.3:exon4:c.C1827T:p.N609N,SPECC1:uc010cqx.3:exon4:c.C1827T:p.N609N	.	AFR:0.4403,AMR:0.3638,EAS:0.4305,FIN:0.8201,NFE:0.5006,OTH:0.4247,ASJ:0.4905	608793	.	.	.	.	.	.	.	.	.	.	.	17	2(haematopoietic_and_lymphoid_tissue)	0.4786
17	30321567	30321567	T	G	SUZ12	intronic	.	ENSG00000178691	rs1557731	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1643	0.1896	0.162141	0.1814	.	.	.	.	.	.	.	.	.	.	AFR:0.3127,AMR:0.0859,EAS:0.0012,FIN:0.1179,NFE:0.1468,OTH:0.1350,ASJ:0.2185	606245	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	33307586	33307586	G	A	LIG3	UTR5	.	ENSG00000005156	rs12945428	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3654	.	0.306709	0.3954	.	.	.	.	.	.	.	.	.	.	AFR:0.1524,AMR:0.4349,EAS:0.2829,FIN:0.5753,NFE:0.4994,OTH:0.5,ASJ:0.32	600940	.	.	.	.	.	.	.	.	.	.	.	17	MU113836440	hom
17	36861983	36861983	T	C	MLLT6	exonic	nonsynonymous SNV	ENSG00000108292	rs17855918	ENSG00000108292:ENST00000325718:exon1:c.T98C:p.V33A,ENSG00000108292:ENST00000378137:exon1:c.T98C:p.V33A	MLLT6:NM_005937:exon1:c.T98C:p.V33A	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	1	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MLLT6:uc002hqi.4:exon1:c.T98C:p.V33A,MLLT6:uc010cvm.1:exon1:c.T98C:p.V33A,MLLT6:uc010wdr.2:exon1:c.T98C:p.V33A	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600328	.	.	.	.	.	.	.	.	.	.	.	17	1(thyroid)	1
17	36873243	36873243	C	T	MLLT6	intronic	.	ENSG00000263975	rs745630128	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	8.923e-06	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600328	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	37868715	37868715	C	T	ERBB2	intronic	.	ENSG00000141736	rs4252627	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6058	0.5123	0.444489	3(lung)	.	.	.	.	.	.	.	.	.	.	AFR:20(soft_tissue),AMR:MU584146,EAS:0.5113,FIN:0.2147,NFE:0.5573,OTH:0.6358,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|4|170|0.0235294,COCA-CN|5|321|0.0155763	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	17	1(liver)	0.3486
17	37884037	37884037	C	G	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	rs1058808	ENSG00000141736:ENST00000445658:exon21:c.C2680G:p.P894A,ENSG00000141736:ENST00000269571:exon27:c.C3508G:p.P1170A,ENSG00000141736:ENST00000540147:exon27:c.C3418G:p.P1140A,ENSG00000141736:ENST00000541774:exon27:c.C3463G:p.P1155A,ENSG00000141736:ENST00000406381:exon29:c.C3418G:p.P1140A,ENSG00000141736:ENST00000584601:exon31:c.C3418G:p.P1140A	ERBB2:NM_004448:exon27:c.C3508G:p.P1170A,ERBB2:NM_001005862:exon30:c.C3418G:p.P1140A,ERBB2:NM_001289936:exon31:c.C3463G:p.P1155A	clinvar: not_provided 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.6070	0.5135	0.452077	2(oesophagus)	4.041	23.7	0.03	5.04	0.999	.	.	.	ERBB2:uc010wek.2:exon21:c.C2680G:p.P894A,ERBB2:uc002hso.3:exon27:c.C3508G:p.P1170A,ERBB2:uc002hsp.3:exon27:c.C2917G:p.P973A,ERBB2:uc002hsm.3:exon30:c.C3418G:p.P1140A,ERBB2:uc010cwa.3:exon31:c.C3463G:p.P1155A	-0.881	AFR:MU774596,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841,ESCA-CN|2|332|0.0060241,EAS:0.2211,FIN:0.5589,NFE:0.6358,OTH:0.3504,ASJ:0.5139	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,4481,4414,4444,4391,4474,4461,4450,4396,4423,4511,4418,4513,4460,4469,4490,4386,4472,4473,4379,4470,4468,4410,4459,4500,4483,4479,4415,4439,4435,4417,4380,4467,4485,4445,4420,4493,4510,4438,4454,4494,4431,4440,4416,4448,4403,4484,4458,4496,4491,4476,4407,4433,4422,4427,4402,4503,4456,4387,4457,4377,4455,4501,4401,4478,4424,4488,4408,4465,4409,4512,4388,4432,4382,4381,4480,4378,4412,4389,4394,4452,4436,4495,4477,4482,4504,4419,4453,4447,4383,4390,4392,4475,4384,4395,4411,4426,4399,4451,4393,4385,4425,4489,4497,4441,4428,4449,4434,4486,4499,4462,4430,4406,4471,4429,4397,4437,4442,4464,4413,4463,4466,4405,4492,4487,4498,4446,4404,4443,4502,4509,4398,4421,4400	.	.	0.941	-0.81	0.000	0.695	17	1(biliary_tract)	0.6785
17	38569877	38569877	C	T	TOP2A	exonic	synonymous SNV	ENSG00000131747	.	ENSG00000131747:ENST00000423485:exon5:c.G333A:p.P111P,ENSG00000131747:ENST00000581055:exon5:c.G297A:p.P99P	TOP2A:NM_001067:exon5:c.G333A:p.P111P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.0001	0.09	.	TOP2A:uc002huq.3:exon5:c.G333A:p.P111P	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	126430	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	39912145	39912145	T	A	JUP	exonic	nonsynonymous SNV	ENSG00000173801	rs1126821	ENSG00000173801:ENST00000310706:exon14:c.A2089T:p.M697L,ENSG00000173801:ENST00000393930:exon14:c.A2089T:p.M697L,ENSG00000173801:ENST00000393931:exon14:c.A2089T:p.M697L	JUP:NM_001352773:exon14:c.A2089T:p.M697L,JUP:NM_001352774:exon14:c.A2089T:p.M697L,JUP:NM_001352775:exon14:c.A2089T:p.M697L,JUP:NM_001352777:exon14:c.A2089T:p.M697L,JUP:NM_002230:exon14:c.A2089T:p.M697L,JUP:NM_021991:exon14:c.A2089T:p.M697L,JUP:NM_001352776:exon15:c.A2089T:p.M697L	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6592	0.6970	0.58726	LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579	1.242	11.97	0.706	1.12	0.998	.	.	.	JUP:uc002hxq.2:exon14:c.A2089T:p.M697L,JUP:uc002hxr.2:exon14:c.A2089T:p.M697L,JUP:uc002hxs.2:exon14:c.A2089T:p.M697L	-0.959	AFR:0.6634,AMR:0.6017,EAS:0.6821,FIN:0.3202,NFE:0.6645,OTH:0.7421,ASJ:0.4880	173325	601214;611528;	217656;34217;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~34217|KWWH type I<br>Keratoderma with woolly hair type I<br>Keratosis palmoplantaris with arrythmogenic cardiomyopathy<br>Palmoplantar hyperkeratosis with arrythmogenic cardiomyopathy<br>Palmoplantar keratoderma with arrythmogenic cardiomyopathy|-|Autosomal recessive|Infancy<br>Neonatal|601214 ~	~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	0.0	0.31	0.000	-0.625	17	4(lung)	0.7119
17	39923614	39923614	A	G	JUP	intronic	.	ENSG00000173801	rs12942034	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7638	0.8343	0.744209	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.8105,AMR:0.8903,EAS:0.8033,FIN:0.4975,NFE:0.7995,OTH:0.8146,ASJ:0.5704	173325	601214;611528;	217656;34217;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~34217|KWWH type I<br>Keratoderma with woolly hair type I<br>Keratosis palmoplantaris with arrythmogenic cardiomyopathy<br>Palmoplantar hyperkeratosis with arrythmogenic cardiomyopathy<br>Palmoplantar keratoderma with arrythmogenic cardiomyopathy|-|Autosomal recessive|Infancy<br>Neonatal|601214 ~	~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	17	1(lung)	0.7980
17	39925925	39925925	A	G	JUP	exonic	synonymous SNV	ENSG00000173801	rs7405731	ENSG00000173801:ENST00000540235:exon2:c.T213C:p.D71D,ENSG00000173801:ENST00000310706:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000393930:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000393931:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000420370:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000437187:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000449889:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000591690:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000424457:exon4:c.T213C:p.D71D,ENSG00000173801:ENST00000437369:exon4:c.T213C:p.D71D	JUP:NM_001352773:exon3:c.T213C:p.D71D,JUP:NM_001352774:exon3:c.T213C:p.D71D,JUP:NM_001352775:exon3:c.T213C:p.D71D,JUP:NM_001352777:exon3:c.T213C:p.D71D,JUP:NM_002230:exon3:c.T213C:p.D71D,JUP:NM_021991:exon3:c.T213C:p.D71D,JUP:NM_001352776:exon4:c.T213C:p.D71D	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7364	0.7956	0.715655	1(breast)	.	.	.	.	.	.	.	.	JUP:uc010wfs.2:exon2:c.T213C:p.D71D,JUP:uc002hxq.2:exon3:c.T213C:p.D71D,JUP:uc002hxr.2:exon3:c.T213C:p.D71D,JUP:uc002hxs.2:exon3:c.T213C:p.D71D	.	AFR:MU23590898,AMR:LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,EAS:0.8828,FIN:0.5632,NFE:0.8278,OTH:0.5056,ASJ:0.7654	173325	601214;611528;	217656;34217;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~34217|KWWH type I<br>Keratoderma with woolly hair type I<br>Keratosis palmoplantaris with arrythmogenic cardiomyopathy<br>Palmoplantar hyperkeratosis with arrythmogenic cardiomyopathy<br>Palmoplantar keratoderma with arrythmogenic cardiomyopathy|-|Autosomal recessive|Infancy<br>Neonatal|601214 ~	~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	17	2(lung)	0.6822
17	40481529	40481529	G	C	STAT3	intronic	.	ENSG00000168610	rs2293152	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6025	0.6879	0.653754	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.6533,AMR:0.8458,EAS:0.5596,FIN:0.5218,NFE:0.5835,OTH:0.5875,ASJ:0.4462	102582	147060;615952;	438159;2314;	438159|-|-|Autosomal dominant|-|615952 ~2314|AD-HIES<br>Autosomal dominant HIES<br>Autosomal dominant hyperimmunoglobulin E syndrome<br>Buckley syndrome<br>Hyperimmunoglobulin E syndrome type 1<br>Hyperimmunoglobulin E-recurrent infection syndrome<br>Job syndrome<br>STAT3 deficiency|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|147060 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04931 Insulin resistance~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05145 Toxoplasmosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	17	1(breast)	0.6166
17	41222975	41222975	C	T	BRCA1	exonic	nonsynonymous SNV	ENSG00000012048	rs1799967	ENSG00000012048:ENST00000591534:exon3:c.G429A:p.M143I,ENSG00000012048:ENST00000484087:exon9:c.G1269A:p.M423I,ENSG00000012048:ENST00000351666:exon11:c.G1407A:p.M469I,ENSG00000012048:ENST00000309486:exon14:c.G4068A:p.M1356I,ENSG00000012048:ENST00000352993:exon14:c.G1530A:p.M510I,ENSG00000012048:ENST00000493795:exon14:c.G4815A:p.M1605I,ENSG00000012048:ENST00000493919:exon14:c.G1506A:p.M502I,ENSG00000012048:ENST00000357654:exon15:c.G4956A:p.M1652I,ENSG00000012048:ENST00000468300:exon15:c.G1644A:p.M548I,ENSG00000012048:ENST00000478531:exon15:c.G1644A:p.M548I,ENSG00000012048:ENST00000491747:exon15:c.G1644A:p.M548I,ENSG00000012048:ENST00000471181:exon16:c.G5019A:p.M1673I	BRCA1:NM_007297:exon14:c.G4815A:p.M1605I,BRCA1:NM_007298:exon14:c.G1644A:p.M548I,BRCA1:NM_007294:exon15:c.G4956A:p.M1652I,BRCA1:NM_007299:exon15:c.G1644A:p.M548I,BRCA1:NM_007300:exon16:c.G5019A:p.M1673I	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.0176	0.0108	0.0111821	6(lung)	2.771	21.2	0.079	3.78	0.971	.	.	BRCT domain	BRCA1:uc010whn.2:exon3:c.G429A:p.M143I,BRCA1:uc010whq.1:exon9:c.G1143A:p.M381I,BRCA1:uc010cyx.3:exon14:c.G4815A:p.M1605I,BRCA1:uc010whl.2:exon14:c.G1644A:p.M548I,BRCA1:uc010whp.2:exon14:c.G1503A:p.M501I,BRCA1:uc010whr.1:exon14:c.G1506A:p.M502I,BRCA1:uc002icp.4:exon15:c.G4743A:p.M1581I,BRCA1:uc002icq.3:exon15:c.G4956A:p.M1652I,BRCA1:uc002icu.3:exon15:c.G1644A:p.M548I,BRCA1:uc002idc.1:exon15:c.G1644A:p.M548I,BRCA1:uc002ict.3:exon16:c.G5019A:p.M1673I	-0.854	AFR:1(meninges),AMR:.,EAS:0.0196,FIN:0.0014,NFE:0.0024,OTH:0.0199,ASJ:.	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1792,1786,1780,1795,1777,1772,1784,1787,1778,1794,1791,1776,1785,1798,1788,1779,1781,1793,1790,1773,1782,1799,1789,1783,1797,1796	.	,1775,1774	0.166	-1.77	0.143	0.175	17	10(prostate)	0.0006
17	41223094	41223094	T	C	BRCA1	exonic	nonsynonymous SNV	ENSG00000012048	rs1799966	ENSG00000012048:ENST00000591534:exon3:c.A310G:p.S104G,ENSG00000012048:ENST00000484087:exon9:c.A1150G:p.S384G,ENSG00000012048:ENST00000351666:exon11:c.A1288G:p.S430G,ENSG00000012048:ENST00000309486:exon14:c.A3949G:p.S1317G,ENSG00000012048:ENST00000352993:exon14:c.A1411G:p.S471G,ENSG00000012048:ENST00000493795:exon14:c.A4696G:p.S1566G,ENSG00000012048:ENST00000493919:exon14:c.A1387G:p.S463G,ENSG00000012048:ENST00000357654:exon15:c.A4837G:p.S1613G,ENSG00000012048:ENST00000468300:exon15:c.A1525G:p.S509G,ENSG00000012048:ENST00000478531:exon15:c.A1525G:p.S509G,ENSG00000012048:ENST00000491747:exon15:c.A1525G:p.S509G,ENSG00000012048:ENST00000471181:exon16:c.A4900G:p.S1634G	BRCA1:NM_007297:exon14:c.A4696G:p.S1566G,BRCA1:NM_007298:exon14:c.A1525G:p.S509G,BRCA1:NM_007294:exon15:c.A4837G:p.S1613G,BRCA1:NM_007299:exon15:c.A1525G:p.S509G,BRCA1:NM_007300:exon16:c.A4900G:p.S1634G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.3496	0.2982	0.355831	1(urinary_tract)	-0.337	0.547	0.032	1.5	0.030	.	.	BRCA1, serine-rich domain;BRCT domain	BRCA1:uc010whn.2:exon3:c.A310G:p.S104G,BRCA1:uc010whq.1:exon9:c.A1024G:p.S342G,BRCA1:uc010cyx.3:exon14:c.A4696G:p.S1566G,BRCA1:uc010whl.2:exon14:c.A1525G:p.S509G,BRCA1:uc010whp.2:exon14:c.A1384G:p.S462G,BRCA1:uc010whr.1:exon14:c.A1387G:p.S463G,BRCA1:uc002icp.4:exon15:c.A4624G:p.S1542G,BRCA1:uc002icq.3:exon15:c.A4837G:p.S1613G,BRCA1:uc002icu.3:exon15:c.A1525G:p.S509G,BRCA1:uc002idc.1:exon15:c.A1525G:p.S509G,BRCA1:uc002ict.3:exon16:c.A4900G:p.S1634G	-1.080	AFR:3(haematopoietic_and_lymphoid_tissue),AMR:1(breast),EAS:9(meninges),FIN:MU153243,NFE:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,PRAD-CN|1|65|0.0153846,OTH:0.3179,ASJ:1(thymus)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1792,1786,1780,1795,1777,1772,1784,1787,1778,1794,1791,1776,1785,1798,1788,1779,1781,1793,1790,1773,1782,1799,1789,1783,1797,1796	.	,1775,1774	0.002	-1.93	0.000	1.845	17	2(large_intestine)	0.2330
17	41234470	41234470	A	G	BRCA1	exonic	synonymous SNV	ENSG00000012048	rs1060915	ENSG00000012048:ENST00000484087:exon6:c.T621C:p.S207S,ENSG00000012048:ENST00000487825:exon6:c.T624C:p.S208S,ENSG00000012048:ENST00000351666:exon8:c.T759C:p.S253S,ENSG00000012048:ENST00000309486:exon11:c.T3420C:p.S1140S,ENSG00000012048:ENST00000352993:exon11:c.T882C:p.S294S,ENSG00000012048:ENST00000493795:exon11:c.T4167C:p.S1389S,ENSG00000012048:ENST00000493919:exon11:c.T858C:p.S286S,ENSG00000012048:ENST00000346315:exon12:c.T4308C:p.S1436S,ENSG00000012048:ENST00000354071:exon12:c.T4308C:p.S1436S,ENSG00000012048:ENST00000357654:exon12:c.T4308C:p.S1436S,ENSG00000012048:ENST00000468300:exon12:c.T999C:p.S333S,ENSG00000012048:ENST00000471181:exon12:c.T4308C:p.S1436S,ENSG00000012048:ENST00000478531:exon12:c.T996C:p.S332S,ENSG00000012048:ENST00000491747:exon12:c.T999C:p.S333S	BRCA1:NM_007297:exon11:c.T4167C:p.S1389S,BRCA1:NM_007298:exon11:c.T999C:p.S333S,BRCA1:NM_007294:exon12:c.T4308C:p.S1436S,BRCA1:NM_007299:exon12:c.T999C:p.S333S,BRCA1:NM_007300:exon12:c.T4308C:p.S1436S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3431	0.2796	0.336262	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	BRCA1:uc010whq.1:exon6:c.T495C:p.S165S,BRCA1:uc010cyx.3:exon11:c.T4167C:p.S1389S,BRCA1:uc010whl.2:exon11:c.T999C:p.S333S,BRCA1:uc010whp.2:exon11:c.T858C:p.S286S,BRCA1:uc010whr.1:exon11:c.T858C:p.S286S,BRCA1:uc002icp.4:exon12:c.T4095C:p.S1365S,BRCA1:uc002icq.3:exon12:c.T4308C:p.S1436S,BRCA1:uc002ict.3:exon12:c.T4308C:p.S1436S,BRCA1:uc002icu.3:exon12:c.T999C:p.S333S,BRCA1:uc002idc.1:exon12:c.T996C:p.S332S	.	AFR:9(meninges),AMR:MU12924798,EAS:0.3011,FIN:0.1748,NFE:0.3210,OTH:0.3179,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1792,1786,1780,1795,1777,1772,1784,1787,1778,1794,1791,1776,1785,1798,1788,1779,1781,1793,1790,1773,1782,1799,1789,1783,1797,1796	.	,1775,1774	.	.	.	.	17	1(liver)	0.3675
17	41244000	41244000	T	C	BRCA1	exonic	nonsynonymous SNV	ENSG00000012048	rs16942	ENSG00000012048:ENST00000309486:exon9:c.A2660G:p.K887R,ENSG00000012048:ENST00000493795:exon9:c.A3407G:p.K1136R,ENSG00000012048:ENST00000346315:exon10:c.A3548G:p.K1183R,ENSG00000012048:ENST00000354071:exon10:c.A3548G:p.K1183R,ENSG00000012048:ENST00000357654:exon10:c.A3548G:p.K1183R,ENSG00000012048:ENST00000471181:exon10:c.A3548G:p.K1183R	BRCA1:NM_007297:exon9:c.A3407G:p.K1136R,BRCA1:NM_007294:exon10:c.A3548G:p.K1183R,BRCA1:NM_007300:exon10:c.A3548G:p.K1183R	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.3490	0.2952	0.352636	1(ovary)	-2.334	0.001	1.0	-2.35	0.005	.	.	.	BRCA1:uc010wht.1:exon2:c.A2660G:p.K887R,BRCA1:uc002ide.1:exon4:c.A3041G:p.K1014R,BRCA1:uc002idd.3:exon9:c.A3548G:p.K1183R,BRCA1:uc010cyx.3:exon9:c.A3407G:p.K1136R,BRCA1:uc010cza.2:exon9:c.A3470G:p.K1157R,BRCA1:uc002icp.4:exon10:c.A3335G:p.K1112R,BRCA1:uc002icq.3:exon10:c.A3548G:p.K1183R,BRCA1:uc002ict.3:exon10:c.A3548G:p.K1183R,BRCA1:uc010cyy.1:exon10:c.A3548G:p.K1183R,BRCA1:uc010whs.1:exon10:c.A3548G:p.K1183R,BRCA1:uc010cyz.2:exon11:c.A3407G:p.K1136R	-1.024	AFR:1(stomach),AMR:2(prostate),EAS:14(soft_tissue),FIN:40(lung),NFE:1(thyroid),OTH:MU153252,ASJ:4(large_intestine)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1792,1786,1780,1795,1777,1772,1784,1787,1778,1794,1791,1776,1785,1798,1788,1779,1781,1793,1790,1773,1782,1799,1789,1783,1797,1796	.	,1775,1774	0.0	-0.35	0.000	-0.485	17	1(breast)	LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579
17	41244435	41244435	T	C	BRCA1	exonic	nonsynonymous SNV	ENSG00000012048	rs16941	ENSG00000012048:ENST00000309486:exon9:c.A2225G:p.E742G,ENSG00000012048:ENST00000493795:exon9:c.A2972G:p.E991G,ENSG00000012048:ENST00000346315:exon10:c.A3113G:p.E1038G,ENSG00000012048:ENST00000354071:exon10:c.A3113G:p.E1038G,ENSG00000012048:ENST00000357654:exon10:c.A3113G:p.E1038G,ENSG00000012048:ENST00000471181:exon10:c.A3113G:p.E1038G	BRCA1:NM_007297:exon9:c.A2972G:p.E991G,BRCA1:NM_007294:exon10:c.A3113G:p.E1038G,BRCA1:NM_007300:exon10:c.A3113G:p.E1038G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.3429	0.2790	0.335663	3(haematopoietic_and_lymphoid_tissue)	2.989	22.2	0.028	-0.974	0.952	.	.	.	BRCA1:uc010wht.1:exon2:c.A2225G:p.E742G,BRCA1:uc002ide.1:exon4:c.A2606G:p.E869G,BRCA1:uc002idd.3:exon9:c.A3113G:p.E1038G,BRCA1:uc010cyx.3:exon9:c.A2972G:p.E991G,BRCA1:uc010cza.2:exon9:c.A3035G:p.E1012G,BRCA1:uc002icp.4:exon10:c.A2900G:p.E967G,BRCA1:uc002icq.3:exon10:c.A3113G:p.E1038G,BRCA1:uc002ict.3:exon10:c.A3113G:p.E1038G,BRCA1:uc010cyy.1:exon10:c.A3113G:p.E1038G,BRCA1:uc010whs.1:exon10:c.A3113G:p.E1038G,BRCA1:uc010cyz.2:exon11:c.A2972G:p.E991G	-1.094	AFR:1(thymus),AMR:1(breast),EAS:MU153259,FIN:LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,NFE:0.3004,OTH:0.1749,ASJ:9(meninges)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1792,1786,1780,1795,1777,1772,1784,1787,1778,1794,1791,1776,1785,1798,1788,1779,1781,1793,1790,1773,1782,1799,1789,1783,1797,1796	.	,1775,1774	0.012	-1.24	0.000	2.275	17	35(lung)	0.3182
17	41244936	41244936	G	A	BRCA1	exonic	nonsynonymous SNV	ENSG00000012048	rs799917	ENSG00000012048:ENST00000309486:exon9:c.C1724T:p.P575L,ENSG00000012048:ENST00000493795:exon9:c.C2471T:p.P824L,ENSG00000012048:ENST00000346315:exon10:c.C2612T:p.P871L,ENSG00000012048:ENST00000354071:exon10:c.C2612T:p.P871L,ENSG00000012048:ENST00000357654:exon10:c.C2612T:p.P871L,ENSG00000012048:ENST00000471181:exon10:c.C2612T:p.P871L	BRCA1:NM_007297:exon9:c.C2471T:p.P824L,BRCA1:NM_007294:exon10:c.C2612T:p.P871L,BRCA1:NM_007300:exon10:c.C2612T:p.P871L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.4100	0.4932	0.54393	1(stomach)	1.633	14.03	1.0	5.04	0.979	.	.	.	BRCA1:uc010wht.1:exon2:c.C1724T:p.P575L,BRCA1:uc002ide.1:exon4:c.C2105T:p.P702L,BRCA1:uc002idd.3:exon9:c.C2612T:p.P871L,BRCA1:uc010cyx.3:exon9:c.C2471T:p.P824L,BRCA1:uc010cza.2:exon9:c.C2534T:p.P845L,BRCA1:uc002icp.4:exon10:c.C2399T:p.P800L,BRCA1:uc002icq.3:exon10:c.C2612T:p.P871L,BRCA1:uc002ict.3:exon10:c.C2612T:p.P871L,BRCA1:uc010cyy.1:exon10:c.C2612T:p.P871L,BRCA1:uc010whs.1:exon10:c.C2612T:p.P871L,BRCA1:uc010cyz.2:exon11:c.C2471T:p.P824L	-0.937	AFR:3(haematopoietic_and_lymphoid_tissue),AMR:9(meninges),EAS:4(large_intestine),FIN:1(peritoneum),NFE:1(breast),OTH:MU153268,ASJ:1(skin)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1792,1786,1780,1795,1777,1772,1784,1787,1778,1794,1791,1776,1785,1798,1788,1779,1781,1793,1790,1773,1782,1799,1789,1783,1797,1796	.	,1775,1774	0.0	-0.05	0.000	-3.445	17	14(soft_tissue)	LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579
17	41245237	41245237	A	G	BRCA1	exonic	synonymous SNV	ENSG00000012048	rs16940	ENSG00000012048:ENST00000309486:exon9:c.T1423C:p.L475L,ENSG00000012048:ENST00000493795:exon9:c.T2170C:p.L724L,ENSG00000012048:ENST00000346315:exon10:c.T2311C:p.L771L,ENSG00000012048:ENST00000354071:exon10:c.T2311C:p.L771L,ENSG00000012048:ENST00000357654:exon10:c.T2311C:p.L771L,ENSG00000012048:ENST00000471181:exon10:c.T2311C:p.L771L	BRCA1:NM_007297:exon9:c.T2170C:p.L724L,BRCA1:NM_007294:exon10:c.T2311C:p.L771L,BRCA1:NM_007300:exon10:c.T2311C:p.L771L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3420	0.2776	0.335264	9(meninges)	.	.	.	.	.	.	.	.	BRCA1:uc010wht.1:exon2:c.T1423C:p.L475L,BRCA1:uc002ide.1:exon4:c.T1804C:p.L602L,BRCA1:uc002idd.3:exon9:c.T2311C:p.L771L,BRCA1:uc010cyx.3:exon9:c.T2170C:p.L724L,BRCA1:uc010cza.2:exon9:c.T2233C:p.L745L,BRCA1:uc002icp.4:exon10:c.T2098C:p.L700L,BRCA1:uc002icq.3:exon10:c.T2311C:p.L771L,BRCA1:uc002ict.3:exon10:c.T2311C:p.L771L,BRCA1:uc010cyy.1:exon10:c.T2311C:p.L771L,BRCA1:uc010whs.1:exon10:c.T2311C:p.L771L,BRCA1:uc010cyz.2:exon11:c.T2170C:p.L724L	.	AFR:1(lung),AMR:MU153274,EAS:0.2998,FIN:0.1749,NFE:0.3206,OTH:0.3179,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1792,1786,1780,1795,1777,1772,1784,1787,1778,1794,1791,1776,1785,1798,1788,1779,1781,1793,1790,1773,1782,1799,1789,1783,1797,1796	.	,1775,1774	.	.	.	.	17	2(large_intestine)	0.3657
17	41245466	41245466	G	A	BRCA1	exonic	synonymous SNV	ENSG00000012048	rs1799949	ENSG00000012048:ENST00000309486:exon9:c.C1194T:p.S398S,ENSG00000012048:ENST00000493795:exon9:c.C1941T:p.S647S,ENSG00000012048:ENST00000346315:exon10:c.C2082T:p.S694S,ENSG00000012048:ENST00000354071:exon10:c.C2082T:p.S694S,ENSG00000012048:ENST00000357654:exon10:c.C2082T:p.S694S,ENSG00000012048:ENST00000471181:exon10:c.C2082T:p.S694S	BRCA1:NM_007297:exon9:c.C1941T:p.S647S,BRCA1:NM_007294:exon10:c.C2082T:p.S694S,BRCA1:NM_007300:exon10:c.C2082T:p.S694S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3483	0.2957	0.336462	13(soft_tissue)	.	.	.	.	.	.	.	.	BRCA1:uc010wht.1:exon2:c.C1194T:p.S398S,BRCA1:uc002ide.1:exon4:c.C1575T:p.S525S,BRCA1:uc002idd.3:exon9:c.C2082T:p.S694S,BRCA1:uc010cyx.3:exon9:c.C1941T:p.S647S,BRCA1:uc010cza.2:exon9:c.C2004T:p.S668S,BRCA1:uc002icp.4:exon10:c.C1869T:p.S623S,BRCA1:uc002icq.3:exon10:c.C2082T:p.S694S,BRCA1:uc002ict.3:exon10:c.C2082T:p.S694S,BRCA1:uc010cyy.1:exon10:c.C2082T:p.S694S,BRCA1:uc010whs.1:exon10:c.C2082T:p.S694S,BRCA1:uc010cyz.2:exon11:c.C1941T:p.S647S	.	AFR:3(lung),AMR:1(breast),EAS:MU153282,FIN:LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,NFE:0.3160,OTH:0.2290,ASJ:2(large_intestine)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1792,1786,1780,1795,1777,1772,1784,1787,1778,1794,1791,1776,1785,1798,1788,1779,1781,1793,1790,1773,1782,1799,1789,1783,1797,1796	.	,1775,1774	.	.	.	.	17	3(haematopoietic_and_lymphoid_tissue)	0.3234
17	42930673	42930673	G	A	EFTUD2	exonic	nonsynonymous SNV	ENSG00000108883	.	ENSG00000108883:ENST00000402521:exon24:c.C2447T:p.A816V,ENSG00000108883:ENST00000426333:exon25:c.C2552T:p.A851V,ENSG00000108883:ENST00000591382:exon25:c.C2552T:p.A851V,ENSG00000108883:ENST00000592576:exon25:c.C2522T:p.A841V	EFTUD2:NM_001142605:exon24:c.C2447T:p.A816V,EFTUD2:NM_001258353:exon25:c.C2552T:p.A851V,EFTUD2:NM_001258354:exon25:c.C2522T:p.A841V,EFTUD2:NM_004247:exon25:c.C2552T:p.A851V	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	7.238	34	0.014	5.33	1.000	.	.	116kDa U5 small nuclear ribonucleoprotein component, C-terminal|EF-G domain III/V-like|Elongation factor EFG, domain V-like;Ribosomal protein S5 domain 2-type fold|Ribosomal protein S5 domain 2-type fold, subgroup|Translation elongation factor EFG/EF2, domain IV	EFTUD2:uc010wje.1:exon24:c.C2447T:p.A816V,EFTUD2:uc002ihn.2:exon25:c.C2552T:p.A851V,EFTUD2:uc010wjf.1:exon25:c.C2522T:p.A841V,EFTUD2:uc031rav.1:exon25:c.C2552T:p.A851V	-0.199	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603892	610536;	79113;	79113|Growth delay-intellectual disability-mandibulofacial dysostosis-microcephaly-cleft palate syndrome<br>MFDM syndrome<br>Mandibulofacial dysostosis, Guion-Almeida type|<1 / 1 000 000|Autosomal dominant|Neonatal|610536 ~	.	.	.	.	0.98	-0.1	0.412	3.125	17	.	hom
17	42949808	42949808	G	A	EFTUD2	intronic	.	ENSG00000108883	rs11654183	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2673	0.2648	0.242612	0.2780	.	.	.	.	.	0	0.036	.	.	.	AFR:0.2317,AMR:0.2363,EAS:0.2615,FIN:0.3267,NFE:0.2989,OTH:0.2710,ASJ:0.24	603892	610536;	79113;	79113|Growth delay-intellectual disability-mandibulofacial dysostosis-microcephaly-cleft palate syndrome<br>MFDM syndrome<br>Mandibulofacial dysostosis, Guion-Almeida type|<1 / 1 000 000|Autosomal dominant|Neonatal|610536 ~	.	.	.	.	.	.	.	.	17	MU12926828	hom
17	42961009	42961009	C	T	EFTUD2	intronic	.	ENSG00000108883	rs2289677	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5693	0.6431	0.560503	0.6292	.	.	.	.	.	0.0001	0.012	.	.	.	AFR:0.7327,AMR:0.4654,EAS:0.4950,FIN:0.5642,NFE:0.6115,OTH:0.5622,ASJ:0.6523	603892	610536;	79113;	79113|Growth delay-intellectual disability-mandibulofacial dysostosis-microcephaly-cleft palate syndrome<br>MFDM syndrome<br>Mandibulofacial dysostosis, Guion-Almeida type|<1 / 1 000 000|Autosomal dominant|Neonatal|610536 ~	.	.	.	.	.	.	.	.	17	MU12926862	hom
17	45364540	45364540	T	C	ITGB3	exonic	synonymous SNV	ENSG00000259207;ENSG00000259753	rs5919	ENSG00000259207:ENST00000435993:exon6:c.T741C:p.P247P,ENSG00000259207:ENST00000559488:exon6:c.T882C:p.P294P,ENSG00000259207:ENST00000571680:exon6:c.T882C:p.P294P	ITGB3:NM_000212:exon6:c.T882C:p.P294P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1029	0.0982	0.14397	0.1006	.	.	.	.	.	.	.	.	ITGB3:uc002ili.1:exon6:c.T882C:p.P294P,ITGB3:uc002ilj.3:exon6:c.T882C:p.P294P	.	AFR:0.1626,AMR:0.0632,EAS:0.2608,FIN:0.0384,NFE:0.0648,OTH:0.0754,ASJ:0.1358	173470	187800;273800;608446;	849;140957;	849|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|273800 ~140957|-|<1 / 1 000 000|Autosomal dominant|-|187800 613112 615193 ~	~ko04015 Rap1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	17	MU12929114	het
17	45368337	45368337	A	C	ITGB3	exonic	synonymous SNV	ENSG00000259207;ENSG00000259753	rs15908	ENSG00000259207:ENST00000435993:exon9:c.A1002C:p.V334V,ENSG00000259207:ENST00000559488:exon9:c.A1143C:p.V381V,ENSG00000259207:ENST00000571680:exon9:c.A1143C:p.V381V	ITGB3:NM_000212:exon9:c.A1143C:p.V381V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3902	0.3851	0.43111	0.3933	.	.	.	.	.	.	.	.	ITGB3:uc002ili.1:exon9:c.A1143C:p.V381V,ITGB3:uc002ilj.3:exon9:c.A1143C:p.V381V	.	AFR:0.4354,AMR:0.3222,EAS:0.6072,FIN:0.3199,NFE:0.3673,OTH:0.3834,ASJ:0.4033	173470	187800;273800;608446;	849;140957;	849|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|273800 ~140957|-|<1 / 1 000 000|Autosomal dominant|-|187800 613112 615193 ~	~ko04015 Rap1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	17	MU13755074	hom
17	45369777	45369777	A	G	ITGB3	exonic	synonymous SNV	ENSG00000259207;ENSG00000259753	rs4642	ENSG00000259207:ENST00000435993:exon10:c.A1392G:p.E464E,ENSG00000259207:ENST00000559488:exon10:c.A1533G:p.E511E	ITGB3:NM_000212:exon10:c.A1533G:p.E511E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2871	0.2839	0.28734	0.2891	.	.	.	.	.	.	.	.	ITGB3:uc002ilj.3:exon10:c.A1533G:p.E511E	.	AFR:0.2635,AMR:0.2566,EAS:0.3493,FIN:0.2818,NFE:0.3007,OTH:0.3027,ASJ:0.2649	173470	187800;273800;608446;	849;140957;	849|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|273800 ~140957|-|<1 / 1 000 000|Autosomal dominant|-|187800 613112 615193 ~	~ko04015 Rap1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	17	MU775201	hom
17	45369789	45369789	G	A	ITGB3	exonic	synonymous SNV	ENSG00000259207;ENSG00000259753	rs4634	ENSG00000259207:ENST00000435993:exon10:c.G1404A:p.R468R,ENSG00000259207:ENST00000559488:exon10:c.G1545A:p.R515R	ITGB3:NM_000212:exon10:c.G1545A:p.R515R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2873	0.2839	0.28734	0.2890	.	.	.	.	.	.	.	.	ITGB3:uc002ilj.3:exon10:c.G1545A:p.R515R	.	AFR:0.2638,AMR:0.2560,EAS:0.3502,FIN:0.2815,NFE:0.3001,OTH:0.3041,ASJ:0.2649	173470	187800;273800;608446;	849;140957;	849|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|273800 ~140957|-|<1 / 1 000 000|Autosomal dominant|-|187800 613112 615193 ~	~ko04015 Rap1 signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	17	MU775204	hom
17	46805894	46805894	G	A	HOXB13	exonic	nonsynonymous SNV	ENSG00000159184	rs772484566	ENSG00000159184:ENST00000290295:exon1:c.C62T:p.A21V	HOXB13:NM_006361:exon1:c.C62T:p.A21V	clinvar: Uncertain_significance 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	8.623e-06	.	.	.	2.862	21.7	0.03	3.06	0.862	.	.	Homeobox protein Hox1A3 N-terminal	HOXB13:uc002ioa.3:exon1:c.C62T:p.A21V	-0.919	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604607	.	.	.	.	.	.	.	0.001	0.66	0.107	1.385	17	.	hom
17	48263021	48263021	C	T	COL1A1	intronic	.	ENSG00000108821	rs2249492	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5828	0.5103	0.485024	0.5145	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.2833,AMR:0.6835,EAS:0.5075,FIN:0.6341,NFE:0.6035,OTH:0.5969,ASJ:0.6722	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU797249	het
17	48265495	48265495	T	C	COL1A1	exonic	nonsynonymous SNV	ENSG00000108821	rs1800215	ENSG00000108821:ENST00000225964:exon44:c.A3223G:p.T1075A	COL1A1:NM_000088:exon44:c.A3223G:p.T1075A	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9848	0.9710	0.978834	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	COL1A1:uc002iqm.3:exon44:c.A3223G:p.T1075A	.	AFR:0.9727,AMR:0.9433,EAS:0.9967,FIN:1,NFE:0.9794,OTH:0.9834,ASJ:0.9869	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	1(thyroid)	0.9836
17	48268223	48268223	A	G	COL1A1	exonic	synonymous SNV	ENSG00000108821	rs2734272	ENSG00000108821:ENST00000225964:exon33:c.T2298C:p.T766T	COL1A1:NM_000088:exon33:c.T2298C:p.T766T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9998	0.9998	0.9998	0.9996	.	.	.	.	.	.	.	.	COL1A1:uc002iqm.3:exon33:c.T2298C:p.T766T	.	AFR:0.9991,AMR:0.9988,EAS:1,FIN:1,NFE:0.9998,OTH:1,ASJ:1	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU4564816	hom
17	48434467	48434467	G	A	XYLT2	exonic	nonsynonymous SNV	ENSG00000015532	.	ENSG00000015532:ENST00000017003:exon9:c.G1795A:p.D599N,ENSG00000015532:ENST00000507602:exon9:c.G1795A:p.D599N	XYLT2:NM_022167:exon9:c.G1795A:p.D599N	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	6.075	28.1	0.082	5.02	1.000	.	.	.	XYLT2:uc002iqo.3:exon9:c.G1795A:p.D599N	-0.240	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608125	264800;605822;	85194;758;	85194|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|605822 ~758|Gronblad-Strandberg-Touraine syndrome<br>PXE|1-9 / 100 000|Autosomal recessive|All ages|177850 264800 ~	.	.	.	.	1.0	0.29	0.417	2.525	17	.	hom
17	57093165	57093165	A	T	TRIM37	intronic	.	ENSG00000108395	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.9998	0.964	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605073	253250;	2576;	2576|MULIBREY dwarfism<br>Muscle-liver-brain-eye nanism<br>Perheentupa syndrome<br>Pericardial constriction-growth failure syndrome|Unknown|Autosomal recessive|Infancy<br>Neonata253250 ~	.	.	.	.	.	.	.	.	17	.	hom
17	58014921	58014921	T	G	RPS6KB1	intronic	.	ENSG00000108443	rs76664915	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	.	0.0003	.	.	.	.	.	.	.	.	.	.	AFR:0.0006,AMR:0,EAS:0,FIN:0.0006,NFE:0,OTH:0,ASJ:0.0034	608938	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04350 TGF-beta signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	17	.	het
17	58014949	58014949	C	T	RPS6KB1	intronic	.	ENSG00000108443	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	.	0.0007	.	.	.	.	.	.	.	.	.	.	AFR:0.0012,AMR:0,EAS:0.0021,FIN:0.0018,NFE:0.0002,OTH:0,ASJ:0	608938	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04350 TGF-beta signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	17	MU89319966	het
17	59763465	59763465	T	C	BRIP1	exonic	synonymous SNV	ENSG00000136492	rs4986765	ENSG00000136492:ENST00000577598:exon18:c.A2637G:p.E879E,ENSG00000136492:ENST00000259008:exon19:c.A2637G:p.E879E	BRIP1:NM_032043:exon19:c.A2637G:p.E879E	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7188	0.7343	0.815096	0.7178	.	.	.	.	.	.	.	.	BRIP1:uc002izl.1:exon8:c.A780G:p.E260E,BRIP1:uc002izk.2:exon19:c.A2637G:p.E879E	.	AFR:0.9073,AMR:0.8473,EAS:0.8812,FIN:0.5120,NFE:0.6355,OTH:0.6307,ASJ:0.7483	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	17	MU13758307	hom
17	59856129	59856129	G	A	BRIP1	intronic	.	ENSG00000136492	rs4968449	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.989816	0.9893	.	.	.	.	.	.	.	.	.	.	AFR:0.9623,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	17	.	hom
17	60043884	60043884	G	A	MED13	exonic	synonymous SNV	ENSG00000108510	rs671347	ENSG00000108510:ENST00000397786:exon19:c.C4320T:p.D1440D	MED13:NM_005121:exon19:c.C4320T:p.D1440D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9983	0.9931	0.996206	0.9943	.	.	.	.	.	.	.	.	MED13:uc002izo.3:exon19:c.C4320T:p.D1440D	.	AFR:0.9796,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	603808	.	.	.	.	.	.	.	.	.	.	.	17	MU81997073	hom
17	72860654	72860654	G	A	FDXR	exonic	synonymous SNV	ENSG00000161513	rs2070921	ENSG00000161513:ENST00000420580:exon7:c.C630T:p.A210A,ENSG00000161513:ENST00000544854:exon7:c.C594T:p.A198A,ENSG00000161513:ENST00000293195:exon8:c.C750T:p.A250A,ENSG00000161513:ENST00000442102:exon8:c.C879T:p.A293A,ENSG00000161513:ENST00000581530:exon8:c.C768T:p.A256A,ENSG00000161513:ENST00000582944:exon8:c.C726T:p.A242A,ENSG00000161513:ENST00000413947:exon9:c.C843T:p.A281A,ENSG00000161513:ENST00000455107:exon9:c.C618T:p.A206A	FDXR:NM_001258015:exon7:c.C630T:p.A210A,FDXR:NM_001258016:exon7:c.C594T:p.A198A,FDXR:NM_001258012:exon8:c.C879T:p.A293A,FDXR:NM_001258014:exon8:c.C726T:p.A242A,FDXR:NM_004110:exon8:c.C768T:p.A256A,FDXR:NM_024417:exon8:c.C750T:p.A250A,FDXR:NM_001258013:exon9:c.C843T:p.A281A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0336	0.0072	0.0553115	0.0160	.	.	.	.	.	.	.	.	FDXR:uc010wri.2:exon7:c.C594T:p.A198A,FDXR:uc010wrm.2:exon7:c.C630T:p.A210A,FDXR:uc002jlx.3:exon8:c.C768T:p.A256A,FDXR:uc002jly.3:exon8:c.C750T:p.A250A,FDXR:uc002jlz.3:exon8:c.C726T:p.A242A,FDXR:uc010wrj.3:exon8:c.C744T:p.A248A,FDXR:uc010wrl.2:exon8:c.C879T:p.A293A,FDXR:uc010wrk.2:exon9:c.C843T:p.A281A	.	AFR:0.0020,AMR:0.0825,EAS:0.1300,FIN:0.0011,NFE:0.0118,OTH:0.0134,ASJ:0.0132	103270	.	.	.	.	.	.	.	.	.	.	.	17	MU21491471	hom
17	72860689	72860689	T	A	FDXR	intronic	.	ENSG00000161513	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.0006	0.04	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	103270	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	72862593	72862593	C	T	FDXR	exonic	nonsynonymous SNV	ENSG00000161513	rs690514	ENSG00000161513:ENST00000544854:exon3:c.G212A:p.R71Q,ENSG00000161513:ENST00000579893:exon3:c.G215A:p.R72Q,ENSG00000161513:ENST00000293195:exon4:c.G368A:p.R123Q,ENSG00000161513:ENST00000442102:exon4:c.G497A:p.R166Q,ENSG00000161513:ENST00000581219:exon4:c.G473A:p.R158Q,ENSG00000161513:ENST00000581530:exon4:c.G368A:p.R123Q,ENSG00000161513:ENST00000582944:exon4:c.G344A:p.R115Q,ENSG00000161513:ENST00000583917:exon4:c.G371A:p.R124Q,ENSG00000161513:ENST00000413947:exon5:c.G461A:p.R154Q,ENSG00000161513:ENST00000455107:exon5:c.G236A:p.R79Q	FDXR:NM_001258016:exon3:c.G212A:p.R71Q,FDXR:NM_001258012:exon4:c.G497A:p.R166Q,FDXR:NM_001258014:exon4:c.G344A:p.R115Q,FDXR:NM_004110:exon4:c.G368A:p.R123Q,FDXR:NM_024417:exon4:c.G368A:p.R123Q,FDXR:NM_001258013:exon5:c.G461A:p.R154Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2103	0.1678	0.185104	2(thyroid)	.	.	.	.	.	.	.	.	FDXR:uc010wri.2:exon3:c.G212A:p.R71Q,FDXR:uc002jlx.3:exon4:c.G368A:p.R123Q,FDXR:uc002jly.3:exon4:c.G368A:p.R123Q,FDXR:uc002jlz.3:exon4:c.G344A:p.R115Q,FDXR:uc010wrj.3:exon4:c.G362A:p.R121Q,FDXR:uc010wrl.2:exon4:c.G497A:p.R166Q,FDXR:uc010wrk.2:exon5:c.G461A:p.R154Q	.	AFR:1(breast),AMR:MU796866,EAS:0.1663,FIN:0.0567,NFE:0.1492,OTH:0.3510,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	103270	.	.	.	.	.	.	.	.	.	.	.	17	1(lung)	0.4200
17	73625430	73625430	G	A	RECQL5	exonic	synonymous SNV	ENSG00000108469	rs4788902	ENSG00000108469:ENST00000582548:exon1:c.C93T:p.H31H,ENSG00000108469:ENST00000580707:exon9:c.C540T:p.H180H,ENSG00000108469:ENST00000317905:exon16:c.C2073T:p.H691H,ENSG00000108469:ENST00000423245:exon16:c.C1992T:p.H664H	RECQL5:NM_004259:exon16:c.C2073T:p.H691H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6127	0.4752	0.525958	0.5025	.	.	.	.	.	.	.	.	RECQL5:uc010dgk.3:exon15:c.C1992T:p.H664H,RECQL5:uc010dgl.3:exon16:c.C2073T:p.H691H	.	AFR:0.2075,AMR:0.6507,EAS:0.8189,FIN:0.6151,NFE:0.6010,OTH:0.5789,ASJ:0.4834	603781	.	.	.	.	.	.	.	.	.	.	.	17	MU75672	hom
17	73625478	73625478	T	C	RECQL5	exonic	synonymous SNV	ENSG00000108469	rs820191	ENSG00000108469:ENST00000582548:exon1:c.A45G:p.T15T,ENSG00000108469:ENST00000580707:exon9:c.A492G:p.T164T,ENSG00000108469:ENST00000317905:exon16:c.A2025G:p.T675T,ENSG00000108469:ENST00000423245:exon16:c.A1944G:p.T648T	RECQL5:NM_004259:exon16:c.A2025G:p.T675T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9968	0.9896	0.989217	0.9894	.	.	.	.	.	.	.	.	RECQL5:uc010dgk.3:exon15:c.A1944G:p.T648T,RECQL5:uc010dgl.3:exon16:c.A2025G:p.T675T	.	AFR:0.9629,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	603781	.	.	.	.	.	.	.	.	.	.	.	17	MU4565309	hom
17	73627539	73627539	T	C	RECQL5	exonic	nonsynonymous SNV	ENSG00000108469	rs820196	ENSG00000108469:ENST00000578201:exon8:c.A1439G:p.D480G,ENSG00000108469:ENST00000317905:exon9:c.A1439G:p.D480G,ENSG00000108469:ENST00000423245:exon9:c.A1358G:p.D453G	RECQL5:NM_004259:exon9:c.A1439G:p.D480G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2536	0.2013	0.265775	0.2116	1.615	13.94	1.0	5.97	0.933	.	.	Winged helix-turn-helix DNA-binding domain	RECQL5:uc010dgk.3:exon8:c.A1358G:p.D453G,RECQL5:uc010dgl.3:exon9:c.A1439G:p.D480G	-1.019	AFR:0.1812,AMR:0.3317,EAS:0.2642,FIN:0.2039,NFE:0.2175,OTH:0.2219,ASJ:0.2384	603781	.	.	.	.	.	.	.	0.0	0.24	0.000	-0.975	17	MU25518356	hom
17	73627565	73627565	A	G	RECQL5	exonic	synonymous SNV	ENSG00000108469	rs820197	ENSG00000108469:ENST00000578201:exon8:c.T1413C:p.Y471Y,ENSG00000108469:ENST00000317905:exon9:c.T1413C:p.Y471Y,ENSG00000108469:ENST00000423245:exon9:c.T1332C:p.Y444Y	RECQL5:NM_004259:exon9:c.T1413C:p.Y471Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9968	0.9896	0.988618	0.9890	.	.	.	.	.	.	.	.	RECQL5:uc010dgk.3:exon8:c.T1332C:p.Y444Y,RECQL5:uc010dgl.3:exon9:c.T1413C:p.Y471Y	.	AFR:0.9615,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	603781	.	.	.	.	.	.	.	.	.	.	.	17	MU4565311	hom
17	74475024	74475024	G	A	RHBDF2	exonic	nonsynonymous SNV	ENSG00000129667	rs3744045	ENSG00000129667:ENST00000313080:exon6:c.C623T:p.P208L,ENSG00000129667:ENST00000389760:exon6:c.C536T:p.P179L,ENSG00000129667:ENST00000591885:exon6:c.C536T:p.P179L	RHBDF2:NM_001005498:exon5:c.C536T:p.P179L,RHBDF2:NM_024599:exon6:c.C623T:p.P208L	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8787	0.7952	0.765176	0.8090	2.245	17.80	0.078	4.57	0.047	.	.	.	RHBDF2:uc002jrr.1:exon3:c.C179T:p.P60L,RHBDF2:uc002jrs.1:exon3:c.C608T:p.P203L,RHBDF2:uc010wtf.1:exon5:c.C536T:p.P179L,RHBDF2:uc021udh.1:exon5:c.C536T:p.P179L,RHBDF2:uc002jrq.2:exon6:c.C623T:p.P208L	-1.042	AFR:0.5027,AMR:0.8804,EAS:0.9523,FIN:0.9178,NFE:0.9344,OTH:0.8891,ASJ:0.9272	614404	148500;	2198;	2198|Bennion-Patterson syndrome<br>Howell-Evans syndrome<br>Keratosis palmoplantaris-esophageal carcinoma syndrome<br>Palmoplantar hyperkeratosis-esophageal carcinoma syndrome<br>Tylosis-oesophageal carcinoma syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|148500 ~	.	.	.	.	0.247	-0.18	0.000	1.81	17	MU4552271	hom
17	75303298	75303298	T	C	SEPTIN9	intronic	.	ENSG00000184640	rs4789439	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8853	0.8623	0.91873	0.8897	.	.	.	.	.	.	.	.	.	.	AFR:0.9079,AMR:0.9129,EAS:0.9889,FIN:0.9123,NFE:0.8646,OTH:0.8837,ASJ:0.7682	604061	162100;	2901;	2901|Acute brachial plexus neuritis<br>Brachial plexus neuritis<br>Immune brachial plexus neuropathy<br>Mononeuritis multiplex with brachial predilection<br>Neuralgic shoulder amyotrophy<br>Winged scapula|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|162100 ~	.	.	.	.	.	.	.	.	17	MU82000309	hom
17	75494705	75494705	A	G	SEPTIN9	exonic	nonsynonymous SNV	ENSG00000184640	rs2627223	ENSG00000184640:ENST00000427180:exon10:c.A1390G:p.M464V,ENSG00000184640:ENST00000541152:exon10:c.A973G:p.M325V,ENSG00000184640:ENST00000585930:exon10:c.A1054G:p.M352V,ENSG00000184640:ENST00000591088:exon10:c.A973G:p.M325V,ENSG00000184640:ENST00000592951:exon10:c.A973G:p.M325V,ENSG00000184640:ENST00000329047:exon11:c.A1672G:p.M558V,ENSG00000184640:ENST00000423034:exon11:c.A1705G:p.M569V,ENSG00000184640:ENST00000427674:exon11:c.A1234G:p.M412V,ENSG00000184640:ENST00000588690:exon11:c.A1234G:p.M412V,ENSG00000184640:ENST00000590294:exon11:c.A1672G:p.M558V,ENSG00000184640:ENST00000591198:exon11:c.A1669G:p.M557V,ENSG00000184640:ENST00000427177:exon12:c.A1726G:p.M576V,ENSG00000184640:ENST00000431235:exon12:c.A1234G:p.M412V,ENSG00000184640:ENST00000449803:exon12:c.A1234G:p.M412V	SEPTIN9:NM_001113495:exon10:c.A1390G:p.M464V,SEPTIN9:NM_001113496:exon10:c.A973G:p.M325V,SEPTIN9:NM_001293696:exon10:c.A1054G:p.M352V,SEPTIN9:NM_001293697:exon10:c.A973G:p.M325V,SEPTIN9:NM_001293698:exon10:c.A973G:p.M325V,SEPTIN9:NM_001113493:exon11:c.A1705G:p.M569V,SEPTIN9:NM_001113494:exon11:c.A1234G:p.M412V,SEPTIN9:NM_001293695:exon11:c.A1669G:p.M557V,SEPTIN9:NM_006640:exon11:c.A1672G:p.M558V,SEPTIN9:NM_001113491:exon12:c.A1726G:p.M576V,SEPTIN9:NM_001113492:exon12:c.A1234G:p.M412V	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9371	0.8923	0.90655	0.8893	-0.847	0.034	1.0	2.77	0.063	.	.	P-loop containing nucleoside triphosphate hydrolase|Septin-type guanine nucleotide-binding (G) domain;Septin-type guanine nucleotide-binding (G) domain	SEPT9:uc002jty.4:exon10:c.A973G:p.M325V,SEPT9:uc010dhd.3:exon10:c.A1390G:p.M464V,SEPT9:uc010wtl.2:exon10:c.A1054G:p.M352V,SEPT9:uc010wtm.2:exon10:c.A973G:p.M325V,SEPT9:uc010wtn.2:exon10:c.A973G:p.M325V,SEPT9:uc002jtu.4:exon11:c.A1672G:p.M558V,SEPT9:uc002jtv.3:exon11:c.A1705G:p.M569V,SEPT9:uc002jtw.3:exon11:c.A1234G:p.M412V,SEPT9:uc010wtk.2:exon11:c.A1669G:p.M557V,SEPT9:uc002jts.4:exon12:c.A1726G:p.M576V,SEPT9:uc002jtt.4:exon12:c.A1234G:p.M412V	-0.966	AFR:0.7668,AMR:0.9614,EAS:1,FIN:0.9147,NFE:0.9343,OTH:0.9255,ASJ:0.9503	604061	162100;	2901;	2901|Acute brachial plexus neuritis<br>Brachial plexus neuritis<br>Immune brachial plexus neuropathy<br>Mononeuritis multiplex with brachial predilection<br>Neuralgic shoulder amyotrophy<br>Winged scapula|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|162100 ~	.	.	.	.	0.0	1.55	0.000	-2.36	17	MU4565432	hom
17	78298938	78298938	A	G	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs6565674	ENSG00000173821:ENST00000456466:exon18:c.A3133G:p.N1045D,ENSG00000173821:ENST00000582970:exon18:c.A3133G:p.N1045D,ENSG00000173821:ENST00000508628:exon19:c.A3280G:p.N1094D	RNF213:NM_001256071:exon18:c.A3133G:p.N1045D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9999	.	0.999401	0.9999	.	.	.	.	.	.	.	.	RNF213:uc002jyg.1:exon15:c.A2326G:p.N776D,RNF213:uc021uen.2:exon18:c.A3133G:p.N1045D	.	AFR:1,AMR:1,EAS:0.9981,FIN:1,NFE:1,OTH:1,ASJ:1	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	MU82001690	hom
17	78305871	78305871	G	A	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs10782008	ENSG00000173821:ENST00000456466:exon21:c.G3583A:p.V1195M,ENSG00000173821:ENST00000582970:exon21:c.G3583A:p.V1195M,ENSG00000173821:ENST00000508628:exon22:c.G3730A:p.V1244M	RNF213:NM_001256071:exon21:c.G3583A:p.V1195M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5764	0.5907	0.488818	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	0.340	6.078	0.203	1.26	0.018	.	.	.	RNF213:uc002jyg.1:exon18:c.G2776A:p.V926M,RNF213:uc021uen.2:exon21:c.G3583A:p.V1195M	-0.996	AFR:0.5731,AMR:0.4597,EAS:0.6233,FIN:0.4054,NFE:0.6884,OTH:0.6364,ASJ:0.3947	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	1.88	0.000	0.99	17	2(lung)	0.6150
17	78306102	78306102	G	C	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs9913636	ENSG00000173821:ENST00000456466:exon21:c.G3814C:p.E1272Q,ENSG00000173821:ENST00000582970:exon21:c.G3814C:p.E1272Q,ENSG00000173821:ENST00000508628:exon22:c.G3961C:p.E1321Q	RNF213:NM_001256071:exon21:c.G3814C:p.E1272Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4389	0.3866	0.343251	1(lung)	-0.469	0.263	0.481	-2.58	0.000	.	.	.	RNF213:uc002jyg.1:exon18:c.G3007C:p.E1003Q,RNF213:uc021uen.2:exon21:c.G3814C:p.E1272Q	-0.918	AFR:MU12980178,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.2291,FIN:0.2745,NFE:0.4735,OTH:0.3888,ASJ:0.4053	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	1.86	0.000	2.045	17	1(haematopoietic_and_lymphoid_tissue)	0.5682
17	78306280	78306280	A	G	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs8074015	ENSG00000173821:ENST00000456466:exon21:c.A3992G:p.D1331G,ENSG00000173821:ENST00000582970:exon21:c.A3992G:p.D1331G,ENSG00000173821:ENST00000508628:exon22:c.A4139G:p.D1380G	RNF213:NM_001256071:exon21:c.A3992G:p.D1331G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6440	0.7032	0.596645	MU12980184	-0.774	0.049	0.198	-2.19	0.000	.	.	.	RNF213:uc002jyg.1:exon18:c.A3185G:p.D1062G,RNF213:uc021uen.2:exon21:c.A3992G:p.D1331G	-1.081	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579,AMR:0.6691,EAS:0.4522,FIN:0.6788,NFE:0.4024,OTH:0.7059,ASJ:0.7250	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	3.93	0.000	2.14	17	1(haematopoietic_and_lymphoid_tissue)	0.6691
17	78306308	78306308	C	G	RNF213	exonic	synonymous SNV	ENSG00000173821	rs9908287	ENSG00000173821:ENST00000456466:exon21:c.C4020G:p.V1340V,ENSG00000173821:ENST00000582970:exon21:c.C4020G:p.V1340V,ENSG00000173821:ENST00000508628:exon22:c.C4167G:p.V1389V	RNF213:NM_001256071:exon21:c.C4020G:p.V1340V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5725	0.5907	0.48742	MU14558322	.	.	.	.	.	.	.	.	RNF213:uc002jyg.1:exon18:c.C3213G:p.V1071V,RNF213:uc021uen.2:exon21:c.C4020G:p.V1340V	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,AMR:0.5724,EAS:0.3938,FIN:0.6258,NFE:0.3937,OTH:0.6883,ASJ:0.4601	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	2(large_intestine)	0.6360
17	78311508	78311508	G	A	RNF213	exonic	synonymous SNV	ENSG00000173821	rs4890009	ENSG00000173821:ENST00000582970:exon24:c.G4650A:p.A1550A,ENSG00000173821:ENST00000508628:exon25:c.G4797A:p.A1599A	RNF213:NM_001256071:exon24:c.G4650A:p.A1550A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6463	0.7081	0.598043	0.6720	.	.	.	.	.	.	.	.	RNF213:uc021uen.2:exon24:c.G4650A:p.A1550A	.	AFR:0.7383,AMR:0.4532,EAS:0.3756,FIN:0.7053,NFE:0.6702,OTH:0.6602,ASJ:0.6867	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	MU4565558	hom
17	78319380	78319380	G	C	RNF213	exonic	synonymous SNV	ENSG00000173821	rs4890012	ENSG00000173821:ENST00000336301:exon4:c.G1464C:p.P488P,ENSG00000173821:ENST00000582970:exon29:c.G7245C:p.P2415P,ENSG00000173821:ENST00000508628:exon30:c.G7392C:p.P2464P	RNF213:NM_001256071:exon29:c.G7245C:p.P2415P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5673	0.5725	0.473243	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	RNF213:uc021uen.2:exon29:c.G7245C:p.P2415P	.	AFR:0.5618,AMR:0.4197,EAS:0.6324,FIN:0.3897,NFE:0.6884,OTH:0.6375,ASJ:0.3969	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	3(large_intestine)	0.6181
17	78327358	78327358	G	A	RNF213	exonic	synonymous SNV	ENSG00000173821	rs7216493	ENSG00000173821:ENST00000336301:exon9:c.G4689A:p.E1563E,ENSG00000173821:ENST00000582970:exon34:c.G10470A:p.E3490E,ENSG00000173821:ENST00000508628:exon35:c.G10617A:p.E3539E	RNF213:NM_001256071:exon34:c.G10470A:p.E3490E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6657	0.7094	0.628994	1(stomach)	.	.	.	.	.	.	.	.	RNF213:uc021uen.2:exon34:c.G10470A:p.E3490E	.	AFR:MU584313,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.6880,FIN:0.4797,NFE:0.7152,OTH:0.5329,ASJ:0.6846	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.7239
17	78327482	78327482	T	A	RNF213-AS1	ncRNA_exonic	.	ENSG00000263069	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	.	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	78334206	78334206	G	A	RNF213-AS1	ncRNA_intronic	.	ENSG00000263069	rs8078251	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.45008	0.5860	.	.	.	.	.	.	.	.	.	.	AFR:0.3870,AMR:0.4189,EAS:0.3572,FIN:0.7182,NFE:0.6973,OTH:0.6609,ASJ:0.7053	.	.	.	.	.	.	.	.	.	.	.	.	17	MU14558984	het
17	78410833	78410833	G	A	ENDOV	UTR3	.	ENSG00000173818	rs41303566	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.0708866	0.0611	.	.	.	.	.	.	.	.	.	.	AFR:0.0189,AMR:0.1611,EAS:0.0494,FIN:0.0641,NFE:0.0804,OTH:0.0765,ASJ:0.0166	.	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	78820272	78820272	G	A	RPTOR	splicing	.	ENSG00000141564	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	4.206	23.9	.	4.92	0.925	0.9999	0.92	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607130	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	78820329	78820329	C	T	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs3751945	ENSG00000141564:ENST00000537330:exon10:c.C714T:p.G238G,ENSG00000141564:ENST00000306801:exon11:c.C1269T:p.G423G,ENSG00000141564:ENST00000544334:exon11:c.C1269T:p.G423G	RPTOR:NM_001163034:exon11:c.C1269T:p.G423G,RPTOR:NM_020761:exon11:c.C1269T:p.G423G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5777	0.4962	0.436701	1(thyroid)	.	.	.	.	.	.	.	.	RPTOR:uc010wuf.1:exon10:c.C714T:p.G238G,RPTOR:uc002jyt.1:exon11:c.C1269T:p.G423G,RPTOR:uc010wug.1:exon11:c.C1269T:p.G423G	.	AFR:1(large_intestine),AMR:MU153336,EAS:0.5072,FIN:0.2247,NFE:0.6065,OTH:0.4901,ASJ:SKCA-BR|1|100|0.01,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,BLCA-CN|1|103|0.00970874	607130	.	.	.	.	.	.	.	.	.	.	.	17	2(lung)	0.4466
17	79518110	79518110	T	A	FAAP100	exonic	nonsynonymous SNV	ENSG00000185504	.	ENSG00000185504:ENST00000536161:exon2:c.A230T:p.D77V,ENSG00000185504:ENST00000327787:exon3:c.A410T:p.D137V	FAAP100:NM_025161:exon3:c.A410T:p.D137V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	3.148	22.6	0.045	3.38	0.005	.	.	WD40/YVTN repeat-like-containing domain	C17orf70:uc002kaq.3:exon3:c.A410T:p.D137V	-1.019	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	611301	.	.	.	.	.	.	.	0.95	1.41	0.083	2.25	17	.	hom
17	79974731	79974731	T	C	ASPSCR1	exonic	synonymous SNV	ENSG00000169696	rs13087	ENSG00000169696:ENST00000584454:exon15:c.T1351C:p.C451R	ASPSCR1:NM_001330528:exon13:c.T1305C:p.D435D,ASPSCR1:NM_024083:exon14:c.T1461C:p.D487D,ASPSCR1:NM_001251888:exon15:c.T1743C:p.D581D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5906	0.6464	0.580272	1(urinary_tract)	.	.	.	.	.	.	.	.	ASPSCR1:uc002kda.3:exon13:c.T1305C:p.D435D,ASPSCR1:uc021ufj.1:exon13:c.T1230C:p.D410D,ASPSCR1:uc002kcx.3:exon14:c.T1461C:p.D487D,ASPSCR1:uc002kcy.3:exon15:c.T1743C:p.D581D	.	AFR:1(stomach),AMR:2(lung),EAS:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,FIN:0.6414,NFE:0.7619,OTH:0.5167,ASJ:MU796615	606236	606243;	163699;	163699|ASPS<br>Alveolar soft-part sarcoma|-|-|All ages|606243 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	17	1(thyroid)	0.6093
17	80050439	80050439	G	A	FASN	exonic	synonymous SNV	ENSG00000169710	.	ENSG00000169710:ENST00000306749:exon8:c.C921T:p.G307G	FASN:NM_004104:exon8:c.C921T:p.G307G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	FASN:uc002kdu.3:exon8:c.C921T:p.G307G	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600212	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	80050557	80050557	G	-	FASN	intronic	.	ENSG00000169710	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600212	.	.	.	.	.	.	.	.	.	.	.	17	.	unknown
18	724612	724612	A	G	YES1	exonic	synonymous SNV	ENSG00000176105	rs537141	ENSG00000176105:ENST00000314574:exon12:c.T1444C:p.L482L,ENSG00000176105:ENST00000577961:exon12:c.T1459C:p.L487L,ENSG00000176105:ENST00000584307:exon12:c.T1444C:p.L482L	YES1:NM_005433:exon12:c.T1444C:p.L482L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9973	0.9913	0.989816	0.9924	.	.	.	.	.	.	.	.	YES1:uc002kky.3:exon12:c.T1444C:p.L482L,YES1:uc002kkz.3:exon12:c.T1444C:p.L482L	.	AFR:0.9731,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	164880	.	.	.	.	.	.	.	.	.	.	.	18	MU82003345	hom
18	20577669	20577669	G	A	RBBP8	exonic	synonymous SNV	ENSG00000101773	rs17852769	ENSG00000101773:ENST00000583057:exon4:c.G459A:p.K153K,ENSG00000101773:ENST00000327155:exon14:c.G2115A:p.K705K,ENSG00000101773:ENST00000360790:exon14:c.G2115A:p.K705K,ENSG00000101773:ENST00000399722:exon14:c.G2115A:p.K705K,ENSG00000101773:ENST00000399725:exon14:c.G2115A:p.K705K	RBBP8:NM_002894:exon14:c.G2115A:p.K705K,RBBP8:NM_203291:exon14:c.G2115A:p.K705K,RBBP8:NM_203292:exon14:c.G2115A:p.K705K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1610	0.1943	0.16873	ESAD-UK|1|409|0.00244499	.	.	.	.	.	.	.	.	RBBP8:uc010xap.2:exon2:c.G114A:p.K38K,RBBP8:uc002ktw.3:exon14:c.G2115A:p.K705K,RBBP8:uc002kty.3:exon14:c.G2115A:p.K705K,RBBP8:uc002ktz.3:exon14:c.G2115A:p.K705K,RBBP8:uc002kua.3:exon14:c.G2115A:p.K705K	.	AFR:0.1736,AMR:0.3333,EAS:0.1589,FIN:0.0012,NFE:0.1147,OTH:0.1216,ASJ:0.0668	604124	251255;606744;	808;313795;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~313795|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|251255 ~	.	.	.	.	.	.	.	.	18	1(haematopoietic_and_lymphoid_tissue)	0.1426
18	28673565	28673565	T	C	DSC2	exonic	synonymous SNV	ENSG00000134755	rs12954874	ENSG00000134755:ENST00000251081:exon2:c.A111G:p.L37L,ENSG00000134755:ENST00000280904:exon2:c.A111G:p.L37L	DSC2:NM_004949:exon2:c.A111G:p.L37L,DSC2:NM_024422:exon2:c.A111G:p.L37L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1127	0.1071	0.123602	ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	DSC2:uc002kwk.4:exon2:c.A111G:p.L37L,DSC2:uc002kwl.4:exon2:c.A111G:p.L37L,DSC2:uc010xbo.1:exon2:c.A111G:p.L37L	.	AFR:0.0998,AMR:0.0819,EAS:0.1424,FIN:0.1166,NFE:0.0370,OTH:0.1185,ASJ:0.1541	125645	610476;	217656;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	18	1(breast)	0.1063
18	29126670	29126670	T	C	DSG2	exonic	synonymous SNV	ENSG00000046604	rs1791235	ENSG00000046604:ENST00000261590:exon15:c.T3321C:p.V1107V	DSG2:NM_001943:exon15:c.T3321C:p.V1107V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4233	0.4731	0.542931	LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	DSG2:uc002kwu.4:exon15:c.T3321C:p.V1107V	.	AFR:0.4896,AMR:0.6868,EAS:0.3311,FIN:0.6954,NFE:0.4066,OTH:0.3807,ASJ:0.4928	125671	610193;612877;	154;217656;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	18	1(lung)	0.4051
18	42456653	42456653	G	A	SETBP1	exonic	nonsynonymous SNV	ENSG00000152217	rs663651	ENSG00000152217:ENST00000426838:exon4:c.G664A:p.A222T	SETBP1:NM_001130110:exon4:c.G664A:p.A222T	clinvar: Likely_benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5073	.	0.493011	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	0.009	2.674	0.0	-0.915	0.008	.	.	.	SETBP1:uc002lay.3:exon4:c.G664A:p.A222T	-0.932	AFR:0.5436,AMR:0.5363,EAS:0.5430,FIN:0.4806,NFE:0.5923,OTH:0.5489,ASJ:0.4330	611060	269150;616078;	436151;798;	436151|Intellectual disability-loss of expressive language-facial dysmorphism syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616078 616083 ~798|SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal<br>Infancy|269150 ~	.	,9643	.	9646,,9647	0.0	.	0.000	.	18	1(haematopoietic_and_lymphoid_tissue)	0.5521
18	42456670	42456670	-	TCTT	SETBP1	exonic	frameshift insertion	ENSG00000152217	rs3085861	ENSG00000152217:ENST00000426838:exon4:c.681_682insTCTT:p.L227fs	SETBP1:NM_001130110:exon4:c.681_682insTCTT:p.L227fs	clinvar: Benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5146	0.5344	0.49381	.	.	.	.	.	.	.	.	.	SETBP1:uc002lay.3:exon4:c.681_682insTCTT:p.L227fs	.	AFR:.,AMR:0.5398,EAS:0.4305,FIN:0.54,NFE:0.4763,OTH:0.5917,ASJ:0.5336	611060	269150;616078;	436151;798;	436151|Intellectual disability-loss of expressive language-facial dysmorphism syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616078 616083 ~798|SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal<br>Infancy|269150 ~	.	,9643	.	9646,,9647	.	.	.	.	18	16(upper_aerodigestive_tract)	0.5438
18	42533130	42533130	A	G	SETBP1	exonic	synonymous SNV	ENSG00000152217	rs8096662	ENSG00000152217:ENST00000282030:exon4:c.A3825G:p.S1275S	SETBP1:NM_015559:exon4:c.A3825G:p.S1275S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8775	0.8996	0.906949	0.9062	.	.	.	.	.	.	.	.	SETBP1:uc010dni.3:exon4:c.A3825G:p.S1275S	.	AFR:0.9722,AMR:0.9427,EAS:0.9560,FIN:0.8886,NFE:0.8676,OTH:0.8663,ASJ:0.8775	611060	269150;616078;	436151;798;	436151|Intellectual disability-loss of expressive language-facial dysmorphism syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616078 616083 ~798|SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal<br>Infancy|269150 ~	.	,9643	.	9646,,9647	.	.	.	.	18	MU21144927	hom
18	49867224	49867224	T	C	DCC	exonic	nonsynonymous SNV	ENSG00000187323	rs9951523	ENSG00000187323:ENST00000442544:exon1:c.T67C:p.F23L	DCC:NM_005215:exon1:c.T67C:p.F23L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9862	0.9892	0.995807	0.9833	1.932	15.79	1.0	4.83	0.995	.	.	Immunoglobulin-like domain	DCC:uc002lfe.2:exon1:c.T67C:p.F23L	-0.966	AFR:0.9979,AMR:0.9904,EAS:1,FIN:0.9399,NFE:0.9834,OTH:0.9735,ASJ:0.9801	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	0.0	0.84	0.000	0	18	MU82007106	hom
18	50432602	50432602	C	G	DCC	exonic	nonsynonymous SNV	ENSG00000187323	rs2229080	ENSG00000187323:ENST00000412726:exon3:c.C145G:p.R49G,ENSG00000187323:ENST00000442544:exon3:c.C601G:p.R201G	DCC:NM_005215:exon3:c.C601G:p.R201G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4447	0.3594	0.477436	MU788932	2.708	20.9	0.114	-0.494	0.993	.	.	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	DCC:uc002lfe.2:exon3:c.C601G:p.R201G,DCC:uc010xdr.1:exon3:c.C145G:p.R49G	-0.913	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.3620,EAS:0.5769,FIN:0.4867,NFE:0.5330,OTH:0.3907,ASJ:0.3290	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	0.083	1.11	0.000	0.405	18	1(haematopoietic_and_lymphoid_tissue)	0.3401
18	53303101	53303101	C	G	TCF4	exonic	nonsynonymous SNV	ENSG00000196628	rs611326	ENSG00000196628:ENST00000398339:exon1:c.G28C:p.A10P,ENSG00000196628:ENST00000565124:exon1:c.G28C:p.A10P	TCF4:NM_001243226:exon1:c.G28C:p.A10P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9994	0.9988	0.996805	0.9987	.	.	.	.	.	.	.	.	TCF4:uc002lga.3:exon1:c.G28C:p.A10P,TCF4:uc021ukp.1:exon1:c.G28C:p.A10P	.	AFR:0.9953,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	602272	610954;613267;	98974;2896;	98974|Endoepithelial corneal dystrophy<br>FECD<br>Late hereditary endothelial dystrophy|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|136800 610158 613267 613268 613269 613270 613271 615523 ~2896|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|610954 ~	.	.	.	.	.	.	.	.	18	MU82007295	hom
18	60970036	60970036	C	A	BCL2	intronic	.	ENSG00000171791	rs4941195	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.583067	0.5089	.	.	.	.	.	.	.	.	.	.	AFR:0.6602,AMR:0.4544,EAS:0.7348,FIN:0.4121,NFE:0.4239,OTH:0.4561,ASJ:0.6026	151430	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04141 Protein processing in endoplasmic reticulum~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04261 Adrenergic signaling in cardiomyocytes~ko04340 Hedgehog signaling pathway~ko04510 Focal adhesion~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04915 Estrogen signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05162 Measles~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05215 Prostate cancer~ko05222 Small cell lung cancer~ko05226 Gastric cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	18	MU13088314	hom
18	67718688	67718688	A	G	RTTN	exonic	nonsynonymous SNV	ENSG00000176225	rs4891392	ENSG00000176225:ENST00000255674:exon39:c.T5282C:p.F1761S	RTTN:NM_001318520:exon38:c.T2546C:p.F849S,RTTN:NM_173630:exon39:c.T5282C:p.F1761S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9184	0.8027	0.790735	0.8082	-0.332	0.561	0.978	-1.23	0.000	.	.	Armadillo-like helical	RTTN:uc010dqp.2:exon5:c.T38C:p.F13S,RTTN:uc010xfb.1:exon38:c.T2546C:p.F849S,RTTN:uc002lkp.2:exon39:c.T5282C:p.F1761S	-1.032	AFR:0.4213,AMR:0.9391,EAS:1,FIN:0.9619,NFE:0.9574,OTH:0.9439,ASJ:0.9404	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	0.0	0.93	0.000	-0.65	18	MU82008699	hom
18	67802449	67802449	T	C	RTTN	exonic	synonymous SNV	ENSG00000176225	rs35139926	ENSG00000176225:ENST00000255674:exon22:c.A2856G:p.L952L,ENSG00000176225:ENST00000437017:exon22:c.A2856G:p.L952L	RTTN:NM_001318520:exon21:c.A120G:p.L40L,RTTN:NM_173630:exon22:c.A2856G:p.L952L	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0193	0.0181	0.00539137	0.0237	.	.	.	.	.	.	.	.	RTTN:uc010xfb.1:exon21:c.A120G:p.L40L,RTTN:uc002lkp.2:exon22:c.A2856G:p.L952L	.	AFR:0.0036,AMR:0.0024,EAS:0,FIN:0.0522,NFE:0.0323,OTH:0.0316,ASJ:0.0132	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	.	.	.	.	18	.	hom
18	67863850	67863850	-	CTC	RTTN	exonic	nonframeshift insertion	ENSG00000176225	rs58913700	ENSG00000176225:ENST00000583043:exon2:c.97_98insGAG:p.D33delinsGD,ENSG00000176225:ENST00000255674:exon7:c.727_728insGAG:p.D243delinsGD,ENSG00000176225:ENST00000437017:exon7:c.727_728insGAG:p.D243delinsGD,ENSG00000176225:ENST00000454359:exon7:c.727_728insGAG:p.D243delinsGD,ENSG00000176225:ENST00000581161:exon7:c.727_728insGAG:p.D243delinsGD	RTTN:NM_173630:exon7:c.727_728insGAG:p.D243delinsGD	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9870	0.9540	0.952676	0.9584	.	.	.	.	.	.	.	.	RTTN:uc002lkp.2:exon7:c.727_728insGAG:p.D243delinsGD,RTTN:uc002lkq.1:exon7:c.727_728insGAG:p.D243delinsGD	.	AFR:0.8541,AMR:0.9892,EAS:1,FIN:1,NFE:0.9994,OTH:0.9969,ASJ:1	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	.	.	.	.	18	.	hom
18	72343008	72343008	T	C	ZNF407	exonic	synonymous SNV	ENSG00000215421	rs7243081	ENSG00000215421:ENST00000299687:exon1:c.T33C:p.D11D,ENSG00000215421:ENST00000309902:exon1:c.T33C:p.D11D,ENSG00000215421:ENST00000577538:exon1:c.T33C:p.D11D,ENSG00000215421:ENST00000582337:exon2:c.T33C:p.D11D	ZNF407:NM_001146189:exon1:c.T33C:p.D11D,ZNF407:NM_001146190:exon1:c.T33C:p.D11D,ZNF407:NM_017757:exon1:c.T33C:p.D11D	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9898	0.9987	0.99361	0.9969	.	.	.	.	.	.	.	.	ZNF407:uc002llw.2:exon1:c.T33C:p.D11D,ZNF407:uc010dqu.2:exon1:c.T33C:p.D11D,ZNF407:uc010xfc.2:exon1:c.T33C:p.D11D,ZNF407:uc002llu.2:exon2:c.T30C:p.D10D	.	AFR:0.9984,AMR:0.9093,EAS:1,FIN:1,NFE:0.9999,OTH:0.9939,ASJ:1	615894	.	.	.	.	.	.	.	.	.	.	.	18	MU82009013	hom
18	72343344	72343344	A	G	ZNF407	exonic	synonymous SNV	ENSG00000215421	.	ENSG00000215421:ENST00000299687:exon1:c.A369G:p.G123G,ENSG00000215421:ENST00000309902:exon1:c.A369G:p.G123G,ENSG00000215421:ENST00000577538:exon1:c.A369G:p.G123G,ENSG00000215421:ENST00000582337:exon2:c.A369G:p.G123G	ZNF407:NM_001146189:exon1:c.A369G:p.G123G,ZNF407:NM_001146190:exon1:c.A369G:p.G123G,ZNF407:NM_017757:exon1:c.A369G:p.G123G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	ZNF407:uc002llw.2:exon1:c.A369G:p.G123G,ZNF407:uc010dqu.2:exon1:c.A369G:p.G123G,ZNF407:uc010xfc.2:exon1:c.A369G:p.G123G,ZNF407:uc002llu.2:exon2:c.A366G:p.G122G	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	615894	.	.	.	.	.	.	.	.	.	.	.	18	.	hom
18	72776374	72776374	G	A	ZNF407	exonic	nonsynonymous SNV	ENSG00000215421	rs377200520	ENSG00000215421:ENST00000299687:exon8:c.G6697A:p.A2233T	ZNF407:NM_017757:exon8:c.G6697A:p.A2233T	clinvar: Uncertain_significance 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0004	.	.	0.0001	1.134	11.40	0.234	2.93	0.000	.	.	.	ZNF407:uc002llw.2:exon8:c.G6697A:p.A2233T	-1.073	AFR:0.0005,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	615894	.	.	.	.	.	.	.	0.036	2.81	0.029	0.255	18	.	hom
18	74980809	74980809	G	A	GALR1	exonic	nonsynonymous SNV	ENSG00000166573	rs5376	ENSG00000166573:ENST00000299727:exon3:c.G1001A:p.S334N	GALR1:NM_001480:exon3:c.G1001A:p.S334N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9731	0.8956	0.90615	0.9156	-0.581	0.139	0.882	1.01	0.007	.	.	.	GALR1:uc002lms.4:exon3:c.G1001A:p.S334N	-0.988	AFR:0.7061,AMR:0.9749,EAS:1,FIN:1,NFE:0.9992,OTH:0.9807,ASJ:1	600377	.	.	.	.	.	.	.	0.0	-0.49	0.000	-0.845	18	MU82009144	hom
19	929753	929753	A	G	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs1799595	ENSG00000116017:ENST00000263620:exon2:c.A225G:p.P75P	ARID3A:NM_005224:exon2:c.A225G:p.P75P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8572	0.8751	0.884185	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon2:c.A225G:p.P75P	.	AFR:0.8675,AMR:0.9034,EAS:0.8344,FIN:0.9994,NFE:0.8457,OTH:0.8432,ASJ:0.8077	603265	.	.	.	.	.	.	.	.	.	.	.	19	1(large_intestine)	0.8415
19	965043	965043	T	C	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs12608658	ENSG00000116017:ENST00000587532:exon4:c.T702C:p.N234N,ENSG00000116017:ENST00000263620:exon6:c.T1161C:p.N387N	ARID3A:NM_005224:exon6:c.T1161C:p.N387N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9575	0.9483	0.938898	0.9532	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon6:c.T1161C:p.N387N	.	AFR:0.8858,AMR:0.8699,EAS:1,FIN:0.9951,NFE:0.9802,OTH:0.9735,ASJ:0.9868	603265	.	.	.	.	.	.	.	.	.	.	.	19	MU82010062	hom
19	1624007	1624007	A	G	TCF3	intronic	.	ENSG00000071564	rs55677929	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2663	0.2472	0.366813	0.2731	.	.	.	.	.	0	0	.	.	.	AFR:0.2959,AMR:0.2518,EAS:0.6677,FIN:0.2319,NFE:0.2289,OTH:0.2602,ASJ:0.2815	147141	616941;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	~ko04550 Signaling pathways regulating pluripotency of stem cells~ko05166 Human T-cell leukemia virus 1 infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	19	MU27524588	hom
19	3119184	3119184	T	G	GNA11	intronic	.	ENSG00000267139	rs308046	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8340	0.8159	0.773562	0.8281	.	.	.	.	.	.	.	.	.	.	AFR:0.7489,AMR:0.8914,EAS:0.7451,FIN:0.8723,NFE:0.8656,OTH:0.8801,ASJ:0.8411	139313	145981;615361;	2238;428;101049;405;	2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~101049|FHH type 2|-|Autosomal dominant|-|145981 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~	~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04270 Vascular smooth muscle contraction~ko04540 Gap junction~ko04725 Cholinergic synapse~ko04730 Long-term depression~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	19	MU21352930	het
19	3119239	3119239	C	T	GNA11	exonic	synonymous SNV	ENSG00000088256	rs4900	ENSG00000088256:ENST00000078429:exon6:c.C771T:p.T257T	GNA11:NM_002067:exon6:c.C771T:p.T257T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4263	0.3822	0.348842	10(meninges)	.	.	.	.	.	.	.	.	GNA11:uc002lxd.3:exon6:c.C771T:p.T257T	.	AFR:1(lung),AMR:MU58843,EAS:0.3830,FIN:0.2226,NFE:0.4448,OTH:0.3775,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	139313	145981;615361;	2238;428;101049;405;	2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~101049|FHH type 2|-|Autosomal dominant|-|145981 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~	~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04270 Vascular smooth muscle contraction~ko04540 Gap junction~ko04725 Cholinergic synapse~ko04730 Long-term depression~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer ~	,5850,5858,5856,5855,5852,5849,5853,5854,5859,5857,5851	.	.	.	.	.	.	19	1(large_intestine)	0.4158
19	4117528	4117528	G	A	MAP2K2	exonic	synonymous SNV	ENSG00000126934	rs8157	ENSG00000126934:ENST00000262948:exon2:c.C192T:p.V64V	MAP2K2:NM_030662:exon2:c.C192T:p.V64V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0619	0.0631	0.0583067	0.0710	.	.	.	.	.	.	.	.	MAP2K2:uc002lzk.3:exon2:c.C192T:p.V64V	.	AFR:0.0747,AMR:0.0346,EAS:0.0247,FIN:0.0822,NFE:0.0732,OTH:0.0866,ASJ:0.0298	601263	615280;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04620 Toll-like receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05020 Prion diseases~ko05135 Yersinia infection~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7233	.	.	.	.	.	.	19	MU116661746	hom
19	4362691	4362691	G	C	SH3GL1	exonic	synonymous SNV	ENSG00000141985	rs243261	ENSG00000141985:ENST00000417295:exon7:c.C627G:p.P209P,ENSG00000141985:ENST00000269886:exon8:c.C771G:p.P257P,ENSG00000141985:ENST00000598564:exon8:c.C579G:p.P193P	SH3GL1:NM_001199943:exon7:c.C627G:p.P209P,SH3GL1:NM_001199944:exon8:c.C579G:p.P193P,SH3GL1:NM_003025:exon8:c.C771G:p.P257P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3346	0.3021	0.391573	0.3198	.	.	.	.	.	.	.	.	SH3GL1:uc010xig.2:exon7:c.C627G:p.P209P,SH3GL1:uc002maj.3:exon8:c.C771G:p.P257P,SH3GL1:uc002mak.3:exon8:c.C579G:p.P193P	.	AFR:0.3323,AMR:0.4484,EAS:0.5743,FIN:0.3356,NFE:0.2734,OTH:0.3340,ASJ:0.3133	601768	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	19	MU4612009	het
19	5595354	5595354	T	C	SAFB2	intronic	.	ENSG00000130254	rs10413286	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7299	0.7219	0.809305	0.7275	.	.	.	.	.	.	.	.	.	.	AFR:0.8615,AMR:0.7780,EAS:0.8908,FIN:0.6507,NFE:0.6490,OTH:0.6837,ASJ:0.77	608066	.	.	.	.	.	.	.	.	.	.	.	19	MU19175690	hom
19	5696245	5696245	A	G	LONP1	intronic	.	ENSG00000196365	rs4073993	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6030	0.6852	0.540735	MU734612	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.6411,EAS:0.5156,FIN:0.6358,NFE:0.2515,OTH:0.5842,ASJ:0.6682	605490	600373;	1458;	1458|Cerebro-oculo-dento-auriculo-skeletal syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|600373 ~	.	.	.	.	.	.	.	.	19	1(liver)	0.6880
19	6586268	6586268	G	A	CD70	exonic	synonymous SNV	ENSG00000125726	rs1862511	ENSG00000125726:ENST00000245903:exon3:c.C345T:p.C115C,ENSG00000125726:ENST00000423145:exon3:c.C345T:p.C115C	CD70:NM_001252:exon3:c.C345T:p.C115C,CD70:NM_001330332:exon3:c.C345T:p.C115C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3201	0.2632	0.350639	0.2883	.	.	.	.	.	.	.	.	CD70:uc002mfi.3:exon3:c.C345T:p.C115C,CD70:uc010xjf.1:exon3:c.C345T:p.C115C	.	AFR:0.1934,AMR:0.2279,EAS:0.6958,FIN:0.3762,NFE:0.2822,OTH:0.2971,ASJ:0.2616	602840	.	.	.	.	.	.	.	.	.	.	.	19	MU4574437	hom
19	6822219	6822219	T	C	VAV1	intronic	.	ENSG00000141968	rs347033	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2609	0.2214	0.211262	0.2123	.	.	.	.	.	.	.	.	.	.	AFR:0.2801,AMR:0.1480,EAS:0.2419,FIN:0.1973,NFE:0.1791,OTH:0.1840,ASJ:0.1954	164875	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	MU82014037	hom
19	7166388	7166388	G	A	INSR	exonic	synonymous SNV	ENSG00000171105	rs2229429	ENSG00000171105:ENST00000600492:exon2:c.C39T:p.D13D,ENSG00000171105:ENST00000302850:exon8:c.C1638T:p.D546D,ENSG00000171105:ENST00000341500:exon8:c.C1638T:p.D546D	INSR:NM_000208:exon8:c.C1638T:p.D546D,INSR:NM_001079817:exon8:c.C1638T:p.D546D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2075	0.2776	0.256589	MU727999	.	.	.	.	.	.	.	.	INSR:uc002mgd.1:exon8:c.C1638T:p.D546D,INSR:uc002mge.1:exon8:c.C1638T:p.D546D,INSR:uc002mgf.3:exon8:c.C1638T:p.D546D	.	AFR:ESAD-UK|2|409|0.00488998,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,AMR:0.2495,EAS:0.1607,FIN:0.2053,NFE:0.0551,OTH:0.1377,ASJ:0.4311	147670	246200;262190;609968;610549;	2297;263458;769;508;	2297|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610549 ~263458|Hyperinsulinemic hypoglycemia due to INSR deficiency<br>Hyperinsulinemic hypoglycemia due to insulin receptor deficiency|<1 / 1 000 000|Autosomal dominant|All ages|609968 ~769|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|262190 ~508|Donohue syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|246200 ~	.	.	.	.	.	.	.	.	19	2(lung)	0.2008
19	7184518	7184518	G	A	INSR	exonic	synonymous SNV	ENSG00000171105	rs891087	ENSG00000171105:ENST00000302850:exon3:c.C783T:p.D261D,ENSG00000171105:ENST00000341500:exon3:c.C783T:p.D261D	INSR:NM_000208:exon3:c.C783T:p.D261D,INSR:NM_001079817:exon3:c.C783T:p.D261D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1029	0.1255	0.138578	LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647	.	.	.	.	.	.	.	.	INSR:uc002mgd.1:exon3:c.C783T:p.D261D,INSR:uc002mge.1:exon3:c.C783T:p.D261D,INSR:uc002mgf.3:exon3:c.C783T:p.D261D	.	AFR:0.1165,AMR:0.2039,EAS:0.0563,FIN:0.0316,NFE:0.0803,OTH:0.0895,ASJ:0.0549	147670	246200;262190;609968;610549;	2297;263458;769;508;	2297|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610549 ~263458|Hyperinsulinemic hypoglycemia due to INSR deficiency<br>Hyperinsulinemic hypoglycemia due to insulin receptor deficiency|<1 / 1 000 000|Autosomal dominant|All ages|609968 ~769|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|262190 ~508|Donohue syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|246200 ~	.	.	.	.	.	.	.	.	19	4(soft_tissue)	0.0949
19	10265312	10265312	T	C	DNMT1	exonic	synonymous SNV	ENSG00000130816	rs721186	ENSG00000130816:ENST00000340748:exon20:c.A1734G:p.T578T,ENSG00000130816:ENST00000540357:exon20:c.A1734G:p.T578T,ENSG00000130816:ENST00000359526:exon21:c.A1782G:p.T594T	DNMT1:NM_001318730:exon20:c.A1734G:p.T578T,DNMT1:NM_001379:exon20:c.A1734G:p.T578T,DNMT1:NM_001130823:exon21:c.A1782G:p.T594T,DNMT1:NM_001318731:exon21:c.A1419G:p.T473T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9910	0.9897	0.995807	0.9905	.	.	.	.	.	.	.	.	DNMT1:uc002mng.3:exon20:c.A1734G:p.T578T,DNMT1:uc010xld.2:exon20:c.A1734G:p.T578T,DNMT1:uc002mnh.3:exon21:c.A1419G:p.T473T,DNMT1:uc010xlc.2:exon21:c.A1782G:p.T594T	.	AFR:0.9961,AMR:0.9916,EAS:1,FIN:0.9888,NFE:0.9862,OTH:0.9969,ASJ:0.9901	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	MU82016881	hom
19	10461586	10461586	T	C	TYK2	exonic	nonsynonymous SNV	ENSG00000105397	rs55886939	ENSG00000105397:ENST00000524462:exon21:c.A2933G:p.E978G,ENSG00000105397:ENST00000264818:exon23:c.A3488G:p.E1163G,ENSG00000105397:ENST00000525621:exon25:c.A3488G:p.E1163G	TYK2:NM_003331:exon25:c.A3488G:p.E1163G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0] 	0.0067	0.0026	0.00658946	0.0021	2.094	16.82	0.02	5.68	0.851	.	.	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase, catalytic domain|Tyrosine-protein kinase, catalytic domain	TYK2:uc010dxe.3:exon21:c.A2933G:p.E978G,TYK2:uc002moc.4:exon25:c.A3488G:p.E1163G	-1.009	AFR:0.0001,AMR:0.0024,EAS:0,FIN:0.0037,NFE:0.0029,OTH:0.0061,ASJ:0.0033	176941	611521;	331226;	331226|Autosomal recessive hyper-IgE syndrome due to TYK2 deficiency|-|Autosomal recessive|-|611521 ~	.	.	.	.	0.0	-1.71	0.090	0.65	19	.	het
19	11105608	11105608	T	C	SMARCA4	exonic	synonymous SNV	ENSG00000127616	rs7935	ENSG00000127616:ENST00000413806:exon8:c.T1524C:p.H508H,ENSG00000127616:ENST00000450717:exon8:c.T1524C:p.H508H,ENSG00000127616:ENST00000344626:exon9:c.T1524C:p.H508H,ENSG00000127616:ENST00000358026:exon9:c.T1524C:p.H508H,ENSG00000127616:ENST00000590574:exon9:c.T1524C:p.H508H,ENSG00000127616:ENST00000429416:exon10:c.T1524C:p.H508H,ENSG00000127616:ENST00000444061:exon10:c.T1524C:p.H508H,ENSG00000127616:ENST00000541122:exon10:c.T1524C:p.H508H,ENSG00000127616:ENST00000589677:exon10:c.T1524C:p.H508H	SMARCA4:NM_001128845:exon8:c.T1524C:p.H508H,SMARCA4:NM_001128846:exon8:c.T1524C:p.H508H,SMARCA4:NM_001128848:exon8:c.T1524C:p.H508H,SMARCA4:NM_001128847:exon9:c.T1524C:p.H508H,SMARCA4:NM_001128849:exon9:c.T1524C:p.H508H,SMARCA4:NM_003072:exon9:c.T1524C:p.H508H,SMARCA4:NM_001128844:exon10:c.T1524C:p.H508H	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3353	0.3283	0.311502	11(soft_tissue)	.	.	.	.	.	.	.	.	SMARCA4:uc002mqg.1:exon8:c.T1524C:p.H508H,SMARCA4:uc002mqj.4:exon8:c.T1524C:p.H508H,SMARCA4:uc010dxq.3:exon8:c.T1524C:p.H508H,SMARCA4:uc010dxr.3:exon8:c.T1524C:p.H508H,SMARCA4:uc010dxs.3:exon8:c.T1524C:p.H508H,SMARCA4:uc002mqe.2:exon9:c.T1524C:p.H508H,SMARCA4:uc002mqf.4:exon9:c.T1524C:p.H508H,SMARCA4:uc010dxo.3:exon9:c.T1524C:p.H508H,SMARCA4:uc010dxp.3:exon10:c.T1524C:p.H508H	.	AFR:96(meninges),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,FIN:0.3248,NFE:0.3065,OTH:0.2127,ASJ:MU763313	603254	613325;614609;	1465;231108;69077;	1465|CSS|<1 / 1 000 000|Autosomal dominant|Neonatal|135900 614607 614608 614609 615866 616938 ~231108|RTPS<br>Rhabdoid tumor predisposition syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|609322 613325 ~69077|Malignant rhabdoid tumor|Unknown|-|Antenatal<br>Neonatal<br>Infancy<br>Childhood|609322 613325 ~	.	,9728	,9727	.	.	.	.	.	19	1(liver)	0.3808
19	11170521	11170521	G	-	SMARCA4	exonic	frameshift deletion	ENSG00000127616	.	ENSG00000127616:ENST00000413806:exon31:c.4638delG:p.E1546fs,ENSG00000127616:ENST00000450717:exon31:c.4635delG:p.E1545fs,ENSG00000127616:ENST00000590574:exon32:c.4629delG:p.E1543fs,ENSG00000127616:ENST00000344626:exon33:c.4728delG:p.E1576fs,ENSG00000127616:ENST00000444061:exon33:c.4626delG:p.E1542fs,ENSG00000127616:ENST00000541122:exon33:c.4638delG:p.E1546fs,ENSG00000127616:ENST00000589677:exon33:c.4635delG:p.E1545fs,ENSG00000127616:ENST00000358026:exon34:c.4824delG:p.E1608fs,ENSG00000127616:ENST00000429416:exon34:c.4728delG:p.E1576fs	SMARCA4:NM_001128845:exon31:c.4638delG:p.E1546fs,SMARCA4:NM_001128846:exon31:c.4635delG:p.E1545fs,SMARCA4:NM_001128848:exon31:c.4626delG:p.E1542fs,SMARCA4:NM_001128847:exon32:c.4629delG:p.E1543fs,SMARCA4:NM_003072:exon33:c.4728delG:p.E1576fs,SMARCA4:NM_001128844:exon34:c.4728delG:p.E1576fs,SMARCA4:NM_001128849:exon34:c.4824delG:p.E1608fs	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 1, 0, 1, 0, 0, 1, 0, 1, 0, 1, 1] 	.	.	.	.	.	.	.	.	.	.	.	.	SMARCA4:uc002mqh.4:exon15:c.1998delG:p.E666fs,SMARCA4:uc002mqj.4:exon31:c.4638delG:p.E1546fs,SMARCA4:uc010dxq.3:exon31:c.4629delG:p.E1543fs,SMARCA4:uc010dxr.3:exon31:c.4626delG:p.E1542fs,SMARCA4:uc010dxs.3:exon31:c.4635delG:p.E1545fs,SMARCA4:uc002mqf.4:exon33:c.4728delG:p.E1576fs,SMARCA4:uc010dxo.3:exon34:c.4824delG:p.E1608fs,SMARCA4:uc010dxp.3:exon34:c.4728delG:p.E1576fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603254	613325;614609;	1465;231108;69077;	1465|CSS|<1 / 1 000 000|Autosomal dominant|Neonatal|135900 614607 614608 614609 615866 616938 ~231108|RTPS<br>Rhabdoid tumor predisposition syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|609322 613325 ~69077|Malignant rhabdoid tumor|Unknown|-|Antenatal<br>Neonatal<br>Infancy<br>Childhood|609322 613325 ~	.	,9728	,9727	.	.	.	.	.	19	.	het
19	11221454	11221454	T	C	LDLR	intronic	.	ENSG00000130164	rs2738442	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0] 	0.9999	.	1	0.9999	.	.	.	.	.	0	0.006	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:1,ASJ:1	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	MU82017144	unknown
19	11221457	11221457	G	C	LDLR	intronic	.	ENSG00000130164	rs12710260	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3849	0.3377	0.276957	0.3290	.	.	.	.	.	.	.	.	.	.	AFR:0.0849,AMR:0.4021,EAS:0.1947,FIN:0.4894,NFE:0.4385,OTH:0.3929,ASJ:0.4139	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	MU82287187	unknown
19	11224265	11224265	A	G	LDLR	exonic	synonymous SNV	ENSG00000130164	rs5930	ENSG00000130164:ENST00000455727:exon8:c.A909G:p.R303R,ENSG00000130164:ENST00000535915:exon9:c.A1290G:p.R430R,ENSG00000130164:ENST00000545707:exon9:c.A1032G:p.R344R,ENSG00000130164:ENST00000557933:exon10:c.A1413G:p.R471R,ENSG00000130164:ENST00000558013:exon10:c.A1413G:p.R471R,ENSG00000130164:ENST00000558518:exon10:c.A1413G:p.R471R	LDLR:NM_001195800:exon8:c.A909G:p.R303R,LDLR:NM_001195799:exon9:c.A1290G:p.R430R,LDLR:NM_001195803:exon9:c.A1032G:p.R344R,LDLR:NM_000527:exon10:c.A1413G:p.R471R,LDLR:NM_001195798:exon10:c.A1413G:p.R471R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6266	0.6566	0.654952	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	LDLR:uc010xlo.2:exon8:c.A909G:p.R303R,LDLR:uc010xll.2:exon9:c.A1290G:p.R430R,LDLR:uc010xlm.2:exon9:c.A972G:p.R324R,LDLR:uc010xln.2:exon9:c.A1032G:p.R344R,LDLR:uc021upc.1:exon9:c.A1050G:p.R350R,LDLR:uc002mqk.4:exon10:c.A1413G:p.R471R,LDLR:uc010xlk.2:exon10:c.A1413G:p.R471R,LDLR:uc021upd.1:exon10:c.A624G:p.R208R	.	AFR:0.6454,AMR:0.7415,EAS:0.5762,FIN:0.6163,NFE:0.6376,OTH:0.5965,ASJ:0.6933	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5900
19	11227602	11227602	C	T	LDLR	exonic	synonymous SNV	ENSG00000130164	rs688	ENSG00000130164:ENST00000455727:exon10:c.C1269T:p.N423N,ENSG00000130164:ENST00000535915:exon11:c.C1650T:p.N550N,ENSG00000130164:ENST00000545707:exon11:c.C1392T:p.N464N,ENSG00000130164:ENST00000557933:exon12:c.C1773T:p.N591N,ENSG00000130164:ENST00000558013:exon12:c.C1773T:p.N591N,ENSG00000130164:ENST00000558518:exon12:c.C1773T:p.N591N	LDLR:NM_001195800:exon10:c.C1269T:p.N423N,LDLR:NM_001195799:exon11:c.C1650T:p.N550N,LDLR:NM_001195803:exon11:c.C1392T:p.N464N,LDLR:NM_000527:exon12:c.C1773T:p.N591N,LDLR:NM_001195798:exon12:c.C1773T:p.N591N	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3781	0.3352	0.275759	0.3273	.	.	.	.	.	.	.	.	LDLR:uc010xlo.2:exon10:c.C1269T:p.N423N,LDLR:uc010xll.2:exon11:c.C1650T:p.N550N,LDLR:uc010xlm.2:exon11:c.C1332T:p.N444N,LDLR:uc010xln.2:exon11:c.C1392T:p.N464N,LDLR:uc021upc.1:exon11:c.C1410T:p.N470N,LDLR:uc002mqk.4:exon12:c.C1773T:p.N591N,LDLR:uc010xlk.2:exon12:c.C1773T:p.N591N,LDLR:uc021upd.1:exon12:c.C984T:p.N328N	.	AFR:0.1001,AMR:0.3995,EAS:0.1960,FIN:0.4782,NFE:0.4299,OTH:0.3842,ASJ:0.3808	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	MU82017159	het
19	11233941	11233941	A	G	LDLR	exonic	synonymous SNV	ENSG00000130164	rs5927	ENSG00000130164:ENST00000455727:exon13:c.A1728G:p.R576R,ENSG00000130164:ENST00000545707:exon13:c.A1698G:p.R566R,ENSG00000130164:ENST00000535915:exon14:c.A2109G:p.R703R,ENSG00000130164:ENST00000557933:exon15:c.A2232G:p.R744R,ENSG00000130164:ENST00000558013:exon15:c.A2232G:p.R744R,ENSG00000130164:ENST00000558518:exon15:c.A2232G:p.R744R	LDLR:NM_001195800:exon13:c.A1728G:p.R576R,LDLR:NM_001195803:exon13:c.A1698G:p.R566R,LDLR:NM_001195799:exon14:c.A2109G:p.R703R,LDLR:NM_000527:exon15:c.A2232G:p.R744R,LDLR:NM_001195798:exon15:c.A2232G:p.R744R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7762	0.7387	0.780152	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LDLR:uc010xln.2:exon13:c.A1698G:p.R566R,LDLR:uc010xlo.2:exon13:c.A1728G:p.R576R,LDLR:uc010xll.2:exon14:c.A2109G:p.R703R,LDLR:uc010xlm.2:exon14:c.A1791G:p.R597R,LDLR:uc021upc.1:exon14:c.A1869G:p.R623R,LDLR:uc002mqk.4:exon15:c.A2232G:p.R744R,LDLR:uc010xlk.2:exon15:c.A2232G:p.R744R,LDLR:uc021upd.1:exon15:c.A1443G:p.R481R	.	AFR:0.7480,AMR:0.6849,EAS:0.7053,FIN:0.9491,NFE:0.7702,OTH:0.7530,ASJ:0.8484	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.75
19	13318673	13318690	CTGCTGCTGCTGCTGCTG	-	CACNA1A	exonic	nonframeshift deletion	ENSG00000141837	rs765169827	ENSG00000141837:ENST00000587525:exon19:c.2383_2400del:p.795_800del,ENSG00000141837:ENST00000585802:exon23:c.2980_2997del:p.994_999del,ENSG00000141837:ENST00000360228:exon47:c.6958_6975del:p.2320_2325del	CACNA1A:NM_001127222:exon47:c.6958_6975del:p.2320_2325del	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0300	.	.	0.0997	.	.	.	.	.	.	.	.	CACNA1A:uc002mwv.3:exon19:c.2473_2490del:p.825_830del,CACNA1A:uc002mwx.3:exon23:c.3040_3057del:p.1014_1019del,CACNA1A:uc010dzc.2:exon38:c.5536_5553del:p.1846_1851del,CACNA1A:uc002mwy.3:exon47:c.6958_6975del:p.2320_2325del,CACNA1A:uc010xne.2:exon47:c.6967_6984del:p.2323_2328del	.	AFR:0.0560,AMR:0.0693,EAS:0.0783,FIN:0.1930,NFE:0.1071,OTH:0.1373,ASJ:0.1053	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	.	hom
19	13372245	13372245	C	G	CACNA1A	intronic	.	ENSG00000141837	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	.	hom
19	13411482	13411482	G	A	CACNA1A	intronic	.	ENSG00000141837	rs16018	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7491	0.6452	0.739217	0.6801	.	.	.	.	.	0	0.006	.	.	.	AFR:0.5061,AMR:0.7955,EAS:0.9981,FIN:0.7861,NFE:0.7122,OTH:0.7209,ASJ:0.7219	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	MU82017954	hom
19	15271844	15271844	C	A	NOTCH3	exonic	nonsynonymous SNV	ENSG00000074181	.	ENSG00000074181:ENST00000263388:exon33:c.G6595T:p.G2199W	NOTCH3:NM_000435:exon33:c.G6595T:p.G2199W	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 0] 	.	.	.	.	4.592	24.4	0.004	3.57	0.284	.	.	.	NOTCH3:uc002nan.3:exon33:c.G6595T:p.G2199W	-0.789	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	0.876	-1.55	0.258	0.69	19	.	hom
19	15280905	15280905	G	A	NOTCH3	exonic	nonsynonymous SNV	ENSG00000074181	.	ENSG00000074181:ENST00000263388:exon28:c.C5191T:p.R1731W	NOTCH3:NM_000435:exon28:c.C5191T:p.R1731W	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 0] 	.	.	.	.	7.201	34	0.001	0.74	0.932	.	.	.	NOTCH3:uc002nan.3:exon28:c.C5191T:p.R1731W	0.453	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	1.0	-1.95	0.704	3.28	19	.	hom
19	15292437	15292437	T	C	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1043997	ENSG00000074181:ENST00000601011:exon16:c.A2583G:p.P861P,ENSG00000074181:ENST00000263388:exon17:c.A2742G:p.P914P	NOTCH3:NM_000435:exon17:c.A2742G:p.P914P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8019	0.7905	0.739018	0.7822	.	.	.	.	.	.	.	.	NOTCH3:uc002nao.1:exon16:c.A2586G:p.P862P,NOTCH3:uc002nan.3:exon17:c.A2742G:p.P914P	.	AFR:0.6053,AMR:0.7076,EAS:0.8340,FIN:0.8445,NFE:0.8651,OTH:0.8187,ASJ:0.8709	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU4550901	hom
19	15292546	15292546	C	T	NOTCH3	exonic	nonsynonymous SNV	ENSG00000074181	.	ENSG00000074181:ENST00000601011:exon16:c.G2474A:p.G825D,ENSG00000074181:ENST00000263388:exon17:c.G2633A:p.G878D	NOTCH3:NM_000435:exon17:c.G2633A:p.G878D	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 2, 1, 0] 	.	.	.	.	6.464	29.9	0.0	5.45	0.420	.	.	EGF-like calcium-binding domain|EGF-like domain|EGF-like, conserved site;EGF-like calcium-binding domain|EGF-like domain|EGF-like, conserved site|Growth factor receptor cysteine-rich domain	NOTCH3:uc002nao.1:exon16:c.G2477A:p.G826D,NOTCH3:uc002nan.3:exon17:c.G2633A:p.G878D	1.086	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	1.0	-4.78	0.974	2.985	19	.	hom
19	15295134	15295134	G	A	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1043996	ENSG00000074181:ENST00000263388:exon16:c.C2538T:p.C846C	NOTCH3:NM_000435:exon16:c.C2538T:p.C846C	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6427	0.5664	0.519968	0.5867	.	.	.	.	.	.	.	.	NOTCH3:uc002nan.3:exon16:c.C2538T:p.C846C	.	AFR:0.2616,AMR:0.5395,EAS:0.6050,FIN:0.7516,NFE:0.7284,OTH:0.6988,ASJ:0.6887	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU786918	het
19	17394504	17394504	A	C	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs891017	ENSG00000160117:ENST00000394458:exon5:c.A931C:p.T311P,ENSG00000160117:ENST00000404085:exon5:c.A997C:p.T333P,ENSG00000160117:ENST00000404261:exon5:c.A931C:p.T311P,ENSG00000160117:ENST00000433424:exon5:c.A1093C:p.T365P,ENSG00000160117:ENST00000594072:exon5:c.A898C:p.T300P,ENSG00000160117:ENST00000598347:exon5:c.A931C:p.T311P	ANKLE1:NM_001278443:exon5:c.A898C:p.T300P,ANKLE1:NM_001278444:exon5:c.A931C:p.T311P,ANKLE1:NM_001278445:exon5:c.A889C:p.T297P,ANKLE1:NM_152363:exon5:c.A931C:p.T311P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7211	0.8005	0.635383	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	-0.449	0.293	.	0.314	0.003	.	.	LEM domain|LEM/LEM-like domain	ANKLE1:uc002nfz.2:exon4:c.A49C:p.T17P,ANKLE1:uc002nfy.2:exon5:c.A898C:p.T300P,ANKLE1:uc002nga.2:exon5:c.A931C:p.T311P,ANKLE1:uc010eao.1:exon5:c.A997C:p.T333P,ANKLE1:uc010xpn.1:exon5:c.A1093C:p.T365P	-0.972	AFR:0.7912,AMR:0.7954,EAS:0.8245,FIN:0.3402,NFE:0.8756,OTH:0.8296,ASJ:0.5680	.	.	.	.	.	.	.	.	0.0	.	0.000	-1.15	19	1(haematopoietic_and_lymphoid_tissue)	0.7848
19	17397481	17397481	G	T	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs1465581	ENSG00000160117:ENST00000598347:exon8:c.G1751T:p.C584F	ANKLE1:NM_001278444:exon8:c.G1751T:p.C584F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1944	.	.	15(upper_aerodigestive_tract)	.	.	.	.	.	.	.	.	ANKLE1:uc010xpn.1:exon8:c.G1913T:p.C638F	.	AFR:1(skin),AMR:MU4566645,EAS:0.3276,FIN:0.2027,NFE:0.3154,OTH:0.4053,ASJ:BTCA-JP|1|239|0.0041841,THCA-SA|1|243|0.00411523	.	.	.	.	.	.	.	.	.	.	.	.	19	1(biliary_tract)	0.1114
19	17397496	17397501	TGTGTT	-	ANKLE1	exonic	nonframeshift deletion	ENSG00000160117	rs778248870	ENSG00000160117:ENST00000598347:exon8:c.1766_1771del:p.589_591del	ANKLE1:NM_001278444:exon8:c.1766_1771del:p.589_591del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0404	.	.	0.0954	.	.	.	.	.	.	.	.	ANKLE1:uc010xpn.1:exon8:c.1928_1933del:p.643_645del	.	AFR:0.1530,AMR:0.0445,EAS:0.1331,FIN:0.1105,NFE:0.0568,OTH:0.0674,ASJ:0.0888	.	.	.	.	.	.	.	.	.	.	.	.	19	MU112762366	unknown
19	18273047	18273047	T	C	PIK3R2	exonic	nonsynonymous SNV	ENSG00000105647;ENSG00000268173	rs1011320	ENSG00000105647:ENST00000426902:exon7:c.T937C:p.S313P,ENSG00000105647:ENST00000222254:exon8:c.T937C:p.S313P,ENSG00000268173:ENST00000593731:exon8:c.T937C:p.S313P	PIK3R2:NM_005027:exon8:c.T937C:p.S313P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9501	0.9552	0.953474	0.9570	-1.239	0.006	0.722	-1.99	0.006	.	.	.	PIK3R2:uc002nia.2:exon8:c.T937C:p.S313P	-1.020	AFR:0.9703,AMR:0.9737,EAS:0.9635,FIN:0.9587,NFE:0.9480,OTH:0.9418,ASJ:0.9667	603157	603387;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.0	0.88	0.000	-1.04	19	MU82021073	hom
19	18279531	18279531	C	T	PIK3R2	intronic	.	ENSG00000105647;ENSG00000268173	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	603157	603387;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	19	.	hom
19	33467576	33467576	G	A	FAAP24	exonic	synonymous SNV	ENSG00000131944	rs7258185	ENSG00000131944:ENST00000590179:exon3:c.G351A:p.T117T,ENSG00000131944:ENST00000589646:exon4:c.G351A:p.T117T,ENSG00000131944:ENST00000588258:exon5:c.G636A:p.T212T,ENSG00000131944:ENST00000590281:exon5:c.G636A:p.T212T	FAAP24:NM_001300978:exon3:c.G351A:p.T117T,FAAP24:NM_152266:exon5:c.G636A:p.T212T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2636	0.2550	0.26877	0.2731	.	.	.	.	.	.	.	.	C19orf40:uc002nud.4:exon5:c.G636A:p.T212T	.	AFR:0.3063,AMR:0.4069,EAS:0.1627,FIN:0.2519,NFE:0.2649,OTH:0.2566,ASJ:0.2351	610884	.	.	.	.	.	.	.	.	.	.	.	19	MU655292	hom
19	36212162	36212162	C	T	KMT2B	exonic	nonsynonymous SNV	ENSG00000272333	.	ENSG00000272333:ENST00000222270:exon3:c.C1913T:p.A638V,ENSG00000272333:ENST00000420124:exon3:c.C1913T:p.A638V	KMT2B:NM_014727:exon3:c.C1913T:p.A638V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	-0.304	0.651	0.198	-0.53	0.012	.	.	.	KMT2B:uc021usu.2:exon3:c.C1913T:p.A638V,KMT2B:uc021usv.1:exon3:c.C1913T:p.A638V	-0.910	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606834	.	.	.	.	.	.	.	0.0	-1.65	0.266	0	19	.	hom
19	36220086	36220086	G	A	KMT2B	exonic	synonymous SNV	ENSG00000272333	.	ENSG00000272333:ENST00000222270:exon22:c.G4806A:p.G1602G,ENSG00000272333:ENST00000420124:exon22:c.G4806A:p.G1602G	KMT2B:NM_014727:exon22:c.G4806A:p.G1602G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	KMT2B:uc021usv.1:exon22:c.G4806A:p.G1602G	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606834	.	.	.	.	.	.	.	.	.	.	.	19	.	hom
19	36224705	36224705	A	G	KMT2B	exonic	nonsynonymous SNV	ENSG00000272333	rs231591	ENSG00000272333:ENST00000222270:exon30:c.A7091G:p.D2364G,ENSG00000272333:ENST00000420124:exon30:c.A7091G:p.D2364G	KMT2B:NM_014727:exon30:c.A7091G:p.D2364G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5331	0.5792	0.620407	1(pleura)	-0.588	0.134	1.0	1.66	0.103	.	.	.	KMT2B:uc021usv.1:exon30:c.A7091G:p.D2364G	-0.961	AFR:1(lung),AMR:1(stomach),EAS:MU112187,FIN:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,NFE:0.5734,OTH:0.7952,ASJ:1(haematopoietic_and_lymphoid_tissue)	606834	.	.	.	.	.	.	.	0.0	-1.64	0.000	-0.69	19	1(large_intestine)	0.4209
19	38939305	38939305	C	T	RYR1	exonic	nonsynonymous SNV	ENSG00000196218	.	ENSG00000196218:ENST00000355481:exon11:c.C974T:p.A325V,ENSG00000196218:ENST00000359596:exon11:c.C974T:p.A325V,ENSG00000196218:ENST00000360985:exon11:c.C974T:p.A325V	RYR1:NM_000540:exon11:c.C974T:p.A325V,RYR1:NM_001042723:exon11:c.C974T:p.A325V	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	2.901	21.9	0.551	2.37	0.967	.	.	MIR motif	RYR1:uc002oit.3:exon11:c.C974T:p.A325V,RYR1:uc002oiu.3:exon11:c.C974T:p.A325V	-0.009	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	0.794	-2.76	0.588	0.97	19	.	hom
19	38946182	38946182	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2288888	ENSG00000196218:ENST00000355481:exon15:c.G1668A:p.S556S,ENSG00000196218:ENST00000359596:exon15:c.G1668A:p.S556S,ENSG00000196218:ENST00000360985:exon15:c.G1668A:p.S556S	RYR1:NM_000540:exon15:c.G1668A:p.S556S,RYR1:NM_001042723:exon15:c.G1668A:p.S556S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6366	0.6321	0.571286	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon15:c.G1668A:p.S556S,RYR1:uc002oiu.3:exon15:c.G1668A:p.S556S	.	AFR:0.6389,AMR:0.5420,EAS:0.6954,FIN:0.6088,NFE:0.7077,OTH:0.6745,ASJ:0.7100	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	3(lung)	0.6838
19	38956803	38956803	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2228069	ENSG00000196218:ENST00000355481:exon24:c.G2943A:p.T981T,ENSG00000196218:ENST00000359596:exon24:c.G2943A:p.T981T,ENSG00000196218:ENST00000360985:exon24:c.G2943A:p.T981T	RYR1:NM_000540:exon24:c.G2943A:p.T981T,RYR1:NM_001042723:exon24:c.G2943A:p.T981T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5962	0.5971	0.545527	1(liver)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon24:c.G2943A:p.T981T,RYR1:uc002oiu.3:exon24:c.G2943A:p.T981T	.	AFR:MU153475,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EAS:0.5620,FIN:0.6993,NFE:0.6556,OTH:0.5235,ASJ:0.5968	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5798
19	38959680	38959680	C	T	RYR1	exonic	synonymous SNV	ENSG00000196218	rs11083462	ENSG00000196218:ENST00000355481:exon26:c.C3456T:p.I1152I,ENSG00000196218:ENST00000359596:exon26:c.C3456T:p.I1152I,ENSG00000196218:ENST00000360985:exon26:c.C3456T:p.I1152I	RYR1:NM_000540:exon26:c.C3456T:p.I1152I,RYR1:NM_001042723:exon26:c.C3456T:p.I1152I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3956	0.3829	0.449281	1(stomach)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon26:c.C3456T:p.I1152I,RYR1:uc002oiu.3:exon26:c.C3456T:p.I1152I	.	AFR:1(oesophagus),AMR:MU136593,EAS:0.3870,FIN:0.4362,NFE:0.2947,OTH:0.3212,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(kidney)	0.4776
19	38983180	38983180	G	T	RYR1	exonic	nonsynonymous SNV	ENSG00000196218	rs35364374	ENSG00000196218:ENST00000355481:exon38:c.G6178T:p.G2060C,ENSG00000196218:ENST00000359596:exon38:c.G6178T:p.G2060C,ENSG00000196218:ENST00000360985:exon38:c.G6178T:p.G2060C	RYR1:NM_000540:exon38:c.G6178T:p.G2060C,RYR1:NM_001042723:exon38:c.G6178T:p.G2060C	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0694	0.0514	0.0549121	0.0449	2.773	21.2	0.058	1.7	0.992	.	.	.	RYR1:uc002oit.3:exon38:c.G6178T:p.G2060C,RYR1:uc002oiu.3:exon38:c.G6178T:p.G2060C	-1.003	AFR:0.0130,AMR:0.0609,EAS:0.0019,FIN:0.0192,NFE:0.0718,OTH:0.0633,ASJ:0.0596	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	0.973	-0.68	0.034	1.935	19	.	het
19	38987506	38987506	A	G	RYR1	exonic	nonsynonymous SNV	ENSG00000196218	.	ENSG00000196218:ENST00000355481:exon42:c.A6803G:p.Q2268R,ENSG00000196218:ENST00000359596:exon42:c.A6803G:p.Q2268R,ENSG00000196218:ENST00000360985:exon42:c.A6803G:p.Q2268R	RYR1:NM_000540:exon42:c.A6803G:p.Q2268R,RYR1:NM_001042723:exon42:c.A6803G:p.Q2268R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	1.356	12.56	1.0	5.04	1.000	.	.	RIH (RyR and IP3R Homology) domain	RYR1:uc002oit.3:exon42:c.A6803G:p.Q2268R,RYR1:uc002oiu.3:exon42:c.A6803G:p.Q2268R	-0.483	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	0.001	-3.59	0.315	-2.77	19	.	hom
19	38994910	38994910	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2229144	ENSG00000196218:ENST00000355481:exon50:c.G7977A:p.T2659T,ENSG00000196218:ENST00000359596:exon50:c.G7977A:p.T2659T,ENSG00000196218:ENST00000360985:exon50:c.G7977A:p.T2659T	RYR1:NM_000540:exon50:c.G7977A:p.T2659T,RYR1:NM_001042723:exon50:c.G7977A:p.T2659T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3261	0.3195	0.41234	MU584624	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon50:c.G7977A:p.T2659T,RYR1:uc002oiu.3:exon50:c.G7977A:p.T2659T	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.3252,EAS:0.3493,FIN:0.2550,NFE:0.3786,OTH:0.2901,ASJ:0.4657	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(stomach)	0.2477
19	39002725	39002725	A	G	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2071089	ENSG00000196218:ENST00000355481:exon62:c.A9186G:p.P3062P,ENSG00000196218:ENST00000359596:exon62:c.A9186G:p.P3062P,ENSG00000196218:ENST00000360985:exon62:c.A9186G:p.P3062P	RYR1:NM_000540:exon62:c.A9186G:p.P3062P,RYR1:NM_001042723:exon62:c.A9186G:p.P3062P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3251	0.3109	0.406949	3(lung)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon62:c.A9186G:p.P3062P,RYR1:uc002oiu.3:exon62:c.A9186G:p.P3062P	.	AFR:MU153517,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.4374,FIN:0.3508,NFE:0.2384,OTH:0.3770,ASJ:0.3203	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(thyroid)	0.3012
19	39008003	39008003	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2304151	ENSG00000196218:ENST00000355481:exon66:c.G9690A:p.L3230L,ENSG00000196218:ENST00000359596:exon66:c.G9690A:p.L3230L,ENSG00000196218:ENST00000360985:exon66:c.G9690A:p.L3230L	RYR1:NM_000540:exon66:c.G9690A:p.L3230L,RYR1:NM_001042723:exon66:c.G9690A:p.L3230L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0852	0.0544	0.0904553	LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,BTCA-JP|1|239|0.0041841	.	.	.	.	.	.	.	.	RYR1:uc010xuf.1:exon5:c.G450A:p.L150L,RYR1:uc002oit.3:exon66:c.G9690A:p.L3230L,RYR1:uc002oiu.3:exon66:c.G9690A:p.L3230L	.	AFR:0.0635,AMR:0.0291,EAS:0.0695,FIN:0.1461,NFE:0.0908,OTH:0.0677,ASJ:0.0585	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	3(lung)	0.0746
19	39408360	39408360	A	G	SARS2	intronic	.	ENSG00000104835;ENSG00000269547	rs7508411	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7066	0.7052	0.834665	0.7254	.	.	.	.	.	0	0.074	.	.	.	AFR:0.8753,AMR:0.7803,EAS:0.9659,FIN:0.6919,NFE:0.6179,OTH:0.6801,ASJ:0.7416	612804	613845;	363694;	363694|HUPRA syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613845 ~	.	.	.	.	.	.	.	.	19	MU9418845	hom
19	39416887	39416887	C	T	SARS2	exonic	synonymous SNV	ENSG00000104835;ENSG00000269547	rs11544093	ENSG00000104835:ENST00000221431:exon2:c.G321A:p.E107E,ENSG00000104835:ENST00000430193:exon2:c.G321A:p.E107E,ENSG00000104835:ENST00000455102:exon2:c.G321A:p.E107E,ENSG00000104835:ENST00000598343:exon2:c.G321A:p.E107E,ENSG00000104835:ENST00000600042:exon2:c.G321A:p.E107E,ENSG00000104835:ENST00000448145:exon6:c.G321A:p.E107E	SARS2:NM_001145901:exon2:c.G321A:p.E107E,SARS2:NM_017827:exon2:c.G321A:p.E107E	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1773	0.1374	0.189896	MU13194184	.	.	.	.	.	.	.	.	SARS2:uc002oka.2:exon2:c.G321A:p.E107E,SARS2:uc010xup.1:exon2:c.G321A:p.E107E,SARS2:uc010xus.1:exon2:c.G321A:p.E107E,SARS2:uc010xuq.1:exon6:c.G321A:p.E107E	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.1629,EAS:0.1301,FIN:0.1523,NFE:0.3085,OTH:0.2298,ASJ:0.0977	612804	613845;	363694;	363694|HUPRA syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613845 ~	.	.	.	.	.	.	.	.	19	1(urinary_tract)	0.1703
19	39421388	39421388	A	G	MRPS12;SARS2	UTR5	.	ENSG00000104835;ENSG00000128626	rs730078	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7121	0.7138	0.842053	0.7293	.	.	.	.	.	.	.	.	.	.	AFR:0.8959,AMR:0.7769,EAS:0.9605,FIN:0.6932,NFE:0.6155,OTH:0.6820,ASJ:0.76	.	.	.	.	.	.	.	.	.	.	.	.	19	MU82024794	hom
19	39913537	39913537	-	TGGAAGGGCTCGAAAGTTCCATTGCAGCTGAAATGCCCAGCAA	PLEKHG2	exonic	frameshift insertion	ENSG00000090924	.	ENSG00000090924:ENST00000425673:exon16:c.1756_1757insTGGAAGGGCTCGAAAGTTCCATTGCAGCTGAAATGCCCAGCAA:p.L586fs,ENSG00000090924:ENST00000409794:exon18:c.1843_1844insTGGAAGGGCTCGAAAGTTCCATTGCAGCTGAAATGCCCAGCAA:p.L615fs,ENSG00000090924:ENST00000458508:exon18:c.1666_1667insTGGAAGGGCTCGAAAGTTCCATTGCAGCTGAAATGCCCAGCAA:p.L556fs	PLEKHG2:NM_001351693:exon18:c.1666_1667insTGGAAGGGCTCGAAAGTTCCATTGCAGCTGAAATGCCCAGCAA:p.L556fs,PLEKHG2:NM_022835:exon18:c.1843_1844insTGGAAGGGCTCGAAAGTTCCATTGCAGCTGAAATGCCCAGCAA:p.L615fs	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	PLEKHG2:uc010xva.2:exon14:c.1177_1178insTGGAAGGGCTCGAAAGTTCCATTGCAGCTGAAATGCCCAGCAA:p.L393fs,PLEKHG2:uc010xuy.2:exon18:c.1666_1667insTGGAAGGGCTCGAAAGTTCCATTGCAGCTGAAATGCCCAGCAA:p.L556fs,PLEKHG2:uc010xuz.2:exon18:c.1843_1844insTGGAAGGGCTCGAAAGTTCCATTGCAGCTGAAATGCCCAGCAA:p.L615fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	.	hom
19	39913634	39913634	G	A	PLEKHG2	exonic	nonsynonymous SNV	ENSG00000090924	rs10407035	ENSG00000090924:ENST00000425673:exon16:c.G1853A:p.R618H,ENSG00000090924:ENST00000409794:exon18:c.G1940A:p.R647H,ENSG00000090924:ENST00000458508:exon18:c.G1763A:p.R588H	PLEKHG2:NM_001351693:exon18:c.G1763A:p.R588H,PLEKHG2:NM_022835:exon18:c.G1940A:p.R647H	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1735	0.1454	0.245008	1(liver)	0.008	2.660	0.133	-2.84	0.002	.	.	.	PLEKHG2:uc010xva.2:exon14:c.G1274A:p.R425H,PLEKHG2:uc010xuy.2:exon18:c.G1763A:p.R588H,PLEKHG2:uc010xuz.2:exon18:c.G1940A:p.R647H	-1.033	AFR:1(breast),AMR:MU13194408,EAS:0.1542,FIN:0.2010,NFE:0.1770,OTH:0.2219,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	611893	616763;	.	.	.	.	.	.	0.955	-0.33	0.000	0	19	1(stomach)	0.3789
19	39914748	39914748	G	A	PLEKHG2	exonic	nonsynonymous SNV	ENSG00000090924	rs31726	ENSG00000090924:ENST00000425673:exon17:c.G2888A:p.R963K,ENSG00000090924:ENST00000409794:exon19:c.G2975A:p.R992K,ENSG00000090924:ENST00000458508:exon19:c.G2798A:p.R933K	PLEKHG2:NM_001351693:exon19:c.G2798A:p.R933K,PLEKHG2:NM_022835:exon19:c.G2975A:p.R992K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5083	0.5226	0.575879	2(large_intestine)	0.257	5.263	0.101	0.404	0.001	.	.	.	PLEKHG2:uc010xva.2:exon15:c.G2309A:p.R770K,PLEKHG2:uc010xuy.2:exon19:c.G2798A:p.R933K,PLEKHG2:uc010xuz.2:exon19:c.G2975A:p.R992K	-0.924	AFR:MU146422,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.6473,FIN:0.5119,NFE:0.5232,OTH:0.5702,ASJ:0.5393	611893	616763;	.	.	.	.	.	.	0.004	-0.57	0.000	1.835	19	1(biliary_tract)	0.5350
19	40900865	40900865	C	T	PRX	exonic	nonsynonymous SNV	ENSG00000105227	rs268674	ENSG00000105227:ENST00000324001:exon7:c.G3394A:p.G1132R	PRX:NM_181882:exon7:c.G3394A:p.G1132R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9469	0.9538	0.965455	0.9599	0.019	2.769	0.129	3.64	0.017	.	.	.	PRX:uc002onq.3:exon3:c.G2977A:p.G993R,PRX:uc002onr.3:exon7:c.G3394A:p.G1132R	-1.009	AFR:0.9899,AMR:0.9678,EAS:0.9691,FIN:0.9472,NFE:0.9444,OTH:0.9561,ASJ:0.9437	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	0.0	4.2	0.000	-0.625	19	MU69136	hom
19	40901496	40901496	T	C	PRX	exonic	nonsynonymous SNV	ENSG00000105227	rs268673	ENSG00000105227:ENST00000324001:exon7:c.A2763G:p.I921M	PRX:NM_181882:exon7:c.A2763G:p.I921M	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3504	0.3663	0.296725	0.3517	-1.801	0.002	0.315	-5.36	0.878	.	.	.	PRX:uc002onq.3:exon3:c.A2346G:p.I782M,PRX:uc002onr.3:exon7:c.A2763G:p.I921M	-0.919	AFR:0.3290,AMR:0.4391,EAS:0.1300,FIN:0.3443,NFE:0.3845,OTH:0.3652,ASJ:0.3576	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	0.0	4.05	0.000	-1.79	19	MU133393	hom
19	40901604	40901604	A	G	PRX	exonic	synonymous SNV	ENSG00000105227	rs268672	ENSG00000105227:ENST00000324001:exon7:c.T2655C:p.P885P	PRX:NM_181882:exon7:c.T2655C:p.P885P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5070	0.6091	0.531949	0.5686	.	.	.	.	.	.	.	.	PRX:uc002onq.3:exon3:c.T2238C:p.P746P,PRX:uc002onr.3:exon7:c.T2655C:p.P885P	.	AFR:0.8020,AMR:0.5337,EAS:0.1805,FIN:0.4487,NFE:0.5106,OTH:0.4949,ASJ:0.4901	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	.	.	.	.	19	MU4560643	unknown
19	40901614	40901614	A	G	PRX	exonic	nonsynonymous SNV	ENSG00000105227	rs268671	ENSG00000105227:ENST00000324001:exon7:c.T2645C:p.V882A	PRX:NM_181882:exon7:c.T2645C:p.V882A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5069	0.6097	0.531949	0.5680	-2.006	0.001	0.381	2.7	0.001	.	.	.	PRX:uc002onq.3:exon3:c.T2228C:p.V743A,PRX:uc002onr.3:exon7:c.T2645C:p.V882A	-1.137	AFR:0.8017,AMR:0.5337,EAS:0.1818,FIN:0.4487,NFE:0.5097,OTH:0.4980,ASJ:0.4867	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	0.0	5.32	0.000	-1.95	19	MU707749	unknown
19	40904741	40904741	G	A	PRX	intronic	.	ENSG00000105227	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	.	.	.	.	19	.	hom
19	41512792	41512792	C	T	CYP2B6	intronic	.	ENSG00000197408	rs4803419	.	.	clinvar: drug_response 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3353	0.2394	0.289137	0.2824	.	.	.	.	.	.	.	.	.	.	AFR:0.1143,AMR:0.4617,EAS:0.4512,FIN:0.3721,NFE:0.3277,OTH:0.3224,ASJ:0.3013	123930	614546;	240869;	240869|-|-|-|-|614546 ~	.	.	.	.	.	.	.	.	19	MU30125766	hom
19	41727820	41727820	A	G	AXL	exonic	nonsynonymous SNV	ENSG00000167601	rs140091980	ENSG00000167601:ENST00000301178:exon4:c.A445G:p.T149A,ENSG00000167601:ENST00000359092:exon4:c.A445G:p.T149A	AXL:NM_001699:exon4:c.A445G:p.T149A,AXL:NM_021913:exon4:c.A445G:p.T149A	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0009	0.0008	0.000798722	0.0006	-0.089	1.812	0.451	-2.41	0.976	.	.	Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	AXL:uc010ehi.1:exon4:c.A445G:p.T149A,AXL:uc010ehj.3:exon4:c.A445G:p.T149A,AXL:uc010ehk.3:exon4:c.A445G:p.T149A	-0.966	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0007,OTH:0.0010,ASJ:0.0166	109135	.	.	.	.	.	.	.	0.0	2.64	0.024	1.39	19	.	hom
19	41743861	41743861	A	G	AXL	exonic	nonsynonymous SNV	ENSG00000167601	rs7249222	ENSG00000167601:ENST00000301178:exon7:c.A796G:p.N266D,ENSG00000167601:ENST00000359092:exon7:c.A796G:p.N266D	AXL:NM_001699:exon7:c.A796G:p.N266D,AXL:NM_021913:exon7:c.A796G:p.N266D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	AXL:uc010ehi.1:exon7:c.A796G:p.N266D,AXL:uc010ehj.3:exon7:c.A796G:p.N266D,AXL:uc010ehk.3:exon7:c.A796G:p.N266D	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	109135	.	.	.	.	.	.	.	.	.	.	.	19	23(upper_aerodigestive_tract)	1
19	41762525	41762525	A	G	AXL	intronic	.	ENSG00000167601	rs2304232	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1418	0.1400	0.150958	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.1425,AMR:0.1045,EAS:0.1987,FIN:0.3061,NFE:0.1334,OTH:0.1494,ASJ:0.1089	109135	.	.	.	.	.	.	.	.	.	.	.	19	1(liver)	0.1497
19	41858921	41858921	G	A	TGFB1	exonic	nonsynonymous SNV	ENSG00000105329	rs1800470	ENSG00000105329:ENST00000221930:exon1:c.C29T:p.P10L	TGFB1:NM_000660:exon1:c.C29T:p.P10L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5623	.	0.545327	1(pancreas)	2.279	18.03	0.83	1.45	1.000	.	.	.	TGFB1:uc002oqh.2:exon1:c.C29T:p.P10L	-0.945	AFR:MU68390,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.5855,FIN:0.4856,NFE:0.5066,OTH:0.4199,ASJ:0.5998	190180	131300;219700;	586;1328;	586|CF<br>Mucoviscidosis|1-9 / 100 000|Autosomal recessive|All ages|219700 ~1328|Progressive diaphyseal dysplasia|Unknown|Autosomal dominant|All ages|131300 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04659 Th17 cell differentiation~ko04672 Intestinal immune network for IgA production~ko04926 Relaxin signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05144 Malaria~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05321 Inflammatory bowel disease (IBD)~ko05323 Rheumatoid arthritis~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	1.73	0.000	.	19	1(thyroid)	0.7066
19	42752987	42752987	T	A	ERF	exonic	nonsynonymous SNV	ENSG00000105722	.	ENSG00000105722:ENST00000222329:exon4:c.A1277T:p.K426M,ENSG00000105722:ENST00000440177:exon4:c.A1052T:p.K351M	ERF:NM_001301035:exon4:c.A1052T:p.K351M,ERF:NM_001308402:exon4:c.A1052T:p.K351M,ERF:NM_001312656:exon4:c.A1052T:p.K351M,ERF:NM_006494:exon4:c.A1277T:p.K426M	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	2.948	22.0	0.0	2.12	0.998	.	.	.	ERF:uc002otd.4:exon2:c.A470T:p.K157M,ERF:uc002ote.4:exon4:c.A1277T:p.K426M	-0.988	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	611888	600775;	2343;3267;35093;	2343|-|Unknown|Not applicable|Neonatal|148800 600775 ~3267|-|-|-|-|600775 ~35093|Isolated dolichocephaly<br>Non-syndromic sagittal synostosis|-|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|123100 600775 615529 ~	.	.	.	.	0.003	2.77	0.070	2.12	19	.	hom
19	44047826	44047826	T	A	XRCC1	exonic	nonsynonymous SNV	ENSG00000073050	rs2682557	ENSG00000073050:ENST00000543982:exon15:c.A1633T:p.N545Y,ENSG00000073050:ENST00000262887:exon16:c.A1726T:p.N576Y	XRCC1:NM_006297:exon16:c.A1726T:p.N576Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	0.9999	1	1	.	.	.	.	.	.	.	.	XRCC1:uc010xwp.1:exon15:c.A1633T:p.N545Y,XRCC1:uc002owt.2:exon16:c.A1726T:p.N576Y	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	194360	.	.	.	.	.	.	.	.	.	.	.	19	MU82026153	hom
19	44050195	44050195	C	T	XRCC1	intronic	.	ENSG00000073050	rs25479	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3636	0.3922	0.289337	0.3802	.	.	.	.	.	.	.	.	.	.	AFR:0.3275,AMR:0.2110,EAS:0.1183,FIN:0.4449,NFE:0.4335,OTH:0.4002,ASJ:0.3389	194360	.	.	.	.	.	.	.	.	.	.	.	19	MU708115	het
19	44055726	44055726	T	C	XRCC1	exonic	nonsynonymous SNV	ENSG00000073050	rs25487	ENSG00000073050:ENST00000543982:exon9:c.A1103G:p.Q368R,ENSG00000073050:ENST00000262887:exon10:c.A1196G:p.Q399R	XRCC1:NM_006297:exon10:c.A1196G:p.Q399R	clinvar: drug_response 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, -1, 0, 1] 	0.6834	0.7092	0.739617	0.7200	0.745	9.117	1.0	4.13	0.976	.	.	BRCT domain	XRCC1:uc010xwp.1:exon9:c.A1103G:p.Q368R,XRCC1:uc002owt.2:exon10:c.A1196G:p.Q399R	-0.976	AFR:0.8520,AMR:0.7231,EAS:0.7370,FIN:0.7022,NFE:0.6510,OTH:0.6691,ASJ:0.5960	194360	.	.	.	.	,10431	.	,10432	0.0	2.81	0.000	.	19	MU71535	hom
19	49459104	49459104	A	G	BAX	intronic	.	ENSG00000087088	rs1805419	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6744	0.6774	0.621805	LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BLCA-CN|1|103|0.00970874	.	.	.	.	.	.	.	.	.	.	AFR:0.6610,AMR:0.5862,EAS:0.8079,FIN:0.5753,NFE:0.6486,OTH:0.7149,ASJ:0.6118	600040	114500;613065;	513;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04141 Protein processing in endoplasmic reticulum~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04722 Neurotrophin signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05016 Huntington disease~ko05020 Prion diseases~ko05130 Pathogenic Escherichia coli infection~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	19	2(lung)	0.6828
19	49464213	49464213	C	A	BAX	exonic	synonymous SNV	ENSG00000087088	.	ENSG00000087088:ENST00000293288:exon5:c.C516A:p.L172L	BAX:NM_001291430:exon3:c.C282A:p.L94L,BAX:NM_001291429:exon4:c.C405A:p.L135L,BAX:NM_004324:exon5:c.C516A:p.L172L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	BAX:uc002plh.1:exon3:c.C282A:p.L94L,BAX:uc002plg.1:exon4:c.C405A:p.L135L,BAX:uc002plf.1:exon5:c.C516A:p.L172L	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600040	114500;613065;	513;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04141 Protein processing in endoplasmic reticulum~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04722 Neurotrophin signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05016 Huntington disease~ko05020 Prion diseases~ko05130 Pathogenic Escherichia coli infection~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	19	.	hom
19	49464754	49464754	C	A	BAX	exonic	synonymous SNV	ENSG00000087088	.	.	BAX:NM_001291428:exon6:c.C489A:p.A163A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600040	114500;613065;	513;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04141 Protein processing in endoplasmic reticulum~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04722 Neurotrophin signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05016 Huntington disease~ko05020 Prion diseases~ko05130 Pathogenic Escherichia coli infection~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	19	.	hom
19	50140092	50140092	G	A	RRAS	exonic	synonymous SNV	ENSG00000126458	rs1865077	ENSG00000126458:ENST00000246792:exon3:c.C333T:p.N111N	RRAS:NM_006270:exon3:c.C333T:p.N111N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7034	0.6968	0.738219	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	RRAS:uc002pop.1:exon3:c.C333T:p.N111N	.	AFR:0.7243,AMR:0.7670,EAS:0.6577,FIN:0.8284,NFE:0.6881,OTH:0.6947,ASJ:0.8329	165090	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04360 Axon guidance~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	1(large_intestine)	0.6814
19	50143186	50143186	G	A	RRAS	intronic	.	ENSG00000126458	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	165090	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04360 Axon guidance~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	.	hom
19	50713762	50713762	A	C	MYH14	exonic	nonsynonymous SNV	ENSG00000105357	.	ENSG00000105357:ENST00000262269:exon1:c.A140C:p.Q47P,ENSG00000105357:ENST00000596571:exon1:c.A140C:p.Q47P,ENSG00000105357:ENST00000376970:exon2:c.A140C:p.Q47P,ENSG00000105357:ENST00000425460:exon2:c.A140C:p.Q47P,ENSG00000105357:ENST00000440075:exon2:c.A140C:p.Q47P,ENSG00000105357:ENST00000598205:exon2:c.A140C:p.Q47P,ENSG00000105357:ENST00000599920:exon2:c.A140C:p.Q47P,ENSG00000105357:ENST00000601313:exon2:c.A140C:p.Q47P	MYH14:NM_001077186:exon2:c.A140C:p.Q47P,MYH14:NM_001145809:exon2:c.A140C:p.Q47P,MYH14:NM_024729:exon2:c.A140C:p.Q47P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 2, 0, 0] 	.	.	.	.	3.127	22.6	0.001	3.47	0.905	.	.	.	MYH14:uc002prq.1:exon2:c.A140C:p.Q47P,MYH14:uc002prr.1:exon2:c.A140C:p.Q47P,MYH14:uc010enu.1:exon2:c.A140C:p.Q47P	0.579	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	1.0	-2.26	0.772	2.825	19	.	hom
19	50726570	50726570	G	A	MYH14	exonic	synonymous SNV	ENSG00000105357	rs4801822	ENSG00000105357:ENST00000262269:exon4:c.G657A:p.A219A,ENSG00000105357:ENST00000596571:exon4:c.G657A:p.A219A,ENSG00000105357:ENST00000376970:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000425460:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000440075:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000598205:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000599920:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000601313:exon5:c.G657A:p.A219A	MYH14:NM_001077186:exon5:c.G657A:p.A219A,MYH14:NM_001145809:exon5:c.G657A:p.A219A,MYH14:NM_024729:exon5:c.G657A:p.A219A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6057	0.4933	0.472843	1(large_intestine)	.	.	.	.	.	.	.	.	MYH14:uc002prq.1:exon5:c.G657A:p.A219A,MYH14:uc002prr.1:exon5:c.G657A:p.A219A,MYH14:uc010enu.1:exon5:c.G657A:p.A219A	.	AFR:MU115546,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763,EAS:0.2085,FIN:0.4233,NFE:0.5099,OTH:0.5513,ASJ:0.4990	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	1(prostate)	0.6498
19	50762418	50762418	A	G	MYH14	exonic	synonymous SNV	ENSG00000105357	rs1651553	ENSG00000105357:ENST00000596571:exon16:c.A2127G:p.P709P,ENSG00000105357:ENST00000262269:exon18:c.A2250G:p.P750P,ENSG00000105357:ENST00000376970:exon18:c.A2226G:p.P742P,ENSG00000105357:ENST00000425460:exon18:c.A2151G:p.P717P,ENSG00000105357:ENST00000598205:exon18:c.A2151G:p.P717P,ENSG00000105357:ENST00000599920:exon18:c.A2151G:p.P717P,ENSG00000105357:ENST00000440075:exon19:c.A2250G:p.P750P,ENSG00000105357:ENST00000601313:exon19:c.A2250G:p.P750P	MYH14:NM_024729:exon17:c.A2127G:p.P709P,MYH14:NM_001077186:exon18:c.A2151G:p.P717P,MYH14:NM_001145809:exon19:c.A2250G:p.P750P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7719	0.7375	0.761182	0.7616	.	.	.	.	.	.	.	.	MYH14:uc002prr.1:exon17:c.A2127G:p.P709P,MYH14:uc002prq.1:exon18:c.A2151G:p.P717P,MYH14:uc010enu.1:exon19:c.A2250G:p.P750P	.	AFR:0.7206,AMR:0.8365,EAS:0.8255,FIN:0.8212,NFE:0.7614,OTH:0.7939,ASJ:0.6126	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU17693652	hom
19	50796905	50796905	G	A	MYH14	exonic	synonymous SNV	ENSG00000105357	rs3745509	ENSG00000105357:ENST00000596571:exon36:c.G5307A:p.S1769S,ENSG00000105357:ENST00000262269:exon38:c.G5430A:p.S1810S,ENSG00000105357:ENST00000376970:exon38:c.G5406A:p.S1802S,ENSG00000105357:ENST00000425460:exon38:c.G5331A:p.S1777S,ENSG00000105357:ENST00000598205:exon38:c.G5331A:p.S1777S,ENSG00000105357:ENST00000440075:exon39:c.G5430A:p.S1810S,ENSG00000105357:ENST00000601313:exon39:c.G5430A:p.S1810S	MYH14:NM_024729:exon37:c.G5307A:p.S1769S,MYH14:NM_001077186:exon38:c.G5331A:p.S1777S,MYH14:NM_001145809:exon39:c.G5430A:p.S1810S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7480	0.6146	0.682109	0.6579	.	.	.	.	.	.	.	.	MYH14:uc002prs.1:exon6:c.G360A:p.S120S,MYH14:uc010ycb.2:exon8:c.G360A:p.S120S,MYH14:uc002prr.1:exon37:c.G5307A:p.S1769S,MYH14:uc002prq.1:exon38:c.G5331A:p.S1777S,MYH14:uc010enu.1:exon39:c.G5430A:p.S1810S	.	AFR:0.3589,AMR:0.8313,EAS:0.9247,FIN:0.7665,NFE:0.7606,OTH:0.7546,ASJ:0.6921	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU82029104	hom
19	50805038	50805038	G	A	MYH14	exonic	nonsynonymous SNV	ENSG00000105357	.	ENSG00000105357:ENST00000596571:exon37:c.G5467A:p.A1823T,ENSG00000105357:ENST00000262269:exon39:c.G5590A:p.A1864T,ENSG00000105357:ENST00000376970:exon39:c.G5566A:p.A1856T,ENSG00000105357:ENST00000425460:exon39:c.G5491A:p.A1831T,ENSG00000105357:ENST00000598205:exon39:c.G5491A:p.A1831T,ENSG00000105357:ENST00000440075:exon40:c.G5590A:p.A1864T,ENSG00000105357:ENST00000601313:exon40:c.G5590A:p.A1864T	MYH14:NM_024729:exon38:c.G5467A:p.A1823T,MYH14:NM_001077186:exon39:c.G5491A:p.A1831T,MYH14:NM_001145809:exon40:c.G5590A:p.A1864T	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	4.555	24.4	0.631	4.14	1.000	.	.	Myosin tail	MYH14:uc002prs.1:exon7:c.G520A:p.A174T,MYH14:uc010ycb.2:exon9:c.G520A:p.A174T,MYH14:uc002prr.1:exon38:c.G5467A:p.A1823T,MYH14:uc002prq.1:exon39:c.G5491A:p.A1831T,MYH14:uc010enu.1:exon40:c.G5590A:p.A1864T	-0.501	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	0.868	-1.69	0.417	0.67	19	.	hom
19	50805138	50805138	C	T	MYH14	intronic	.	ENSG00000105357	rs3826772	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8300	0.7947	0.750799	0.7877	.	.	.	.	.	.	.	.	.	.	AFR:0.6329,AMR:0.8577,EAS:0.8077,FIN:0.8333,NFE:0.8556,OTH:0.8429,ASJ:0.87	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU82029120	hom
19	50910306	50910306	C	T	POLD1	exonic	nonsynonymous SNV	ENSG00000062822	.	ENSG00000062822:ENST00000595904:exon12:c.C1561T:p.R521W,ENSG00000062822:ENST00000440232:exon13:c.C1561T:p.R521W,ENSG00000062822:ENST00000599857:exon13:c.C1561T:p.R521W,ENSG00000062822:ENST00000600859:exon13:c.C1561T:p.R521W	POLD1:NM_001308632:exon12:c.C1561T:p.R521W,POLD1:NM_001256849:exon13:c.C1561T:p.R521W,POLD1:NM_002691:exon13:c.C1561T:p.R521W	clinvar: Uncertain_significance 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 1, 0] 	.	.	.	3.232e-05	7.587	34	0.0	3.96	0.958	.	.	Ribonuclease H-like domain	POLD1:uc010eny.4:exon12:c.C1561T:p.R521W,POLD1:uc002psb.5:exon13:c.C1561T:p.R521W,POLD1:uc002psc.5:exon13:c.C1561T:p.R521W	-0.375	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.67e-05,OTH:0,ASJ:0	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	0.999	2.13	0.212	4.155	19	.	hom
19	50919797	50919797	C	T	POLD1	intronic	.	ENSG00000062822;ENSG00000142539	rs3218776	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5793	0.5810	0.408347	0.5601	.	.	.	.	.	.	.	.	.	.	AFR:0.3293,AMR:0.6938,EAS:0.1361,FIN:0.6914,NFE:0.6986,OTH:0.6286,ASJ:0.5298	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	MU27559754	hom
19	55665584	55665584	A	C	TNNI3	intronic	.	ENSG00000129991	rs7252610	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	0.0052	0.15	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	191044	115210;611880;613286;613690;	154;154;75249;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~75249|Familial or idiopathic restrictive cardiomyopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|115210 609578 612422 615248 617047 ~	.	.	.	.	.	.	.	.	19	MU82031742	hom
19	55668509	55668509	A	T	TNNI3	intronic	.	ENSG00000129991;ENSG00000267110	rs3729836	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3537	0.3162	0.458067	0.3397	.	.	.	.	.	0.0021	0.14	.	.	.	AFR:0.6132,AMR:0.4294,EAS:0.4355,FIN:0.2298,NFE:0.1976,OTH:0.2867,ASJ:0.2086	191044	115210;611880;613286;613690;	154;154;75249;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~75249|Familial or idiopathic restrictive cardiomyopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|115210 609578 612422 615248 617047 ~	.	.	.	.	.	.	.	.	19	MU18536585	hom
20	2637071	2637071	T	C	NOP56	exonic	synonymous SNV	ENSG00000101361	rs8958	ENSG00000101361:ENST00000329276:exon9:c.T1035C:p.T345T	NOP56:NM_006392:exon9:c.T1035C:p.T345T	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6336	0.6509	0.673722	0.6509	.	.	.	.	.	.	.	.	NOP56:uc002wgi.3:exon8:c.T537C:p.T179T,NOP56:uc002wgh.3:exon9:c.T1035C:p.T345T	.	AFR:0.7235,AMR:0.7351,EAS:0.6194,FIN:0.5441,NFE:0.6347,OTH:0.6426,ASJ:0.5563	614154	614153;	276198;	276198|Asidan<br>SCA36|<1 / 1 000 000|Autosomal dominant|Adult|614153 ~	.	.	.	.	.	.	.	.	20	MU4554470	hom
20	3783764	3783764	C	T	CDC25B	exonic	synonymous SNV	ENSG00000101224	rs2228464	ENSG00000101224:ENST00000340833:exon12:c.C1144T:p.L382L,ENSG00000101224:ENST00000379598:exon12:c.C994T:p.L332L,ENSG00000101224:ENST00000245960:exon13:c.C1267T:p.L423L,ENSG00000101224:ENST00000344256:exon13:c.C1075T:p.L359L,ENSG00000101224:ENST00000439880:exon13:c.C1225T:p.L409L	CDC25B:NM_001287524:exon9:c.C691T:p.L231L,CDC25B:NM_001287518:exon12:c.C994T:p.L332L,CDC25B:NM_001287522:exon12:c.C808T:p.L270L,CDC25B:NM_021872:exon12:c.C1144T:p.L382L,CDC25B:NM_001287516:exon13:c.C1075T:p.L359L,CDC25B:NM_001287517:exon13:c.C1033T:p.L345L,CDC25B:NM_001287519:exon13:c.C931T:p.L311L,CDC25B:NM_001287520:exon13:c.C931T:p.L311L,CDC25B:NM_004358:exon13:c.C1225T:p.L409L,CDC25B:NM_021873:exon13:c.C1267T:p.L423L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0463	0.0519	0.0289537	0.0440	.	.	.	.	.	.	.	.	CDC25B:uc002wjq.3:exon9:c.C667T:p.L223L,CDC25B:uc002wjp.3:exon12:c.C1144T:p.L382L,CDC25B:uc010zqm.2:exon12:c.C994T:p.L332L,CDC25B:uc021waa.1:exon12:c.C808T:p.L270L,CDC25B:uc002wjl.3:exon13:c.C931T:p.L311L,CDC25B:uc002wjm.3:exon13:c.C931T:p.L311L,CDC25B:uc002wjn.3:exon13:c.C1267T:p.L423L,CDC25B:uc002wjo.3:exon13:c.C1225T:p.L409L,CDC25B:uc010zqk.2:exon13:c.C1075T:p.L359L,CDC25B:uc010zql.2:exon13:c.C1033T:p.L345L	.	AFR:0.0116,AMR:0.0382,EAS:0.0037,FIN:0.0350,NFE:0.0694,OTH:0.0470,ASJ:0.0464	116949	.	.	.	.	.	.	.	.	.	.	.	20	.	hom
20	5099516	5099516	G	A	PCNA	intronic	.	ENSG00000132646	rs17349	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1043	0.1693	0.124401	0.1441	.	.	.	.	.	0	0	.	.	.	AFR:0.2932,AMR:0.0899,EAS:0.0006,FIN:0.0633,NFE:0.0976,OTH:0.1022,ASJ:0.1391	176740	615919;	438134;	438134|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|615919 ~	.	.	.	.	.	.	.	.	20	.	hom
20	5100209	5100209	G	C	PCNA	intronic	.	ENSG00000132646	rs17347	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1364	0.1662	0.128395	0.1471	.	.	.	.	.	.	.	.	.	.	AFR:0.3033,AMR:0.0907,EAS:0.0006,FIN:0.0636,NFE:0.0978,OTH:0.1033,ASJ:0.1391	176740	615919;	438134;	438134|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|615919 ~	.	.	.	.	.	.	.	.	20	.	hom
20	5753579	5753579	C	T	SHLD1	exonic	nonsynonymous SNV	ENSG00000171984	rs237422	ENSG00000171984:ENST00000303142:exon2:c.C68T:p.A23V,ENSG00000171984:ENST00000378979:exon2:c.C68T:p.A23V,ENSG00000171984:ENST00000442185:exon3:c.C209T:p.A70V,ENSG00000171984:ENST00000445603:exon3:c.C68T:p.A23V	SHLD1:NM_001303479:exon2:c.C68T:p.A23V,SHLD1:NM_152504:exon2:c.C68T:p.A23V,SHLD1:NM_001303477:exon3:c.C68T:p.A23V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2495	0.2730	0.234026	1(lung)	-1.138	0.008	1.0	1.73	0.000	.	.	.	C20orf196:uc002wmf.3:exon2:c.C68T:p.A23V	-0.950	AFR:1(prostate),AMR:1(stomach),EAS:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,FIN:0.2604,NFE:0.2852,OTH:0.2715,ASJ:MU585454	.	.	.	.	.	.	.	.	0.002	1.24	0.000	0.72	20	2(haematopoietic_and_lymphoid_tissue)	0.1788
20	5843812	5843812	T	C	SHLD1	exonic	synonymous SNV	ENSG00000171984	rs1699233	ENSG00000171984:ENST00000303142:exon3:c.T321C:p.G107G,ENSG00000171984:ENST00000442185:exon4:c.T462C:p.G154G,ENSG00000171984:ENST00000445603:exon4:c.T321C:p.G107G	SHLD1:NM_152504:exon3:c.T321C:p.G107G,SHLD1:NM_001303477:exon4:c.T321C:p.G107G,SHLD1:NM_001303478:exon4:c.T225C:p.G75G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4237	0.4872	0.433107	0.4795	.	.	.	.	.	.	.	.	C20orf196:uc002wmf.3:exon3:c.T321C:p.G107G	.	AFR:0.6056,AMR:0.4029,EAS:0.3226,FIN:0.4505,NFE:0.4362,OTH:0.4501,ASJ:0.4801	.	.	.	.	.	.	.	.	.	.	.	.	20	MU11286276	het
20	5844121	5844121	C	T	SHLD1	UTR3	.	ENSG00000171984	rs1699232	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3104	0.3235	0.33127	0.3384	.	.	.	.	.	.	.	.	.	.	AFR:0.4486,AMR:0.3110,EAS:0.2215,FIN:0.3159,NFE:0.2965,OTH:0.3021,ASJ:0.3233	.	.	.	.	.	.	.	.	.	.	.	.	20	MU11286280	unknown
20	5844122	5844122	A	G	SHLD1	UTR3	.	ENSG00000171984	rs1777353	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4028	0.3803	0.469848	0.4107	.	.	.	.	.	.	.	.	.	.	AFR:0.5571,AMR:0.5251,EAS:0.4609,FIN:0.3803,NFE:0.3251,OTH:0.3577,ASJ:0.3767	.	.	.	.	.	.	.	.	.	.	.	.	20	MU782719	unknown
20	5935825	5935825	A	G	MCM8	exonic	nonsynonymous SNV	ENSG00000125885	rs145133959	ENSG00000125885:ENST00000265187:exon5:c.A414G:p.I138M,ENSG00000125885:ENST00000378883:exon5:c.A414G:p.I138M,ENSG00000125885:ENST00000378886:exon5:c.A414G:p.I138M,ENSG00000125885:ENST00000378896:exon5:c.A414G:p.I138M	MCM8:NM_001281520:exon5:c.A414G:p.I138M,MCM8:NM_001281521:exon5:c.A414G:p.I138M,MCM8:NM_001281522:exon5:c.A414G:p.I138M,MCM8:NM_032485:exon5:c.A414G:p.I138M,MCM8:NM_182802:exon5:c.A414G:p.I138M	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0067	0.0033	0.0071885	0.0014	-0.138	1.466	0.13	1.95	0.088	.	.	Nucleic acid-binding, OB-fold	MCM8:uc002wmi.3:exon5:c.A414G:p.I138M,MCM8:uc002wmj.3:exon5:c.A414G:p.I138M,MCM8:uc002wmk.3:exon5:c.A414G:p.I138M,MCM8:uc002wml.3:exon5:c.A414G:p.I138M,MCM8:uc010gbp.3:exon5:c.A414G:p.I138M	-0.971	AFR:0.0002,AMR:0,EAS:0,FIN:0.0006,NFE:0.0022,OTH:0.0031,ASJ:0.0132	608187	612885;	.	.	.	.	.	.	0.015	4.02	0.013	2.14	20	.	hom
20	6100088	6100088	A	G	FERMT1	exonic	synonymous SNV	ENSG00000101311	rs10373	ENSG00000101311:ENST00000217289:exon2:c.T114C:p.H38H,ENSG00000101311:ENST00000378844:exon2:c.T114C:p.H38H	FERMT1:NM_017671:exon2:c.T114C:p.H38H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5243	0.5324	0.524561	ESAD-UK|1|409|0.00244499,SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	FERMT1:uc002wmr.3:exon2:c.T114C:p.H38H,FERMT1:uc002wms.3:exon2:c.T114C:p.H38H	.	AFR:0.5005,AMR:0.5294,EAS:0.6225,FIN:0.3752,NFE:0.4129,OTH:0.5169,ASJ:0.4845	607900	173650;	306539;	306539|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|173650 ~	.	.	.	.	.	.	.	.	20	1(haematopoietic_and_lymphoid_tissue)	0.4878
20	8755243	8755243	T	C	PLCB1	exonic	synonymous SNV	ENSG00000182621	rs2235613	ENSG00000182621:ENST00000338037:exon27:c.T2988C:p.A996A,ENSG00000182621:ENST00000378637:exon27:c.T2988C:p.A996A,ENSG00000182621:ENST00000378641:exon27:c.T2988C:p.A996A	PLCB1:NM_015192:exon27:c.T2988C:p.A996A,PLCB1:NM_182734:exon27:c.T2988C:p.A996A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6155	0.6402	0.613219	MU146166	.	.	.	.	.	.	.	.	PLCB1:uc002wnd.1:exon15:c.T1719C:p.A573A,PLCB1:uc002wnc.1:exon25:c.T2685C:p.A895A,PLCB1:uc002wna.4:exon27:c.T2988C:p.A996A,PLCB1:uc002wnb.4:exon27:c.T2988C:p.A996A,PLCB1:uc010zrb.1:exon27:c.T2685C:p.A895A	.	AFR:LICA-CN|3|402|0.00746269,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.6163,EAS:0.5096,FIN:0.7119,NFE:0.5167,OTH:0.5516,ASJ:0.6384	607120	613722;	293181;3451;	293181|MMPEI<br>MMPSI<br>MPEI<br>MPSI<br>Malignant migrating partial epilepsy of infancy<br>Migrating partial epilepsy of infancy<br>Migrating partial seizures of infancy|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|613722 614959 615338 616645 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04062 Chemokine signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04973 Carbohydrate digestion and absorption~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	20	1(prostate)	0.6330
20	8769180	8769180	C	T	PLCB1	intronic	.	ENSG00000182621	rs2327089	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9408	0.8914	0.896965	0.9039	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.7424,AMR:0.9630,EAS:0.9988,FIN:0.9820,NFE:0.9625,OTH:0.9481,ASJ:0.9371	607120	613722;	293181;3451;	293181|MMPEI<br>MMPSI<br>MPEI<br>MPSI<br>Malignant migrating partial epilepsy of infancy<br>Migrating partial epilepsy of infancy<br>Migrating partial seizures of infancy|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|613722 614959 615338 616645 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04062 Chemokine signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04973 Carbohydrate digestion and absorption~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	20	MU82035692	hom
20	10620386	10620386	A	G	JAG1	exonic	synonymous SNV	ENSG00000101384	rs1051419	ENSG00000101384:ENST00000423891:exon24:c.T2940C:p.Y980Y,ENSG00000101384:ENST00000254958:exon26:c.T3417C:p.Y1139Y	JAG1:NM_000214:exon26:c.T3417C:p.Y1139Y	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6592	0.7272	0.71266	3(lung)	.	.	.	.	.	.	.	.	JAG1:uc002wnw.2:exon26:c.T3417C:p.Y1139Y	.	AFR:1(large_intestine),AMR:MU110199,EAS:0.6923,FIN:0.9037,NFE:0.6146,OTH:0.5828,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	1(urinary_tract)	0.4141
20	10633237	10633237	G	A	JAG1	exonic	synonymous SNV	ENSG00000101384	rs1131695	ENSG00000101384:ENST00000423891:exon4:c.C288T:p.Y96Y,ENSG00000101384:ENST00000254958:exon6:c.C765T:p.Y255Y	JAG1:NM_000214:exon6:c.C765T:p.Y255Y	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4541	0.4247	0.423323	LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	JAG1:uc002wnw.2:exon6:c.C765T:p.Y255Y	.	AFR:0.4224,AMR:0.3535,EAS:0.4934,FIN:0.3276,NFE:0.4487,OTH:0.4636,ASJ:0.4177	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	3(large_intestine)	0.4507
20	31022959	31022959	T	C	ASXL1	exonic	nonsynonymous SNV	ENSG00000171456	rs6058694	ENSG00000171456:ENST00000306058:exon12:c.T2429C:p.L810P,ENSG00000171456:ENST00000375687:exon13:c.T2444C:p.L815P	ASXL1:NM_001363734:exon11:c.T2261C:p.L754P,ASXL1:NM_015338:exon12:c.T2444C:p.L815P	clinvar: not_provided 	 CancerVar: 8#Tier_II_potential EVS=[1, 1, 1, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	1.0000	0.9999	1	1	.	.	.	.	.	.	.	.	ASXL1:uc010geb.3:exon9:c.T2117C:p.L706P,ASXL1:uc002wxs.3:exon12:c.T2441C:p.L814P,ASXL1:uc021wbw.1:exon13:c.T2444C:p.L815P	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	612990	605039;614286;	52688;97297;	52688|-|1-9 / 100 000|-|All ages|614286 ~97297|BOS syndrome<br>Bohring syndrome<br>C-like syndrome<br>Oberklaid-Danks syndrome<br>Opitz trigonocephaly-like syndrome|<1 / 1 000 000|-|-|605039 ~	.	,842,839,844	,853	,848,851,849,846,847,854,843,845,850,852	.	.	.	.	20	MU82037741	hom
20	31024274	31024274	T	C	ASXL1	exonic	synonymous SNV	ENSG00000171456	rs4911231	ENSG00000171456:ENST00000306058:exon12:c.T3744C:p.S1248S,ENSG00000171456:ENST00000375687:exon13:c.T3759C:p.S1253S	ASXL1:NM_001363734:exon11:c.T3576C:p.S1192S,ASXL1:NM_015338:exon12:c.T3759C:p.S1253S	clinvar: Benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 1, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4183	0.3201	0.405751	1(biliary_tract)	.	.	.	.	.	.	.	.	ASXL1:uc010geb.3:exon9:c.T3432C:p.S1144S,ASXL1:uc002wxs.3:exon12:c.T3756C:p.S1252S,ASXL1:uc021wbw.1:exon13:c.T3759C:p.S1253S	.	AFR:MU4554836,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,EAS:0.1945,FIN:0.4460,NFE:0.2848,OTH:0.7880,ASJ:0.3695	612990	605039;614286;	52688;97297;	52688|-|1-9 / 100 000|-|All ages|614286 ~97297|BOS syndrome<br>Bohring syndrome<br>C-like syndrome<br>Oberklaid-Danks syndrome<br>Opitz trigonocephaly-like syndrome|<1 / 1 000 000|-|-|605039 ~	.	,842,839,844	,853	,848,851,849,846,847,854,843,845,850,852	.	.	.	.	20	15(soft_tissue)	0.4639
20	31383353	31383353	T	G	DNMT3B	intronic	.	ENSG00000088305	rs910085	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4836	0.4029	0.584864	0.4343	.	.	.	.	.	.	.	.	.	.	AFR:0.4486,AMR:0.6499,EAS:0.9406,FIN:0.3651,NFE:0.3789,OTH:0.3990,ASJ:0.3818	602900	242860;	2268;	2268|Immunodeficiency-centromeric instability-facial anomalies syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|242860 614069 616910 616911 ~	.	.	.	.	.	.	.	.	20	MU25969455	hom
20	31386449	31386449	T	C	DNMT3B	exonic	synonymous SNV	ENSG00000088305	rs2424922	ENSG00000088305:ENST00000456297:exon12:c.T1386C:p.Y462Y,ENSG00000088305:ENST00000443239:exon13:c.T1488C:p.Y496Y,ENSG00000088305:ENST00000201963:exon14:c.T1650C:p.Y550Y,ENSG00000088305:ENST00000344505:exon14:c.T1614C:p.Y538Y,ENSG00000088305:ENST00000348286:exon14:c.T1614C:p.Y538Y,ENSG00000088305:ENST00000353855:exon14:c.T1614C:p.Y538Y,ENSG00000088305:ENST00000328111:exon15:c.T1674C:p.Y558Y	DNMT3B:NM_001207056:exon12:c.T1386C:p.Y462Y,DNMT3B:NM_001207055:exon13:c.T1488C:p.Y496Y,DNMT3B:NM_175848:exon14:c.T1614C:p.Y538Y,DNMT3B:NM_175849:exon14:c.T1614C:p.Y538Y,DNMT3B:NM_175850:exon14:c.T1650C:p.Y550Y,DNMT3B:NM_006892:exon15:c.T1674C:p.Y558Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5792	0.5777	0.755791	0.5958	.	.	.	.	.	0.0001	0.2	.	DNMT3B:uc002wyg.3:exon8:c.T771C:p.Y257Y,DNMT3B:uc010zua.2:exon12:c.T1386C:p.Y462Y,DNMT3B:uc010ztz.2:exon13:c.T1488C:p.Y496Y,DNMT3B:uc002wyd.3:exon14:c.T1614C:p.Y538Y,DNMT3B:uc002wye.3:exon14:c.T1614C:p.Y538Y,DNMT3B:uc002wyf.3:exon14:c.T1650C:p.Y550Y,DNMT3B:uc002wyc.3:exon15:c.T1674C:p.Y558Y	.	AFR:0.8515,AMR:0.7064,EAS:0.9957,FIN:0.4333,NFE:0.4433,OTH:0.5102,ASJ:0.4702	602900	242860;	2268;	2268|Immunodeficiency-centromeric instability-facial anomalies syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|242860 614069 616910 616911 ~	.	.	.	.	.	.	.	.	20	MU4554877	hom
20	31387954	31387954	C	G	DNMT3B	intronic	.	ENSG00000088305	rs1997797	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5663	0.5340	0.714058	0.5577	.	.	.	.	.	0.0005	0.056	.	.	.	AFR:0.7205,AMR:0.6986,EAS:0.9957,FIN:0.4313,NFE:0.4426,OTH:0.5031,ASJ:0.4636	602900	242860;	2268;	2268|Immunodeficiency-centromeric instability-facial anomalies syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|242860 614069 616910 616911 ~	.	.	.	.	.	.	.	.	20	MU30256080	hom
20	36030939	36030939	G	C	SRC	exonic	synonymous SNV	ENSG00000197122	rs1885257	ENSG00000197122:ENST00000358208:exon10:c.G1218C:p.A406A,ENSG00000197122:ENST00000373558:exon10:c.G1236C:p.A412A,ENSG00000197122:ENST00000373567:exon10:c.G1218C:p.A406A,ENSG00000197122:ENST00000360723:exon11:c.G1236C:p.A412A,ENSG00000197122:ENST00000445403:exon11:c.G1218C:p.A406A,ENSG00000197122:ENST00000373578:exon12:c.G1218C:p.A406A	SRC:NM_005417:exon12:c.G1218C:p.A406A,SRC:NM_198291:exon12:c.G1218C:p.A406A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	1	.	1	1	.	.	.	.	.	.	.	.	SRC:uc002xgx.3:exon12:c.G1218C:p.A406A,SRC:uc002xgy.3:exon12:c.G1218C:p.A406A	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	190090	114500;616937;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04015 Rap1 signaling pathway~ko04062 Chemokine signaling pathway~ko04137 Mitophagy - animal~ko04144 Endocytosis~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko04540 Gap junction~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04727 GABAergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05131 Shigellosis~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	9876,9878,9877,9880,,9874,9879,9872,9875,9870,9869,9871,9873	.	.	.	.	.	.	20	MU82038480	hom
20	39797465	39797465	T	C	PLCG1	exonic	nonsynonymous SNV	ENSG00000124181	rs753381	ENSG00000124181:ENST00000373271:exon21:c.T2438C:p.I813T,ENSG00000124181:ENST00000373272:exon21:c.T2438C:p.I813T,ENSG00000124181:ENST00000244007:exon22:c.T2438C:p.I813T	PLCG1:NM_002660:exon21:c.T2438C:p.I813T,PLCG1:NM_182811:exon21:c.T2438C:p.I813T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6155	0.6693	0.732827	0.6790	1.643	14.09	0.547	5.82	0.998	.	.	Pleckstrin homology domain|SH3 domain	PLCG1:uc010ggf.3:exon4:c.T410C:p.I137T,PLCG1:uc010zwe.1:exon10:c.T1316C:p.I439T,PLCG1:uc002xjo.1:exon21:c.T2438C:p.I813T,PLCG1:uc002xjp.1:exon21:c.T2438C:p.I813T	-0.938	AFR:0.9256,AMR:0.6031,EAS:0.8300,FIN:0.5917,NFE:0.5500,OTH:0.6043,ASJ:0.58	172420	.	.	.	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05135 Yersinia infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	0.0	0.91	0.000	-1.165	20	MU17685332	hom
20	40743829	40743829	A	G	PTPRT	intronic	.	ENSG00000196090	rs2076248	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5308	0.5650	0.55651	0.5599	.	.	.	.	.	.	.	.	.	.	AFR:0.6257,AMR:0.5144,EAS:0.5632,FIN:0.5309,NFE:0.5305,OTH:0.5431,ASJ:0.6225	608712	.	.	.	.	.	.	.	.	.	.	.	20	MU23851333	hom
20	40790172	40790172	-	CTGCCATCTGCTTCGAAAAGAAGGAGGCAGAACAGATCATCACCTATT	PTPRT	exonic	nonframeshift insertion	ENSG00000196090	.	ENSG00000196090:ENST00000373184:exon16:c.2471_2472insAATAGGTGATGATCTGTTCTGCCTCCTTCTTTTCGAAGCAGATGGCAG:p.S824delinsRIGDDLFCLLLFEADGS,ENSG00000196090:ENST00000373201:exon16:c.2471_2472insAATAGGTGATGATCTGTTCTGCCTCCTTCTTTTCGAAGCAGATGGCAG:p.S824delinsRIGDDLFCLLLFEADGS,ENSG00000196090:ENST00000356100:exon17:c.2528_2529insAATAGGTGATGATCTGTTCTGCCTCCTTCTTTTCGAAGCAGATGGCAG:p.S843delinsRIGDDLFCLLLFEADGS,ENSG00000196090:ENST00000373187:exon17:c.2501_2502insAATAGGTGATGATCTGTTCTGCCTCCTTCTTTTCGAAGCAGATGGCAG:p.S834delinsRIGDDLFCLLLFEADGS,ENSG00000196090:ENST00000373190:exon17:c.2498_2499insAATAGGTGATGATCTGTTCTGCCTCCTTCTTTTCGAAGCAGATGGCAG:p.S833delinsRIGDDLFCLLLFEADGS,ENSG00000196090:ENST00000373193:exon17:c.2510_2511insAATAGGTGATGATCTGTTCTGCCTCCTTCTTTTCGAAGCAGATGGCAG:p.S837delinsRIGDDLFCLLLFEADGS,ENSG00000196090:ENST00000373198:exon18:c.2558_2559insAATAGGTGATGATCTGTTCTGCCTCCTTCTTTTCGAAGCAGATGGCAG:p.S853delinsRIGDDLFCLLLFEADGS	PTPRT:NM_007050:exon17:c.2501_2502insAATAGGTGATGATCTGTTCTGCCTCCTTCTTTTCGAAGCAGATGGCAG:p.S834delinsRIGDDLFCLLLFEADGS,PTPRT:NM_133170:exon18:c.2558_2559insAATAGGTGATGATCTGTTCTGCCTCCTTCTTTTCGAAGCAGATGGCAG:p.S853delinsRIGDDLFCLLLFEADGS	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	PTPRT:uc010ggi.3:exon2:c.110_111insAATAGGTGATGATCTGTTCTGCCTCCTTCTTTTCGAAGCAGATGGCAG:p.S37delinsRIGDDLFCLLLFEADGS,PTPRT:uc002xkg.3:exon17:c.2501_2502insAATAGGTGATGATCTGTTCTGCCTCCTTCTTTTCGAAGCAGATGGCAG:p.S834delinsRIGDDLFCLLLFEADGS,PTPRT:uc010ggj.3:exon18:c.2558_2559insAATAGGTGATGATCTGTTCTGCCTCCTTCTTTTCGAAGCAGATGGCAG:p.S853delinsRIGDDLFCLLLFEADGS	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608712	.	.	.	.	.	.	.	.	.	.	.	20	.	het
20	41306488	41306488	-	A	PTPRT	intronic	.	ENSG00000196090	rs111229158	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.4460	.	0.419728	0.4007	.	.	.	.	.	.	.	.	.	.	AFR:0.4509,AMR:0.3950,EAS:0.3794,FIN:0.4109,NFE:0.3728,OTH:0.3903,ASJ:0.3370	608712	.	.	.	.	.	.	.	.	.	.	.	20	.	hom
20	42320881	42320881	C	T	MYBL2	exonic	synonymous SNV	ENSG00000101057	rs2229036	ENSG00000101057:ENST00000396863:exon5:c.C513T:p.D171D,ENSG00000101057:ENST00000217026:exon6:c.C585T:p.D195D	MYBL2:NM_001278610:exon5:c.C513T:p.D171D,MYBL2:NM_002466:exon6:c.C585T:p.D195D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0472	0.0405	0.0505192	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	MYBL2:uc010zwj.1:exon5:c.C513T:p.D171D,MYBL2:uc002xlb.1:exon6:c.C585T:p.D195D	.	AFR:0.0385,AMR:0.0259,EAS:0.0596,FIN:0.0760,NFE:0.0309,OTH:0.0434,ASJ:0.0346	601415	.	.	.	.	.	.	.	.	.	.	.	20	2(haematopoietic_and_lymphoid_tissue)	0.0388
20	42328639	42328639	T	C	MYBL2	exonic	synonymous SNV	ENSG00000101057	rs285162	ENSG00000101057:ENST00000396863:exon6:c.T834C:p.P278P,ENSG00000101057:ENST00000217026:exon7:c.T906C:p.P302P	MYBL2:NM_001278610:exon6:c.T834C:p.P278P,MYBL2:NM_002466:exon7:c.T906C:p.P302P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9141	0.9372	0.932109	0.9385	.	.	.	.	.	.	.	.	MYBL2:uc010zwj.1:exon6:c.T834C:p.P278P,MYBL2:uc002xlb.1:exon7:c.T906C:p.P302P	.	AFR:0.9724,AMR:0.7602,EAS:0.9082,FIN:0.9505,NFE:0.9297,OTH:0.9235,ASJ:0.9570	601415	.	.	.	.	.	.	.	.	.	.	.	20	MU25976801	hom
20	42331457	42331457	A	G	MYBL2	exonic	nonsynonymous SNV	ENSG00000101057	rs2070235	ENSG00000101057:ENST00000396863:exon7:c.A1207G:p.S403G,ENSG00000101057:ENST00000217026:exon8:c.A1279G:p.S427G	MYBL2:NM_001278610:exon7:c.A1207G:p.S403G,MYBL2:NM_002466:exon8:c.A1279G:p.S427G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1080	0.1525	0.15655	1(breast)	1.102	11.22	0.55	2.73	0.923	.	.	.	MYBL2:uc010zwj.1:exon7:c.A1207G:p.S403G,MYBL2:uc002xlb.1:exon8:c.A1279G:p.S427G	-0.903	AFR:MU4557321,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.2664,FIN:0.0694,NFE:0.1159,OTH:0.0883,ASJ:0.1377	601415	.	.	.	.	.	.	.	0.002	2.52	0.000	0.805	20	1(haematopoietic_and_lymphoid_tissue)	0.0922
20	46267950	46267950	C	T	NCOA3	intronic	.	ENSG00000124151	rs4810648	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9411	0.9406	0.978435	0.9373	.	.	.	.	.	0.0002	0.034	.	.	.	AFR:0.9842,AMR:0.9533,EAS:1,FIN:0.9273,NFE:0.9051,OTH:0.9257,ASJ:0.9570	601937	.	.	.	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	MU82039696	hom
20	47567970	47567970	T	C	ARFGEF2	exonic	synonymous SNV	ENSG00000124198	.	ENSG00000124198:ENST00000371917:exon4:c.T387C:p.P129P	ARFGEF2:NM_006420:exon4:c.T387C:p.P129P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	ARFGEF2:uc002xtx.4:exon4:c.T387C:p.P129P	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605371	608097;	2149;98892;	2149|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|All ages|300049 608097 608098 612881 615544 ~98892|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|-|300049 608097 608098 612881 615544 ~	.	.	.	.	.	.	.	.	20	.	hom
20	47648621	47648621	T	C	ARFGEF2	exonic	nonsynonymous SNV	ENSG00000124198	rs759674594	ENSG00000124198:ENST00000371917:exon38:c.T5099C:p.V1700A	ARFGEF2:NM_006420:exon38:c.T5099C:p.V1700A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	1.647e-05	.	.	.	3.144	22.6	0.158	5.93	0.984	.	.	Armadillo-like helical|Armadillo-type fold	ARFGEF2:uc010zyf.2:exon24:c.T2978C:p.V993A,ARFGEF2:uc002xtx.4:exon38:c.T5099C:p.V1700A	-0.908	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605371	608097;	2149;98892;	2149|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|All ages|300049 608097 608098 612881 615544 ~98892|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|-|300049 608097 608098 612881 615544 ~	.	.	.	.	0.021	-0.14	0.178	1.43	20	.	hom
20	50408482	50408482	A	G	SALL4	exonic	synonymous SNV	ENSG00000101115	rs6013281	ENSG00000101115:ENST00000217086:exon2:c.T540C:p.N180N,ENSG00000101115:ENST00000395997:exon2:c.T540C:p.N180N	SALL4:NM_001318031:exon2:c.T540C:p.N180N,SALL4:NM_020436:exon2:c.T540C:p.N180N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9965	0.9956	0.997404	0.9967	.	.	.	.	.	.	.	.	SALL4:uc002xwh.4:exon2:c.T540C:p.N180N,SALL4:uc010gii.3:exon2:c.T540C:p.N180N	.	AFR:0.9976,AMR:0.9988,EAS:1,FIN:0.9991,NFE:0.9953,OTH:0.9980,ASJ:0.9901	607343	147750;607323;	93293;959;2307;	93293|Duane-radial ray syndrome|-|Autosomal dominant|-|607323 ~959|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Antenatal|607323 ~2307|Oculo-oto-radial syndrome<br>Radial ray defects, hearing impairment, external ophthalmoplegia, and thrombocytopenia|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|147750 ~	.	.	.	.	.	.	.	.	20	MU82040420	hom
20	52185814	52185814	C	A	LOC101927770	ncRNA_intronic	.	ENSG00000197670	rs4602270	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7256	.	0.779153	0.7405	.	.	.	.	.	0	0	.	.	.	AFR:0.8270,AMR:0.7626,EAS:0.8209,FIN:0.7318,NFE:0.6834,OTH:0.7301,ASJ:0.7152	.	.	.	.	.	.	.	.	.	.	.	.	20	MU14541605	hom
20	52198224	52198224	C	T	ZNF217	exonic	nonsynonymous SNV	ENSG00000171940	.	ENSG00000171940:ENST00000302342:exon1:c.G1142A:p.G381D,ENSG00000171940:ENST00000371471:exon2:c.G1142A:p.G381D	ZNF217:NM_006526:exon1:c.G1142A:p.G381D	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	4.803	24.8	0.006	5.7	0.961	.	.	Zinc finger C2H2-type	ZNF217:uc002xwq.4:exon1:c.G1142A:p.G381D,ZNF217:uc010gij.1:exon2:c.G1118A:p.G373D	-0.842	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602967	.	.	.	.	.	.	.	0.995	1.36	0.186	2	20	.	hom
20	52198967	52198967	A	G	ZNF217	exonic	synonymous SNV	ENSG00000171940	rs1326862	ENSG00000171940:ENST00000302342:exon1:c.T399C:p.C133C,ENSG00000171940:ENST00000371471:exon2:c.T399C:p.C133C	ZNF217:NM_006526:exon1:c.T399C:p.C133C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0619	0.0599	0.110823	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ZNF217:uc002xwq.4:exon1:c.T399C:p.C133C,ZNF217:uc010gij.1:exon2:c.T375C:p.C125C	.	AFR:MU148294,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,EAS:0.1203,FIN:0.1002,NFE:0.0166,OTH:0.1442,ASJ:0.0642	602967	.	.	.	.	.	.	.	.	.	.	.	20	1(urinary_tract)	0.0415
20	54961463	54961463	T	C	AURKA	exonic	nonsynonymous SNV	ENSG00000087586	rs1047972	ENSG00000087586:ENST00000347343:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000395907:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000395913:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000395915:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000312783:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000371356:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000395911:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000395914:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000422322:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000441357:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000395909:exon5:c.A169G:p.I57V,ENSG00000087586:ENST00000420474:exon5:c.A169G:p.I57V,ENSG00000087586:ENST00000451915:exon5:c.A169G:p.I57V,ENSG00000087586:ENST00000456249:exon5:c.A169G:p.I57V	AURKA:NM_003600:exon3:c.A169G:p.I57V,AURKA:NM_198435:exon3:c.A169G:p.I57V,AURKA:NM_198437:exon3:c.A169G:p.I57V,AURKA:NM_001323303:exon4:c.A169G:p.I57V,AURKA:NM_001323304:exon4:c.A169G:p.I57V,AURKA:NM_198434:exon4:c.A169G:p.I57V,AURKA:NM_198436:exon4:c.A169G:p.I57V,AURKA:NM_001323305:exon5:c.A169G:p.I57V,AURKA:NM_198433:exon5:c.A169G:p.I57V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8482	0.8378	0.84984	COCA-CN|5|321|0.0155763	-2.027	0.001	1.0	1.97	0.069	.	.	.	AURKA:uc002xxg.1:exon3:c.A169G:p.I57V,AURKA:uc002xxh.1:exon3:c.A169G:p.I57V,AURKA:uc002xxi.1:exon3:c.A169G:p.I57V,AURKA:uc002xxe.1:exon4:c.A169G:p.I57V,AURKA:uc002xxf.1:exon4:c.A169G:p.I57V,AURKA:uc002xxj.1:exon4:c.A169G:p.I57V,AURKA:uc002xxd.1:exon5:c.A169G:p.I57V	-0.937	AFR:0.8413,AMR:0.8405,EAS:0.8676,FIN:0.8881,NFE:0.8129,OTH:0.8406,ASJ:0.8986	603072	114500;	.	.	.	.	.	.	0.0	-0.1	0.000	.	20	1(stomach)	0.8262
20	57478807	57478807	C	T	GNAS	exonic	synonymous SNV	ENSG00000087460	rs7121	ENSG00000087460:ENST00000265620:exon4:c.C348T:p.I116I,ENSG00000087460:ENST00000371095:exon4:c.C351T:p.I117I,ENSG00000087460:ENST00000371102:exon4:c.C2280T:p.I760I,ENSG00000087460:ENST00000306090:exon5:c.C351T:p.I117I,ENSG00000087460:ENST00000349036:exon5:c.C444T:p.I148I,ENSG00000087460:ENST00000354359:exon5:c.C396T:p.I132I,ENSG00000087460:ENST00000371085:exon5:c.C393T:p.I131I,ENSG00000087460:ENST00000371100:exon5:c.C2322T:p.I774I,ENSG00000087460:ENST00000603546:exon5:c.C216T:p.I72I,ENSG00000087460:ENST00000604005:exon5:c.C216T:p.I72I	GNAS:NM_001077489:exon4:c.C348T:p.I116I,GNAS:NM_080426:exon4:c.C351T:p.I117I,GNAS:NM_000516:exon5:c.C393T:p.I131I,GNAS:NM_001077488:exon5:c.C396T:p.I132I,GNAS:NM_001309840:exon5:c.C216T:p.I72I,GNAS:NM_001309861:exon5:c.C216T:p.I72I,GNAS:NM_080425:exon5:c.C2322T:p.I774I	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5473	0.5794	0.644369	15(meninges)	.	.	.	.	.	.	.	.	GNAS:uc002yae.3:exon2:c.C168T:p.I56I,GNAS:uc002yad.3:exon3:c.C66T:p.I22I,GNAS:uc002yaa.3:exon4:c.C348T:p.I116I,GNAS:uc021wfp.1:exon4:c.C351T:p.I117I,GNAS:uc002xzt.3:exon5:c.C297T:p.I99I,GNAS:uc002xzw.3:exon5:c.C2322T:p.I774I,GNAS:uc002xzx.3:exon5:c.C216T:p.I72I,GNAS:uc010gjq.3:exon5:c.C216T:p.I72I,GNAS:uc021wfn.1:exon5:c.C393T:p.I131I,GNAS:uc021wfo.1:exon5:c.C396T:p.I132I	.	AFR:1(eye),AMR:MU84578,EAS:0.5563,FIN:0.7561,NFE:0.6235,OTH:0.64,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	139320	102200;103580;166350;174800;219080;603233;612462;612463;	79445;79444;94089;189427;562;2762;79443;314777;96256;963;99725;	79445|AHO-PPHP syndrome<br>Albright hereditary osteodystrophy-PPHP syndrome|Unknown|Autosomal dominant|All ages|612463 ~79444|-|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|612462 ~94089|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Infancy<br>Childhood<br>Adolescent|603233 ~189427|Primary bilateral macronodular adrenal hyperplasia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|219080 615954 ~562|Gonadotropin-independent female-limited sexual precocity|1-9 / 1 000 000|Not applicable|Childhood|174800 ~2762|Familial ectopic ossification<br>POH|-|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|166350 ~79443|AHO-PHP syndrome Ia<br>Albright hereditary osteodystrophy-PHP syndrome Ia|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|103580 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	~ko01522 Endocrine resistance~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04361 Axon regeneration~ko04540 Gap junction~ko04611 Platelet activation~ko04713 Circadian entrainment~ko04714 Thermogenesis~ko04724 Glutamatergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04913 Ovarian steroidogenesis~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04962 Vasopressin-regulated water reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04976 Bile secretion~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05032 Morphine addiction~ko05034 Alcoholism~ko05110 Vibrio cholerae infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05414 Dilated cardiomyopathy (DCM) ~	,5904,5905	.	.	.	.	.	.	20	1(urinary_tract)	0.6584
21	40193614	40193614	G	T	ETS2	exonic	nonsynonymous SNV	ENSG00000157557	.	ENSG00000157557:ENST00000360938:exon9:c.G1180T:p.A394S,ENSG00000157557:ENST00000360214:exon10:c.G1180T:p.A394S	ETS2:NM_005239:exon9:c.G1180T:p.A394S,ETS2:NM_001256295:exon10:c.G1600T:p.A534S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	1.628	14.01	1.0	5.33	0.436	.	.	Ets domain|Winged helix-turn-helix DNA-binding domain	ETS2:uc002yxg.4:exon9:c.G1180T:p.A394S,ETS2:uc002yxf.3:exon10:c.G1600T:p.A534S	-0.987	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	164740	.	.	.	.	.	.	.	0.0	2.57	0.013	-1.195	21	.	hom
21	44838185	44838185	T	C	SIK1;SIK1B	exonic	nonsynonymous SNV	ENSG00000142178	.	ENSG00000142178:ENST00000270162:exon12:c.A1699G:p.S567G	SIK1B:NM_001320643:exon12:c.A1699G:p.S567G,SIK1:NM_173354:exon12:c.A1699G:p.S567G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	4.79	0.724	.	.	.	SIK1:uc002zdf.2:exon12:c.A1699G:p.S567G	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605705	616341;	1934;1935;3451;	1934|EIEE<br>Early infantile epileptic encephalopathy with suppression-bursts<br>Ohtahara syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|300672 308350 609304 612164 613402 613721 615473 616341 ~1935|Early myoclonic encephalopathy with suppression-bursts|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|609304 616341 617105 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	21	.	hom
21	44838330	44838330	C	A	SIK1;SIK1B	exonic	synonymous SNV	ENSG00000142178	rs34487963	ENSG00000142178:ENST00000270162:exon12:c.G1554T:p.A518A	SIK1B:NM_001320643:exon12:c.G1554T:p.A518A,SIK1:NM_173354:exon12:c.G1554T:p.A518A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0349	0.0161	0.0535144	0.0159	.	.	.	.	.	.	.	.	SIK1:uc002zdf.2:exon12:c.G1554T:p.A518A	.	AFR:0.0137,AMR:0.0084,EAS:0.0580,FIN:0.0049,NFE:0.0150,OTH:0.0246,ASJ:0.0199	605705	616341;	1934;1935;3451;	1934|EIEE<br>Early infantile epileptic encephalopathy with suppression-bursts<br>Ohtahara syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|300672 308350 609304 612164 613402 613721 615473 616341 ~1935|Early myoclonic encephalopathy with suppression-bursts|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|609304 616341 617105 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	21	MU749038	hom
21	46875564	46875564	T	C	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs914230	ENSG00000182871:ENST00000355480:exon1:c.T120C:p.H40H,ENSG00000182871:ENST00000359759:exon1:c.T120C:p.H40H	COL18A1:NM_030582:exon1:c.T120C:p.H40H,COL18A1:NM_130444:exon1:c.T120C:p.H40H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9705	0.9693	0.988419	0.9678	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon1:c.T120C:p.H40H	.	AFR:0.9925,AMR:0.9785,EAS:1,FIN:0.9631,NFE:0.9510,OTH:0.9551,ASJ:0.9801	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU82046823	hom
21	46900410	46900410	C	T	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs2236467	ENSG00000182871:ENST00000355480:exon11:c.C1968T:p.F656F,ENSG00000182871:ENST00000359759:exon11:c.C2673T:p.F891F,ENSG00000182871:ENST00000400337:exon12:c.C1428T:p.F476F	COL18A1:NM_030582:exon11:c.C1968T:p.F656F,COL18A1:NM_130444:exon11:c.C2673T:p.F891F,COL18A1:NM_130445:exon12:c.C1428T:p.F476F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0876	0.1296	0.15595	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon11:c.C1968T:p.F656F,COL18A1:uc002zhg.3:exon12:c.C1428T:p.F476F	.	AFR:MU11355673,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,EAS:0.2682,FIN:0.0871,NFE:0.0695,OTH:0.0853,ASJ:0.1189	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(breast)	0.0206
21	46910210	46910210	G	A	COL18A1	exonic	nonsynonymous SNV	ENSG00000182871	rs62000962	ENSG00000182871:ENST00000342220:exon1:c.G22A:p.V8I,ENSG00000182871:ENST00000355480:exon19:c.G2521A:p.V841I,ENSG00000182871:ENST00000359759:exon19:c.G3226A:p.V1076I,ENSG00000182871:ENST00000400337:exon20:c.G1981A:p.V661I	COL18A1:NM_030582:exon19:c.G2521A:p.V841I,COL18A1:NM_130444:exon19:c.G3226A:p.V1076I,COL18A1:NM_130445:exon20:c.G1981A:p.V661I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2169	0.1234	0.115615	SKCA-BR|1|100|0.01	-0.436	0.315	0.424	-2.52	0.008	.	.	.	COL18A1:uc002zhi.3:exon19:c.G2521A:p.V841I,COL18A1:uc002zhg.3:exon20:c.G1981A:p.V661I	-0.859	AFR:0.1330,AMR:0.1533,EAS:0.1358,FIN:0.0144,NFE:0.1644,OTH:0.1285,ASJ:0.0974	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	0.048	-3.2	0.004	0.05	21	1(liver)	0.1360
21	46924426	46924434	GGCCCCCCA	-	COL18A1	exonic	frameshift deletion	ENSG00000182871	rs149296338	ENSG00000182871:ENST00000342220:exon15:c.865_873del:p.289_291del,ENSG00000182871:ENST00000355480:exon33:c.3364_3372del:p.1122_1124del,ENSG00000182871:ENST00000359759:exon33:c.4069_4077del:p.1357_1359del,ENSG00000182871:ENST00000400337:exon34:c.2824_2832del:p.942_944del	COL18A1:NM_030582:exon33:c.3364delG:p.G1122fs,COL18A1:NM_130444:exon33:c.4069delG:p.G1357fs,COL18A1:NM_130445:exon34:c.2824delG:p.G942fs	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9693	0.8055	.	0.9637	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon33:c.3364_3372del:p.1122_1124del,COL18A1:uc002zhg.3:exon34:c.2824_2832del:p.942_944del	.	AFR:0.9550,AMR:0.9737,EAS:0.9994,FIN:0.9728,NFE:0.9608,OTH:0.9762,ASJ:0.9868	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU56575	hom
21	46932328	46932328	G	A	COL18A1	UTR3	.	ENSG00000182871	rs7499	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4461	0.4030	0.467252	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841	.	.	.	.	.	.	.	.	.	.	AFR:0.4212,AMR:0.4371,EAS:0.3576,FIN:0.5584,NFE:0.4191,OTH:0.4000,ASJ:0.4330	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(biliary_tract)	0.3959
22	18904414	18904414	A	G	LOC102724788;PRODH	exonic	synonymous SNV	ENSG00000100033	rs455072	ENSG00000100033:ENST00000334029:exon12:c.T1191C:p.F397F,ENSG00000100033:ENST00000357068:exon12:c.T1515C:p.F505F,ENSG00000100033:ENST00000420436:exon12:c.T1191C:p.F397F	PRODH:NM_001195226:exon12:c.T1191C:p.F397F,LOC102724788:NM_001368250:exon12:c.T1191C:p.F397F,LOC102724788:NM_001368249:exon13:c.T1515C:p.F505F,PRODH:NM_016335:exon13:c.T1515C:p.F505F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9034	.	0.83746	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PRODH:uc002zoj.5:exon12:c.T1191C:p.F397F,PRODH:uc002zol.4:exon12:c.T1191C:p.F397F,PRODH:uc002zok.4:exon13:c.T1515C:p.F505F	.	AFR:0.8495,AMR:0.6583,EAS:0.9404,FIN:0.9016,NFE:0.9156,OTH:0.9287,ASJ:0.9474	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	1(thyroid)	0.9084
22	18908875	18908875	A	G	LOC102724788;PRODH	exonic	synonymous SNV	ENSG00000100033	rs1808320	ENSG00000100033:ENST00000334029:exon8:c.T667C:p.L223L,ENSG00000100033:ENST00000357068:exon8:c.T991C:p.L331L,ENSG00000100033:ENST00000420436:exon8:c.T667C:p.L223L	PRODH:NM_001195226:exon8:c.T667C:p.L223L,LOC102724788:NM_001368250:exon8:c.T667C:p.L223L,LOC102724788:NM_001368249:exon9:c.T991C:p.L331L,PRODH:NM_016335:exon9:c.T991C:p.L331L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6781	0.6645	0.73143	0.6492	.	.	.	.	.	.	.	.	PRODH:uc002zoj.5:exon8:c.T667C:p.L223L,PRODH:uc002zol.4:exon8:c.T667C:p.L223L,PRODH:uc002zok.4:exon9:c.T991C:p.L331L	.	AFR:0.8364,AMR:0.5692,EAS:0.8062,FIN:0.5492,NFE:0.5560,OTH:0.5749,ASJ:0.6424	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	MU82163080	hom
22	18912678	18912678	A	G	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs386819653	ENSG00000100033:ENST00000334029:exon4:c.T229C:p.W77R,ENSG00000100033:ENST00000357068:exon4:c.T553C:p.W185R,ENSG00000100033:ENST00000420436:exon4:c.T229C:p.W77R,ENSG00000100033:ENST00000450579:exon4:c.T76C:p.W26R	PRODH:NM_001195226:exon4:c.T229C:p.W77R,LOC102724788:NM_001368250:exon4:c.T229C:p.W77R,LOC102724788:NM_001368249:exon5:c.T553C:p.W185R,PRODH:NM_016335:exon5:c.T553C:p.W185R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6417	0.6739	0.78095	0.6509	-0.442	0.306	0.503	2.88	0.105	.	.	FAD-linked oxidoreductase-like	PRODH:uc002zoj.5:exon4:c.T229C:p.W77R,PRODH:uc002zol.4:exon4:c.T229C:p.W77R,PRODH:uc002zok.4:exon5:c.T553C:p.W185R	-0.991	AFR:0.8626,AMR:0.6583,EAS:0.9617,FIN:0.4811,NFE:0.5384,OTH:0.5685,ASJ:0.6424	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	0.0	-0.92	0.000	.	22	MU82047927	hom
22	19808874	19808874	G	A	GNB1L	exonic	nonsynonymous SNV	ENSG00000185838	rs36070348	ENSG00000185838:ENST00000403325:exon2:c.C5T:p.T2M,ENSG00000185838:ENST00000453108:exon2:c.C5T:p.T2M,ENSG00000185838:ENST00000329517:exon3:c.C5T:p.T2M,ENSG00000185838:ENST00000405009:exon3:c.C5T:p.T2M	GNB1L:NM_053004:exon3:c.C5T:p.T2M	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0312	0.0213	0.0323482	0.0183	4.572	24.4	0.043	3.7	0.007	.	.	.	GNB1L:uc002zqf.1:exon3:c.C5T:p.T2M	-0.983	AFR:0.0047,AMR:0.0167,EAS:0.0037,FIN:0.0223,NFE:0.0263,OTH:0.0286,ASJ:0.0132	610778	.	.	.	.	.	.	.	0.013	1.12	0.059	-0.345	22	.	hom
22	21337325	21337325	G	A	LZTR1	exonic	synonymous SNV	ENSG00000099949	rs13054014	ENSG00000099949:ENST00000443265:exon2:c.G215A:p.S72N	LZTR1:NM_006767:exon2:c.G210A:p.K70K	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2850	0.2623	0.285144	MU116325	.	.	.	.	.	.	.	.	LZTR1:uc002zto.3:exon2:c.G210A:p.K70K,LZTR1:uc011ahy.2:exon2:c.G210A:p.K70K,LZTR1:uc002ztn.3:exon3:c.G87A:p.K29K	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.2716,EAS:0.4153,FIN:0.2219,NFE:0.2177,OTH:0.2582,ASJ:0.2520	600574	615670;616564;	648;93921;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~93921|NF3<br>Neurilemmomatosis<br>Schwannomatosis|Unknown|Autosomal dominant|Adult<br>Elderly|162091 162260 615670 ~	.	.	.	.	.	.	.	.	22	37(meninges)	0.2845
22	23637200	23637200	T	C	BCR	intronic	.	ENSG00000186716	rs2239666	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3210	0.3528	0.341454	0.3275	.	.	.	.	.	0	0.018	.	.	.	AFR:0.4510,AMR:0.3473,EAS:0.1829,FIN:0.2331,NFE:0.2946,OTH:0.2929,ASJ:0.3146	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	MU718621	hom
22	26166900	26166900	G	C	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs3859866	ENSG00000133454:ENST00000539302:exon5:c.G1641C:p.W547C,ENSG00000133454:ENST00000335473:exon6:c.G1641C:p.W547C,ENSG00000133454:ENST00000407587:exon6:c.G1641C:p.W547C,ENSG00000133454:ENST00000536101:exon6:c.G1641C:p.W547C	MYO18B:NM_001318245:exon6:c.G1641C:p.W547C,MYO18B:NM_032608:exon6:c.G1641C:p.W547C	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9579	0.9776	0.938498	0.9730	1.276	12.14	0.049	3.72	0.972	.	.	P-loop containing nucleoside triphosphate hydrolase	MYO18B:uc011akb.1:exon2:c.G180C:p.W60C,MYO18B:uc003aca.1:exon4:c.G1284C:p.W428C,MYO18B:uc010guy.1:exon4:c.G1284C:p.W428C,MYO18B:uc010guz.1:exon4:c.G1284C:p.W428C,MYO18B:uc003abz.1:exon6:c.G1641C:p.W547C	-0.952	AFR:0.9534,AMR:0.9857,EAS:0.8844,FIN:0.9914,NFE:0.9891,OTH:0.9715,ASJ:0.9768	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-0.56	0.000	-1.245	22	MU28574395	hom
22	26173661	26173661	T	C	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs5761170	ENSG00000133454:ENST00000539302:exon7:c.T1981C:p.W661R,ENSG00000133454:ENST00000335473:exon8:c.T1981C:p.W661R,ENSG00000133454:ENST00000407587:exon8:c.T1981C:p.W661R,ENSG00000133454:ENST00000536101:exon8:c.T1981C:p.W661R	MYO18B:NM_001318245:exon8:c.T1981C:p.W661R,MYO18B:NM_032608:exon8:c.T1981C:p.W661R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9647	0.9714	0.932508	0.9680	-1.452	0.003	1.0	-0.033	0.975	.	.	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	MYO18B:uc011akb.1:exon4:c.T520C:p.W174R,MYO18B:uc003aca.1:exon6:c.T1624C:p.W542R,MYO18B:uc010guy.1:exon6:c.T1624C:p.W542R,MYO18B:uc010guz.1:exon6:c.T1624C:p.W542R,MYO18B:uc003abz.1:exon8:c.T1981C:p.W661R	-0.944	AFR:0.9366,AMR:0.9857,EAS:0.8820,FIN:0.9914,NFE:0.9888,OTH:0.9684,ASJ:0.9768	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-2.18	0.000	.	22	MU635506	hom
22	26194045	26194045	T	C	MYO18B	exonic	synonymous SNV	ENSG00000133454	rs738643	ENSG00000133454:ENST00000335473:exon12:c.T2502C:p.G834G,ENSG00000133454:ENST00000407587:exon12:c.T2502C:p.G834G,ENSG00000133454:ENST00000536101:exon12:c.T2502C:p.G834G	MYO18B:NM_001318245:exon12:c.T2502C:p.G834G,MYO18B:NM_032608:exon12:c.T2502C:p.G834G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6636	0.5936	0.56889	0.5952	.	.	.	.	.	.	.	.	MYO18B:uc011akb.1:exon8:c.T1041C:p.G347G,MYO18B:uc003aca.1:exon10:c.T2145C:p.G715G,MYO18B:uc010guy.1:exon10:c.T2145C:p.G715G,MYO18B:uc010guz.1:exon10:c.T2145C:p.G715G,MYO18B:uc003abz.1:exon12:c.T2502C:p.G834G	.	AFR:0.3391,AMR:0.6806,EAS:0.6966,FIN:0.6597,NFE:0.7093,OTH:0.6834,ASJ:0.5232	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	MU13839222	hom
22	26239850	26239850	C	A	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs5761268	ENSG00000133454:ENST00000335473:exon18:c.C3357A:p.H1119Q,ENSG00000133454:ENST00000407587:exon18:c.C3360A:p.H1120Q,ENSG00000133454:ENST00000536101:exon18:c.C3357A:p.H1119Q	MYO18B:NM_001318245:exon18:c.C3360A:p.H1120Q,MYO18B:NM_032608:exon18:c.C3357A:p.H1119Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7340	0.6421	0.723442	0.6653	-0.536	0.179	1.0	-3.23	0.984	.	.	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	MYO18B:uc011akb.1:exon14:c.C1896A:p.H632Q,MYO18B:uc011aka.1:exon15:c.C819A:p.H273Q,MYO18B:uc003aca.1:exon16:c.C3000A:p.H1000Q,MYO18B:uc010guy.1:exon16:c.C3003A:p.H1001Q,MYO18B:uc010guz.1:exon16:c.C3000A:p.H1000Q,MYO18B:uc003abz.1:exon18:c.C3357A:p.H1119Q	-0.932	AFR:0.4657,AMR:0.7721,EAS:0.9975,FIN:0.7676,NFE:0.7124,OTH:0.7352,ASJ:0.5927	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-2.06	0.000	-2.535	22	MU4555172	hom
22	26247456	26247456	G	A	MYO18B	exonic	synonymous SNV	ENSG00000133454	rs5996988	ENSG00000133454:ENST00000335473:exon21:c.G3795A:p.G1265G,ENSG00000133454:ENST00000407587:exon21:c.G3798A:p.G1266G,ENSG00000133454:ENST00000536101:exon21:c.G3795A:p.G1265G	MYO18B:NM_001318245:exon21:c.G3798A:p.G1266G,MYO18B:NM_032608:exon21:c.G3795A:p.G1265G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3586	0.3179	0.242013	LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	MYO18B:uc011akb.1:exon17:c.G2334A:p.G778G,MYO18B:uc011aka.1:exon18:c.G1257A:p.G419G,MYO18B:uc003aca.1:exon19:c.G3438A:p.G1146G,MYO18B:uc010guy.1:exon19:c.G3441A:p.G1147G,MYO18B:uc010guz.1:exon19:c.G3438A:p.G1146G,MYO18B:uc003abz.1:exon21:c.G3795A:p.G1265G	.	AFR:0.3211,AMR:0.2050,EAS:0.3543,FIN:0.0898,NFE:0.3576,OTH:0.3950,ASJ:0.4103	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	1(large_intestine)	0.3931
22	26343805	26343805	A	G	MYO18B	intronic	.	ENSG00000133454	rs2072007	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8055	0.8749	0.711861	MU585744	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|3|205|0.0146341,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.8292,EAS:0.6124,FIN:0.9603,NFE:0.4714,OTH:0.7786,ASJ:0.8210	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	3(haematopoietic_and_lymphoid_tissue)	0.8942
22	26360824	26360824	G	A	MYO18B	intronic	.	ENSG00000232464	rs78845954	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.0926518	0.1636	.	.	.	.	.	.	.	.	.	.	AFR:0.0541,AMR:0.1148,EAS:0,FIN:0.2428,NFE:0.2265,OTH:0.1939,ASJ:0.2020	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	MU33313602	hom
22	26423488	26423488	G	A	MYO18B	exonic	synonymous SNV	ENSG00000133454	.	ENSG00000133454:ENST00000540454:exon1:c.G474A:p.V158V,ENSG00000133454:ENST00000335473:exon43:c.G7548A:p.V2516V,ENSG00000133454:ENST00000407587:exon43:c.G7551A:p.V2517V,ENSG00000133454:ENST00000536101:exon43:c.G7548A:p.V2516V	MYO18B:NM_001318245:exon43:c.G7551A:p.V2517V,MYO18B:NM_032608:exon43:c.G7548A:p.V2516V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	MYO18B:uc010gva.1:exon4:c.G1497A:p.V499V,MYO18B:uc011akb.1:exon39:c.G6087A:p.V2029V,MYO18B:uc011aka.1:exon40:c.G5010A:p.V1670V,MYO18B:uc003aca.1:exon41:c.G7191A:p.V2397V,MYO18B:uc010guy.1:exon41:c.G7194A:p.V2398V,MYO18B:uc010guz.1:exon41:c.G7188A:p.V2396V,MYO18B:uc003abz.1:exon43:c.G7548A:p.V2516V	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	.	hom
22	28195352	28195352	G	A	MN1	exonic	stopgain	ENSG00000169184	.	ENSG00000169184:ENST00000302326:exon1:c.C1180T:p.Q394X	MN1:NM_002430:exon1:c.C1180T:p.Q394X	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	11.572	37	.	5.29	1.000	.	.	.	MN1:uc003adj.3:exon1:c.C1180T:p.Q394X	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	156100	607174;	263662;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~	.	.	.	.	.	.	.	.	22	.	hom
22	31737661	31737661	A	G	PATZ1	exonic	synonymous SNV	ENSG00000100105	.	ENSG00000100105:ENST00000215919:exon3:c.T1344C:p.V448V	PATZ1:NM_032051:exon3:c.T1344C:p.V448V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	PATZ1:uc003aks.3:exon3:c.T1344C:p.V448V	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605165	.	.	.	.	.	.	.	.	.	.	.	22	.	hom
22	31741067	31741067	G	A	PATZ1	exonic	synonymous SNV	ENSG00000100105	rs714909	ENSG00000100105:ENST00000215919:exon1:c.C522T:p.L174L,ENSG00000100105:ENST00000266269:exon1:c.C522T:p.L174L,ENSG00000100105:ENST00000351933:exon1:c.C522T:p.L174L,ENSG00000100105:ENST00000405309:exon1:c.C522T:p.L174L	PATZ1:NM_014323:exon1:c.C522T:p.L174L,PATZ1:NM_032050:exon1:c.C522T:p.L174L,PATZ1:NM_032051:exon1:c.C522T:p.L174L,PATZ1:NM_032052:exon1:c.C522T:p.L174L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2406	0.2008	0.155152	MU4548042	.	.	.	.	.	.	.	.	PATZ1:uc003akp.3:exon1:c.C522T:p.L174L,PATZ1:uc003akq.3:exon1:c.C522T:p.L174L,PATZ1:uc003akr.3:exon1:c.C522T:p.L174L,PATZ1:uc003aks.3:exon1:c.C522T:p.L174L	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.2269,EAS:0.2584,FIN:0.2715,NFE:0.1400,OTH:0.3454,ASJ:0.0539	605165	.	.	.	.	.	.	.	.	.	.	.	22	1(lung)	0.3023
22	33253280	33253280	T	C	TIMP3	exonic	synonymous SNV	ENSG00000100234	rs9862	ENSG00000100234:ENST00000266085:exon3:c.T249C:p.H83H	TIMP3:NM_000362:exon3:c.T249C:p.H83H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5518	0.6127	0.650958	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TIMP3:uc003anb.3:exon3:c.T249C:p.H83H	.	AFR:0.5980,AMR:0.8374,EAS:0.5629,FIN:0.5945,NFE:0.4422,OTH:0.4965,ASJ:0.6993	188826	136900;	59181;	59181|-|Unknown|Autosomal dominant|Adult|136900 264420 ~	~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	22	1(haematopoietic_and_lymphoid_tissue)	0.5051
22	36684354	36684354	T	C	MYH9	exonic	nonsynonymous SNV	ENSG00000100345	rs2269529	ENSG00000100345:ENST00000216181:exon34:c.A4876G:p.I1626V	MYH9:NM_002473:exon34:c.A4876G:p.I1626V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2584	0.1555	0.294129	0.1759	0.134	3.970	0.332	4.47	0.359	.	.	Myosin tail	MYH9:uc003apg.3:exon34:c.A4876G:p.I1626V	-0.911	AFR:0.0724,AMR:0.2440,EAS:0.6067,FIN:0.1758,NFE:0.1814,OTH:0.2137,ASJ:0.3179	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	0.042	-1.05	0.000	0.805	22	MU14584538	unknown
22	36684358	36684358	C	A	MYH9	exonic	synonymous SNV	ENSG00000100345	rs2269530	ENSG00000100345:ENST00000216181:exon34:c.G4872T:p.A1624A	MYH9:NM_002473:exon34:c.G4872T:p.A1624A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2582	0.1552	0.29373	0.1754	.	.	.	.	.	.	.	.	MYH9:uc003apg.3:exon34:c.G4872T:p.A1624A	.	AFR:0.0712,AMR:0.2440,EAS:0.6068,FIN:0.1755,NFE:0.1813,OTH:0.2137,ASJ:0.3179	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU14584585	unknown
22	36691607	36691607	A	C	MYH9	exonic	synonymous SNV	ENSG00000100345	rs710181	ENSG00000100345:ENST00000216181:exon26:c.T3429G:p.A1143A	MYH9:NM_002473:exon26:c.T3429G:p.A1143A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9766	0.9712	0.982628	0.9725	.	.	.	.	.	.	.	.	MYH9:uc003apg.3:exon26:c.T3429G:p.A1143A	.	AFR:0.9718,AMR:0.9773,EAS:0.9994,FIN:0.9673,NFE:0.9719,OTH:0.9693,ASJ:0.9404	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU82051855	hom
22	36708084	36708084	C	T	MYH9	intronic	.	ENSG00000100345	rs2413396	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8714	0.7555	0.760783	0.7779	.	.	.	.	.	.	.	.	.	.	AFR:0.4512,AMR:0.9021,EAS:0.9030,FIN:0.8967,NFE:0.9108,OTH:0.8755,ASJ:0.8874	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU14584855	hom
22	38369976	38369976	A	G	SOX10	exonic	synonymous SNV	ENSG00000100146	rs139884	ENSG00000100146:ENST00000396884:exon4:c.T927C:p.H309H,ENSG00000100146:ENST00000360880:exon5:c.T927C:p.H309H	SOX10:NM_006941:exon4:c.T927C:p.H309H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6537	0.6958	0.713259	0.6920	.	.	.	.	.	.	.	.	SOX10:uc003aun.1:exon4:c.T927C:p.H309H,SOX10:uc003auo.1:exon5:c.T927C:p.H309H	.	AFR:0.8266,AMR:0.6244,EAS:0.7833,FIN:0.6317,NFE:0.6281,OTH:0.6207,ASJ:0.6033	602229	609136;611584;613266;	897;3440;895;163746;	897|Shah-Waardenburg syndrome<br>WS4<br>Waardenburg syndrome type 4<br>Waardenburg-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|277580 613265 613266 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~895|WS2<br>Waardenburg syndrome type II|Unknown|Autosomal dominant|Neonatal|193510 600193 606662 608890 611584 ~163746|PCWH<br>Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Hirschsprung disease-Waardenburg syndrome<br>WS4 plus|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609136 ~	.	.	.	.	.	.	.	.	22	MU4560542	hom
22	38370020	38370020	C	T	SOX10	exonic	nonsynonymous SNV	ENSG00000100146	.	ENSG00000100146:ENST00000396884:exon4:c.G883A:p.A295T,ENSG00000100146:ENST00000360880:exon5:c.G883A:p.A295T	SOX10:NM_006941:exon4:c.G883A:p.A295T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	3.673	23.3	0.2	2.62	0.998	.	.	.	SOX10:uc003aun.1:exon4:c.G883A:p.A295T,SOX10:uc003auo.1:exon5:c.G883A:p.A295T	-0.928	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602229	609136;611584;613266;	897;3440;895;163746;	897|Shah-Waardenburg syndrome<br>WS4<br>Waardenburg syndrome type 4<br>Waardenburg-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|277580 613265 613266 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~895|WS2<br>Waardenburg syndrome type II|Unknown|Autosomal dominant|Neonatal|193510 600193 606662 608890 611584 ~163746|PCWH<br>Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Hirschsprung disease-Waardenburg syndrome<br>WS4 plus|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609136 ~	.	.	.	.	0.002	-1.01	0.183	1.59	22	.	hom
22	39381826	39381826	A	G	APOBEC3B	exonic	nonsynonymous SNV	ENSG00000179750	rs2076109	ENSG00000179750:ENST00000333467:exon3:c.A184G:p.K62E,ENSG00000179750:ENST00000335760:exon3:c.A184G:p.K62E,ENSG00000179750:ENST00000402182:exon3:c.A184G:p.K62E,ENSG00000179750:ENST00000407298:exon3:c.A184G:p.K62E	APOBEC3B:NM_001270411:exon3:c.A184G:p.K62E,APOBEC3B:NM_004900:exon3:c.A184G:p.K62E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6016	0.6057	0.641174	0.6012	-1.879	0.002	0.72	-1.15	0.000	.	.	APOBEC-like, N-terminal|Cytidine and deoxycytidylate deaminase domain|Cytidine deaminase-like	APOBEC3B:uc003awo.2:exon3:c.A184G:p.K62E,APOBEC3B:uc003awp.2:exon3:c.A184G:p.K62E	-0.903	AFR:0.6745,AMR:0.5195,EAS:0.6416,FIN:0.6176,NFE:0.5592,OTH:0.5826,ASJ:0.4796	607110	.	.	.	.	.	.	.	0.032	-0.14	0.000	0.185	22	MU151842	hom
22	39381899	39381899	T	C	APOBEC3B	exonic	nonsynonymous SNV	ENSG00000179750	.	ENSG00000179750:ENST00000333467:exon3:c.T257C:p.F86S,ENSG00000179750:ENST00000335760:exon3:c.T257C:p.F86S,ENSG00000179750:ENST00000402182:exon3:c.T257C:p.F86S,ENSG00000179750:ENST00000407298:exon3:c.T257C:p.F86S	APOBEC3B:NM_001270411:exon3:c.T257C:p.F86S,APOBEC3B:NM_004900:exon3:c.T257C:p.F86S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	1.821	15.11	0.031	-2.27	0.065	.	.	APOBEC-like, N-terminal|APOBEC/CMP deaminase, zinc-binding|Cytidine and deoxycytidylate deaminase domain|Cytidine deaminase-like	APOBEC3B:uc003awo.2:exon3:c.T257C:p.F86S,APOBEC3B:uc003awp.2:exon3:c.T257C:p.F86S	-0.886	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607110	.	.	.	.	.	.	.	0.735	-0.11	0.185	1.385	22	.	hom
22	39381999	39381999	T	C	APOBEC3B	exonic	synonymous SNV	ENSG00000179750	rs2076111	ENSG00000179750:ENST00000333467:exon3:c.T357C:p.S119S,ENSG00000179750:ENST00000335760:exon3:c.T357C:p.S119S,ENSG00000179750:ENST00000402182:exon3:c.T357C:p.S119S,ENSG00000179750:ENST00000407298:exon3:c.T357C:p.S119S	APOBEC3B:NM_001270411:exon3:c.T357C:p.S119S,APOBEC3B:NM_004900:exon3:c.T357C:p.S119S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5857	.	.	0.5927	.	.	.	.	.	.	.	.	APOBEC3B:uc003awo.2:exon3:c.T357C:p.S119S,APOBEC3B:uc003awp.2:exon3:c.T357C:p.S119S	.	AFR:0.6495,AMR:0.5225,EAS:0.6783,FIN:0.6151,NFE:0.5550,OTH:0.5689,ASJ:0.4755	607110	.	.	.	.	.	.	.	.	.	.	.	22	MU4559442	hom
22	39382079	39382079	C	A	APOBEC3B	exonic	nonsynonymous SNV	ENSG00000179750	rs5995649	ENSG00000179750:ENST00000333467:exon3:c.C437A:p.T146K,ENSG00000179750:ENST00000335760:exon3:c.C437A:p.T146K,ENSG00000179750:ENST00000402182:exon3:c.C437A:p.T146K,ENSG00000179750:ENST00000407298:exon3:c.C437A:p.T146K	APOBEC3B:NM_001270411:exon3:c.C437A:p.T146K,APOBEC3B:NM_004900:exon3:c.C437A:p.T146K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9492	0.9511	0.949681	0.9538	-0.635	0.103	1.0	-4.25	0.000	.	.	APOBEC-like, N-terminal|Cytidine deaminase-like	APOBEC3B:uc003awo.2:exon3:c.C437A:p.T146K,APOBEC3B:uc003awp.2:exon3:c.C437A:p.T146K	-0.995	AFR:0.9398,AMR:0.9526,EAS:0.9757,FIN:0.9672,NFE:0.9586,OTH:0.9557,ASJ:0.87	607110	.	.	.	.	.	.	.	0.0	-0.02	0.000	-1.695	22	MU82052701	hom
22	39387374	39387374	C	T	APOBEC3B	exonic	nonsynonymous SNV	ENSG00000179750	rs138093253	ENSG00000179750:ENST00000335760:exon5:c.C607T:p.R203W,ENSG00000179750:ENST00000333467:exon6:c.C761T:p.A254V,ENSG00000179750:ENST00000402182:exon6:c.C761T:p.A254V	APOBEC3B:NM_004900:exon6:c.C761T:p.A254V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0] 	0.0082	0.0148	0.0195687	0.0181	3.135	22.6	0.115	2.0	0.000	.	.	APOBEC-like, N-terminal|APOBEC/CMP deaminase, zinc-binding|Cytidine and deoxycytidylate deaminase domain|Cytidine deaminase-like	APOBEC3B:uc003awo.2:exon6:c.C761T:p.A254V	-0.669	AFR:0.0522,AMR:0.0102,EAS:0,FIN:0.0028,NFE:0.0038,OTH:0.0046,ASJ:0.0041	607110	.	.	.	.	.	.	.	0.987	-1.85	0.214	1.73	22	.	hom
22	39414166	39414166	A	G	APOBEC3C	intronic	.	ENSG00000243811;ENSG00000244509	rs4820361	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.647564	0.6780	.	.	.	.	.	.	.	.	.	.	AFR:0.6676,AMR:0.7201,EAS:0.6938,FIN:0.7478,NFE:0.6645,OTH:0.6855,ASJ:0.6192	607750	.	.	.	.	.	.	.	.	.	.	.	22	MU26443964	hom
22	39414224	39414224	A	G	APOBEC3C	intronic	.	ENSG00000243811;ENSG00000244509	rs4821854	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6487	0.6434	0.647764	0.6781	.	.	.	.	.	.	.	.	.	.	AFR:0.6680,AMR:0.7201,EAS:0.6948,FIN:0.7477,NFE:0.6645,OTH:0.6824,ASJ:0.6192	607750	.	.	.	.	.	.	.	.	.	.	.	22	MU26546283	hom
22	39427677	39427679	CCT	-	APOBEC3D	intronic	.	ENSG00000243811	rs568859873	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 0, 0] 	0.0012	.	0.000798722	9.71e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0001,OTH:0.0010,ASJ:0	609900	.	.	.	.	.	.	.	.	.	.	.	22	MU86148493	het
22	39496336	39496336	G	T	APOBEC3H	exonic	nonsynonymous SNV	ENSG00000100298	rs139293	ENSG00000100298:ENST00000348946:exon2:c.G53T:p.R18L,ENSG00000100298:ENST00000401756:exon2:c.G53T:p.R18L,ENSG00000100298:ENST00000421988:exon2:c.G53T:p.R18L,ENSG00000100298:ENST00000442487:exon2:c.G53T:p.R18L	APOBEC3H:NM_001166002:exon2:c.G53T:p.R18L,APOBEC3H:NM_001166003:exon2:c.G53T:p.R18L,APOBEC3H:NM_001166004:exon2:c.G53T:p.R18L,APOBEC3H:NM_181773:exon2:c.G53T:p.R18L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2685	0.2090	0.201677	MU156027	2.007	16.25	0.142	-0.212	0.000	.	.	Cytidine and deoxycytidylate deaminase domain	APOBEC3H:uc021wps.1:exon2:c.G53T:p.R18L,APOBEC3H:uc021wpt.1:exon2:c.G53T:p.R18L,APOBEC3H:uc021wpu.1:exon2:c.G53T:p.R18L,APOBEC3H:uc021wpv.1:exon2:c.G53T:p.R18L	-1.017	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.2325,EAS:0.2416,FIN:0.2318,NFE:0.1642,OTH:0.3842,ASJ:0.0817	610976	.	.	.	.	.	.	.	0.989	0.04	0.000	1.845	22	8(soft_tissue)	0.2881
22	39496412	39496412	G	C	APOBEC3H	exonic	synonymous SNV	ENSG00000100298	rs139294	ENSG00000100298:ENST00000348946:exon2:c.G129C:p.T43T,ENSG00000100298:ENST00000401756:exon2:c.G129C:p.T43T,ENSG00000100298:ENST00000421988:exon2:c.G129C:p.T43T,ENSG00000100298:ENST00000442487:exon2:c.G129C:p.T43T	APOBEC3H:NM_001166002:exon2:c.G129C:p.T43T,APOBEC3H:NM_001166003:exon2:c.G129C:p.T43T,APOBEC3H:NM_001166004:exon2:c.G129C:p.T43T,APOBEC3H:NM_181773:exon2:c.G129C:p.T43T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4772	0.5600	0.514776	MU156022	.	.	.	.	.	.	.	.	APOBEC3H:uc021wps.1:exon2:c.G129C:p.T43T,APOBEC3H:uc021wpt.1:exon2:c.G129C:p.T43T,APOBEC3H:uc021wpu.1:exon2:c.G129C:p.T43T,APOBEC3H:uc021wpv.1:exon2:c.G129C:p.T43T	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,AMR:0.5530,EAS:0.3640,FIN:0.4901,NFE:0.3625,OTH:0.5436,ASJ:0.7686	610976	.	.	.	.	.	.	.	.	.	.	.	22	2(lung)	0.4649
22	39497404	39497404	G	C	APOBEC3H	exonic	nonsynonymous SNV	ENSG00000100298	rs139297	ENSG00000100298:ENST00000348946:exon3:c.G313C:p.G105R,ENSG00000100298:ENST00000401756:exon3:c.G313C:p.G105R,ENSG00000100298:ENST00000421988:exon3:c.G313C:p.G105R,ENSG00000100298:ENST00000442487:exon3:c.G313C:p.G105R	APOBEC3H:NM_001166002:exon3:c.G313C:p.G105R,APOBEC3H:NM_001166003:exon3:c.G313C:p.G105R,APOBEC3H:NM_001166004:exon3:c.G313C:p.G105R,APOBEC3H:NM_181773:exon3:c.G313C:p.G105R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4818	0.5795	0.52476	1(haematopoietic_and_lymphoid_tissue)	-1.664	0.002	1.0	-4.63	0.000	.	.	APOBEC-like, N-terminal|Cytidine and deoxycytidylate deaminase domain|Cytidine deaminase-like	APOBEC3H:uc021wps.1:exon3:c.G313C:p.G105R,APOBEC3H:uc021wpt.1:exon3:c.G313C:p.G105R,APOBEC3H:uc021wpu.1:exon3:c.G313C:p.G105R,APOBEC3H:uc021wpv.1:exon3:c.G313C:p.G105R	-0.968	AFR:MU156016,AMR:LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,EAS:0.8187,FIN:0.3744,NFE:0.4932,OTH:0.3319,ASJ:0.5719	610976	.	.	.	.	.	.	.	0.0	0.03	0.000	-2.595	22	1(large_intestine)	0.5531
22	39497509	39497509	A	G	APOBEC3H	splicing	.	ENSG00000100298	rs139300	ENSG00000100298:ENST00000348946:exon3:c.A418G:p.K140E,ENSG00000100298:ENST00000401756:exon3:c.A418G:p.K140E,ENSG00000100298:ENST00000421988:exon3:c.A418G:p.N140D,ENSG00000100298:ENST00000442487:exon3:c.A418G:p.K140E	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0.006	.	APOBEC3H:uc021wps.1:exon3:c.A418G:p.N140D,APOBEC3H:uc021wpt.1:exon3:c.A418G:p.K140E,APOBEC3H:uc021wpu.1:exon3:c.A418G:p.K140E,APOBEC3H:uc021wpv.1:exon3:c.A418G:p.K140E	.	AFR:0.9998,AMR:0.9998,EAS:1,FIN:1,NFE:1,OTH:0.9998,ASJ:1	610976	.	.	.	.	.	.	.	.	.	.	.	22	1(thyroid)	1
22	39498038	39498038	G	C	APOBEC3H	exonic	nonsynonymous SNV	ENSG00000100298	rs139302	ENSG00000100298:ENST00000348946:exon4:c.G534C:p.E178D,ENSG00000100298:ENST00000401756:exon4:c.G534C:p.E178D,ENSG00000100298:ENST00000442487:exon4:c.G534C:p.E178D	APOBEC3H:NM_001166002:exon4:c.G534C:p.E178D,APOBEC3H:NM_001166003:exon4:c.G534C:p.E178D,APOBEC3H:NM_181773:exon4:c.G534C:p.E178D	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4786	0.5709	0.515575	0.5635	-1.565	0.002	0.328	-6.12	0.000	.	.	APOBEC-like, N-terminal	APOBEC3H:uc021wpt.1:exon4:c.G534C:p.E178D,APOBEC3H:uc021wpu.1:exon4:c.G534C:p.E178D,APOBEC3H:uc021wpv.1:exon4:c.G534C:p.E178D	-1.012	AFR:0.7992,AMR:0.3389,EAS:0.3592,FIN:0.5505,NFE:0.4691,OTH:0.5184,ASJ:0.4934	610976	.	.	.	.	.	.	.	0.006	-0.08	0.000	0.59	22	MU155996	hom
22	41551039	41551039	T	A	EP300	exonic	synonymous SNV	ENSG00000100393	rs20552	ENSG00000100393:ENST00000263253:exon17:c.T3183A:p.T1061T	EP300:NM_001362843:exon16:c.T3105A:p.T1035T,EP300:NM_001429:exon17:c.T3183A:p.T1061T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6572	0.5831	0.673922	0.5925	.	.	.	.	.	.	.	.	EP300:uc003azl.4:exon17:c.T3183A:p.T1061T	.	AFR:0.5116,AMR:0.8122,EAS:0.8058,FIN:0.6084,NFE:0.5985,OTH:0.6133,ASJ:0.6225	602700	114500;613684;	353284;783;	353284|-|-|-|-|613684 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	,3901	.	.	.	.	.	.	22	MU13931129	het
22	41911525	41911525	C	T	ACO2	exonic	synonymous SNV	ENSG00000100412	rs1799932	ENSG00000100412:ENST00000216254:exon5:c.C670T:p.L224L,ENSG00000100412:ENST00000396512:exon5:c.C670T:p.L224L	ACO2:NM_001098:exon5:c.C670T:p.L224L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3993	0.3837	0.270367	1(thyroid)	.	.	.	.	.	.	.	.	ACO2:uc003bac.3:exon5:c.C670T:p.L224L	.	AFR:MU4554543,AMR:LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.1564,FIN:0.2506,NFE:0.4233,OTH:0.1634,ASJ:0.3708	100850	614559;616289;	313850;	313850|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614559 ~	.	.	.	.	.	.	.	.	22	1(salivary_gland)	0.4417
22	42522613	42522613	G	C	CYP2D6	exonic	nonsynonymous SNV	ENSG00000100197	rs1135840	ENSG00000100197:ENST00000359033:exon8:c.C1304G:p.T435S,ENSG00000100197:ENST00000360608:exon9:c.C1457G:p.T486S,ENSG00000100197:ENST00000389970:exon10:c.C1457G:p.T486S	CYP2D6:NM_001025161:exon8:c.C1304G:p.T435S,CYP2D6:NM_000106:exon9:c.C1457G:p.T486S	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4556	0.4083	0.401158	1(pancreas)	.	.	.	.	.	.	.	.	CYP2D6:uc010gyu.3:exon7:c.C539G:p.T180S,CYP2D6:uc003bcf.3:exon8:c.C1304G:p.T435S,CYP2D6:uc003bce.3:exon9:c.C1457G:p.T486S	.	AFR:1(breast),AMR:MU157529,EAS:0.4196,FIN:0.3487,NFE:0.5652,OTH:0.3742,ASJ:LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	124030	608902;	.	.	.	.	.	.	.	.	.	.	22	1(central_nervous_system)	0.2780
22	42523505	42523505	C	T	CYP2D6	exonic	nonsynonymous SNV	ENSG00000100197	rs61737946	ENSG00000100197:ENST00000359033:exon6:c.G964A:p.G322S,ENSG00000100197:ENST00000360608:exon7:c.G1117A:p.G373S,ENSG00000100197:ENST00000389970:exon8:c.G1117A:p.G373S	CYP2D6:NM_001025161:exon6:c.G964A:p.G322S,CYP2D6:NM_000106:exon7:c.G1117A:p.G373S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0171	.	.	2(stomach)	1.956	15.94	0.276	2.84	0.022	.	.	.	CYP2D6:uc010gyu.3:exon5:c.G199A:p.G67S,CYP2D6:uc003bcf.3:exon6:c.G964A:p.G322S,CYP2D6:uc003bce.3:exon7:c.G1117A:p.G373S	-0.987	AFR:8(upper_aerodigestive_tract),AMR:1(breast),EAS:1(bone),FIN:MU157535,NFE:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,BRCA-KR|1|50|0.02,OTH:0.0224,ASJ:1(large_intestine)	124030	608902;	.	.	.	.	.	.	0.009	-0.29	0.071	1.085	22	16(lung)	0.0231
22	42523514	42523514	C	T	CYP2D6	exonic	nonsynonymous SNV	ENSG00000100197	rs61745683	ENSG00000100197:ENST00000359033:exon6:c.G955A:p.V319I,ENSG00000100197:ENST00000360608:exon7:c.G1108A:p.V370I,ENSG00000100197:ENST00000389970:exon8:c.G1108A:p.V370I	CYP2D6:NM_001025161:exon6:c.G955A:p.V319I,CYP2D6:NM_000106:exon7:c.G1108A:p.V370I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0139	.	.	.	-0.017	2.428	0.911	-6.63	0.058	.	.	.	CYP2D6:uc010gyu.3:exon5:c.G190A:p.V64I,CYP2D6:uc003bcf.3:exon6:c.G955A:p.V319I,CYP2D6:uc003bce.3:exon7:c.G1108A:p.V370I	-0.993	AFR:0.0082,AMR:0.0121,EAS:0.0076,FIN:0.0092,NFE:0.0029,OTH:0.0074,ASJ:0.0028	124030	608902;	.	.	.	.	.	.	0.0	-0.57	0.164	0.995	22	2(lung)	0.0062
22	42523943	42523943	A	G	CYP2D6	exonic	nonsynonymous SNV	ENSG00000100197	rs16947	ENSG00000100197:ENST00000359033:exon5:c.T733C:p.C245R,ENSG00000100197:ENST00000360608:exon6:c.T886C:p.C296R,ENSG00000100197:ENST00000389970:exon7:c.T886C:p.C296R	CYP2D6:NM_001025161:exon5:c.T733C:p.C245R,CYP2D6:NM_000106:exon6:c.T886C:p.C296R	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6567	0.5996	0.640775	MU157540	.	.	.	.	.	.	.	.	CYP2D6:uc003bcf.3:exon5:c.T733C:p.C245R,CYP2D6:uc003bce.3:exon6:c.T886C:p.C296R	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.6150,EAS:0.7,FIN:0.65,NFE:0.8514,OTH:0.6486,ASJ:0.4759	124030	608902;	.	.	.	.	.	.	.	.	.	.	22	19(soft_tissue)	0.6542
22	42525132	42525132	G	C	CYP2D6	exonic	synonymous SNV	ENSG00000100197	rs1058164	ENSG00000100197:ENST00000360608:exon3:c.C408G:p.V136V,ENSG00000100197:ENST00000389970:exon4:c.C408G:p.V136V	CYP2D6:NM_000106:exon3:c.C408G:p.V136V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4515	0.3929	0.400958	2(large_intestine)	.	.	.	.	.	.	.	.	CYP2D6:uc003bce.3:exon3:c.C408G:p.V136V	.	AFR:MU69977,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.3528,FIN:0.5692,NFE:0.3841,OTH:0.2731,ASJ:0.4233	124030	608902;	.	.	.	.	.	.	.	.	.	.	22	3(lung)	0.5297
22	50656473	50656473	G	A	TUBGCP6	exonic	nonsynonymous SNV	ENSG00000128159	rs539568209	ENSG00000128159:ENST00000425018:exon9:c.C1249T:p.R417C,ENSG00000128159:ENST00000248846:exon24:c.C5242T:p.R1748C	TUBGCP6:NM_020461:exon24:c.C5242T:p.R1748C	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	7.557e-05	.	0.000199681	.	7.015	33	0.001	4.87	0.997	.	.	.	TUBGCP6:uc003bka.1:exon9:c.C2452T:p.R818C,TUBGCP6:uc003bkb.1:exon24:c.C5242T:p.R1748C,TUBGCP6:uc010har.1:exon24:c.C5218T:p.R1740C	-1.054	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	1.0	3.04	0.114	1.645	22	.	hom
22	50657010	50657010	C	G	TUBGCP6	exonic	nonsynonymous SNV	ENSG00000128159	rs4838864	ENSG00000128159:ENST00000425018:exon7:c.G919C:p.V307L,ENSG00000128159:ENST00000248846:exon22:c.G4861C:p.V1621L	TUBGCP6:NM_020461:exon22:c.G4861C:p.V1621L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9956	0.9947	0.998802	0.9955	1.233	11.92	1.0	1.61	0.999	.	.	.	TUBGCP6:uc003bka.1:exon7:c.G2122C:p.V708L,TUBGCP6:uc003bkb.1:exon22:c.G4861C:p.V1621L,TUBGCP6:uc010har.1:exon22:c.G4837C:p.V1613L	-1.016	AFR:0.9985,AMR:0.9976,EAS:1,FIN:0.9994,NFE:0.9922,OTH:0.9949,ASJ:1	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	0.003	3.43	0.000	-2.67	22	MU82055240	hom
22	50664612	50664612	A	G	TUBGCP6	exonic	nonsynonymous SNV	ENSG00000128159	rs4838865	ENSG00000128159:ENST00000248846:exon9:c.T1700C:p.L567S,ENSG00000128159:ENST00000439308:exon9:c.T1700C:p.L567S	TUBGCP6:NM_020461:exon9:c.T1700C:p.L567S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7912	0.8244	0.858826	0.8162	-1.386	0.003	0.692	-5.69	0.055	.	.	.	TUBGCP6:uc003bkb.1:exon9:c.T1700C:p.L567S,TUBGCP6:uc010har.1:exon9:c.T1700C:p.L567S	-1.069	AFR:0.9504,AMR:0.6563,EAS:0.8241,FIN:0.7956,NFE:0.7544,OTH:0.7888,ASJ:0.7318	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	0.005	3.31	0.000	-0.51	22	MU67370157	hom
X	31213723	31213723	C	T	DMD	intronic	.	ENSG00000198947	rs5972332	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.94649	0.9636	.	.	.	.	.	.	.	.	.	.	AFR:0.9022,AMR:0.9900,EAS:0.9700,FIN:0.9954,NFE:0.9868,OTH:0.9747,ASJ:0.9622	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	.	hom
X	31224684	31224684	A	G	DMD	intronic	.	ENSG00000198947	rs2293668	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8836	0.8265	0.803974	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.8406,AMR:0.7370,EAS:0.8723,FIN:0.7939,NFE:0.8858,OTH:0.8864,ASJ:0.9152	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	1(haematopoietic_and_lymphoid_tissue)	0.8396
X	31676096	31676096	G	A	DMD	intronic	.	ENSG00000198947	rs2270672	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3398	0.3389	0.328477	0.3560	.	.	.	.	.	.	.	.	.	.	AFR:0.3183,AMR:0.2039,EAS:0.3036,FIN:0.4195,NFE:0.3714,OTH:0.4003,ASJ:0.3770	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	MU14600441	het
X	32380996	32380996	C	T	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs1801187	ENSG00000198947:ENST00000357033:exon37:c.G5234A:p.R1745H,ENSG00000198947:ENST00000378677:exon37:c.G5222A:p.R1741H	DMD:NM_004011:exon9:c.G1211A:p.R404H,DMD:NM_004012:exon9:c.G1202A:p.R401H,DMD:NM_000109:exon37:c.G5210A:p.R1737H,DMD:NM_004006:exon37:c.G5234A:p.R1745H,DMD:NM_004009:exon37:c.G5222A:p.R1741H,DMD:NM_004010:exon37:c.G4865A:p.R1622H	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.5142	0.3331	0.465166	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	6.788	32	0.006	5.24	0.940	.	.	.	DMD:uc004dcw.2:exon9:c.G1202A:p.R401H,DMD:uc004dcx.2:exon9:c.G1211A:p.R404H,DMD:uc004dcy.1:exon37:c.G5222A:p.R1741H,DMD:uc004dcz.2:exon37:c.G4865A:p.R1622H,DMD:uc004dda.1:exon37:c.G5234A:p.R1745H,DMD:uc004ddb.1:exon37:c.G5210A:p.R1737H	-0.904	AFR:0.3913,AMR:0.0789,EAS:0.4293,FIN:0.7234,NFE:0.5224,OTH:0.4730,ASJ:0.6987	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.999	0.74	0.000	2.64	X	1(lung)	0.5245
X	32503194	32503194	T	C	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs228406	ENSG00000198947:ENST00000357033:exon21:c.A2645G:p.D882G,ENSG00000198947:ENST00000378677:exon21:c.A2633G:p.D878G	DMD:NM_000109:exon21:c.A2621G:p.D874G,DMD:NM_004006:exon21:c.A2645G:p.D882G,DMD:NM_004009:exon21:c.A2633G:p.D878G,DMD:NM_004010:exon21:c.A2276G:p.D759G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7211	0.6502	0.748344	0.6958	0.631	8.366	0.523	3.07	0.978	.	.	.	DMD:uc004dcy.1:exon21:c.A2633G:p.D878G,DMD:uc004dcz.2:exon21:c.A2276G:p.D759G,DMD:uc004dda.1:exon21:c.A2645G:p.D882G,DMD:uc004ddb.1:exon21:c.A2621G:p.D874G	-0.978	AFR:0.6291,AMR:0.8068,EAS:0.8869,FIN:0.8215,NFE:0.6750,OTH:0.7336,ASJ:0.6243	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.0	0.73	0.000	0	X	MU4584954	hom
X	32716132	32716132	G	T	DMD	intronic	.	ENSG00000198947	rs72470514	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0214	0.0070	0.00847682	GACA-JP|1|585|0.0017094	.	.	.	.	.	.	.	.	.	.	AFR:0.0166,AMR:0.0029,EAS:0,FIN:0.0080,NFE:0.0246,OTH:0.0237,ASJ:0.0065	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	1(stomach)	0.0182
X	32716133	32716133	G	C	DMD	intronic	.	ENSG00000198947	rs72470515	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0212	0.0074	0.00847682	0.0165	.	.	.	.	.	.	.	.	.	.	AFR:0.0028,AMR:0.0065,EAS:0.0080,FIN:0.0247,NFE:0.0237,OTH:0.0181,ASJ:0	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	.	unknown
X	41043944	41043944	T	C	USP9X	intronic	.	ENSG00000124486	rs5918130	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3395	0.2995	0.181457	0.2800	.	.	.	.	.	.	.	.	.	.	AFR:0.0932,AMR:0.1790,EAS:0.1133,FIN:0.3857,NFE:0.3775,OTH:0.2975,ASJ:0.4497	300072	300919;300968;	777;	777|X-linked non-specific intellectual disability|Unknown|X-linked recessive|Childhood|300046 300047 300062 300114 300115 300143 300210 300271 300324 300355 300372 300387 300419 300428 300433 300436 300454 300498 300504 300505 300518 300558 300705 300716 300802 300803 300844 300848 300849 300850 300851 300852 300919 300928 300978 300983 300984 309530 309549 ~	.	.	.	.	.	.	.	.	X	MU13579566	hom
X	44935925	44935925	T	-	KDM6A	intronic	.	ENSG00000147050	rs10605935	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6166	.	0.605828	0.7357	.	.	.	.	.	.	.	.	.	.	AFR:0.5684,AMR:0.8716,EAS:0.6364,FIN:0.6648,NFE:0.8421,OTH:0.7743,ASJ:0.7984	300128	300867;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	X	MU112687125	het
X	48676839	48676839	G	A	HDAC6	intronic	.	ENSG00000094631	rs2075837	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2293	0.2438	0.244238	0.2349	.	.	.	.	.	.	.	.	.	.	AFR:0.3379,AMR:0.1403,EAS:0.1663,FIN:0.2245,NFE:0.1964,OTH:0.1807,ASJ:0.1913	300272	300863;	163966;	163966|X-linked dominant chondrodysplasia-hydrocephaly-microphthalmia syndrome|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|300863 ~	~ko05034 Alcoholism~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	X	MU778028	het
X	53224207	53224207	C	T	KDM5C	exonic	nonsynonymous SNV	ENSG00000126012	rs202160290	ENSG00000126012:ENST00000452825:exon20:c.G3143A:p.R1048H,ENSG00000126012:ENST00000375383:exon21:c.G3221A:p.R1074H,ENSG00000126012:ENST00000375379:exon22:c.G3344A:p.R1115H,ENSG00000126012:ENST00000375401:exon22:c.G3344A:p.R1115H,ENSG00000126012:ENST00000404049:exon22:c.G3341A:p.R1114H	KDM5C:NM_001146702:exon20:c.G3143A:p.R1048H,KDM5C:NM_001282622:exon22:c.G3341A:p.R1114H,KDM5C:NM_001353978:exon22:c.G3344A:p.R1115H,KDM5C:NM_001353979:exon22:c.G3341A:p.R1114H,KDM5C:NM_001353981:exon22:c.G3344A:p.R1115H,KDM5C:NM_001353982:exon22:c.G3341A:p.R1114H,KDM5C:NM_001353984:exon22:c.G3344A:p.R1115H,KDM5C:NM_004187:exon22:c.G3344A:p.R1115H	clinvar: UNK 	 CancerVar: 10#Tier_II_potential EVS=[1, 0, 0, 1, 0, 0, 1, 0, 2, 2, 1, 2] 	.	.	.	.	6.359	29.4	0.003	4.78	1.000	.	.	Lysine-specific demethylase-like domain	KDM5C:uc022bxe.1:exon20:c.G3143A:p.R1048H,KDM5C:uc004drz.3:exon22:c.G3344A:p.R1115H,KDM5C:uc004dsa.3:exon22:c.G3341A:p.R1114H	0.486	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	314690	300534;	85279;	85279|-|<1 / 1 000 000|X-linked recessive|Childhood|300534 ~	.	,6279	.	.	0.98	-2.23	0.701	2.3	X	1(central_nervous_system)	.
X	53228148	53228148	C	A	KDM5C	intronic	.	ENSG00000126012	rs1977364	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8920	0.7829	0.730331	0.8161	.	.	.	.	.	.	.	.	.	.	AFR:0.4295,AMR:0.8821,EAS:0.7619,FIN:0.9883,NFE:0.9786,OTH:0.9393,ASJ:0.9227	314690	300534;	85279;	85279|-|<1 / 1 000 000|X-linked recessive|Childhood|300534 ~	.	.	.	.	.	.	.	.	X	MU14608707	hom
X	53563589	53563589	A	G	HUWE1	exonic	synonymous SNV	ENSG00000086758	rs426298	ENSG00000086758:ENST00000342160:exon78:c.T12177C:p.G4059G,ENSG00000086758:ENST00000262854:exon79:c.T12177C:p.G4059G	HUWE1:NM_031407:exon79:c.T12177C:p.G4059G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9973	0.9920	0.994967	0.9942	.	.	.	.	.	.	.	.	HUWE1:uc004dsn.4:exon48:c.T8601C:p.G2867G,HUWE1:uc004dsp.4:exon79:c.T12177C:p.G4059G	.	AFR:0.9787,AMR:0.9984,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	300697	300706;	85328;	85328|-|<1 / 1 000 000|X-linked dominant|-|300706 ~	.	.	.	.	.	.	.	.	X	MU82057962	hom
X	53641647	53641647	T	C	HUWE1	exonic	synonymous SNV	ENSG00000086758	rs6638360	ENSG00000086758:ENST00000342160:exon22:c.A2109G:p.S703S,ENSG00000086758:ENST00000218328:exon23:c.A2109G:p.S703S,ENSG00000086758:ENST00000262854:exon23:c.A2109G:p.S703S	HUWE1:NM_031407:exon23:c.A2109G:p.S703S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4895	0.3779	0.389669	LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	HUWE1:uc004dsp.4:exon23:c.A2109G:p.S703S	.	AFR:0.4342,AMR:0.0918,EAS:0.5222,FIN:0.5035,NFE:0.5784,OTH:0.5694,ASJ:0.5237	300697	300706;	85328;	85328|-|<1 / 1 000 000|X-linked dominant|-|300706 ~	.	.	.	.	.	.	.	.	X	2(haematopoietic_and_lymphoid_tissue)	0.5319
X	70782824	70782824	-	T	OGT	exonic	frameshift insertion	ENSG00000147162	.	ENSG00000147162:ENST00000373701:exon16:c.2076dupT:p.T692fs,ENSG00000147162:ENST00000373719:exon16:c.2106dupT:p.T702fs	OGT:NM_181672:exon16:c.2106dupT:p.T702fs,OGT:NM_181673:exon16:c.2076dupT:p.T692fs	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	OGT:uc004ead.3:exon11:c.963dupT:p.T321fs,OGT:uc004eac.3:exon12:c.1689dupT:p.T563fs,OGT:uc004eaa.2:exon16:c.2106dupT:p.T702fs,OGT:uc004eab.2:exon16:c.2076dupT:p.T692fs	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300255	.	.	.	.	.	.	.	.	.	.	.	X	.	het
X	71426689	71426689	T	C	ERCC6L	exonic	nonsynonymous SNV	ENSG00000186871	.	ENSG00000186871:ENST00000334463:exon2:c.A1928G:p.Q643R,ENSG00000186871:ENST00000373657:exon3:c.A1559G:p.Q520R	ERCC6L:NM_017669:exon2:c.A1928G:p.Q643R,ERCC6L:NM_001009954:exon3:c.A1559G:p.Q520R	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	4.455	24.2	0.007	5.46	0.998	.	.	.	ERCC6L:uc004eaq.1:exon2:c.A1928G:p.Q643R,ERCC6L:uc004eap.1:exon3:c.A1559G:p.Q520R	-1.120	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300687	.	.	.	.	.	.	.	0.949	1.82	0.060	2.295	X	.	hom
X	76937963	76937963	G	C	ATRX	exonic	nonsynonymous SNV	ENSG00000085224	rs3088074	ENSG00000085224:ENST00000395603:exon8:c.C2671G:p.Q891E,ENSG00000085224:ENST00000373344:exon9:c.C2785G:p.Q929E	ATRX:NM_138270:exon8:c.C2671G:p.Q891E,ATRX:NM_000489:exon9:c.C2785G:p.Q929E	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 1, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3924	0.5083	0.552318	78(meninges)	.	.	.	.	.	.	.	.	ATRX:uc004ecq.4:exon8:c.C2671G:p.Q891E,ATRX:uc010nly.1:exon8:c.C2620G:p.Q874E,ATRX:uc004ecp.4:exon9:c.C2785G:p.Q929E,ATRX:uc004ecr.2:exon9:c.C2581G:p.Q861E,ATRX:uc004eco.4:exon10:c.C2140G:p.Q714E,ATRX:uc010nlx.1:exon10:c.C2698G:p.Q900E	.	AFR:2(urinary_tract),AMR:MU152592,EAS:0.4765,FIN:0.8691,NFE:0.2512,OTH:0.3161,ASJ:COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	300504	.	.	.	.	.	,933	.	.	.	.	.	X	1(large_intestine)	0.4430
X	96139406	96139406	G	A	RPA4	exonic	nonsynonymous SNV	ENSG00000204086	rs2642219	ENSG00000204086:ENST00000373040:exon1:c.G97A:p.A33T	RPA4:NM_013347:exon1:c.G97A:p.A33T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3297	0.4205	0.401854	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	-0.340	0.538	0.222	1.31	0.000	.	.	.	RPA4:uc004efv.4:exon1:c.G97A:p.A33T	-1.004	AFR:0.3766,AMR:0.6483,EAS:0.2414,FIN:0.3333,NFE:0.2502,OTH:0.2741,ASJ:0.4013	300767	.	.	.	.	.	.	.	0.18	2.21	0.000	0.695	X	1(lung)	0.2553
X	96139459	96139459	T	C	RPA4	exonic	synonymous SNV	ENSG00000204086	rs2642218	ENSG00000204086:ENST00000373040:exon1:c.T150C:p.N50N	RPA4:NM_013347:exon1:c.T150C:p.N50N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3313	0.4232	0.406093	LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	RPA4:uc004efv.4:exon1:c.T150C:p.N50N	.	AFR:0.3798,AMR:0.6565,EAS:0.2363,FIN:0.3277,NFE:0.2487,OTH:0.2743,ASJ:0.4142	300767	.	.	.	.	.	.	.	.	.	.	.	X	1(stomach)	0.2566
X	123034511	123034511	A	C	XIAP	exonic	nonsynonymous SNV	ENSG00000101966	rs5956583	ENSG00000101966:ENST00000355640:exon6:c.A1268C:p.Q423P,ENSG00000101966:ENST00000371199:exon6:c.A1268C:p.Q423P,ENSG00000101966:ENST00000434753:exon6:c.A1268C:p.Q423P	XIAP:NM_001167:exon6:c.A1268C:p.Q423P,XIAP:NM_001204401:exon6:c.A1268C:p.Q423P	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.3334	0.3966	0.303576	MU147576	0.341	6.079	0.046	4.61	0.626	.	.	.	XIAP:uc010nqv.3:exon5:c.A146C:p.Q49P,XIAP:uc004etx.3:exon6:c.A1268C:p.Q423P,XIAP:uc010nqu.3:exon6:c.A1268C:p.Q423P	-0.948	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.3870,EAS:0.3695,FIN:0.3017,NFE:0.0989,OTH:0.4023,ASJ:0.4649	300079	300635;	2442;	2442|Duncan disease<br>Purtilo syndrome<br>XLP|<1 / 1 000 000|X-linked recessive|Childhood|300635 308240 ~	~ko01524 Platinum drug resistance~ko04064 NF-kappa B signaling pathway~ko04120 Ubiquitin mediated proteolysis~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04510 Focal adhesion~ko04621 NOD-like receptor signaling pathway~ko05145 Toxoplasmosis~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.002	1.53	0.000	2.24	X	1(large_intestine)	0.3713
X	129147079	129147079	T	C	BCORL1	exonic	nonsynonymous SNV	ENSG00000085185	rs4830173	ENSG00000085185:ENST00000540052:exon3:c.T331C:p.F111L,ENSG00000085185:ENST00000218147:exon4:c.T331C:p.F111L,ENSG00000085185:ENST00000303743:exon4:c.T331C:p.F111L,ENSG00000085185:ENST00000359304:exon4:c.T331C:p.F111L	BCORL1:NM_001184772:exon3:c.T331C:p.F111L,BCORL1:NM_021946:exon3:c.T331C:p.F111L	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	BCORL1:uc010nrd.1:exon1:c.T37C:p.F13L,BCORL1:uc022cdu.1:exon3:c.T331C:p.F111L	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	300688	.	.	.	.	,968	.	.	.	.	.	.	X	MU82059516	hom
X	140967121	140967121	A	T	MAGEC3	exonic	nonsynonymous SNV	ENSG00000165509	rs12852593	ENSG00000165509:ENST00000298296:exon3:c.A419T:p.D140V	MAGEC3:NM_138702:exon3:c.A419T:p.D140V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0902	0.0429	0.0831788	0.0452	2.715	20.9	0.001	-0.286	0.001	.	.	.	MAGEC3:uc011mwp.2:exon3:c.A419T:p.D140V	-0.994	AFR:0.0817,AMR:0.2144,EAS:0.0297,FIN:0.0336,NFE:0.0206,OTH:0.0350,ASJ:0.0053	300469	.	.	.	.	.	.	.	0.969	3.0	0.001	0	X	MU85288574	hom
X	140993843	140993947	CTGAGAGAACTCAGAGTACTTTTGAGGGTTTTGCCCAGTCTCCTCTCCAGATTCCTGTGAGCCCCTCCTCCTCCTCCACTTTACTGAGTCTTTTCCAGAGTTTCT	-	MAGEC1	exonic	nonframeshift deletion	ENSG00000155495	.	ENSG00000155495:ENST00000285879:exon4:c.653_757del:p.218_253del	MAGEC1:NM_005462:exon4:c.653_757del:p.218_253del	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0421	.	.	0.0115	.	.	.	.	.	.	.	.	MAGEC1:uc004fbt.3:exon4:c.653_757del:p.218_253del	.	AFR:0.0102,AMR:0.0198,EAS:0.0032,FIN:0.0168,NFE:0.0113,OTH:0.0149,ASJ:0	300223	.	.	.	.	.	.	.	.	.	.	.	X	.	unknown
X	140993852	140993852	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176038	ENSG00000155495:ENST00000285879:exon4:c.C662G:p.T221S	MAGEC1:NM_005462:exon4:c.C662G:p.T221S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3109	.	.	5(biliary_tract)	-1.617	0.002	0.612	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C662G:p.T221S	-0.928	AFR:18(upper_aerodigestive_tract),AMR:1(skin),EAS:MU24313706,FIN:SKCA-BR|1|100|0.01,LICA-CN|5|402|0.0124378,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,THCA-CN|2|50|0.04,NFE:0.4042,OTH:0.4465,ASJ:1(haematopoietic_and_lymphoid_tissue)	300223	.	.	.	.	.	.	.	0.002	3.86	0.005	1.1	X	4(thyroid)	0.4260
X	140993859	140993859	T	A	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs6634333	ENSG00000155495:ENST00000285879:exon4:c.T669A:p.S223R	MAGEC1:NM_005462:exon4:c.T669A:p.S223R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3075	.	0.410861	1(skin)	1.014	10.74	0.352	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T669A:p.S223R	-0.927	AFR:MU29513613,AMR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,THCA-CN|1|50|0.02,EAS:0.4339,FIN:0.3969,NFE:0.3649,OTH:0.3150,ASJ:0.4004	300223	.	.	.	.	.	.	.	0.162	4.26	0.004	1.65	X	1(bone)	0.3734
X	140993864	140993864	T	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs34836042	ENSG00000155495:ENST00000285879:exon4:c.T674C:p.F225S	MAGEC1:NM_005462:exon4:c.T674C:p.F225S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3129	.	.	2(thyroid)	-1.227	0.006	0.41	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T674C:p.F225S	-0.927	AFR:1(pancreas),AMR:1(kidney),EAS:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,THCA-CN|1|50|0.02,FIN:0.4010,NFE:0.4345,OTH:0.3969,ASJ:MU633586	300223	.	.	.	.	.	.	.	0.002	4.41	0.003	1.1	X	1(haematopoietic_and_lymphoid_tissue)	0.3649
X	140993877	140993877	C	A	MAGEC1	exonic	synonymous SNV	ENSG00000155495	rs176039	ENSG00000155495:ENST00000285879:exon4:c.C687A:p.A229A	MAGEC1:NM_005462:exon4:c.C687A:p.A229A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3381	.	.	1(upper_aerodigestive_tract)	.	.	.	.	.	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C687A:p.A229A	.	AFR:1(skin),AMR:MU624431,EAS:0.3915,FIN:0.4299,NFE:0.4207,OTH:0.3662,ASJ:SKCA-BR|1|100|0.01,LICA-CN|3|402|0.00746269,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	300223	.	.	.	.	.	.	.	.	.	.	.	X	2(large_intestine)	0.3098
X	140993905	140993905	C	T	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176040	ENSG00000155495:ENST00000285879:exon4:c.C715T:p.P239S	MAGEC1:NM_005462:exon4:c.C715T:p.P239S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4364	.	0.329272	2(large_intestine)	-1.155	0.008	0.465	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C715T:p.P239S	-0.926	AFR:MU578592,AMR:LICA-CN|3|402|0.00746269,LUSC-KR|2|170|0.0117647,EAS:0.4115,FIN:0.4096,NFE:0.3731,OTH:0.2952,ASJ:0.4009	300223	.	.	.	.	.	.	.	0.002	4.35	0.000	0	X	2(stomach)	0.3991
X	140993913	140993913	C	G	MAGEC1	exonic	synonymous SNV	ENSG00000155495	rs176041	ENSG00000155495:ENST00000285879:exon4:c.C723G:p.S241S	MAGEC1:NM_005462:exon4:c.C723G:p.S241S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4509	.	.	MU578589	.	.	.	.	.	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C723G:p.S241S	.	AFR:LICA-CN|3|402|0.00746269,LUSC-KR|3|170|0.0176471,AMR:0.3260,EAS:0.3477,FIN:0.3594,NFE:0.2277,OTH:0.3174,ASJ:0.3468	300223	.	.	.	.	.	.	.	.	.	.	.	X	1(stomach)	0.3273
X	140994171	140994171	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176047	ENSG00000155495:ENST00000285879:exon4:c.C981G:p.H327Q	MAGEC1:NM_005462:exon4:c.C981G:p.H327Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7166	0.6707	0.702517	2(pancreas)	-1.999	0.001	1.0	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C981G:p.H327Q	-0.955	AFR:2(lung),AMR:MU13865040,EAS:0.6995,FIN:0.6181,NFE:0.7429,OTH:0.6620,ASJ:LICA-CN|3|402|0.00746269,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	300223	.	.	.	.	.	.	.	0.001	4.46	0.000	-0.345	X	1(large_intestine)	0.7494
X	140994280	140994280	A	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs4824884	ENSG00000155495:ENST00000285879:exon4:c.A1090G:p.T364A	MAGEC1:NM_005462:exon4:c.A1090G:p.T364A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2552	0.1684	0.26596	0.1846	0.721	8.961	0.0	.	0.000	.	.	.	MAGEC1:uc022cfi.1:exon1:c.A67G:p.T23A,MAGEC1:uc004fbt.3:exon4:c.A1090G:p.T364A	-0.891	AFR:0.0674,AMR:0.3041,EAS:0.4577,FIN:0.2378,NFE:0.2024,OTH:0.2164,ASJ:0.2109	300223	.	.	.	.	.	.	.	0.414	3.88	0.000	0	X	MU14623882	hom
X	153215839	153215839	G	A	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs3027875	ENSG00000172534:ENST00000310441:exon24:c.C5859T:p.C1953C,ENSG00000172534:ENST00000369984:exon24:c.C5994T:p.C1998C,ENSG00000172534:ENST00000354233:exon25:c.C5652T:p.C1884C	HCFC1:NM_005334:exon24:c.C5859T:p.C1953C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4320	0.4393	0.191258	1(thyroid)	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon24:c.C5859T:p.C1953C	.	AFR:MU125153,AMR:LUSC-KR|1|170|0.00588235,EAS:0.0921,FIN:0.2626,NFE:0.5459,OTH:0.0049,ASJ:0.4317	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	1(urinary_tract)	0.5878
X	153219996	153219996	A	G	HCFC1	exonic	nonsynonymous SNV	ENSG00000172534	.	ENSG00000172534:ENST00000310441:exon17:c.T3854C:p.V1285A,ENSG00000172534:ENST00000369984:exon17:c.T3854C:p.V1285A,ENSG00000172534:ENST00000354233:exon18:c.T3647C:p.V1216A	HCFC1:NM_005334:exon17:c.T3854C:p.V1285A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	-1.201	0.007	0.116	1.59	0.099	.	.	Immunoglobulin-like fold	HCFC1:uc004fjp.3:exon17:c.T3854C:p.V1285A	-0.910	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	0.0	3.86	0.008	0.49	X	.	hom
X	153592486	153592486	A	T	FLNA	exonic	nonsynonymous SNV	ENSG00000196924	.	ENSG00000196924:ENST00000344736:exon14:c.T2184A:p.N728K,ENSG00000196924:ENST00000360319:exon14:c.T2184A:p.N728K,ENSG00000196924:ENST00000369850:exon15:c.T2184A:p.N728K,ENSG00000196924:ENST00000422373:exon15:c.T2184A:p.N728K	FLNA:NM_001110556:exon15:c.T2184A:p.N728K,FLNA:NM_001456:exon15:c.T2184A:p.N728K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 0] 	.	.	.	.	3.286	22.8	0.007	-7.97	0.933	.	.	Immunoglobulin E-set|Immunoglobulin-like fold	FLNA:uc004fkk.2:exon15:c.T2184A:p.N728K,FLNA:uc010nuu.1:exon15:c.T2184A:p.N728K	-0.639	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300017	300048;300049;300244;300321;304120;305620;309350;311300;314400;	1864;669;90650;2484;1826;669;90652;88630;2149;98892;2301;2978;	1864|-|Unknown|Not applicable|Childhood|314400 ~669|Taybi syndrome|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|304120 311300 ~90650|OPD I syndrome<br>OPD syndrome 1<br>Taybi syndrome|-|X-linked dominant|-|311300 ~2484|Melnick-Needles osteodysplasty|<1 / 1 000 000|X-linked dominant|Childhood|309350 ~1826|-|<1 / 1 000 000|X-linked dominant<br>or&nbsp;Autosomal dominant|Neonatal|305620 617137 ~669|Taybi syndrome|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|304120 311300 ~90652|OPD II syndrome<br>OPD syndrome 2|<1 / 1 000 000|X-linked dominant|Neonatal|304120 ~88630|-|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|300244 ~2149|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|All ages|300049 608097 608098 612881 615544 ~98892|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|-|300049 608097 608098 612881 615544 ~2301|-|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|300048 615237 ~2978|CIPO|Unknown|-|All ages|243180 300048 601223 609629 ~	~ko04010 MAPK signaling pathway~ko04510 Focal adhesion~ko05132 Salmonella infection~ko05205 Proteoglycans in cancer ~	.	.	.	0.312	-0.71	0.320	1.82	X	.	unknown
X	153592490	153592490	C	T	FLNA	exonic	nonsynonymous SNV	ENSG00000196924	.	ENSG00000196924:ENST00000344736:exon14:c.G2180A:p.G727D,ENSG00000196924:ENST00000360319:exon14:c.G2180A:p.G727D,ENSG00000196924:ENST00000369850:exon15:c.G2180A:p.G727D,ENSG00000196924:ENST00000422373:exon15:c.G2180A:p.G727D	FLNA:NM_001110556:exon15:c.G2180A:p.G727D,FLNA:NM_001456:exon15:c.G2180A:p.G727D	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 0] 	.	.	.	.	4.456	24.2	0.324	4.95	0.977	.	.	Immunoglobulin E-set|Immunoglobulin-like fold	FLNA:uc004fkk.2:exon15:c.G2180A:p.G727D,FLNA:uc010nuu.1:exon15:c.G2180A:p.G727D	0.288	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300017	300048;300049;300244;300321;304120;305620;309350;311300;314400;	1864;669;90650;2484;1826;669;90652;88630;2149;98892;2301;2978;	1864|-|Unknown|Not applicable|Childhood|314400 ~669|Taybi syndrome|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|304120 311300 ~90650|OPD I syndrome<br>OPD syndrome 1<br>Taybi syndrome|-|X-linked dominant|-|311300 ~2484|Melnick-Needles osteodysplasty|<1 / 1 000 000|X-linked dominant|Childhood|309350 ~1826|-|<1 / 1 000 000|X-linked dominant<br>or&nbsp;Autosomal dominant|Neonatal|305620 617137 ~669|Taybi syndrome|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|304120 311300 ~90652|OPD II syndrome<br>OPD syndrome 2|<1 / 1 000 000|X-linked dominant|Neonatal|304120 ~88630|-|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|300244 ~2149|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|All ages|300049 608097 608098 612881 615544 ~98892|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|-|300049 608097 608098 612881 615544 ~2301|-|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|300048 615237 ~2978|CIPO|Unknown|-|All ages|243180 300048 601223 609629 ~	~ko04010 MAPK signaling pathway~ko04510 Focal adhesion~ko05132 Salmonella infection~ko05205 Proteoglycans in cancer ~	.	.	.	0.69	-1.87	0.681	3.08	X	.	unknown
X	153760462	153760462	G	A	G6PD	exonic	synonymous SNV	ENSG00000160211	rs398123547	ENSG00000160211:ENST00000369620:exon12:c.C1536T:p.T512T,ENSG00000160211:ENST00000393562:exon12:c.C1488T:p.T496T,ENSG00000160211:ENST00000393564:exon12:c.C1398T:p.T466T	G6PD:NM_000402:exon12:c.C1488T:p.T496T,G6PD:NM_001042351:exon12:c.C1398T:p.T466T,G6PD:NM_001360016:exon12:c.C1398T:p.T466T	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0014	.	0.0010596	.	.	.	.	.	.	.	.	.	G6PD:uc004flx.1:exon12:c.C1488T:p.T496T,G6PD:uc004fly.1:exon12:c.C1398T:p.T466T	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	305900	134700;300908;611162;	673;466026;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~466026|Class I G6PD deficiency<br>Severe hemolytic anemia due to G6PD deficiency|-|X-linked recessive|-|300908 ~	~ko00030 Pentose phosphate pathway~ko00480 Glutathione metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko05230 Central carbon metabolism in cancer~~M00004 Pentose phosphate pathway (Pentose phosphate cycle)~M00006 Pentose phosphate pathway, oxidative phase, glucose 6P =>~~M00008 Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P~ ~	.	.	.	.	.	.	.	X	.	hom
X	153994596	153994596	G	T	DKC1	exonic	synonymous SNV	ENSG00000130826	rs2728532	ENSG00000130826:ENST00000452771:exon4:c.G327T:p.T109T,ENSG00000130826:ENST00000369550:exon5:c.G369T:p.T123T,ENSG00000130826:ENST00000413910:exon5:c.G369T:p.T123T	DKC1:NM_001142463:exon5:c.G369T:p.T123T,DKC1:NM_001288747:exon5:c.G369T:p.T123T,DKC1:NM_001363:exon5:c.G369T:p.T123T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9974	0.9919	0.992583	0.9937	.	.	.	.	.	.	.	.	DKC1:uc004fmm.3:exon5:c.G369T:p.T123T,DKC1:uc010nvf.3:exon5:c.G369T:p.T123T	.	AFR:0.9777,AMR:0.9935,EAS:1,FIN:1,NFE:1,OTH:0.9986,ASJ:1	300126	305000;	1775;3322;	1775|DC<br>DKC<br>Zinsser-Engman-Cole syndrome|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|127550 224230 305000 613987 613988 613989 613990 615190 616353 ~3322|Progressive pancytopenia-immunodeficiency-cerebellar hypoplasia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|305000 613989 613990 615190 616353 616553 ~	.	.	.	.	.	.	.	.	X	MU82060809	hom
X	154020114	154020114	C	A	MPP1	exonic	synonymous SNV	ENSG00000130830	rs1126762	ENSG00000130830:ENST00000369531:exon3:c.G204T:p.T68T,ENSG00000130830:ENST00000369534:exon3:c.G255T:p.T85T,ENSG00000130830:ENST00000393529:exon3:c.G117T:p.T39T,ENSG00000130830:ENST00000393531:exon3:c.G255T:p.T85T,ENSG00000130830:ENST00000413259:exon4:c.G165T:p.T55T	MPP1:NM_001166460:exon3:c.G204T:p.T68T,MPP1:NM_001166461:exon3:c.G255T:p.T85T,MPP1:NM_002436:exon3:c.G255T:p.T85T,MPP1:NM_001166462:exon4:c.G165T:p.T55T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6400	0.5528	0.544106	0.5864	.	.	.	.	.	.	.	.	MPP1:uc004fmp.2:exon3:c.G255T:p.T85T,MPP1:uc010nvg.2:exon3:c.G255T:p.T85T,MPP1:uc011mzw.2:exon3:c.G204T:p.T68T,MPP1:uc011mzv.2:exon4:c.G165T:p.T55T	.	AFR:0.2496,AMR:0.5728,EAS:0.7547,FIN:0.7600,NFE:0.7057,OTH:0.7155,ASJ:0.6441	305360	.	.	.	.	.	.	.	.	.	.	.	X	MU13868845	hom
X	154124483	154124483	T	C	F8	exonic	nonsynonymous SNV	ENSG00000185010	.	ENSG00000185010:ENST00000360256:exon22:c.A6298G:p.I2100V	F8:NM_000132:exon22:c.A6298G:p.I2100V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	.	.	.	.	1.118	11.31	0.25	3.15	0.974	.	.	Coagulation factor 5/8 C-terminal domain|Galactose-binding domain-like	F8:uc010nvi.1:exon5:c.A500G:p.Y167C,F8:uc004fmt.3:exon22:c.A6298G:p.I2100V	0.682	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300841	306700;	98878;	98878|Factor VIII deficiency|1-9 / 100 000|X-linked recessive|Infancy<br>Neonatal|306700 ~	.	.	.	.	0.009	-5.26	0.843	0.515	X	.	hom
X	154133316	154133316	-	A	F8	intronic	.	ENSG00000185010	rs782172618	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0654	0.1184	.	0.0169	.	.	.	.	.	.	.	.	.	.	AFR:0.0044,AMR:0.0152,EAS:0,FIN:0.0664,NFE:0.0233,OTH:0.0169,ASJ:0.0244	300841	306700;	98878;	98878|Factor VIII deficiency|1-9 / 100 000|X-linked recessive|Infancy<br>Neonatal|306700 ~	.	.	.	.	.	.	.	.	X	MU112692411	het
